Citrus Sinensis ID: 045271
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 338 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.931 | 0.371 | 0.536 | 9e-99 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.896 | 0.355 | 0.552 | 4e-94 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.931 | 0.378 | 0.5 | 1e-91 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.866 | 0.437 | 0.510 | 4e-91 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.902 | 0.360 | 0.502 | 1e-90 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.899 | 0.373 | 0.532 | 2e-90 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.934 | 0.373 | 0.512 | 4e-90 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.905 | 0.363 | 0.505 | 2e-89 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.857 | 0.344 | 0.531 | 3e-89 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.958 | 0.395 | 0.489 | 9e-89 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 360 bits (924), Expect = 9e-99, Method: Compositional matrix adjust.
Identities = 189/352 (53%), Positives = 234/352 (66%), Gaps = 37/352 (10%)
Query: 23 SYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKR 82
S I+ K V + ELP+F L+ I AT +F EN+LG GGFGPVYKGVL D +EIAVKR
Sbjct: 499 SVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKR 558
Query: 83 LSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDST 139
LS SGQG+ EFKN LIAKLQH+NLVRLLGCC EG E +L+ EYMPNKSLDF LFD T
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 140 RSVQLDWNRRMCIINGIAR-------------------------DHKMNPKISDFGMARV 174
+ +DW R II GIAR D +MNPKISDFGMAR+
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ 234
FGGNQ+EANT RVVGTYGYM+PEYA+EGLFSVKSDV+SFGVLLLEI+SG+++T E
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 235 GQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294
G SL+ Y W L+ G ++EL+DP ++ + E L+ IH+ +LCVQ+ A+RP M+SV+
Sbjct: 739 G-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLL 797
Query: 295 MLATDTITLLQPTQPAFSVGRVKS--------PSDLKVCSANEVTLSTLSPR 338
ML +DT TL P QP F+ R S S + S+NE+T + + R
Sbjct: 798 MLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 188/340 (55%), Positives = 234/340 (68%), Gaps = 37/340 (10%)
Query: 31 KKVESQ--ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG 88
K+ +SQ ++P F L+ I AT NFSN NKLG+GGFGPVYKG+ D+EIAVKRLSR SG
Sbjct: 508 KQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSG 567
Query: 89 QGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLD 145
QGL+EFKN LIAKLQH+NLVRLLG C+ G E LL+ EYMP+KSLDF +FD +LD
Sbjct: 568 QGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLD 627
Query: 146 WNRRMCIINGIAR-------------------------DHKMNPKISDFGMARVFGGNQS 180
W R II GIAR D +MNPKISDFG+AR+FGG+++
Sbjct: 628 WKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSET 687
Query: 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLT 240
ANTNRVVGTYGYM+PEYALEGLFS KSDVFSFGV+++E ISG+++T F+ E+ SLL
Sbjct: 688 SANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLG 747
Query: 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML-ATD 299
+ W LW EL+D L+ES E LK +++GLLCVQEDP DRPTMS+VVFML +++
Sbjct: 748 HAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSE 807
Query: 300 TITLLQPTQPAFSVGRV------KSPSDLKVCSANEVTLS 333
TL P QPAF + R S + + CS NE+T++
Sbjct: 808 AATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTIT 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 179/358 (50%), Positives = 238/358 (66%), Gaps = 43/358 (12%)
Query: 17 DDDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDK 76
D DE + + + K ++ELPLF L+ I AT NFS++NKLG GGFGPVYKGVL +
Sbjct: 483 DFDESFRFE----QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRM 538
Query: 77 EIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDF 133
EIAVKRLSR+SGQG++EFKN LI+KLQH+NLVR+LGCC+E E +L+ EY+PNKSLD+
Sbjct: 539 EIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDY 598
Query: 134 LLFDSTRSVQLDWNRRMCIINGIAR-------------------------DHKMNPKISD 168
+F + +LDW +RM I+ GIAR D +M PKISD
Sbjct: 599 FIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISD 658
Query: 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTR 228
FGMAR+FGGNQ E T+RVVGT+GYMAPEYA+EG FS+KSDV+SFGVL+LEII+G+K++
Sbjct: 659 FGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA 718
Query: 229 FYLYEQGQSLLTYTWKLWCEGNAQELMDPVL-KESFILEELLKRIHIGLLCVQEDPADRP 287
F +E+ +L+ + W LW G A E++D ++ +E++ E++K I IGLLCVQE+ +DR
Sbjct: 719 F--HEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRV 776
Query: 288 TMSSVVFMLATDTITLLQPTQPAFSVGRVKSPSDLKVC-------SANEVTLSTLSPR 338
MSSVV ML + L P PAF+ R + + C S N+VT S + R
Sbjct: 777 DMSSVVIMLGHNATNLPNPKHPAFTSARRRGGEN-GACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 4e-91, Method: Compositional matrix adjust.
Identities = 168/329 (51%), Positives = 222/329 (67%), Gaps = 36/329 (10%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQ 102
I AT +F NK+G+GGFG VYKG L+D E+AVKRLS+SSGQG EFKN L+AKLQ
Sbjct: 341 IQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQ 400
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---- 158
H+NLVRLLG CL+G E +L+ EY+PNKSLD+ LFD + QLDW RR II G+AR
Sbjct: 401 HRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILY 460
Query: 159 ---------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197
D MNPKI+DFGMAR+FG +Q+E NT+R+VGTYGYM+PE
Sbjct: 461 LHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPE 520
Query: 198 YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
YA+ G +S+KSDV+SFGVL+LEIISG+K++ FY + L++Y W LW G EL+DP
Sbjct: 521 YAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDP 580
Query: 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPA-FSVGRV 316
+ E+ E+++ +HIGLLCVQEDPA+RPT+S++V ML ++T+TL P QP F R+
Sbjct: 581 AIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRI 640
Query: 317 -KSPSDLKVC------SANEVTLSTLSPR 338
K P D S ++ +++ + PR
Sbjct: 641 GKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 174/346 (50%), Positives = 236/346 (68%), Gaps = 41/346 (11%)
Query: 32 KVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGL 91
K S+ELPLF L I AT NF+ +NKLG GGFGPVYKGVL + EIAVKRLS+SSGQG+
Sbjct: 502 KSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGM 561
Query: 92 QEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR 148
+EFKN LI+KLQH+NLVR+LGCC+E E +L+ EY+PNKSLD+ +F + +LDW +
Sbjct: 562 EEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPK 621
Query: 149 RMC-------------------IIN------GIARDHKMNPKISDFGMARVFGGNQSEAN 183
RM II+ + D++M PKI+DFG+AR+FGGNQ E +
Sbjct: 622 RMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGS 681
Query: 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW 243
TNRVVGTYGYM+PEYA++G FS+KSDV+SFGVL+LEII+G++++ F YE+ +L+ + W
Sbjct: 682 TNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF--YEESLNLVKHIW 739
Query: 244 KLWCEGNAQELMDPVL-KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302
W G A E++D ++ +E++ E++K +HIGLLCVQE+ +DRP MSSVVFML + I
Sbjct: 740 DRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAID 799
Query: 303 LLQPTQPAFSVGRVKS----------PSDLKVCSANEVTLSTLSPR 338
L P PAF+ GR ++ PS + N+VTL+ + R
Sbjct: 800 LPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 179/336 (53%), Positives = 228/336 (67%), Gaps = 32/336 (9%)
Query: 34 ESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQE 93
E +LP+F I AT +FS N LG GGFGPVYKG L D +EIAVKRLS +SGQG++E
Sbjct: 481 EDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEE 540
Query: 94 FKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM 150
FKN LIAKLQH+NLVRLLGCC++G E +LI EYMPNKSLDF +FD RS +LDW +RM
Sbjct: 541 FKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRM 600
Query: 151 CIINGIAR-------------------------DHKMNPKISDFGMARVFGGNQSEANTN 185
IING+AR D+ MNPKISDFG+A+ FGG+QSE++TN
Sbjct: 601 NIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTN 660
Query: 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245
RVVGTYGYM PEYA++G FSVKSDVFSFGVL+LEII+G+ + F + +LL + WK+
Sbjct: 661 RVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKM 720
Query: 246 WCEGNA-QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304
W E + + L+E+ ++ E+L+ IH+ LLCVQ+ P DRPTM+SVV M +D+ +L
Sbjct: 721 WVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLP 779
Query: 305 QPTQPAFSVGR--VKSPSDLKVCSANEVTLSTLSPR 338
PTQP F R S L + S NEV+++ L R
Sbjct: 780 HPTQPGFFTNRNVPDISSSLSLRSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 182/355 (51%), Positives = 223/355 (62%), Gaps = 39/355 (10%)
Query: 23 SYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKR 82
S S + K + ELPL + AT NFS +NKLG+GGFG VYKG+L D KEIAVKR
Sbjct: 493 SRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKR 552
Query: 83 LSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDST 139
LS+ S QG EF N LIAKLQH NLVRLLGCC++ E +LI EY+ N SLD LFD T
Sbjct: 553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612
Query: 140 RSVQLDWNRRMCIINGIAR-------------------------DHKMNPKISDFGMARV 174
RS L+W +R IINGIAR D M PKISDFGMAR+
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672
Query: 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ 234
FG ++EANT RVVGTYGYM+PEYA++G+FS+KSDVFSFGVLLLEIISG+++ FY +
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
Query: 235 GQSLLTYTWKLWCEGNAQELMDPV----LKESFILEELLKRIHIGLLCVQEDPADRPTMS 290
+LL + W+ W EG E++DP+ L F E+L+ I IGLLCVQE DRP MS
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792
Query: 291 SVVFMLATDTITLLQPTQPAFSVGRVKSPSDLKV-------CSANEVTLSTLSPR 338
SV+ ML ++T + QP +P F VGR D C+ N+VTLS + R
Sbjct: 793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 172/340 (50%), Positives = 225/340 (66%), Gaps = 34/340 (10%)
Query: 32 KVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGL 91
+V++ +LP+F D + AT +F+ ENKLG+GGFG VYKG ++ +EIAVKRLS S QGL
Sbjct: 504 QVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGL 563
Query: 92 QEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR 148
+EFKN LIAKLQH+NLVRLLGCC+E NE +L+ EYMPNKSLD LFD ++ LDW +
Sbjct: 564 EEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRK 623
Query: 149 RMCIINGIAR-------------------------DHKMNPKISDFGMARVFGGNQSEAN 183
R +I GIAR D +MNPKISDFGMAR+F Q AN
Sbjct: 624 RWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHAN 683
Query: 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW 243
T RVVGTYGYMAPEYA+EG+FS KSDV+SFGVL+LEI+SGRK+ F + G SL+ Y W
Sbjct: 684 TIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAW 742
Query: 244 KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303
LW +G +E++DP++K++ + E ++ IH+G+LC Q+ RP M SV+ ML + T L
Sbjct: 743 HLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQL 802
Query: 304 LQPTQPAF----SVGRVKSPSD-LKVCSANEVTLSTLSPR 338
P QP F + G ++ D V S N+VT +T+ R
Sbjct: 803 PPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 175/329 (53%), Positives = 215/329 (65%), Gaps = 39/329 (11%)
Query: 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKN 105
AT NFSN+NKLG+GGFG VYKG L D KEIAVKRLS+ S QG EF N LIAKLQH N
Sbjct: 515 ATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHIN 574
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------- 158
LVRLLGCC++ E +LI EY+ N SLD LFD TRS L+W +R IINGIAR
Sbjct: 575 LVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQ 634
Query: 159 ------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
D M PKISDFGMAR+FG ++EANT RVVGTYGYM+PEYA+
Sbjct: 635 DSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAM 694
Query: 201 EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV-- 258
+G+FS+KSDVFSFGVLLLEIISG+++ FY + +LL + W+ W EGN E++DP+
Sbjct: 695 DGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINI 754
Query: 259 --LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGRV 316
L F E+L+ I IGLLCVQE DRP MSSV+ ML ++T + QP +P F +GR
Sbjct: 755 DSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRS 814
Query: 317 KSPSDLKV-------CSANEVTLSTLSPR 338
+D C+ N++TLS + R
Sbjct: 815 PLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (838), Expect = 9e-89, Method: Compositional matrix adjust.
Identities = 180/368 (48%), Positives = 232/368 (63%), Gaps = 44/368 (11%)
Query: 6 LRSREGRTGDDDDDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFG 65
++ R + G D + L G K + +ELPLF ++ AT NFS NKLG+GGFG
Sbjct: 462 MKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFG 521
Query: 66 PVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLI 122
PVYKG L + +EIAVKRLSR+SGQGL+E N +I+KLQH+NLV+LLGCC+ G E +L+
Sbjct: 522 PVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLV 581
Query: 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------------------ 158
E+MP KSLD+ LFDS R+ LDW R IINGI R
Sbjct: 582 YEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNIL 641
Query: 159 -DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLL 217
D + PKISDFG+AR+F GN+ EANT RVVGTYGYMAPEYA+ GLFS KSDVFS GV+L
Sbjct: 642 LDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVIL 701
Query: 218 LEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLL 277
LEIISGR+++ +LL Y W +W EG L+DP + + +E+ K IHIGLL
Sbjct: 702 LEIISGRRNS-------NSTLLAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLL 754
Query: 278 CVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGRVKSP-------SDLKVCSANEV 330
CVQE DRP++S+V ML+++ + +P QPAF + R P SDLK S N V
Sbjct: 755 CVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAF-ISRNNVPEAESSENSDLKD-SINNV 812
Query: 331 TLSTLSPR 338
T++ ++ R
Sbjct: 813 TITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 338 | ||||||
| 224113927 | 381 | predicted protein [Populus trichocarpa] | 0.914 | 0.811 | 0.656 | 1e-123 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.937 | 0.475 | 0.608 | 1e-117 | |
| 255555021 | 686 | ATP binding protein, putative [Ricinus c | 0.952 | 0.469 | 0.600 | 1e-116 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.949 | 0.393 | 0.596 | 1e-113 | |
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.949 | 0.479 | 0.596 | 1e-113 | |
| 356510387 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.914 | 0.477 | 0.590 | 1e-109 | |
| 225462833 | 399 | PREDICTED: G-type lectin S-receptor-like | 0.937 | 0.794 | 0.577 | 1e-108 | |
| 356554939 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.890 | 0.454 | 0.592 | 1e-105 | |
| 356546303 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.893 | 0.456 | 0.588 | 1e-105 | |
| 356554943 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.893 | 0.450 | 0.588 | 1e-105 |
| >gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-123, Method: Compositional matrix adjust.
Identities = 224/341 (65%), Positives = 268/341 (78%), Gaps = 32/341 (9%)
Query: 30 KKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQ 89
+++V+SQ+LPL LD+I+EAT+ FS+ENKLG+GGFGPVY+G L D KE+AVKRLSR+SGQ
Sbjct: 41 EREVKSQDLPLIRLDVINEATKQFSDENKLGQGGFGPVYRGTLEDGKEVAVKRLSRTSGQ 100
Query: 90 GLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW 146
G +EF N LIA+LQH+NLVRLLGCCLE NE LLI EYMPNKSLD +LF S+ V LDW
Sbjct: 101 GQREFLNEVVLIARLQHRNLVRLLGCCLEKNEKLLIYEYMPNKSLDVILFGSSNGVLLDW 160
Query: 147 NRRMCIINGIAR-------------------------DHKMNPKISDFGMARVFGGNQSE 181
RR+ IINGIAR D++MNPKISDFGMAR+FGGNQSE
Sbjct: 161 QRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDYEMNPKISDFGMARIFGGNQSE 220
Query: 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241
ANTNR+VGTYGYMAPEYA+ GLFSVKSDVFSFGVLLLEIISG K+ F+L E+G+SLLT+
Sbjct: 221 ANTNRIVGTYGYMAPEYAMVGLFSVKSDVFSFGVLLLEIISGEKNVGFHLSEEGESLLTF 280
Query: 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301
WKLW +G ELMDP+L++S + E+L+ IHIGLLCVQEDPADRPTMSSV+ MLA+DTI
Sbjct: 281 AWKLWSDGQGLELMDPMLEKSGVATEVLRCIHIGLLCVQEDPADRPTMSSVLHMLASDTI 340
Query: 302 TLLQPTQPAFSVGRVKS----PSDLKVCSANEVTLSTLSPR 338
TL P QPAFS+GR + S+ KVCS+NE+T+S LSPR
Sbjct: 341 TLPIPKQPAFSIGRFVAMEGQSSNQKVCSSNELTISVLSPR 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 219/360 (60%), Positives = 265/360 (73%), Gaps = 43/360 (11%)
Query: 22 YSYSILRGKKK-----------VESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKG 70
++Y++ R KK+ V+SQ+ L LD++ +AT +SNENKLG+GGFGPVYKG
Sbjct: 307 FAYTMWRRKKRDDCSNEIMYGEVKSQDSFLIQLDIVLKATNQYSNENKLGQGGFGPVYKG 366
Query: 71 VLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127
V+ D KEIAVKRLSR+SGQGL+EF N LIA+LQH+NLV+LLGCCLE NE LL+ EYMP
Sbjct: 367 VMEDGKEIAVKRLSRTSGQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEYMP 426
Query: 128 NKSLDFLLFDSTRSVQLDWNRRMCIINGIAR-------------------------DHKM 162
NKSLD LFDS VQLDW RR+ IINGIAR D++M
Sbjct: 427 NKSLDVFLFDSAMRVQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEM 486
Query: 163 NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
NPKISDFGMAR+FGGN SEANTNR+VGTYGYMAPEYA+EGL SVKSDVFSFGVL+LEIIS
Sbjct: 487 NPKISDFGMARIFGGNHSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIIS 546
Query: 223 GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQED 282
G+++ F+L E+G+SLL +TWKLW EG ELMD +L++S + E+LK IHIGLLCVQED
Sbjct: 547 GKRNGGFHLSEEGKSLLNFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQED 606
Query: 283 PADRPTMSSVVFMLATDTITLLQPTQPAFSVGRV----KSPSDLKVCSANEVTLSTLSPR 338
P DRPTMSSVV MLA D + PT+PAFSVGR+ + S+ +V S N+VTLS + PR
Sbjct: 607 PVDRPTMSSVVVMLAGDNFKIPIPTKPAFSVGRIVAEETTSSNQRVSSVNKVTLSNVLPR 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1088), Expect = e-116, Method: Compositional matrix adjust.
Identities = 218/363 (60%), Positives = 266/363 (73%), Gaps = 41/363 (11%)
Query: 9 REGRTGDDDDDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVY 68
+EGRT D+ YS ++++Q+ P+ P D+I EAT +FS++ KLGEGGFGPVY
Sbjct: 332 KEGRTRDE-------YSCENITGEMDAQDFPMIPFDIIEEATEHFSDDAKLGEGGFGPVY 384
Query: 69 KGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEY 125
KG L D KEIAVKRLSR+SGQGL EF N LI KLQH+NLVRLLGCCLE +E LLI EY
Sbjct: 385 KGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLIFKLQHRNLVRLLGCCLEKSEKLLIYEY 444
Query: 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR-------------------------DH 160
MPNKSLD LFDS V+LDW RR+ II+GIAR D+
Sbjct: 445 MPNKSLDVFLFDSHMGVRLDWQRRLSIISGIARGLLYLHEDSRLRIIHRDLKASNILLDY 504
Query: 161 KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEI 220
MNPKISDFGMAR+FGGN S++ TNR+VGTYGYM+PEYA+EGLFS+KSD+FSFGVLLLEI
Sbjct: 505 DMNPKISDFGMARIFGGNDSKS-TNRIVGTYGYMSPEYAMEGLFSMKSDIFSFGVLLLEI 563
Query: 221 ISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQ 280
ISGR++ RFY+ E+G+SLLT+ WKLW + EL+DP + S + E+LK +HIGLLCVQ
Sbjct: 564 ISGRRNNRFYVEEEGESLLTFAWKLWNKDQGLELLDPAVVNSSVAIEVLKCVHIGLLCVQ 623
Query: 281 EDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGR-----VKSPSDLKVCSANEVTLSTL 335
+DPA+RPTMSSVV MLA+DTITL QP +PAFS+G+ S S+ KV S N+VTLS +
Sbjct: 624 DDPAERPTMSSVVVMLASDTITLPQPRKPAFSIGQFVARSATSSSNPKVSSVNQVTLSNV 683
Query: 336 SPR 338
SPR
Sbjct: 684 SPR 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1065), Expect = e-113, Method: Compositional matrix adjust.
Identities = 210/352 (59%), Positives = 256/352 (72%), Gaps = 31/352 (8%)
Query: 18 DDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKE 77
D E YS L+G +S+E P+ D+++EAT++FSN+NKLGEGGFGPVYKG L+D KE
Sbjct: 464 DAEDYSSETLQGDMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKE 523
Query: 78 IAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFL 134
IAVKRLSR+SGQGLQEFKN LIAKLQH+NLVRLLGCCLEGNELLLI EYMPNKSLDF
Sbjct: 524 IAVKRLSRTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFF 583
Query: 135 LFDSTRSVQLDWNRRMCIINGIAR-------------------------DHKMNPKISDF 169
LFDSTR ++LDW R IINGIAR D MNPKISDF
Sbjct: 584 LFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDF 643
Query: 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229
G+AR+F G+++ NT ++VG+YGYMAPEYA+EGL+S KSDVFSFGV+LLEII+GRK+ F
Sbjct: 644 GLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGF 703
Query: 230 YLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTM 289
+L G SLL+Y W+LW EG ELMDP+L +S +E L+ HIGLLCVQED DRPTM
Sbjct: 704 HLSGMGLSLLSYAWQLWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPTM 763
Query: 290 SSVVFMLATDTITLLQPTQPAFSVGRVKSPSDL---KVCSANEVTLSTLSPR 338
SSV+ ML +++++L QP +PAFSVGR + ++ S N +T ST PR
Sbjct: 764 SSVIIMLRSESLSLRQPERPAFSVGRFANNQEIASGSSSSVNGLTASTAVPR 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-113, Method: Compositional matrix adjust.
Identities = 210/352 (59%), Positives = 255/352 (72%), Gaps = 31/352 (8%)
Query: 18 DDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKE 77
D E YS L+G +S+E P+ D+++EAT++FSN+NKLGEGGFGPVYKG L+D KE
Sbjct: 319 DAEDYSSETLQGDMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKE 378
Query: 78 IAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFL 134
IAVKRLS +SGQGLQEFKN LIAKLQH+NLVRLLGCCLEGNELLLI EYMPNKSLDF
Sbjct: 379 IAVKRLSSTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFF 438
Query: 135 LFDSTRSVQLDWNRRMCIINGIAR-------------------------DHKMNPKISDF 169
LFDSTR ++LDW R IINGIAR D MNPKISDF
Sbjct: 439 LFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDF 498
Query: 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229
G+AR+F G+++ NT ++VG+YGYMAPEYA+EGL+S KSDVFSFGV+LLEII+GRK+ F
Sbjct: 499 GLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGF 558
Query: 230 YLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTM 289
+L G SLL+Y W+LW EG ELMDP+L +S +E L+ HIGLLCVQED DRPTM
Sbjct: 559 HLSGMGLSLLSYAWQLWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPTM 618
Query: 290 SSVVFMLATDTITLLQPTQPAFSVGRVKSPSDL---KVCSANEVTLSTLSPR 338
SSV+ ML ++++TL QP +PAFSVGR + ++ S N +T ST PR
Sbjct: 619 SSVIIMLRSESLTLRQPERPAFSVGRFANNQEIASGSSSSVNGLTASTTVPR 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1031), Expect = e-109, Method: Compositional matrix adjust.
Identities = 202/342 (59%), Positives = 251/342 (73%), Gaps = 33/342 (9%)
Query: 30 KKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQ 89
K++ + +LP+ PL I ++T NFS+E+KLG+GGFGPVYKGVL D ++IAVKRLS++S Q
Sbjct: 306 KEESMNADLPMMPLSTILKSTNNFSDEHKLGKGGFGPVYKGVLPDGRQIAVKRLSKTSVQ 365
Query: 90 GLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW 146
G++EFKN LIAKLQH+NLVRLL CC+E NE LL+ E+MPN SLDF LFD + L+W
Sbjct: 366 GVEEFKNEVILIAKLQHRNLVRLLACCIEQNEKLLVYEFMPNSSLDFHLFDMEKGEHLEW 425
Query: 147 NRRMCIINGIAR-------------------------DHKMNPKISDFGMARVFGGNQSE 181
R+ IINGIA+ DH+MNPKISDFG+AR FGG+Q +
Sbjct: 426 KNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNILLDHEMNPKISDFGLARTFGGDQKQ 485
Query: 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241
ANT RVVGTYGYMAPEYA+EGLFSVKSDVFSFGVLLLEIISG++ ++FYL +QGQSLL Y
Sbjct: 486 ANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKRSSKFYLSDQGQSLLIY 545
Query: 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301
W LWCE ELMDP++++S + E+LK +HIGLLCVQED ADRP MSSVV MLA+DT+
Sbjct: 546 AWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGLLCVQEDAADRPKMSSVVHMLASDTV 605
Query: 302 TLLQPTQPAFSVGRVKSPSDLKV-----CSANEVTLSTLSPR 338
+L PT+PAFSVGR + + S NE T+S + PR
Sbjct: 606 SLSVPTRPAFSVGRAVTERECSSNTSMHYSVNEATVSEVIPR 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462833|ref|XP_002269514.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 201/348 (57%), Positives = 248/348 (71%), Gaps = 31/348 (8%)
Query: 22 YSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVK 81
Y L G +S++LPL L+LIH+AT++FS ENKLG+GG GPVY+G L D +EIAVK
Sbjct: 52 YPSENLHGDTLAKSKDLPLIGLELIHKATQHFSEENKLGQGGLGPVYRGTLADGREIAVK 111
Query: 82 RLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDS 138
RLSR+SGQGL+EFKN LIA+LQH+NLVRLLGCCLEGNE LLI EYMPNKSLD LFDS
Sbjct: 112 RLSRTSGQGLEEFKNEVTLIARLQHRNLVRLLGCCLEGNESLLIYEYMPNKSLDVFLFDS 171
Query: 139 TRSVQLDWNRRMCIINGIAR-------------------------DHKMNPKISDFGMAR 173
T S QLDW R+ IINGIAR D MNPKISDFGMAR
Sbjct: 172 TTSAQLDWKTRLNIINGIARGISYLHEDSRLRIIHRDLKPSNVLLDSDMNPKISDFGMAR 231
Query: 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYE 233
+F G+++ NT R+VG+YGYMAPEYA+EGL+S+KSDV+SFGV+LLEII+GRK+ F+L
Sbjct: 232 IFAGSENGTNTARIVGSYGYMAPEYAMEGLYSIKSDVYSFGVVLLEIITGRKNAGFHLSG 291
Query: 234 QGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
G SLL++ W+ W EG ELMDP+L +S +E L+ HIGLLCVQED +DRPTMSSV+
Sbjct: 292 MGPSLLSHAWQSWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDASDRPTMSSVI 351
Query: 294 FMLATDTITLLQPTQPAFSVGRVKSPSDL---KVCSANEVTLSTLSPR 338
ML +++++L QP +PAFSVGR + + S N +T S PR
Sbjct: 352 VMLKSESVSLRQPERPAFSVGRSTNQHETASGSSSSVNGLTASIALPR 399
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 388 bits (997), Expect = e-105, Method: Compositional matrix adjust.
Identities = 199/336 (59%), Positives = 240/336 (71%), Gaps = 35/336 (10%)
Query: 37 ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN 96
+LP PL I ++T NFS +KLGEGG+GPVYKG+L D ++IAVKRLS++SGQG +EFKN
Sbjct: 328 DLPTIPLITIQQSTDNFSEASKLGEGGYGPVYKGILPDGRQIAVKRLSQASGQGSEEFKN 387
Query: 97 ---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
IAKLQH+NLVRLL CCLE NE +L+ EY+ N SL+F LFD + QLDW R+ II
Sbjct: 388 EVMFIAKLQHRNLVRLLACCLEENEKILVYEYLSNASLNFHLFDDEKKKQLDWKLRLSII 447
Query: 154 NGIAR-------------------------DHKMNPKISDFGMARVFGGNQSEANTNRVV 188
NGIAR DH MNPKISDFG+AR F Q +ANTNRV+
Sbjct: 448 NGIARGILYLHEDSRLRVIHRDLKASNVLLDHDMNPKISDFGLARAFSKGQKQANTNRVM 507
Query: 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248
GTYGYMAPEYA+EGLFSVKSDVFSFGVL+LEII G+K++ FYL E GQ LL Y WK+WC
Sbjct: 508 GTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEIICGKKNSGFYLSECGQGLLLYAWKIWCA 567
Query: 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQ 308
G EL+DPVL+ES I E++K IHIGLLCVQED ADRP MS+VV MLA+DT+ L +P +
Sbjct: 568 GKFLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPNMSTVVVMLASDTMVLPKPNR 627
Query: 309 PAFSVGRVK------SPSDLKVCSANEVTLSTLSPR 338
PAFSVGR+ S S K S N++T+S + PR
Sbjct: 628 PAFSVGRMALGDASTSKSSNKH-SINDITISNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 387 bits (995), Expect = e-105, Method: Compositional matrix adjust.
Identities = 197/335 (58%), Positives = 241/335 (71%), Gaps = 33/335 (9%)
Query: 37 ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN 96
+LP PL I ++T NFS +KLGEGGFGPVYKG L D ++IAVKRLS++SGQG +EFKN
Sbjct: 328 DLPTIPLITILKSTDNFSEASKLGEGGFGPVYKGTLPDGRQIAVKRLSQASGQGSEEFKN 387
Query: 97 ---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
IAKLQH NLVRLL CCLEG E +L+ EY+ N SLDF LFD + QLDWN R+ II
Sbjct: 388 EVMFIAKLQHCNLVRLLACCLEGKEKILVYEYLSNASLDFHLFDERKKRQLDWNLRLSII 447
Query: 154 NGIAR-------------------------DHKMNPKISDFGMARVFGGNQSEANTNRVV 188
NGIA+ D +MNPKISDFG+AR F Q++ANTNRV+
Sbjct: 448 NGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEKGQNQANTNRVM 507
Query: 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248
GTYGYM+PEYA+EGLFSVKSDVFS+GVL+LEII G+K++ FYL E GQSL Y WK+WC
Sbjct: 508 GTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQSLTLYAWKIWCA 567
Query: 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQ 308
G + ELMDPVL++S I E++K IHIGLLCVQED ADRPTMS+VV MLA+D ++L +P Q
Sbjct: 568 GKSLELMDPVLEKSCIESEVMKCIHIGLLCVQEDAADRPTMSTVVVMLASDKMSLPEPNQ 627
Query: 309 PAFSVGRV-----KSPSDLKVCSANEVTLSTLSPR 338
PAFSVGR+ + K S N+VT++ + PR
Sbjct: 628 PAFSVGRMTLEGASTSKSSKNLSINDVTVTNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554943|ref|XP_003545800.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 387 bits (993), Expect = e-105, Method: Compositional matrix adjust.
Identities = 197/335 (58%), Positives = 241/335 (71%), Gaps = 33/335 (9%)
Query: 37 ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN 96
+LP PL I ++T NFS +KLGEGG+GPVYKG+L D ++IAVKRLS++SGQG +EFKN
Sbjct: 336 DLPTIPLITILKSTDNFSEASKLGEGGYGPVYKGILPDGRQIAVKRLSQASGQGSEEFKN 395
Query: 97 ---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
IAKLQH+NLVRLL CCLEG+E +L+ EY+ N SLDF LFD + QLDWN R+ II
Sbjct: 396 EVMFIAKLQHRNLVRLLACCLEGHEKILVYEYLSNASLDFHLFDERKKRQLDWNLRLSII 455
Query: 154 NGIAR-------------------------DHKMNPKISDFGMARVFGGNQSEANTNRVV 188
NGIA+ D +MNPKISDFG+AR F Q++ANT RV+
Sbjct: 456 NGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARAFEKGQNQANTKRVM 515
Query: 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248
GTYGYM+PEYA+EGLFSVKSDVFS+GVL+LEII G+K++ FYL E GQSL Y WKLWC
Sbjct: 516 GTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSECGQSLTLYAWKLWCA 575
Query: 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQ 308
G EL+DPVL+ES I E++K IHIGLLCVQED ADRPTMS+VV MLA+D + L +P Q
Sbjct: 576 GKCLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPTMSTVVVMLASDKMPLPKPNQ 635
Query: 309 PAFSVGRV-----KSPSDLKVCSANEVTLSTLSPR 338
PAFSVGR+ + K S N+VT+S + PR
Sbjct: 636 PAFSVGRMTLEDASTSKSSKNLSINDVTVSNILPR 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 338 | ||||||
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.535 | 0.213 | 0.534 | 1.7e-83 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.547 | 0.219 | 0.505 | 1.3e-79 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.529 | 0.219 | 0.530 | 4.9e-79 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.511 | 0.258 | 0.537 | 6.6e-79 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.547 | 0.218 | 0.520 | 8.7e-78 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.497 | 0.248 | 0.558 | 2.5e-77 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.541 | 0.283 | 0.529 | 5.9e-76 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.544 | 0.234 | 0.507 | 6e-76 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.544 | 0.218 | 0.5 | 6e-76 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.479 | 0.242 | 0.548 | 1.2e-75 |
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 1.7e-83, Sum P(2) = 1.7e-83
Identities = 102/191 (53%), Positives = 136/191 (71%)
Query: 153 INGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFS 212
++ + D +MNPKISDFGMAR+FGGNQ+EANT RVVGTYGYM+PEYA+EGLFSVKSDV+S
Sbjct: 657 VSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYS 716
Query: 213 FGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRI 272
FGVLLLEI+SG+++T E G SL+ Y W L+ G ++EL+DP ++ + E L+ I
Sbjct: 717 FGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCI 775
Query: 273 HIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGRVKS--------PSDLKV 324
H+ +LCVQ+ A+RP M+SV+ ML +DT TL P QP F+ R S S +
Sbjct: 776 HVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYI 835
Query: 325 CSANEVTLSTL 335
S+NE+T ST+
Sbjct: 836 VSSNEIT-STV 845
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 1.3e-79, Sum P(2) = 1.3e-79
Identities = 99/196 (50%), Positives = 132/196 (67%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ + D M PKISDFGMAR+FG ++EANT RVVGTYGYM+PEYA++G+FS+KSDVFSF
Sbjct: 648 SNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSF 707
Query: 214 GVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV----LKESFILEELL 269
GVLLLEIISG+++ FY + +LL + W+ W EGN E++DP+ L F E+L
Sbjct: 708 GVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEIL 767
Query: 270 KRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGRVKSPSDLKV----- 324
+ I IGLLCVQE DRP MSSV+ ML ++T + QP +P F +GR +D
Sbjct: 768 RCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRD 827
Query: 325 --CSANEVTLSTLSPR 338
C+ N++TLS + R
Sbjct: 828 DECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 4.9e-79, Sum P(2) = 4.9e-79
Identities = 97/183 (53%), Positives = 131/183 (71%)
Query: 159 DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLL 218
D+ MNPKISDFG+A+ FGG+QSE++TNRVVGTYGYM PEYA++G FSVKSDVFSFGVL+L
Sbjct: 634 DNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVL 693
Query: 219 EIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV-LKESFILEELLKRIHIGLL 277
EII+G+ + F + +LL + WK+W E E+ + L+E+ ++ E+L+ IH+ LL
Sbjct: 694 EIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALL 753
Query: 278 CVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGR-VKS-PSDLKVCSANEVTLSTL 335
CVQ+ P DRPTM+SVV M +D+ +L PTQP F R V S L + S NEV+++ L
Sbjct: 754 CVQQKPEDRPTMASVVLMFGSDS-SLPHPTQPGFFTNRNVPDISSSLSLRSQNEVSITML 812
Query: 336 SPR 338
R
Sbjct: 813 QGR 815
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 6.6e-79, Sum P(2) = 6.6e-79
Identities = 94/175 (53%), Positives = 128/175 (73%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ I D MNPKI+DFGMAR+FG +Q+E NT+R+VGTYGYM+PEYA+ G +S+KSDV+SF
Sbjct: 477 SNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSF 536
Query: 214 GVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIH 273
GVL+LEIISG+K++ FY + L++Y W LW G EL+DP + E+ E+++ +H
Sbjct: 537 GVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVH 596
Query: 274 IGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPA-FSVGRV-KSPSDLKVCS 326
IGLLCVQEDPA+RPT+S++V ML ++T+TL P QP F R+ K P D S
Sbjct: 597 IGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTS 651
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 8.7e-78, Sum P(2) = 8.7e-78
Identities = 102/196 (52%), Positives = 133/196 (67%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ + D M PKISDFGMAR+FG ++EANT RVVGTYGYM+PEYA++G+FS+KSDVFSF
Sbjct: 652 SNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSF 711
Query: 214 GVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV----LKESFILEELL 269
GVLLLEIISG+++ FY + +LL + W+ W EG E++DP+ L F E+L
Sbjct: 712 GVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEIL 771
Query: 270 KRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGR----VKSPSDLK-- 323
+ I IGLLCVQE DRP MSSV+ ML ++T + QP +P F VGR V S S +
Sbjct: 772 RCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRD 831
Query: 324 -VCSANEVTLSTLSPR 338
C+ N+VTLS + R
Sbjct: 832 DECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 2.5e-77, Sum P(2) = 2.5e-77
Identities = 95/170 (55%), Positives = 128/170 (75%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ I D +NPKI+DFGMAR+FG +Q++ NT+R+VGTYGYMAPEYA+ G FS+KSDV+SF
Sbjct: 482 SNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSF 541
Query: 214 GVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIH 273
GVL+LEIISGRK++ F + Q LLT+TW+LW A +L+DP++ + E+++ IH
Sbjct: 542 GVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIH 601
Query: 274 IGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSV--GRVKSPSD 321
IGLLCVQEDPA RPT+S+V ML ++T+TL P QP F + VK P+D
Sbjct: 602 IGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFIQSSPVKDPTD 651
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 5.9e-76, Sum P(2) = 5.9e-76
Identities = 100/189 (52%), Positives = 131/189 (69%)
Query: 156 IARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGV 215
I D MNPKI+DFGMAR+FG +Q+EA T RVVGTYGYM+PEYA+ G FS+KSDV+SFGV
Sbjct: 457 ILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGV 516
Query: 216 LLLEIISGRKDTRFYLYEQGQ-SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHI 274
L+LEIISG K++ Y ++ +L+TYTW+LW G+ EL+DP +++ E+ + IHI
Sbjct: 517 LVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHI 576
Query: 275 GLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAF---SVGRVKSPS-DLKV-CSANE 329
LLCVQED DRPTMSS+V ML T I L +P P F S PS D CS +E
Sbjct: 577 ALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDE 636
Query: 330 VTLSTLSPR 338
+++ ++PR
Sbjct: 637 ASITRVTPR 645
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 6.0e-76, Sum P(2) = 6.0e-76
Identities = 97/191 (50%), Positives = 130/191 (68%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ + D MN KISDFG+AR GG+++EANT RVVGTYGYM+PEY ++G FS+KSDVFSF
Sbjct: 594 SNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSF 653
Query: 214 GVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI-LEELLKRI 272
GVL+LEI+SGR++ F E +LL + W+ + E A E++D + ES + E+L+ I
Sbjct: 654 GVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVI 713
Query: 273 HIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGRVKSPSD-----LKVCSA 327
HIGLLCVQ+DP DRP MS VV ML+++ + LL P QP F R SD L++ S
Sbjct: 714 HIGLLCVQQDPKDRPNMSVVVLMLSSEML-LLDPRQPGFFNERNLLFSDTVSINLEIPSN 772
Query: 328 NEVTLSTLSPR 338
N T+S + PR
Sbjct: 773 NFQTMSVIDPR 783
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 466 (169.1 bits), Expect = 6.0e-76, Sum P(2) = 6.0e-76
Identities = 95/190 (50%), Positives = 128/190 (67%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ I D +MNPKISDFGMAR+F Q ANT RVVGTYGYMAPEYA+EG+FS KSDV+SF
Sbjct: 654 SNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSF 713
Query: 214 GVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIH 273
GVL+LEI+SGRK+ F + G SL+ Y W LW +G +E++DP++K++ + E ++ IH
Sbjct: 714 GVLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIH 772
Query: 274 IGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAF----SVGRVKSPSD-LKVCSAN 328
+G+LC Q+ RP M SV+ ML + T L P QP F + G ++ D V S N
Sbjct: 773 VGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVN 832
Query: 329 EVTLSTLSPR 338
+VT +T+ R
Sbjct: 833 DVTFTTIVGR 842
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 478 (173.3 bits), Expect = 1.2e-75, Sum P(2) = 1.2e-75
Identities = 90/164 (54%), Positives = 122/164 (74%)
Query: 154 NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
+ I D MNPKI+DFGMAR+FG +QS+ANT R+ GT+GYM+PEYA+ G FS+KSDV+SF
Sbjct: 474 SNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSF 533
Query: 214 GVLLLEIISGRKDTRFY-LYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRI 272
GVL+LEIISG+K++ FY + + G +L+T+ W+LW G+ EL+DP + ES+ E + I
Sbjct: 534 GVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCI 593
Query: 273 HIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSV-GR 315
HI LLCVQEDPADRP + +++ ML + T TL P P F + GR
Sbjct: 594 HIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGR 637
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_XI1869 | hypothetical protein (382 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 338 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.003 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.003 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.004 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.004 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.004 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.004 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 88/285 (30%), Positives = 116/285 (40%), Gaps = 67/285 (23%)
Query: 57 NKLGEGGFGPVYKGVLND----DKEIAVKRLSRS-SGQGLQEFKNLIA---KLQHKNLVR 108
KLGEG FG VYKG L E+AVK L S + ++F KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 109 LLGCCLEGNELLLICEYMPNKSL-DFL-----LFDSTRSVQLDWNRRMCIINGIAR---- 158
LLG C E L L+ EYM L D+L +F S L + IA+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 159 ------------------DHKMNPKISDFGMAR-VFGGNQSEANTNRVVGTYGYMAPEYA 199
+ KISDFG++R V+ + T + +MAPE
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESL 179
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS-------GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252
+G+F+ KSDV+SFGVLL EI + G + + L +G
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-----EYLR--------KGYRL 226
Query: 253 ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297
+ E L EL+ C Q DP DRPT S +V L
Sbjct: 227 PKPEYCPDE---LYELMLS------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 88/277 (31%), Positives = 115/277 (41%), Gaps = 62/277 (22%)
Query: 58 KLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSG-QGLQEFKN---LIAKLQHKNLVR 108
KLGEG FG VYKG L D E +AVK L + + +EF ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA--------- 157
LLG C +G L ++ EYMP L L + L +M I G+
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 158 RD---------HKMNPKISDFGMAR-VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
RD + KISDFG++R ++ + + +MAPE +G F+ K
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKFTSK 184
Query: 208 SDVFSFGVLLLEIIS-------GRKDTRFYLY-EQGQSLLTYTWKLWCEGNAQELMDPVL 259
SDV+SFGVLL EI + G + E G L C ELM
Sbjct: 185 SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP---ENCPDELYELM---- 237
Query: 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L C DP DRPT S +V L
Sbjct: 238 ----------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-37
Identities = 93/285 (32%), Positives = 130/285 (45%), Gaps = 70/285 (24%)
Query: 54 SNENKLGEGGFGPVYKGVLNDDK-----EIAVKRL-SRSSGQGLQEFKN---LIAKLQHK 104
+ KLGEG FG VYKG L E+AVK L +S Q ++EF ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------ 157
N+V+LLG C E L+++ EYMP L D+L R +L + + IA
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYL 119
Query: 158 -------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEY 198
RD + KISDFG++R + + + +V G +MAPE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
EG F+ KSDV+SFGVLL EI + G+ + + E++
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEI-----------FTLGEEP-------YPGMSNAEVL-EY 216
Query: 259 LKESFILE-------ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
LK+ + L EL K + L C EDP DRPT S +V +L
Sbjct: 217 LKKGYRLPKPPNCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 88/285 (30%), Positives = 124/285 (43%), Gaps = 71/285 (24%)
Query: 54 SNENKLGEGGFGPVYKGVLND-----DKEIAVKRL-SRSSGQGLQEFKN---LIAKLQHK 104
+ KLGEG FG VYKG L E+AVK L +S Q ++EF ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIAR----- 158
N+V+LLG C E L ++ EYM L +L +L + + IAR
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYL 118
Query: 159 -----------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEY 198
+ KISDFG++R + + + R G +MAPE
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
EG F+ KSDV+SFGVLL EI + G+ + + + +E++
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI-----------FTLGE-------QPYPGMSNEEVL-EY 215
Query: 259 LKESFILE-------ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
LK + L EL + L C EDP DRPT S +V +L
Sbjct: 216 LKNGYRLPQPPNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 73/276 (26%), Positives = 105/276 (38%), Gaps = 66/276 (23%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLL 110
KLG G FG VYK K +AVK L + S +E + L +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRIL-RRLSHPNIVRLI 64
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------ 158
+ + L L+ EY L L L + I I R
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSNGIIH 121
Query: 159 ----------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVK 207
D KI+DFG+A+ + S T VGT YMAPE L G + K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPK 179
Query: 208 SDVFSFGVLLLEIISGR-------KDTRFYLYEQGQS-LLTYTWKLWCEGN--AQELMDP 257
DV+S GV+L E+++G+ + L + L + W G+ A++L+
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK- 238
Query: 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
L DP+ RPT ++
Sbjct: 239 -----------------KCLNK--DPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 42/261 (16%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF----KNLIAKLQHKNLV 107
+ KLGEG FG VY ++ A+K + + + +E ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA-------- 157
RL + ++L L+ EY L LL + D R I++ +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 158 -RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
RD + K++DFG+AR + VGT YMAPE L +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 208 SDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267
D++S GV+L E+++G+ + G L +K + P S ++
Sbjct: 177 VDIWSLGVILYELLTGK-----PPF-PGDDQLLELFKKIGKPKP-PFPPPEWDISPEAKD 229
Query: 268 LLKRIHIGLLCVQEDPADRPT 288
L+++ LL DP R T
Sbjct: 230 LIRK----LLVK--DPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 62/190 (32%), Positives = 94/190 (49%), Gaps = 31/190 (16%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRLLGC 112
LGEGGFG VY K++A+K + + L+E + L KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEIL-KKLNHPNIVKLYGV 59
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---------RD-- 159
+ N L L+ EY SL LL ++ + D R+ I+ G+ RD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 160 --------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGLFSVKSDV 210
K++DFG++++ ++S T +VGT YMAPE L +G +S KSD+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 211 FSFGVLLLEI 220
+S GV+L E+
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 47/262 (17%)
Query: 57 NKLGEGGFGPVYKGVLNDD-KEIAVK--RLSRSSGQGLQEFKNLIA---KLQHKNLVRLL 110
LG G FG VY + D + +AVK LS S + L+ + I LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 111 GCCL--EGNELLLICEYMPNKSLDFLL--FDS---------TRSV--QLDWNRRMCIING 155
G E N L + EY+ SL LL F TR + L + I++
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 156 ------IARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
I D K++DFG A+ G ++ T V GT +MAPE + +D
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185
Query: 210 VFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL---MDPVLKESFILE 266
++S G ++E+ +G+ + + L +K+ G E+ + K+ F+
Sbjct: 186 IWSLGCTVIEMATGKPP--WSELGNPMAAL---YKIGSSGEPPEIPEHLSEEAKD-FL-- 237
Query: 267 ELLKRIHIGLLCVQEDPADRPT 288
C++ DP RPT
Sbjct: 238 ---------RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 68/197 (34%), Positives = 95/197 (48%), Gaps = 33/197 (16%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRL---SRSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
E KLG G FG V+ G N ++AVK L + S LQE ++ KL+H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQE-AQIMKKLRHDKLVQLYAV 69
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN------ 163
C E + ++ EYM SL DFL + ++L M I G+A N
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129
Query: 164 ------------PKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVKS 208
KI+DFG+AR+ ++ A G + APE A G F++KS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKS 185
Query: 209 DVFSFGVLLLEIIS-GR 224
DV+SFG+LL EI++ GR
Sbjct: 186 DVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 78/268 (29%), Positives = 121/268 (45%), Gaps = 51/268 (19%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRL---SRSSGQGLQEFKNLIAKLQHKNLVRLLGCCL 114
KLG G FG V++G+ N+ +AVK L + L E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAE-AQIMKKLRHPKLIQLYAVCT 71
Query: 115 EGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN-------- 163
+ ++ E M SL ++L + R+++L M + +G+A N
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA 131
Query: 164 ----------PKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVKSDV 210
K++DFG+ARV + EA G + APE AL FS+KSDV
Sbjct: 132 RNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 211 FSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWC-EGNAQELMDPVLKESFILEEL 268
+SFG+LL EI++ GR + + +++ C G +EL D
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD------------ 235
Query: 269 LKRIHIGLLCVQEDPADRPTMSSVVFML 296
I L C +EDP DRPT ++ + L
Sbjct: 236 -----IMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-23
Identities = 69/195 (35%), Positives = 93/195 (47%), Gaps = 40/195 (20%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEF---KNLIAKLQHKNLVRLLGCCLE 115
+G+G FG V G K +AVK L S Q F +++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 116 GNELLLICEYMPNKSLDFLLFDSTRSV-----QLDWNRRMCIINGIA---------RD-- 159
GN L ++ EYM SL L R+V QL + +C G+ RD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC--EGMEYLEEKNFVHRDLA 129
Query: 160 -------HKMNPKISDFGMARVFGGNQSEANTNRVVGTY--GYMAPEYALEGLFSVKSDV 210
+ K+SDFG+A+ EA+ + G + APE E FS KSDV
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 211 FSFGVLLLEIIS-GR 224
+SFG+LL EI S GR
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 66/265 (24%), Positives = 115/265 (43%), Gaps = 51/265 (19%)
Query: 53 FSNENKLGEGGFGPVYKG-VLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVR 108
F K+G+GGFG VYK KE+A+K + S + ++ N ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING---------IA 157
G L+ +EL ++ E+ SL LL + +++ +C ++ G I
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 158 RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
RD K + K+ DFG++ N +VGT +MAPE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 209 DVFSFGVLLLEIISG----RKDTRF-YLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
D++S G+ +E+ G + L++ + L +P K S
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATN------------GPPGLRNPE-KWSD 225
Query: 264 ILEELLKRIHIGLLCVQEDPADRPT 288
++ LK+ C+Q++P RPT
Sbjct: 226 EFKDFLKK------CLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 59/293 (20%)
Query: 51 RNFSNENKLGEGGFGPVYKGVL--NDDK---EIAVKRLSRSSG-QGLQEFKNLIA---KL 101
R+ +LGEG FG V D ++AVK L+ S Q +F+ I L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 102 QHKNLVRLLGCCLE--GNELLLICEYMPNKSL-DFLLFDSTR---SVQLDWNRRMCIING 155
H+N+V+ G C + G L LI EY+P+ SL D+L + L ++ ++C G
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC--KG 121
Query: 156 I--------------AR----DHKMNPKISDFGMARVFGGNQSE----ANTNRVVGTYGY 193
+ AR + + KISDFG+A+V + + + Y
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY 179
Query: 194 MAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKD-------TRFYLYEQGQSLLTYTWKL 245
APE FS SDV+SFGV L E+ + G R QGQ ++T +L
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298
EG + L P + + LC + +P DRP+ + ++ ++
Sbjct: 239 LKEG--ERLPRPPSCPDEVY-------DLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 26/194 (13%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI---AKLQHKNLVRL 109
F+ E KLG G FG V++G+ + +A+K L Q+F+ + +L+HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-----LDWNRR----MCII---NGIA 157
C G + +I E M SL L V +D + M + N I
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 158 RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
RD + K++DFG+AR+ + ++ ++ Y + APE A G FS KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 209 DVFSFGVLLLEIIS 222
DV+SFG+LL E+ +
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-21
Identities = 70/188 (37%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGCCLE 115
KLG G FG V+ G N+ ++AVK L S Q E NL+ LQH LVRL +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 116 GNELLLICEYMPNKSL-DFLLFDSTRSVQL----DWNRR----MCII---NGIARDHK-- 161
+ +I EYM SL DFL D V L D++ + M I N I RD +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 132
Query: 162 -------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFG 214
+ KI+DFG+ARV N+ A + APE G F++KSDV+SFG
Sbjct: 133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 215 VLLLEIIS 222
+LL EI++
Sbjct: 192 ILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 70/196 (35%), Positives = 95/196 (48%), Gaps = 32/196 (16%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRL---SRSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
KLG G FG V+ G N ++A+K L S S L E NL+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAE-ANLMKQLQHPRLVRLYAV 69
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRR----------MCII---NGIAR 158
+ + +I EYM N SL DFL + ++L N+ M I N I R
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 159 D---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
D + KI+DFG+AR+ N+ A + APE G F++KSD
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 185
Query: 210 VFSFGVLLLEIIS-GR 224
V+SFG+LL EI++ GR
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 57/215 (26%)
Query: 59 LGEGGFGPVYKGVLNDDKE------IAVKRLSRS-SGQGLQEFKN---LIAKLQHKNLVR 108
LGEG FG VYKG L E +A+K L + + QEF+ L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 109 LLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRS-------------------------- 141
LLG C + ++ EY+ + L +FL+ +S S
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 142 -------------VQLDWNRRMCIINGIARDHKMNPKISDFGMAR-VFGGNQSEANTNRV 187
V D R C++ + KISDFG++R ++ + + +
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVG-----EGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ +M PE L G F+ +SD++SFGV+L EI S
Sbjct: 188 LPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-19
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 57/214 (26%)
Query: 59 LGEGGFGPVYKGVL-----NDDKEI-AVKRLSRSSGQGLQE-FK---NLIAKLQHKNLVR 108
LGEG FG V+ G +DKE+ AVK L ++ ++ F+ L+ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 109 LLGCCLEGNELLLICEYMPNKSL---------DFLLFDSTRSV--QLDWNRRMCIINGIA 157
G C EG+ +++ EYM + L D S S +L ++ + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 158 -------------RD---------HKMNPKISDFGMARVFGGNQSEANTN---RVVGT-- 190
RD + + KI DFGM+R + T RV G
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVGGHTM 185
Query: 191 --YGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+M PE + F+ +SDV+SFGV+L EI +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 86.7 bits (213), Expect = 5e-19
Identities = 68/279 (24%), Positives = 111/279 (39%), Gaps = 43/279 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSR---SSGQGLQEFKNLIAKLQ----HK 104
++ KLGEG FG VY D K +A+K L++ S + ++ F I L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLL--FDSTRSVQLDWNRRMC--IINGIARDH 160
N+V+L + L L+ EY+ SL+ LL + + I++ + H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 161 KMN-------------------PKISDFGMARVFGGNQSEAN----TNRVVGTYGYMAPE 197
K+ DFG+A++ S ++ + VGT GYMAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 198 YALEGLF---SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254
L S SD++S G+ L E+++G E+ S + T K+ E L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSL 235
Query: 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
P+ S + + +DP +R + SS +
Sbjct: 236 ASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 7e-19
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 69/281 (24%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSS-GQGLQEFKNLIAKLQHK 104
+ ++G+G FG VY D KEI + +S L E K ++ KL H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHP 59
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-------LDWNRRMCI----- 152
N+++ E +L ++ EY L + + + LDW ++C+
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 153 --INGIARDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201
+ RD K K+ DFG+++V A T VVGT Y++PE +
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE-LCQ 176
Query: 202 GL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260
++ KSD++S G +L E+ + + F +G++L EL +LK
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP--F----EGENL-------------LELALKILK 217
Query: 261 ESFI---------LEELLKRIHIGLLCVQEDPADRPTMSSV 292
+ L L+ +Q+DP +RP+++ +
Sbjct: 218 GQYPPIPSQYSSELRNLVSS------LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-19
Identities = 57/193 (29%), Positives = 87/193 (45%), Gaps = 30/193 (15%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRLLGC 112
K+G+G FG VYKGVL + E+AVK + LQE + L + H N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR--RMCI-----------INGIARD 159
C++ + ++ E +P L F + +L + +M + N I RD
Sbjct: 61 CVQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDV 210
KISDFGM+R G + + APE G ++ +SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 211 FSFGVLLLEIISG 223
+S+G+LL E S
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 66/269 (24%), Positives = 101/269 (37%), Gaps = 65/269 (24%)
Query: 58 KLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLG 111
LG+G G VYK K+I V Q L+E K L + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYG 66
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC------IINGIA-------- 157
+ E+ ++ EYM SL LL + V + I+ G+
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL----KKVGK-IPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 158 --RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
RD K KI+DFG+++V + NT VGT YM+PE +S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESYSY 179
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD-------PVL 259
+D++S G+ LLE G+ + + ++ + ELM P L
Sbjct: 180 AADIWSLGLTLLECALGK-----FPF---LPPGQPSF--F------ELMQAICDGPPPSL 223
Query: 260 KESFILEELLKRIHIGLLCVQEDPADRPT 288
E C+Q+DP RP+
Sbjct: 224 PAEEFSPEF---RDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 29/200 (14%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKN 105
+F NK+G+G FG V+K V D K+I + +++R + + ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLL---FDSTRSVQLDWNRRMCIINGIARDHK- 161
++R L+ +L ++ EY N L LL W + I+ G+A H
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 162 -----------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
N KI D G+A++ N + ANT +VGT Y++PE + +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPY 178
Query: 205 SVKSDVFSFGVLLLEIISGR 224
+ KSDV++ GV+L E +G+
Sbjct: 179 NEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 37/200 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVR 108
LG G FG VYKGV + E +A+K L + L E ++A + H ++VR
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY-VMASVDHPHVVR 73
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ----LDWNRRMCIINGIA--RDHKM 162
LLG CL +++ LI + MP L + + ++ L+W + I G++ + ++
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ--IAKGMSYLEEKRL 130
Query: 163 -------------NP---KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
P KI+DFG+A++ ++ E + +MA E L +++
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 207 KSDVFSFGVLLLEIIS-GRK 225
KSDV+S+GV + E+++ G K
Sbjct: 191 KSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 80/274 (29%), Positives = 112/274 (40%), Gaps = 50/274 (18%)
Query: 57 NKLGEGGFGPVYKGVL----NDDKEIAVKRLSRS-SGQGLQEF---KNLIAKLQHKNLVR 108
+LG G FG V KGV + E+AVK L + G +EF +++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 109 LLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQ--LDW----NRRMCIING---IAR 158
L+G C G L+L+ E P L +L V + M + + R
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 159 D---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTY--GYMAPEYALEGLFSVK 207
D ++ KISDFGM+R G S+ G + + APE G FS K
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 208 SDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWC-EGNAQELMDPVLKESFIL 265
SDV+S+GV L E S G K + ++L +L E QE+
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS--------- 229
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299
I L C + P DRPT S + D
Sbjct: 230 --------IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 9e-18
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFK---NLIAKLQHKN 105
N+ + +G G FG VYKG+ L +A+K++S + L+ +L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII------NGIA-- 157
+V+ +G + L +I EY N SL ++ + + + G+A
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-----FPESLVAVYVYQVLQGLAYL 115
Query: 158 -------RDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201
RD K K++DFG+A + + VVGT +MAPE
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEM 173
Query: 202 GLFSVKSDVFSFGVLLLEIISGR 224
S SD++S G ++E+++G
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 47/215 (21%)
Query: 44 DLIHEA--TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIA- 99
D++ E + N K+GEG G VYK KE+A+K++ R Q + N I
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILI 68
Query: 100 --KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-RM--CIIN 154
+H N+V L G+EL ++ EYM SL + + N RM I
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI---------ITQNFVRMNEPQIA 119
Query: 155 GIARD--------HKMNP------------------KISDFGMARVFGGNQSEANTNRVV 188
+ R+ H N K++DFG A +S+ N+ VV
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VV 177
Query: 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG 223
GT +MAPE + K D++S G++ +E+ G
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 65/193 (33%), Positives = 95/193 (49%), Gaps = 26/193 (13%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGCC 113
KLG G FG V+ G N + ++AVK L S + E ++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 114 LEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN------- 163
E + ++ EYM SL DFL R+++L M + G+A +MN
Sbjct: 71 SE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 164 -----------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFS 212
KI+DFG+AR+ N+ A + APE AL G F++KSDV+S
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 213 FGVLLLEIIS-GR 224
FG+LL E+++ GR
Sbjct: 189 FGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 61/209 (29%), Positives = 85/209 (40%), Gaps = 47/209 (22%)
Query: 57 NKLGEGGFGPVYKGVL----NDDKEIAVKRLSR---SSGQGLQEFKN---LIAKLQHKNL 106
LG G FG VY+G+ D E+ V + S Q +F +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 107 VRLLGCCLEGNELLLICEYM-------------PN---------KSLDFLLFD------- 137
VRL+G E ++ E M P K L F D
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 138 --STRSVQLDWNRRMCIIN--GIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY 193
+ D R C++ G R KI+DFGMAR R + +
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGR----VAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 194 MAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
M PE L+G+F+ K+DV+SFGVLL EI S
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 37/195 (18%)
Query: 56 ENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGLQEF---KNLIAKLQHKNLVRLLG 111
++KLG G +G VY+GV +AVK L + ++EF ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRS--------------------------VQLD 145
C +I E+M +L L + R + D
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 146 WNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
R C++ ++ + K++DFG++R+ G+ A+ + APE FS
Sbjct: 130 LAARNCLVG----ENHL-VKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 183
Query: 206 VKSDVFSFGVLLLEI 220
+KSDV++FGVLL EI
Sbjct: 184 IKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 60/208 (28%), Positives = 85/208 (40%), Gaps = 46/208 (22%)
Query: 59 LGEGGFGPVYKGVLND-------DKEIAVKRLSRSSGQGLQEFK------NLIAKLQHKN 105
LG G FG VY+G D +AVK L + G QE K +L++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPN 60
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDS--------------------------- 138
+V+LLG CL +I E M L L D+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 139 ----TRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYM 194
+ D R C+++ D KI DFG+AR + + +M
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIIS 222
APE L+G F+ +SDV+SFGVL+ EI++
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 55/263 (20%)
Query: 59 LGEGGFGPVYKGVLNDDKE-IAVK--------RLSRSSGQGLQEFKNLIAKLQHKNLVRL 109
LG G FG VY+G+ DD + AVK + + + + L++ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLL--FDSTRSVQLDWNRRMCIINGIARDHKMNP--- 164
LG E + L + E +P SL LL + S + R I+ G+ H N
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-ILLGLEYLHDRNTVHR 126
Query: 165 ---------------KISDFGMARV---FGGNQSEANTNRVVGTYGYMAPEYAL-EGLFS 205
K++DFGMA+ F +S G+ +MAPE +G +
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS------FKGSPYWMAPEVIAQQGGYG 180
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
+ +D++S G +LE+ +G+ + E ++ +K+ G ++EL P + +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP--WSQLEGVAAV----FKI---GRSKEL--PPIPDHLSD 229
Query: 266 EELLKRIHIGLLCVQEDPADRPT 288
E + I L C+Q DP+ RPT
Sbjct: 230 E---AKDFI-LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 59/277 (21%)
Query: 56 ENKLGEGGFGPVYKGVLN----DDKEIAVKRL-SRSSGQGLQEF---KNLIAKLQHKNLV 107
E +G G FG V +G L + ++A+K L + SS + +F +++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK----MN 163
RL G + +++I EYM N SLD L + + + ++ GIA K MN
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 164 P------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
K+SDFG++R +++ T + APE F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
SDV+SFG+++ E++S Y + + + + Q+++ V ++ + L
Sbjct: 187 SASDVWSFGIVMWEVMS------------------YGERPYWDMSNQDVIKAV-EDGYRL 227
Query: 266 E------ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L ++ L C Q+D +RPT S +V L
Sbjct: 228 PPPMDCPSALYQLM--LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 28/194 (14%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRL---SRSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
E KLG+G FG V+ G N +A+K L + S LQE ++ KL+H+ LV+L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE-AQVMKKLRHEKLVQLYAV 69
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN------ 163
E + ++ EYM SL DFL + + ++L M I +G+A +MN
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 164 ------------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVF 211
K++DFG+AR+ N+ A + APE AL G F++KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 187
Query: 212 SFGVLLLEIIS-GR 224
SFG+LL E+ + GR
Sbjct: 188 SFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 74/258 (28%), Positives = 113/258 (43%), Gaps = 44/258 (17%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGCC 113
E KLG G FG V+ N ++AVK + S + N++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HAV 69
Query: 114 LEGNELLLICEYMPNKSL-DFLLFDSTRSVQL----DWNRR----MCII---NGIARDHK 161
+ + +I E+M SL DFL D L D++ + M I N I RD +
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129
Query: 162 ---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFS 212
+ KI+DFG+ARV N+ A + APE G F++KSDV+S
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWS 188
Query: 213 FGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLW-CEGNAQELMDPVLKESFILEELLK 270
FG+LL+EI++ GR + L +++ E +EL + +++
Sbjct: 189 FGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR---------- 238
Query: 271 RIHIGLLCVQEDPADRPT 288
C + P +RPT
Sbjct: 239 -------CWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 67/232 (28%), Positives = 101/232 (43%), Gaps = 55/232 (23%)
Query: 42 PLDLIHEATRN-FSNENKLGEGGFGPV----YKGVLNDDKEI--AVKRLSRSSGQGLQEF 94
PLD E R+ + LGEG FG V G+ N ++ AVK L + + ++
Sbjct: 2 PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDL 59
Query: 95 KNLIAKL-------QHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLL----------F 136
+L++++ +HKN++ LLG C + L ++ EY + +L DFL
Sbjct: 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 137 DSTRS----------VQLDWN--RRM-------CIINGIA-------RDHKMNPKISDFG 170
D R V + R M CI +A DH M KI+DFG
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM--KIADFG 177
Query: 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+AR T +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 42/261 (16%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGCC 113
+ KLG+G FG V+ G N ++A+K L + + ++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 114 LEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN------- 163
E + ++ E+M SL DFL + ++L M I +G+A +MN
Sbjct: 71 SE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129
Query: 164 -----------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFS 212
KI+DFG+AR+ N+ A + APE AL G F++KSDV+S
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 213 FGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKR 271
FG+LL E+++ GR + + + +++ C E L EL+K
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE----------SLHELMK- 237
Query: 272 IHIGLLCVQEDPADRPTMSSV 292
LC ++DP +RPT +
Sbjct: 238 -----LCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 72/295 (24%), Positives = 115/295 (38%), Gaps = 88/295 (29%)
Query: 59 LGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLV 107
LG+G FG VY+G+ + +A+K ++ ++ L E +++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCHHVV 72
Query: 108 RLLGCCLEGNELLLICEYM-----------------------PNKSLDFLLF-------- 136
RLLG G L++ E M P F+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 137 ---DSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMAR-VFGGNQSEANTNRVVGT-- 190
+ + V D R C++ + KI DFGM R ++ E + R G
Sbjct: 133 AYLAAKKFVHRDLAARNCMVA-----EDLTVKIGDFGMTRDIY-----ETDYYRKGGKGL 182
Query: 191 --YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ---GQS---LLTYT 242
+MAPE +G+F+ KSDV+SFGV+L E+ + L EQ G S +L +
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------LAEQPYQGLSNEEVLKFV 234
Query: 243 WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297
+G +D L EL++ C Q +P RPT +V L
Sbjct: 235 ----IDGG---HLDLPENCPDKLLELMRM------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 59/193 (30%), Positives = 86/193 (44%), Gaps = 31/193 (16%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRL---SRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLE 115
LG G FG V+ G ++A+K + + S ++E K ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK-VMMKLSHPNLVQLYGVCTK 70
Query: 116 GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCI-----------INGIARD----- 159
+ ++ EYM N L L + + +W MC I RD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130
Query: 160 ----HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVKSDVFS 212
K+SDFG+AR +Q ++ GT + PE FS KSDV+S
Sbjct: 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 213 FGVLLLEIISGRK 225
FGVL+ E+ S K
Sbjct: 187 FGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 43/208 (20%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQ 102
IH + E +G G FG V+ G + +++A+K + R ++F ++ KL
Sbjct: 1 IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLS 57
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSL-DFL------------------------LFD 137
H LV+L G C E + + L+ E+M + L D+L +
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 138 STRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYM 194
S+ + D R C++ K+SDFGM R +Q ++T GT +
Sbjct: 118 SSNVIHRDLAARNCLVG-----ENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWS 168
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIIS 222
+PE +S KSDV+SFGVL+ E+ S
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 38/203 (18%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRS------SGQGLQEFKNLIAKLQHKN 105
+ K+GEG +G VYK EI A+K++ L+E K L+ +L H N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPN 59
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-----IINGIARDH 160
+++LL +L L+ E+M D R L + ++ G+A H
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCH 115
Query: 161 K-------MNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-E 201
+ P K++DFG+AR FG T+ VV T Y APE L +
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGD 173
Query: 202 GLFSVKSDVFSFGVLLLEIISGR 224
+S D++S G + E++S R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 36/202 (17%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---------QGLQEFKNLIAKLQHKNLV 107
LG+G +G VY G+ N + IAVK++ + + LQE +L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLL--FDS-TRSVQLDWNRRMCIINGIA------- 157
+ LG CL+ N + + E++P S+ +L F V + ++ I++G+A
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVAYLHNNCV 123
Query: 158 --RDHKMNP---------KISDFGMAR---VFGGNQSEANTNRVV-GTYGYMAPEYALEG 202
RD K N K+ DFG AR G + + +N + + GT +MAPE E
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
+ KSD++S G + E+ +G+
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 38/201 (18%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ---HKNLVR 108
F KLGEG +G VYK + + +A+K + + LQE I+ L+ +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 109 LLGCCLEGNELLLICEY-----------MPNKSLD-----FLLFDSTRSVQLDWNRRMCI 152
G + +L ++ EY + NK+L +L+ + + ++ + +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK-- 120
Query: 153 INGIARD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
I RD + K++DFG++ ++ NT V+GT +MAPE E
Sbjct: 121 ---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 175
Query: 204 FSVKSDVFSFGVLLLEIISGR 224
++ K+D++S G+ +E+ G+
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 59/280 (21%)
Query: 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRL-------SRSSGQGLQEFKNLIAKL 101
NF E K+G+G F VYK + L D + +A+K++ +++ L+E L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID-LLKQL 59
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSLDFL---------LFDSTRSVQLDWNRRMCI 152
H N+++ L +E NEL ++ E L + L R++ W + +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTI---WKYFVQL 115
Query: 153 INGIARDHK-------MNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYM 194
+ + H + P K+ D G+ R F + A++ +VGT YM
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254
+PE E ++ KSD++S G LL E+ + + Y +L + C+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSL-----CKKIEKCD 224
Query: 255 MDPVLKESFI--LEELLKRIHIGLLCVQEDPADRPTMSSV 292
P+ + + L +L+ R C+ DP RP +S V
Sbjct: 225 YPPLPADHYSEELRDLVSR------CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 43/208 (20%)
Query: 58 KLGEGGFGPVYKGV---LNDDKE---IAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVR 108
+LGEG FG V+ L +++ +AVK L +S Q+F+ L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 109 LLGCCLEGNELLLICEYMPNKSLD-FL--------LFDSTRSV---QLDWNRRMCIINGI 156
G C EG LL++ EYM + L+ FL + V QL + + I + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 157 A-------------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYM 194
A RD + KI DFGM+R R + +M
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIIS 222
PE L F+ +SD++SFGV+L EI +
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 71/287 (24%), Positives = 108/287 (37%), Gaps = 79/287 (27%)
Query: 58 KLGEGGFGPVYKG----VLNDDKEIAVKRLSRSSGQG-LQEFK---NLIAKLQHKNLVRL 109
KLG+G FG V +G +AVK L + +F ++ L H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLD-------WNRRMCIING------- 155
G L + L+++ E P SL D R L + + I NG
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 156 -------------IARDHKMNPKISDFGMARVFGGNQS--EANTNRVVGTYGYMAPEYAL 200
+A D K+ KI DFG+ R N+ + V + + APE
Sbjct: 117 RFIHRDLAARNILLASDDKV--KIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLR 173
Query: 201 EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260
FS SDV+ FGV L E + TY + W + +++ + K
Sbjct: 174 TRTFSHASDVWMFGVTLWE------------------MFTYGEEPWAGLSGSQILKKIDK 215
Query: 261 ESFILE----------ELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297
E LE ++ + C +PADRPT +++ L
Sbjct: 216 EGERLERPEACPQDIYNVMLQ------CWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 43/265 (16%)
Query: 56 ENKLGEGGFGPVYKG-VLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCL 114
EN + G G YKG + + + VK ++ + E ++ KLQH N+V+L+G C
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM-GKLQHPNIVKLIGLCR 753
Query: 115 EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARV 174
LI EY+ K+L +L + L W RR I GIA+ + + V
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRF---LHCRCSPAV 804
Query: 175 FGGNQSEANT---------------------NRVVGTYGYMAPEYALEGLFSVKSDVFSF 213
GN S + + Y+APE + KSD++ F
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGF 864
Query: 214 GVLLLEIISGR--KDTRFYLYEQGQSLLTYTWKLWCEGNAQELM--DPVLKE--SFILEE 267
G++L+E+++G+ D F ++ S++ W +C + M DP ++ S E
Sbjct: 865 GLILIELLTGKSPADAEFGVHG---SIV--EWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 268 LLKRIHIGLLCVQEDPADRPTMSSV 292
+++ +++ L C DP RP + V
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 63/228 (27%)
Query: 52 NFSNENKLGEGGFGPVYK----GVL--NDDKEIAVKRLSR-SSGQGLQEFKN---LIAKL 101
N +G+G FG V++ G+L +AVK L +S +F+ L+A+
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSV------------------ 142
H N+V+LLG C G + L+ EYM L +FL S R+
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 143 QLDWNRRMCIINGIA-------------RD---------HKMNPKISDFGMAR------V 174
L ++CI +A RD M KI+DFG++R
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ ++++A R +M PE ++ +SDV+++GV+L EI S
Sbjct: 186 YKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 64/197 (32%), Positives = 91/197 (46%), Gaps = 44/197 (22%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRLS-RSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEG 116
+GEG FG V +G K +AVK + + Q E ++ KL HKNLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEYTGQK-VAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH- 70
Query: 117 NELLLICEYMPNKSL-DFL-------------------------LFDSTRSVQLDWNRRM 150
N L ++ E M +L +FL +S + V D R
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN 130
Query: 151 CII--NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
++ +G+A K+SDFG+ARV + +++ + APE FS KS
Sbjct: 131 ILVSEDGVA-------KVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKS 178
Query: 209 DVFSFGVLLLEIIS-GR 224
DV+S+GVLL E+ S GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 75/283 (26%), Positives = 115/283 (40%), Gaps = 71/283 (25%)
Query: 59 LGEGGFGPV----YKGVLNDDKE-IAVKRLSRSSGQGLQEFKNLI---AKLQHKNLVRLL 110
LG+G FG V Y + ++ E +AVK+L S+ + L++F+ I LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 111 GCCLEG--NELLLICEYMPNKSL-DFLL-----FDSTRSVQLDWN---------RRMCII 153
G C L L+ EY+P SL D+L D + + + +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 154 NGIAR-----DHKMNPKISDFGMARVFGGNQSEANTNRVVG---TYGYMAPEYALEGLFS 205
+A + + KI DFG+ +V ++ E R G + Y APE E FS
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFS 189
Query: 206 VKSDVFSFGVLLLEIIS----GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261
V SDV+SFGV+L E+ + ++ G + Q +
Sbjct: 190 VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG-----------NDKQGQMI------- 231
Query: 262 SFILEELLKR-------------IH-IGLLCVQEDPADRPTMS 290
+ L ELLK I+ I C DP+ RP+ S
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 62/298 (20%), Positives = 106/298 (35%), Gaps = 88/298 (29%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD-KEIAVKRLSRS-------SGQGLQEFKNLIAKL-Q 102
+F +GEG F V + KE A+K L + E K ++ +L
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLNG 60
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPN----------KSLDFLLFDSTR--SVQLDWNRRM 150
H +++L + L + EY PN SLD TR + ++ +
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE---KCTRFYAAEI-----L 112
Query: 151 CII-----NGIA-RD---------HKMNPKISDFGMARVFGGNQSEANTNRV-------- 187
+ GI RD M+ KI+DFG A+V N S +
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 188 ----------VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG----RKDTRFYLYE 233
VGT Y++PE E SD+++ G ++ ++++G R + ++
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 234 QGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSS 291
+ E + P K+ ++E+LL DP DR ++
Sbjct: 233 KILK---------LEYSFPPNFPPDAKD--LIEKLLVL----------DPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 73/291 (25%), Positives = 114/291 (39%), Gaps = 69/291 (23%)
Query: 58 KLGEGGFGPVY----KGVLN---------DDKE--IAVKRL-----SRSSGQGLQEFKNL 97
KLGEG FG V+ +G+ D + +AVK L + L+E K +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK-I 70
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLL---------------------- 135
+++L++ N++RLLG C+ + L +I EYM N L+ L
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 136 --------------FDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSE 181
S V D R C++ + KI+DFGM+R
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLV-----GNHYTIKIADFGMSRNLYSGDYY 185
Query: 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241
R V +MA E L G F+ SDV++FGV L E+ + K+ + L Q +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245
Query: 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+G L L S + + +++ C D DRPT + +
Sbjct: 246 GEFFRNQGRQIYLSQTPLCPSPVFKLMMR-------CWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRL 109
++GEG +G VYK E+ A+K++ + ++E K L+ KL+H N+VRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK-LLQKLRHPNIVRL 63
Query: 110 LGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCI----INGIA------ 157
+ ++ EYM + D + V+ ++ C + G+
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGLF 204
RD + K++DFG+AR + S TNRV+ T Y PE L +
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRY 179
Query: 205 SVKSDVFSFGVLLLEIISGR 224
+ D++S G +L E+ G+
Sbjct: 180 GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 68/218 (31%), Positives = 93/218 (42%), Gaps = 39/218 (17%)
Query: 41 FPLDLIHEATR-NFSNENKLGEGGFGPVYK----GVLNDDK--EIAVKRLS----RSSGQ 89
P DL E R N S LG G FG V + G+ D ++AVK L S +
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 90 GL-QEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY---------MPNKSLDFLLFDST 139
L E K + H+N+V LLG C G +L+I EY + K FL +
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL 143
Query: 140 RSVQLDWNRRMCII---NGIARD---------HKMNPKISDFGMARVFGGNQ---SEANT 184
S + M + N I RD H KI DFG+AR + + N
Sbjct: 144 LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
V +MAPE +++ +SDV+S+G+LL EI S
Sbjct: 204 RLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 37/198 (18%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVK----RLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCC 113
LG+G +G VY L+ IA+K R SR Q L E L + L+H+N+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC------IING---------IAR 158
E + E +P SL LL ++ L N + I+ G + R
Sbjct: 75 SENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 159 DHKMNP----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL--FSV 206
D K + KISDFG ++ G T GT YMAPE +G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKGPRGYGA 190
Query: 207 KSDVFSFGVLLLEIISGR 224
+D++S G ++E+ +G+
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 60/191 (31%), Positives = 88/191 (46%), Gaps = 31/191 (16%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQ----EFKNLIAKLQHKNLVRLLGCCL 114
LG+G FG V+KG L D +AVK Q L+ ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 115 EGNELLLICEYMPNKSLDFLLF-----DSTRSVQL-----DWNRRMCII---NGIARDHK 161
+ + ++ E +P DFL F D ++ QL D M + N I RD
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 162 MNP---------KISDFGMARVF-GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVF 211
KISDFGM+R G S + ++ + APE G +S +SDV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSESDVW 178
Query: 212 SFGVLLLEIIS 222
S+G+LL E S
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 61/190 (32%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRLSR-SSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGN 117
+G+G FG V G +K +AVK + ++ Q +++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 118 -ELLLICEYMPNKSLDFLLFDSTRSV---------QLDWNRRMCIING---IARDHKMN- 163
L ++ EYM SL L RSV LD M + + RD
Sbjct: 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARN 132
Query: 164 --------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGV 215
K+SDFG+ + Q + APE E FS KSDV+SFG+
Sbjct: 133 VLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGI 187
Query: 216 LLLEIIS-GR 224
LL EI S GR
Sbjct: 188 LLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 5e-13
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 42/205 (20%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKR---------LSRSSGQGLQEFKNLIAKLQ 102
+ KLGEG +G VYK + +A+K+ + ++ L+E L+ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LREIS-LLKELK 56
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCI----INGIA- 157
H N+V+LL +L L+ EY + L L R L N I + G+A
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 158 --------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
RD K++DFG+AR F G T+ VV T Y APE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171
Query: 201 -EGLFSVKSDVFSFGVLLLEIISGR 224
+S D++S G + E+I+G+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 36/202 (17%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG------------QGLQEFKNLIAKLQHKN 105
+G G FG VY G+ E+ AVK++ S L L+ +LQH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLL-----FDST------RSV--QLDWNRRMCI 152
+V+ LG L+ + L + EY+P S+ LL F+ T R + L++ I
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 153 IN------GIARDHKMNPKISDFGMARVFGGN--QSEANTNR--VVGTYGYMAPEYALEG 202
I+ I D+K KISDFG+++ N ++ N R + G+ +MAPE +
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
++ K+D++S G L++E+++G+
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 59 LGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
+G G FG V+ D K+I V+++++ Q ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSV----------------------QLDWNRRM 150
LE L+++ EY P +L + S+ +L +R +
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 151 CIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDV 210
N + HKM KI DFG++++ ++S+A T VVGT Y++PE ++ KSD+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEGKPYNQKSDI 184
Query: 211 FSFGVLLLEIIS 222
++ G +L E+ S
Sbjct: 185 WALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 36/197 (18%)
Query: 57 NKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSSGQGLQEFKNLIAKLQ------HKNLVR 108
+LG G G V K VL+ K +AVK + K ++ +L +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVG 63
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING----------I 156
G ++ + EYM SLD +L + + ++ ++ G I
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 157 ARD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
RD + K+ DFG++ S A T VGT YMAPE +SVK
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGNDYSVK 179
Query: 208 SDVFSFGVLLLEIISGR 224
SD++S G+ L+E+ +GR
Sbjct: 180 SDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 30/193 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSG-QGLQEFKN---LIAKLQHKNLVRL 109
LG G FG VYKG+ + E +A+K L+ ++G + EF + ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ----LDW------------NRRMCII 153
LG CL + L+ + MP+ L + + ++ L+W RR+
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 154 NGIARD----HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
+ AR+ + KI+DFG+AR+ G++ E N + +MA E F+ +SD
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193
Query: 210 VFSFGVLLLEIIS 222
V+S+GV + E+++
Sbjct: 194 VWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 59/220 (26%)
Query: 59 LGEGGFGPVYKGVLNDDK------EIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLV 107
LGEG FG V K K +AVK L ++ L EF NL+ ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQVNHPHVI 66
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR----SVQLDWNRRMC------------ 151
+L G C + LLLI EY SL L +S + + D NR
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 152 ---------IINGIA---------RD-----------HKMNPKISDFGMARVFGGNQSEA 182
I G+ RD KM KISDFG++R S
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKM--KISDFGLSRDVYEEDSYV 184
Query: 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
++ +MA E + +++ +SDV+SFGVLL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 56/235 (23%)
Query: 47 HEATRNFSNENKLGEGGFGPVYKG------VLNDDKEIAVKRLSRSSGQGLQEFK---NL 97
H R+ + +LGEG FG V+ D +AVK L + ++F+ L
Sbjct: 1 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 60
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD----------FLLFD---------- 137
+ LQH+++V+ G C +G+ L+++ EYM + L+ +L D
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 138 --------------------STRSVQLDWNRRMCIINGIARDHKMNPKISDFGMAR-VFG 176
S V D R C++ + KI DFGM+R V+
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA-----NLLVKIGDFGMSRDVYS 175
Query: 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231
+ + ++ +M PE + F+ +SDV+SFGV+L EI + K F L
Sbjct: 176 TDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 47 HEATRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSGQGLQEFK---NL 97
H N + +LGEG FG V+ D +AVK L +S ++F L
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD----------FLLFDSTRSVQLDWN 147
+ LQH+++V+ G C+EG+ L+++ EYM + L+ L+ + R +L +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 148 RRMCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANT 184
+ + I IA RD + KI DFGM+R V+ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231
+ ++ +M PE + F+ +SDV+S GV+L EI + K + L
Sbjct: 181 HTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 67/271 (24%), Positives = 110/271 (40%), Gaps = 57/271 (21%)
Query: 57 NKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLL 110
NK+G G FG VY V D KEI ++ + + + + ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---------RD 159
G + ++ + EY +L+ LL + R + R ++ G+A RD
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 160 HKMNP---------KISDFGMARVFGGNQSEANT--NRVVGTYGYMAPEYALEGLFSVK- 207
K K+ DFG A N + + GT YMAPE G
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 208 --SDVFSFGVLLLEIISGRK-----DTRFYL-YEQGQSLLTYTWKLWCEGNAQELMDPVL 259
+D++S G ++LE+ +G++ D F + + G G+ + D L
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA------------GHKPPIPDS-L 231
Query: 260 KESFILEELLKRIHIGLLCVQEDPADRPTMS 290
+ S ++ L R C++ DP RPT S
Sbjct: 232 QLSPEGKDFLDR------CLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 49/270 (18%)
Query: 52 NFSNENKLGEGGFGPVYK-GVLNDDKEIAVKR--LSRSSGQGLQEFKN---LIAKLQHKN 105
+F KLG+G +G VYK L+D++ A+K L S + ++ N ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSV-----QLDWNRRMCIING----- 155
++ L+GN+L ++ EY P L + + Q W + ++ G
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 156 ----IARDHK------MNP---KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
+ RD K + KI D G+++V N A T +GT YMAPE
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKT--QIGTPHYMAPEVWKGR 176
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
+S KSD++S G LL E+ + F + +S+ +K+ G P +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFA--PPF----EARSMQDLRYKV-QRGKY-----PPIPPI 224
Query: 263 FILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+ ++L I +Q P RP +
Sbjct: 225 YS-QDLQNFIR---SMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 31/191 (16%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRL---SRSSGQGLQEFKNLIAKLQHKNLVRLLGCCL 114
+LG G FG V G ++A+K + S S + ++E K ++ KL H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM-KLSHEKLVQLYGVCT 69
Query: 115 EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIAR-------------- 158
+ + ++ EYM N L L + + Q MC + G+A
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAAR 129
Query: 159 ----DHKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVKSDVF 211
D + K+SDFG++R ++ ++ VG+ + PE L FS KSDV+
Sbjct: 130 NCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 212 SFGVLLLEIIS 222
+FGVL+ E+ S
Sbjct: 186 AFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 30/167 (17%)
Query: 58 KLGEGGFGPVYK-GVLNDDKEIAVKRLSRSSGQG------LQEFKNLIAKLQHKNLVRLL 110
++GEG G V+K + +A+K+++ +G L+E K L QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKAL-QACQHPYVVKLL 65
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRR--MCIINGIARDHKMN----- 163
G+ +L+ EYMP+ L +L D R + + ++ G+A H
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 164 --P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197
P KI+DFG+AR+F + +++ V T Y APE
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 57/203 (28%), Positives = 86/203 (42%), Gaps = 41/203 (20%)
Query: 59 LGEGGFGPVYKGVL------NDDKEIAVKRLSRSSGQGLQ-EFK---NLIAKLQHKNLVR 108
LG G FG V+ + + VK L ++ + LQ EF+ ++ KL HKN+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 109 LLGCCLEGNELLLICEYMPNKSL-DFLL-----FDSTRSVQLDWNRRMCIINGIAR--DH 160
LLG C E +I EY L FL + + L +++ + IA DH
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 161 KMNP--------------------KISDFGMAR-VFGGNQSEANTNRVVGTYGYMAPEYA 199
N K+S +++ V+ N + ++APE
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY--NSEYYKLRNALIPLRWLAPEAV 190
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS 222
E FS KSDV+SFGVL+ E+ +
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 79/297 (26%), Positives = 118/297 (39%), Gaps = 88/297 (29%)
Query: 58 KLGEGGFGPVY-------------KGVLNDDKEI----AVKRLSRS-SGQGLQEFKN--- 96
KLGEG FG V+ ND+ + AVK L S ++F
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 97 LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD-FL----LFDSTRS---------- 141
++++L N+ RLLG C L +I EYM N L+ FL S +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 142 --------------------VQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSE 181
V D R C++ +++ + KI+DFGM+R N
Sbjct: 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVG---KNYTI--KIADFGMSR----NLYS 182
Query: 182 ANTNRVVGT----YGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQ-- 234
++ RV G +MA E L G F+ KSDV++FGV L EI++ R+ YE
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP----YEHLT 238
Query: 235 GQSLLTYTWKLWCEGNAQELMD-P--VLKESFILEELLKRIHIGLLCVQEDPADRPT 288
Q ++ + + Q + P K+ + EL+ C + D DRPT
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY---ELMLE------CWRRDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 66/272 (24%), Positives = 123/272 (45%), Gaps = 47/272 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRL-------SRSSGQGLQEFKNLIAKLQH 103
NF E K+G G F VY+ L D +A+K++ +++ ++E +L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNH 61
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLL--FDSTRSV---QLDWNRRMCIINGIAR 158
N+++ +E NEL ++ E L ++ F + + + W + + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 159 DHK-------MNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
H + P K+ D G+ R F + A++ +VGT YM+PE
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIH 179
Query: 201 EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260
E ++ KSD++S G LL E+ + + + FY G + Y+ C+ ++ P L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQ--SPFY----GDKMNLYS---LCK-KIEQCDYPPLP 229
Query: 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
EEL + ++ +C+ DP RP ++ V
Sbjct: 230 SDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 66/200 (33%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 59 LGEGGFGPV----YKGVLNDDKE-IAVKRLSRSSGQGLQE-FK---NLIAKLQHKNLVRL 109
LGEG FG V Y + E +AVK L R GQ +K N++ L H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 110 LGCCLEGNE--LLLICEYMPNKSL-DFLLFDSTRSVQLD-WNRRMCIINGIARDHKMN-- 163
GCC E L LI EY+P SL D+L QL + +++C G+A H +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC--EGMAYLHSQHYI 129
Query: 164 ----------------PKISDFGMAR-VFGGNQ----SEANTNRVVGTYGYMAPEYALEG 202
KI DFG+A+ V G++ E + V + A E E
Sbjct: 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKEN 185
Query: 203 LFSVKSDVFSFGVLLLEIIS 222
FS SDV+SFGV L E+++
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 51/274 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRL-------SRSSGQGLQEFKNLIAKLQH 103
NF E K+G G F VY+ L D K +A+K++ +++ ++E +L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEI-DLLKQLNH 61
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLL--FDSTRSV---QLDWNRRMCIINGIAR 158
N+++ L +E NEL ++ E L ++ F + + + W + + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 159 DHK-------MNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
H + P K+ D G+ R F + A++ +VGT YM+PE
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIH 179
Query: 201 EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260
E ++ KSD++S G LL E+ + + Y +L + C+ Q P+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSL-----CQKIEQCDYPPLPT 230
Query: 261 ESFI--LEELLKRIHIGLLCVQEDPADRPTMSSV 292
E + L EL+ +C+ DP RP + V
Sbjct: 231 EHYSEKLRELVS------MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 39/197 (19%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ----GLQEFKNLIAKLQH---KNLVRLL 110
+G G +G VY+G + A+K ++ + +Q L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII--------------NGI 156
G L+G L +I EY S+ L+ ++ + + + +I I
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA-EKYISVIIREVLVALKYIHKVGVI 123
Query: 157 ARDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSV 206
RD K N K+ DFG+A + N S+ +T VGT +MAPE EG +
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDT 181
Query: 207 KSDVFSFGVLLLEIISG 223
K+D++S G+ + E+ +G
Sbjct: 182 KADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 49/208 (23%)
Query: 54 SNENKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSSG---QGLQEF---KNLIAKLQHKN 105
+ + +G G FG V++G+L KE+AV + G + Q+F +++ + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK- 161
++RL G + ++I EYM N +LD L D S QL + ++ GIA K
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKY 122
Query: 162 ---MN------------------PKISDFGMARVFGGNQSEANTNRVVGTYG------YM 194
MN K+SDFG++RV E + T G +
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKIPIRWT 177
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIIS 222
APE F+ SDV+SFG+++ E++S
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 52/265 (19%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGCCLE 115
+LG G FG V+ G ++A+K ++ S + E ++ KL H LV+L G C +
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 116 GNELLLICEYMPNKSL-------------DFLL------------FDSTRSVQLDWNRRM 150
L ++ E+M N L D LL + + D R
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130
Query: 151 CIIN--GIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
C+++ G+ K+SDFGM R ++ +++ + PE +S KS
Sbjct: 131 CLVSSTGVV-------KVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKS 182
Query: 209 DVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268
DV+SFGVL+ E+ + K F + + + G L P L + E +
Sbjct: 183 DVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMIS-----RGF--RLYRPKLASMTVYEVM 234
Query: 269 LKRIHIGLLCVQEDPADRPTMSSVV 293
C E P RPT + ++
Sbjct: 235 YS-------CWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 78/300 (26%), Positives = 120/300 (40%), Gaps = 70/300 (23%)
Query: 58 KLGEGGFGPVYKGVLND------DKEIAVKRLSRS-SGQGLQEFKN---LIAKLQHKNLV 107
+LG+G FG VY+G D + +AVK ++ S S + EF N ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLL-------------------------------- 135
RLLG +G L++ E M + L L
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 136 --FDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY 193
++ + V D R C++ A D + KI DFGM R + + +
Sbjct: 133 AYLNAKKFVHRDLAARNCMV---AHDFTV--KIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 194 MAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253
MAPE +G+F+ SD++SFGV+L EI S L EQ L+ L +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS--------LAEQPYQGLSNEQVLKFVMDGGY 239
Query: 254 LMDPVLKESFILEELLKRIH-IGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFS 312
L P + +R+ + +C Q +P RPT +V +L D L P+ P S
Sbjct: 240 LDQP--------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----LHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 55/210 (26%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRL---SRSSGQ------GLQEFKNLIAKLQHKN 105
KLGEG + VYK + +A+K++ R + L+E K L+ +L+H N
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPN 63
Query: 106 LVRLLGCCLEGNELLLICEYMP--------NKSLDFLLFDSTRSVQLDWNRRMCIINGIA 157
++ LL + + L+ E+M +KS+ D +S L M + G+
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYML-----M-TLRGLE 116
Query: 158 ---------RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA 199
RD K + K++DFG+AR F G+ + T++VV T Y APE
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPEL- 173
Query: 200 LEGLFSVKS-----DVFSFGVLLLEIISGR 224
LF + D++S G + E++
Sbjct: 174 ---LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 53/269 (19%)
Query: 59 LGEGGFGP--VYKGVLNDD----KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
LG+G FG +Y+ +D KE+ + RLS + +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 113 CLEGNELLLICEYMPNKSL-------DFLLFDSTRSVQLDWNRRMCIINGIARDHKMN-- 163
++ N LL+ EY +L LF+ + L + ++ + ++ HK
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIV--SAVSYIHKAGIL 123
Query: 164 ----------------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
K+ DFG++++ G S A T VVGT YM+PE ++ K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFK 181
Query: 208 SDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267
SD+++ G +L E+++ ++ + L K+ +GN ++ E L
Sbjct: 182 SDIWALGCVLYELLTLKRTF------DATNPLNLVVKI-VQGNYTPVVSVYSSE---LIS 231
Query: 268 LLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L+ +Q+DP RPT V+
Sbjct: 232 LVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 49/223 (21%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLS-RSSGQGLQEFKN-- 96
I+ +T F E LGE FG VYKG L + +A+K L ++ G +EFK+
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 97 -LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLF------------DSTRSV 142
+ ++LQH N+V LLG + L +I Y + L +FL+ D T
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 143 QLDWNRRMCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQ 179
L+ + I+ IA +D K+N KISD G+ R V+ +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ N ++ +M+PE + G FS+ SD++S+GV+L E+ S
Sbjct: 180 YKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 39/203 (19%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRL-----SRSSGQGLQEFKNLIAKLQHKN 105
F+ ++G+G FG VYKG+ N KE+ ++ + + +Q+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 106 LVRLLGCCLEGNELLLICEYMPN-------------------------KSLDFLLFDSTR 140
+ R G L+G +L +I EY+ K LD+L S R
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYL--HSER 121
Query: 141 SVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
+ D +++ + + K++DFG+A Q + NT VGT +MAPE
Sbjct: 122 KIHRDIKAANVLLS-----EQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 201 EGLFSVKSDVFSFGVLLLEIISG 223
+ + K+D++S G+ +E+ G
Sbjct: 175 QSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 75/288 (26%)
Query: 59 LGEGGFGPVYKGVLNDDK----EIAVK--RLSRSSGQGLQEFKNLIAKLQ---HKNLVRL 109
LGEG FG V +G L+ D ++AVK +L + ++EF + A ++ H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 110 LGCCLEGNEL------LLICEYMPNKSL-DFLLFD------------------------- 137
+G C E + L ++I +M + L FLL+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 138 ---STRS-VQLDWNRRMCIINGIARDHKMNPKISDFGMAR-VFGGN---QSEANTNRVVG 189
S R+ + D R C++ M ++DFG+++ ++ G+ Q V
Sbjct: 127 EYLSNRNFIHRDLAARNCML-----REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-- 179
Query: 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG 249
++A E + +++ KSDV++FGV + EI + R T Y ++ Y +
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIAT-RGQTP---YPGVENHEIYDYLR---- 229
Query: 250 NAQELMDPVLKESFILEELLKRIH-IGLLCVQEDPADRPTMSSVVFML 296
+ L P E+ L ++ + C + DP DRPT + + +L
Sbjct: 230 HGNRLKQP--------EDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 60/234 (25%), Positives = 92/234 (39%), Gaps = 60/234 (25%)
Query: 41 FPLDLIHEATRNFSNENKLGEGGFGPVY------------KGVLNDDKE-----IAVKRL 83
FP + + + KLGEG FG V+ K D +AVK L
Sbjct: 2 FPRKRL-------TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML 54
Query: 84 SRSSGQG-----LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLL--- 135
+ + L+E K ++++L+ N++RLL C+ + L +I EYM N L+ L
Sbjct: 55 REDANKNARNDFLKEIK-IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH 113
Query: 136 -------FDSTRSVQLDWNRRMCI-----------INGIARD---------HKMNPKISD 168
++ M +N + RD KI+D
Sbjct: 114 EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
FGM+R R V +M+ E L G F+ SDV++FGV L EI++
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 53 FSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQG----LQEFKNLIAKLQHKNLV 107
F+ +G+G FG VYK + ++ +A+K + + +Q+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII-------------N 154
+ G L+G++L +I EY S D + +LD I+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 155 GIARDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
I RD K + K++DFG++ S+ NT VGT +MAPE + +
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYD 176
Query: 206 VKSDVFSFGVLLLEIISG 223
K+D++S G+ +E+ G
Sbjct: 177 EKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 38/203 (18%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKE-----IAVKRL----SRSSGQGLQEFKNLIAKLQH 103
F LG G FG VYKG+ + E +A+K L S + + + + ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ--------LDW--------- 146
++ RLLG CL + + LI + MP L D R + L+W
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 147 ---NRRMCIINGIARDHKM-NP---KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA 199
RR+ + AR+ + P KI+DFG+A++ G ++ E + +MA E
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS 222
L +++ +SDV+S+GV + E+++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 1e-10
Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 30/193 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSS----GQGLQEF--KNLIAKLQHKNLVRLLG 111
LG+G FG V D ++ A+K L + + +N+++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 112 CCLEGNE-LLLICEYMPNKSLDFLL-----FDSTRS--------VQLDWNRRMCII---- 153
+ E L L+ EY P L L F R+ + L++ + II
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 154 --NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVF 211
I D + K++DFG+A+ S NT GT Y+APE L + D +
Sbjct: 120 KPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 212 SFGVLLLEIISGR 224
S GVLL E+++G+
Sbjct: 178 SLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 35/203 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQG-----LQEFKNLIAKLQHKN 105
NF KLGEG + VYKG EI A+K + + +G ++E +L+ +L+H+N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI-SLMKELKHEN 59
Query: 106 LVRLLGCCLEGNELLLICEYMPN---KSLDF------LLFDSTRSV--QLDWNRRMCIIN 154
+VRL N+L+L+ EYM K +D L ++ +S QL C N
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 155 GIA-RDHK-----MNP----KISDFGMARVFGGNQSEANT--NRVVGTYGYMAPEYALEG 202
+ RD K +N K++DFG+AR FG NT N VV T Y AP+ L
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGS 175
Query: 203 -LFSVKSDVFSFGVLLLEIISGR 224
+S D++S G ++ E+I+GR
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 77/305 (25%), Positives = 127/305 (41%), Gaps = 78/305 (25%)
Query: 37 ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSR-SSGQG 90
ELPL + + E LGE FG +YKG L + + +A+K L ++ Q
Sbjct: 1 ELPLSAVRFMEE----------LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ 50
Query: 91 LQEFK---NLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLF---------- 136
EF+ +L+A+L H N+V LLG + + ++ EY+ L +FL+
Sbjct: 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110
Query: 137 ---DSTRSVQLDWNRRMCIINGIARD----------HK------------MNPKISDFGM 171
D T LD + I IA HK ++ KISD G+
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 172 AR-VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230
+R ++ + ++ +M PE + G FS SD++SFGV+L EI S
Sbjct: 171 SREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS-------- 221
Query: 231 LYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI--LEELLKRIHIGLL-CVQEDPADRP 287
+ + + + QE+++ V K + E+ R++ + C QE P+ RP
Sbjct: 222 ----------FGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
Query: 288 TMSSV 292
+
Sbjct: 272 RFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 33/195 (16%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRL--------SRSSGQGLQEFKNLIAKLQHKNLVRL 109
LG+G FG VY ++ +E+AVK++ ++ L+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 110 LGCCLEGNELLLICEYMPNKSL-DFLLFDS--TRSVQLDWNRRMCIINGIA--------- 157
GC + L + EYMP S+ D L T +V + R+ I+ G+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ--ILEGVEYLHSNMIVH 127
Query: 158 ---------RDHKMNPKISDFGMA-RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
RD N K+ DFG + R+ S V GT +M+PE + K
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
Query: 208 SDVFSFGVLLLEIIS 222
+DV+S G ++E+++
Sbjct: 188 ADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 71/230 (30%)
Query: 58 KLGEGGFGPVYKGVLNDDKE-----------------IAVKRLSRSSGQG-----LQEFK 95
KLGEG FG V+ + + ++ +AVK L + + L+E K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 96 NLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLL-------------------- 135
++++L+ N++RLLG C++ + L +I EYM N L+ L
Sbjct: 72 -ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 136 -----------------------FDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMA 172
S V D R C++ + KI+DFGM+
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE-----NLTIKIADFGMS 185
Query: 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
R R V +MA E L G F+ SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 43/201 (21%)
Query: 59 LGEGGFGPVYKGVL--NDDKEI--AVKRLSR-SSGQGLQEF--KNLIAK-LQHKNLVRLL 110
+G+G FG VY G L +D ++I AVK L+R + + +++F + +I K H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 111 GCCL--EGNELLLICEYMPNKSL--------------DFLLFD-----------STRSVQ 143
G CL EG+ L+++ YM + L D + F S + V
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 144 LDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQ--SEANTNRVVGTYGYMAPEYALE 201
D R C++ D K++DFG+AR + S N +MA E
Sbjct: 122 RDLAARNCML-----DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 202 GLFSVKSDVFSFGVLLLEIIS 222
F+ KSDV+SFGVLL E+++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 41/200 (20%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRL---SRSSG---QGLQEFKNLIAKLQHKNLVRLL 110
K+GEG +G VYK + +A+K++ + G ++E +L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI-SLLKELNHPNIVRLL 64
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLF-DSTRSVQLDWNRRMC------IINGIA------ 157
N+L L+ E++ LD + DS+ LD + ++ GIA
Sbjct: 65 DVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLD--PPLIKSYLYQLLQGIAYCHSHR 119
Query: 158 ---RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-LF 204
RD K K++DFG+AR F G T+ VV T Y APE L +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 205 SVKSDVFSFGVLLLEIISGR 224
S D++S G + E+++ R
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 49/207 (23%)
Query: 58 KLGEGGFGPVY----KGVLNDDKE--IAVKRLSRSSGQGLQ-EFKNLIAKLQHKN---LV 107
+LG+G FG VY KGV+ D+ E +A+K ++ ++ + EF N + ++ N +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLL-------------------------------- 135
RLLG +G L+I E M L L
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 136 --FDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY 193
++ + V D R C++ A D + KI DFGM R + + +
Sbjct: 133 AYLNANKFVHRDLAARNCMV---AEDFTV--KIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 194 MAPEYALEGLFSVKSDVFSFGVLLLEI 220
M+PE +G+F+ SDV+SFGV+L EI
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 42/200 (21%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ-----GLQEFKNLIAKLQHKNLVRLLG 111
+LG+G FG VY + E+ A+K++ + L+E K+L +H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN--RRMC--IINGIARDHK------ 161
E +EL + EYM +L + L + + R + I+ G+A HK
Sbjct: 66 VFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR 123
Query: 162 -MNP-----------KISDFGMARVFGGNQSEANTNRV----VGTYGYMAPEYALE-GLF 204
+ P KI+DFG+AR E + V T Y APE L +
Sbjct: 124 DLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEILLRSTSY 176
Query: 205 SVKSDVFSFGVLLLEIISGR 224
S D+++ G ++ E+ + R
Sbjct: 177 SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 32/202 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ------GLQEFKNLIAKLQHK 104
+++ K+GEG +G VYKG + +A+K++ S + ++E +L+ +LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI-SLLKELQHP 59
Query: 105 NLVRLLGCCLEGNELLLICEYMP---NKSLDFLLFDSTRSVQLDWNRRMCIINGI----A 157
N+V L ++ + L LI E++ K LD L +L + I+ GI +
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 158 R--------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG- 202
R D+K K++DFG+AR F G T+ VV T Y APE L
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
+S D++S G + E+ + +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 41/198 (20%)
Query: 58 KLGEGGFGPVYKGVLN-DDKEIAVKRLSRS-----SGQGLQEFKNLIAKLQHKNLVRLLG 111
++G G FG V+ G L D+ +AVK + + LQE + ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIG 60
Query: 112 CCLEGNELLLICEYMPNKSLDFLLF---------------------------DSTRSVQL 144
C + + ++ E + + DFL F +S +
Sbjct: 61 VCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 145 DWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
D R C++ K KISDFGM+R + + APE G +
Sbjct: 119 DLAARNCLVT-----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 205 SVKSDVFSFGVLLLEIIS 222
S +SDV+SFG+LL E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 50/198 (25%), Positives = 76/198 (38%), Gaps = 67/198 (33%)
Query: 53 FSNENKLGEGGFGPVYKGVL---NDDKEIAVKRL--SRSSGQGL-----QEFKNLIAKLQ 102
+ E +G G +G VYK D KE A+K+ + G+ +E L+ +L+
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA-LLRELK 60
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFD--------------STRSVQLDWNR 148
H+N+V L+ LE + + +LLFD + V +
Sbjct: 61 HENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSI--PP 107
Query: 149 RMC------IINGIA---------RDHK------MNP-------KISDFGMARVFGGN-Q 179
M I+NG+ RD K M KI D G+AR+F +
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 180 SEANTNRVVGTYGYMAPE 197
A+ + VV T Y APE
Sbjct: 168 PLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 38/197 (19%)
Query: 59 LGEGGFGPVYKGVLNDDKE-----IAVKRL-SRSSGQGLQEFKN---LIAKLQHKNLVRL 109
LG G FG V+KG+ + + +A+K + RS Q QE + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ--------LDW------------NRR 149
LG C G L L+ + P SL D R + L+W R
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 150 MCIINGIARDHKMNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
M N AR+ + +I+DFG+A + + + + +MA E L G ++
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 206 VKSDVFSFGVLLLEIIS 222
+SDV+S+GV + E++S
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 50/196 (25%), Positives = 77/196 (39%), Gaps = 37/196 (18%)
Query: 59 LGEGGFGPVYK-GVLNDDKEIAVKRLSRSS--GQGLQEF----KNLIAKLQHKNLVRLLG 111
LG GGFG V V + ++ A+K + + G QE K ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQL--DWNRRMCI------------INGIA 157
+ + ++ EY L+ R L ++ R I I
Sbjct: 61 TFKDKKYIYMLMEYCLGGE----LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 158 RDHKMN---------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
RD K K+ DFG A+ Q T GT Y+APE L +
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 209 DVFSFGVLLLEIISGR 224
D +S G+LL E+++GR
Sbjct: 174 DYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 40/208 (19%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLI------ 98
+ + + ++ K+G+G G VY + + +E+A+K+++ Q K LI
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILV 69
Query: 99 -AKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-----RMCI 152
+ +H N+V L L G+EL ++ EY+ SL D +D + R C+
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125
Query: 153 -------ING-IARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
N I RD K + K++DFG QS+ +T +VGT +MA
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEIISG 223
PE + K D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 61/234 (26%)
Query: 59 LGEGGFGPVYKGVLNDDKEI---AVKRL-----SRSSGQGLQEFKNLIAKLQHKNLVRLL 110
LGEG FG V +G LN D I AVK + +RS + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 111 GCCLEGNEL------LLICEYMPNKSL-DFLLF--------------------------- 136
G CL+ E ++I +M + L FLL+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 137 --DSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMA-RVFGGNQSEANTNRVVGT-YG 192
S + D R C++N MN ++DFG++ +++ G+ R+
Sbjct: 127 YLSSKSFIHRDLAARNCMLN-----ENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVK 179
Query: 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIIS-------GRKDTRFYLY-EQGQSL 238
++A E + +++ KSDV+SFGV + EI + G +++ Y Y QG L
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 40/205 (19%)
Query: 57 NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRL 109
+G+G FG V K +D K + K + + Q + E N++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRY 64
Query: 110 LG---------------CCLEGNELLLI--C----EYMPNKSLDFLLFDSTRSVQLDWNR 148
C G+ LI C +Y+ + + +L ++ NR
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 149 RMCIINGIARDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA 199
+ RD K N K+ DFG+A++ G + S A T VGT YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQL 182
Query: 200 LEGLFSVKSDVFSFGVLLLEIISGR 224
+ KSD++S G L+ E+ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 72/262 (27%), Positives = 114/262 (43%), Gaps = 44/262 (16%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIA------KLQHKN 105
FS+ ++G G FG VY + + + +A+K++S S Q ++++++I KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIING---------- 155
++ GC L + L+ EY + D L L + +G
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 156 ---IARDHKM-NPKISDFGMARV--FGGNQSEANTNRVVGTYGYMAPEYAL---EGLFSV 206
I RD K N +S+ G+ ++ FG A N VGT +MAPE L EG +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266
K DV+S G+ +E ++ RK F + S L + AQ P L+ E
Sbjct: 194 KVDVWSLGITCIE-LAERKPPLFNM--NAMSALYHI--------AQN-ESPALQSGHWSE 241
Query: 267 ELLKRIHIGLLCVQEDPADRPT 288
+ C+Q+ P DRPT
Sbjct: 242 YFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 40/201 (19%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIAKL------QHKNLVRL 109
++LGEG G V K L + I A+K ++ LQ K ++ +L + +V+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKY 64
Query: 110 LGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM------CIING------ 155
G L+ + + + EY SLD ++ + ++ ++ G
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 156 ---IARDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
I RD K K+ DFG++ S A T GT YMAPE
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPERIQGKP 179
Query: 204 FSVKSDVFSFGVLLLEIISGR 224
+S+ SDV+S G+ LLE+ R
Sbjct: 180 YSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 37/203 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKE-IAVKRL---SRSSGQGLQEFKN----------LIAKLQHK 104
+G+G +G VY + E +AVK++ + +G+ K+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLL-----FDS--TRSV-------------QL 144
N+V+ LG L + EY+P S+ L F+ R +
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 145 DWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE--YALEG 202
+R + N + D KISDFG+++ + G+ +MAPE ++
Sbjct: 129 ILHRDLKADN-LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187
Query: 203 LFSVKSDVFSFGVLLLEIISGRK 225
+S K D++S G ++LE+ +GR+
Sbjct: 188 GYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 43/203 (21%)
Query: 56 ENKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSSGQGLQEFKN------LIAKLQHKNLV 107
E +G G FG V G L +EI V + +G ++ ++ ++ + H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGI----------- 156
L G + ++++ EYM N SLD L Q + + ++ GI
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 157 -------ARDHKMNP----KISDFGMARVFGGNQSEANTNRVVGTYG------YMAPEYA 199
AR+ +N K+SDFG++RV + A T R G + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS 222
F+ SDV+S+G+++ E++S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 57/234 (24%)
Query: 44 DLIHEATRNFSNEN-----KLGEGGFGPVYKG-VLNDDKE-------IAVKRLSRSSGQG 90
+L + FS + LGEG FG V L DK+ +AVK L + +
Sbjct: 3 ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE- 61
Query: 91 LQEFKNLIAKLQ-------HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLL-------- 135
++ +L+++++ HKN++ LLG C + L +I EY +L L
Sbjct: 62 -KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 136 ---FDSTR------------SVQLDWNRRM-------CIINGIARDHKMNP-----KISD 168
+D R S R M CI +A + + KI+D
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 180
Query: 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
FG+AR T +MAPE + +++ +SDV+SFGVL+ EI +
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 27/195 (13%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSG----QGLQEFKNLIAKLQHKNLV 107
F+ ++G+G FG V+KG+ N ++ +A+K + + +Q+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 108 RLLGCCLEGNELLLICEYMPNKS-LDFLL---FDSTRSVQ--------LDW-------NR 148
+ G L+G +L +I EY+ S LD L FD + LD+ +R
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 149 RMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
+ N + + + K++DFG+A Q + NT VGT +MAPE + + K+
Sbjct: 126 DIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKA 182
Query: 209 DVFSFGVLLLEIISG 223
D++S G+ +E+ G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 24/200 (12%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---LIAKL 101
I + + ++ K+G+G G V+ + + +E+A+K+++ + N ++ +L
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCII------- 153
++ N+V L L G+EL ++ EY+ SL D + Q+ R C+
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHA 133
Query: 154 -NGIARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
I RD K + K++DFG QS+ +T +VGT +MAPE
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 204 FSVKSDVFSFGVLLLEIISG 223
+ K D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 57/235 (24%)
Query: 41 FPLDLIHEATR-NFSNENKLGEGGFGPVYK----GVLNDDKE----IAVKRLSRSSGQGL 91
PLD E R LGEG FG V + G+ + +AVK L ++
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-- 58
Query: 92 QEFKNLIAKLQ-------HKNLVRLLGCCLEGNELLLICEYMPNKSL-DFL--------- 134
++ +LI++++ HKN++ LLG C + L +I EY +L +FL
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 135 -LFDSTRSV--QLDW-----------------NRRMCIINGIA-------RDHKMNPKIS 167
FD T+ QL + R CI +A D+ M KI+
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVM--KIA 176
Query: 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
DFG+AR T+ +MAPE + +++ +SDV+SFG+L+ EI +
Sbjct: 177 DFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIA------KLQHKN 105
F++ ++G G FG VY + ++ +A+K++S S Q ++++++I +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIING---------- 155
+ GC L + L+ EY + D L L I +G
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 156 ---IARDHKM-NPKISDFGMARV--FGGNQSEANTNRVVGTYGYMAPEYAL---EGLFSV 206
I RD K N +++ G ++ FG + N VGT +MAPE L EG +
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 207 KSDVFSFGVLLLEIISGRKDTRF------YLYEQGQ----SLLTYTWKLWCEGNAQELMD 256
K DV+S G+ +E ++ RK F LY Q +L + W + +
Sbjct: 204 KVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262
Query: 257 PVLKESFILEELLKRIHI 274
+ ++ EELLK + +
Sbjct: 263 KIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 31/194 (15%)
Query: 59 LGEGGFGPVY------KGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
LG+GGFG V G + K++ KRL + G+ + + I + + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 113 CLEG-NELLLICEYMPNKSLDFLL-------FDSTRSV---------QLDWNRRMCIIN- 154
E ++L L+ M L + + F R++ ++R +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 155 ----GIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDV 210
+ D N +ISD G+A G + GT GYMAPE ++ D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 211 FSFGVLLLEIISGR 224
F+ G L E+I+GR
Sbjct: 178 FALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 56/216 (25%)
Query: 59 LGEGGFGPVYKG-VLNDDKE-------IAVKRLSRSSGQGLQEFKNLIAKLQ-------H 103
LGEG FG V + DKE +AVK L + + ++ +LI++++ H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKH 83
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWN--------------- 147
KN++ LLG C + L +I EY +L ++L ++ +N
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 148 --------------RRMCIINGIA-------RDHKMNPKISDFGMARVFGGNQSEANTNR 186
+ CI +A D+ M KI+DFG+AR T
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHIDYYKKTTN 201
Query: 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 64/289 (22%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ------GLQEFKNLIAKLQHKN 105
+ N +GEG +G V K + +I A+K+ S ++E + ++ +L+H+N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHEN 61
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLL-----FDSTRSVQLDWNRRMCIINGIARDH 160
LV L+ L L+ E++ + LD L D +R + + I+ GI H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ----ILRGIEFCH 117
Query: 161 KMN-------P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-E 201
N P K+ DFG AR E T+ V T Y APE + +
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGD 175
Query: 202 GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLW-CEGNA----QELMD 256
+ D+++ G L+ E+++G G S + + + C GN QE+
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEP------LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 257 ----------PVLKESFILEELLKRIHIGLL-----CVQEDPADRPTMS 290
P +KE LE+ ++ +L C++ DP DRP+ S
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 74/293 (25%), Positives = 117/293 (39%), Gaps = 79/293 (26%)
Query: 56 ENKLGEGGFGPVYKGVLNDD---KEIAVKRLSRSSGQGLQEFKNLIAKLQ-------HKN 105
++ +GEG FG V K + D + A+KR+ + + + ++ +L+ H N
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPN 69
Query: 106 LVRLLGCCLEGNELLLICEYMPNKS-LDFL-------------LFDSTRSV----QL--- 144
++ LLG C L L EY P+ + LDFL + +ST S QL
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 145 --DWNRRMCIING---IARD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT 190
D R M ++ I RD KI+DFG++R E + +G
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 184
Query: 191 YG--YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKD-----TRFYLYEQGQSLLTYTW 243
+MA E +++ SDV+S+GVLL EI+S T LYE+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244
Query: 244 KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L C+ +LM C +E P +RP+ + ++ L
Sbjct: 245 PLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIA------KLQHKN 105
F +++G G FG VY + E+ AVK++S S Q ++++++I +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIING---------- 155
+ GC L+ + L+ EY + D L L I +G
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 156 ---IARDHKM-NPKISDFGMARV--FGGNQSEANTNRVVGTYGYMAPEYAL---EGLFSV 206
I RD K N +++ G ++ FG + N VGT +MAPE L EG +
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDG 199
Query: 207 KSDVFSFGVLLLEI 220
K DV+S G+ +E+
Sbjct: 200 KVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 54/195 (27%), Positives = 78/195 (40%), Gaps = 31/195 (15%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ------GLQEFKNLIAKLQHKNLVRLL 110
+GEG +G V K EI A+K+ S L+E K L L+H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ-LRHENIVNLK 66
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN----- 163
L L+ EY+ L+ LL S + D R ++ IA H N
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125
Query: 164 --P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS-D 209
P K+ DFG AR + T+ V T Y APE + K D
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNYGKPVD 184
Query: 210 VFSFGVLLLEIISGR 224
V++ G ++ E++ G
Sbjct: 185 VWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 66/276 (23%)
Query: 56 ENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSGQGLQEFKNL-----IAKLQHKNL 106
E LG G FG + +G L + +A+ L R+ Q L + + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK----- 161
VRL G GN ++++ EYM N +LD L QL + M ++ G+A K
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 162 -----------------MNPKISDFGMARVFGGNQSEA--NTNRVVGTYGYMAPEYALEG 202
+ KIS F + ++SEA T + APE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
FS SDV+SFG+++ E++S Y + + + + Q+++ V ++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS------------------YGERPYWDMSGQDVIKAV-EDG 224
Query: 263 FIL------EELLKRIHIGLLCVQEDPADRPTMSSV 292
F L LL ++ L C Q++ +RP S +
Sbjct: 225 FRLPAPRNCPNLLHQLM--LDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 61/237 (25%)
Query: 41 FPLDLIHEATRNFSNENK-LGEGGFGPVYKG-VLNDDKE-------IAVKRLSRSSGQGL 91
P D E +R K LGEG FG V + DK+ +AVK L +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-- 58
Query: 92 QEFKNLIAKLQ-------HKNLVRLLGCCLEGNELLLICEY------------------- 125
++ +L+++++ HKN++ LLG C + L ++ EY
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 126 -------MPNKSLDF-----LLFDSTRSVQLDWNRRMCIINGIA-------RDHKMNPKI 166
+P + L F + R ++ +++ CI +A D+ M KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAARNVLVTEDNVM--KI 175
Query: 167 SDFGMAR-VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+DFG+AR V + + TN + +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 41/203 (20%)
Query: 56 ENKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSSGQGLQEFKNLIA------KLQHKNLV 107
E +G G FG V +G L +EI V + SG ++ ++ ++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 108 RLLGCCLEGNELLLICEYMPNKSLD-FLLFDSTR--SVQLDWNRRMCIINGIARDHK--- 161
L G + +++I E+M N +LD FL + + +QL + ++ GIA K
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLS 123
Query: 162 -MN------------------PKISDFGMARVFGGNQSEANTNRVVG---TYGYMAPEYA 199
MN K+SDFG++R + S+ +G + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS 222
F+ SDV+S+G+++ E++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 50/272 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKN 105
+ K+GEG FG +Y D KEI + ++ + ++ L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------- 157
+V E L ++ EY L + R V ++ + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 158 -----RDHK----------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
RD K M K+ DFG+AR + A T VGT Y++PE
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNR 177
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE- 261
++ K+D++S G +L E+ + + +G +L K+ C+G P+
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPF------EGNNLHQLVLKI-CQGY----FAPISPNF 226
Query: 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
S L L+ ++ + P DRP+++S++
Sbjct: 227 SRDLRSLISQL------FKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 45/202 (22%)
Query: 56 ENKLGEGGFGPVY-----KGVLNDD----KEIAVKRLS-RSSGQGLQEFKNLIAKLQHKN 105
+ +LG+G FG VY K V + KEI V L+ + Q QE L++KL H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-AQLLSKLDHPA 63
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-------LDW------------ 146
+V+ LE + +I EY + LD L + + + +W
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 147 NRRMCIINGIARDHKMNP--------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
RR+ + RD K KI DFG++R+ G+ A T GT YM+PE
Sbjct: 124 QRRI-----LHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176
Query: 199 ALEGLFSVKSDVFSFGVLLLEI 220
+ KSD++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 70/276 (25%), Positives = 108/276 (39%), Gaps = 78/276 (28%)
Query: 57 NKLGEGGFGPVYK------------GVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHK 104
N++G G G VYK V+ + E V+R Q +E + ++ + H
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR------QICREIE-ILRDVNHP 132
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM-- 162
N+V+ E+ ++ E+M SL+ + + D R+ I++GIA H+
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-DVARQ--ILSGIAYLHRRHI 189
Query: 163 ----------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE--------- 197
N KI+DFG++R+ Q+ N VGT YM+PE
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 198 ----YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW-KLWCEGNAQ 252
YA D++S GV +LE GR F + QG W L C A
Sbjct: 248 AYDGYA--------GDIWSLGVSILEFYLGR--FPFGVGRQGD------WASLMC---AI 288
Query: 253 ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT 288
+ P + E R I C+Q +PA R +
Sbjct: 289 CMSQPPEAPATASREF--RHFIS-CCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 51/223 (22%)
Query: 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQ------GLQEFKNLIAKL 101
R++ KLGEG FG VYK +A+K++ + + L+E K ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK-ILKKL 64
Query: 102 QHKNLVRLLGCCLEG--------NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-- 151
+H N+V L+ +E + ++ YM + L LL SV+L ++ C
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLL--ENPSVKLTESQIKCYM 121
Query: 152 --IINGIA---------RD---------HKMNPKISDFGMARVF---------GGNQSEA 182
++ GI RD ++ KI+DFG+AR + GG
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 183 NTNRVVGTYGYMAPEYAL-EGLFSVKSDVFSFGVLLLEIISGR 224
+V T Y PE L E ++ D++ G + E+ + R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 55/208 (26%)
Query: 61 EGGFGPVYKGVLND-----DKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRLL 110
EG FG ++ G+L D ++E+ VK + + + LQE L L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPIL 74
Query: 111 GCCLEGNELLLICEYMPNKS-LDFLLFD------------STRS---------------- 141
C+E E + N L L ST+
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 142 ----VQLDWNRRMCIINGIARDHKMNPKISDFGMAR-VFGGNQS--EANTNRVVGTYGYM 194
+ D R C+I D ++ KI+D ++R +F + N NR V +M
Sbjct: 135 KRGVIHKDIAARNCVI-----DEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WM 186
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIIS 222
A E + +S SDV+SFGVLL E+++
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 37/195 (18%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLL 110
++G+GG+G V+ D EI A+KR+ +S L E ++++ + + LV+LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-----RMCIING------IARD 159
+ L L EY+P LL ++ + D R ++ I RD
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 160 HKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
K P K++DFG+++ G + AN+ VVG+ YMAPE +
Sbjct: 127 LK--PENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEVLRGKGYDFTV 179
Query: 209 DVFSFGVLLLEIISG 223
D +S G +L E + G
Sbjct: 180 DYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 58 KLGEGGFGPVYKGVLNDDK---EIAVKRLSRSSGQGLQEFKNLIAKLQHK----NLVRLL 110
+LG G FG V KGV K ++A+K L + + +++ A++ H+ +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 111 GCCLEGNELLLICEYMPNKSLDFLL------FDSTRSVQLDWNRRMCII-----NGIARD 159
G C E L+L+ E L+ L + V+L M + N + RD
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTY--GYMAPEYALEGLFSVKS 208
++ KISDFG+++ G + S R G + + APE FS +S
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 209 DVFSFGVLLLEIIS-GRK 225
DV+S+G+ + E S G+K
Sbjct: 180 DVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 36/200 (18%)
Query: 52 NFSNENKLGEGGFGPVYKG-VLNDDKEIAVKRLSRSSGQGLQEFKNLIAKL---QHKNLV 107
N K+GEG G V + +++AVK++ Q + N + + QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIING------------ 155
+ L G+EL ++ E++ +L D +++ + +
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQG 135
Query: 156 -IARDHKMNP---------KISDFGMARVFGGNQSEANTNR--VVGTYGYMAPEYALEGL 203
I RD K + K+SDFG F S+ R +VGT +MAPE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 204 FSVKSDVFSFGVLLLEIISG 223
+ + D++S G++++E++ G
Sbjct: 192 YGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 67/265 (25%), Positives = 113/265 (42%), Gaps = 38/265 (14%)
Query: 47 HEATRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIA------ 99
+ + F++ ++G G FG VY E+ A+K++S S Q ++++++I
Sbjct: 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 100 KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFL--LFDSTRSVQ--------LDWNRR 149
+L+H N + GC L + L+ EY + D L + V+ L
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 150 MCIINGIARDHKM-NPKISDFGMARV--FGGNQSEANTNRVVGTYGYMAPEYAL---EGL 203
+ I RD K N +++ G ++ FG + N VGT +MAPE L EG
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
+ K DV+S G+ +E ++ RK F + S L + AQ P L +
Sbjct: 191 YDGKVDVWSLGITCIE-LAERKPPLFNM--NAMSALYHI--------AQN-DSPTLSSND 238
Query: 264 ILEELLKRIHIGLLCVQEDPADRPT 288
+ + C+Q+ P DRP+
Sbjct: 239 WSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 50/211 (23%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVK--RLSRSSG----QGLQEFKNLIAKLQHK 104
F N++GEG +G VY+ EI A+K R+ L+E L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT-LLLNLRHP 66
Query: 105 NLVRLLGCCLEGNEL---LLICEY-----------MPN-------KSLDFLLFDSTRSVQ 143
N+V L + G L L+ EY MP K L L
Sbjct: 67 NIVELKE-VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRG----- 120
Query: 144 LDWNRRMCIINGIARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYM 194
L + II+ RD K++ KI+DFG+AR + G ++ T +VV T Y
Sbjct: 121 LQYLHENFIIH---RDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYR 175
Query: 195 APEYALEGLFSVKS-DVFSFGVLLLEIISGR 224
APE L + D+++ G +L E+++ +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 41/206 (19%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKE----IAVKRL---SRSSG---QGLQEFKNLIAKL 101
NF K+GEG +G VYK +K +A+K++ + + G ++E +L+ +L
Sbjct: 1 NFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-SLLKEL 56
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIA 157
H N+V+LL N+L L+ E++ F+ D++ + L + ++ G+A
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 158 ---------RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA 199
RD K +N K++DFG+AR F G T+ VV T Y APE
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 200 L-EGLFSVKSDVFSFGVLLLEIISGR 224
L +S D++S G + E+++ R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-08
Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKL--- 101
+ + + ++ K+G+G G VY + + +E+A+K+++ + N I +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCII------- 153
++ N+V L L G+EL ++ EY+ SL D + Q+ R C+
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHS 133
Query: 154 -NGIARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
I RD K + K++DFG QS+ +T +VGT +MAPE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 204 FSVKSDVFSFGVLLLEIISG 223
+ K D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 33/196 (16%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGCCL 114
LG+G FG VYK + A K + S + L++F +++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 115 EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING---------IARDHKM- 162
N+L ++ E+ +LD ++ + R + R +C ++ I RD K
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 163 --------NPKISDFGMARVFGGNQSEANT-NRVVGTYGYMAPEYALEGLFS-----VKS 208
+ K++DFG V N+S + +GT +MAPE F K+
Sbjct: 133 NILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 209 DVFSFGVLLLEIISGR 224
D++S G+ L+E+
Sbjct: 190 DIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-08
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 27/195 (13%)
Query: 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQG----LQEFKNLIAKLQHKNLV 107
F+ K+G+G FG V+KG+ N K +A+K + + +Q+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 108 RLLGCCLEGNELLLICEYMPNKS-LDFLL---FDSTRSVQ--------LDW-------NR 148
+ G L+ +L +I EY+ S LD L D T+ LD+ +R
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 149 RMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
+ N + +H K++DFG+A ++ N VGT +MAPE + + K+
Sbjct: 126 DIKAANVLLSEHG-EVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 209 DVFSFGVLLLEIISG 223
D++S G+ +E+ G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 30/193 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKE-----IAVKRL----SRSSGQGLQEFKNLIAKLQHKNLVRL 109
LG G FG VYKG+ D E +A+K L S + + + + ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 110 LGCCLEGNELLLICEYMPNKSL-DFLLFDSTR---SVQLDW----NRRMCIINGIARDHK 161
LG CL + + L+ + MP L D++ + R L+W + M + + H+
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133
Query: 162 ---------MNP---KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
+P KI+DFG+AR+ +++E + + +MA E L F+ +SD
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSD 193
Query: 210 VFSFGVLLLEIIS 222
V+S+GV + E+++
Sbjct: 194 VWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 79/280 (28%)
Query: 58 KLGEGGFGPVYKGVLNDD---------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVR 108
K+GEG FG K +L KEI + ++S + ++ +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ------LDWNRRMCIINGIARDHKM 162
E L ++ +Y L + ++ R V LDW ++C+ D K+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 163 ----------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
K+ DFG+ARV A T +GT Y++PE ++
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNN 180
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF--- 263
KSD+++ G +L E+ T + +E GN + L+ +++ S+
Sbjct: 181 KSDIWALGCVLYEMC-----TLKHAFEA--------------GNMKNLVLKIIRGSYPPV 221
Query: 264 ----------ILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
++ +L KR +P DRP+++S++
Sbjct: 222 SSHYSYDLRNLVSQLFKR----------NPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 49/268 (18%)
Query: 57 NKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQGLQEFKNLIAKLQ------HKNLVRL 109
+G G VY + + E +A+KR+ Q L ++Q H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKY 64
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII------------NG-I 156
+ G+EL L+ Y+ SL ++ S LD ++ NG I
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 157 ARDHKMNP---------KISDFGMARVF--GGNQSEANTNRVVGTYGYMAPEYALEGL-F 204
RD K KI+DFG++ GG+++ VGT +MAPE + +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF- 263
K+D++SFG+ +E+ +G + Y + L+ L + + L + +
Sbjct: 185 DFKADIWSFGITAIELATGAAP--YSKYPPMKVLM-----LTLQNDPPSLETGADYKKYS 237
Query: 264 -ILEELLKRIHIGLLCVQEDPADRPTMS 290
+++ LC+Q+DP+ RPT
Sbjct: 238 KSFRKMIS------LCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 50/212 (23%)
Query: 56 ENKLGEGGFGPVYKGVLNDD---KEIAVKRLSR-SSGQGLQEFK---NLIAKL-QHKNLV 107
E+ +GEG FG V + ++ D A+K L +S ++F ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFLLFD----------------STRSVQLDWNRRM 150
LLG C L + EY P +L DFL ST + Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 151 CIING---------IARD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG 192
+ G I RD + KI+DFG++R E + +G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181
Query: 193 --YMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+MA E +++ KSDV+SFGVLL EI+S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 29/200 (14%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKN------LIAKLQHK 104
+F +G+G FG V D K++ A+K +++ +N ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLL-----FDSTR--------SVQLDWNRRMC 151
LV L + + L+ + + L + L F + + L++
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 152 II------NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
II + I D + + I+DF +A + T GT GYMAPE +S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYS 177
Query: 206 VKSDVFSFGVLLLEIISGRK 225
V D +S GV E + G++
Sbjct: 178 VAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 36/198 (18%)
Query: 59 LGEGGFGPVY------KGVLNDDKEIAVKRLSRSSGQG----LQEFKNLIAKLQHKNLVR 108
LGEG FG V +G N +++AVK L SG L++ ++ L H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 109 LLGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSV----QLDWNRRMC-------IING 155
G C E GN + LI E++P+ SL L + + QL + ++C
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY 130
Query: 156 IARD---------HKMNPKISDFGMARVFGGNQS--EANTNRVVGTYGYMAPEYALEGLF 204
+ RD + KI DFG+ + ++ + + Y APE ++ F
Sbjct: 131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKF 189
Query: 205 SVKSDVFSFGVLLLEIIS 222
+ SDV+SFGV L E+++
Sbjct: 190 YIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 36/145 (24%), Positives = 66/145 (45%), Gaps = 40/145 (27%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPEYALEGLFSVKSDVFSFGVLLLE 219
KI DFG+AR ++N VV +MAPE + +++V+SDV+S+G+LL E
Sbjct: 252 KICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306
Query: 220 IIS-GRK-------DTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKR 271
I S G+ +++FY ++ +++ A + ++K
Sbjct: 307 IFSLGKSPYPGILVNSKFY------KMVKRGYQMSRPDFAPPEIYSIMK----------- 349
Query: 272 IHIGLLCVQEDPADRPTMSSVVFML 296
+C +P +RPT S + ++
Sbjct: 350 -----MCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 41/190 (21%), Positives = 80/190 (42%), Gaps = 29/190 (15%)
Query: 57 NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ---HKNLVRLLGC 112
++G G +G VYK + + +A+K + G + + I+ L+ H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMNP------ 164
L ++L ++ EY SL + + + +C + G+A H+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128
Query: 165 ------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE---GLFSVKSD 209
K++DFG++ ++ + +GT +MAPE A G + K D
Sbjct: 129 GANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDGKCD 186
Query: 210 VFSFGVLLLE 219
+++ G+ +E
Sbjct: 187 IWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 44/195 (22%), Positives = 90/195 (46%), Gaps = 37/195 (18%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI----AVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLL 110
+LG+G FG VYK +KE A K + S + L+++ ++A H +V+LL
Sbjct: 19 ELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKM------ 162
G +L ++ E+ P ++D ++ + R + + +C ++ + H M
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 163 ------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-----EGLFS 205
+ K++DFG++ ++ + +GT +MAPE + + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 206 VKSDVFSFGVLLLEI 220
K+D++S G+ L+E+
Sbjct: 194 YKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 52/212 (24%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLS-RSSGQG-----LQEFKNLIAKLQHK 104
+ N++ EG +G VY+ EI A+K+L +G L+E N++ KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILLKLQHP 64
Query: 105 NLVRL----LGCCLEGNELLLICEYMPN--KSL------DFLLFD-STRSVQLDWNRRMC 151
N+V + +G L +++ ++ EY+ + KSL FL + +QL
Sbjct: 65 NIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------- 115
Query: 152 IINGIA---------RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGY 193
++G+A RD K +N KI DFG+AR +G T VV T Y
Sbjct: 116 -LSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLWY 172
Query: 194 MAPEYAL-EGLFSVKSDVFSFGVLLLEIISGR 224
APE L +S D++S G + E+++ +
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKL--- 101
+ + + ++ K+G+G G VY + + +E+A+++++ + N I +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCII------- 153
++ N+V L L G+EL ++ EY+ SL D + Q+ R C+
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 154 -NGIARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
I RD K + K++DFG QS+ + +VGT +MAPE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA 192
Query: 204 FSVKSDVFSFGVLLLEIISG 223
+ K D++S G++ +E+I G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 57/196 (29%), Positives = 82/196 (41%), Gaps = 32/196 (16%)
Query: 59 LGEGGFGPVY------KGVLNDDKEIAVKRLSRSSG-QGLQEFKNLIAKLQHKNLVRLLG 111
LG+GGFG V G L K++ KRL + G +G K ++AK+ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-----IING---------IA 157
+L L+ M L + +++ R C II+G I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 158 RDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
RD K N +ISD G+A QS+ T GT G+MAPE +
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 209 DVFSFGVLLLEIISGR 224
D F+ GV L E+I+ R
Sbjct: 179 DYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 38/197 (19%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLS-RSSGQGLQEFK----NLIAKLQHKNLVRLLG 111
K+GEG +G V+K + EI A+KR+ +G+ L+ +L+HKN+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTR------SVQLDWNRRMCIINGIARDHKMN-- 163
+L L+ EY + FDS V+ + ++ G+A H N
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKY--FDSCNGDIDPEIVKSFMFQ---LLKGLAFCHSHNVL 121
Query: 164 -----P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSV 206
P K++DFG+AR F G + VV T Y P+ L+S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179
Query: 207 KSDVFSFGVLLLEIISG 223
D++S G + E+ +
Sbjct: 180 SIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 46/208 (22%)
Query: 53 FSNENKLGEGGFGPVYKG---VLNDDKEIAVK--RLSRSS----GQGLQEFKNLIAKLQH 103
+ K+GEG +G VYK V N+ IA+K RL + ++E +L+ ++QH
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREI-SLLKEMQH 60
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLF-DSTRSVQLDWNRRMC------IINGI 156
N+VRL L L+ EY+ LD DS S N R+ I+ GI
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGI 115
Query: 157 ARDHK-------MNP------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197
A H + P K++DFG+AR F G T+ VV T Y APE
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPE 173
Query: 198 YALEGL-FSVKSDVFSFGVLLLEIISGR 224
L +S D++S G + E+++ +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 33/195 (16%)
Query: 59 LGEGGFGPV------YKGVLNDDKEIAVKRLSRSSGQGLQEF-KNLIAKLQHKNLVRLLG 111
LG+GGFG V G + K++ KRL + SG+ + K ++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGIARDHKM----- 162
L L+ M L + +++ L+ R + I GI H M
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 163 -------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
N ++SD G+A ++ + GT GYMAPE E +S D
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVD 176
Query: 210 VFSFGVLLLEIISGR 224
F+ G + E+++GR
Sbjct: 177 WFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 45/201 (22%)
Query: 58 KLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRL 109
+LG G FG V KG+ +K +AVK L + L N++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 110 LGCCLEGNELLLICEY----------MPNK--------------SLDFLLFDSTRSVQLD 145
+G C E +L+ E NK S+ + T V D
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 146 WNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-- 203
R ++ H KISDFG+++ G ++ N + + YA E +
Sbjct: 121 LAARNVLL---VTQHY--AKISDFGLSKALG---ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 204 --FSVKSDVFSFGVLLLEIIS 222
FS KSDV+SFGVL+ E S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 31/197 (15%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRL--------SRSSGQGLQEFKNLIAKLQHKNLVRL 109
LG+G FG VY ++ +E+A K++ + L+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 110 LGCCLEGNE--LLLICEYMPNKSLDFLLFDS---TRSVQLDWNRR----MCIING----- 155
GC + E L + EYMP S+ L T SV + R+ M ++
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 156 -------IARDHKMNPKISDFGMA-RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
I RD N K+ DFG + R+ S V GT +M+PE + K
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189
Query: 208 SDVFSFGVLLLEIISGR 224
+DV+S G ++E+++ +
Sbjct: 190 ADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 49/210 (23%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ------GLQEFKNLIAKLQHKNLVRL 109
++GEG +G VYK D E+ A+K++ + + ++E K ++ +L H+N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK-ILRQLNHRNIVNL 71
Query: 110 LGCCLEGNELL----------LICEYMPNKSLDFLLFDSTRSVQLDWNRRMC------II 153
+ + L L+ EYM D L S + ++ ++
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 154 NGIARDHKMN------------------PKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
G+ HK N K++DFG+AR++ +S TN+V+ T Y
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRP 185
Query: 196 PEYAL-EGLFSVKSDVFSFGVLLLEIISGR 224
PE L E + DV+S G +L E+ + +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 48/202 (23%)
Query: 62 GGFGPVY---KGVLNDDKEIAVKRLSRSSGQG-------LQEFKNLIAKLQHKNLVRLLG 111
G +G V+ K D A+K + ++ L E ++++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTE-RDILSQAQSPYVVKLYY 60
Query: 112 CCLEGNELLLICEYMPNKSLDFLL-----FDSTRSVQ--------LDWNRRMCIINGIAR 158
L L+ EY+P L LL D + L++ II+ R
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH---R 117
Query: 159 DHKMNP-----------KISDFGMARV------FGGNQSEANTNRVVGTYGYMAPEYALE 201
D K P K++DFG+++V N E R+VGT Y+APE L
Sbjct: 118 DLK--PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 202 GLFSVKSDVFSFGVLLLEIISG 223
S D +S G +L E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 26/189 (13%)
Query: 58 KLGEGGFGPV-YKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCC 113
K+GEG G V V + K +AVK++ Q + N ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 114 LEGNELLLICEYMPNKSLDFLLF------DSTRSVQLDWNRRMCIING---IARD----- 159
L G+EL ++ E++ +L ++ + +V L + + +++ I RD
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 160 ----HKMNPKISDFGM-ARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFG 214
H K+SDFG A+V ++ +VGT +MAPE + + D++S G
Sbjct: 147 ILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 215 VLLLEIISG 223
++++E++ G
Sbjct: 204 IMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 36/200 (18%)
Query: 59 LGEGGFGPVYK------GVLNDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVR 108
LG G F Y+ G L K++ R + S + L++ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDS---TRSVQLDWNRRMCIINGIA-------- 157
+LG E + L E+M S+ LL +V +++ ++ G++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL--RGLSYLHENQII 125
Query: 158 -RDHK----------MNPKISDFGMARVFGGNQSEAN--TNRVVGTYGYMAPEYALEGLF 204
RD K +I+DFG A + A +++GT +MAPE +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185
Query: 205 SVKSDVFSFGVLLLEIISGR 224
DV+S G +++E+ + +
Sbjct: 186 GRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
K+ DFG++ G + + VGT YM+PE G ++VKSDV+S G+ ++E+ G+
Sbjct: 144 KLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 54/211 (25%)
Query: 59 LGEGGFGPVYKGVLNDD---KEIAVKRLSRSSGQGLQ-----EFKNLIAKLQHKNLVRLL 110
+GEG FG V K + D + A+KR+ + + E + L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 111 GCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLD-------------WNRRMC----- 151
G C L L EY P+ +L DFL +R ++ D ++++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 152 IING---------IARD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG- 192
+ G I RD KI+DFG++R E + +G
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPV 175
Query: 193 -YMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+MA E +++ SDV+S+GVLL EI+S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 31/192 (16%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAV-KRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGCC 113
+LG+G FG VYK + +A K + S + L+++ +++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-----IING------IARDHKM 162
N L ++ E+ ++D ++ + R + R +C +N I RD K
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131
Query: 163 ---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-----EGLFSVKS 208
+ K++DFG++ ++ + +GT +MAPE + + + K+
Sbjct: 132 GNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 209 DVFSFGVLLLEI 220
DV+S G+ L+E+
Sbjct: 190 DVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 44/200 (22%)
Query: 58 KLGEGGFGPVYKGV---LNDDK-EIAVKR----LSRSSGQGLQEFKNLIAKLQHKNLVRL 109
+GEG FG VY+GV ++K +AVK S S + + ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 110 LGCC---------------------------LEGNELLLICEYMPNKSLDFLLFDSTRSV 142
+G L+ L+L Y + +L +L +S R V
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS-YQLSTALAYL--ESKRFV 129
Query: 143 QLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
D R +++ K+ DFG++R ++S ++ +MAPE
Sbjct: 130 HRDIAARNVLVSS-----PDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESINFR 183
Query: 203 LFSVKSDVFSFGVLLLEIIS 222
F+ SDV+ FGV + EI+
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 51/205 (24%)
Query: 57 NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG------LQEFKNL--IAKLQHKNLV 107
++GEG +G VYK LN + +A+K++ + L+E L + +H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 108 RLLGCCL-----EGNELLLICEY----------------MPNKSLDFLLFDSTRSVQLDW 146
RLL C +L L+ E+ +P +++ L+ R V D+
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV--DF 122
Query: 147 NRRMCIINGIARDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
I++ RD K P KI+DFG+AR++ E VV T Y A
Sbjct: 123 LHSHRIVH---RDLK--PQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRA 174
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEI 220
PE L+ ++ D++S G + E+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 67/226 (29%)
Query: 57 NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG------------------LQEFKNL 97
LGEG +G V K K +A+K++ L+E K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-I 73
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPN---KSLDFLLFDSTRSVQLDWNRRMCI-- 152
+ +++H+N++ L+ +EG+ + L+ + M + K +D R ++L ++ CI
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-------RKIRLTESQVKCILL 126
Query: 153 --INGIARDHK-------MNP-----------KISDFGMARVFG------------GNQS 180
+NG+ HK ++P KI+DFG+AR +G Q
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 181 EAN-TNRVVGTYGYMAPEYAL-EGLFSVKSDVFSFGVLLLEIISGR 224
T++VV T Y APE + + D++S G + E+++G+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 23/58 (39%), Positives = 32/58 (55%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
KI DFG+AR + +MAPE + +++ +SDV+SFGVLL EI S
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 57/199 (28%), Positives = 80/199 (40%), Gaps = 41/199 (20%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRS-------SGQGLQEFKNLIAKLQHKNLVRLL 110
LG+G FG V L E A+K L + + E + L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 111 GCCLEGNE-LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IING---------I 156
C + E L + EY+ L F + S R D R II G I
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKGII 118
Query: 157 ARDHKMNP---------KISDFGMAR--VFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD K++ KI+DFGM + + G E + GT Y+APE ++
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKGQKYN 174
Query: 206 VKSDVFSFGVLLLEIISGR 224
D +SFGVLL E++ G+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 47/209 (22%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 58 KLGEGGFGPVYKG--VLNDDKEIAVKRL---SRSSGQGLQEFKNL-----IAKLQHKNLV 107
++GEG +G V+K + N + +A+KR+ + G L + + + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 108 RLLGCCL-----EGNELLLICEYMPN---------------------------KSLDFLL 135
RL C +L L+ E++ + LDFL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL- 126
Query: 136 FDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
S R V D + ++ + K++DFG+AR++ + VV T Y A
Sbjct: 127 -HSHRVVHRDLKPQNILVTSSGQ-----IKLADFGLARIY---SFQMALTSVVVTLWYRA 177
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEIISGR 224
PE L+ ++ D++S G + E+ +
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGVLNDDK---EIAVKRLSRS------SGQGLQEFKN 96
I E + N + +G G +G V D K +AVK+LSR + + +E +
Sbjct: 12 IWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELR- 68
Query: 97 LIAKLQHKNLVRLLGCCL------EGNELLLI-------------CEYMPNKSLDFLLFD 137
L+ ++H+N++ LL E N++ L+ C+ + + + FL++
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128
Query: 138 STRSVQL----DWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY 193
R ++ D R + +A + KI DFG+AR ++ V T Y
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 183
Query: 194 MAPEYALEGL-FSVKSDVFSFGVLLLEIISGR 224
APE L + ++ D++S G ++ E+++GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 67/264 (25%), Positives = 111/264 (42%), Gaps = 50/264 (18%)
Query: 59 LGEGGFGPVYKGVL----NDDKEIAVK--RLSRSSGQGLQEFKN--LIAKLQHKNLVRLL 110
+GEG FG + +L N D++ A+K RL +SS K L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCI-INGIA------R 158
L ++ EY L + L W +MC+ + I R
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 159 DHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
D K K+ DFG AR+ + A T VGT Y+ PE ++ KSD
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSD 182
Query: 210 VFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269
++S G +L E+ + + Q S K+ C+G+ + L S+ L L+
Sbjct: 183 IWSLGCILYELCTLKHPF------QANSWKNLILKV-CQGSYKPL---PSHYSYELRSLI 232
Query: 270 KRIHIGLLCVQEDPADRPTMSSVV 293
K++ + +P RP+ ++++
Sbjct: 233 KQM------FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 23/68 (33%), Positives = 37/68 (54%), Gaps = 6/68 (8%)
Query: 159 DHKMNPKISDFGMAR--VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVL 216
D + + KI+DFGM + + GG T+ GT Y+APE + D ++ GVL
Sbjct: 130 DSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVL 185
Query: 217 LLEIISGR 224
L E+++G+
Sbjct: 186 LYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 24/61 (39%), Positives = 39/61 (63%), Gaps = 6/61 (9%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISG 223
K+ DFG++ G ++ N VGT YM+PE L+G ++V+SD++S G+ L+E+ G
Sbjct: 140 KLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIG 194
Query: 224 R 224
R
Sbjct: 195 R 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 48/207 (23%)
Query: 57 NKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVR 108
+++G G FG V G + + VK L S+ LQE + L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRE-LNHPNVLQ 59
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSV----QLDWNRRMC--IINGIARDHKM 162
LG C+E LL+ E+ P L L + V Q D +RM + +G+ H+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 163 NPKISDFGMARVFGGNQSEANTNRVVGTYG----------------------YMAPEYAL 200
+ SD + A+ + +G YG ++APE
Sbjct: 120 DFIHSDLALRNCQ----LTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 201 E---GLFSVK----SDVFSFGVLLLEI 220
L S+++S GV + E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 33/194 (17%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLL 110
LG+G FG V L + + AVK L + + E + L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 111 GCCLEGNELLLICEYMPNKSLDFLL-----FDSTR---------SVQLDWNRRMCI---- 152
C + L + E++ L F + FD R S + + + I
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 153 -INGIARDHKMNPKISDFGMAR--VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
++ + DH+ + K++DFGM + +F G T+ GT Y+APE E L+ D
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEMLYGPSVD 178
Query: 210 VFSFGVLLLEIISG 223
++ GVLL E++ G
Sbjct: 179 WWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 11/99 (11%)
Query: 59 LGEGGFGPVYKGVLNDDK--------EIAVKRLS---RSSGQGLQEFKNLIAKLQHKNLV 107
LG+G F ++KG+ + E+ +K L R+ + E +++++L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW 146
G C+ G+E +++ EY+ SLD L + + + W
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 46/204 (22%)
Query: 59 LGEGGFGPVYKGVLND-DKEIAVKRLS-----RSSGQGLQEFKNLIAKLQHKNLVRLLGC 112
+G G FG V K + +AVKR+ + + L + ++ +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 113 CL-EGNELLLICEYMPNKSLDFL---LFDSTRSV---QLDWNRRMCIING---------- 155
EG+ IC + + SLD +++ +SV ++ + +
Sbjct: 72 LFREGD--CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129
Query: 156 IARDHKM---------NPKISDFGMARVFGGN--QSEANTNRVVGTYGYMAPE----YAL 200
I RD K N K+ DFG++ G S A T R G YMAPE A
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKT-RDAGCRPYMAPERIDPSAR 184
Query: 201 EGLFSVKSDVFSFGVLLLEIISGR 224
+G + V+SDV+S G+ L E+ +G+
Sbjct: 185 DG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 37/134 (27%), Positives = 56/134 (41%), Gaps = 32/134 (23%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
K+ DFG++ S A T VGT YMAPE + + SDV+S G+ +E+ GR
Sbjct: 135 KLCDFGVSTQL--VNSIAKT--YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
Query: 225 KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLL------- 277
+ Y Q Q N LM P+ I++E + +G
Sbjct: 191 -----FPYPQIQ------------KNQGSLM-PLQLLQCIVDEDPPVLPVGQFSEKFVHF 232
Query: 278 ---CVQEDPADRPT 288
C+++ P +RP
Sbjct: 233 ITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 38/201 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ----HKNLVRLLGCCL 114
+G G +G VYKG ++A ++ +G +E K I L+ H+N+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 115 EGN------ELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMC--IINGIARDHK---- 161
+ N +L L+ E+ S+ L+ ++ +++ +W +C I+ G++ H+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 162 --------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-----EG 202
K+ DFG++ +++ N +GT +MAPE +
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDA 191
Query: 203 LFSVKSDVFSFGVLLLEIISG 223
+ KSD++S G+ +E+ G
Sbjct: 192 TYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 72/281 (25%), Positives = 112/281 (39%), Gaps = 81/281 (28%)
Query: 57 NKLGEGGFGPVYK------GVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ--HK---- 104
++LG+G +G VYK GV KEI RL + F +I +L HK
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLELDESK----FNQIIMELDILHKAVSP 59
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN--RRMC--IING----- 155
+V G + + EYM SLD L + + + RR+ ++ G
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 156 -----IARDHKMNP---------KISDFGMARVFGGN--QSEANTNRVVGTYGYMAPEYA 199
I RD K K+ DFG++ GN S A TN +G YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN--IGCQSYMAPERI 173
Query: 200 LEG------LFSVKSDVFSFGVLLLEIISGR----KDTRFYLYEQGQSLLTYTWKLWCEG 249
G ++V+SDV+S G+ +LE+ GR +T ++ Q ++ +G
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI--------VDG 225
Query: 250 NAQELMDPVLKESFILE--ELLKRIHIGLLCVQEDPADRPT 288
+ P L + + + + C+ + P RPT
Sbjct: 226 DP-----PTLPSGYSDDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 41/132 (31%), Positives = 55/132 (41%), Gaps = 14/132 (10%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
KI DFG+AR + +MAPE + +++ +SDV+SFGVLL EI S
Sbjct: 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 225 KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPA 284
Y Q K A E P + I L C Q DP
Sbjct: 274 ASP--YPGVQINEEFCQRLKDGTRMRAPENATPEIYR------------IMLACWQGDPK 319
Query: 285 DRPTMSSVVFML 296
+RPT S++V +L
Sbjct: 320 ERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 21/123 (17%)
Query: 156 IARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFG 214
I D + +ISD G+A F + A+ VGT+GYMAPE +G+ + +D FS G
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLG 183
Query: 215 VLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF------ILEEL 268
+L +++ G R + + + T M L +SF +LE L
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTMAVELPDSFSPELRSLLEGL 233
Query: 269 LKR 271
L+R
Sbjct: 234 LQR 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 45/203 (22%), Positives = 78/203 (38%), Gaps = 40/203 (19%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKL-QHKNLVRLLGCCL 114
+GEG +G VYK ++ ++ +E K N++ K H N+ G +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 115 ------EGNELLLICEYMPNKSLDFL---LFDSTRSVQLDWNRRMC--IING-------- 155
++L L+ E S+ L L + ++ +W + + G
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133
Query: 156 -IARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE-----YAL 200
I RD K K+ DFG++ NT +GT +MAPE
Sbjct: 134 VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQP 191
Query: 201 EGLFSVKSDVFSFGVLLLEIISG 223
+ + +SDV+S G+ +E+ G
Sbjct: 192 DASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 27/74 (36%), Positives = 41/74 (55%), Gaps = 6/74 (8%)
Query: 153 INGIARDHKMNPKISDFGMAR--VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDV 210
++ I D + KI+DFGM + + G +A T GT Y+APE L ++ D
Sbjct: 124 LDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 211 FSFGVLLLEIISGR 224
+SFGVLL E++ G+
Sbjct: 180 WSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 65/217 (29%)
Query: 53 FSNENKLGEGGFGPV---YKGVLNDDKEIAVKRLSR------SSGQGLQEFKNLIAKLQH 103
+ N +G G G V Y V + +A+K+LSR + + +E L+ + H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYRELV-LMKLVNH 74
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLD-----FL---LFDST--RSVQLDWN-RRM-- 150
KN++ LL + P KSL+ +L L D+ + +Q+D + RM
Sbjct: 75 KNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY 122
Query: 151 ------CIING------IARDHKMNP-----------KISDFGMARVFGGNQSEANTNRV 187
C I I RD K P KI DFG+AR G + T V
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLK--PSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYV 178
Query: 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
V Y Y APE L + D++S G ++ E+I G
Sbjct: 179 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
K+ DFG++ G ++ N VGT YM+PE +SV+SD++S G+ L+E+ GR
Sbjct: 144 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 22/58 (37%), Positives = 33/58 (56%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
KI DFG+AR + + + +MAPE + L++ SDV+S+G+LL EI S
Sbjct: 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 35/197 (17%)
Query: 59 LGEGGFGPVYKGVLNDD-KEIAVKRL-----SRSSGQGLQEFK---NLIAKLQHKNLVRL 109
LG G FG VY D +E+AVK++ S+ + + + + L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 110 LGCCLEGNE--LLLICEYMPNKSLDFLLFDS---TRSVQLDWNRRMCIING--------- 155
GC + E L + EYMP S+ L T +V + R+ I+ G
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ--ILQGVSYLHSNMI 127
Query: 156 ---------IARDHKMNPKISDFGMA-RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
I RD N K+ DFG + R+ S V GT +M+PE +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG 187
Query: 206 VKSDVFSFGVLLLEIIS 222
K+DV+S ++E+++
Sbjct: 188 RKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 56/192 (29%), Positives = 80/192 (41%), Gaps = 28/192 (14%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ------GLQEFKNLIAKLQHKNLVRLLG 111
+GEG +G V K + KEI A+K+ S L+E K ++ L+ +N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK-MLRTLKQENIVELKE 67
Query: 112 CCLEGNELLLICEYMPNKSLDFL-------LFDSTRS--VQLDWNRRMCIINGIA-RDHK 161
+L L+ EY+ L+ L + RS QL C N I RD K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 162 MNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFS 212
K+ DFG AR S AN V T Y +PE L + D++S
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186
Query: 213 FGVLLLEIISGR 224
G +L E+ G+
Sbjct: 187 VGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 35/208 (16%)
Query: 53 FSNENKLGEGGFGPV------YKGVLNDDKEIAVKRLSRSSGQ--GLQEFKNLIAKLQHK 104
F + LG+GGFG V G + K++ KR+ + G+ L E K ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KRILEKVNSR 60
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLL-------FDSTRSV--------QLDWNRR 149
+V L + L L+ M L F + FD R++ L+ +R
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 150 MCII------NGIARDHKMNPKISDFGMARVFGGNQSEANTNR-VVGTYGYMAPEYALEG 202
I+ I D + + +ISD G+A E T R VGT GYMAPE
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEVINNE 176
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFY 230
++ D + G L+ E+I G+ R
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
KI DFG+AR + +MAPE + +++++SDV+SFGVLL EI S
Sbjct: 219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 9/117 (7%)
Query: 156 IARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFG 214
I D + +ISD G+A F + A+ VGT+GYMAPE +G + +D FS G
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSSADWFSLG 183
Query: 215 VLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKR 271
+L +++ G R + + + T + E + P LK +LE LL+R
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE--LPDSFSPELKS--LLEGLLQR 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 53/192 (27%), Positives = 76/192 (39%), Gaps = 47/192 (24%)
Query: 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGG 177
E LL Y K + FL S + D R I H KI DFG+AR
Sbjct: 214 EDLLSFSYQVAKGMSFLA--SKNCIHRDLAAR-----NILLTHGRITKICDFGLAR---- 262
Query: 178 NQSEANTNRVVGTYG-----YMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRK------ 225
++N VV +MAPE +++ +SDV+S+G+LL EI S G
Sbjct: 263 -DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
Query: 226 -DTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPA 284
D++FY K+ EG ++ P S + + I C DP
Sbjct: 322 VDSKFY-------------KMIKEG--YRMLSPECAPSEMYD-------IMKSCWDADPL 359
Query: 285 DRPTMSSVVFML 296
RPT +V ++
Sbjct: 360 KRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCC 113
K+GEG G V + K++AVK++ Q + N ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 114 LEGNELLLICEYMPNKSLDFLLF------DSTRSVQLDWNRRMCIING---IARDHKMNP 164
L G+EL ++ E++ +L ++ + +V L R + ++ I RD K +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 165 ---------KISDFGMARVFGGNQSEANTNR--VVGTYGYMAPEYALEGLFSVKSDVFSF 213
K+SDFG F S+ R +VGT +MAPE + + D++S
Sbjct: 149 ILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 204
Query: 214 GVLLLEIISG 223
G++++E+I G
Sbjct: 205 GIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
K+ DFG++ G ++ N VGT YM+PE +SV+SD++S G+ L+E+ GR
Sbjct: 144 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 53/188 (28%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRL---SRSSG---QGLQEFKNLIAKLQHKNLVRL 109
K+G+G FG V+K K+I A+K++ + G L+E K ++ L+H+N+V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNL 76
Query: 110 LGCC----LEGN----ELLLI---CEY-----MPNKSLDFLLFDSTRSVQLDWNRRMCII 153
+ C N L+ CE+ + NK++ F L + + +++ ++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM-------LL 129
Query: 154 NGIARDHK-------MNP-----------KISDFGMARVFGGNQSEAN---TNRVVGTYG 192
NG+ H+ M K++DFG+AR F +++ TNRVV T
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188
Query: 193 YMAPEYAL 200
Y PE L
Sbjct: 189 YRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 59 LGEGGFGPVYKGVLNDD-KEIAVKRL--------SRSSGQGLQEFKNLIAKLQHKNLVRL 109
LG+G FG VY D +E+AVK++ + L+ L+ L H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 110 LGCCLEGNE--LLLICEYMPNKSLDFLLFDS---TRSVQLDWNRRMCIING--------- 155
GC + E L + E+MP S+ L T +V + R+ I+ G
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ--ILEGVSYLHSNMI 127
Query: 156 ---------IARDHKMNPKISDFGMARVFGG-NQSEANTNRVVGTYGYMAPEYALEGLFS 205
I RD N K+ DFG ++ S V GT +M+PE +
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG 187
Query: 206 VKSDVFSFGVLLLEIISGR 224
K+D++S G ++E+++ +
Sbjct: 188 RKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 45/203 (22%)
Query: 59 LGEGGFGPVYKGVLNDD-------KEIAVKRL---------SRSSGQGLQEFKNLIAKLQ 102
LG G FG VYK ++ KEI V +S G + E + +L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR------SVQLDWNR--RMCII- 153
H N+VR LE + L ++ + + L F+S + + + WN +M +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLG-EHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 154 -------NGIARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197
+ RD N I+DFG+A+ Q E+ VVGT Y PE
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPE 183
Query: 198 YALEGLFSVKSDVFSFGVLLLEI 220
+ K+DV++FG +L ++
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 36/194 (18%)
Query: 58 KLGEGGFGPV-YKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCC 113
K+GEG G V + +++AVK + Q + N ++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR----------RMCIING---IARDH 160
L G EL ++ E++ +L D +L+ + +C ++ I RD
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 161 KMNP---------KISDFGMARVFGGNQSEANTNR--VVGTYGYMAPEYALEGLFSVKSD 209
K + K+SDFG F S+ R +VGT +MAPE + + D
Sbjct: 144 KSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 210 VFSFGVLLLEIISG 223
++S G++++E++ G
Sbjct: 200 IWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 57 NKLGEGGFGPVYKG--VLNDD----KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLL 110
+KLGEG + VYKG L D+ KEI ++ + ++E +L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREV-SLLKDLKHANIVTLH 70
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC---IINGIARDHK------ 161
L L+ EY+ +K L L D S+ + N ++ ++ G+ H+
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 162 -MNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKS 208
+ P K++DFG+AR ++ +N VV T Y P+ L +S +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQI 186
Query: 209 DVFSFGVLLLEIISGR 224
D++ G + E+ +GR
Sbjct: 187 DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 30/78 (38%), Positives = 39/78 (50%), Gaps = 11/78 (14%)
Query: 59 LGEGGFGPVYK----GVLNDDK--EIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLV 107
LG G FG V + G+ +D +AVK L S+ + E K L QHKN+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 108 RLLGCCLEGNELLLICEY 125
LLG C G +L+I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
K+ DFG ++++ S+ GT Y+APE +S K+D+FS GVLL E+++ +
Sbjct: 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 225 KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPA 284
R + E + ++ T G L + E ++ I LL DP
Sbjct: 243 ---RPFDGENMEEVMHKT----LAGRYDPLPPSISPE-------MQEIVTALLS--SDPK 286
Query: 285 DRPTMSSVVFM----LATDTITLLQPTQPAFSVG-RVKSPSDLK 323
RP+ S ++ M L + + TQP FS R ++
Sbjct: 287 RRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQ 330
|
Length = 496 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
KI DFG+AR + + + +MAPE L++ SDV+SFG+LL EI +
Sbjct: 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 28/63 (44%), Positives = 40/63 (63%), Gaps = 8/63 (12%)
Query: 165 KISDFGMAR--VFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEII 221
KI+DFGM + VFG N++ GT Y+APE L+GL ++ D +SFGVLL E++
Sbjct: 136 KIADFGMCKENVFGDNRAST----FCGTPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEML 190
Query: 222 SGR 224
G+
Sbjct: 191 IGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 15/80 (18%)
Query: 156 IARDHKMNP---------KISDFGMAR--VFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
I RD K++ KI+DFGM + +FGG T GT Y+APE +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAPEIIAYQPY 178
Query: 205 SVKSDVFSFGVLLLEIISGR 224
D ++FGVLL E+++G+
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 31/200 (15%)
Query: 53 FSNENKLGEGGFGPV------YKGVLNDDKEIAVKRLSRSSGQGLQ-EFKNLIAKLQHKN 105
F LG+GGFG V G + K++ KR+ + G+ + K ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLL-------FDSTRSVQL---------DWNRR 149
+V L + L L+ M L F + F+ R+V D ++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 150 MCII-----NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
+ I D + +ISD G+A Q+ VGT GYMAPE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERY 178
Query: 205 SVKSDVFSFGVLLLEIISGR 224
+ D ++ G LL E+I+G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 47/211 (22%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQ-----GLQEFKNLIAKLQHKN 105
+ N + +GEG +G V +A+K++S Q L+E K ++ + +H+N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-ILRRFKHEN 64
Query: 106 LVRLL-----GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-----IING 155
++ +L N++ ++ E M L+ ++ L N + I+ G
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLS-NDHIQYFLYQILRG 118
Query: 156 ---------IARDHK-----MNP----KISDFGMARVFGGNQSEANTNRV---VGTYGYM 194
+ RD K +N KI DFG+AR+ + +T + V T Y
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATRWYR 176
Query: 195 APEYALEGLFSVKS-DVFSFGVLLLEIISGR 224
APE L K+ D++S G +L E++S R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 37/198 (18%)
Query: 57 NKLGEGGFGPVYKG--VLNDD----KEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLL 110
KLGEG + V+KG L ++ KEI ++ + ++E +L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREV-SLLKDLKHANIVTLH 70
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFD-----STRSVQLDWNRRMCIINGIARDHK---- 161
L L+ EY+ +K L + D S +V++ + I+ G+A H+
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ---ILRGLAYCHRRKVL 126
Query: 162 ---MNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGLFSV 206
+ P K++DFG+AR ++ +N VV T Y P+ L +S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 207 KSDVFSFGVLLLEIISGR 224
+ D++ G + E+ SGR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 29/193 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLL 110
LG+G FG V L E+ A+K L + + E + L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 111 GCCLEGNELLLICEYMPNKSLDFLL-----FDSTRS--------VQLDWNRRMCII---- 153
C + L + EY+ L F + FD RS + L + R +I
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 154 --NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVF 211
+ I D + + K++DFGM + G + T GT Y+APE E + D +
Sbjct: 123 KLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180
Query: 212 SFGVLLLEIISGR 224
+ GVL+ E+++G+
Sbjct: 181 ALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 39/192 (20%)
Query: 62 GGFGPVY--KGVLNDDKEIAVKRLSRSSGQGLQEFKNLIA-------KLQHKNLVRLLGC 112
G FG VY K D A+K L +S + N+ A + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDY-FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHK-------MN 163
+ L L+ EY+ L+ + + DW ++ ++ G+ H+ +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 164 P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK-SDVF 211
P K++DFG++R N+ + VGT Y+APE + G+ K SD +
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDKMSDWW 177
Query: 212 SFGVLLLEIISG 223
S G ++ E + G
Sbjct: 178 SLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 33/195 (16%)
Query: 59 LGEGGFGPV------YKGVLNDDKEIAVKRLSRSSGQ--GLQEFKNLIAKLQHKNLVRLL 110
LG+GGFG V G + K++ KR+ + G+ L E K ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQILEKVNSRFVVSLA 66
Query: 111 GCCLEGNELLLICEYMPNKSLDFLL-------FDSTRSV--------QLDWNRRMCII-- 153
+ L L+ M L F + FD R+V L+ R I+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126
Query: 154 ----NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
I D + +ISD G+A ++ VGT GYMAPE ++ D
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 210 VFSFGVLLLEIISGR 224
+ G L+ E+I G+
Sbjct: 184 WWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 53/250 (21%), Positives = 109/250 (43%), Gaps = 50/250 (20%)
Query: 12 RTGDDDDDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGV 71
D+E S++ G+ + E + + D+ +++ N +G G FG VY+ +
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEK---MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAI 86
Query: 72 LNDDKE-IAVKRLSRSSGQGLQEFKN----LIAKLQHKNLVRLLGC----CLEGNE---- 118
D E +A+K++ + ++KN ++ L H N++ L C + NE
Sbjct: 87 CIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141
Query: 119 LLLICEYMP-------------NKSLDFLL-----FDSTRSVQLDWNRRMCIINGIARDH 160
L ++ E++P N +L L + R++ ++ +C + ++
Sbjct: 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL 201
Query: 161 KMNP-----KISDFGMAR-VFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSF 213
++P K+ DFG A+ + G +S + + + Y APE L ++ D++S
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVS----YICSRFYRAPELMLGATNYTTHIDLWSL 257
Query: 214 GVLLLEIISG 223
G ++ E+I G
Sbjct: 258 GCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 4/62 (6%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIIS 222
KI DFG+ARV ++S+ T VV Y Y APE L G ++ D++S G + E++
Sbjct: 143 KICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLG 200
Query: 223 GR 224
R
Sbjct: 201 RR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 51/209 (24%)
Query: 51 RNFSNENKLGEGGFGPV---YKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI-AKLQHKNL 106
+ + N +G G G V Y VL D+ +A+K+LSR F+N AK ++ L
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTHAKRAYREL 67
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLD-----FLLFD-------STRSVQLDWNRR----- 149
V L+ C N + L+ + P KSL+ +L+ + ++LD R
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 150 --MCIING------IARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYG 192
+C I I RD K + KI DFG+AR G S T VV Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY- 183
Query: 193 YMAPEYALEGLFSVKSDVFSFGVLLLEII 221
Y APE L + D++S G ++ E++
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 35.4 bits (82), Expect = 0.002
Identities = 15/48 (31%), Positives = 23/48 (47%), Gaps = 7/48 (14%)
Query: 298 TDTITLLQPTQPAFSVGR-------VKSPSDLKVCSANEVTLSTLSPR 338
++T + QP QP F VGR S + + N+VT+S + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 51/212 (24%)
Query: 51 RNFSNENKLGEGGFGPV---YKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI-AKLQHKNL 106
+ + N +G G G V Y +L ++ +A+K+LSR F+N AK ++ L
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYREL 74
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFL--------LFDSTR----SVQLDWNRR----- 149
V L+ C N + L+ + P KSL+ L D+ ++LD R
Sbjct: 75 V-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 150 --MCIING------IARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYG 192
+C I I RD K + KI DFG+AR G S T VV Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY- 190
Query: 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
Y APE L + D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 37/202 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVK--RLSRSSGQGLQEFK--NLIAKLQHKNL 106
++ KLGEG + VYKG + K +A+K RL G + +L+ L+H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 107 VRLLGCCLEGNELLLI--------CEYMPN-------KSLDFLLFDSTRSVQLDWNRRMC 151
V L L L+ C+YM +++ LF R + R +
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI- 124
Query: 152 IINGIARDHKMNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
+ RD K K++DFG+AR S +N VV T Y P+ L
Sbjct: 125 ----LHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVLLGS 178
Query: 203 L-FSVKSDVFSFGVLLLEIISG 223
+S D++ G + +E+I G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.003
Identities = 54/212 (25%), Positives = 81/212 (38%), Gaps = 47/212 (22%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLS-------RSSGQGLQEFKNLIAKLQHKNLVRLL 110
LG G FG V + A+K LS + L E K ++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE-KRILQSIRHPFLVNLY 67
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-------------RMCIINGIA 157
G + + L L+ EY+P L F + R I +
Sbjct: 68 GSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI--VY 124
Query: 158 RDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
RD K P KI+DFG A+ G T + GT Y+APE L +
Sbjct: 125 RDLK--PENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGK 177
Query: 207 KSDVFSFGVLLLEIISG----RKDTRFYLYEQ 234
D ++ G+L+ E+++G D +YE+
Sbjct: 178 AVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 44/201 (21%), Positives = 86/201 (42%), Gaps = 38/201 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKL-QHKNLVRLLGCCL 114
+G G +G VYKG ++A ++ + +E K N++ K H+N+ G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 115 E------GNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC--IINGIARDH----- 160
+ ++L L+ E+ S+ D + +++ DW +C I+ G+A H
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVI 143
Query: 161 -------------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-----EG 202
K+ DFG++ +++ N +GT +MAPE +
Sbjct: 144 HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDA 201
Query: 203 LFSVKSDVFSFGVLLLEIISG 223
+ +SD++S G+ +E+ G
Sbjct: 202 TYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 34/182 (18%)
Query: 77 EIAVKRLSRSSGQGLQEFKN------LIAKLQHKNLVRLLGCCLEGNELLL-ICEYMPNK 129
E+A+K L + + + L A+L H N+V LL LL + EY+P +
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 130 SLDFLLFDSTRSVQLDWNRRMCII---------NGI-------------ARDHKMNPKIS 167
+L +L + R M + GI + + K+
Sbjct: 65 TLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 168 DFGMARVFGGNQSEA-----NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
DFG+ + G + T V+GT Y APE + SD++++G++ LE ++
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
Query: 223 GR 224
G+
Sbjct: 185 GQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 52/211 (24%)
Query: 59 LGEGGFGPVYKGVLND-DKEIAVKRLS----RSSGQGLQEFKNLIAKLQHKNLVRL---- 109
LG G G V+ V +D DK +AVK++ +S L+E K +I +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVL 71
Query: 110 ----------LGCCLEGNELLLICEYM-------------PNKSLDFLLFDSTRSVQLDW 146
+G E N + ++ EYM + ++ R ++
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKY-- 129
Query: 147 NRRMCIINGIARDHK----------MNPKISDFGMARVFGGNQSEAN--TNRVVGTYGYM 194
+ N + RD K + KI DFG+AR+ + S + +V + Y
Sbjct: 130 ---IHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YR 185
Query: 195 APEYALEGLFSVKS-DVFSFGVLLLEIISGR 224
+P L K+ D+++ G + E+++G+
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 58 KLGEGGFGPVYKGVL---NDDKEIAVKRLSRSSGQGLQEFKN--LIAKLQHKNLVRLLGC 112
K+G G +G VYK DD++ A+K++ +G + + L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 113 CLE--GNELLLICEY-----------------------MPN---KSLDFLLFDSTRSVQL 144
L ++ L+ +Y +P KSL + + D +
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 145 DW--NRRMCIINGIARD---HKMNPKISDFGMARVFGGN-QSEANTNRVVGTYGYMAPEY 198
+W +R + N + + KI+D G AR+F + A+ + VV T+ Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 199 ALEGLFSVKS-DVFSFGVLLLEIIS 222
L K+ D+++ G + E+++
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 54/205 (26%)
Query: 57 NKLGEGGFGPVYKG-VLNDDKEIAVKRLSRSSGQGLQEFKNL-----IAKLQ-HKNLVRL 109
K+GEG F V K K A+K + + + L++ NL + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 110 LGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII-------------- 153
+ + L L+ E M D L++ + R+ +
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIK------GRKRPLPEKRVKSYMYQLLKS 112
Query: 154 ------NGI-ARD--------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
NGI RD K++DFG R G S+ + T Y APE
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDDILKLADFGSCR---GIYSKPPYTEYISTRWYRAPEC 169
Query: 199 AL-EGLFSVKSDVFSFGVLLLEIIS 222
L +G + K D+++ G + EI+S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 28/78 (35%), Positives = 35/78 (44%), Gaps = 11/78 (14%)
Query: 59 LGEGGFGPVYK----GVLNDDK--EIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLV 107
LG G FG V + G+ D +AVK L S+ + E K L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 108 RLLGCCLEGNELLLICEY 125
LLG C G L+I EY
Sbjct: 103 NLLGACTVGGPTLVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 9/78 (11%)
Query: 58 KLGEGGFGPVYKGVLNDD---KEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRL 109
++G G FG V G +N ++ VK L S+ + L+E + + LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRS-LQHSNLLQC 60
Query: 110 LGCCLEGNELLLICEYMP 127
LG C E LL+ E+ P
Sbjct: 61 LGQCTEVTPYLLVMEFCP 78
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 33/205 (16%)
Query: 53 FSNENKLGEGGFGPV------YKGVLNDDKEIAVKRLSRSSGQGLQ-EFKNLIAKLQHKN 105
F LG+GGFG V G + K + KR+ + G+ + K ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLL-------FDSTRSV--------QLDWNRRM 150
+V L + L L+ M L F + F+ R++ L+ R
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 151 CII------NGIARDHKMNPKISDFGMA-RVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
+ I D + +ISD G+A ++ G VGT GYMAPE
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQR 177
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTR 228
+++ D + G L+ E+I G+ R
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 23/71 (32%), Positives = 36/71 (50%), Gaps = 10/71 (14%)
Query: 165 KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG- 223
K++DFG+++ E GT YMAPE + +D +SFGVL+ E+++G
Sbjct: 138 KLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195
Query: 224 -------RKDT 227
RK+T
Sbjct: 196 LPFQGKDRKET 206
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 34/195 (17%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQ------GLQEFKNLIAKLQHKNLVRLL 110
K+GEG +G V+K + +I A+K+ S L+E + L +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML-KQLKHPNLVNLI 66
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN----- 163
+L L+ EY + L+ L + R V +++ + + HK N
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 164 --P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG--LFSVKS 208
P K+ DFG AR+ G + V T Y APE L G +
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPEL-LVGDTQYGPPV 182
Query: 209 DVFSFGVLLLEIISG 223
DV++ G + E+++G
Sbjct: 183 DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.004
Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 61/218 (27%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLI-AK---------- 100
+ +G G +G V V +++A+K++S F +LI AK
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54
Query: 101 -LQHKNLVRLL-----GCCLEGNELLLICEYMPN------KSLDFLLFDSTRSVQLDWNR 148
L+H+N++ LL + N++ ++ E M KS L D +
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYF------ 108
Query: 149 RMC-IINGIARDHKMN-------P-----------KISDFGMARVFGGNQSEAN--TNRV 187
+ I+ G+ H N P KI DFG+AR ++ E T V
Sbjct: 109 -LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 188 VGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGR 224
V T Y APE L ++ D++S G + E+++ +
Sbjct: 168 V-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 338 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.58 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.56 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.55 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.54 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.51 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.34 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.33 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.29 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.27 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.26 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.23 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.11 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.04 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.01 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.01 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.93 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.93 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.86 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.71 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.35 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.95 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.8 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.32 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.0 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.74 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.69 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 96.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 95.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 94.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 94.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 93.77 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 93.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 93.26 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.65 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 92.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 91.62 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 90.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 90.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 89.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 89.11 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 87.69 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 87.31 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 85.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 85.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 83.51 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=313.13 Aligned_cols=225 Identities=20% Similarity=0.307 Sum_probs=183.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.+|+..+.||+|+|+.||.++. .+|..||+|++.+. ..+.+..|+++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 78999999999652 3356778899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+|..++|..+++.... ..........|++.|+.|+|+. +|||+|||+|..+. ....+.
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le--~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE--YDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--Cccccc
Confidence 99999999999984433 3445556667889998887753 59999999999884 234556
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
.+.|||+.|.|||++....++..+||||+||++|.|+.|++||......+....+... ...++.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~---------~Y~~P~------- 239 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN---------EYSMPS------- 239 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc---------Cccccc-------
Confidence 6789999999999999889999999999999999999999999865554443333211 111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+||.++|+.||.+|||+.+||.
T Consensus 240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12234677888999999999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=301.28 Aligned_cols=236 Identities=20% Similarity=0.249 Sum_probs=182.3
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC----------cccHHHHHHHHHhcCCCceeeeeeEEEe
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS----------GQGLQEFKNLIAKLQHKNLVRLLGCCLE 115 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~~l~~l~hpnIv~~~~~~~~ 115 (338)
..+.+.|.+.+.||+|+||.|-+|. ..+++.||||++.+.. .....+|+++|+.|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 4477889999999999999999999 6779999999996432 1235689999999999999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCCC---------------------eEEeeeccce
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKMN---------------------PKISDFGMAR 173 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~~---------------------vkL~Dfg~a~ 173 (338)
.+..||||||+.||+|.+.+..... ..........|++.+|.|+|+.+ +||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999887765443 44455677778888888877643 8999999999
Q ss_pred ecCCCCCCccccccccCCccccccccccCC---CCcccchHhHhHHHHHHHhCCCCCcccccccc-cchhhHHHhhhccC
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGL---FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG-QSLLTYTWKLWCEG 249 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~ 249 (338)
..+ ......++|||+.|.|||++.+.. +..++||||+||+||.+++|.+||........ ...+. .+
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~-------~G 397 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL-------KG 397 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh-------cC
Confidence 863 445567899999999999998764 34589999999999999999999975433221 11111 11
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...... ........+.++||.+||..||++|||+.|+|+ ++..
T Consensus 398 ~y~f~p------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 398 RYAFGP------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred cccccC------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 111100 111233446788999999999999999999985 4543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=305.32 Aligned_cols=240 Identities=30% Similarity=0.396 Sum_probs=184.4
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
+......+.+.+++.||+|.||.||.|.+.....||+|.++.. ..+...+|+++|+.|+|+|||++++++..+..++|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 3344445567778999999999999999988889999999753 33567789999999999999999999999889999
Q ss_pred EEecCCCCCHHHHHhccC-c--cccccHHHHHHHHHHhhhc------------------CCCCeEEeeeccceecCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDST-R--SVQLDWNRRMCIINGIARD------------------HKMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~-~--~~~~~~~~~~~~~~~i~~~------------------~~~~vkL~Dfg~a~~~~~~~~ 180 (338)
|||||+.|+|.++++... . ........+.++++|++|+ ++..+||+|||+|+...+. .
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~ 357 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-E 357 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-c
Confidence 999999999999998722 2 2233345566777777764 3455999999999954322 2
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........-+..|.|||++..+.|+.|||||||||+||||+| |+.||......+....+..+.+...+..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~--------- 428 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG--------- 428 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC---------
Confidence 222222233568999999999999999999999999999998 8888877666555444444433322222
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
+.....++|..||..+|++||||+.+...|++..
T Consensus 429 -------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 429 -------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred -------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2234567888999999999999999999998754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=289.86 Aligned_cols=181 Identities=24% Similarity=0.393 Sum_probs=149.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
..++|++.+.||.|+||+||+|+++ ++..||||.+..+. .+.+..|+.+|+.++|||||.+++++++++++|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3568999999999999999999954 47789999997653 34467788999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccc-cccHHHHHHHHHHhhhcCC------------------------CCeEEeeeccceecCC
Q 045271 123 CEYMPNKSLDFLLFDSTRSV-QLDWNRRMCIINGIARDHK------------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~~~~------------------------~~vkL~Dfg~a~~~~~ 177 (338)
||||++|+|..+++..+... ........+++.++..+|+ ..+||+|||+|+.+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~- 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ- 166 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-
Confidence 99999999999998875432 2233344456655554322 348999999999874
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLY 232 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~ 232 (338)
......+.||++.|||||++..+.|+.|+|+||+|+++|+|++|+.||.....
T Consensus 167 --~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 167 --PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred --chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 34445678999999999999999999999999999999999999999975443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.06 Aligned_cols=236 Identities=29% Similarity=0.439 Sum_probs=176.3
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCC-EEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN-ELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~ 125 (338)
...+.+.||.|+||+||+|.+.....||||.+.... ...+..|+.+|..++|||||+++|++.+.. .+++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344556699999999999999666669999997543 236788889999999999999999999877 79999999
Q ss_pred CCCCCHHHHHhcc---CccccccHHHHHHHHHHhhhcCCC--------------------CeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDS---TRSVQLDWNRRMCIINGIARDHKM--------------------NPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~i~~~~~~--------------------~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+++|+|..++... ..........+++++.|+.|+|+. ++||+|||+++...... .
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999999763 223333345566677777776642 58999999998763221 2
Q ss_pred cccccccCCccccccccc--cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 183 NTNRVVGTYGYMAPEYAL--EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......||..|||||++. ...|+.|+|||||||++|||+||..||......+...... .......+..
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~------~~~~Rp~~p~---- 269 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV------VGGLRPPIPK---- 269 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcCCCCCCCc----
Confidence 233368999999999999 5589999999999999999999999998655411111111 0111111111
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
.....+..+|.+||..||.+||++.+|+..|+.......
T Consensus 270 -----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 -----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 122345567888999999999999999999998766554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=279.83 Aligned_cols=231 Identities=25% Similarity=0.308 Sum_probs=174.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCC-EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN-ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~ 123 (338)
..+.+.+..||+|..|+||+++++. ++.+|+|++.... ...+.+|+++++..+||+||++|++|.+.. .++|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3477888999999999999999654 6678999994433 244677888999999999999999999988 599999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||++|+|+.++...++ .....-.++.++++||.|+| ++.|||||||.+..+- ...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv----nS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV----NSI 233 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh----hhh
Confidence 99999999999876433 33334456667778877755 3569999999998873 235
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..++.||..|||||-+.+..|+.++||||||++++|+++|++||....... ......... ...+..+.+...
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~~-Iv~~ppP~lP~~------ 305 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLCA-IVDEPPPRLPEG------ 305 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHHH-HhcCCCCCCCcc------
Confidence 667899999999999999999999999999999999999999987541111 111111111 111111111111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....++.+|+..||+.||.+|||+.|++.
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12234567888899999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=280.74 Aligned_cols=232 Identities=24% Similarity=0.324 Sum_probs=172.3
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC-----CcccHHHHHHHHHhcCCCceeeeee-EEEeCCE-EEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS-----SGQGLQEFKNLIAKLQHKNLVRLLG-CCLEGNE-LLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~~l~~l~hpnIv~~~~-~~~~~~~-~~l 121 (338)
..+|+++++||+|+||.||++. ..+++.||.|.++-. ..+....|+.+|++|+|||||++++ .|..++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4579999999999999999999 678999999988632 2245667888999999999999999 6666666 899
Q ss_pred EEecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC----------------------CCeEEeeecccee
Q 045271 122 ICEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARV 174 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~ 174 (338)
|||+|.+|+|..+++.-. ......|....+++.++.+.|+ +.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999886422 2344556677777766665443 4599999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (338)
+... .......+||++||+||.+.+..|+.|+||||+||++|||+.-.+||......+-...+..+ +...+
T Consensus 178 l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-------d~~~~ 248 (375)
T KOG0591|consen 178 LSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-------DYPPL 248 (375)
T ss_pred hcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-------CCCCC
Confidence 8532 33345689999999999999999999999999999999999999999866433332222211 11111
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
++. ...-.+..++..|+..||+.||+...++..+..
T Consensus 249 p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 110 111234446677999999999985444444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.65 Aligned_cols=238 Identities=29% Similarity=0.403 Sum_probs=185.1
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG 116 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~ 116 (338)
...+.+.+..+.||+|+||.||+|+.. +...||||.++.... +++++|++++..++|||||+++|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344557778899999999999999932 234599999987654 4688899999999999999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCcc---------------ccccHHHHHHHHHHhhhcC------------------CCC
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRS---------------VQLDWNRRMCIINGIARDH------------------KMN 163 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~i~~~~------------------~~~ 163 (338)
+.+|+|+|||..|+|.+|++..... ......++.+++.|+.|+. +..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 9999999999999999999764321 1122456667777777743 234
Q ss_pred eEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHH
Q 045271 164 PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYT 242 (338)
Q Consensus 164 vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~ 242 (338)
|||+|||+++.++..+.......-.-+.+|||||.+..++|+++||||||||+|||+++ |..||.....++....+..+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999998876665444433445789999999999999999999999999999998 88999877665554444333
Q ss_pred HhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 243 WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+. ....+.++||..||+.+|.+||+|.||-.+|+...
T Consensus 722 ~lL~~Pe----------------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 722 QLLSCPE----------------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred CcccCCC----------------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2211111 12235678899999999999999999999998855
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=292.22 Aligned_cols=240 Identities=25% Similarity=0.334 Sum_probs=177.7
Q ss_pred CCCCCCChhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEe
Q 045271 36 QELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLE 115 (338)
Q Consensus 36 ~~~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~ 115 (338)
+.+..+|++.+.+ ++-||.|+.|.||+|+. .+..||||+++.-.. ..++.|++|+|||||.+.++|..
T Consensus 116 ~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE----TdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 116 EELWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE----TDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhhh----hhHHHHHhccCcceeeEeeeecC
Confidence 3455566666654 58899999999999997 567899998864332 34567899999999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCccccc-cHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecC
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTRSVQL-DWNRRMCIINGIARDHK------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~ 176 (338)
...+|||||||..|.|..+++........ .......++.|++|+|. ..|||+|||.++...
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999999999876654332 23344557777776553 238999999998763
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
. . .....++||..|||||++.+.+++.|+||||||||||||+||..||........ . |-. ..+...+
T Consensus 264 ~--~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----I--wGV--GsNsL~L-- 330 (904)
T KOG4721|consen 264 D--K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----I--WGV--GSNSLHL-- 330 (904)
T ss_pred h--h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----E--Eec--cCCcccc--
Confidence 2 2 233468999999999999999999999999999999999999999875322111 0 000 1111111
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccCC
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQ 305 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~~ 305 (338)
..+..+...+.-||++||+-.|..||+|++|+..|+-..+.+..
T Consensus 331 -----pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 331 -----PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred -----cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 11111222344477789999999999999999999987765543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.95 Aligned_cols=230 Identities=22% Similarity=0.312 Sum_probs=179.8
Q ss_pred HhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC---CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS---SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
....|....+||+|+.|.||.+. ..+++.||||.+... ..+.+..|+.+|+..+|+|||++++.|.-++.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34579999999999999999999 667889999998543 33557788899999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|+++|+|.+++...........++...+++||.++|. +.+||+|||+|..+... .....+
T Consensus 351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSKRST 428 (550)
T ss_pred ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--cCcccc
Confidence 9999999999877666555566667777778777654 55999999999987432 224556
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.+||++|||||++....|++++||||||++++||+.|.+||.....-.. .+.....+. .. +. ..-.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng~-P~-----lk--~~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT-PK-----LK--NPEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcCC-CC-----cC--Cccc
Confidence 8999999999999999999999999999999999999999974221111 111111111 11 11 1111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
-...+.+|+.+||+.|+.+|+||.++|+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1234567888999999999999999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=286.33 Aligned_cols=243 Identities=23% Similarity=0.245 Sum_probs=178.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcc----cHHHHHHHHHhcC-CCceeeeeeEEEeCC-EEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ----GLQEFKNLIAKLQ-HKNLVRLLGCCLEGN-ELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----~~~~~~~~l~~l~-hpnIv~~~~~~~~~~-~~~ 120 (338)
.+-++|.++++||.|+||.||+|. ..++..||||.++++... .-.+|++-|+.++ |||||++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345799999999999999999999 667889999999765432 1235566788888 999999999999887 999
Q ss_pred EEEecCCCCCHHHHHhccCccccc--cHHHHHHHHHHhhhcCCCC------------------eEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRSVQL--DWNRRMCIINGIARDHKMN------------------PKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~~~~~------------------vkL~Dfg~a~~~~~~~~ 180 (338)
+||||| ..+|.++++.+.+.... ...+..|+++||.|.|..+ +||+|||+|+.+..
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--- 162 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--- 162 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc---
Confidence 999999 89999999887664443 3456678999999987643 89999999998743
Q ss_pred CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC--ccc--cc
Q 045271 181 EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN--AQE--LM 255 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~ 255 (338)
....+..+.|.+|+|||++... .|+.+.||||+||+++|+.+-++-|++..--++.-.+ ......+.. ..+ .+
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI--c~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI--CEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH--HHHhCCCccccchhHHHH
Confidence 3345567899999999999865 6999999999999999999999888764322221111 111110000 000 00
Q ss_pred Cccccc-----------cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 256 DPVLKE-----------SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 256 ~~~~~~-----------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
...+.. ........++.++|.+|+++||++||||.+++++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000000 01112334678899999999999999999999744
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=277.39 Aligned_cols=261 Identities=44% Similarity=0.711 Sum_probs=211.9
Q ss_pred CCCCCChhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEE
Q 045271 37 ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCC 113 (338)
Q Consensus 37 ~~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~ 113 (338)
....++..++...+++|.....||+|+||.||+|...++..||||.+..... ..+..|+.++..++|||+|+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4566899999999999999999999999999999998889999998866443 4578888899999999999999999
Q ss_pred EeCC-EEEEEEecCCCCCHHHHHhccCccccccHHHHHH----HHHHhhhcCC---------------------CCeEEe
Q 045271 114 LEGN-ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGIARDHK---------------------MNPKIS 167 (338)
Q Consensus 114 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~----~~~~i~~~~~---------------------~~vkL~ 167 (338)
.+.+ +.++|+||+++|+|.+.+...... .+.|..++. ++.||+|+|. .+.||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999876554 567765555 5566666554 468999
Q ss_pred eeccceecCCCCCCcccccc-ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhh
Q 045271 168 DFGMARVFGGNQSEANTNRV-VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
|||+|+..+.. ....... .||..|+|||.+..+..+.|+|||||||++.||++|+.+..............+.+...
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765321 1111122 79999999999999899999999999999999999998776544333444566666677
Q ss_pred ccCCcccccCcccc-ccccH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 247 CEGNAQELMDPVLK-ESFIL-EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 247 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
......+++++.+. ..... .....+..+...|++.+|.+||++.+|++.|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 77789999999986 44443 57777888999999999999999999999996644
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=282.42 Aligned_cols=226 Identities=22% Similarity=0.291 Sum_probs=172.0
Q ss_pred cCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..|+.++.||+|.||.||+|. ..+++.||+|++.-.. .++++.++.+|.+++++||.++|+.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 367888999999999999999 5678889999986433 35577888899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|.+|++.+++..... .......+...++.++.+.| .+.+||+|||++..+... .....+
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr~t 170 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRRKT 170 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhcccc
Confidence 999999999987665 33333334444555555443 357999999999887432 223367
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
++||+.|||||++.+..|+.|+|||||||+.+||++|.+|+........... +..-..+.+.+ .
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~----~ 234 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG----D 234 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc----c
Confidence 8999999999999988999999999999999999999999875443111111 11111222222 1
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+||..||..||+.||||.++|+
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1123455666799999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.01 Aligned_cols=226 Identities=21% Similarity=0.249 Sum_probs=170.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.|++++.. +++.+|+|++++.. ......|..+|..++||+||+++..|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 568999999999999999999954 47789999986532 34567788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccccc-cHHHHHHHHH------------------HhhhcCCCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQL-DWNRRMCIIN------------------GIARDHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~------------------~i~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+||+.||.|...+.+.+..... .....-.++. ||..+++++++|+|||+|+..- .....
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~~~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDGDA 181 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cCCCc
Confidence 9999999999999876654332 2222222333 4444667889999999998542 23334
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..++|||+.|||||++.+..|+.++|+||+||++|+|++|.+||...........+..... ...+..
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~--------~~~p~~----- 248 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL--------PLPPGY----- 248 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC--------CCCCcc-----
Confidence 5568999999999999999999999999999999999999999986554444333332210 001110
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC----CHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRP----TMSSVV 293 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rp----s~~~vl 293 (338)
......+++..+|+.||++|. .+.+|-
T Consensus 249 ---ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 249 ---LSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred ---CCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 112456788889999999996 455543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=276.89 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=174.7
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC--CE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NE 118 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~ 118 (338)
....+.|+.+++||+|+||.||+|+ ..+++.||+|++..+.. ....+|+.+|+.|+|||||++.+...+. ..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 4455689999999999999999999 66789999999865542 2367888999999999999999998876 68
Q ss_pred EEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGN 178 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~ 178 (338)
+|||+||| .-+|.-++..... ......+...|++.|+.| ++++.+||+|||+|+++...
T Consensus 193 iYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999999 5666666655432 233445555667777666 44567999999999987544
Q ss_pred CCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh-----hhccCCcc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK-----LWCEGNAQ 252 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~~ 252 (338)
.... .+..+-|++|+|||++.+. .|+.++|+||+||||.||++|++.|+...--++...+....- .|....+.
T Consensus 272 ~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 3322 4445679999999999987 599999999999999999999998876543333322221111 11100111
Q ss_pred --cccCccccccccHHHH-----HHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 --ELMDPVLKESFILEEL-----LKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 --~~~~~~~~~~~~~~~~-----~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+.+...-...+.+. ...++|+..+|..||.+|.||.++|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111111111111111 24678999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.77 Aligned_cols=242 Identities=21% Similarity=0.255 Sum_probs=169.7
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
+.|+.+.++|+|+||.|++|+++ +|+.||||++..+.. +...+|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46899999999999999999954 588899999976544 335678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcc-CccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDS-TRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
||+..-|..+-+.. +...+....+..+++.+|.+.| ++.+||||||+|+.+.. .....+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YT 159 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYT 159 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhh
Confidence 99776665554332 1222233344455666655543 45699999999998853 233345
Q ss_pred ccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH--------HHhhhccC------C
Q 045271 186 RVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--------TWKLWCEG------N 250 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~------~ 250 (338)
..+.|.+|+|||.+.+ -.|+.++||||+||++.||++|.+-|+....-+..-.+.. ....+... .
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 5788999999999998 4799999999999999999999998886543322211111 11111111 1
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
++++-+......--+....-+++||+.||..||++|++-+|++.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111000000000111224678999999999999999999883
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=253.62 Aligned_cols=237 Identities=22% Similarity=0.303 Sum_probs=173.4
Q ss_pred cCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|..+++||+|+||.||+|+ ..+++.||||+++.... -...+|++.|+.++|+||+.++|+|-+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 478999999999999999999 66799999999965432 246778899999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccc--cHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQL--DWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+ ..+|...++........ .....+.++.|++|.| ++.+||+|||+|+.++.......
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~- 159 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT- 159 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc-
Confidence 99 78999999887664433 2344555677777654 35699999999998865433222
Q ss_pred cccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc----------
Q 045271 185 NRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE---------- 253 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 253 (338)
..+-|.+|+|||.+.+.. |+..+||||.||++.||+.|.+-|+....-++...+- ..........
T Consensus 160 -~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If---~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 160 -HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF---RALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred -cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH---HHcCCCCcccCccccccccH
Confidence 236789999999999874 9999999999999999999986655443322222111 1111111110
Q ss_pred -----ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 -----LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+. ..........++|+.+||.+||.+|+|+.|+++
T Consensus 236 ~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 236 VKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 0000010 011122334588999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=279.02 Aligned_cols=226 Identities=22% Similarity=0.239 Sum_probs=173.4
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+-|++++.||.|+.|.|-+|+ ..+|+..|||.+.+. ....+.+|+.+|+.+.||||+.+|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3578999999999999999999 456889999998654 234578888899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHh------------------hhcCCCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGI------------------ARDHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i------------------~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
.||+++|.|.+++...+. ..........+++.|+ ..+++.++||+|||+|..- .....
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCCcc
Confidence 999999999888876654 3333344444444444 3466778999999999863 23344
Q ss_pred ccccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
..+.||+++|.|||++.+.+|. .++||||+|||||.|++|+.||.++.......+...+ ..+.. ..+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--------~f~MP-s~I--- 235 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--------VFEMP-SNI--- 235 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--------cccCC-CcC---
Confidence 5678999999999999999885 7899999999999999999999855443332222211 01111 111
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
..++-+|+++||..||++|.|.+||+++
T Consensus 236 -----s~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 236 -----SSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----CHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1134457778999999999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=279.56 Aligned_cols=224 Identities=23% Similarity=0.283 Sum_probs=174.6
Q ss_pred cCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCccc-----HHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|.+.+.||+|+||.||+|+ ..+.+.||+|.+.+..... +.+|+++++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 478999999999999999999 5567789999997655433 7888999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
||. |+|..++..... +......+..++..++.|+|+ +.+|++|||+|+.... ......
T Consensus 82 ~a~-g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vlt 158 (808)
T KOG0597|consen 82 YAV-GDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLT 158 (808)
T ss_pred hhh-hhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cceeee
Confidence 995 599999876554 333445556667777776554 4589999999987643 233345
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
.+.||+.|||||++.+.+|+..+|.||+||++|||++|++||......+-...+... ... ++.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-------~v~----------~p~ 221 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-------PVK----------PPS 221 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-------CCC----------Ccc
Confidence 678999999999999999999999999999999999999999754433222111111 000 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+|+..+|+.||.+|.|..+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23345677888899999999999999985
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.37 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=176.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC--Cc----EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND--DK----EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~--~~----~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
.....++...||+|+||.||.|...+ +. .||||.+.+... ..+.+|+.+|+.++|||||+++|++.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34567888999999999999999433 32 389999876533 346677889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc------cc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccc
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR------SV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMA 172 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~------~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a 172 (338)
.+|++|||.+|+|..++++... .. ......+.++++|+.|++ +..|||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 9999999999999999987622 11 122445566777777643 345999999999
Q ss_pred eecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
+.+...+.........-+..|||||.+.+..|+.|+|||||||++||+++ |..||......+...... ..+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~gg-- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EGG-- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hCC--
Confidence 97655444333322344679999999999999999999999999999999 888887544333221111 011
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
++ ..+..+.-.++++|.+||+.+|++||+|..|++++......
T Consensus 922 -RL-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 -RL-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred -cc-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11 11112223456899999999999999999999988776554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=267.08 Aligned_cols=239 Identities=20% Similarity=0.244 Sum_probs=173.4
Q ss_pred HhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
..+.|++.+.||.|..+.||+|+ ...+..||||++.-.. -+.+.+|.+.++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35699999999999999999999 5567889999985322 256788888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCcc---ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 124 EYMPNKSLDFLLFDSTRS---VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+||.+|++.++++..... ......+....+.+|.|+| ++.|||+|||++..+.......
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999999764332 1122223334566666644 5679999999987664322111
Q ss_pred -cc-cccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 183 -NT-NRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 183 -~~-~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.. ..+.||++|||||++.+. .|+.|+|||||||+..||.+|..||..++.-..........+ +.+.-..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p-------p~~~t~~ 256 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP-------PTLLTSG 256 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC-------CCccccc
Confidence 11 457899999999997654 599999999999999999999999987654332211111111 1001111
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+...........+..++..||+.||.+||||.++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111222235677888899999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=282.46 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=181.7
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC------cccHHHHHHHHHhcC-CCceeeeeeEEEeCC
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGN 117 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~ 117 (338)
.....++|.+++.||+|+||.|+++. ..+++.+|||.+++.. .+....|.+++...+ ||.++.++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 44556799999999999999999999 4557789999997653 244666777776664 999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~ 179 (338)
++|+||||+.||++..+.+...-........+-+++.+|.+ +..+.+||+|||+|+....
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-- 520 (694)
T ss_pred eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC--
Confidence 99999999999996554443444444444444455555554 4456799999999987532
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
......++|||+.|||||++.+..|+.++|+|||||+||||+.|..||+.+.-.+. ++..+
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------------------FdsI~ 581 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------------------FDSIV 581 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------------------HHHHh
Confidence 23356679999999999999999999999999999999999999999975433222 12222
Q ss_pred cccccH--HHHHHHHHHHhhccCCCCCCCCCH-----HHHHH--Hh-hcCccccCCCCCCCcccCCCCCCCCcc
Q 045271 260 KESFIL--EELLKRIHIGLLCVQEDPADRPTM-----SSVVF--ML-ATDTITLLQPTQPAFSVGRVKSPSDLK 323 (338)
Q Consensus 260 ~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~-----~~vl~--~L-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (338)
...... -...+.+++|+++|+.||++|..+ .+|.. ++ +-.|..+..-.-....+++.+++.+.+
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~s 655 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVS 655 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhc
Confidence 211111 112356789999999999999965 45543 12 222333333222223444555555444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=269.46 Aligned_cols=229 Identities=21% Similarity=0.252 Sum_probs=172.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC--------CcccHHHHHHHHHhcC-CCceeeeeeEEEeCC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--------SGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGN 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~--------~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~ 117 (338)
...++|++.+.||+|+||.|+.|. ..++..||+|.+.+. ..+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 446699999999999999999998 556789999977553 1234557888999999 999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhh------------------cCC-CCeEEeeeccceecCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIAR------------------DHK-MNPKISDFGMARVFGG 177 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~------------------~~~-~~vkL~Dfg~a~~~~~ 177 (338)
.+++|||||.+|+|.+++...... .........|++.++.| +.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999884433 22334455566666555 334 689999999998763
Q ss_pred CCCCccccccccCCccccccccccCC-CC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGL-FS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
.......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||........... . ......+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i--~~~~~~~ 242 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------I--RKGEFKI 242 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------H--hcCCccC
Confidence 2234456789999999999999987 86 679999999999999999999986322211111 0 0111111
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+. ...+.+++.+||..||.+|+|+.+|++
T Consensus 243 p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 243 PSYLL-------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11111 234566778899999999999999983
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=264.25 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=173.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeCC--EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN--ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~ 123 (338)
..+|...+.||+|+||.||++... ++...|||.+.... .+.+.+|+.+|+.++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 447888999999999999999954 48889999987654 344788999999999999999999755444 699999
Q ss_pred ecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCC-CCC
Q 045271 124 EYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGN-QSE 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~-~~~ 181 (338)
||+++|+|.+++...+. ..........++++|+.++| ++.+||+|||++...... ...
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 99999999999987653 44444555567888888766 346899999999876431 111
Q ss_pred ccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|||||++.++. ...++||||+||++.||+||+.||... . ...............+.+.+. +
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~----~~~~~~~~ig~~~~~P~ip~~-l- 248 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F----EEAEALLLIGREDSLPEIPDS-L- 248 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c----chHHHHHHHhccCCCCCCCcc-c-
Confidence 2233468999999999999643 345899999999999999999999753 1 111111111212222222211 1
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+|+..|+..||++||||.++|+..-...
T Consensus 249 -------s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 249 -------SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -------CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 124567888999999999999999998555433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.65 Aligned_cols=231 Identities=21% Similarity=0.264 Sum_probs=167.8
Q ss_pred HhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
..++|+++..||+|+||.||+|+ ..+|..+|+|+++++. ...+..|..+|...++|.||+++-.|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45699999999999999999999 4558889999997643 3456677778888999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCccccccHHHHH--HHH------------------HHhhhcCCCCeEEeeeccceecCCC---
Q 045271 122 ICEYMPNKSLDFLLFDSTRSVQLDWNRRM--CII------------------NGIARDHKMNPKISDFGMARVFGGN--- 178 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~--~~~------------------~~i~~~~~~~vkL~Dfg~a~~~~~~--- 178 (338)
||||++||++..++...... ...+.... ..+ .|++.+..|++||+|||+|..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L-~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTL-TEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEecCCccHHHHHHhcCcC-chHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999988765432 22222221 111 2333356788999999999543110
Q ss_pred -----------------C-CCc------------------------cccccccCCccccccccccCCCCcccchHhHhHH
Q 045271 179 -----------------Q-SEA------------------------NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVL 216 (338)
Q Consensus 179 -----------------~-~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~ 216 (338)
. ... .....+|||-|||||++.+..|+..+|+||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0 000 0112479999999999999999999999999999
Q ss_pred HHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 045271 217 LLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT---MSSVV 293 (338)
Q Consensus 217 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~vl 293 (338)
+|||+.|.+||......+....+..-... +..+.......++.+||.+||. ||++|.. +.||.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRET-------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999876655544333211111 1111111112567888889999 9999996 66665
Q ss_pred H
Q 045271 294 F 294 (338)
Q Consensus 294 ~ 294 (338)
.
T Consensus 444 ~ 444 (550)
T KOG0605|consen 444 K 444 (550)
T ss_pred c
Confidence 3
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.12 Aligned_cols=217 Identities=23% Similarity=0.236 Sum_probs=165.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
...++|++++.||.|+||+|.+++ ..++.-+|+|++.+.. .+....|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 345689999999999999999999 4457789999986533 345667888999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCccc-cccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRSV-QLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|||||++||.|..+++..++.. ......+-+++.++.+ +.++.+||+|||+|+.+.
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 9999999999999998765532 2333344445544444 445679999999999873
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
...-+.|||+.|+|||+++...|+.++|+|||||++|||+.|.+||...........+..+.. ..+..+
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-----~fP~~f------ 264 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-----KFPSYF------ 264 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----cCCccc------
Confidence 224568999999999999999999999999999999999999999986544222222221111 111111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCC
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADR 286 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~R 286 (338)
...+.+|+..+|+.|-.+|
T Consensus 265 ------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 ------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------CHHHHHHHHHHHhhhhHhh
Confidence 1234567778999998888
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=266.34 Aligned_cols=233 Identities=21% Similarity=0.253 Sum_probs=171.1
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEecc------CCcccHHHHHHHHHhc-CCCceeeeeeEEEeCCE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSR------SSGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~------~~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~ 118 (338)
..-..+|.+++.||+|+|++|++|+ ..+++.||||++.+ ...+.+..|...|..| +||.|++|+-.|.|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4445689999999999999999999 66788999999854 3344566677778877 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCccccc-cHHHHHHHH------------------HHhhhcCCCCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQL-DWNRRMCII------------------NGIARDHKMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~------------------~~i~~~~~~~vkL~Dfg~a~~~~~~~ 179 (338)
+|+|+||+++|+|..+|+..+..-.. ....+-+++ +||+.+.++++||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999876542211 111222333 33444556779999999999875322
Q ss_pred CC-----------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 180 SE-----------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 180 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
.. .....++||..|.+||++.++..++.+|||+|||++|+|+.|.+||....--. .+.......
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----iFqkI~~l~ 303 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----IFQKIQALD 303 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----HHHHHHHhc
Confidence 21 11245899999999999999999999999999999999999999997432111 111100000
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.. +.+ .+ .....+|+.++|..||.+|+|+.+|.++.
T Consensus 304 y~----fp~------~f--p~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 304 YE----FPE------GF--PEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred cc----CCC------CC--CHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 111 11 12356688889999999999999998643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=262.80 Aligned_cols=228 Identities=18% Similarity=0.283 Sum_probs=174.7
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcc------cHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ------GLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
....-+|++.+.||.|+||.|-+|. +..+..||||.+.++..+ .+++|+++|..|+||||+.+|++|++.+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 3445689999999999999999999 678999999999776543 367888999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCcccc-ccHHHHHHHH------------------HHhhhcCCCCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSVQ-LDWNRRMCII------------------NGIARDHKMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~------------------~~i~~~~~~~vkL~Dfg~a~~~~~~~~ 180 (338)
.|||||..+|.|++++...+.... ....++.++. +||..+.++++||+|||++..+. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999977654322 2223333444 44555677889999999998763 2
Q ss_pred CccccccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....++||++-|.+||++.+.+|. +.+|.||+||+||.|+.|..||+..........+. .+...+...+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-------~GaYrEP~~P-- 276 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-------RGAYREPETP-- 276 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------cccccCCCCC--
Confidence 3345678999999999999999985 67999999999999999999998654333221111 1111111111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
..+.-||++||..||++|.|+.||...
T Consensus 277 ---------SdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 277 ---------SDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------chHHHHHHHHHhcCcccchhHHHHhhh
Confidence 112237788999999999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=268.13 Aligned_cols=236 Identities=26% Similarity=0.356 Sum_probs=165.5
Q ss_pred hcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC-C
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG-N 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~-~ 117 (338)
.++|++.+.||+|+||.||+|.+ .++..||+|.+..... ..+..|..+++.+ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45899999999999999999974 2245799999865332 2355677788888 899999999988754 4
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc--------------------------------------------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS-------------------------------------------------------- 141 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 141 (338)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999888653210
Q ss_pred -------ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCccccc
Q 045271 142 -------VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAP 196 (338)
Q Consensus 142 -------~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 196 (338)
.........+++.+|.++|+ +.+||+|||+++...............++..|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 00112244567777777554 35899999999865322221222233456789999
Q ss_pred cccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHH
Q 045271 197 EYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIG 275 (338)
Q Consensus 197 E~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 275 (338)
|++.+..++.++|||||||++|||++ |..||........ .. ............. .....+.+++
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~~---~~~~~~~~~~~~~---------~~~~~l~~li 310 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---FC---QRLKDGTRMRAPE---------NATPEIYRIM 310 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---HH---HHHhcCCCCCCCC---------CCCHHHHHHH
Confidence 99999899999999999999999997 9999875332111 00 0000111000000 0112456788
Q ss_pred hhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 276 LLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 276 ~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.+||+.||++|||+.+|++.|+...
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 8999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=266.05 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=185.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++...+.++||+|.||.|++|....+..||||.++....+ .+..|+++|.+++||||+.++++|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 44577889999999999999999877899999999765543 46778889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccc---cccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDSTRSV---QLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+.+|+|.+++..+.... .....++.+++.|++| +.+.++||+|||+++.+...+....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999999998774432 2234456667777776 3456799999999998876555554
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHh--CCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS--GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....+-+..|||||.+..++|++++|+|+||+++||+++ ...||......+........ ......+.++
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~---~~~~~~~~~l------ 766 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF---FRDQGRQVVL------ 766 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh---cCCCCcceec------
Confidence 555677889999999999999999999999999999865 56777654433322211111 1111111111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
+.+.-+...++++|.+||..|..+||||+++...|.+..
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111222345668899999999999999999999998754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=273.57 Aligned_cols=243 Identities=27% Similarity=0.315 Sum_probs=174.9
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcC--C--cE-EEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLND--D--KE-IAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCC 113 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~--~--~~-vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~ 113 (338)
.+....++..+.++||+|+||.||+|.... + .. ||||..+... ...+..|+++++.++|||||+++|+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334445577778999999999999999433 2 23 8999887422 23466788999999999999999999
Q ss_pred EeCCEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccce
Q 045271 114 LEGNELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMAR 173 (338)
Q Consensus 114 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~ 173 (338)
.....+++|||+|++|+|.++++.... ............+.||.|+|. ..+||+|||+++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999999999987764 233334455557777777654 336999999987
Q ss_pred ecCCCCCCcccc-ccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCc
Q 045271 174 VFGGNQSEANTN-RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 174 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
... ...... ...-+..|+|||++....|+.++|||||||++||+++ |..||......+....+.. ...
T Consensus 311 ~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~-------~~~ 380 (474)
T KOG0194|consen 311 AGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK-------NGY 380 (474)
T ss_pred CCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh-------cCc
Confidence 642 111111 1134678999999999999999999999999999998 7888876554433222210 000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccCC
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQ 305 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~~ 305 (338)
...... ........++.+||..||++|||+.++.+.|+........
T Consensus 381 r~~~~~--------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 RMPIPS--------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cCCCCC--------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 000111 1112234467789999999999999999999887765443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=265.94 Aligned_cols=227 Identities=21% Similarity=0.264 Sum_probs=174.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE-EEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE-LLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~ 123 (338)
++|+.++.+|+|+||.++++++ .+.+.+++|.+.-... .....|..+++.+.|||||.+++.|+.++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5899999999999999999994 4577899999854332 245667788999999999999999998887 99999
Q ss_pred ecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 124 EYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+||+||++.+.+..... .....+....+++.++.|.|. ..|||+|||+|+.+.... .
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S 161 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence 99999999999876552 122234455566667666653 458999999999874332 3
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
...+..||+.||+||++.+.+|+.|+|||||||++|||++-+++|...........+... ...+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~----------------~~~P 225 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG----------------LYSP 225 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc----------------cCCC
Confidence 455689999999999999999999999999999999999999998754433322221111 1112
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.+.....++..+|+.||+.+|..||++.++|.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222334456678889999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=255.70 Aligned_cols=240 Identities=26% Similarity=0.337 Sum_probs=165.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-----------------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-----------------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~ 108 (338)
.++|++.++||+|+||.||+|.+.. +..||+|.+..... ..+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4589999999999999999998432 23689999865432 23556778899999999999
Q ss_pred eeeEEEeCCEEEEEEecCCCCCHHHHHhccCccc--------------------cccHHHHHHHHHHhhhcCC-------
Q 045271 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSV--------------------QLDWNRRMCIINGIARDHK------- 161 (338)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------------~~~~~~~~~~~~~i~~~~~------- 161 (338)
+++++.+.+..++||||+++|+|.+++....... ...+....+++.++.++|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999999886532110 1123455566666666553
Q ss_pred -----------CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh--CCCCCc
Q 045271 162 -----------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS--GRKDTR 228 (338)
Q Consensus 162 -----------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~--g~~Pf~ 228 (338)
+.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 4589999999986533222112223455788999999998889999999999999999987 455665
Q ss_pred ccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 229 FYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.... ............... ..+ .....+.+|+.+||+.||++|||+.+|...|++
T Consensus 244 ~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~---~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQVIEN---AGEFFRDQGRQVYLF---RPP---PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHHHHHH---HHHHhhhcccccccc---CCC---CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4322111110 000000000000000 000 111345678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=261.34 Aligned_cols=235 Identities=20% Similarity=0.194 Sum_probs=178.6
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcC-CCceeeeeeEEEeC
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQ-HKNLVRLLGCCLEG 116 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~-hpnIv~~~~~~~~~ 116 (338)
....+.+.|++.+.||.|.||.||+|.. .+++.+|+|.+.+... ....+|+.+|+.+. |||||.++++|++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 3345667899999999999999999995 4589999999965433 46788999999998 99999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC----------------------CCeEEeeecccee
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARV 174 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~ 174 (338)
+.+++|||+|.||.|.+.+...............+++.++.+.|. +.+|++|||++..
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999988876622222233344456666665443 3599999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (338)
... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+..+ ...
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-------~~~-- 256 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-------DFD-- 256 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-------CCC--
Confidence 743 33455689999999999999999999999999999999999999999755432222211111 110
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
............+.+|++.||..||.+|+|+.++|+.
T Consensus 257 ----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 ----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0001111112356778889999999999999999984
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=259.69 Aligned_cols=176 Identities=24% Similarity=0.322 Sum_probs=142.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|+||.||++... ++..+|+|.+..... ..+..|.++++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999954 577889998864322 346677889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|.+++..... ..........+++.++.+.|+ +.+||+|||++..+... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 159 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 159 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----cc
Confidence 9999999998865432 223334455567777776553 34899999999765321 22
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
....|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 345789999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=253.53 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=176.3
Q ss_pred HhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEe-----CC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLE-----GN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~-----~~ 117 (338)
....|..++.||.|+||.|..+. ..++..||||++.+.- .+...+|+++|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44577778999999999999999 5668899999986432 2446678889999999999999999976 35
Q ss_pred EEEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~ 178 (338)
.+|+|+|+| +.+|..+++... ......-....|++.|+.+.|+. .+||+|||+|+.....
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 689999999 899999998776 33333445566788888887764 3899999999987433
Q ss_pred CCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc--------C
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE--------G 249 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~ 249 (338)
......+..+-|.+|+|||++... .|+.+.||||+||++.||++|++-|++...-++...+......... .
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 223334556889999999999865 6999999999999999999999988865443333322211110000 0
Q ss_pred CcccccCccccc-cccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 250 NAQELMDPVLKE-SFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 250 ~~~~~~~~~~~~-~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+...... ...+ .....+++|+.+||..||.+|+|++|+|.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011111111111 0111 11224678999999999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=263.95 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=175.8
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
..+.+..+...+...||+|.||+||+|+|.. .||||++.-+.. +.++.|...+++-+|.||+-+.|++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4555666678889999999999999999744 599999865433 346677788999999999999999988776
Q ss_pred EEEEEecCCCCCHHHHHhccCccccc--cHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQL--DWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
.||..+|.|.+|+.+++.......+ .+-++.++++|+.|+| ++.|||+|||++..-...
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 9999999999999998765433222 2345556777766644 256999999998754333
Q ss_pred CCCccccccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
..........|...|||||++.. .+|+..+|||||||++|||++|..||......+.. +.........+..
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------fmVGrG~l~pd~s 615 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------FMVGRGYLMPDLS 615 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------EEecccccCccch
Confidence 33333445678899999999973 47999999999999999999999999732222211 1111111112211
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
...+...+ .+.+|+..||.+++++||+|.+||..|+++...
T Consensus 616 ---~~~s~~pk---~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 616 ---KIRSNCPK---AMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---hhhccCHH---HHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11122222 344566679999999999999999988887653
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=269.33 Aligned_cols=227 Identities=29% Similarity=0.398 Sum_probs=173.9
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
-.||+|+||+||-|+.. +....|||.+..... +-+.+|+.+.+.|+|.|||+++|.+..++++-|.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999954 456789999965443 45788999999999999999999999999999999999999999
Q ss_pred HHHhccCccc----cccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCCcccccccc
Q 045271 133 FLLFDSTRSV----QLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 133 ~~l~~~~~~~----~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
.+++..=.+. ...-....++++|+.|+|.. -+||+|||.++.+-+. .....++.|
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTG 738 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTG 738 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccccc
Confidence 9997643322 22344566899999998764 3899999999887432 333456899
Q ss_pred CCccccccccccCC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 190 TYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 190 t~~y~aPE~~~~~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
|..|||||++..++ |+.++|||||||++.||.||++||......+...+....++ .. + +.+-+.
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK---------vH-P----~iPeel 804 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK---------VH-P----PIPEEL 804 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee---------cC-C----CCcHHH
Confidence 99999999998764 89999999999999999999999975443333222111111 00 0 111222
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
..++..||.+|+.+||.+||+|.++|. +|...
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 335678999999999999999999995 55543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=253.13 Aligned_cols=224 Identities=19% Similarity=0.294 Sum_probs=162.6
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEe----CCEEEEEEec
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLE----GNELLLICEY 125 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~ 125 (338)
...||+|++|.||+|.. +++.||||.+..... +.+.+|+.+++.++||||+++++++.+ ...+++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 688999999865432 234577889999999999999999876 4578999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+++|+|.+++..... ..........+++.++.+.|+ +.+||+|||++..+... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 999999999876432 222233444556666665543 34899999998765321 12
Q ss_pred ccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 186 RVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
...|+..|+|||++.+ ..++.++|||||||++|||++|..||......+..... .. .......+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~-~~~~~~~~------- 244 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------IN-KNNSLKLP------- 244 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hh-cCCCCCCC-------
Confidence 3468889999999976 57999999999999999999999999754322111110 00 00000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
......+.+|+.+||+.||++|||+.++++.|+...
T Consensus 245 -~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 -LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011224567888999999999999999999998654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=248.63 Aligned_cols=231 Identities=20% Similarity=0.193 Sum_probs=167.9
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEec-----cCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLS-----RSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~-----~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+.+.|++.+.||+|.|+.|+++.+ .+|+.+|+|.+. ....+.+.+|+++-+.|+||||+++.+.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 4567899999999999999999994 457777777663 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCccccccHHH-HHHHHHHhhhcCCC---------------------CeEEeeeccceecCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRSVQLDWNR-RMCIINGIARDHKM---------------------NPKISDFGMARVFGGNQ 179 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~~~~~~~-~~~~~~~i~~~~~~---------------------~vkL~Dfg~a~~~~~~~ 179 (338)
|+|++.|++|..-+..+.-.......| ..++++++.|-|.. -+||+|||+|..+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 999999999965544332111122222 23456666654432 38999999999885
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.........||+.|||||++...+|+.++|||+.||+||-|+.|.+||....-......+..+ ........+.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-------~yd~~~~~w~ 237 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-------AYDYPSPEWD 237 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-------ccCCCCcccC
Confidence 334455678999999999999999999999999999999999999999753211111111111 1000000011
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+..+|+++||..||.+|.|+.|.|+
T Consensus 238 ------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 238 ------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11124567888899999999999999884
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=265.12 Aligned_cols=234 Identities=27% Similarity=0.358 Sum_probs=165.5
Q ss_pred hcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~ 118 (338)
.++|++.+.||+|+||.||+|.+ .++..||||.++.... +.+.+|+.+++.+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999973 2355799999864322 2355678888888 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCcc---------------------------------------------------------
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRS--------------------------------------------------------- 141 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------- 141 (338)
.++|||||++|+|..++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999888643210
Q ss_pred -------------------ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 142 -------------------VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 142 -------------------~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
.........+++.++.+.|+ ..+||+|||++............
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 00112334466777776554 34799999999876432221112
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||++.+..++.++|||||||++|+|++ |..||........ .... ..... ...... .
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~----~~~~~-~~~~~~-----~ 341 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM----IKEGY-RMLSPE-----C 341 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH----HHhCc-cCCCCC-----C
Confidence 22345667999999999999999999999999999998 8888864322111 1110 00000 000000 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 342 ---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 ---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11245678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=246.43 Aligned_cols=243 Identities=21% Similarity=0.258 Sum_probs=170.0
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcc-----cHHHHHHHHHhcCCCceeeeeeEEEe--CCEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ-----GLQEFKNLIAKLQHKNLVRLLGCCLE--GNEL 119 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~ 119 (338)
...+.|+.+.+|++|+||.||+|+ .+++..||+|+++-+... ...+|+.+|.+.+|||||.+..+..- -+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 334579999999999999999999 556778999999755432 24677789999999999999998874 4679
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
||||||| .-+|..++..-.. ..........|++.|+.|+| ++.+||+|||+|+.++...
T Consensus 153 y~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999999 7788888866543 22334555667777777755 4569999999999875431
Q ss_pred CCccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH-----HhhhccCCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT-----WKLWCEGNAQE 253 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 253 (338)
...+..+-|.+|+|||.+.+.. |++++|+||+|||+.||+++.+-|+...--++...+... ...|..-....
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2234567899999999999875 999999999999999999999888754322222211110 01111000000
Q ss_pred ccCccccccc-c-------HHHH---HHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKESF-I-------LEEL---LKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~~~-~-------~~~~---~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
... ....+. . +... ...++|+..+|.+||++|.||.|.|+
T Consensus 310 ~~k-~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVK-KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhh-ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 000000 0 1111 23567888999999999999999985
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.74 Aligned_cols=224 Identities=22% Similarity=0.261 Sum_probs=161.6
Q ss_pred CCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHH---HhcCCCceeeeeeEEEeCCEEEEE
Q 045271 53 FSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLI---AKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l---~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
|++++.||+|+||.||+|.. .+++.||||.+.... .+.+..+..++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999995 458889999986432 12233444433 566899999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||+++++|...+...............+++.++.+.|+ +.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 999999999888866544444445556667777776553 4589999999875321 11222
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+|++.|+|||++.+..++.++|||||||++|+|++|..||......+..... . ..... ....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~-~~~~~--~p~~------ 223 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------V-NDEVR--YPRF------ 223 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCCC--CCCC------
Confidence 3467999999999999989999999999999999999999998643322111110 0 00000 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRP-----TMSSVVFM 295 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~~ 295 (338)
....+.+++.+||+.||.+|| ++.++++.
T Consensus 224 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 --LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112346788899999999999 57777753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=252.47 Aligned_cols=241 Identities=20% Similarity=0.233 Sum_probs=165.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++.++||.|+||.||+|.. .++..||+|.+.... .....+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5799999999999999999995 457889999986432 23456788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++ ++|..++...... .........+++.+|.+.|+ +.+||+|||++....... ....
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~ 161 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYS 161 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cccc
Confidence 96 5888877654322 22233445567777776554 458999999997653221 1122
Q ss_pred ccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH-----hhhcc----CCccccc
Q 045271 186 RVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW-----KLWCE----GNAQELM 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~~----~~~~~~~ 255 (338)
...+++.|+|||++.+ ..++.++||||+||++|+|++|..||......+......... ..+.. .......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 3468899999999876 468999999999999999999999997543322211111000 00000 0000000
Q ss_pred Ccccccccc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFI----LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+....... ........+|+.+||++||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 001224678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=254.52 Aligned_cols=243 Identities=21% Similarity=0.224 Sum_probs=166.1
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++.+.||+|+||.||+|+.. ++..||+|.+.... ......|+.+++.++||||+++++++..++.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999964 57789999986432 2345667889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|++++.+..+..... ...........+++.++.+.|. +.+||+|||++..+..... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYT 159 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cccc
Confidence 998887766554322 2222233445567777766553 4589999999987632211 1122
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------Hhhh-ccCCcccccC
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLW-CEGNAQELMD 256 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~ 256 (338)
...|+..|+|||++.+..++.++|||||||++|+|++|..||............... ...+ ..........
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 357899999999999888999999999999999999999999754321111000000 0000 0000000000
Q ss_pred ccccccccH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFIL------EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~------~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+........ .....+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 01224678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=250.39 Aligned_cols=227 Identities=22% Similarity=0.268 Sum_probs=164.0
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|+..+.||+|+||.||+|. ..+++.||+|.+..... .....|..+++.++|+||+++++++.+++.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47888999999999999999 45688999998854321 234567789999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+++|+|...+.... ...........+++.++.+.|+ +.++|+|||++...... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---Ce
Confidence 999999987775432 1222334445567777777554 45899999999875321 11
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||............. ..... .... ...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~-~~~~-~~~------ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKE-DQEE-YSE------ 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhc-cccc-CCc------
Confidence 233578999999999999999999999999999999999999997533211111110 00000 0000 000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
.....+.+|+.+||+.||.+||| +.++++
T Consensus 227 --~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 --KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01124566888999999999997 788885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=257.79 Aligned_cols=223 Identities=22% Similarity=0.225 Sum_probs=165.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .+.+..|..+++.++||||+++++++.+++.+++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 358999999999999999999954 57889999986432 23456778899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++|+|...+..... ..........+++.+|.+.| ++.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----- 171 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----
Confidence 999999999988865433 22223334455666666644 356999999999875321
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .. ...... +....
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i-~~~~~~--~p~~~---- 238 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------KI-LAGRLK--FPNWF---- 238 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------HH-hcCCcC--CCCCC----
Confidence 223579999999999999889999999999999999999999986432211100 00 001100 01100
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
...+.+|+.+||+.||.+||+ +.+++.
T Consensus 239 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 ----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 123467888999999999997 688874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=261.86 Aligned_cols=173 Identities=24% Similarity=0.285 Sum_probs=140.3
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc--ccHHHHHHHHHhcC-C-----CceeeeeeEEEeCCEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQ-H-----KNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~-h-----pnIv~~~~~~~~~~~~~lv 122 (338)
+|++++.||+|+||.|.+|. ..+++.||||++++... .....|+.+|..++ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 89999999999999999999 56688999999987654 34556777888876 3 4899999999999999999
Q ss_pred EecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC--------------------CCeEEeeeccceecCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK--------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~--------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
+|.+ .-+|.++++.... +......+..+++.+|..+|. ..|||+|||.++...
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~--- 342 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES--- 342 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC---
Confidence 9999 8899999976543 233334455566766665443 359999999998752
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
......+.+..|+|||++.+.+|+.+.||||||||++||++|.+-|+..
T Consensus 343 --q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 343 --QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred --CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 2222678999999999999999999999999999999999998777654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=254.65 Aligned_cols=223 Identities=21% Similarity=0.188 Sum_probs=166.0
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|... +++.||+|.+.... ...+..|..+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999954 68889999985422 234566788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++|+|.+++..... ..........+++.+|.+.|+ +.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999998865433 223334455567777766553 4599999999986532 12
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+|++.|+|||++.+..++.++|||||||++|+|++|..||............. .... . +...
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~-~-~~~~------ 220 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-------AGKL-E-FPRH------ 220 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCc-C-CCcc------
Confidence 23578999999999998889999999999999999999999986532211111100 0000 0 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPT-----MSSVVFM 295 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~~ 295 (338)
....+.+++.+||+.||.+||+ +.+++..
T Consensus 221 --~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 --LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1124567888999999999995 8998853
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.26 Aligned_cols=231 Identities=20% Similarity=0.273 Sum_probs=167.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|... ++..||||++.... ...+..|..+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 57889999986432 123456777889999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++|+|..++..... ..........+++.+|.++| ++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999865432 22233334455666666544 35699999999976532 22
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||......+...... .+. ..... + ......
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~-~~~~~---~-~~~~~~ 226 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWK-ETLQR---P-VYDDPR 226 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hcc-ccccC---C-CCCccc
Confidence 34679999999999999899999999999999999999999997543222111110 000 00000 0 000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
......+.+++.+||+.+|.+|||+.+++..
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1122345678889999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=262.79 Aligned_cols=237 Identities=27% Similarity=0.368 Sum_probs=167.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
...++|++.+.||+|+||.||+|... ++..||+|.+..... ..+..|..+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34558999999999999999999832 234799999865432 2355677888888 899999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc--------------------------------------------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-------------------------------------------------------- 140 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 140 (338)
+.+++|||||++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999988854211
Q ss_pred ---------------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 141 ---------------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 141 ---------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
..........+++.+|.++|+ ..+||+|||++...............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 000113344567777777664 34899999999865322211111223
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.++..|+|||++.+..++.++|||||||++|+|++ |..||........ ...... .. ........
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~----~~-~~~~~~~~-------- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVK----RG-YQMSRPDF-------- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHH----cc-cCccCCCC--------
Confidence 45667999999998899999999999999999997 9999875432111 000000 00 00000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
....+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 013456788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=262.16 Aligned_cols=236 Identities=27% Similarity=0.354 Sum_probs=175.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
-+.+...-.+||-|.||.||.|.|+. ...||||.++.+.. +.+..|+.+|+.++|||+|+++++|.....+|||.||
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34456667899999999999999755 66799999987654 3466677899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCcccccc---HHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLD---WNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~---~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|.+|+|.++++...+..... ...+.++..++.|+. +.-||++|||+++.+.+.......
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 99999999998765543221 223344555555432 344999999999987543322211
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
...=+..|.|||-+.-+.|+.|+|||+|||+|||+.| |-.||+.....+...++..+++...+.
T Consensus 425 -GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe-------------- 489 (1157)
T KOG4278|consen 425 -GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE-------------- 489 (1157)
T ss_pred -CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC--------------
Confidence 1122568999999999999999999999999999998 667887665555444444332211111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
-+..+.++||+.||+++|.+||+|.|+-+.|+.+..
T Consensus 490 --GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 490 --GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 112345678889999999999999999988877654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=254.14 Aligned_cols=240 Identities=21% Similarity=0.249 Sum_probs=171.0
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----------------cccHHHHHHHHHhcCCCceee
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----------------GQGLQEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----------------~~~~~~~~~~l~~l~hpnIv~ 108 (338)
.+..+.|++++.||+|.||.|-+|+ ..+++.||||++.+.. .+...+|+.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4456789999999999999999999 5568889999985432 134677888999999999999
Q ss_pred eeeEEEeC--CEEEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEe
Q 045271 109 LLGCCLEG--NELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKIS 167 (338)
Q Consensus 109 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~ 167 (338)
++++..+. +.+|||+|||..|.+...-.... ......+.+...+..||.|+| ++.+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999864 67999999999998854332222 233344455555666666654 4679999
Q ss_pred eeccceecCCCC---CCccccccccCCccccccccccC---CC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhh
Q 045271 168 DFGMARVFGGNQ---SEANTNRVVGTYGYMAPEYALEG---LF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 168 Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~---~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~ 240 (338)
|||++....... .........||+.|+|||++.++ .| +.+.||||+||+||+|+.|..||......+....+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI- 331 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI- 331 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH-
Confidence 999998663221 11122346899999999999873 33 46799999999999999999999754332221111
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
+..-+..+...+.--.+.++|++||++||++|.+..+|....--.+.
T Consensus 332 --------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 332 --------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11111111111222345678889999999999999999866544443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=254.27 Aligned_cols=177 Identities=25% Similarity=0.324 Sum_probs=141.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++.++||+|+||.||++... ++..+|+|.+..... ..+..|+++++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999954 577789998765322 345677889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|.+++..... ..........+++.++.+.|+ +.+||+|||++..+... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~ 159 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 159 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----cc
Confidence 9999999998865432 222233444556666666552 34899999998765221 12
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
....|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2357899999999999888999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=260.12 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=168.4
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcC-CCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~ 116 (338)
...++|++++.||+|+||.||+|.... +..||||.+..... +.+..|+.+++.++ ||||+++++++...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 346689999999999999999998421 24699999864332 34566778899996 99999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCcc-------------------------------------------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRS------------------------------------------------------- 141 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 141 (338)
+.+|+|||||++|+|.+++......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999887543110
Q ss_pred ------------------------------------------ccccHHHHHHHHHHhhhcCCC-----------------
Q 045271 142 ------------------------------------------VQLDWNRRMCIINGIARDHKM----------------- 162 (338)
Q Consensus 142 ------------------------------------------~~~~~~~~~~~~~~i~~~~~~----------------- 162 (338)
.........+++.++.++|+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 000122444577777776643
Q ss_pred -CeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 163 -NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 163 -~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~~ 351 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--YN 351 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--HH
Confidence 389999999987643222222223456778999999998889999999999999999997 88888643221110 00
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
... ... .... .......+.+++.+||+.||++|||+.+|.+.|+...
T Consensus 352 ---~~~-~~~-~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 ---KIK-SGY-RMAK--------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHh-cCC-CCCC--------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 000 000 0000 0011234567888999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=255.12 Aligned_cols=231 Identities=22% Similarity=0.284 Sum_probs=179.6
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcc-----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ-----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+.+=|.+.+.||+|.|+.|-+|+ ..+|..||||++.+..-+ .+..|.+.|+.+.|||||++|+++.....+|+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 345679999999999999999999 567999999999765543 45677889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQS 180 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~ 180 (338)
|+|+-++|+|.+++..+..+. .+....+.+++.+|.|-|.. -|||.|||++..+ ..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf---~P 171 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF---QP 171 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC---CC
Confidence 999999999999997655443 34445566677777765542 3899999999876 34
Q ss_pred CccccccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....+.||++.|.|||++.+..|+ +++||||+||+||-|++|+.||+.....+....+ ++...
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDCKY 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDCKY 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcccc
Confidence 4556778999999999999999987 6799999999999999999999865443332221 11111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
..+..-..++.+||..||..||.+|.|.++|.. +|+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 111122235678999999999999999999873 4443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=244.68 Aligned_cols=230 Identities=24% Similarity=0.367 Sum_probs=167.0
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
++|++.+.||+|+||.||++.+.++..+|+|.+.... ...+..|+.+++.++||||+++++++...+.+++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4688999999999999999998778889999876432 24566788899999999999999999999999999999999
Q ss_pred CCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
|+|.+++..... ..........+++.++.+.|+ +.+||+|||.+......... ......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~ 162 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAK 162 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCC
Confidence 999998865332 222233444556666666543 34899999998765322111 111224
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
++..|+|||++.+..++.++||||||+++|+|++ |..||......+......... . ...+.. .
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------~---~~~~~~-------~ 226 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------R---LYRPKL-------A 226 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------C---CCCCCC-------C
Confidence 5568999999988889999999999999999999 888886433221111111000 0 000000 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
...+.+++.+||+.||.+|||+.++++.|.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 124567888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.33 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=174.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC---Cc--EEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND---DK--EIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~---~~--~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
++..++.++||.|.||.||+|.+.+ |. .||||..+.+. .+.+..|+.+++.++|||||+++|+|.+ ...|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3455667899999999999999543 22 38999987632 3446667789999999999999999975 6789
Q ss_pred EEEecCCCCCHHHHHhccCcccccc--HHHHHHHHHHhhhcCCCC------------------eEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRSVQLD--WNRRMCIINGIARDHKMN------------------PKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~i~~~~~~~------------------vkL~Dfg~a~~~~~~~~ 180 (338)
||||.++.|.|..+++......... .....+++.+++|+++.+ |||+|||+++.+.+...
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999999998876655443 344556777777766543 89999999998854433
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.. .....-+..|||||.+.-..|+.++|||-|||.+||++. |..||......+....+..+.+...+
T Consensus 547 Yk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P----------- 614 (974)
T KOG4257|consen 547 YK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP----------- 614 (974)
T ss_pred hh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC-----------
Confidence 32 223345678999999998899999999999999999876 89999865544443333222221111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
..+...++.+|.+||++||.+||.+.++...|.+..+
T Consensus 615 -----~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 -----PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1122345578889999999999999999887766544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=247.45 Aligned_cols=232 Identities=25% Similarity=0.376 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|.+.+.||+|+||.||+|.... +..||+|.+..... ..+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3578999999999999999998533 46799999865433 3466778899999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCcc---------------ccccHHHHHHHHHHhhhcCC------------------CCeEE
Q 045271 120 LLICEYMPNKSLDFLLFDSTRS---------------VQLDWNRRMCIINGIARDHK------------------MNPKI 166 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~i~~~~~------------------~~vkL 166 (338)
++||||+++++|..++...... .........+++.++.+.|+ +.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999998754321 11112334456666666553 45899
Q ss_pred eeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhh
Q 045271 167 SDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~------ 237 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI------ 237 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------
Confidence 99999976532222111223345778999999999999999999999999999998 99998643322111110
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.......... .....+.+++.+||+.||++|||+.||++.|+
T Consensus 238 -~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 -TQGRLLQRPR---------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HcCCcCCCCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0111111000 11134567888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=248.67 Aligned_cols=232 Identities=27% Similarity=0.389 Sum_probs=168.2
Q ss_pred cCCCCCceecccCCeeEEEEEEcC-C-----cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND-D-----KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
++|++.+.||+|+||.||+|.... + ..||+|.+..... ..+.+++.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478999999999999999998533 2 4689998864432 23556778899999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhccCcc-----------------ccccHHHHHHHHHHhhhcCC------------------CCeE
Q 045271 121 LICEYMPNKSLDFLLFDSTRS-----------------VQLDWNRRMCIINGIARDHK------------------MNPK 165 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~~~~~i~~~~~------------------~~vk 165 (338)
++|||+++++|.+++...... ....+....+++.++.++|. +.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 999999999999988653221 11123455567777776554 3489
Q ss_pred EeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHh
Q 045271 166 ISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWK 244 (338)
Q Consensus 166 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~ 244 (338)
|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~------ 238 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM------ 238 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------
Confidence 999999986533222222233456788999999998889999999999999999998 9999865332211110
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
......... .......+.+|+.+||+.||++|||+.+|+++|+.
T Consensus 239 -i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 000110000 01112345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=256.93 Aligned_cols=175 Identities=17% Similarity=0.175 Sum_probs=138.0
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
..+|++++.||+|+||.||+|.. .+++.||+|.... ....+|+.+++.++||||++++++|......++|||++ .
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~ 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence 46899999999999999999994 5678899997542 34567889999999999999999999999999999999 5
Q ss_pred CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
++|..++.... ...........+++.+|.+.|+ +.+||+|||++....... .......+|
T Consensus 167 ~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g 245 (391)
T PHA03212 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAG 245 (391)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccC
Confidence 77777765432 2223334455567777777554 458999999997542211 122234579
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
|+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 246 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9999999999998999999999999999999999988753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=248.94 Aligned_cols=240 Identities=21% Similarity=0.226 Sum_probs=162.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ....+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999954 678899999864322 235677889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++ ++|..++..... ..........+++.++.+.|+ +.+||+|||++....... ...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccC
Confidence 995 677666654322 222234445567777766543 458999999997643211 112
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC---------cccc
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN---------AQEL 254 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 254 (338)
....+++.|+|||++.+. .++.++||||+||++|+|++|..||........ ............. ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhcccc
Confidence 335688999999998764 588999999999999999999999975321110 0000000000000 0000
Q ss_pred c-Ccc-ccccccHH-------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 255 M-DPV-LKESFILE-------ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 255 ~-~~~-~~~~~~~~-------~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ... ........ ....+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 000 00000000 0124567889999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=249.69 Aligned_cols=226 Identities=31% Similarity=0.455 Sum_probs=156.9
Q ss_pred CCceecccCCeeEEEEEEc-----CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 55 NENKLGEGGFGPVYKGVLN-----DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+.+.||.|.||.||+|.+. .+..|+||.++.... +.+.++.+.++.++||||+++++++...+.+++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999965 245689999955332 3456677788899999999999999988889999999
Q ss_pred CCCCCHHHHHhcc---CccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDS---TRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++|+|.+++... .......+....+++.++.++|+ +.+||+|||++............
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 22333445566678888777543 45899999999876322222222
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+...|+|||.+.+..++.++||||||+++|||++ |..||......+..... . ...... ...
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~---~----~~~~~~-~~~------ 228 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL---K----QGQRLP-IPD------ 228 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH---H----TTEETT-SBT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c----ccccce-ecc------
Confidence 23356678999999999989999999999999999999 67887544221111111 0 000000 000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.....+.+++.+||+.||++|||+.+|++.|
T Consensus 229 --~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 --NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0112345678889999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=254.52 Aligned_cols=233 Identities=22% Similarity=0.308 Sum_probs=168.8
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-----cccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~l 121 (338)
.....|+++++||.|+.+.||++...+...+|+|.+.... .+.+..|+..|.+|+ |.+||+++|+-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3345799999999999999999998888889988774322 245778888888875 8999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcC-----------------CCCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDH-----------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~-----------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||||= ..+|..+++....... .......++++++...| +|.+||+|||+|..+.......
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccce
Confidence 99974 7899999987766544 22233344555555433 3569999999999876555555
Q ss_pred cccccccCCccccccccccCC-----------CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 183 NTNRVVGTYGYMAPEYALEGL-----------FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
.....+||+.||+||.+.... .+.++||||+||+||+|+.|++||..... . +....... ..+
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~---~aKl~aI~-~P~- 589 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--Q---IAKLHAIT-DPN- 589 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--H---HHHHHhhc-CCC-
Confidence 556679999999999996322 56899999999999999999999974321 1 11111110 010
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.++.-+.+... ..++++|+.||++||++|||+.++|+
T Consensus 590 ~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 590 HEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11111111111 11678888999999999999999996
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=262.62 Aligned_cols=245 Identities=18% Similarity=0.219 Sum_probs=162.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeC--------CEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEG--------NEL 119 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--------~~~ 119 (338)
..++|++++.||+|+||.||+|.. .++..||||.+.... ....+|+.+++.++||||+++++++... ..+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 346799999999999999999995 457889999885433 3445688899999999999999987532 247
Q ss_pred EEEEecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceec
Q 045271 120 LLICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVF 175 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~ 175 (338)
++||||++ +++..++... ............+++.+|.++|+ ..+||+|||+|+.+
T Consensus 143 ~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 79999996 4665555321 11222334445567777777553 24899999999876
Q ss_pred CCCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH-----------
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW----------- 243 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~----------- 243 (338)
.... ......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||......+.........
T Consensus 222 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 222 LAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred cCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3221 22235789999999998765 68999999999999999999999997543222111110000
Q ss_pred -hhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 244 -KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
..+............+...........+.+|+.+||++||.+|||+.|++. ++..
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 000000000000000000000011235678999999999999999999984 4544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=252.35 Aligned_cols=228 Identities=24% Similarity=0.292 Sum_probs=159.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|+.+++||+|+||.||+|... +++.||||.+..... ..+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 457888999999999999999954 588999999864332 345677889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|+.+|+|..... ...........+++.+|.++| ++.+||+|||++..+.... .....
T Consensus 153 ~~~~~~L~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 227 (353)
T PLN00034 153 FMDGGSLEGTHI---ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNS 227 (353)
T ss_pred cCCCCccccccc---CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccc
Confidence 999999864321 111222334455666666544 3458999999998763211 11233
Q ss_pred cccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 187 VVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
..||..|+|||++.. ...+.++|||||||++|+|++|..||........... ..... ......
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~-~~~~~~-------- 295 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAIC-MSQPPE-------- 295 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHh-ccCCCC--------
Confidence 578999999998853 2345689999999999999999999973221111000 00000 000000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
........+.+||.+||+.||++|||+.|+++.
T Consensus 296 -~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 -APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112346678889999999999999999963
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=252.36 Aligned_cols=219 Identities=21% Similarity=0.190 Sum_probs=159.2
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||+|.. .+++.||+|++.... ......|..+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 568889999986432 123455677889999999999999999999999999999999
Q ss_pred CHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccC
Q 045271 130 SLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGT 190 (338)
Q Consensus 130 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt 190 (338)
+|..++..... ..........+++.+|.+.|+ +.+||+|||+++..... .......+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecC
Confidence 99888765432 222233344567777776554 45899999998753211 1222346799
Q ss_pred CccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
+.|+|||++.+..++.++|||||||++|+|++|..||............ . .... . +.. .....
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~-~~~~-~-~p~--------~~~~~ 221 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-MEEI-R-FPR--------TLSPE 221 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------H-cCCC-C-CCC--------CCCHH
Confidence 9999999999989999999999999999999999999643221111100 0 0000 0 000 01124
Q ss_pred HHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 271 RIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
+.+|+.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 56788899999999999 7999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=245.10 Aligned_cols=238 Identities=20% Similarity=0.214 Sum_probs=167.8
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeC--C---EEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEG--N---ELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~---~~~lv~e~ 125 (338)
.|+-.+++|.|+||.||+|. ..+++.||||++-.+.. .-.+|.++|+.++|||||++.-+|... + ...+||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 67778999999999999999 45578999998854433 345677899999999999999988642 2 35699999
Q ss_pred CCCCCHHHHHhc-----cCccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCC
Q 045271 126 MPNKSLDFLLFD-----STRSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 126 ~~~g~L~~~l~~-----~~~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+ -.+|..+++. .....-.......|+..|++|+|. +.+||||||.|+.+.. .
T Consensus 104 m-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~---~ 179 (364)
T KOG0658|consen 104 M-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK---G 179 (364)
T ss_pred c-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc---C
Confidence 9 4667677663 222333345566678888887664 3489999999998742 2
Q ss_pred ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc-----CC-----
Q 045271 182 ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE-----GN----- 250 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~----- 250 (338)
........|..|+|||.+.+. .|+.+.||||.||++.||+.|++-|+.....++...+....-.... .+
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 233456779999999999997 5999999999999999999999998876554443332221111000 00
Q ss_pred --cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 --AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 --~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+.+....+..-.......+.++|+.++|+++|.+|.++.|++.
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01111111100011223345678899999999999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=248.98 Aligned_cols=229 Identities=21% Similarity=0.287 Sum_probs=169.6
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+-|.++++||+|+||.||++.+ .+|+.+|||.+.-. .-+.+..|+.++++.+.|++|++|+.+.....+|+|||||..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3567789999999999999995 45888999998543 345566777899999999999999999888899999999999
Q ss_pred CCHHHHHhccCcccccc--HHHHHHHHHHhhhc------------------CCCCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTRSVQLD--WNRRMCIINGIARD------------------HKMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~~~~~~--~~~~~~~~~~i~~~------------------~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
|++.++++.+....... ..+....+.|+.|+ ..+..||+|||+|..+. +.-...++..
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKRNTVI 190 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKRNTVI 190 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhhCccc
Confidence 99999998766644322 22222334444443 34568999999998774 2333455679
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
||+.|||||++..-.|+.++||||+|++..||..|++||.....-.....+ +.+ ..+..+. +-...
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------PT~----PPPTF~K--PE~WS 256 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------PTK----PPPTFKK--PEEWS 256 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------cCC----CCCCCCC--hHhhh
Confidence 999999999999989999999999999999999999998753221110000 000 0111111 11223
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 269 LKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
..+-+|+++||-.+|++|-||.++++.
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 356789999999999999999998763
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=255.83 Aligned_cols=232 Identities=19% Similarity=0.210 Sum_probs=167.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|.. .++..||+|.+.... ...+..+..+++.++||||+++++++.+++.+|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45899999999999999999995 457889999985421 12345677889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||+++|+|..++...............+++.+|.++|+ +.+||+|||++........ ...
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~ 200 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRC 200 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccC
Confidence 999999999999876544333334445567777776553 4589999999987532211 112
Q ss_pred cccccCCccccccccccC----CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 185 NRVVGTYGYMAPEYALEG----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...+||+.|+|||++.+. .++.++|||||||++|+|++|..||........... ......... +.
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~~~~~~~-~~---- 269 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMDHKNSLT-FP---- 269 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH------HHcCCCcCC-CC----
Confidence 345799999999998754 378999999999999999999999975432111100 000000000 00
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVFM 295 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~~ 295 (338)
........+.+|+.+||+.+|.+ |+|+.+++..
T Consensus 270 --~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 --DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10111234567888899999988 9999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=243.55 Aligned_cols=233 Identities=23% Similarity=0.294 Sum_probs=165.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... ..+..+...++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357999999999999999999842 345789999875432 234567778888999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++|+|..++..... .....+....+++.++.+.|+ +.++++|||.+........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~- 162 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI- 162 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-
Confidence 9999999999998875432 223334555667777777654 3478999998764321111
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||++.+..++.++|||||||++|++++ |..||............. ... .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~-~~~~~---- 230 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGF-RLPAP---- 230 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCC-CCCCC----
Confidence 11112345678999999999999999999999999999775 999986543222111110 000 00000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 231 ----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 ----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01122456688889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=241.87 Aligned_cols=232 Identities=30% Similarity=0.379 Sum_probs=168.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.++||+|+||.||+|...++..||+|.+.... .+.+..+..+++.++|+||+++++.+...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 45899999999999999999998778889999876432 2456678889999999999999999999999999999999
Q ss_pred CCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++..... ..........+++.++.+.|. +.++|+|||++......... ....
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 163 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREG 163 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCC
Confidence 9999998865321 111223344456666666554 34899999999876322111 1122
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||............ .... .. . .. .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------~~~~-~~--~-~~-----~ 227 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-------QRGY-RM--P-RM-----E 227 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-------HcCC-CC--C-CC-----C
Confidence 345678999999988889999999999999999998 89998643221111110 0000 00 0 00 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011245678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=239.48 Aligned_cols=234 Identities=24% Similarity=0.340 Sum_probs=169.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|.. .++..||||.+.... ...+..|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5899999999999999999994 568899999875321 123456778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 124 EYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||+++++|..++.... ...........+++.++.+.|+ +.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 9999999988875321 1222234455567777776554 348999999988763221
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ........... .. +..
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~-~~----~~~- 229 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKIEQCD-YP----PLP- 229 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHHhcCC-CC----CCC-
Confidence 11223468889999999988889999999999999999999999985432111 11111100000 00 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.......+.++|.+||+.||++|||+.+|++.|+.+
T Consensus 230 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 ---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011123466788899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=260.52 Aligned_cols=227 Identities=18% Similarity=0.167 Sum_probs=163.8
Q ss_pred CCCCCceecccCCeeEEEEEEc-C-CcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-D-DKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.|.+.+.||+|++|.||+|... + +..||+|.+..... .....|+.+++.++||||+++++++..++.+|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999843 3 56788887644332 23556788999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 127 PNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 127 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
++|+|.+.+.... ...........+++.+|.+.|+ +.+||+|||++..+........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 9999988775421 1112223344466666666553 4589999999987643322222
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .... ..... ...
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~~-~~~~~-~~~------ 293 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVLY-GKYDP-FPC------ 293 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-CCCCC-CCc------
Confidence 345679999999999998899999999999999999999999986432211110 0000 00000 000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.++|.+||+.||++|||+.+++.
T Consensus 294 --~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 --PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01124567888999999999999999874
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=239.31 Aligned_cols=230 Identities=21% Similarity=0.293 Sum_probs=163.5
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++++.||+|+||.||+|.. .++..||+|.+..... ..+..|..+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4788999999999999999994 5678899999864422 2355677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..+.. ...........+++.++.+.|+ +.++|+|||++..+... .....
T Consensus 81 ~~~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~ 153 (279)
T cd06619 81 MDGGSLDVYRK---IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTY 153 (279)
T ss_pred CCCCChHHhhc---CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCC
Confidence 99999965532 1222233445556666666543 45899999999865321 12335
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.|+..|+|||++.+..++.++|+|||||++|+|++|..||............................ .. ..
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~----~~ 225 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP----VG----QF 225 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC----CC----cC
Confidence 78999999999998889999999999999999999999986533222111111000100000000000 00 01
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+.+|+.+||+.||++||++.+++..
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1245678889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=255.07 Aligned_cols=231 Identities=22% Similarity=0.299 Sum_probs=167.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|... +++.||||++.... ......+..+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999954 68899999986432 234566778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC-----
Q 045271 124 EYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ----- 179 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~----- 179 (338)
||+++++|..++.... ...........+++.+|.++|. +.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999887652 2333334455567777766553 458999999997653322
Q ss_pred ----------------------CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccc
Q 045271 180 ----------------------SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS 237 (338)
Q Consensus 180 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~ 237 (338)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 0011233578999999999999999999999999999999999999997543211111
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT-MSSVVFM 295 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~vl~~ 295 (338)
... .+ ..... ...... ....+.+|+.+||+ ||.+||+ +.+++..
T Consensus 241 ~i~----~~-~~~~~--~p~~~~------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 241 KII----NW-KESLR--FPPDPP------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHh----cc-CCccc--CCCCCC------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 000 00 00000 000000 12345567888997 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=242.03 Aligned_cols=235 Identities=20% Similarity=0.206 Sum_probs=170.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
-.+.|+++++||.|.-|+||+++..+ +..+|+|++.+.. ..+.+.|.+||+.++||.+.++|..|+.++..|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34578889999999999999999544 5789999996532 2346667789999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCcc-cc--ccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCC---
Q 045271 122 ICEYMPNKSLDFLLFDSTRS-VQ--LDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGG--- 177 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~-~~--~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~--- 177 (338)
|||||+||+|..+.+.+... .. .....+-.++.+|.| -.++++.|+||.++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999998887654331 11 112222223333333 3467899999998743210
Q ss_pred ------------------------------C-C--------------------CCccccccccCCccccccccccCCCCc
Q 045271 178 ------------------------------N-Q--------------------SEANTNRVVGTYGYMAPEYALEGLFSV 206 (338)
Q Consensus 178 ------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 206 (338)
. . ...+...++||..|+|||++.++..+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 001223468999999999999999999
Q ss_pred ccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCC
Q 045271 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADR 286 (338)
Q Consensus 207 ~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 286 (338)
++|+|+|||++|||+.|..||......+....+ +.+-+..+........+.+||+++|.+||.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 999999999999999999999865544432222 22222222222334567789999999999999
Q ss_pred CC----HHHHHH--Hhhc
Q 045271 287 PT----MSSVVF--MLAT 298 (338)
Q Consensus 287 ps----~~~vl~--~L~~ 298 (338)
.. |.||-+ ++++
T Consensus 380 lg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred hccccchHHhhcCccccC
Confidence 98 888875 4444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=251.70 Aligned_cols=225 Identities=21% Similarity=0.224 Sum_probs=164.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC--CcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND--DKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
..++|++.+.||+|+||.||+|.... +..||+|.+... ..+.+..|..+++.++||||+++++++.+.+.+|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34589999999999999999998433 357999988532 1234556788999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+++|+|..++..... ..........+++.+|.+.| ++.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---- 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---- 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC----
Confidence 99999999999998865433 22222334455666666544 35699999999987532
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .. ..... .+....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i-~~~~~--~~p~~~-- 251 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KI-LEGII--YFPKFL-- 251 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HH-hcCCC--CCCCCC--
Confidence 1234579999999999998889999999999999999999999996432111100 00 01100 011111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVFM 295 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~~ 295 (338)
...+.+++.+||+.||.+|+ |+.++++.
T Consensus 252 ------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 252 ------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12346788899999999995 89999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=269.71 Aligned_cols=235 Identities=20% Similarity=0.266 Sum_probs=167.1
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEe--CC
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLE--GN 117 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~ 117 (338)
.....++|+++++||+|+||.||+|... ++..||+|.+.... ...+..|+.+++.++|||||+++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3455679999999999999999999954 46678999886432 2335667889999999999999999865 45
Q ss_pred EEEEEEecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcCCC------------------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDHKM------------------------------ 162 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~~~------------------------------ 162 (338)
.+||||||+++|+|..++... .......+.+..+++.+|.++|..
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 789999999999999888642 223333455566677777776641
Q ss_pred ------------CeEEeeeccceecCCCCCCccccccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCCc
Q 045271 163 ------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 163 ------------~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
.+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 2799999999865322 12234579999999999865 358899999999999999999999996
Q ss_pred ccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 229 FYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
....... ... ...... .+. +. .....+.+||..||+.||.+|||+.++|. ++...
T Consensus 245 ~~~~~~q--li~---~lk~~p---~lp---i~-----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 245 KANNFSQ--LIS---ELKRGP---DLP---IK-----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCCcHHH--HHH---HHhcCC---CCC---cC-----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 4321110 110 000000 000 00 01134567888999999999999999984 55443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=251.65 Aligned_cols=246 Identities=14% Similarity=0.143 Sum_probs=168.2
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.....+|++++.||+|+||.||+|... .+..||+|.+... ....+|+.+++.++||||+++++++...+.+|+||
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 344568999999999999999999843 3467899987543 34567888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++ .++|..++.... ........+..+++.+|.++|. +.++|+|||++..+.........
T Consensus 166 e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 999 467777764322 2333344555667777776554 45899999999766433222223
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc----------
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL---------- 254 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 254 (338)
....||..|+|||++.+..|+.++|||||||++|+|++|..||...........................
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence 3467999999999999889999999999999999999999999754332211111100000000000000
Q ss_pred ---cCccccccccH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 255 ---MDPVLKESFIL-------EELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 255 ---~~~~~~~~~~~-------~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
........... .....+.++|.+||+.||.+|||+.+++..
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 011245678889999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=242.91 Aligned_cols=228 Identities=22% Similarity=0.268 Sum_probs=163.6
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|++.++||+|+||.||++.. .++..||+|.+..... ....+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999995 4578899999864321 224457789999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+.+|+|...+..... ..........+++.++.+.|+ +.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC---Cc
Confidence 9999999887754321 222333445567777766543 45899999999875321 11
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|+..|+|||++.+..++.++||||+||++|+|++|..||............. .... ..... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~~~--~~~~~-~-------- 224 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVK--EDQEE-Y-------- 224 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HHhh--hcccc-c--------
Confidence 223578999999999998889999999999999999999999997432211110000 0000 00000 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRP-----TMSSVVFM 295 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~~ 295 (338)
.......+.+|+.+||+.||++|| ++++++..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001122356788899999999999 88898753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=240.28 Aligned_cols=230 Identities=25% Similarity=0.350 Sum_probs=167.5
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
++|++++.||+|+||.||.|....+..+|+|.+.... .+.+..+..+++.++||||+++++++...+.+++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4789999999999999999997777779999886543 23456778889999999999999999988899999999999
Q ss_pred CCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
|+|.+++..... .....+....+++.++.+.|+ +.+||+|||.+........ .......
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~ 162 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSK 162 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCc
Confidence 999998865432 222234555667777777553 4589999999876532211 1111223
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
++..|+|||.+.+..++.++|||||||++|+|++ |..||............. ........ . . .
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~-~-~-------~ 226 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-------QGLRLYRP-H-L-------A 226 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-------cCCCCCCC-C-C-------C
Confidence 5678999999988889999999999999999998 988886433211111110 00000000 0 0 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
...+.+++.+||+.||.+|||+.+|+..|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 234567888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=248.17 Aligned_cols=217 Identities=18% Similarity=0.219 Sum_probs=155.6
Q ss_pred ecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||+|+||.||+|... +++.||+|.+.... ......|..+++.++||||+++++++.+.+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999954 57789999986421 12345577788999999999999999999999999999999999
Q ss_pred HHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 132 DFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 132 ~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
..++..... ..........+++.+|.+.|+ +.+||+|||++...... .......+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccccCCcc
Confidence 888865432 222333344566677666543 45899999999754221 122334679999
Q ss_pred cccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHH
Q 045271 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRI 272 (338)
Q Consensus 193 y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
|+|||++.+..++.++|||||||++|+|++|..||......+... ... .... . +.. .....+.
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~------~~~-~~~~-~-~~~--------~~~~~~~ 221 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR------KIL-QEPL-R-FPD--------GFDRDAK 221 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH------HHH-cCCC-C-CCC--------cCCHHHH
Confidence 999999999899999999999999999999999997432211110 000 0000 0 000 0112456
Q ss_pred HHHhhccCCCCCCCCC---HHHHHH
Q 045271 273 HIGLLCVQEDPADRPT---MSSVVF 294 (338)
Q Consensus 273 ~li~~cl~~dP~~Rps---~~~vl~ 294 (338)
+++.+||+.||.+||+ +.+++.
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 7888899999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=238.19 Aligned_cols=232 Identities=28% Similarity=0.350 Sum_probs=168.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.+.||+|++|.||+|....++.||+|.+..... ..+.++..+++.++||||+++++++...+.+++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 457999999999999999999977778899999865432 346677889999999999999999999999999999999
Q ss_pred CCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++.... ...........+++.++.+.|+ +.++|+|||++........ .....
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 163 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREG 163 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCC
Confidence 999999986543 1222233444456666666554 4589999999987642111 11111
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
...+..|+|||++.+..++.++||||||+++|+|++ |..||........... .. ........ .
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~-----~~~~~~~~--------~ 227 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ---VD-----QGYRMPCP--------P 227 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HH-----cCCCCCCC--------C
Confidence 223457999999988889999999999999999999 9988864322111100 00 00000000 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||+.||.+||++.++++.|++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112345678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=254.52 Aligned_cols=230 Identities=21% Similarity=0.253 Sum_probs=163.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|.. .+++.||||++.... ...+..|..+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999995 457889999986431 123556788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc--
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA-- 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~-- 182 (338)
|||++|+|.+++..... ..........+++.+|.+.|+ +.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999998865433 222333445567777766553 458999999987643211000
Q ss_pred ----------------------------------cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCc
Q 045271 183 ----------------------------------NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 183 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112469999999999998899999999999999999999999997
Q ss_pred ccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 045271 229 FYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT---MSSVVF 294 (338)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~vl~ 294 (338)
............ .+ ..... +.... .....+.+++.+||. ||.+|++ +.+++.
T Consensus 241 ~~~~~~~~~~i~----~~-~~~~~--~~~~~------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 241 SDNPQETYRKII----NW-KETLQ--FPDEV------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCHHHHHHHHH----cC-CCccC--CCCCC------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 543221110000 00 00000 00000 111245567778996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=242.51 Aligned_cols=233 Identities=27% Similarity=0.368 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+..|..+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3579999999999999999999643 45788998764332 2345567788999999999999999988899
Q ss_pred EEEEecCCCCCHHHHHhccCcc----ccc----cHHHHHHHHHHhhhcCCC---------------------CeEEeeec
Q 045271 120 LLICEYMPNKSLDFLLFDSTRS----VQL----DWNRRMCIINGIARDHKM---------------------NPKISDFG 170 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~----~~~----~~~~~~~~~~~i~~~~~~---------------------~vkL~Dfg 170 (338)
++||||+++++|..++...... ..+ ......+++.++.++|.. .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 9999999999999988654321 111 223445567777765532 38999999
Q ss_pred cceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
++..+.............++..|+|||++.+..++.++|||||||++|+|++ |..||............. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------~~~ 238 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------GGG 238 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------cCC
Confidence 9987632221111122234567999999998889999999999999999997 998986543222111100 000
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.. . .. ......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 239 ~~-~-~~--------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 RL-D-PP--------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cC-C-CC--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 00 0 00 0111345678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=241.74 Aligned_cols=234 Identities=25% Similarity=0.367 Sum_probs=164.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
..++|++.+.||+|+||.||+|... .+..||+|.+..... ..+..+..+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999999843 245699998854322 224566778899999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCccc-----------cccHHHHHHHHHHhhhcCC------------------CCeEEeee
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSV-----------QLDWNRRMCIINGIARDHK------------------MNPKISDF 169 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~i~~~~~------------------~~vkL~Df 169 (338)
.++||||+++++|.+++....... ........+++.+|.+.|+ +.++|+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999999886532210 1112234456677666553 45899999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||............ ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~-------~~ 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-------ME 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------Hc
Confidence 99876532222111122345778999999998889999999999999999999 67887643221111100 00
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
........ .....+.+++.+||+.||++|||+.++++.|++
T Consensus 237 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111000 011245678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=240.09 Aligned_cols=233 Identities=23% Similarity=0.287 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....|+.+++.++||||+++++++..++.+++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45899999999999999999995 5678899999864432 2355677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++++|.+++..... ..........+++.++.+.|+ +.++|+|||++..+.... .....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCc
Confidence 999999988764332 222333444556666665443 458999999998663211 11223
Q ss_pred cccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 187 VVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 187 ~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..|+..|+|||.+. ...++.++|+|||||++|+|++|..||............. ..... ......
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~---~~~~~~-- 233 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS-------KSNFQ---PPKLKD-- 233 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee-------cCCCC---CCCCcc--
Confidence 56888999999885 3447889999999999999999999985432111100000 00000 000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.......+.+++.+||+.||++|||+.+|++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001123566788899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=252.54 Aligned_cols=231 Identities=21% Similarity=0.274 Sum_probs=159.7
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|++++.||+|+||.||+|.. .++..||||++.... ...+..|..+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688999999999999999994 457789999986432 1235567788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC-----
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS----- 180 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~----- 180 (338)
||++|+|..++..... ..........+++.+|.+.| ++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999988865432 22222333445666666544 35689999999754311000
Q ss_pred ----------------------------------------CccccccccCCccccccccccCCCCcccchHhHhHHHHHH
Q 045271 181 ----------------------------------------EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEI 220 (338)
Q Consensus 181 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el 220 (338)
.......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0001235799999999999988899999999999999999
Q ss_pred HhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 045271 221 ISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLL--CVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 221 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~Rps~~~vl~~ 295 (338)
++|..||......+..... ........ +..... ....+.+|+.+ |+..++..|||+.+++..
T Consensus 242 ltG~~Pf~~~~~~~~~~~i------~~~~~~~~-~~~~~~------~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKV------INWENTLH-IPPQVK------LSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HhCCCCCcCCCHHHHHHHH------HccccccC-CCCCCC------CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999753321111100 00000000 001001 11234556666 556677779999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=253.88 Aligned_cols=237 Identities=25% Similarity=0.322 Sum_probs=167.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcC-CCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~ 116 (338)
...++|.+.++||+|+||.||+|.+. .++.||+|++..... +.+..|..++..+. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33457889999999999999999853 245799999975432 23556778888887 99999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCccc------------------------------------------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRSV------------------------------------------------------ 142 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------------ 142 (338)
+..++|||||++|+|.+++.......
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999886432100
Q ss_pred ---------------------------------------------cccHHHHHHHHHHhhhcCCC---------------
Q 045271 143 ---------------------------------------------QLDWNRRMCIINGIARDHKM--------------- 162 (338)
Q Consensus 143 ---------------------------------------------~~~~~~~~~~~~~i~~~~~~--------------- 162 (338)
.....+..+++.++.++|+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 00122344677777776653
Q ss_pred ---CeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccch
Q 045271 163 ---NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSL 238 (338)
Q Consensus 163 ---~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~ 238 (338)
.+||+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-- 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-- 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence 379999999986532221111223456788999999998889999999999999999998 88888643221110
Q ss_pred hhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 239 LTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
. .......... .. ......+.+|+.+||+.||.+||++.+|+..|+..
T Consensus 352 ~----~~~~~~~~~~-~p--------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 Y----NAIKRGYRMA-KP--------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H----HHHHcCCCCC-CC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0000000000 00 00123456788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=248.32 Aligned_cols=219 Identities=20% Similarity=0.190 Sum_probs=159.2
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||++.. .++..||+|.+.... ......|..+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999994 568899999986431 123445777899999999999999999999999999999999
Q ss_pred CHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccC
Q 045271 130 SLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGT 190 (338)
Q Consensus 130 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt 190 (338)
+|..++..... ..........+++.+|.++|+ +.+||+|||++...... ........|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCC
Confidence 99888765432 223334455667777776554 45899999998753211 1122345799
Q ss_pred CccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
+.|+|||++.+..++.++|||||||++|+|++|..||............ . .... . +... ....
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~-~~~~-~-~p~~--------~~~~ 221 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------L-MEEI-R-FPRT--------LSPE 221 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------h-cCCC-C-CCCC--------CCHH
Confidence 9999999999889999999999999999999999998643221111100 0 0000 0 0000 1123
Q ss_pred HHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 271 RIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 45688889999999998 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=246.94 Aligned_cols=226 Identities=19% Similarity=0.249 Sum_probs=157.9
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|.++.... ..+..+..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999995 4578899999965321 2244566677776 799999999999999999999999999
Q ss_pred CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++.... ...........+++.++.+.|. +.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99988775443 2333344455567777776553 4589999999875321 1122334689
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc--chhhHHHhhhccCCcccccCccccccccHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ--SLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
|..|+|||++.+..++.++|||||||++|+|++|..||......... ............... . +... .
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~p~~--------~ 228 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-IPRS--------L 228 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-CCCC--------C
Confidence 99999999999989999999999999999999999999643221110 000111111111110 0 0000 1
Q ss_pred HHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPT------MSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps------~~~vl~ 294 (338)
...+.+++.+||+.||.+|+| +.++++
T Consensus 229 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 124567888999999999997 677774
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=252.99 Aligned_cols=229 Identities=20% Similarity=0.200 Sum_probs=163.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.++..+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999995 4688899999865321 33566777888999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||+++|+|..++..... ..........+++.+|.+.| ++.+||+|||++..+...... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence 99999999999876522 22223334455666666654 356999999999876432211 1
Q ss_pred ccccccCCccccccccc------cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 184 TNRVVGTYGYMAPEYAL------EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~------~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||.......... ..........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~---- 229 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQRFLK---- 229 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCCccC----
Confidence 22347899999999987 4567899999999999999999999996433211110 0000000000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+........+.+|+..||+ ||.+|||+.+++.
T Consensus 230 ---~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 ---FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000112235567778998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=225.77 Aligned_cols=225 Identities=21% Similarity=0.238 Sum_probs=172.3
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||.|.||.||+|+ .+++-.||+|++.++. ...+.+|+++-..|+||||+++|++|.+...+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4689999999999999999999 5556789999986543 24466777788889999999999999999999999
Q ss_pred EecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhc------------------CCCCeEEeeeccceecCCCCCC
Q 045271 123 CEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARD------------------HKMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~------------------~~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||+++|.+...++... ......+....+++.++.+. +.+.+|++|||-+..- .+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~----p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PS 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec----CC
Confidence 99999999998887332 23344555566666666654 4456899999998764 24
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....+.|||.-|.+||+..+..++..+|+|++||+.||++.|.+||......+....+... .... ...+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------~~~~--p~~i-- 245 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------DLKF--PSTI-- 245 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------cccC--Cccc--
Confidence 4456789999999999999999999999999999999999999999755432222222111 1111 0111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....++|.+||..+|.+|.+..|++..
T Consensus 246 ------s~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 246 ------SGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------ChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1234567778999999999999999863
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=242.22 Aligned_cols=247 Identities=26% Similarity=0.300 Sum_probs=167.2
Q ss_pred CC-CCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEE
Q 045271 52 NF-SNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNEL 119 (338)
Q Consensus 52 ~y-~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~ 119 (338)
+| ++++.||+|+||.||++.. .++..||+|.+..... ..+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8999999999999988652 3467899999865432 335567789999999999999998865 3468
Q ss_pred EEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
++||||+++++|.+++...............+++.++.++|+ +.++|+|||++.........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 999999999999999876554444445556667777776554 34899999999865322111
Q ss_pred cc-ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 AN-TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||........ ........................
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCC
Confidence 11 1123456679999999888899999999999999999999999754321100 000000000000000000000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.+........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000111123566788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=241.22 Aligned_cols=232 Identities=25% Similarity=0.348 Sum_probs=164.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
++|++.+.||+|+||.||+|.. ..+..|++|.+..... ..+..|..+++.++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4788999999999999999984 2356799999864332 235567789999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc------------------cccccHHHHHHHHHHhhhcCC------------------CCeE
Q 045271 122 ICEYMPNKSLDFLLFDSTR------------------SVQLDWNRRMCIINGIARDHK------------------MNPK 165 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~~~i~~~~~------------------~~vk 165 (338)
||||+++++|.+++..... ..........+++.++.+.|+ ..+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 9999999999998853321 011112344456666666554 3489
Q ss_pred EeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHh
Q 045271 166 ISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWK 244 (338)
Q Consensus 166 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~ 244 (338)
|+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||........... ..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~---~~- 240 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM---VR- 240 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH-
Confidence 999999986533222222233455678999999988889999999999999999998 8888854321111110 00
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
...... ... . ....+.+++.+||+.||.+||++.+|++.|..
T Consensus 241 ---~~~~~~-~~~----~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 ---KRQLLP-CSE----D----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---cCCcCC-CCC----C----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000000 000 0 11235668888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=242.04 Aligned_cols=240 Identities=22% Similarity=0.287 Sum_probs=158.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-c-CCcEEEEEEeccCCc-----ccHHHHHHHHHh---cCCCceeeeeeEEE-----e
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-N-DDKEIAVKRLSRSSG-----QGLQEFKNLIAK---LQHKNLVRLLGCCL-----E 115 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~---l~hpnIv~~~~~~~-----~ 115 (338)
++|++.+.||+|+||.||+|.. . ++..||+|.+..... .....+..+++. ++||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999995 3 356799998854321 123345555554 47999999999985 2
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeecccee
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARV 174 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~ 174 (338)
...+++||||++ ++|..++..... ..........+++.+|.+.|+ +.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 688877754321 222334455667777776553 4589999999987
Q ss_pred cCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc-
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE- 253 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 253 (338)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|.+||......+....+..............
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 5322 222345789999999999988899999999999999999999999875432221111110000000000000
Q ss_pred --ccCccc--cccccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 --LMDPVL--KESFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 --~~~~~~--~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...... ....... ....+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0000111 1123467899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=260.53 Aligned_cols=235 Identities=20% Similarity=0.175 Sum_probs=167.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCC-cEEEEEEeccCCc---ccHHHHHHHHHhcC-CCceeeeeeEE-Ee------CC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDD-KEIAVKRLSRSSG---QGLQEFKNLIAKLQ-HKNLVRLLGCC-LE------GN 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~-~~vavK~~~~~~~---~~~~~~~~~l~~l~-hpnIv~~~~~~-~~------~~ 117 (338)
.-++++.+.|.+|+|+.||+|....+ ..||+|++.-... ....+|+.+|+.|+ |+|||.++|.. .. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34788899999999999999996555 9999998754433 34678889999997 99999999932 21 24
Q ss_pred EEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhh--------------------cCCCCeEEeeecccee
Q 045271 118 ELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIAR--------------------DHKMNPKISDFGMARV 174 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~--------------------~~~~~vkL~Dfg~a~~ 174 (338)
++.|+||||.+|.|-+++..+. ........+..++++++++ .++++.||||||.|..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6889999999999988886432 2233334444445555444 4456799999999865
Q ss_pred cCCCCCCccc-------cccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh
Q 045271 175 FGGNQSEANT-------NRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK 244 (338)
Q Consensus 175 ~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 244 (338)
.......... -....|+.|+|||++. +.+.+.|+|||||||+||-|+...+||.....
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------ 263 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------ 263 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence 3211110000 0124688999999985 56789999999999999999999999964211
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
..++......+........+.+||+.||+.||++||++.+|+..+.+++...
T Consensus 264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1111222222222334456677888899999999999999999888877654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.64 Aligned_cols=221 Identities=28% Similarity=0.366 Sum_probs=165.5
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|.-++.||.|+||.||-++ ..+...||||++..+.. +++..++..|+.++|||+|.+.+.|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667899999999999999 55677899999865433 346667788999999999999999999889999999
Q ss_pred cCCCCCHHHHHhccCcccccc--HHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLD--WNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|| -|+-.+++.-...+.... .++....+.|++|+|+ +.|||+|||.|... ...
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------~PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------APA 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc------Cch
Confidence 99 777777776665555443 3344446677777664 34899999998754 335
Q ss_pred cccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
+.++||++|||||++. .+.|+.++||||+||++.||...++|+..+.. ....+.+... -.+.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQN------esPtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN------ESPTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhc------CCCCCC-
Confidence 5689999999999997 45799999999999999999999999764322 1111111111 111122
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......+.+|+..||+.-|.+|||..+++.
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1233445677888999999999999998875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=247.91 Aligned_cols=220 Identities=20% Similarity=0.188 Sum_probs=159.6
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||++.. .++..||+|.+.... ......|..+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999994 468899999986432 123455677889999999999999999999999999999999
Q ss_pred CHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccC
Q 045271 130 SLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGT 190 (338)
Q Consensus 130 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt 190 (338)
+|...+..... ..........+++.+|.++|+ +.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCC
Confidence 99888765432 222334455567777777554 45899999998753211 1222345799
Q ss_pred CccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
+.|+|||++.+..++.++|||||||++|+|++|..||........... .. .... . +... ....
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~------~~-~~~~-~-~p~~--------~~~~ 221 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL-MEDI-K-FPRT--------LSAD 221 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH------hc-cCCc-c-CCCC--------CCHH
Confidence 999999999988999999999999999999999999964322111100 00 0000 0 0010 1123
Q ss_pred HHHHHhhccCCCCCCCC-----CHHHHHHH
Q 045271 271 RIHIGLLCVQEDPADRP-----TMSSVVFM 295 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rp-----s~~~vl~~ 295 (338)
+.+|+.+||+.||++|+ ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 56788899999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.04 Aligned_cols=246 Identities=18% Similarity=0.243 Sum_probs=162.3
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC-----CEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG-----NELL 120 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 120 (338)
+|++.++||+|+||.||+|.. .++..||||.+.... ...+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999994 468899999986421 12355678899999999999999988643 3589
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||| +++|..++..... ..........+++.+|.+.|+ +.+||+|||++.........
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 5788877764432 223334455567777776554 45899999999764321111
Q ss_pred -ccccccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccCC
Q 045271 182 -ANTNRVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEGN 250 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~ 250 (338)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............... ........
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 11233578999999999876 57899999999999999999999999653321111000000 00000000
Q ss_pred cccccCccccc-cccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 251 AQELMDPVLKE-SFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 251 ~~~~~~~~~~~-~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
........... .... .....+.+++.+||+.||++|||+.++++ ++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000000000 0000 01123567889999999999999999995 4444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=252.85 Aligned_cols=232 Identities=19% Similarity=0.217 Sum_probs=164.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||++... +++.||+|.+.+. ....+.++..+++.++||||+++++++.+++.+|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999954 5778999998542 122355677889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||||++|+|..++...............+++.+|.+.|+ +.+||+|||+|..+.... ....
T Consensus 122 ~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~ 200 (370)
T cd05621 122 MEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRC 200 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-ceec
Confidence 999999999999876544433344455567777766553 458999999998763221 1122
Q ss_pred cccccCCccccccccccC----CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 185 NRVVGTYGYMAPEYALEG----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...+||+.|+|||++.+. .++.++||||+||++|+|++|..||.......... .......... +..
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~-~p~--- 270 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDHKNSLN-FPE--- 270 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCcccC-CCC---
Confidence 346799999999999764 37889999999999999999999996433211110 0000000000 001
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVFM 295 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~~ 295 (338)
.......+.+++..||+.++.+ |+|+.+++++
T Consensus 271 ---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 ---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111223456777799855543 8899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=246.00 Aligned_cols=220 Identities=21% Similarity=0.282 Sum_probs=158.5
Q ss_pred CceecccCCeeEEEEEE----cCCcEEEEEEeccCC-------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 56 ENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++.||+|+||.||++.. ..++.||+|.+.... ......|..+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 46899999999999984 246789999986421 1234567788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|+++++|...+...... .........+++.+|.+.| ++.+||+|||+++..... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CCccc
Confidence 99999999888654432 1222333445666666644 345899999998754211 12223
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..+|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ... .... . +...
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~------~~~-~~~~-~-~~~~------- 222 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID------KIL-KGKL-N-LPPY------- 222 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH------HHH-cCCC-C-CCCC-------
Confidence 4579999999999998889999999999999999999999996433211110 000 0000 0 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 266 EELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+++.+||+.||++|| ++.+++.
T Consensus 223 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 -LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112456788899999999999 8888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=242.17 Aligned_cols=240 Identities=27% Similarity=0.345 Sum_probs=163.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC---------------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND---------------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLL 110 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~ 110 (338)
.++|++.+.||+|+||.||+|.... ...||+|.+..... ..+..|+++++.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999988532 22489999865432 2355678899999999999999
Q ss_pred eEEEeCCEEEEEEecCCCCCHHHHHhccCc-------------cccccHHHHHHHHHHhhhcCC----------------
Q 045271 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTR-------------SVQLDWNRRMCIINGIARDHK---------------- 161 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~~~~---------------- 161 (338)
+++...+..++||||+++++|.+++..... ..........+++.++.+.|+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 999999999999999999999998854321 111112344556666666553
Q ss_pred --CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh--CCCCCcccccccccc
Q 045271 162 --MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS--GRKDTRFYLYEQGQS 237 (338)
Q Consensus 162 --~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~--g~~Pf~~~~~~~~~~ 237 (338)
+.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 3589999999976532221111222345678999999998889999999999999999998 555665322211111
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
. ....+.......... ... .....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 244 ~---~~~~~~~~~~~~~~~---~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 244 N---TGEFFRNQGRQIYLS---QTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H---HHHhhhhccccccCC---CCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0 000000000000000 000 011356778899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=236.07 Aligned_cols=225 Identities=24% Similarity=0.305 Sum_probs=159.1
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
+.||+|+||.||+|.. .+++.||+|.+..... ..+..+..+++.++||||+++++++...+.+++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999995 4688899998754322 3456677889999999999999999999999999999999999
Q ss_pred HHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCC
Q 045271 132 DFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTY 191 (338)
Q Consensus 132 ~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~ 191 (338)
.+++..... .....+....+++.++.+.|+ +.+||+|||++................++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 998865432 222234455567777776554 348999999987643211111111112345
Q ss_pred ccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 192 GYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 192 ~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
.|+|||.+.+..++.++|||||||++|+|++ |..||............. ........ ......
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~--------~~~~~~ 224 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--------QGVRLPCP--------ELCPDA 224 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH--------cCCCCCCc--------ccCCHH
Confidence 6999999988889999999999999999998 888875432211111000 00000000 011234
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 271 RIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
+.+++.+||+.||++|||+.++++.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 567888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=237.59 Aligned_cols=234 Identities=26% Similarity=0.354 Sum_probs=166.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++.+.||+|+||.||+|.+.. ...||+|.+..... ..+..+..+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3579999999999999999999632 34689998864332 234556778899999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++++|..++..... ..........+++.++.++|+ +.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 9999999999999865432 222333444556666666554 44899999999876422222
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||............. ...... . . .
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~~--~-~-~- 231 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE------DGYRLP--P-P-M- 231 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH------cCCCCC--C-C-C-
Confidence 11222345678999999998889999999999999999998 998885433221111110 000000 0 0 0
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.....+.+++.+||+.||++||++.+|++.|+..
T Consensus 232 -----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 232 -----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112356788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=246.42 Aligned_cols=235 Identities=25% Similarity=0.396 Sum_probs=167.1
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCc----EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDK----EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+|++.+.||+|+||.||+|.+. ++. .||+|.+..... ..+..+..+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 47999999999999999999853 333 389999864322 3455667789999999999999998764 5779
Q ss_pred EEecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|+||+++|+|.+++...... ....+....+++.+|.++|+ +.+||+|||++..+......
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 99999999999988764322 22234455677888887665 34899999999876432222
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..... .... ......
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~-~~~~~~--- 234 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE-RLPQPP--- 234 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------hCCC-CCCCCC---
Confidence 22222334668999999999899999999999999999997 99988643222111100 0000 000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+++.+||+.||++|||+.+++..|......
T Consensus 235 -----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 235 -----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0112456788899999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=239.93 Aligned_cols=231 Identities=29% Similarity=0.406 Sum_probs=169.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
..+|++.++||.|+||.||+|....+..+++|.+..... ..+..++.+++.++||||+++++++.+.+.+++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 347999999999999999999987788999999865543 34666778899999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++++|.+++..... ..........+++.++.+.|+ +.+||+|||.+......... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--cc
Confidence 99999999875321 112223344456666666543 35899999999765321111 11
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...... . . ... +..
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~----~-~~~--------~~~ 226 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---A----G-YRM--------PCP 226 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---h----C-CcC--------CCC
Confidence 2345678999999988889999999999999999998 888886433211111110 0 0 000 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=241.45 Aligned_cols=175 Identities=23% Similarity=0.316 Sum_probs=139.4
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++.+.||+|+||.||++... ++..+|+|.+..... ..+..|+++++.++||||+++++.+.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999954 577788898764322 2355677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+++++|..++..... ..........+++.++.+.|+ +.++|+|||++...... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~ 156 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccc
Confidence 999999999865432 222333455567777777663 24899999998765221 123
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 45788999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=240.39 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=164.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-----------------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-----------------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~ 108 (338)
.++|++.+.||+|+||.||++... +...||+|.+..... ..+..|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998632 233589998865432 34567788999999999999
Q ss_pred eeeEEEeCCEEEEEEecCCCCCHHHHHhccCccc------------cccHHHHHHHHHHhhhcCC---------------
Q 045271 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSV------------QLDWNRRMCIINGIARDHK--------------- 161 (338)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------~~~~~~~~~~~~~i~~~~~--------------- 161 (338)
+++++...+..++||||+++++|..++....... ...+....+++.++.+.|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999887643211 1123444556666666554
Q ss_pred ---CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh--CCCCCccccccccc
Q 045271 162 ---MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS--GRKDTRFYLYEQGQ 236 (338)
Q Consensus 162 ---~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~--g~~Pf~~~~~~~~~ 236 (338)
+.++|+|||++..+.............++..|+|||+..+..++.++|||||||++|||++ |..||......+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3489999999976532221111222344678999999888889999999999999999998 66777543222111
Q ss_pred chhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.. ....+............ . .....+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 244 ~~---~~~~~~~~~~~~~~~~~---~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 EN---TGEFFRDQGRQVYLPKP---A---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHhhccccccCCCC---C---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 00001000000000000 0 011345678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=240.86 Aligned_cols=239 Identities=27% Similarity=0.340 Sum_probs=166.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-----------------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-----------------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~ 108 (338)
.++|++++.||+|+||.||+|.... +..||+|.+..... +.+..|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4589999999999999999988432 23579998865432 23556778899999999999
Q ss_pred eeeEEEeCCEEEEEEecCCCCCHHHHHhccCc------------cccccHHHHHHHHHHhhhcCC---------------
Q 045271 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTR------------SVQLDWNRRMCIINGIARDHK--------------- 161 (338)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~i~~~~~--------------- 161 (338)
+++++..++.+++||||+++++|..++..... .....+....+++.+|.++|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 99999999999999999999999998865431 122234445566777766553
Q ss_pred ---CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh--CCCCCccccccccc
Q 045271 162 ---MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS--GRKDTRFYLYEQGQ 236 (338)
Q Consensus 162 ---~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~--g~~Pf~~~~~~~~~ 236 (338)
+.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..||........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~- 242 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV- 242 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH-
Confidence 3589999999986543222222223456778999999988889999999999999999998 5667653321111
Q ss_pred chhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.......+........... .......+.+++.+||+.||.+|||+.+|++.|+
T Consensus 243 --~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 243 --IENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111000000100100 0011135677889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=244.19 Aligned_cols=236 Identities=26% Similarity=0.354 Sum_probs=168.0
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~ 117 (338)
..++|++.+.||+|+||.||+|... .+..||+|.+..... +.+..|..+++.+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457999999999999999999731 244689998865432 2356677888999 7999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFG 176 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~ 176 (338)
..++||||+++|+|..++..... ..........+++.+|.+.|+. .++|+|||++..+.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 99999999999999999865332 2222334445677777766643 37999999998654
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
............++..|+|||.+.+..++.++||||+||++|+|++ |..||......... ... .... .....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----~~~~-~~~~~ 265 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----IKEG-YRMAQ 265 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH----HHcC-CcCCC
Confidence 3221111222345678999999998889999999999999999998 99998643321110 000 0000 00000
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
. ......+.+|+.+||+.||++|||+.++++.|+..
T Consensus 266 ~--------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 P--------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C--------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 00112466788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=242.17 Aligned_cols=235 Identities=25% Similarity=0.366 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
..+|.+.+.||+|+||.||++... ++..+|+|.+..... ..+..++.+++.++||||+++++++...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357899999999999999999842 234588998865432 34667788899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc--------------cccccHHHHHHHHHHhhhcCC------------------CCeEEee
Q 045271 121 LICEYMPNKSLDFLLFDSTR--------------SVQLDWNRRMCIINGIARDHK------------------MNPKISD 168 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~D 168 (338)
+||||+++++|..++..... .....+....+++.++.+.|+ +.++|+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 99999999999998865431 112223344556666666554 3489999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhc
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWC 247 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 247 (338)
||++................++..|+|||++.+..++.++|||||||++|+|++ |..||............ .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-------~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-------T 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------H
Confidence 999986532221111222345778999999998889999999999999999998 88888643321111110 0
Q ss_pred cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
......... . ....+.+|+.+||+.||.+|||+.+++..|+...
T Consensus 237 ~~~~~~~~~-----~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 237 QGRVLQRPR-----T----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred cCCcCCCCC-----C----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 011000000 0 1124677888999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=236.23 Aligned_cols=230 Identities=23% Similarity=0.325 Sum_probs=164.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
++|++.+.||+|++|.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4799999999999999999994 4688999998854321 235567778999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|+||+++++|.+.+..... ..........+++.+|.+.|+ +.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999988865432 222233344556666666543 468999999997653221111
Q ss_pred c-ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 183 N-TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 183 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||........ ............ +..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~-~~~---- 230 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPTNPQ-LPS---- 230 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccCCCCC-CCc----
Confidence 1 1234678899999999998899999999999999999999999864211110 000000000000 110
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+++.+||..||.+|||+.++++.
T Consensus 231 ----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 ----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 112235668889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=239.11 Aligned_cols=229 Identities=20% Similarity=0.281 Sum_probs=167.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..+|++++.||+|+||.||+|.. .++..|++|.+..... +....+..+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 45899999999999999999994 5678899998865432 3455677888999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..++...............+++.++.+.|+ +.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~ 176 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTM 176 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcc
Confidence 999999998865443333334455566777766554 448999999987653221 112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||.+.+..++.++|||||||++|+|++|..||........ .... .... ... +... ...
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~~~---~~~~-~~~-----~~~~--~~~ 242 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLI---ATNG-TPE-----LQNP--EKL 242 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HHHH---hcCC-CCC-----CCCc--ccc
Confidence 688899999999988899999999999999999999999864322111 0000 0000 000 0000 011
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+++.+||..||++|||+.+++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 123567888999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=238.80 Aligned_cols=233 Identities=26% Similarity=0.380 Sum_probs=167.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ....+++.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4589999999999999999998532 35799999864432 2345667788999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCcc-----------ccccHHHHHHHHHHhhhcCC------------------CCeEEeeec
Q 045271 120 LLICEYMPNKSLDFLLFDSTRS-----------VQLDWNRRMCIINGIARDHK------------------MNPKISDFG 170 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg 170 (338)
++||||+++|+|..++...... ....+....+++.++.+.|. +.+||+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999988653221 11223345567777777654 348999999
Q ss_pred cceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
+++.+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||........... . ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---~----~~~ 237 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---V----IDG 237 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH---H----hcC
Confidence 9876543222222223456788999999988889999999999999999998 8888864322111110 0 011
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
........ ....+.+++.+||+.||++|||+.+++..|+.
T Consensus 238 ~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 12345678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=240.35 Aligned_cols=235 Identities=25% Similarity=0.330 Sum_probs=168.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe-CCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE-GNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~-~~~~ 119 (338)
.++|++.+.||+|+||.||+|.+.. +..|++|.+..... ..+..+..+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5689999999999999999999655 67789998864432 234566778899999999999998765 5678
Q ss_pred EEEEecCCCCCHHHHHhccCc---------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccc
Q 045271 120 LLICEYMPNKSLDFLLFDSTR---------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMA 172 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a 172 (338)
++++||+++++|..++..... ..........+++.++.++|+ +.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 999999999999998865322 122233455567777777654 34799999999
Q ss_pred eecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
+.+.............++..|+|||++.+..++.++|||||||++|++++ |..||......+ ...... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~~~~ 238 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---DGYRL 238 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---cCCCC
Confidence 86532222111222345678999999988889999999999999999998 999986432211 111000 00000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
. .. .. ....+.+++.+||+.||++|||+.+++..|+...
T Consensus 239 ~---~~-~~------~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 239 A---QP-IN------CPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C---CC-Cc------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 00 00 1123567888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=244.89 Aligned_cols=219 Identities=23% Similarity=0.240 Sum_probs=157.0
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... ++..||||.+.+.. ......+..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 57789999986432 12234455666666 699999999999999999999999999
Q ss_pred CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|...+.... ...........+++.+|.++|+ +.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccceec
Confidence 99988876553 2333334455567777776554 45899999998753211 112233578
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+..|+|||++.+..++.++|||||||++|+|++|..||.......... ... .... .+... ...
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~------~i~-~~~~--~~~~~--------~~~ 221 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ------SIL-EDEV--RYPRW--------LSK 221 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH------HHH-cCCC--CCCCc--------CCH
Confidence 999999999999999999999999999999999999996433211110 000 0000 01110 112
Q ss_pred HHHHHHhhccCCCCCCCCCH-----HHHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTM-----SSVVF 294 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~-----~~vl~ 294 (338)
.+.+|+.+||+.||++|||+ .+++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 45678889999999999999 88875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=235.69 Aligned_cols=230 Identities=25% Similarity=0.343 Sum_probs=165.0
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
.+|++.+.||+|+||.||+|.+..+..+|+|.+.... ......+..+++.++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3688999999999999999998777789999986432 23456678899999999999999999999999999999999
Q ss_pred CCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
++|.+++...... .........+++.++.+.| ++.+||+|||++.......... .....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 162 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTK 162 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc-cCCCC
Confidence 9999988654322 2222344455666666544 3458999999997653211111 11122
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.... ....... ... ...
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~---~~~-------~~~ 226 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES------VSAGYRL---YRP-------KLA 226 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH------HHcCCcC---CCC-------CCC
Confidence 3457999999998889999999999999999998 7888864322211110 0000000 000 011
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
...+.+++.+||+.+|++|||+.++++.|.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 224667888999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=248.28 Aligned_cols=236 Identities=27% Similarity=0.363 Sum_probs=163.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEe-CC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLE-GN 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~-~~ 117 (338)
.++|++.+.||+|+||.||+|... +++.||+|.+..... +.+..+..+++.+ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 458999999999999999999732 246799999864332 2344567778888 89999999998864 46
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc--------------------------------------------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS-------------------------------------------------------- 141 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 141 (338)
.++++|||+++++|..++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999888543210
Q ss_pred ------ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCcccccc
Q 045271 142 ------VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197 (338)
Q Consensus 142 ------~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 197 (338)
.........+++.++.++|+ +.++|+|||++..+.............++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 00112234456676666553 458999999998763322222222345567899999
Q ss_pred ccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHh
Q 045271 198 YALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGL 276 (338)
Q Consensus 198 ~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 276 (338)
++.+..++.++|||||||++|+|++ |..||......+. .. ....... ..... ......+.+++.
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~---~~~~~~~-~~~~~--------~~~~~~~~~l~~ 310 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC---RRLKEGT-RMRAP--------EYATPEIYSIML 310 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH---HHHhccC-CCCCC--------ccCCHHHHHHHH
Confidence 9999999999999999999999998 9999864221111 00 0000000 00000 011234677888
Q ss_pred hccCCCCCCCCCHHHHHHHhhcCc
Q 045271 277 LCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 277 ~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
+||+.+|++|||+.+|++.|+...
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=241.84 Aligned_cols=234 Identities=26% Similarity=0.361 Sum_probs=168.9
Q ss_pred cCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
++|.+.+.||+|+||.||+|... ++..+++|.+..... +.+.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999842 244588888865443 346677788999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeEE
Q 045271 122 ICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPKI 166 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL 166 (338)
||||+++++|.+++..... .....+....+++.++.++|+ +.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 9999999999999865321 111223445566777766554 34899
Q ss_pred eeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhh
Q 045271 167 SDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~------- 237 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC------- 237 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------
Confidence 99999976533221112223456788999999998889999999999999999998 9999865332221111
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
........... .....+.+++.+||+.||++|||+.+|++.|+...
T Consensus 238 ~~~~~~~~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 238 ITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HhCCCCCCCCc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 00111111000 01224567888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=241.55 Aligned_cols=232 Identities=26% Similarity=0.325 Sum_probs=163.1
Q ss_pred cCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.+|++.+.||+|+||.||+|.... +..||+|.+..... ..+..+..+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357888999999999999998532 46799999875433 23456667888999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeE
Q 045271 121 LICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPK 165 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vk 165 (338)
+++||+++++|..++..... ..........+++.++.+.|+ ..+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999988853211 111112344456666666553 4589
Q ss_pred EeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHh
Q 045271 166 ISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWK 244 (338)
Q Consensus 166 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~ 244 (338)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i----- 239 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI----- 239 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence 999999886533222222223356778999999988889999999999999999998 77787643221111110
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
. ......... .....+.+++.+||+.||++||++.+|+.+|+.
T Consensus 240 -~-~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 -R-NRQVLPCPD---------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -H-cCCcCCCCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 000000000 111234568889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=252.87 Aligned_cols=231 Identities=20% Similarity=0.261 Sum_probs=161.5
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.+|++++.||+|+||.||+|+. .+++.||||.+... .......|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3799999999999999999994 45788999998542 2234567788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC-----
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ----- 179 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~----- 179 (338)
|||++|+|.+++..... ..........+++.+|.+.|. +.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999866443 222223344566777666553 458999999975321000
Q ss_pred ------------------------------------CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhC
Q 045271 180 ------------------------------------SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG 223 (338)
Q Consensus 180 ------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g 223 (338)
........+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00001135799999999999998999999999999999999999
Q ss_pred CCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 045271 224 RKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRP---TMSSVVFM 295 (338)
Q Consensus 224 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~vl~~ 295 (338)
..||......+...... .+ ..... +..... ....+.+++.+|+ .||.+|+ |+.+++..
T Consensus 241 ~~Pf~~~~~~~~~~~i~----~~--~~~~~-~~~~~~------~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAETQLKVI----NW--ETTLH-IPSQAK------LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHHHHHh----cc--Ccccc-CCCCCC------CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99997543221111000 00 00000 000000 1123345666666 4999999 89999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=244.18 Aligned_cols=229 Identities=22% Similarity=0.244 Sum_probs=160.9
Q ss_pred CCCCCceecccCCeeEEEEEE----cCCcEEEEEEeccCC-------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~ 119 (338)
+|++++.||+|+||.||+++. .++..||+|.+.+.. .+....|..+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999984 257789999986421 12345567788888 589999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
++||||+++|+|..++..... ..........+++.+|.+.|+ +.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999888865432 222333444467777666553 4599999999976532211
Q ss_pred CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||............. .... ... ..+..
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~-~~~--~~~~~-- 232 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRIL-KCD--PPFPS-- 232 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHh-cCC--CCCCC--
Confidence 122345799999999999875 47889999999999999999999996432221111111 0000 000 00000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
.....+.+++.+||+.||++|| ++.++++
T Consensus 233 ------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 233 ------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0112345688889999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=243.21 Aligned_cols=219 Identities=24% Similarity=0.262 Sum_probs=155.6
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHh-cCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAK-LQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... +++.||+|.+.... ......+..+++. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 47789999986531 1223334445554 5899999999999999999999999999
Q ss_pred CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++.... ...........+++.+|.++|+ +.+||+|||++...... ........|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCceeeecC
Confidence 99998886542 2333334455667777777554 35899999998754211 112234578
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|..|+|||++.+..++.++|||||||++|+|++|..||......+...... ... ...... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-------~~~--~~~~~~--------~~~ 221 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-------MDN--PCYPRW--------LTR 221 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCC--CCCCcc--------CCH
Confidence 999999999998899999999999999999999999996433211111100 000 001111 112
Q ss_pred HHHHHHhhccCCCCCCCCCHH-HHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMS-SVVF 294 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~-~vl~ 294 (338)
.+.+++.+||+.||.+||++. +++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 356788899999999999997 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=252.16 Aligned_cols=231 Identities=19% Similarity=0.215 Sum_probs=160.7
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|.. .+++.||||++.... ...+..|..+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999994 568889999985421 133556778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC---
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE--- 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~--- 181 (338)
||+++|+|..++..... ..........+++.+|.++|+ +.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999988865432 222223344566666666543 45899999998633110000
Q ss_pred ---------c---------------------------------cccccccCCccccccccccCCCCcccchHhHhHHHHH
Q 045271 182 ---------A---------------------------------NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLE 219 (338)
Q Consensus 182 ---------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~e 219 (338)
. .....+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0012469999999999998899999999999999999
Q ss_pred HHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 045271 220 IISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADR---PTMSSVVFM 295 (338)
Q Consensus 220 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~~vl~~ 295 (338)
|++|..||......+....+ ........ +... ......+.+|+.+||+ +|.+| +|+.+++..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i------~~~~~~~~-~p~~------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKI------INWRETLY-FPDD------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHH------HccCCccC-CCCC------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999643321111100 00000000 0000 0111245667888997 77775 599999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=242.69 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=164.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++++.||+|+||.||+|.. .++..||+|.+..... ....+|..+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5799999999999999999995 4577899999864322 2355678899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++ ++|..++..... ..........+++.++.+.|+ +.+||+|||++........ ...
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 162 (309)
T cd07872 86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYS 162 (309)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccc
Confidence 96 577777654432 222233344567777776554 4589999999976432211 122
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------Hhhhcc------CC
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCE------GN 250 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~------~~ 250 (338)
...++..|+|||++.+. .++.++|||||||++|+|++|..||......+........ ++.... ..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 34678899999998764 5899999999999999999999999754332221111100 000000 00
Q ss_pred cccc-cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 251 AQEL-MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 251 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.... ....... .......+.+++.+||+.||.+|||+.|++. +++..
T Consensus 243 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 243 FPKYKPQPLINH--APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cCccCCCchhhh--ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0000 0000000 0011224568899999999999999999986 55543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=234.87 Aligned_cols=231 Identities=28% Similarity=0.404 Sum_probs=166.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.++||+|+||.||+|...++..+|+|.+.... .+.+.+|+.+++.++|+||+++++++. .+..+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45899999999999999999998778889999986533 345667888999999999999999875 456889999999
Q ss_pred CCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++.... ...........+++.++.+.|+ +.++|+|||++..+...... ....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 162 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQG 162 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccC
Confidence 999999886532 1222234444556666666543 34899999999875322211 1112
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||............ . ... .. ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~-~~~-~~--------~~~~ 226 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV------E-RGY-RM--------PCPQ 226 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------H-cCC-CC--------CCCC
Confidence 345668999999988889999999999999999999 88888643221111110 0 000 00 0001
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+|+.+||+.||.+|||+.++.+.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112346678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=238.43 Aligned_cols=221 Identities=23% Similarity=0.280 Sum_probs=155.0
Q ss_pred ecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||+|+||.||++.. .+++.||+|.+.... ......|..+++.++||||+++++++.++..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999994 458899999985422 12234577889999999999999999999999999999999999
Q ss_pred HHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccC
Q 045271 132 DFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGT 190 (338)
Q Consensus 132 ~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt 190 (338)
...+..... ..........+++.++.+.|+ +.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCC
Confidence 887754322 112223344566777766553 458999999998763221 12234688
Q ss_pred CccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
..|+|||++.+..++.++||||+||++|+|++|..||......... ........ ........ . .....
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~~~~~~-~--------~~~~~ 225 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDEVKFEH-Q--------NFTEE 225 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-cccccccc-c--------cCCHH
Confidence 9999999999888999999999999999999999998643211110 00000000 00000000 0 01123
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 045271 271 RIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+.+++.+||+.||++||+++|+++
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchh
Confidence 567888899999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=244.61 Aligned_cols=224 Identities=22% Similarity=0.216 Sum_probs=159.5
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCC-ceeeeeeEEEeCCEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHK-NLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~ 123 (338)
+|++++.||+|+||.||+|... +++.||||++.... ......+..+++.++|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999954 56789999986431 12344556677777765 6888999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++|+|..++..... ..........+++.+|.+.|. +.+||+|||++....... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--Cce
Confidence 99999999888865433 223334445567777776553 458999999987532111 122
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|+|||++.+..++.++||||+||++|+|++|..||......+..... . .... . +...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~-~~~~-~-~~~~------ 223 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------M-EHNV-S-YPKS------ 223 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-cCCC-C-CCCC------
Confidence 3457999999999999999999999999999999999999999643321111100 0 0000 0 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTM-----SSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~-----~~vl~ 294 (338)
....+.+++.+||+.||.+|+++ .++++
T Consensus 224 --~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 224 --LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11245678889999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=243.78 Aligned_cols=218 Identities=22% Similarity=0.246 Sum_probs=154.0
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHH-hcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIA-KLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... ++..||+|.++... ......+..++. .++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999954 57889999986432 122333444554 45899999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++..... ..........+++.+|.++|+ +.++|+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999888865432 222333445567777776553 4589999999875321 1122334679
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|..|+|||++.+..++.++|||||||++|+|++|..||............. .. .... ... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-------~~-~~~~-~~~--------~~~ 221 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-------VD-TPHY-PRW--------ITK 221 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hC-CCCC-CCC--------CCH
Confidence 999999999999999999999999999999999999996433211111000 00 0000 000 112
Q ss_pred HHHHHHhhccCCCCCCCCCHH-HHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMS-SVV 293 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~-~vl 293 (338)
.+.+++.+||+.||++||++. +++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 456788899999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=235.87 Aligned_cols=226 Identities=21% Similarity=0.278 Sum_probs=164.7
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... .+....+..+++.++|+||+++++.+.+++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 588999999999999999994 467889999885432 234556677899999999999999999999999999999
Q ss_pred CCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++++|..++.... ...........+++.++.+.|+ +.++|+|||.+....... ....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cccc
Confidence 9999988875422 1222233445567777766554 358999999997663221 1122
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||......... ... ....... ...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~~-~~~-------- 222 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------LKV-CQGSYKP-LPS-------- 222 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------HHH-hcCCCCC-CCc--------
Confidence 356888999999998888999999999999999999999998643221110 000 0011110 100
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+++.+||+.||++|||+.+++.+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011235678889999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=239.24 Aligned_cols=233 Identities=29% Similarity=0.393 Sum_probs=164.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|.+.++||+|+||.||++... ++..+|+|.+..... ..+..++.+++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999732 345688898765432 34666778899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc----------------cccccHHHHHHHHHHhhhcCC------------------CCeEE
Q 045271 121 LICEYMPNKSLDFLLFDSTR----------------SVQLDWNRRMCIINGIARDHK------------------MNPKI 166 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL 166 (338)
++|||+++++|.+++..... ..........+++.++.++|+ +.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 99999999999998865431 111223334456666666553 45899
Q ss_pred eeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhh
Q 045271 167 SDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.............
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----- 238 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT----- 238 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-----
Confidence 99999976532221111222345678999999998899999999999999999998 888885432211111110
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
......... .....+.+|+.+||+.||.+||++.+|+..|+.
T Consensus 239 --~~~~~~~~~---------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 --QGRELERPR---------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --cCccCCCCC---------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000000000 011234578888999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=243.36 Aligned_cols=226 Identities=19% Similarity=0.263 Sum_probs=155.2
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|.+.+... .....|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 4577899999865321 1234455555554 899999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|...+..... ..........+++.+|.+.| ++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccccC
Confidence 999887754432 22233444556677766654 345899999998753211 112234679
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc--chhhHHHhhhccCCcccccCccccccccHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ--SLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
|..|+|||++.+..++.++|||||||++|+|++|..||......... ............... . +.. ..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-~p~--------~~ 228 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-IPR--------SL 228 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-CCC--------CC
Confidence 99999999999999999999999999999999999999642211111 001111111111110 0 010 11
Q ss_pred HHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTM------SSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~------~~vl~ 294 (338)
...+.+++.+||+.||++|||+ .++++
T Consensus 229 ~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 1245678889999999999984 67664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=258.49 Aligned_cols=232 Identities=21% Similarity=0.244 Sum_probs=166.4
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN---- 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~---- 117 (338)
...++|++.+.||+|+||.||+|. ..+++.||||.+..... .....|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345699999999999999999999 45688999999864322 23445667788899999999988775322
Q ss_pred ----EEEEEEecCCCCCHHHHHhccCc-----cccccHHHHHHHHHHhhhcCC------------------CCeEEeeec
Q 045271 118 ----ELLLICEYMPNKSLDFLLFDSTR-----SVQLDWNRRMCIINGIARDHK------------------MNPKISDFG 170 (338)
Q Consensus 118 ----~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg 170 (338)
.+++||||+++|+|.+++..... ..........+++.+|.+.|+ +.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 36899999999999998865322 122233455567777777653 458999999
Q ss_pred cceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
+++.+............+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ... ...
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~------~~~-~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KTL-AGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHh-cCC
Confidence 9987643322233345689999999999999899999999999999999999999996432211110 000 000
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
... ... .....+.+++.+||+.||.+|||+.+++..
T Consensus 262 ~~~-~~~--------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP-LPP--------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-CCC--------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 000 111245678888999999999999999863
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=245.21 Aligned_cols=180 Identities=21% Similarity=0.285 Sum_probs=141.1
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|.. .+++.||+|++.... ...+..|..+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999995 457889999986432 134556778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC---
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE--- 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~--- 181 (338)
|||++|+|..++..... ..........+++.+|.+.|+ +.+||+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999998865432 233334445566667666553 45899999998754211000
Q ss_pred ------------------------------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 182 ------------------------------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 182 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=246.27 Aligned_cols=178 Identities=24% Similarity=0.248 Sum_probs=135.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN---- 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~---- 117 (338)
...++|++.+.||+|+||.||+|.. .++..||+|.+.... .....+++.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4567999999999999999999995 458899999986432 233456778899999999999999987543
Q ss_pred --EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCC
Q 045271 118 --ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 118 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~ 177 (338)
.+|+||||+++ ++...+... ...........+++.+|.++|+ +.+||+|||++.....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhcc-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999954 555554322 2222233445567777776554 4589999999976422
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
........||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 176 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 ---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 11223357899999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=241.38 Aligned_cols=236 Identities=28% Similarity=0.329 Sum_probs=165.9
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
...++|++.+.||+|+||.||++.... ...+|+|.+..... ..+..|+.+++.+ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 334689999999999999999998532 35689998865332 2245566788888 799999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------ 161 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------ 161 (338)
+.++++|||+++|+|..++..... ..........+++.++.++|.
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999999864321 111112344556666666553
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
+.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++ |..||......+......
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 4589999999987643221111222234567999999988889999999999999999997 888886433222111110
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
...... ........+.+|+.+||..||++|||+.++++.|+..
T Consensus 249 -------~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 249 -------EGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -------cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 000000 0011123456788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=251.35 Aligned_cols=179 Identities=23% Similarity=0.334 Sum_probs=137.9
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|+++++||+|+||.||+|+. .+++.||+|.+.... ...+..|..+++.++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999999995 457789999986432 2345667789999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC-----
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS----- 180 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~----- 180 (338)
||++|+|..++..... ..........+++.+|.+.| ++.+||+|||+|..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999988865432 22222333445666665544 45689999999753210000
Q ss_pred ----------------------------------------CccccccccCCccccccccccCCCCcccchHhHhHHHHHH
Q 045271 181 ----------------------------------------EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEI 220 (338)
Q Consensus 181 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el 220 (338)
.......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0001234789999999999998999999999999999999
Q ss_pred HhCCCCCccc
Q 045271 221 ISGRKDTRFY 230 (338)
Q Consensus 221 ~~g~~Pf~~~ 230 (338)
++|..||...
T Consensus 242 ltG~~Pf~~~ 251 (382)
T cd05625 242 LVGQPPFLAQ 251 (382)
T ss_pred HhCCCCCCCC
Confidence 9999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=241.20 Aligned_cols=219 Identities=23% Similarity=0.267 Sum_probs=153.7
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHH-hcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIA-KLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|.++.... .....+..++. ..+||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 4577899999864321 11223333444 45899999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++..... ..........+++.+|.++|+ +.+||+|||++....... ......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccC
Confidence 999888865432 222334445667777776553 458999999997643221 22334679
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|..|+|||++.+..++.++|||||||++|+|++|..||......+... ... .. ...+... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~-~~--~~~~~~~--------~~~ 221 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SIL-ND--RPHFPRW--------ISK 221 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-cC--CCCCCCC--------CCH
Confidence 999999999998899999999999999999999999997533211111 000 00 0001110 112
Q ss_pred HHHHHHhhccCCCCCCCCCHH-HHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMS-SVVF 294 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~-~vl~ 294 (338)
.+.+++.+||+.||.+||++. +++.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 345688889999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=234.52 Aligned_cols=232 Identities=30% Similarity=0.402 Sum_probs=167.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
..++|+++++||+|+||.||+|...+++.||+|.+..... ..+.+|..+++.++|+||+++++++. .+.++++|||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 4568999999999999999999987888999999865432 45667888999999999999999875 46689999999
Q ss_pred CCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
.+++|.+++..... ..........+++.++.++|+ +.++|+|||++........ ....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 161 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TARE 161 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cccc
Confidence 99999988765332 112223344566777776554 3489999999977642111 1112
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...++..|+|||++....++.++|||||||++|+|++ |..||............. .. ...... .
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~-~~~~~~----~--- 226 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RG-YRMPRP----D--- 226 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cC-CCCCCC----C---
Confidence 2345678999999988889999999999999999999 999986433211111100 00 000000 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||+.||++|||+.+++..|+.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011246678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=235.75 Aligned_cols=232 Identities=26% Similarity=0.365 Sum_probs=166.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+..|+.+++.++||||+++++.+. .+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 45799999999999999999997676789999987533 234667888999999999999999875 456899999999
Q ss_pred CCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+|+|.+++..... ..........+++.+|.+.|+ +.++|+|||.+..+..... .....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~ 162 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG 162 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccC
Confidence 9999999865321 222233444556666666554 3489999999976632221 11122
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||...+..++.++|||||||++|+|++ |..||.......... ........ ....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~------~~~~~~~~----------~~~~ 226 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QVERGYRM----------PCPP 226 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH------HHhcCCCC----------CCcc
Confidence 346678999999988889999999999999999999 777876432211110 00000000 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.....+.+++.+||+.||++|||+.++++.|++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=255.20 Aligned_cols=226 Identities=27% Similarity=0.305 Sum_probs=166.5
Q ss_pred cCCCCCceecccCCeeEEEEEEcC--Cc--EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND--DK--EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+...+.++||+|.||.|++|.|.. |+ .||||.+..+.. +++..|+.+|-.|+|||+|++||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 355667999999999999999643 33 489999975543 567888889999999999999999987 778899
Q ss_pred EecCCCCCHHHHHhccCccc---cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTRSV---QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||+++.|+|.+.++...... ....-.+.+++.++.|+.. ..|||+|||+.+.++.....
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999999987733221 1122344456667666432 34999999999988654432
Q ss_pred -ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 -ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......-...|+|||.+....|+.++|+|+|||++|||++ |..||......+....+. ..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----------------~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----------------AGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----------------ccc
Confidence 22222334568999999999999999999999999999998 778887654433322221 111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
.-.....+...++++|++||+.+|++||||..|.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 1112223445678899999999999999999996
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=238.33 Aligned_cols=236 Identities=27% Similarity=0.358 Sum_probs=165.2
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+..+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999999743 234789998764432 123456678899999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCcc-------c----cccHHHHHHHHHHhhhcCC------------------CCeEEeee
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRS-------V----QLDWNRRMCIINGIARDHK------------------MNPKISDF 169 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~-------~----~~~~~~~~~~~~~i~~~~~------------------~~vkL~Df 169 (338)
.++||||+++|+|.+++...... . ........+++.+|.+.|+ +.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999999998653211 0 0112234456666666543 45899999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
|+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||......... . ... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~---~~~-~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---K---FVM-D 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHH-c
Confidence 99886532222111222345678999999998889999999999999999998 77787542221110 0 000 0
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
........ .....+.+++.+||+.||++|||+.++++.|.+..
T Consensus 237 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCC---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00000000 01134667888999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=235.51 Aligned_cols=232 Identities=28% Similarity=0.379 Sum_probs=166.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.+|++.+.||+|+||.||+|.. ..++.||+|.+..... .....+..+++.++||||+++++++...+.+++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4688889999999999999995 4577899999865432 245667788999999999999999999999999999999
Q ss_pred CCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++..... ..........+++.++.++|+ +.+||+|||++.......... ...
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~ 164 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAG 164 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCC
Confidence 9999998865332 111223344567777777664 348999999998754321111 111
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...... ...... .. .
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~-~~--------~ 228 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KGYRME-RP--------E 228 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCCCC-CC--------C
Confidence 234567999999988889999999999999999998 888886432221111100 000000 00 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.....+.+++.+||+.||++|||+.++++.|+..
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1123456788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=236.41 Aligned_cols=221 Identities=24% Similarity=0.309 Sum_probs=155.7
Q ss_pred ecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||+|+||.||+|.. .+++.||+|.+..... +....|..+++.++|+||+++.+++...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999994 4678999999864321 2334577789999999999999999999999999999999999
Q ss_pred HHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 132 DFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 132 ~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
...+.... ...........+++.+|.+.|+ +.++|+|||++..+..... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 87774321 1222233445566776666543 4589999999986643221 223357
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ....... ... .. ......
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~-~~~--------~~--~~~~~~ 225 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL-NDS--------VT--YPDKFS 225 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc-ccC--------CC--CcccCC
Confidence 8999999999999999999999999999999999999986432111100 0000000 000 00 000112
Q ss_pred HHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 269 LKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
..+.+++.+||+.||++|| |+.+++.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2356688889999999999 6777875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=239.90 Aligned_cols=233 Identities=27% Similarity=0.343 Sum_probs=164.8
Q ss_pred CCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
+|++.+.||+|+||.||+|.... ...+++|.+..... ..+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47889999999999999998432 24588888764432 235567788999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCcc-------------------------ccccHHHHHHHHHHhhhcCC---------------
Q 045271 122 ICEYMPNKSLDFLLFDSTRS-------------------------VQLDWNRRMCIINGIARDHK--------------- 161 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~-------------------------~~~~~~~~~~~~~~i~~~~~--------------- 161 (338)
||||+.+++|.+++...... ....+....+++.+|.++|+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987643210 01113444556666666543
Q ss_pred ---CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccc
Q 045271 162 ---MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQS 237 (338)
Q Consensus 162 ---~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~ 237 (338)
+.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-- 238 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL-- 238 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 4589999999976533222222223355678999999988889999999999999999998 9988864322111
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...... . ... .........+.+|+.+||+.||++||++.++++.|+.+.
T Consensus 239 -~~~~~~----~-~~~--------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 239 -FNLLKT----G-YRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHhC----C-CCC--------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111100 0 000 000011134567888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=243.27 Aligned_cols=224 Identities=22% Similarity=0.229 Sum_probs=158.5
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+|++++.||+|+||.||+|... ++..||+|.+.+... .....+..++..+ .|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999954 567899999864321 1123344455555 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++|+|...+..... ..........+++.++.+.|+ +.+||+|||++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--CCcc
Confidence 99999999888765432 223334455567777766553 45899999999754211 1122
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..... +..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-------~~~~~--~p~------- 222 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNVA--YPK------- 222 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC--CCC-------
Confidence 34679999999999999999999999999999999999999996533211111100 00000 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTM-----SSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~-----~~vl~ 294 (338)
.....+.+++.+||+.||.+|+++ .++++
T Consensus 223 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 223 -SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred -cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 011245678889999999999985 56653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=237.66 Aligned_cols=232 Identities=27% Similarity=0.386 Sum_probs=165.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ..+..++.+++.++||||+++++++.+++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457999999999999999999853 456799998865432 2355677889999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc-----------------------cccccHHHHHHHHHHhhhcCC---------------
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-----------------------SVQLDWNRRMCIINGIARDHK--------------- 161 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-----------------------~~~~~~~~~~~~~~~i~~~~~--------------- 161 (338)
++||||+++|+|..++..... .....+....+++.+|.+.|.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 999999999999999864321 011123455556666666543
Q ss_pred ---CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccc
Q 045271 162 ---MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQS 237 (338)
Q Consensus 162 ---~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~ 237 (338)
+.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 3589999999886533222111222344667999999988889999999999999999997 777875432211110
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
............ .....+.+|+.+||+.||.+|||+.|+++.|+
T Consensus 244 -------~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 244 -------YVRDGNVLSCPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -------HHhcCCCCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 011111110000 11234677889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=234.31 Aligned_cols=227 Identities=23% Similarity=0.316 Sum_probs=166.1
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..|+.++.||.|+||.||+|... ++..||+|.+..... ..+..+..+++.++||||+++++.+.+++.+++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999954 578899998864332 3455677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|.+++...............+++.++.+.|. +.++|+|||++........ .....
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccc
Confidence 999999998876443333333344456666665443 4589999999987643221 12234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||++.+..++.++|+|||||++|+|++|..||............ ............
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~ 225 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----------------PKNNPPTLTGEF 225 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh----------------hcCCCCCCchhh
Confidence 6788999999998888999999999999999999999998643211110000 000000111123
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+.+++.+||+.||++||++.+++..
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3456678999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=234.13 Aligned_cols=231 Identities=23% Similarity=0.345 Sum_probs=161.1
Q ss_pred CCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE-----
Q 045271 53 FSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE----- 118 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~----- 118 (338)
|++.+.||+|+||.||+|.... +..||+|.++.... .....+...++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998532 36799999865322 234566778899999999999998865443
Q ss_pred -EEEEEecCCCCCHHHHHhccCc-------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccc
Q 045271 119 -LLLICEYMPNKSLDFLLFDSTR-------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMA 172 (338)
Q Consensus 119 -~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a 172 (338)
.+++|||+++|+|..++..... ..........+++.++.+.|+ +.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 7999999999999888754321 111223344566677766554 35899999999
Q ss_pred eecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..... . ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~---~-~~~~ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL---R-HGNR 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---H-cCCC
Confidence 87643222111112335678999999988889999999999999999999 888876432211 11100 0 0000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.... ......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 234 ~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LKQP---------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 11123567788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=234.89 Aligned_cols=234 Identities=24% Similarity=0.342 Sum_probs=168.3
Q ss_pred cCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|. ..++..+|||.+..... ..+..|..+++.++||||+++++++..++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 578999999999999999999 45788999998754221 23456778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-----cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 124 EYMPNKSLDFLLFDSTR-----SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||+++++|..++..... .....+....+++.++.++|+ +.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999988763211 222233445567777766554 458999999987653221
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||....... ........ ... .....
T Consensus 161 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~-----~~~~~ 229 (267)
T cd08229 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIE-QCD-----YPPLP 229 (267)
T ss_pred -cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhhhh-cCC-----CCCCC
Confidence 11223568889999999988889999999999999999999999985432110 01000000 000 00000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.......+.+++.+||+.||.+|||+.+|++.+++.
T Consensus 230 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 ---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 001122456788899999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=242.72 Aligned_cols=172 Identities=18% Similarity=0.220 Sum_probs=133.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
...+|++++.||+|+||.||+|... ++..||+|..... ....|+.+++.++||||+++++++...+..++|||++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~- 139 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY- 139 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence 3457999999999999999999954 4678899975432 2345778999999999999999999999999999999
Q ss_pred CCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
.++|..++...... ......+..+++.+|.++|. +.+||+|||++..... .......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~~ 216 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APAFLGL 216 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Ccccccc
Confidence 56777777543332 22334455567777777654 3489999999975321 1122345
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCC
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDT 227 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf 227 (338)
.||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 7899999999999989999999999999999999866554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=236.24 Aligned_cols=227 Identities=23% Similarity=0.268 Sum_probs=161.6
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|++.+.||+|+||.||++.. .+++.||+|.+..... .....|+.+++.++|+||+.+++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999994 4678899998864321 224457778999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+++++|.+++.... ...........+++.+|.+.|+ +.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence 999999988875432 1222233444556677666554 458999999987653211 1
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||................. ........
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~~------ 226 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-----EVQEEYSE------ 226 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-----hhhhhcCc------
Confidence 2234789999999999988899999999999999999999999974321111000000000 00000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
.....+.+|+.+||+.||++||| +.++++
T Consensus 227 --~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 --KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01123567888899999999999 889886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=249.24 Aligned_cols=235 Identities=19% Similarity=0.201 Sum_probs=164.6
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
...++|++.+.||+|+||.||+|... +++.||+|.+.... .....++..+++.++||||+++++++.+++.++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 33479999999999999999999954 57789999985321 123456777889999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 121 LICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+||||+++|+|..++...............+++.+|.+.|+ +.+||+|||++..+.... ..
T Consensus 120 lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cc
Confidence 99999999999999876544433334445566777666543 468999999998763221 11
Q ss_pred cccccccCCccccccccccC----CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 183 NTNRVVGTYGYMAPEYALEG----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..............
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~~~~~~~~-- 270 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNHKNSLTFPD-- 270 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHcCCCcccCCC--
Confidence 22346799999999999754 3789999999999999999999999753321111 11110000000000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHh
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVFML 296 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~~L 296 (338)
.......+.+++..||+.++.+ |+++.++++..
T Consensus 271 -----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 271 -----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0011223456777899844433 77999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=233.17 Aligned_cols=235 Identities=25% Similarity=0.350 Sum_probs=169.2
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|... +++.||+|.++... ...+..++.+++.++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999965 78899999875321 234567778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-----cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 124 EYMPNKSLDFLLFDSTR-----SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||+++++|..++..... ..........+++.++.++|+ +.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999988854211 112223344456666665443 4589999999876532221
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ....... ..........
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~~----- 229 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEKCDYPPLP----- 229 (267)
T ss_pred --ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-hhcCCCCCCC-----
Confidence 122346888999999998888999999999999999999999998543211 0000000 0000000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.......+.+++.+||..+|.+|||+.+|++.|+.+.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0012234567888999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=246.69 Aligned_cols=220 Identities=20% Similarity=0.184 Sum_probs=159.7
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||++.. .+++.||+|.+.... ......+.++++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 568889999986432 123345667888999999999999999999999999999999
Q ss_pred CHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 130 SLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 130 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
+|..++..... ..........+++.+|.+.|+ +.+||+|||++...... ........|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--CcccccccC
Confidence 99888765432 223334455677888887774 24899999998754211 112234579
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|+.|+|||++.+..++.++|||||||++|+|++|..||............ . .... . +... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~-~~~~-~-~p~~--------~~~ 221 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-MEEI-R-FPRT--------LSP 221 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------h-cCCC-C-CCCC--------CCH
Confidence 99999999999889999999999999999999999999643221111110 0 0000 0 0000 112
Q ss_pred HHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 045271 270 KRIHIGLLCVQEDPADRP-----TMSSVVFM 295 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rp-----s~~~vl~~ 295 (338)
.+.+++.+||+.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 356688889999999997 89999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=236.86 Aligned_cols=230 Identities=26% Similarity=0.356 Sum_probs=166.0
Q ss_pred CCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCcccH-----HHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 53 FSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGL-----QEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~-----~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
|++++.||+|+||.||++.... ++.||+|.+........ ..+..+++.++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999654 56899999976654332 23667888999999999999999999999999999
Q ss_pred CCCCHHHHHh-ccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 127 PNKSLDFLLF-DSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 127 ~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
++++|..++. ..............+++.++.++| +++++|+|||.+.... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 9989999887 333333444555566676666644 4568999999998641 122233346
Q ss_pred ccCCccccccccc-cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYAL-EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~-~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.++..|+|||++. +..++.++||||+|+++|+|++|..||................... ......... .
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~------~ 228 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----LPSSSQQSR------E 228 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----HHHHTTSHT------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----ccccccccc------h
Confidence 7889999999998 7789999999999999999999999987552111111111110000 000000000 0
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0145677888999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.69 Aligned_cols=243 Identities=20% Similarity=0.240 Sum_probs=163.2
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC-----EEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN-----ELL 120 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 120 (338)
+|++++.||+|+||.||+|.. .+++.||||.+..... ....+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999995 5688999999864321 23556778899999999999999998766 789
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+. ++|...+..... ..........+++.+|.++|+ +.+||+|||++........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~- 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES- 158 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-
Confidence 9999995 677766654332 223334445567777776554 4589999999986532211
Q ss_pred ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH---------------Hh-
Q 045271 182 ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT---------------WK- 244 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~---------------~~- 244 (338)
.......++..|+|||++.+. .++.++||||+||++|+|++|+.||...........+... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 112234678899999999875 4899999999999999999999999754322111111000 00
Q ss_pred hh-ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 245 LW-CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.. .............. ........+.+|+.+||+.||++|||+.+++. ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 239 HILRGPHKPPSLPVLYT--LSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHhCCCCCCchHHhcc--cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 00 00000000000000 00001234677899999999999999999985 4554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=242.61 Aligned_cols=219 Identities=22% Similarity=0.260 Sum_probs=154.4
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... +++.||+|.+.... ......+..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 57889999986431 12233444555544 799999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++..... ..........+++.+|.+.| ++.+||+|||++...... .......+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccccccc
Confidence 999888765432 22333344556677766644 345899999998754211 112234579
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|+.|+|||++.+..++.++|||||||++|+|++|..||............ . .... . .... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~-~~~~-~-~~~~--------~~~ 221 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------L-NDEV-V-YPTW--------LSQ 221 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------h-cCCC-C-CCCC--------CCH
Confidence 99999999999888999999999999999999999999643322111110 0 0000 0 0000 112
Q ss_pred HHHHHHhhccCCCCCCCCCH------HHHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTM------SSVVF 294 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~------~~vl~ 294 (338)
.+.+++.+||+.||++||++ .+++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 45678889999999999998 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.43 Aligned_cols=220 Identities=22% Similarity=0.247 Sum_probs=156.4
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... ++..||+|.+..... .....+..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 577899999864321 1233455566644 799999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|...+..... ..........+++.+|.+.| ++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccccccc
Confidence 999888765432 22233344556777766655 345899999999764221 122234578
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+..|+|||++.+..++.++|||||||++|+|++|..||........... .. .... ..... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~-~~~~--~~p~~--------~~~ 221 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------IL-HDDV--LYPVW--------LSK 221 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HH-cCCC--CCCCC--------CCH
Confidence 9999999999988999999999999999999999999975432211111 00 0000 00000 112
Q ss_pred HHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 045271 270 KRIHIGLLCVQEDPADRP-------TMSSVVFM 295 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rp-------s~~~vl~~ 295 (338)
.+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 456788899999999999 88888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.90 Aligned_cols=215 Identities=20% Similarity=0.224 Sum_probs=152.2
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccH-HHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGL-QEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~-~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|.+..... ... .++..+++.++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 4688899999864321 112 2223356789999999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++..... ..........+++.+|.+.| ++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999888765432 22223334556777766654 34589999999875321 1122234579
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|+.|+|||++.+..++.++|||||||++|+|++|..||......+... ... .... . .... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~-~~~~-~-~~~~--------~~~ 221 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NIL-NKPL-R-LKPN--------ISV 221 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHH-cCCC-C-CCCC--------CCH
Confidence 999999999999899999999999999999999999996432211110 000 0000 0 0000 123
Q ss_pred HHHHHHhhccCCCCCCCCCHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMS 290 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~ 290 (338)
.+.+++.+||+.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 456788889999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=239.17 Aligned_cols=173 Identities=25% Similarity=0.388 Sum_probs=129.6
Q ss_pred CceecccCCeeEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEEEEecCCCC
Q 045271 56 ENKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLLICEYMPNK 129 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g 129 (338)
..+||+|+||.||+|... ++..||+|.+.... .....+|+.+++.++||||+++++++.. +..+++||||+ ++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CC
Confidence 468999999999999954 45679999986543 3346678889999999999999999864 46789999999 56
Q ss_pred CHHHHHhccCc----------cccccHHHHHHHHHHhhhcCC----------------------CCeEEeeeccceecCC
Q 045271 130 SLDFLLFDSTR----------SVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 130 ~L~~~l~~~~~----------~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~~~~ 177 (338)
+|..++..... ..........+++.++.++|+ +.+||+|||++.....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 77776643211 111233455567777766543 3589999999987632
Q ss_pred CCC-CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 178 NQS-EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 178 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
... ........||+.|+|||++.+. .++.++||||+||++|+|++|.+||..
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 211 1122345789999999999875 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=234.18 Aligned_cols=227 Identities=22% Similarity=0.302 Sum_probs=167.8
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++.+.||.|++|.||+|... ++..||+|.+..... ..+..++.+++.++|+||+++++++.++..+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999954 578899999864431 2355677789999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..++...............+++.++.+.|+ +.++|+|||++..+.... ......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccc
Confidence 999999999876544444445556667777766543 458999999998764321 122335
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||.+.+..++.++|||||||++|+|++|..||........ .. . ........+.. .. .
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~---~-~~~~~~~~~~~-----~~---~ 223 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF---L-IPKNNPPSLEG-----NK---F 223 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH---H-hhhcCCCCCcc-----cc---c
Confidence 688899999999988899999999999999999999999864321110 00 0 00000011000 00 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+++.+||..||++|||+++++.
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 223566888899999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=247.74 Aligned_cols=244 Identities=21% Similarity=0.243 Sum_probs=167.1
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC--
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG-- 116 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~-- 116 (338)
....+.++|++++.||.|+||.||+|.. .+++.||||.+..... ....+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3456678999999999999999999994 5678899999864322 2345677899999999999999988643
Q ss_pred ----CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeecccee
Q 045271 117 ----NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARV 174 (338)
Q Consensus 117 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~ 174 (338)
..+|++++++ +++|..++...............+++.+|.++|+ +.+||+|||++..
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4579999998 8889888765554444555566677777776553 4589999999986
Q ss_pred cCCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hh
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KL 245 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~ 245 (338)
... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||......+......... ..
T Consensus 168 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 168 ADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred cCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 532 1233578999999999987 468999999999999999999999996533211110000000 00
Q ss_pred hccCCcccccCcccccc-ccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 WCEGNAQELMDPVLKES-FILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
................. .... ....+.+|+.+||+.||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000 0000 0113567899999999999999999995
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=233.05 Aligned_cols=246 Identities=23% Similarity=0.247 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCc-eeeeeeEEEeCC-----
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKN-LVRLLGCCLEGN----- 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpn-Iv~~~~~~~~~~----- 117 (338)
...|+.+++||+|+||.||+|+ ..+++.||+|++..... ....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4568888999999999999999 66788999999865433 34578888999999999 999999998876
Q ss_pred -EEEEEEecCCCCCHHHHHhccCc---ccc--ccHHHHHHHHHHhhhcC------------------CCCeEEeeeccce
Q 045271 118 -ELLLICEYMPNKSLDFLLFDSTR---SVQ--LDWNRRMCIINGIARDH------------------KMNPKISDFGMAR 173 (338)
Q Consensus 118 -~~~lv~e~~~~g~L~~~l~~~~~---~~~--~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~ 173 (338)
.+++||||+ ..+|..++..... ..+ .......|++.|+.+.| ++.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 8899888876552 222 33445566777777654 4569999999998
Q ss_pred ecCCCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH-----hhhc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW-----KLWC 247 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~ 247 (338)
...-.. .......+|..|+|||++.+. .|++.+||||+||+++||+++..-|+.....+....+-... ..|.
T Consensus 169 a~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 653111 113456789999999999988 69999999999999999999998887654322211111100 0000
Q ss_pred cCC----cccccCccccccccHHH-----HHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcC
Q 045271 248 EGN----AQELMDPVLKESFILEE-----LLKRIHIGLLCVQEDPADRPTMSSVVFM--LATD 299 (338)
Q Consensus 248 ~~~----~~~~~~~~~~~~~~~~~-----~~~~~~li~~cl~~dP~~Rps~~~vl~~--L~~~ 299 (338)
... ....+... ........ .....+++.+||++||++|.||..++.+ +...
T Consensus 247 ~v~~~~~~k~~f~~~-~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKW-PGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCC-CCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 000 00000000 00000000 1246788889999999999999999975 5543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=245.94 Aligned_cols=179 Identities=24% Similarity=0.257 Sum_probs=136.3
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC----
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG---- 116 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~---- 116 (338)
....++|++++.||+|+||.||+|.. ..++.||||.+..... ....+|..+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 35678999999999999999999994 4578899999864322 2344567788999999999999998643
Q ss_pred --CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecC
Q 045271 117 --NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 117 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~ 176 (338)
..+++||||+++ ++...+... ...........+++.+|.+.|+ +.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999954 565555432 2222334455567777776554 458999999998653
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
. ........||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 11223357899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=232.96 Aligned_cols=226 Identities=27% Similarity=0.370 Sum_probs=164.7
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|++|.||+|.. .+++.|++|.+.... ......+..+++.++||||+++++++.+.+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578889999999999999995 457889999885422 23345567788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-c--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDST-R--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~-~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++++|..++.... . .....+....+++.++.+.|+ +.++|+|||++..+.... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--chh
Confidence 99999999887642 1 222223444566666666553 458999999998764322 112
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ... ...........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~~-------- 223 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------ILK-IIRGVFPPVSQ-------- 223 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHcCCCCCCcc--------
Confidence 335688899999999988899999999999999999999999864431110 000 00000000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 -MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 112346778889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=231.85 Aligned_cols=233 Identities=29% Similarity=0.412 Sum_probs=167.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
..++|++.+.||+|+||.||+|...++..||||.+.... ...+.+++.+++.++|+||+++++++......++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 356899999999999999999997777889999986533 245677888999999999999999999889999999999
Q ss_pred CCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++++|.+++..... ..........+++.++.+.| ++.++|+|||++..+.... .....
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 162 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTARE 162 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhh
Confidence 99999998865431 11122333344556665544 3458999999998764211 11111
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...++..|+|||.+.+..++.++|+||+||++|+|++ |..||........ .. ..... .......
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~~~~~--~~~~~~~------- 227 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LE---QVERG--YRMPRPP------- 227 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHcC--CCCCCCC-------
Confidence 2234568999999998889999999999999999998 8988854321111 11 00000 0000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||+.||.+|||++++.+.|+.
T Consensus 228 -~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 -NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 012245678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=235.02 Aligned_cols=232 Identities=20% Similarity=0.262 Sum_probs=163.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc---cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ---GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++.+.||+|+||.||+|.. .+++.||+|.++..... ...++..+++.++||||+++++++...+.+++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34889999999999999999994 45788999998654322 345677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++++|.+++..... ..........+++.++.+.| ++.++|+|||++...... ......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~ 165 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKS 165 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cccccc
Confidence 999999998865432 22233344455666666544 345899999998765321 112234
Q ss_pred cccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 187 VVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 187 ~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..|+..|+|||++. ...++.++|+|||||++|+|++|..||......... ..... .............
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~--- 236 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMTK----SNFQPPKLKDKMK--- 236 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hhhhc----cCCCCCcccccCC---
Confidence 57899999999875 445889999999999999999999998543211110 00000 0000000000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
....+.+++.+||+.||++|||+.+|+..
T Consensus 237 ---~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 237 ---WSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11235678889999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=232.01 Aligned_cols=230 Identities=27% Similarity=0.397 Sum_probs=166.2
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
.+|++.+.||+|+||.||+|.+..+..+|+|.+.... ...+..|..+++.++||||+++++++.....+++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4788899999999999999997667889999886433 24566788899999999999999999999999999999999
Q ss_pred CCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
++|.+++..... ..........+++.++.+.|+ +.++|+|||++......... ......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 162 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTK 162 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCc
Confidence 999988865432 222223344456666666543 34899999998865322111 111223
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
++..|+|||.+.+..++.++|||||||++|+|++ |..||............. .. .....+.. .
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~--~~~~~~~~-------~ 226 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AG--FRLYKPRL-------A 226 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CC--CCCCCCCC-------C
Confidence 5668999999988889999999999999999998 888886433211111100 00 00011111 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
...+.+|+.+||+.||++|||+.++++.|.
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 134667889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=237.00 Aligned_cols=234 Identities=21% Similarity=0.303 Sum_probs=165.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|+||.||++... +++.||+|.+..... ..+..|.++++.++||||+++++.+...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357999999999999999999954 578899998754322 345667788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|..++..... ..........+++.++.++| ++.++|+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IA 159 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----cc
Confidence 9999999988765332 22223334444566655544 235899999998754211 12
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc-----chhhHHHhhhccCCcccccCccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ-----SLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
....|+..|+|||++.+..++.++|||||||++|+|++|..||......... .......... ...... +
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~ 233 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPR-----L 233 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCC-----C
Confidence 2357899999999998888999999999999999999999999754322110 0000000000 000000 0
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.. ......+.+|+.+||+.||++|||+.++++..
T Consensus 234 ~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred Cc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 01123456788899999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=239.04 Aligned_cols=236 Identities=27% Similarity=0.335 Sum_probs=164.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEc--------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN--------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
.++|.+.+.||+|+||.||+|... ....+|+|.+..... ..+..|..+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 458899999999999999999742 234689998865432 2345567788888 699999999999998
Q ss_pred CEEEEEEecCCCCCHHHHHhccCcc-------------cccc----HHHHHHHHHHhhhcCC------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRS-------------VQLD----WNRRMCIINGIARDHK------------------ 161 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~----~~~~~~~~~~i~~~~~------------------ 161 (338)
+.+++||||+++|+|..++...... .... .....+++.++.+.|+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999999998653210 0111 2234456666666543
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 4589999999986543222111122234567999999998889999999999999999999 888886433221111110
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
........ ......+.+++.+||+.||++|||+.++++.|.....
T Consensus 251 -------~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 251 -------EGHRMDKP---------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -------cCCCCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 00000000 0111245578889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=255.57 Aligned_cols=246 Identities=16% Similarity=0.131 Sum_probs=161.7
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHhcC------CCceeeeeeEEEeC-C
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQ------HKNLVRLLGCCLEG-N 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~------hpnIv~~~~~~~~~-~ 117 (338)
...++|+++++||+|+||.||+|.. ..++.||||++.... ......|..+++.+. |.++++++++|... +
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 3457899999999999999999995 457789999986432 123344555665554 45689999988764 5
Q ss_pred EEEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC-C---------------------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK-M--------------------------------- 162 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~-~--------------------------------- 162 (338)
++|+|||++ +++|.+++.... ........+..+++.+|.++|. .
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 789999998 777777665432 2223334455667777777663 1
Q ss_pred -CeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH
Q 045271 163 -NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241 (338)
Q Consensus 163 -~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~ 241 (338)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+..
T Consensus 285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 28999999886431 122346899999999999999999999999999999999999999975332111111100
Q ss_pred H-------Hhhhcc-CCcccccC------cc---------ccccc--cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--
Q 045271 242 T-------WKLWCE-GNAQELMD------PV---------LKESF--ILEELLKRIHIGLLCVQEDPADRPTMSSVVF-- 294 (338)
Q Consensus 242 ~-------~~~~~~-~~~~~~~~------~~---------~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~-- 294 (338)
. +..... .....++. .. ..... .......+.+||.+||++||++|||+.|+|+
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 0 000000 00000000 00 00000 0001224568999999999999999999996
Q ss_pred HhhcC
Q 045271 295 MLATD 299 (338)
Q Consensus 295 ~L~~~ 299 (338)
++...
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 55543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=247.87 Aligned_cols=178 Identities=24% Similarity=0.264 Sum_probs=135.8
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC-----
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG----- 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~----- 116 (338)
...++|++.+.||+|+||.||+|.. ..++.||||.+.... .....++..+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3467999999999999999999994 457889999986432 12345677788999999999999988643
Q ss_pred -CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCC
Q 045271 117 -NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 117 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~ 177 (338)
..+|+||||++ ++|...+... ...........+++.+|.+.|+ +.+||+|||++.....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHhc-CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 35799999995 5666655432 2222333445567777776554 4589999999986532
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
........||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 179 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 11223457899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=256.66 Aligned_cols=233 Identities=24% Similarity=0.375 Sum_probs=175.3
Q ss_pred CCCCCceecccCCeeEEEEEEcC-C---cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND-D---KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
...+.+.||.|.||.|++|+.+. + ..||||.++.-.. .++..|+.||-+++||||++|.|+......+.||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 35567899999999999999543 3 3599999975443 34667788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCccc--------------------cccHHHHHHHHHHhhhcCCCCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTRSV--------------------QLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~--------------------~~~~~~~~~~~~~i~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||.+|.|+.|++...... .+.+.|+...+.||+.+.+...|++|||+++.+.+.. ...
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ 788 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAA 788 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-Ccc
Confidence 9999999999998764321 1233344444455555566678999999999875433 222
Q ss_pred cccccc--CCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 184 TNRVVG--TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 184 ~~~~~g--t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
..+..| +..|.|||.+.-.+|+.++|||||||++||+++ |..||=....++....+..+++
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR---------------- 852 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR---------------- 852 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC----------------
Confidence 222222 468999999999999999999999999999886 8888866555444443333322
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
-+++..+...+.+||.+||++|-.+||.|.||+..|..+--
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 22233344567789999999999999999999999987543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=242.26 Aligned_cols=232 Identities=16% Similarity=0.190 Sum_probs=159.6
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+++.. +++.||+|.+.+.. ...+.++..+++.++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999954 57789999986421 122456677888899999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||+++|+|..++..... ..........+++.+|.+.| ++.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 99999999999875322 22223334445666666544 35589999999987632221 11
Q ss_pred ccccccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 184 TNRVVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||......+... ....... ...+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~-~~~~p~~ 232 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEE-RFQFPSH 232 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCC-cccCCCc
Confidence 223579999999999875 457889999999999999999999996433211111 0000000 0001111
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVFM 295 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~~ 295 (338)
.. .....+.+++.+||..++.+ |+++.+++..
T Consensus 233 ~~-----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 IT-----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc-----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 10 01124556777888876544 4688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=235.80 Aligned_cols=233 Identities=25% Similarity=0.333 Sum_probs=162.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCc----EEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDK----EIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
++|++++.||+|+||.||+|.+. ++. .+++|.+...... .+..+...++.++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 47889999999999999999953 343 4777877543221 2333444667889999999999875 456789
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
++||+++|+|.+++..... ..........+++.++.+.|+ +.+||+|||+++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999999999865433 222334455567777777554 34899999999876432222
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||............ .... .......
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~--~~~~~~~- 235 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGE--RLAQPQI- 235 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCC--cCCCCCC-
Confidence 22233456778999999998889999999999999999998 99898643221111111 0111 0000101
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
......+++.+||..||++|||+.++++.|....
T Consensus 236 ------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 236 ------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1123456788899999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=238.83 Aligned_cols=235 Identities=27% Similarity=0.307 Sum_probs=163.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC--------CcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND--------DKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
.++|.+.+.||+|+||.||++.... ...+|+|.+..... ..+..+..+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3589999999999999999998421 24689999865422 2344566778888 799999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------ 161 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------ 161 (338)
+..++||||+++|+|..++..... ..........+++.+|.+.|+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 999999999999999999865421 111112334456666665443
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
+.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......+......
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 4589999999876532211111112234568999999998889999999999999999998 888875433211111100
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....... .......+.+++.+||..+|.+|||+.+|++.|+...
T Consensus 257 -------~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 257 -------EGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -------cCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 0000000 0011234566888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=231.41 Aligned_cols=231 Identities=27% Similarity=0.388 Sum_probs=165.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.+.||+|++|.||+|....+..+|+|.+..... +....|+.+++.++|+|++++++++. .+..++||||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 357999999999999999999977777899998764332 34567788999999999999999875 456899999999
Q ss_pred CCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++..... ..........+++.+|.+.|+ +.++|+|||++........ .....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 162 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQG 162 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCC
Confidence 9999998865322 112223444566777777654 3489999999976532211 11122
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||...+..++.++|||||||++|+|++ |..||............ ... ...... .
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~-~~~~~~--------~ 226 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-------ERG-YRMPCP--------Q 226 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC-CCCCCC--------c
Confidence 345678999999988889999999999999999999 88888643321111100 000 000000 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||+.||++||++.+|+++|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=246.60 Aligned_cols=174 Identities=20% Similarity=0.177 Sum_probs=136.4
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
.+|.+.+.||+|+||.||+|.+. .+..||||... ......|+.+++.++|+|||++++++..++..++|||++ .+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~ 244 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS 244 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence 47999999999999999999954 47789999643 234567888999999999999999999999999999999 57
Q ss_pred CHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 130 SLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 130 ~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
+|..++..... .......+..+++.+|.+.|+ +.+||+|||+++.+.............|
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 324 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAG 324 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCC
Confidence 88777754332 222334455667777776554 4589999999987643222222234579
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCc
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
|..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 325 T~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred CcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 999999999999999999999999999999999886654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=229.26 Aligned_cols=229 Identities=26% Similarity=0.379 Sum_probs=163.6
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc---------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+++.+++.++|+||+++++++.+.+.+++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5889999999999999999987888999998864321 2355677889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC---
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS--- 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~--- 180 (338)
|||+++++|.+++..... ..........+++.++.+.| ++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999999865432 22222334445666655544 44589999999876422111
Q ss_pred -CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 -EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ...... .........
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~---~~~~~~~~~---- 231 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFYIGA---HRGLMPRLP---- 231 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHHhhh---ccCCCCCCC----
Confidence 1112234688899999999988899999999999999999999999864221110 000000 000000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. .....+.+++++||+.||.+|||+.+++.
T Consensus 232 -~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 232 -D----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -C----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 11223567888999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=236.33 Aligned_cols=249 Identities=25% Similarity=0.287 Sum_probs=163.8
Q ss_pred cCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCcc---cHHHHHHHHHhcCCCceeeeeeEEEe--CCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSGQ---GLQEFKNLIAKLQHKNLVRLLGCCLE--GNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~---~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~ 120 (338)
.+|++++.||+|+||.||+|.. .++..||+|.+...... .+..++++++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4789999999999999999974 24678999998655432 45667788999999999999998753 45689
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+||||+++++|..++..... ..........+++.++.++|+ +.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 99999999999999865432 222334455567777776554 4589999999987643221
Q ss_pred Ccc-ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EAN-TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
... .....++..|+|||++.+..++.++|||||||++|||++|..|+................................
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 111 1112334569999999888899999999999999999998766543211000000000000000000000000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
...........+.+|+.+||+.||++|||+.+|+..|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000001122466788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=235.15 Aligned_cols=230 Identities=20% Similarity=0.275 Sum_probs=166.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
..++|++++.||+|+||.||+|.. .+++.||+|.+..... +....+..+++.++|+||+++++.+..++.+++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346899999999999999999994 5688999999864332 335566778899999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|+++++|..++...............+++.++.+.| ++.++|+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRST 174 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCc
Confidence 999999999886544333333344445566655544 45689999999986532221 1223
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
..++..|+|||.+.+..++.++|+|||||++|+|++|..||............ .. ..... .... ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~-~~~~~-----~~~~--~~ 240 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT-NGTPE-----LQNP--ER 240 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------cc-CCCCC-----CCCc--cc
Confidence 46888999999999888999999999999999999999998643221110000 00 00000 0000 01
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123456888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=237.78 Aligned_cols=249 Identities=21% Similarity=0.221 Sum_probs=165.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++.+.||+|+||.||+|.. .++..||+|.+..... ....+|+.+++.++||||+++++++...+.+++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 35799999999999999999995 4578899999864322 245567889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++ ++|..++....... ........+++.+|.+.|+ +.++|+|||++....... ...
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 161 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY 161 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Ccc
Confidence 996 68877776543222 2233344556777666553 458999999987643211 111
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccC------
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEG------ 249 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~------ 249 (338)
....++..|+|||++.+. .++.++|||||||++|+|++|..||......+........ +......
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 234568899999998764 4788999999999999999999999754322111110000 0000000
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCccc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDTIT 302 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~~~ 302 (338)
.........+.. ........+.+|+.+||+.||.+|||+.++++ +++.....
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 242 NYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccCccccccHHh-hcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 000000000000 00001123567899999999999999999996 55444433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=238.39 Aligned_cols=237 Identities=25% Similarity=0.288 Sum_probs=167.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc--------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN--------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCL 114 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~ 114 (338)
...++|++.+.||+|+||.||+|... ++..||+|.+..... ..+..|..+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33568999999999999999999731 234689998864322 3456677788888 8999999999999
Q ss_pred eCCEEEEEEecCCCCCHHHHHhccCcc-------------ccc----cHHHHHHHHHHhhhcCC----------------
Q 045271 115 EGNELLLICEYMPNKSLDFLLFDSTRS-------------VQL----DWNRRMCIINGIARDHK---------------- 161 (338)
Q Consensus 115 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~----~~~~~~~~~~~i~~~~~---------------- 161 (338)
..+.+++||||+++|+|..++...... ... ......+++.++.+.|+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999998754211 011 12334467777776554
Q ss_pred --CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccch
Q 045271 162 --MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSL 238 (338)
Q Consensus 162 --~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~ 238 (338)
+.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 3489999999987643222222222345678999999998889999999999999999998 7777754332221111
Q ss_pred hhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 239 LTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
. ..... .. . .......+.+|+.+||+.+|.+|||+.++++.|+...
T Consensus 252 ~------~~~~~-~~-~--------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 252 L------KEGHR-MD-K--------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred H------HcCCc-CC-C--------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1 00000 00 0 0011234566888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=235.29 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=156.2
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHH---hcCCCceeeeeeEEEe-----CC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIA---KLQHKNLVRLLGCCLE-----GN 117 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~---~l~hpnIv~~~~~~~~-----~~ 117 (338)
+|++.+.||+|+||.||+|... +++.||+|.+..... ....++..+++ .++||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999954 578899998864321 12334555554 4579999999998864 34
Q ss_pred EEEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~ 176 (338)
.+++||||++ ++|..++..... ..........+++.++.+.|+ +.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999996 578777754322 222334455567777776553 458999999998653
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH-----hhhccC-C
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW-----KLWCEG-N 250 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~~~-~ 250 (338)
... ......|+..|+|||++.+..++.++||||+||++|+|++|.+||................ ..+... .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 160 CQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred Ccc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 211 1223467899999999998899999999999999999999999986433221111110000 000000 0
Q ss_pred c-ccccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 A-QELMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~-~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ...+...... .........+.+++.+||++||++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000000 000011123567889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=239.20 Aligned_cols=226 Identities=21% Similarity=0.276 Sum_probs=156.9
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|.+..... ..+..+..++..+ +||||+.+++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 4577899999975321 2244555666666 699999999999999999999999999
Q ss_pred CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++.... ...........+++.+|.+.|+ +.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccC
Confidence 99988775432 2333334455567777766553 45899999998753211 112234679
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|+.|+|||++.+..++.++|||||||++|+|++|..||......................... +... ...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~--------~~~ 228 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPRF--------LSV 228 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--CCCC--------CCH
Confidence 999999999999999999999999999999999999996432222111111111111111000 0000 112
Q ss_pred HHHHHHhhccCCCCCCCCCH------HHHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTM------SSVVF 294 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~------~~vl~ 294 (338)
.+.+++.+||+.||++|+++ .+++.
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 34678888999999999985 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=233.04 Aligned_cols=229 Identities=21% Similarity=0.304 Sum_probs=159.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhc-CCCceeeeeeEEEeC------CE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKL-QHKNLVRLLGCCLEG------NE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l-~hpnIv~~~~~~~~~------~~ 118 (338)
..+.|++.+.||+|+||.||+|.. .++..||+|.+..... ..+..+..+++.+ +|+||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 356789999999999999999995 4577899999865432 3455666677777 799999999998753 46
Q ss_pred EEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~ 177 (338)
+++||||+++++|..++..... ..........+++.++.++|+ +.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 8999999999999998875321 111223344566666666554 3589999999986532
Q ss_pred CCCCccccccccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (338)
. ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..... ....
T Consensus 164 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~~~-~~~~ 234 (272)
T cd06637 164 T--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR-NPAP 234 (272)
T ss_pred c--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHhc-CCCC
Confidence 1 122234578999999999863 35788999999999999999999998533211110 00000 0000
Q ss_pred cccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..... .....+.+|+.+||+.||.+|||+.++++
T Consensus 235 ~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 235 RLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 11124567888999999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=243.02 Aligned_cols=217 Identities=20% Similarity=0.217 Sum_probs=155.7
Q ss_pred CceecccCCeeEEEEEE----cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 56 ENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
++.||+|+||.||++.. .++..||+|++.... ......|..+++.++||||+++++++.+++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999984 356789999986432 123455777899999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 127 PNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 127 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
++|+|..++..... ..........+++.+|.++|+ +.+||+|||++...... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceecc
Confidence 99999888865432 222334445567777766553 45899999998765321 1222346
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+|++.|+|||++.+..++.++|||||||++|+|++|..||......... ..... ... . +... .
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~~-~~~-~-~p~~--------~ 221 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMILK-AKL-G-MPQF--------L 221 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHHc-CCC-C-CCCC--------C
Confidence 7899999999999888999999999999999999999998643221111 00000 000 0 0000 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~ 291 (338)
...+.+++.+||+.||++|||+.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 123456888899999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=239.72 Aligned_cols=235 Identities=27% Similarity=0.324 Sum_probs=165.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC--------CcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND--------DKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
..+|++++.||+|+||.||+|.... ...||+|.+..... ..+..|..+++.+ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3479999999999999999998421 23589998764322 2355677788888 799999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc-------------ccccc----HHHHHHHHHHhhhcCC------------------
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-------------SVQLD----WNRRMCIINGIARDHK------------------ 161 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~----~~~~~~~~~~i~~~~~------------------ 161 (338)
+.++++|||+++|+|.+++..... ..... .....+++.++.++|+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 999999999999999999865321 00111 2244567777776553
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 249 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL- 249 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence 3589999999987643221111222334567999999999899999999999999999998 78887643322211110
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
. ........ ......+.+++.+||+.+|++|||+.++++.|+...
T Consensus 250 -----~-~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 250 -----K-EGHRMDKP---------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -----H-cCCCCCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 0 00000000 011124567888999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=243.67 Aligned_cols=236 Identities=25% Similarity=0.353 Sum_probs=163.2
Q ss_pred hcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEe-CC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLE-GN 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~-~~ 117 (338)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... ..+..|..+++.+ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45899999999999999999973 2456799999865332 2345677788888 68999999998865 45
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc--------------------------------------------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS-------------------------------------------------------- 141 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 141 (338)
.+++|||||++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999988643210
Q ss_pred ------------ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCC
Q 045271 142 ------------VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTY 191 (338)
Q Consensus 142 ------------~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~ 191 (338)
.........+++.+|.+.|+ +.+||+|||++................++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 00012234467777776554 458999999997653222111122234567
Q ss_pred ccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 192 GYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 192 ~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
.|+|||++.+..++.++|||||||++|+|++ |..||........ ... . ......... ... ....
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~---~-~~~~~~~~~-~~~--------~~~~ 310 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR---R-LKEGTRMRA-PDY--------TTPE 310 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH---H-HhccCCCCC-CCC--------CCHH
Confidence 8999999988889999999999999999997 8888864322111 000 0 000100000 000 1124
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 271 RIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
+.+++.+||+.||++|||+.+|++.|+...
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 567888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=233.50 Aligned_cols=227 Identities=23% Similarity=0.306 Sum_probs=162.1
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......|+.+++.++|+||+.+++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999995 467889999985432 1234567789999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+++++|...+.... ...........+++.+|.++|+ +.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Cc
Confidence 999999988775432 2223334455567777776553 35899999999765321 11
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||............. ... ... ......
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~-~~~--~~~~~~------ 226 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRV-LET--EEVYSA------ 226 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhh-hcc--ccccCc------
Confidence 223578999999999998889999999999999999999999996432211111110 000 000 000100
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
.....+.+|+..||+.||++||| +.+++.
T Consensus 227 --~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 --KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 01123456888899999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=236.80 Aligned_cols=226 Identities=24% Similarity=0.337 Sum_probs=165.6
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+.|+..+.||+|+||.||+|.. .++..||+|.+..... +.+..++.+++.++||||+++++++..++.+++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4577788999999999999985 4577899998864332 2456677888999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..++...............+++.++.+.|. +.++|+|||++..+.... ......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTF 161 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcc
Confidence 999999988865444434444455667777777664 348999999997653221 112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... . ..... ...+. ...
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~~~~-----~~~~~----~~~ 225 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L-IPKNS-----PPTLE----GQY 225 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h-hhcCC-----CCCCC----ccc
Confidence 67889999999998889999999999999999999999986332111000 0 00000 00011 111
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+++.+||+.+|++|||+.+++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 234567888999999999999999996
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=240.24 Aligned_cols=179 Identities=21% Similarity=0.295 Sum_probs=138.7
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||++.. .+++.||+|.+.+.. ...+.++..+++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999995 457889999986421 123556777888899999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||+++|+|..++..... ..........+++.+|.+.|+ +.+||+|||++..+..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999998865322 222334445567777766553 4589999999976532211 11
Q ss_pred ccccccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 184 TNRVVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
.....||+.|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 222468999999999873 35788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=231.14 Aligned_cols=231 Identities=22% Similarity=0.352 Sum_probs=165.9
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC---------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS---------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
+|+..+.||+|+||.||+|. ..++..||+|.+.... ...+..|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999 4668889999986432 1345667788999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++++|.+++..... ..........+++.++.+.|+. .++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998865432 2223344456677777765532 3899999998766432111
Q ss_pred --ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 --ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......++..|+|||.+.+..++.++|+||+||++|+|++|..||............. .......
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~--------- 228 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIASATT--------- 228 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhccCC---------
Confidence 11123467889999999988889999999999999999999999986433221111110 0000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...........+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111112234567888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=235.66 Aligned_cols=232 Identities=21% Similarity=0.307 Sum_probs=167.0
Q ss_pred cCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.+|++.+.||.|.+|.||+|. ..+++.|++|.+..... +.+.++..+++.++||||+++++++..++.+++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 479999999999999999999 45688999998864432 34556777889999999999999999999999999999
Q ss_pred CCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccc
Q 045271 127 PNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 127 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
++++|..++...............+++.++.+.| ++.++|+|||++........ ......
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 176 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMV 176 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcC
Confidence 9999999887554333333344445555555543 45699999999876532221 122346
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
++..|+|||.+.+..++.++|+|||||++|+|++|..||........... . .... ... +... ....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~---~~~~-~~~-----~~~~--~~~~ 242 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---ATNG-TPE-----LQNP--EKLS 242 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---HhcC-Ccc-----cCCc--ccCC
Confidence 88899999999988899999999999999999999999864322111100 0 0000 000 0000 0011
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 269 LKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
..+.+++.+||..||.+|||+.+++. ++..
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 23556888999999999999999984 4443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=229.01 Aligned_cols=227 Identities=32% Similarity=0.372 Sum_probs=158.8
Q ss_pred ceecccCCeeEEEEEEcC-C---cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLND-D---KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
++||+|+||.||+|.... + ..+|+|.+..... +....+..+++.++||||+++++++. .+.+++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998422 2 5799999875443 23556677889999999999999876 5678999999999
Q ss_pred CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc-ccccc
Q 045271 129 KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN-TNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~-~~~~~ 188 (338)
++|.+++.... ...........+++.++.++|. +.+||+|||++........... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 99999987654 2222334455567777766553 4489999999987633221111 11122
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. ...... ..... .. ...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~----~~~~~-~~--------~~~ 223 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLES----GERLP-RP--------EEC 223 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHc----CCcCC-CC--------CCC
Confidence 3467999999988889999999999999999998 9999864322111 111000 00000 00 001
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...+.+++.+||+.||++|||+.++++.|+...
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 124567888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=266.77 Aligned_cols=250 Identities=21% Similarity=0.345 Sum_probs=174.5
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
......|.....||+|+||.||+|.. .++..||||.+..... ....++++++.++|||||++++++.+.+..++||||
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 33445788889999999999999995 5688999999865433 233457788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC---CCCeEEeeeccceecC-----------CCCCCccccccccCC
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH---KMNPKISDFGMARVFG-----------GNQSEANTNRVVGTY 191 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~---~~~vkL~Dfg~a~~~~-----------~~~~~~~~~~~~gt~ 191 (338)
+++|+|.++++. ........+..+++.++.|.| ...+...|..-...+- ............++.
T Consensus 765 ~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~ 842 (968)
T PLN00113 765 IEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS 842 (968)
T ss_pred CCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccc
Confidence 999999999864 222333455667888999988 3343333322111100 000000111235788
Q ss_pred ccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc--cccHHHHH
Q 045271 192 GYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE--SFILEELL 269 (338)
Q Consensus 192 ~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 269 (338)
.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.............+++.+.. .....+..
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence 999999999889999999999999999999999998533221 112222222222222233334443322 22345566
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 270 KRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...+++.+||+.||++|||+.||++.|+...
T Consensus 922 ~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 922 EVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 7788999999999999999999999998754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=235.57 Aligned_cols=240 Identities=25% Similarity=0.321 Sum_probs=167.8
Q ss_pred cCCCCCceecccCCeeEEEEEEc-----CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-----DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNEL 119 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~ 119 (338)
+.|++.+.||+|+||.||+|.+. ++..||||.+..... ..+..++.+++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57888999999999999999853 357899999875443 346677788999999999999999887 5689
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++++|..++..... ..........+++.++.++|+ +.++|+|||.+.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 999999999999999876542 222234445556666666553 458999999998764221
Q ss_pred CC-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc--------chhhHHHhhhccCC
Q 045271 180 SE-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ--------SLLTYTWKLWCEGN 250 (338)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~ 250 (338)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|..|+......... ........ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HHHcC
Confidence 11 1111224456799999998888999999999999999999999987643221110 00000000 00000
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
...+........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 243 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 --------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred --------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000011123566788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=234.50 Aligned_cols=236 Identities=21% Similarity=0.309 Sum_probs=162.7
Q ss_pred ChhHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhc-CCCceeeeeeEEEe--
Q 045271 42 PLDLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKL-QHKNLVRLLGCCLE-- 115 (338)
Q Consensus 42 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l-~hpnIv~~~~~~~~-- 115 (338)
++.......+.|++.+.||+|+||.||+|.. .+++.+|+|.+..... .....+..+++.+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344445567999999999999999999995 4577899998854432 2344556667666 79999999999853
Q ss_pred ----CCEEEEEEecCCCCCHHHHHhccCcc-ccc--cHHHHHHHHHHhhhcCC------------------CCeEEeeec
Q 045271 116 ----GNELLLICEYMPNKSLDFLLFDSTRS-VQL--DWNRRMCIINGIARDHK------------------MNPKISDFG 170 (338)
Q Consensus 116 ----~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~--~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg 170 (338)
.+.++++|||+++|+|..++...... ... ......+++.++.+.|+ +.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 46789999999999999888653221 111 22334457777776654 348999999
Q ss_pred cceecCCCCCCccccccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
++....... .......|+..|+|||++. +..++.++|+|||||++|+|++|..||.......... ...
T Consensus 167 ~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--~~~--- 239 (282)
T cd06636 167 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--LIP--- 239 (282)
T ss_pred chhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--hHh---
Confidence 987653211 1123357889999999986 3457889999999999999999999986432111100 000
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......... ......+.+||.+||+.||.+|||+.++++
T Consensus 240 -------~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 -------RNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------hCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000000 011234677888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=239.93 Aligned_cols=232 Identities=17% Similarity=0.197 Sum_probs=157.8
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.++||+|+||.||++... +++.+|+|.+.+.. ...+.++..++..++|+||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999954 46779999985321 123556667888899999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||+++|+|.+++...... .........+++.++.+.| ++.+||+|||++..+..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence 999999999998753222 2222333445566655543 45689999999976532211 11
Q ss_pred ccccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 184 TNRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||......+..... .............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~~~p~~~ 233 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKERFQFPAQV 233 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH------hCCCccccCCCcc
Confidence 22357999999999986 345889999999999999999999999743321111111 0000000000000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVFM 295 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~~ 295 (338)
. .....+.+|+.+||..++++ |+++.++++.
T Consensus 234 ~------~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 234 T------DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c------cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 01123456777777654444 7899999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=229.52 Aligned_cols=231 Identities=22% Similarity=0.273 Sum_probs=166.9
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++.+.||.|+||.||+|.. .++..+++|.+..... +.+..+..+++.++||||+++++++.+.+.+|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46899999999999999999995 4577899999865432 3466677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhcc--CccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDS--TRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+++++|..++... ............+++.++.+.| ++.++|+|||++..+.... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccc
Confidence 9999999888654 2222333444555666666644 3458999999987653211 1123
Q ss_pred ccccCCccccccccccC---CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 186 RVVGTYGYMAPEYALEG---LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~---~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
...++..|+|||.+.+. .++.++|+|||||++|+|++|..||.......... ... .... ....+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~~-----~~~~---~~~~~~-- 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LIS-----KSNF---PPPKLK-- 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-----hccC---CCcccc--
Confidence 35688899999999876 78899999999999999999999986432111100 000 0000 000011
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........+.+|+.+||+.||.+|||+.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11122345678999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=235.06 Aligned_cols=235 Identities=25% Similarity=0.344 Sum_probs=165.1
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCc----EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDK----EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~----~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
..+|+++++||+|+||.||+|.+ .++. .||+|.+..... ..+..+..+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35789999999999999999984 3444 479998864332 234456667888999999999999875 4578
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~~ 180 (338)
+++||+++|+|.+++..... ..........+++.+|.+.|+. .+||+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99999999999998875432 2333444556777887776643 489999999987643222
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........++..|+|||.+.+..++.++|||||||++|||++ |..||............ ........ .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~~~-~--- 233 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-------EKGERLPQ-P--- 233 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCcCCC-C---
Confidence 111112234678999999988889999999999999999998 88887543211110000 00000000 0
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
......+.+++.+||+.||++|||+.+++..|+....
T Consensus 234 -----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 234 -----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0112245678889999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=233.24 Aligned_cols=229 Identities=19% Similarity=0.268 Sum_probs=163.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQ---GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+.|+++++||.|+||.||+|... ++..+++|.+...... ....+..+++.++||||+++++.+..++.+++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999954 4788999998655432 345567788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+++++|..++..... ..........+++.++.+.|+ +.++|+|||++...... .....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccccc
Confidence 999999887754322 223334455567777776554 35899999998764221 11123
Q ss_pred ccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 186 RVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...++..|+|||++. ...++.++|||||||++|+|++|..||........ ..... ........
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~----- 236 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSEPPTLS----- 236 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHh-cCCCccCC-----
Confidence 356888999999985 33478899999999999999999999864321110 00000 00000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........+.+++.+||+.||++||++.++++
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 --QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011224567888999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=230.60 Aligned_cols=229 Identities=28% Similarity=0.357 Sum_probs=153.7
Q ss_pred ceecccCCeeEEEEEEcC---CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVLND---DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||+|...+ +..+|+|.+..... ..+.+|..+++.++||||+++++.+.+...+++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998533 35689998865432 23555778899999999999999999988999999999999
Q ss_pred CHHHHHhccCcc--cc----ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 130 SLDFLLFDSTRS--VQ----LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 130 ~L~~~l~~~~~~--~~----~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+|.+++...... .. .......+++.++.+.|+ +.+||+|||++.............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999988653221 11 112334456777766543 358999999987543221111122
Q ss_pred ccccCCccccccccccC-------CCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 186 RVVGTYGYMAPEYALEG-------LFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-------~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
...++..|+|||++.+. .++.++|||||||++|+|++ |..||......+. ..... . ........+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~---~-~~~~~~~~~ 233 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV---R-EQQLKLPKP 233 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh---h-cccCCCCCC
Confidence 34577889999998642 35789999999999999996 9999864322111 11100 0 011111111
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.+... ....+.++|..|| .||++|||+.+|+..|+
T Consensus 234 ~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1113455778899 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=229.24 Aligned_cols=225 Identities=36% Similarity=0.443 Sum_probs=165.1
Q ss_pred ceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.... +..|++|.+..... ..+..+...++.++|+||+++++++.+...+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999543 77899999875543 3456677888999999999999999999999999999999
Q ss_pred CCHHHHHhcc----------CccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 129 KSLDFLLFDS----------TRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 129 g~L~~~l~~~----------~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
++|..++... .......+....+++.+|.+.|+ +.++|+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999998764 12233345555667777776554 4589999999987643322
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........++..|+|||.+.+..++.++||||+||++|+|++ |..||......+...... . .......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~-~~~~~~~---- 229 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------K-GYRLPKP---- 229 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CCCCCCC----
Confidence 122333567889999999988889999999999999999999 688887542221111110 0 0000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
......+.+++.+||+.||.+|||+.|++..|+
T Consensus 230 -----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 -----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001234567888899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=241.83 Aligned_cols=218 Identities=20% Similarity=0.211 Sum_probs=153.5
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------cc-HHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QG-LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~-~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... +++.||+|.+..... .. ..++..+++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 567899999864321 11 22223356788999999999999999999999999999
Q ss_pred CCHHHHHhccCcc-ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTRS-VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|..++...... .........+++.+|.+.|+ +.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 9999888654332 22223344567777776553 4589999999975421 1122334679
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|+.|+|||++.+..++.++|||||||++|+|++|..||.......... .... .... ... ....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~-~~~~--~~~--------~~~~ 221 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NILN-KPLQ--LKP--------NITN 221 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH------HHHh-CCcC--CCC--------CCCH
Confidence 999999999999999999999999999999999999996433211110 0000 0000 000 0112
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
.+.+++.+||+.||.+||++.+.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCH
Confidence 356678889999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=238.83 Aligned_cols=215 Identities=20% Similarity=0.202 Sum_probs=151.5
Q ss_pred ceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccH-HHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGL-QEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~-~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|... ++..||+|.+.+... ... .++..+++.++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 577899999864321 112 2223467889999999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
++|...+..... ..........+++.++.+.| ++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccC
Confidence 999887765432 22223334456777766654 346899999998753211 122234578
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
++.|+|||++.+..++.++|||||||++|+|++|..||........ ..... .... . +. .....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~-~~~~-~-~~--------~~~~~ 221 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------YDNIL-HKPL-Q-LP--------GGKTV 221 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------HHHHh-cCCC-C-CC--------CCCCH
Confidence 9999999999988899999999999999999999999965322111 11110 0000 0 00 01122
Q ss_pred HHHHHHhhccCCCCCCCCCHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMS 290 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~ 290 (338)
.+.+++.+||+.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 456788889999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=233.37 Aligned_cols=240 Identities=24% Similarity=0.267 Sum_probs=160.3
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|++|.||+|... ++..||+|.+.... ......++.+++.++||||+++++++.+++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999954 58889999885432 13456678899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
++ ++|..++..... ..........+++.+|.+.|+ +.++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--cc
Confidence 96 688777754322 222223445667777776554 458999999997653211 11
Q ss_pred ccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH-----Hhhhcc----CCccc
Q 045271 184 TNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT-----WKLWCE----GNAQE 253 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~----~~~~~ 253 (338)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||............... ...+.. .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 1223568899999998765 4789999999999999999999998643211110000000 000000 00000
Q ss_pred ccCcccccc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKES---FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......... ........+.+++.+||+.||.+|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 00001224567899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=229.33 Aligned_cols=229 Identities=21% Similarity=0.313 Sum_probs=167.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.+.||+|+||.||+|.... +..+++|.+.... .+.+.+|..+++.++||||+++++.+.+...+|+++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3689999999999999999999654 7889999986543 4557778888999999999999999999999999999999
Q ss_pred CCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|.+++...... .........+++.++.+.| ++.++|+|||++........ .....
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 159 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTV 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccc
Confidence 99999988643322 2233344455666666544 34589999999987643221 12234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||++.+..++.++|||||||++|+|++|..||........... .. . . ....... ....
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~-~-~----~~~~~~~--~~~~ 225 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IP-N-K----PPPTLSD--PEKW 225 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hc-c-C----CCCCCCc--hhhc
Confidence 578899999999888899999999999999999999999864322111000 00 0 0 0000000 0111
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+++.+||+.||++|||+.+|+.
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 234677888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=229.17 Aligned_cols=227 Identities=31% Similarity=0.383 Sum_probs=167.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.+.||.|+||.||+|.. .++.||+|.+..... +....|..+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45899999999999999999986 478899999976543 345667788999999999999999999999999999999
Q ss_pred CCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++.... ...........+++.++.+.|. +.++|+|||.+....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~ 158 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-----cc
Confidence 999999986543 2223334445556666665443 458999999998652211 12
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
...+..|+|||.+.+..++.++||||||+++|+|++ |..||............ .. ....... .
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~----~~~~~~~---------~ 222 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV---EK----GYRMEAP---------E 222 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---hc----CCCCCCc---------c
Confidence 234567999999988889999999999999999997 99888644322111100 00 0000000 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||..+|.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 012345678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=229.77 Aligned_cols=224 Identities=26% Similarity=0.354 Sum_probs=156.9
Q ss_pred eecccCCeeEEEEEE---cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 58 KLGEGGFGPVYKGVL---NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 58 ~iG~G~~g~V~~~~~---~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
.||+|+||.||+|.+ .++..+|+|.+..... +.+..+..+++.++||||+++++++. .+.+++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999974 3467899998864432 23556677889999999999999875 45678999999999
Q ss_pred CHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc-ccccccc
Q 045271 130 SLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA-NTNRVVG 189 (338)
Q Consensus 130 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~-~~~~~~g 189 (338)
+|..++..... ..........+++.++.+.|+ +.+||+|||++.......... ......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99988865432 222334444566777666554 347999999998764322211 1112234
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
+..|+|||.+.+..++.++|||||||++|||++ |..||............. ........ . ...
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~~~~~-~--------~~~ 224 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGERMECP-Q--------RCP 224 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCCCCC-C--------CCC
Confidence 578999999988889999999999999999998 999986432221111110 00000100 0 011
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 269 LKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
..+.++|.+||+.||++|||+.+|.+.|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 245678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=245.39 Aligned_cols=180 Identities=22% Similarity=0.300 Sum_probs=139.8
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|.. .+++.||+|.+.... ...+..+..++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999995 457889999985321 234556777889999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC---
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE--- 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~--- 181 (338)
||+++|+|..++..... ..........+++.+|.+.| ++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999998865433 22233344455666665544 456999999998754211000
Q ss_pred ------------------------------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 182 ------------------------------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 182 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0011347999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=227.95 Aligned_cols=227 Identities=23% Similarity=0.294 Sum_probs=166.3
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|+.++.||.|+||.||.+. ..++..+++|.+.... ......|..+++.++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58999999999999999999 4568889999875432 13355677899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++++|.+++.... ...........+++.++.+.|+ +.+||+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence 99999999886542 1222223444556677766553 3489999999987643321 22
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....++..|+|||++.+..++.++|+||||+++|+|++|..||......+. ..... ........
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~~~~--------- 222 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNYTPVV--------- 222 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCCCCCc---------
Confidence 345789999999999888889999999999999999999999864321111 10100 11111000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
......+.+++.+||+.||.+|||+.++++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123456788899999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=234.00 Aligned_cols=227 Identities=22% Similarity=0.315 Sum_probs=162.0
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++++.||+|+||.||++... .+..||+|.+..... ..+..+..+++.++||||+++++.+...+.+++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999954 688899998864322 2355677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC----ccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDST----RSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+++++|..++.... ...........+++.++.+.|. +.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence 99999998887642 2222233444556666666552 35899999999765321
Q ss_pred cccccccCCccccccccccC------CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 183 NTNRVVGTYGYMAPEYALEG------LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~------~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||............. ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~- 231 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----AIVDGDPPTLP- 231 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----HHhhcCCCCCC-
Confidence 12234678899999998643 35789999999999999999999986432211111000 00001111111
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+|+.+||+.||++||++.+++.
T Consensus 232 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 232 --------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --------cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 011234567888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=236.16 Aligned_cols=233 Identities=24% Similarity=0.299 Sum_probs=162.6
Q ss_pred cCCCCCceecccCCeeEEEEEEcC-Cc--EEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND-DK--EIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.+.||+|+||.||+|.... +. .+++|.++.... ..+..|..+++.+ +||||+++++++...+.+++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999998543 32 468888764221 2355567777777 799999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeEEe
Q 045271 123 CEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPKIS 167 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~ 167 (338)
|||+++++|.+++..... ..........+++.++.+.|+ ..+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999999999999865321 111223444556677766554 348999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhh
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
|||++..... .........+..|+|||++.+..++.++|||||||++|+|++ |..||......+..... .
T Consensus 162 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~------~ 232 (297)
T cd05089 162 DFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL------P 232 (297)
T ss_pred CcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------h
Confidence 9999864311 111111233457999999988889999999999999999997 99998644322211100 0
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.. ...... ......+.+|+.+||+.||.+|||+.++++.|+.....
T Consensus 233 -~~-~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 233 -QG-YRMEKP--------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -cC-CCCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000000 01112456788899999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=228.70 Aligned_cols=227 Identities=27% Similarity=0.395 Sum_probs=162.9
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------------ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
+|.+...||+|++|.||+|.. .++..+|+|.+..... +.+..++.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478899999999999999995 4578899998854321 234566778999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
.++||||+++++|..++..... ..........+++.++.+.|+ +.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999998865432 222233444556666666553 458999999998764211
Q ss_pred CC----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 180 SE----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 180 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
.. .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ . .... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~-~~~~~~~~ 233 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I----FKIG-ENASPEIP 233 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H----HHHh-ccCCCcCC
Confidence 11 111234578899999999988899999999999999999999999864321110 0 0000 00000000
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+++.+||+.||.+||++.+|++
T Consensus 234 ---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 234 ---------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011234567888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=229.03 Aligned_cols=233 Identities=21% Similarity=0.310 Sum_probs=165.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++.+.||.|+||.||+|.. .++..+++|.+.... .+.+.+++.+++.++|+||+++++.+..++.+++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4799999999999999999994 457789999986432 23456677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc-
Q 045271 126 MPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA- 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~- 182 (338)
+++++|..++..... ..........+++.++.+.|+ +.++|+|||++..+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999999865322 222233444556666665443 458999999987764332221
Q ss_pred -cccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 183 -NTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......|+..|+|||++... .++.++|+|||||++|+|++|..||............ ... ... ......
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~------~~~-~~~-~~~~~~- 231 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT------LQN-DPP-SLETGA- 231 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH------hcC-CCC-CcCCcc-
Confidence 12334688899999998877 6899999999999999999999998643321111000 000 000 000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........+.+++.+||+.||++|||+.+++.
T Consensus 232 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 --DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00011234567888999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=226.70 Aligned_cols=226 Identities=27% Similarity=0.379 Sum_probs=159.5
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
++||+|+||.||+|....++.||+|.+..... ..+..+..+++.++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999976689999998865433 24566778899999999999999999999999999999999999
Q ss_pred HHHhccCcccc--ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 133 FLLFDSTRSVQ--LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 133 ~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
.++........ .......+++.++.+.|+ +.++|+|||++................++..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 98865332221 223334455666666553 4589999999976532111111111233567
Q ss_pred cccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHH
Q 045271 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKR 271 (338)
Q Consensus 193 y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
|+|||.+.+..++.++|+|||||++|+|++ |..||............. .. ...... ......+
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~-~~~~~~--------~~~~~~~ 224 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SG-YRMPAP--------QLCPEEI 224 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cC-CCCCCC--------ccCCHHH
Confidence 999999988889999999999999999999 788875433211111100 00 000000 0112346
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 272 IHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 272 ~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.+++.+||+.+|.+|||+.++++.|++
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=227.61 Aligned_cols=235 Identities=20% Similarity=0.198 Sum_probs=167.6
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----------ccHHHHHHHHHhc-CCCceeeee
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----------QGLQEFKNLIAKL-QHKNLVRLL 110 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~~~l~~l-~hpnIv~~~ 110 (338)
+.-..+...|+.-+.||.|..+.|-+|. ..+++++|+|++..... +....|..+|+++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 3446777899999999999999999999 55688899998843211 1123456678776 699999999
Q ss_pred eEEEeCCEEEEEEecCCCCCHHHHHhccCcccc-ccHHHHHH------------------HHHHhhhcCCCCeEEeeecc
Q 045271 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-LDWNRRMC------------------IINGIARDHKMNPKISDFGM 171 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~------------------~~~~i~~~~~~~vkL~Dfg~ 171 (338)
|+|+.+..+++|+|.|+.|.|.+++........ ....+..+ ..+||..+++.++||+|||+
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999999999965432111 11112222 22445556778899999999
Q ss_pred ceecCCCCCCccccccccCCcccccccccc------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALE------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
++.+. ........|||+.|+|||.+.- ..|+..+|+||+||++|.|+.|++||-+..---....+..
T Consensus 170 a~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime---- 242 (411)
T KOG0599|consen 170 ACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME---- 242 (411)
T ss_pred eeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh----
Confidence 99873 4455667899999999999862 2488899999999999999999999864321111111111
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+..+.--..+ ........++|.+||+.||.+|.|++|+|.
T Consensus 243 ---GkyqF~speW------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 ---GKYQFRSPEW------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---cccccCCcch------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111111 112223466788899999999999999985
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.14 Aligned_cols=242 Identities=22% Similarity=0.279 Sum_probs=165.7
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++.+.||+|+||.||+|... +++.||+|.+..... +....++.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999965 588899998854321 235567889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|++++.|..++.... ...........+++.+|.++|+ +.++|+|||++..+..... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--ccc
Confidence 999988887765432 2222334455567777776554 4589999999987643221 122
Q ss_pred ccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccCCc-cccc
Q 045271 186 RVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEGNA-QELM 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~ 255 (338)
...++..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ...+..... ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3467889999999876 45889999999999999999999999754322111110000 000000000 0000
Q ss_pred CccccccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+........ .....+.+|+.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 01234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=226.27 Aligned_cols=224 Identities=25% Similarity=0.330 Sum_probs=158.9
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
+.||+|+||.||+|...++..+|+|.+...... .+..|..+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999778889999998654332 3456777889999999999999999999999999999999999
Q ss_pred HHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 133 FLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 133 ~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
.++...... .........+++.++.+.|+ +.+||+|||++........ .......++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~ 159 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIK 159 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCccc
Confidence 888654322 12223334455566665543 3489999999875432111 11111234567
Q ss_pred cccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHH
Q 045271 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKR 271 (338)
Q Consensus 193 y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
|+|||++.+..++.++||||||+++|+|++ |..||........... .. ........ ......+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~------~~-~~~~~~~~---------~~~~~~~ 223 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ------VE-KGYRMSCP---------QKCPDDV 223 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH------HH-cCCCCCCC---------CCCCHHH
Confidence 999999988889999999999999999998 8889864322211110 00 00000000 0112345
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 272 IHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 272 ~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.+++.+||+.||++|||+.++++.|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 67888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.51 Aligned_cols=231 Identities=25% Similarity=0.344 Sum_probs=157.6
Q ss_pred CCCCceecccCCeeEEEEEEcCCc---EEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC------CE
Q 045271 53 FSNENKLGEGGFGPVYKGVLNDDK---EIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG------NE 118 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~~~---~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~------~~ 118 (338)
|.+.+.||+|+||.||+|...... .+|+|.++... ...+..|..+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999999964432 58999876432 12345567788999999999999987432 34
Q ss_pred EEEEEecCCCCCHHHHHhccCc-------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccce
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMAR 173 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~ 173 (338)
.+++|||+++|+|..++..... ..........+++.++.+.|+ +.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999999999887743211 112223344456666666553 458999999998
Q ss_pred ecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (338)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~ 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YDY----LRQGNRL 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHcCCCC
Confidence 7532221111122345678999999998889999999999999999999 7888864322111 110 0111110
Q ss_pred cccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 253 ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.... .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 KQPP---------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1000 0112356788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=228.23 Aligned_cols=226 Identities=27% Similarity=0.331 Sum_probs=163.6
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHhcCCCceeeeeeEEE-eCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-QGLQEFKNLIAKLQHKNLVRLLGCCL-EGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~~ 128 (338)
++|++.+.||+|+||.||++.. .+..||+|.+..... +.+..+..+++.++|+|++++++++. .++..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 4799999999999999999986 477899998865432 34667788999999999999999764 45678999999999
Q ss_pred CCHHHHHhccCcc---ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 129 KSLDFLLFDSTRS---VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 129 g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
++|.+++...... .........+++.++.+.|. +.+||+|||++....... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~ 159 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG 159 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCC
Confidence 9999988754332 12223444566777776554 458999999987653211 123
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.++..|+|||++.+..++.++|||||||++|+|++ |..||......+..... .........+ .
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~---------~ 223 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKMDAPD---------G 223 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCCCCCCCC---------C
Confidence 44668999999988889999999999999999997 99888643221111000 0000000000 0
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
....+.+++.+||+.||++|||+.++++.|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 12245678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=250.72 Aligned_cols=229 Identities=21% Similarity=0.333 Sum_probs=166.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEE-EEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~v-avK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+-|+|+..||.|+||.||+|..+..+.+ |.|++..... +++.-++.||...+||+||++++.|...+.+||+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45688899999999999999997665554 5677755443 3455677899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCcccccc--HHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLD--WNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|+||-++.++....+..... -.++.+++.++.++| ++.++|+|||++.... .......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD 188 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence 99999999887766544332 334444555555544 4569999999987542 2223345
Q ss_pred ccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 186 RVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.++||++|||||++. +.+|+.++|||||||+|.||..+.+|...... ...++... +...+ .++.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllKia-----KSePP----TLlq 257 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIA-----KSEPP----TLLQ 257 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHHHh-----hcCCC----cccC
Confidence 689999999999885 56899999999999999999999988653221 11111110 00111 1111
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+......+.+|+..||..||..||++.++++
T Consensus 258 ---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1233456678888899999999999999885
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=231.76 Aligned_cols=226 Identities=29% Similarity=0.418 Sum_probs=157.7
Q ss_pred ceecccCCeeEEEEEEcC-------CcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 57 NKLGEGGFGPVYKGVLND-------DKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~-------~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+.||+|+||.||+|...+ +..+|+|.+.... ...+.++..+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999999543 2468999875432 23455677889999999999999999998999999999
Q ss_pred CCCCCHHHHHhccCcc--------ccccHHHHHHHHHHhhhcCCC-----------------------CeEEeeecccee
Q 045271 126 MPNKSLDFLLFDSTRS--------VQLDWNRRMCIINGIARDHKM-----------------------NPKISDFGMARV 174 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~i~~~~~~-----------------------~vkL~Dfg~a~~ 174 (338)
+++++|..++...... .........+++.++.+.|+. .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999988653211 111223444566666654432 589999999976
Q ss_pred cCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||......+.... ..... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~------~~~~~-~~~ 233 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH------VTAGG-RLQ 233 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH------HhcCC-ccC
Confidence 533222121222345678999999998899999999999999999998 9998864322111100 00000 000
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
... .....+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 234 -------~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 -------KPE--NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------Ccc--cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 011245678899999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=239.06 Aligned_cols=216 Identities=19% Similarity=0.208 Sum_probs=152.5
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHH-HHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEF-KNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~-~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|++..... .....+ ..+++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 4688899999864311 112222 2356789999999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|...+..... ..........+++.+|.+.|+ +.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccC
Confidence 999887765432 222333445567777766553 45899999998753211 112234579
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+..|+|||++.+..++.++|||||||++|+|++|..||.......... ... .... .... ....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~-~~~~--~~~~--------~~~~ 221 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NIL-HKPL--VLRP--------GASL 221 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHH-cCCc--cCCC--------CCCH
Confidence 999999999999999999999999999999999999996433211110 000 0000 0000 1123
Q ss_pred HHHHHHhhccCCCCCCCCCHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~~ 291 (338)
.+.+++.+||+.||.+||++++
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCC
Confidence 4567888899999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=241.92 Aligned_cols=224 Identities=21% Similarity=0.272 Sum_probs=173.6
Q ss_pred HhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
....|.++.+||+|.|+.|.++. ..++..||||.+.+... ..+.+|.++|+.++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34689999999999999999999 45688999999976543 2356788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCcccc-ccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQ-LDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+.+|.+.+++....+... .......++..++.| +.+.++||+|||++..+. ....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~ 210 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLM 210 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---cccc
Confidence 999999999999987766433 122233334444444 445569999999999873 4455
Q ss_pred ccccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
..++||++.|.|||++.+..|+ +.+|+||+|+++|.|+.|..||.......- -+..+.+.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------------r~rvl~gk 271 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------------RPRVLRGK 271 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------cchheeee
Confidence 6678999999999999998875 779999999999999999999975433322 22222222
Q ss_pred ccHHH--HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 263 FILEE--LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 263 ~~~~~--~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+. ..++.++++++|-.+|.+|++..++++
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22111 224567888999999999999999984
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=231.47 Aligned_cols=230 Identities=21% Similarity=0.291 Sum_probs=167.6
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++.+.||+|+||.||++.. .+++.||+|.+..... +.+..+..+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46899999999999999999984 4678899999854322 3355667788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..++...............+++.++.++|+ +.++|+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 175 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 175 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccc
Confidence 999999999876544433344455567777766554 3489999999876543221 12234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||............. .... .... .....
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~~~------~~~~--~~~~~ 241 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGT------PELQ--NPEKL 241 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cCCC------CCCC--Ccccc
Confidence 68889999999988889999999999999999999999996432211110000 0000 0000 00011
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+.+++.+||+.||.+||++.+++..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1235578889999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=230.18 Aligned_cols=229 Identities=21% Similarity=0.301 Sum_probs=164.1
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc---cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ---GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++++.||.|+||.||+|.. .++..+|+|.+...... ....++.+++.++||||+++++++..++.+++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46799999999999999999995 45788999998654332 355677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+++++|..++..... ..........+++.++.+.| ++.++|+|||++....... ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cccc
Confidence 999999998865432 22333445556777776654 3458999999987653211 1223
Q ss_pred ccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 186 RVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...++..|+|||++. ...++.++|+|||||++|+|++|..||......... . ... ..... .+.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~-~~~~~-----~~~ 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----KIL-KSEPP-----TLD 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----HHh-cCCCC-----CcC
Confidence 356889999999985 344778999999999999999999998643211110 0 000 00000 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+. .....+.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 QPS--KWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred Ccc--cCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 000 01124567888999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=232.86 Aligned_cols=237 Identities=22% Similarity=0.276 Sum_probs=162.5
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhc-CCCceeeeeeEEE-----
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKL-QHKNLVRLLGCCL----- 114 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l-~hpnIv~~~~~~~----- 114 (338)
+......++|++.+.||+|+||.||+|.. .+++.+|+|.+..... .....|..+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 33445677999999999999999999995 4577899998754322 3455677778888 6999999999874
Q ss_pred eCCEEEEEEecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeecc
Q 045271 115 EGNELLLICEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGM 171 (338)
Q Consensus 115 ~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~ 171 (338)
.++.+++||||+++++|..++.... ...........+++.++.++|+ +.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 3567899999999999988775321 1111223344456666666553 4589999999
Q ss_pred ceecCCCCCCccccccccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhh
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
+....... .......|+..|+|||++.. ..++.++||||+||++|+|++|..||......... . . .
T Consensus 171 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~----~-~ 241 (286)
T cd06638 171 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F----K-I 241 (286)
T ss_pred eeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h----h-c
Confidence 98763221 12223468899999999853 34788999999999999999999998643221110 0 0 0
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
..........+. .....+.+++.+||+.||++|||+.+|++.+
T Consensus 242 ~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000000000 0112456788899999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=234.44 Aligned_cols=242 Identities=22% Similarity=0.270 Sum_probs=163.2
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|+++++||+|+||.||+|... +++.||+|.+..... +....|..+++.++||||+++++++..++.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999964 578899998754322 235567788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|++++.|..+..... ...........+++.++.++|+ +.++|+|||++..+.... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccC
Confidence 999998887765432 2222334444556676666553 458999999998763322 1122
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhhccCCc-cccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLWCEGNA-QELM 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~ 255 (338)
...++..|+|||++.+. .++.++|||||||++|+|++|..||......+......... ........ ....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 34678899999998764 47889999999999999999998886432211100000000 00000000 0000
Q ss_pred Ccccccccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFI-----LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......... ......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 011234677899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=236.35 Aligned_cols=233 Identities=27% Similarity=0.340 Sum_probs=162.2
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCc--EEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDK--EIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.+.||+|+||.||+|.+. ++. .+++|.+..... ..+..|+.++..+ +||||+++++++..++.+++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 47899999999999999999954 343 357777654322 2345577778888 899999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeEEe
Q 045271 123 CEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPKIS 167 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~ 167 (338)
|||+++++|..++..... ..........+++.+|.++|+ +.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 999999999998865421 111223445566677766554 358999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhh
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
|||++..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+... ..
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~- 236 (303)
T cd05088 167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KL- 236 (303)
T ss_pred ccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH------HH-
Confidence 9999864311 111111234567999999988889999999999999999998 999986432211110 00
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
....... . . ......+.+|+.+||+.||++|||+.+++..|......
T Consensus 237 ~~~~~~~---~----~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 PQGYRLE---K----P--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hcCCcCC---C----C--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000000 0 0 00112356788899999999999999999988775543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=227.36 Aligned_cols=225 Identities=24% Similarity=0.325 Sum_probs=157.0
Q ss_pred eecccCCeeEEEEEEc---CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCC
Q 045271 58 KLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKS 130 (338)
Q Consensus 58 ~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 130 (338)
.||+|+||.||+|.+. .+..||+|.+..... +.+..|+.+++.++||||+++++++. .+.+++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999853 344689998865432 23556778999999999999999886 457899999999999
Q ss_pred HHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc-cccccc
Q 045271 131 LDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN-TNRVVG 189 (338)
Q Consensus 131 L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~-~~~~~g 189 (338)
|.+++..... ..........+++.++.+.|+ ..+||+|||++..+........ .....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9998864332 222334445567777776554 3489999999976532221111 111233
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
+..|+|||++.+..++.++|||||||++|+|++ |..||............ ....... .+ ....
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~~-~~--------~~~~ 224 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQGKRLD-CP--------AECP 224 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCCCC-CC--------CCCC
Confidence 568999999988889999999999999999996 99998644322111110 0000000 00 0112
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 269 LKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
..+.+++.+||+.||++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3455688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=228.34 Aligned_cols=232 Identities=28% Similarity=0.376 Sum_probs=166.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
..++|++.++||+|+||.||++....+..+|+|.+..... +.+.+|..+++.++|+||+++++.+.. ..++++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4568999999999999999999977777899998865432 345677889999999999999999887 7789999999
Q ss_pred CCCCHHHHHhccCcc---ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDSTRS---VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++++|.+++...... .........+++.++.+.|+ +.+||+|||.+..+..... ....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 161 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TARE 161 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-cccc
Confidence 999999998653211 11122334456777776554 3489999999976532211 1111
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...++..|+|||++....++.++|+|||||++|++++ |..||............. ........
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~--------- 225 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRMPRP--------- 225 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCCCCCc---------
Confidence 2345667999999988889999999999999999999 888886432211111000 00000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
......+.+++.+||+.||++||++.+++..|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112346678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=223.30 Aligned_cols=240 Identities=20% Similarity=0.145 Sum_probs=166.8
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeC-----C
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEG-----N 117 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~ 117 (338)
....++|++.+.||+|+|+.|+++. ..+++.+|+|++.-.. .+...+|+...+.++|||++++++....+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456799999999999999999999 6678899999985443 34567788889999999999999876532 3
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc-----ccccHHHHHHHHHHhhhcCC--------------------CCeEEeeeccc
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS-----VQLDWNRRMCIINGIARDHK--------------------MNPKISDFGMA 172 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~~~~--------------------~~vkL~Dfg~a 172 (338)
..|++++|...|+|.+.+...... ......+..+++.||.+.|. +.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 589999999999998888654332 22234455567777776553 44899999998
Q ss_pred eecCCCCCCc----c---ccccccCCccccccccccC---CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH
Q 045271 173 RVFGGNQSEA----N---TNRVVGTYGYMAPEYALEG---LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT 242 (338)
Q Consensus 173 ~~~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~---~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~ 242 (338)
...+-.-... . -.....|..|+|||.+.-+ ..+.++|||||||+||+|+.|..||......-+.....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA-- 254 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA-- 254 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe--
Confidence 7542100000 0 0112458899999988743 46789999999999999999999997433211111100
Q ss_pred HhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 243 WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
+...-+..+......-.+.++++.||+.||.+||++.+++..+...
T Consensus 255 -----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 -----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0000111111111222345688889999999999999999988764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=228.37 Aligned_cols=216 Identities=21% Similarity=0.376 Sum_probs=153.6
Q ss_pred ceecccCCeeEEEEEEcC-------------CcEEEEEEeccCCcc---cHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 57 NKLGEGGFGPVYKGVLND-------------DKEIAVKRLSRSSGQ---GLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~---~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
+.||+|+||.||+|.... ...|++|.+...... .+.++..+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998432 224788887544332 3455667889999999999999999888999
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCCCC-------------------------eEEeeeccce
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHKMN-------------------------PKISDFGMAR 173 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~~~-------------------------vkL~Dfg~a~ 173 (338)
+||||+++|+|..++..... ..........+++.++.+.|+.+ ++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999988865432 22233455667888888877532 6889999886
Q ss_pred ecCCCCCCccccccccCCccccccccc-cCCCCcccchHhHhHHHHHHH-hCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYAL-EGLFSVKSDVFSFGVLLLEII-SGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiWSlGv~l~el~-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
.... .....++..|+|||++. +..++.++|||||||++|+|+ .|..||......+.. ... ....
T Consensus 161 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~-~~~~ 226 (262)
T cd05077 161 TVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY-EGQC 226 (262)
T ss_pred cccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-hcCc
Confidence 5421 12245788899999887 456899999999999999998 577777543221110 000 0000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
... .. ....+.+||.+||+.||.+||++.+|++.|
T Consensus 227 -~~~------~~---~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 -MLV------TP---SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cCC------CC---ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 00 112456788999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=225.93 Aligned_cols=225 Identities=22% Similarity=0.321 Sum_probs=163.2
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... ...+..|+.+++.++||||+++++.+..++.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999995 467789999986432 22456677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+++++|.+++..... ..........+++.++.+.|+. .++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---c
Confidence 999999999875432 1122233444566766665532 37999999998764321 1
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||......... .... ........+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~------ 224 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV------LKIM-SGTFAPISDR------ 224 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH------HHHH-hcCCCCCCCC------
Confidence 22346788999999998888899999999999999999999998643221110 0000 0000001100
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
....+.+++.+||+.||++|||+.+++..
T Consensus 225 ---~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 ---YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11235678888999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=226.93 Aligned_cols=229 Identities=22% Similarity=0.315 Sum_probs=161.5
Q ss_pred CCCCCceecccCCeeEEEEEEcC--CcEEEEEEeccCC----------ccc---HHHHHHHHH-hcCCCceeeeeeEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND--DKEIAVKRLSRSS----------GQG---LQEFKNLIA-KLQHKNLVRLLGCCLE 115 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~---~~~~~~~l~-~l~hpnIv~~~~~~~~ 115 (338)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ... ...+..+++ .++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999654 6789999874321 111 223344443 5789999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHhcc---C--ccccccHHHHHHHHHHhhhcCC-C------------------CeEEeeecc
Q 045271 116 GNELLLICEYMPNKSLDFLLFDS---T--RSVQLDWNRRMCIINGIARDHK-M------------------NPKISDFGM 171 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~---~--~~~~~~~~~~~~~~~~i~~~~~-~------------------~vkL~Dfg~ 171 (338)
++..++||||+++++|.+++... . ......+....+++.++.++|. . .++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998877431 1 1222234455567777777763 2 389999999
Q ss_pred ceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
+....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......... . ......
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------~-~~~~~~ 230 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------K-IVEAVY 230 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------H-HhhccC
Confidence 98753322 2234568889999999998889999999999999999999999986432111100 0 000000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
..... . .....+.+++.+||+.||++|||+.|+..++++
T Consensus 231 ~~~~~----~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPE----G----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCc----c----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00000 0 011245678889999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=228.55 Aligned_cols=227 Identities=23% Similarity=0.326 Sum_probs=165.1
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+-|++.+.||.|+||.||+|.. .++..||+|.+..... ..+.++..+++.++||||+++++.+..++.+++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3578889999999999999985 4678899998754322 2355677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..++...............+++.++.+.|. +.++|+|||++..+.... ......
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccc
Confidence 999999998876544444444455566666666553 348999999987663221 112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||........ ..... ..... .+.. ..
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~-----~~~~----~~ 225 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIP-KNNPP-----TLEG----NY 225 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHh-cCCCC-----CCCc----cc
Confidence 678899999999888889999999999999999999999853221110 00000 00000 0000 11
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+.+++.+||+.||.+||++.+++..
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2345678888999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=230.28 Aligned_cols=231 Identities=26% Similarity=0.349 Sum_probs=165.3
Q ss_pred cCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
++|++++.||.|+||.||+|+... .+.|++|.+..... +.+..|+.+++.++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 689999999999999999999532 35689998865433 24667788999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhccC----------ccccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccc
Q 045271 121 LICEYMPNKSLDFLLFDST----------RSVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMA 172 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a 172 (338)
+||||+++|+|.+++.... ...........+++.+|.++|+. .++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999986544 12223344455677777776643 4789999998
Q ss_pred eecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
....... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.......... .. .....
T Consensus 165 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~------~~-~~~~~ 236 (275)
T cd05046 165 KDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN------RL-QAGKL 236 (275)
T ss_pred cccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH------HH-HcCCc
Confidence 6542211 111223356778999999988888999999999999999998 777875322111100 00 00011
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
..... . .....+.+++.+||+.||.+|||+.+++..|.
T Consensus 237 ~~~~~----~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPVP----E----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCC----C----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00000 0 01124566888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=227.93 Aligned_cols=233 Identities=26% Similarity=0.382 Sum_probs=163.2
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCc---EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDK---EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~---~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+|+..+.||+|+||.||+|... ++. .+|+|.+..... ..+..++++++.++||||+++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 47888899999999999999954 333 689998865422 2345567788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+++++|..++..... ..........+++.++.+.|+ +.+||+|||++..........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 999999999998865432 222233344456666665443 458999999998664222111
Q ss_pred cc-cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 183 NT-NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 183 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.. .....+..|+|||++.+..++.++|||||||++|+|++ |..||...........+ ... .... .
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i-------~~~--~~~~-~--- 231 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-------NDG--FRLP-A--- 231 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-------hcC--CCCC-C---
Confidence 11 11123457999999988889999999999999999997 99998543221110000 000 0000 0
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.........+++.+||+.||++||++.+|++.|++.
T Consensus 232 ---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 ---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123456788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=236.18 Aligned_cols=219 Identities=22% Similarity=0.244 Sum_probs=156.0
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC---c---ccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---G---QGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~---~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... . .....+..+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999995 457889999986432 1 22344555666665 577888999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++|+|..++..... ..........+++.+|.+.|+ +.+||+|||++...... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--Cccc
Confidence 99999999988865432 333444555567777776553 45899999998754221 1122
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||..|+|||++.+..++.++||||+||++|+|++|..||............ . .... . ...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~-~~~~-~-~p~------- 222 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI------M-EHNV-S-YPK------- 222 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCC-C-CCc-------
Confidence 3457899999999999888999999999999999999999999754321111100 0 0000 0 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTM 289 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~ 289 (338)
.....+.+++.+||+.||.+|+++
T Consensus 223 -~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 -SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -cCCHHHHHHHHHHcccCHhhCCCC
Confidence 011245678889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=229.45 Aligned_cols=233 Identities=25% Similarity=0.355 Sum_probs=164.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CC---cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DD---KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.+.||+|+||.||+|... ++ ..+|+|.+..... ..+..+..+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57899999999999999999853 22 3689998864322 2355667788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+++++|..++..... ..........+++.++.+.|+ +.++|+|||++..+.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 999999999999865432 222234444566677666553 348999999998764322111
Q ss_pred c-ccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 183 N-TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 183 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
. .....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+...... .. .... ..
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~--~~~~-~~-- 231 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-------EG--YRLP-AP-- 231 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-------CC--CcCC-CC--
Confidence 1 111223567999999998889999999999999999886 999986543221111110 00 0000 00
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
......+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 232 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 ----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112346788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=235.39 Aligned_cols=177 Identities=17% Similarity=0.168 Sum_probs=131.4
Q ss_pred CCCceeccc--CCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 54 SNENKLGEG--GFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 54 ~~~~~iG~G--~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+++++||+| +|++||++. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 356889999 678999999 45688899999865321 3456677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCCCC---
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQSE--- 181 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~~~--- 181 (338)
+++|+|.+++..... ..........+++.+|.+.|+. .++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999998864321 2222344555677777776643 4678888765433111000
Q ss_pred --ccccccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 182 --ANTNRVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 182 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 00112356778999999976 35899999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=234.04 Aligned_cols=240 Identities=25% Similarity=0.326 Sum_probs=163.8
Q ss_pred cCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeC--CEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG--NEL 119 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~ 119 (338)
+-|++++.||+|+||.||+|.. .++..||+|.+.... ...+..++.+++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578999999999999999983 346779999986432 23456678899999999999999998864 578
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++++|..++..... ..........+++.++.+.|+ +.++|+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999999998865432 222233444456666666543 458999999998663222
Q ss_pred CC-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccc--------ccchhhHHHhhhccCC
Q 045271 180 SE-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ--------GQSLLTYTWKLWCEGN 250 (338)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~--------~~~~~~~~~~~~~~~~ 250 (338)
.. .......++..|+|||++.+..++.++|||||||++|+|+++..|+....... ................
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 11 11123456778999999988889999999999999999999876543211000 0000000000000000
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.. +........+.+|+.+||+.||++|||+.++++.|+..
T Consensus 244 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 244 RL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 00001123567788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=230.50 Aligned_cols=226 Identities=21% Similarity=0.202 Sum_probs=163.1
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
-++|+.++.||+|.||.|-+|+ ..+++.+|+|++++... .....|.++|+..+||.+..+.-.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4588999999999999999999 66788999999876432 2334566789999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccc-ccc------------H------HHHHHHHHHhhhcCCCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTRSV-QLD------------W------NRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~-~~~------------~------~~~~~~~~~i~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||++||.|...+....... ... + ..+...++|+..+.++++||+|||+|+-- ......
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--ccccce
Confidence 99999999976665432211 111 1 11112445666677889999999999753 122334
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
..++|||+.|+|||++.+..|+.++|+|.+||++|||++|+.||+.........++......+ +..+ +
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF---------Pr~l--s- 392 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF---------PRTL--S- 392 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC---------CccC--C-
Confidence 567899999999999999999999999999999999999999997543222222221111111 1111 1
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
.++..++..+|..||.+|.. |.+|.+
T Consensus 393 -----~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 393 -----PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -----HHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 12344556699999999973 566653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=231.00 Aligned_cols=243 Identities=20% Similarity=0.272 Sum_probs=165.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++.+.||+|+||.||+|... +++.||+|.+.... .+.+..+.++++.++|+||+++++++..++.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999954 57789999886432 2346677889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|++++.+..+..... ......+....+++.++.+.| ++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLT 159 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cccc
Confidence 998877766654432 222233444555666666543 45689999999987643222 1223
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhhccCC---ccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLWCEGN---AQE 253 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~---~~~ 253 (338)
...++..|+|||++.+. .++.++||||||+++|+|++|..||......+......... ..+.... ...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 35678899999999888 78999999999999999999999986432211100000000 0000000 000
Q ss_pred ccCccccc----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKE----SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........ .........+.+|+++||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 000001345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=230.43 Aligned_cols=228 Identities=20% Similarity=0.267 Sum_probs=161.0
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
-|++++.||+|+||.||+|... ++..+++|.+..... .....++.+++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3788899999999999999954 466788998865433 234556778899999999999999999999999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|..++..... ..........+++.++.++|. +.+||+|||++...... .......
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~ 163 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSF 163 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccccc
Confidence 9999887754322 223334455567777776554 34899999998765321 1122335
Q ss_pred ccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 188 VGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 188 ~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.++..|+|||++. +..++.++|||||||++|+|++|..||......... .... .........+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~-----~~~~~~~~~~----- 231 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIA-----KSEPPTLAQP----- 231 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHh-----hcCCCCCCCc-----
Confidence 6889999999984 345788999999999999999999998643211110 0000 0000000000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
......+.+|+.+||+.||.+|||+.+++..
T Consensus 232 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 --SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111345678889999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=227.13 Aligned_cols=226 Identities=19% Similarity=0.285 Sum_probs=163.8
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|+||.||++.. .+++.||+|.+.... ......+..+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999994 467889999885321 12456677789999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+.+++|...+..... ..........+++.++.+.|+ +.++|+|||++........ ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hh
Confidence 999999888764321 222223344567777766553 4589999999987632211 12
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||......+. .... ........ .
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~~~~---------~ 222 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKI-IRGSYPPV---------S 222 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHH-hcCCCCCC---------c
Confidence 234678899999999888899999999999999999999999864321111 0000 00110000 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
......+.+++.+||+.||.+||++.+|++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112345678889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=255.16 Aligned_cols=235 Identities=22% Similarity=0.254 Sum_probs=163.1
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|+++++||+|+||.||+|... +++.||+|++..... ..+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999954 588899999865322 23556788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc--c------c----cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccce
Q 045271 124 EYMPNKSLDFLLFDSTR--S------V----QLDWNRRMCIINGIARDHK------------------MNPKISDFGMAR 173 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~------~----~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~ 173 (338)
||+++|+|..++..... . . ........+++.++.+.|+ +.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999988864211 0 0 1112344456666666543 458999999998
Q ss_pred ecCCCCC----------------CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccc
Q 045271 174 VFGGNQS----------------EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS 237 (338)
Q Consensus 174 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~ 237 (338)
....... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~- 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS- 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh-
Confidence 6521110 00112346999999999999999999999999999999999999998642211110
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhhcC
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT-MSSVVFMLATD 299 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~vl~~L~~~ 299 (338)
...... .... ..+. ......+.+++.+||+.||++||+ ++++++.|+..
T Consensus 241 ---~~~~i~---~P~~-~~p~------~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 241 ---YRDVIL---SPIE-VAPY------REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hhhhcc---Chhh-cccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000 0000 0000 011123456788899999999975 55555655543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=227.10 Aligned_cols=226 Identities=28% Similarity=0.355 Sum_probs=160.4
Q ss_pred ceecccCCeeEEEEEEcC--C--cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLND--D--KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|++|.||+|.+.. + ..||||.+..... +.+..|..+++.++||||+++++++.. +.+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999533 2 2589999876544 245567778899999999999999988 889999999999
Q ss_pred CCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC-ccccc
Q 045271 129 KSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE-ANTNR 186 (338)
Q Consensus 129 g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~-~~~~~ 186 (338)
++|...+.... ......+....+++.+|.+.|+ +.+||+|||++..+...... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999887654 1222334445567777776554 34899999999876432211 11112
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..... ..... .... +.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------~~~~~--~~~~-----~~-- 224 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI------DKEGE--RLER-----PE-- 224 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HhcCC--cCCC-----Cc--
Confidence 456778999999988889999999999999999998 99998543222111100 00000 0000 00
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.....+.+++.+||+.+|++|||+.++++.|.+
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 011245668888999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=229.43 Aligned_cols=234 Identities=26% Similarity=0.391 Sum_probs=166.7
Q ss_pred cCCCCCceecccCCeeEEEEEEcC-Cc----EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND-DK----EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+|++.+.||+|+||.||+|.... +. .+|+|.+..... ..+.+++.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578999999999999999999432 32 588998765432 235567778899999999999999987 78899
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++|+|.+++..... ..........+++.++.+.|+ +.+||+|||++..+......
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 9999999999998876432 222334455567777777664 34799999999876422221
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||.+....++.++|+|||||++|++++ |..||......+...... .... ...+.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~--~~~~~-- 234 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGER--LPQPP-- 234 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCCC--CCCCC--
Confidence 11112234568999999988889999999999999999998 999986543222111110 0000 00000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.....+.+++.+||..||++|||+.++++.|+....
T Consensus 235 -----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 235 -----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011245677888999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=231.30 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=165.1
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc--------cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ--------GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+|++++.||+|+||.||+|.. .++..||||.+...... .+..++.+++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999995 46889999998654322 244577788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+ +++|..++.... ...........+++++|.+.|+ +.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 999999987654 2222334455667777777554 358999999998764321 1
Q ss_pred cccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH-----hhhc-cCCccccc
Q 045271 183 NTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW-----KLWC-EGNAQELM 255 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~ 255 (338)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||................ ..+. ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 1222356788999998865 457899999999999999999977765432111100000000 0000 00000000
Q ss_pred Ccccccccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 256 DPVLKESFI-----LEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 256 ~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
......... ......+.+++.+||+.||++|||+.+++. +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 000000010 111235678999999999999999999997 3554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=231.85 Aligned_cols=173 Identities=25% Similarity=0.390 Sum_probs=127.6
Q ss_pred CceecccCCeeEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEEEEecCCCC
Q 045271 56 ENKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLLICEYMPNK 129 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g 129 (338)
..+||+|+||.||+|... ++..||+|.+.... .....+|..+++.++||||+++++++.. +..+++||||+. +
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 368999999999999954 34679999886543 2346678889999999999999999864 567899999995 5
Q ss_pred CHHHHHhccCc----------cccccHHHHHHHHHHhhhcCC----------------------CCeEEeeeccceecCC
Q 045271 130 SLDFLLFDSTR----------SVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 130 ~L~~~l~~~~~----------~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~~~~ 177 (338)
+|..++..... ..........+++.+|.+.|+ +.+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 66666542211 111223445567777766543 3589999999987643
Q ss_pred CCCC-ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 178 NQSE-ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
.... .......||..|+|||++.+. .++.++|||||||++|+|++|.+||..
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 2211 112335788999999999874 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=230.99 Aligned_cols=239 Identities=20% Similarity=0.231 Sum_probs=159.8
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|+||.||+|.. .++..||+|.+.... ......|+.+++.++||||+++++++.+.+.+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999995 458889999986432 23456678899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++ ++|..++.... ...........+++.++.+.|. +.++|+|||++........ ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcC
Confidence 96 57766665422 2333334555667777766543 4589999999986532211 112
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccc-cchhhH--------HHhhhccCCccccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG-QSLLTY--------TWKLWCEGNAQELM 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~ 255 (338)
...++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...... .+............
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 34578899999998775 478999999999999999999988643221110 000000 00000000000000
Q ss_pred Ccccccccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFI-----LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. ...... ......+.+++.+||+.||.+|||+.+++.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 238 PM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000000 011234567899999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=227.07 Aligned_cols=233 Identities=24% Similarity=0.320 Sum_probs=162.8
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-------------ccHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-------------QGLQEFKNLIAKLQHKNLVRLLGCCLEGN 117 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~ 117 (338)
+|.+.+.||+|+||.||+|.. .+++.||+|.+..... +.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999984 4688899998753211 13455677889999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~ 178 (338)
.+++||||+++++|..++..... ..........+++.++.+.|+ +.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999998876532 112223334556777766554 34899999999765322
Q ss_pred CCCccccccccCCccccccccccCC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
..........|+..|+|||++.... ++.++|+||||+++|+|++|..||........ ..... .......+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~~ 234 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLG-NKRSAPPIP 234 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhh-ccccCCcCC
Confidence 2122223356888999999988654 78999999999999999999999853221110 00000 000010111
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
. .........+.+++.+||+.||.+|||+.+|+..
T Consensus 235 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 P----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 0111122456678889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=233.34 Aligned_cols=228 Identities=19% Similarity=0.249 Sum_probs=164.8
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
..|+....||+|+||.||+|.. .++..||+|.+..... ..+.+++.+++.++||||+++++.+..++..++||||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 3455567899999999999994 4688899999854322 33556677889999999999999999999999999999
Q ss_pred CCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 127 PNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 127 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
++++|..++...............+++.++.+.|+ +.++|+|||++..+.... .......
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 178 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV 178 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence 99999988765444444445555667777776554 458999999987553221 1223357
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
|+..|+|||++.+..++.++|||||||++|+|++|..||........... ....... .. ... ....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~-~~----~~~--~~~~ 244 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-------LRDSPPP-KL----KNA--HKIS 244 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhccCCC-Cc----ccc--CCCC
Confidence 88999999999988899999999999999999999999864321111100 0000000 00 000 0011
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 269 LKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 23566888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=225.67 Aligned_cols=226 Identities=19% Similarity=0.250 Sum_probs=162.3
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe-CCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE-GNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 124 (338)
+|++++.||.|++|.||++.. .+++.||+|.+..... +....+..+++.++|+|++++++.+.. ...+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999994 4577899999854321 235566778899999999999998864 456899999
Q ss_pred cCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+++++|.+.+.... ...........+++.++.+.|+ +.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--Cc
Confidence 999999998886532 1222334444556666666554 348999999998763221 12
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....+++.|+|||++.+..++.++|+|||||++|+|++|..||........ ..... .......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~~~--------- 222 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGKLPPM--------- 222 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcCCCCC---------
Confidence 2345688899999999998899999999999999999999999864322111 00100 0111000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.......+.+++.+||+.||++|||+.+++..
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01122346678899999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=224.66 Aligned_cols=227 Identities=34% Similarity=0.452 Sum_probs=163.7
Q ss_pred CCCCceecccCCeeEEEEEEcC-----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 53 FSNENKLGEGGFGPVYKGVLND-----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+++.+.||.|+||.||+|.... +..||+|.+..... ..+..+..+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999999543 37799999865443 34666778889999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCCCCc
Q 045271 124 EYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||+++++|..++.... ......+....+++.++.+.|+. .++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 9999999999886543 23334455556677777776543 48999999998764321111
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.. ...++..|+|||.+.+..++.++||||+||++|+|++ |..||........... ... ........
T Consensus 161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~------~~~-~~~~~~~~----- 227 (258)
T smart00219 161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY------LKK-GYRLPKPE----- 227 (258)
T ss_pred cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------Hhc-CCCCCCCC-----
Confidence 11 1236788999999988889999999999999999998 7777754221111100 000 00000000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.....+.+++.+||..||.+|||+.++++.|
T Consensus 228 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 ----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0123456688899999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=228.53 Aligned_cols=217 Identities=22% Similarity=0.316 Sum_probs=152.3
Q ss_pred ceecccCCeeEEEEEEcC-------------------------CcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceee
Q 045271 57 NKLGEGGFGPVYKGVLND-------------------------DKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~ 108 (338)
.+||+|+||.||+|.... ...|++|.+..... ..+.++..+++.++||||++
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 369999999999998421 12478888854332 23445667889999999999
Q ss_pred eeeEEEeCCEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCCCC-----------------------
Q 045271 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHKMN----------------------- 163 (338)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~~~----------------------- 163 (338)
+++++...+..++||||+++|+|..++..... ..........+++.+|.+.|+.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999988865332 22333445566788888766532
Q ss_pred --eEEeeeccceecCCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHH-hCCCCCcccccccccchh
Q 045271 164 --PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEII-SGRKDTRFYLYEQGQSLL 239 (338)
Q Consensus 164 --vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~-~g~~Pf~~~~~~~~~~~~ 239 (338)
+|++|||++..... .....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||...........
T Consensus 161 ~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~- 233 (274)
T cd05076 161 PFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF- 233 (274)
T ss_pred ceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence 57888888754321 112356788999998876 46899999999999999995 68888864322111100
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
... ..... . . ....+.+++.+||+.||++|||+.+|++.|+
T Consensus 234 --~~~---~~~~~---~-----~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 --YEK---KHRLP---E-----P----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHh---ccCCC---C-----C----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 00000 0 0 0124567888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=226.80 Aligned_cols=226 Identities=23% Similarity=0.348 Sum_probs=163.4
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcC---CCceeeeeeEEEeCCEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQ---HKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.|++.+.||+|+||.||+|.+ .++..||+|.+..... .....++.+++.++ |||++++++++..++.+++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999995 5688899998864322 23556677788876 999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
||+++++|.+++...............+++.++.+.|. +.++|+|||++..+.... ....
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRS 159 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccc
Confidence 99999999998876533333344455556666666543 458999999998764332 1123
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...|+..|+|||.+.+. .++.++|+|||||++|+|++|..||........... .... ..+.+....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~~----~~~~~~~~~- 226 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML--------IPKS----KPPRLEDNG- 226 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc--------cccC----CCCCCCccc-
Confidence 35688899999998764 478999999999999999999999864322111000 0000 001111100
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+++.+||+.||++|||+.+++.
T Consensus 227 --~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 227 --YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1234567888999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=233.00 Aligned_cols=229 Identities=20% Similarity=0.215 Sum_probs=163.7
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||+|... +++.||+|.+..... ..+..+..+++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999954 488999999865432 23556778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC-
Q 045271 124 EYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE- 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~- 181 (338)
||+.+++|.+++..... ..........+++.+|.+.| ++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998864321 22222334455666666654 345899999998754221110
Q ss_pred --------------------------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccc
Q 045271 182 --------------------------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG 235 (338)
Q Consensus 182 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~ 235 (338)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 011234678899999999988899999999999999999999999864322111
Q ss_pred cchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 045271 236 QSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT----MSSVVF 294 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~vl~ 294 (338)
.. ... .... ...........+.+++.+||+.||++||| +.+++.
T Consensus 241 ~~------~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FS------NIL-KKEV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH------HHh-cCCc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 00 000 0000 00000002235677888999999999999 888776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=228.54 Aligned_cols=233 Identities=21% Similarity=0.274 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|.+.+.||+|+||.||+|...+ ...|+||....... +.+..|+.+++.++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3468899999999999999998533 24688998764432 345667788999999999999999875 55789
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++++|.+++..... ..........+++.+|.+.|+ +.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 9999999999999875432 222233344567777776654 34899999999876432111
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......++..|+|||.+....++.++|||||||++|+|++ |..||......+...... ........
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~~~~~~----- 230 (270)
T cd05056 164 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------NGERLPMP----- 230 (270)
T ss_pred -ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------cCCcCCCC-----
Confidence 1112234567999999988889999999999999999986 999986543221111100 00000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
......+.+++.+||..+|.+|||+.+++..|+...
T Consensus 231 ----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 231 ----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011234566888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=223.71 Aligned_cols=228 Identities=22% Similarity=0.299 Sum_probs=158.1
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--------ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--------QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNEL 119 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~ 119 (338)
.+|+..+.||+|+||.||+|.. .++..|++|.+..... ..+..|+.+++.++||||+++++++.+ ++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999995 4588999998753321 235567778999999999999999875 4678
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+++|||+++++|..++..... ..........+++.+|.++|+ +.++|+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999988865432 222233445567777766554 3489999999876532111
Q ss_pred -CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 -EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||........ .... ........ +
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~~~-~~~~~~~~-----~ 230 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IFKI-ATQPTNPQ-----L 230 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HHHH-hcCCCCCC-----C
Confidence 1111234578899999999988899999999999999999999999864321110 0000 00000000 0
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......+.+++ +||..||++|||++||++
T Consensus 231 ----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 ----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000111223344 588899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=229.07 Aligned_cols=242 Identities=21% Similarity=0.250 Sum_probs=161.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|++|.||+|... +++.||+|.+..... ....+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999954 578899999864322 234568889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++ ++|..++...... .........+++.++.+.|+ +.+||+|||++........ ..
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY 160 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence 996 5888877654322 22233344466777766554 4589999999875421111 11
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccc-cccchhhH--------HHhhhc------c
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYE-QGQSLLTY--------TWKLWC------E 248 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~-~~~~~~~~--------~~~~~~------~ 248 (338)
....++..|+|||++.+. .++.++||||+||++|+|++|..||...... +....... .+.... .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 223467889999998764 5889999999999999999999998643311 00000000 000000 0
Q ss_pred CCcccccCccccc-cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKE-SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..........+.. ...........+++.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000 000111135567889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=231.69 Aligned_cols=230 Identities=20% Similarity=0.273 Sum_probs=165.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+.|.....||+|+||.||++.. .++..||||.+..... +.+..+..+++.++|+||+++++.+..++..++||||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 34556668899999999999995 4578899999864332 2355667788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++++|..++...............+++.++.+.|+ +.++|+|||++....... ......
T Consensus 101 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 178 (292)
T cd06658 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL 178 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence 999999988865544444445555667777776553 458999999987653221 122335
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......... . ... ........... .
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~-~~~-----~~~~~~~~~~~--~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR------R-IRD-----NLPPRVKDSHK--V 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHh-----cCCCccccccc--c
Confidence 68899999999988889999999999999999999999986432111100 0 000 00111111111 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+.+++.+||+.||.+|||+.++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234567888999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=226.14 Aligned_cols=225 Identities=29% Similarity=0.377 Sum_probs=162.9
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
++|++.+.||+|+||.||++.. .++.||+|.+.... ...+..+..+++.++||||+++++++... ..++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 5799999999999999999975 67789999986542 34566778889999999999999998754 479999999999
Q ss_pred CHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 130 SLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 130 ~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
+|..++..... ..........+++.++.+.|+ +.++|+|||++...... .....
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~ 158 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSK 158 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCC
Confidence 99999875432 122223345566777666553 34899999998764211 11223
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.+..|+|||.+.+..++.++|+|||||++|+|++ |..||............. ........ ...
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~---------~~~ 222 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYRMEPP---------EGC 222 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCCCCCC---------CcC
Confidence 4567999999988889999999999999999998 898886543222111110 00000000 011
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
...+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1345678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=228.66 Aligned_cols=225 Identities=27% Similarity=0.341 Sum_probs=155.7
Q ss_pred ceecccCCeeEEEEEEcC-Cc--EEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLND-DK--EIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.... +. .+++|.+..... ..+..|+.+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999544 43 468888764322 3455677788888 799999999999999999999999999
Q ss_pred CCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccce
Q 045271 129 KSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMAR 173 (338)
Q Consensus 129 g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~ 173 (338)
|+|.+++..... ..........+++.+|.+.|+ +.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999865321 111223344556677766554 348999999986
Q ss_pred ecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (338)
.... .........+..|+|||++.+..++.++|||||||++|+|++ |..||.......... .. ......
T Consensus 161 ~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~-~~~~~~ 230 (270)
T cd05047 161 GQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KL-PQGYRL 230 (270)
T ss_pred ccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------HH-hCCCCC
Confidence 3211 111111234567999999988889999999999999999997 999986432211100 00 000000
Q ss_pred cccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 253 ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
... ......+.+++.+||+.||.+|||+.+++..|+.+.
T Consensus 231 ~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 EKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 011124567888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=225.13 Aligned_cols=235 Identities=22% Similarity=0.242 Sum_probs=162.6
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 123 (338)
++|+..+.||.|++|.||+|.. .++..+|+|.+..... ..+.++.++++.++||||+++++++.+ .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688899999999999999995 4577899998864332 345667788999999999999998865 45789999
Q ss_pred ecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 124 EYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||+++++|.+++.... ...........+++.++.+.|. +.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-- 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc--
Confidence 9999999988764321 1222233455567777766553 34899999998754211
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...............+.. .......... ..
T Consensus 159 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~ 233 (287)
T cd06621 159 --LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--NMPNPELKDE-PG 233 (287)
T ss_pred --ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh--cCCchhhccC-CC
Confidence 112346788999999999888999999999999999999999998754221111111111100 0000000000 00
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........+.+|+.+||+.||.+|||+.|++.
T Consensus 234 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 --NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00112234568999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=229.70 Aligned_cols=233 Identities=23% Similarity=0.326 Sum_probs=162.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCc---EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDK---EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~---~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+|++.+.||+|+||.||+|... +++ .||||.+..... ..+..++.+++.++||||+++++++.++..+++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46889999999999999999953 333 599999865322 2455677788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+++++|..++..... ..........+++.++.+.|+ ..+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999999999998865432 222233444556666666443 358999999987653222111
Q ss_pred cccccc---cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 183 NTNRVV---GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 183 ~~~~~~---gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
...... .+..|+|||.+.+..++.++|||||||++|||++ |..||............ ........
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i------~~~~~~~~----- 232 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI------EQDYRLPP----- 232 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH------HcCCcCCC-----
Confidence 111111 2357999999998889999999999999999886 99998643221111110 00000000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.......+.+++.+||+.||.+||++.+|+..|+..
T Consensus 233 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 -----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000112345688889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=226.29 Aligned_cols=229 Identities=24% Similarity=0.291 Sum_probs=150.7
Q ss_pred ceecccCCeeEEEEEEcC---CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVLND---DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||+|.... ...+++|.+..... ..+.+++.+++.++||||+++++.+.+.+.+++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997433 33578887754332 22455677888999999999999999999999999999999
Q ss_pred CHHHHHhccCccc------cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 130 SLDFLLFDSTRSV------QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 130 ~L~~~l~~~~~~~------~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+|.+++....... ........+++.+|.+.|+ +.+||+|||++.............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999986643211 1123445567777776554 458999999986532211111112
Q ss_pred ccccCCcccccccccc-------CCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 186 RVVGTYGYMAPEYALE-------GLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-------~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
...++..|+|||++.. ..++.++|||||||++|+|++ |..||......+. .. .... ........+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~~-~~~~~~~~~ 233 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK---QVVR-EQDIKLPKP 233 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH---HHhh-ccCccCCCC
Confidence 2345678999999753 346789999999999999999 7777754322111 00 0000 011111111
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.+.. .......+++..|| .||++|||+.+|++.|.
T Consensus 234 ~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 11122344667788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=230.89 Aligned_cols=234 Identities=27% Similarity=0.419 Sum_probs=164.4
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCc----EEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDK----EIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
++|+..+.||+|+||.||+|.+. ++. .||+|.+...... .+..+..+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 47888999999999999999853 343 4688887644321 345667788999999999999998754 4679
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
++||+++|+|.+++..... .....+....+++.+|.+.|+ +.+||+|||++..+......
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 9999999999998875432 222334455567777776554 34899999999876432222
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||............. ... .....
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~--~~~~~--- 233 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGE--RLPQP--- 233 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCC--CCCCC---
Confidence 12222345678999999988889999999999999999997 888886432211111110 000 00000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
......+.+++.+||..||++||++.++++.|.....
T Consensus 234 ----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 234 ----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0012345678889999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=225.00 Aligned_cols=216 Identities=25% Similarity=0.411 Sum_probs=154.1
Q ss_pred ceecccCCeeEEEEEEcCCc-----------EEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 57 NKLGEGGFGPVYKGVLNDDK-----------EIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+.||+|+||.||+|...... .+++|.+.... ...+.++..+++.++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999965433 47778765433 3455667788999999999999999988 7789999
Q ss_pred ecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcCCC-------------------------CeEEeeeccceecC
Q 045271 124 EYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDHKM-------------------------NPKISDFGMARVFG 176 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~~~-------------------------~vkL~Dfg~a~~~~ 176 (338)
||+++|+|..++....... ........+++.+|.++|+. .+||+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999987654322 22233445677777775542 38999999987653
Q ss_pred CCCCCccccccccCCccccccccccC--CCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
. .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......... .+.... .
T Consensus 160 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~~--~ 224 (259)
T cd05037 160 S------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQH--R 224 (259)
T ss_pred c------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcCC--C
Confidence 2 1123567789999999876 68999999999999999999 466665432111000 000000 0
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.. .. ....+.+++.+||+.||.+|||+.+|++.|+
T Consensus 225 ~~-----~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 LP-----MP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-----CC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 0145667889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=223.30 Aligned_cols=229 Identities=21% Similarity=0.272 Sum_probs=159.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--------ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--------QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNEL 119 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~ 119 (338)
.+|++.+.||+|+||.||+|.. .++..||||.+..... ..+..|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999995 4588999998753211 234557788999999999999999876 3568
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
++||||+++++|.+++..... ..........+++.++.+.|+ +.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999998865432 222223344556666666543 4589999999876532111
Q ss_pred -CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 -EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........|+..|+|||++.+..++.++|||||||++|+|++|..||........ .. ....... ..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~-~~~~~~~-----~~-- 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----IF-KIATQPT-----NP-- 228 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----HH-HHhcCCC-----CC--
Confidence 1112234688899999999888899999999999999999999999864321111 00 0000000 00
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.........+.+++.+||. +|++|||+.+|++.
T Consensus 229 --~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 --VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111222345668888985 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=224.31 Aligned_cols=228 Identities=25% Similarity=0.309 Sum_probs=154.3
Q ss_pred ceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEE-eCCEEEEEEecCC
Q 045271 57 NKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCL-EGNELLLICEYMP 127 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~ 127 (338)
+.||+|+||.||+|...+ ...||+|.+..... +.+..+..+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998432 34689998754322 23455667889999999999999775 4556889999999
Q ss_pred CCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC--cccc
Q 045271 128 NKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE--ANTN 185 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~--~~~~ 185 (338)
+++|..++........ .......+++.+|.+.|+ +.+||+|||++......... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 9999999865432211 112333467777776554 35899999999765321110 1111
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCC-CCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR-KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...++..|+|||.+.+..++.++|||||||++|+|++|. +||......+ ... ......... ... .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~---~~~~~~~~~--~~~-----~- 226 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV---YLLQGRRLL--QPE-----Y- 226 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHhcCCCCC--CCC-----c-
Confidence 234567899999998888999999999999999999954 4554321111 111 111000000 000 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+++.+||+.||++||++.+|+..|+...
T Consensus 227 --~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 227 --CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0124567888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=222.60 Aligned_cols=230 Identities=18% Similarity=0.168 Sum_probs=161.9
Q ss_pred hHHHHHhcCCCCCcee--cccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHH-hcCCCceeeeeeEEEeCCEE
Q 045271 44 DLIHEATRNFSNENKL--GEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIA-KLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~i--G~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~-~l~hpnIv~~~~~~~~~~~~ 119 (338)
.......++|++.+.+ |+|+||.||++.. .++..+|+|.+........ +..... ..+||||+++++.+...+.+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 4445666788888877 9999999999994 5677899998865432222 111222 23799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------C-CeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------M-NPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~-~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++++|..++.... ...........+++.++.+.|+ + .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999999999999987653 2333445555667777776553 2 5899999998865321
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
....++..|+|||++.+..++.++|||||||++|+|++|..||....... .......... .... ...
T Consensus 164 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------~~~~-~~~ 230 (267)
T PHA03390 164 -----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ------QKKL-PFI 230 (267)
T ss_pred -----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh------cccC-Ccc
Confidence 12467889999999998889999999999999999999999997332211 1111111000 0000 000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPT-MSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~vl~ 294 (338)
......+.+|+.+||+.||.+||+ +.++++
T Consensus 231 -----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 -----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 012234567888899999999996 588874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=228.15 Aligned_cols=235 Identities=22% Similarity=0.261 Sum_probs=161.7
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHhc-CCCceeeeeeEEEeC----
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--GQGLQEFKNLIAKL-QHKNLVRLLGCCLEG---- 116 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~---- 116 (338)
.+....++|++.+.||+|+||.||++.. .+++.+|+|.+.... ......+..+++.+ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 3344577899999999999999999995 567889999986432 23445666777777 899999999998753
Q ss_pred -CEEEEEEecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccc
Q 045271 117 -NELLLICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMA 172 (338)
Q Consensus 117 -~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a 172 (338)
+.+++||||+++++|.+++... ............+++.++.+.|. +.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 4689999999999998887532 11222223344456666665443 45899999998
Q ss_pred eecCCCCCCccccccccCCccccccccccC-----CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEG-----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC 247 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 247 (338)
........ ......|+..|+|||++... .++.++|||||||++|+|++|..||......... ....
T Consensus 176 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~------~~~~- 246 (291)
T cd06639 176 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL------FKIP- 246 (291)
T ss_pred hhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH------HHHh-
Confidence 76532211 11234678899999998643 3688999999999999999999998643211110 0000
Q ss_pred cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...... +... ......+.+++.+||+.||++|||+.+++..
T Consensus 247 ~~~~~~-----~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RNPPPT-----LLHP--EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cCCCCC-----CCcc--cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000 0000 0112246678889999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=222.69 Aligned_cols=225 Identities=27% Similarity=0.335 Sum_probs=162.9
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC--------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS--------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+|+..+.||+|+||.||+|... ++..|++|.+.... ...+..+..+++.++|+||+++++++.+++.+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999955 78899999885432 12355677788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+||+++++|..++..... ..........+++.++.+.| ++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999865442 22223334445666666544 3458999999988753222 1
Q ss_pred ccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....|+..|+|||.+.... ++.++|+|||||++|+|++|..||....... ............... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~-~----- 225 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKELPPIP-D----- 225 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccCCCcC-C-----
Confidence 23456888999999988776 8999999999999999999999986433111 001100000111110 0
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+++.+||+.||++|||+.+++.
T Consensus 226 ---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 ---HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01234466888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=224.05 Aligned_cols=241 Identities=21% Similarity=0.273 Sum_probs=163.2
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|+||.||+|.. .++..||+|.+.... ......+..+++.++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999995 468889999986443 23466777889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+ +++|..++...... .........+++.++.+.|+ +.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYS 158 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cccc
Confidence 9 99999888654322 22233444556666666543 4589999999987643221 1122
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH--------HHhhhccC-Cccccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--------TWKLWCEG-NAQELM 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~ 255 (338)
...++..|+|||++.+. .++.++||||+||++|+|++|.+||.............. .++..... ......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 34688899999998765 468999999999999999999877754321111000000 00000000 000000
Q ss_pred CccccccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 256 DPVLKESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 256 ~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.. ....... .....+.+++.+||+.||++|||+++++..
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 239 FP-ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CC-CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000 112456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=227.09 Aligned_cols=222 Identities=24% Similarity=0.279 Sum_probs=164.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++.+.||+|+||.||++... +++.||+|.+.... .+....++++++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999954 57889999986432 234556778899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++++|.+++..... ..........+++.+|.+.|+ +.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999988865532 222333444567777766553 45899999999875322 2
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||............ ..... .+....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~--~~~~~~----- 221 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-------LEGKV--RFPSFF----- 221 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCc--cCCccC-----
Confidence 3357889999999998888899999999999999999999998643311110000 00000 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
...+.+++.+||+.||.+|+ +++|++.
T Consensus 222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 23445688889999999999 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=224.13 Aligned_cols=230 Identities=23% Similarity=0.316 Sum_probs=165.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++.+.||.|+||.||++... +++.+|+|.+..... ..+.++..+++.++||||+++++.+...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999964 578899998865432 2345667788899999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++++|.+++..... ..........+++.++.+.|+ +.++|+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----A 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----h
Confidence 999999999875422 222233455567777777666 248999999987652111 1
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....++..|+|||.+.+..++.++|||||||++|+|++|..||........ .......... ...... +...
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~-----~~~~-- 227 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEPPPR-----LPSG-- 227 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh-cCCCCC-----CChh--
Confidence 125688899999999988999999999999999999999999864321111 1111110000 000000 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.++|.+||..||++|||+.+++.
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 -KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 01224567888999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=224.18 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=161.2
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHhc-CCCceeeeeeEEEeCC------E
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG--QGLQEFKNLIAKL-QHKNLVRLLGCCLEGN------E 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~------~ 118 (338)
..++|++.+.||+|++|.||+|... ++..+++|.+..... +.+..+..+++.+ +|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 3579999999999999999999964 567899998865432 4466677788887 7999999999997643 5
Q ss_pred EEEEEecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceec
Q 045271 119 LLLICEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVF 175 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~ 175 (338)
+++||||+++++|.+++.... ...........+++.++.+.|+ +.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 899999999999988876432 1222233445557777766554 45899999998765
Q ss_pred CCCCCCccccccccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
.... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||....... ... ... ...
T Consensus 164 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~-~~~ 234 (275)
T cd06608 164 DSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALF----KIP-RNP 234 (275)
T ss_pred ccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHH----Hhh-ccC
Confidence 3221 12233568889999998864 246788999999999999999999986322111 000 000 000
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. .+.. .......+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~-----~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 PP-----TLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CC-----CCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 0110 0111234567888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=226.77 Aligned_cols=226 Identities=20% Similarity=0.265 Sum_probs=155.8
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc----c-HHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ----G-LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~-~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... . ..++...++.++||||+++++++..++.++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4789999999999999999995 46889999998654321 1 2222334677899999999999999999999999
Q ss_pred cCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCC
Q 045271 125 YMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
|++ |+|..++.... ......+....+++.++.+.|+ +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-- 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--
Confidence 995 77777665421 1222233455667777777664 24899999999865321
Q ss_pred CccccccccCCcccccccccc----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 181 EANTNRVVGTYGYMAPEYALE----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|..||..... ...... ... .........
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~---~~~-~~~~~~~~~ 230 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLK---QVV-EEPSPQLPA 230 (283)
T ss_pred -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHH---HHH-hcCCCCCCc
Confidence 11222467889999998865 4468899999999999999999999853211 100000 000 000000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. .....+.+++.+||+.||.+|||+.+++.
T Consensus 231 ~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 E--------KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01124567888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=229.94 Aligned_cols=237 Identities=16% Similarity=0.197 Sum_probs=164.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||++... +++.|++|.+..... ..+..++.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 37899999999999999999954 477899998864321 23446677889999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC-----
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ----- 179 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~----- 179 (338)
||+++++|..++..... ..........+++.++.+.|+ +.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999865432 222222333456666665443 458999999986321000
Q ss_pred --------CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 180 --------SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 180 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
.........++..|+|||.+.+..++.++|+|||||++|+|++|..||......+. .. ... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~---~~---~~~-~~~~ 233 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FG---QVI-SDDI 233 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHH-hccc
Confidence 00011124578889999999888899999999999999999999999864322111 00 000 0000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.. ..... .....+.+++.+||+.||++|||+.++++.|+..+-
T Consensus 234 ~~---~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 234 EW---PEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred CC---CCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 00 00000 111234678889999999999998777777777553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=229.45 Aligned_cols=245 Identities=19% Similarity=0.239 Sum_probs=160.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN----- 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~----- 117 (338)
..++|++.++||+|+||.||+|.. .+++.||||.+..... .....++.+++.++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345899999999999999999995 4588899998854321 12345778899999999999999987543
Q ss_pred ---EEEEEEecCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeecccee
Q 045271 118 ---ELLLICEYMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARV 174 (338)
Q Consensus 118 ---~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~ 174 (338)
..++||||+. ++|...+.... ...........+++.++.+.|+ +.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4699999995 57777665442 2233334555667777776554 3489999999986
Q ss_pred cCCCCCC--ccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 175 FGGNQSE--ANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 175 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
....... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||........................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6332211 1112345788899999887654 788999999999999999999988653322111111110000000000
Q ss_pred c-----cccCcc-ccccc---------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 252 Q-----ELMDPV-LKESF---------ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 252 ~-----~~~~~~-~~~~~---------~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ...... ..... .......+.+|+.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000 00000 0001124567999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=224.10 Aligned_cols=240 Identities=22% Similarity=0.263 Sum_probs=160.1
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ....+|+.+++.++|+||+++++++..++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 36899999999999999999994 4688999999864322 234567788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+. +++...+..... ..........+++.++.++|+ +.++|+|||++....... ...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCC
Confidence 995 666665543322 122223344567777776554 458999999987643211 112
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc-------------cCC
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC-------------EGN 250 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------~~~ 250 (338)
....++..|+|||++.+. .++.++|||||||++|+|++|..||....... ......+.... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 234578899999998764 57889999999999999999999986432110 00000000000 000
Q ss_pred cccccCcccccc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 AQELMDPVLKES-----FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
............ ........+.+++.+||+.||.+|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 00011234567888999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=227.39 Aligned_cols=217 Identities=24% Similarity=0.373 Sum_probs=152.8
Q ss_pred ceecccCCeeEEEEEEcC--------CcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 57 NKLGEGGFGPVYKGVLND--------DKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+.||+|+||.||+|.... ...+++|.+..... +.+.++..+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998532 22477887754332 3456677788999999999999999998999999999
Q ss_pred CCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCCCC--------------------------eEEeeeccceecCC
Q 045271 126 MPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHKMN--------------------------PKISDFGMARVFGG 177 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~~~--------------------------vkL~Dfg~a~~~~~ 177 (338)
+++|+|..++........ .......+++.++.+.|+.+ ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 999999999876543222 22334556777777766432 58899998865421
Q ss_pred CCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCC-CCCcccccccccchhhHHHhhhccCCccccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGR-KDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
.....++..|+|||++.+. .++.++|||||||++|+|++|. .||........ ... . ... ....
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~----~-~~~-~~~~ 225 (258)
T cd05078 161 ------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQF----Y-EDR-HQLP 225 (258)
T ss_pred ------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHH----H-Hcc-ccCC
Confidence 1234678899999999874 5789999999999999999985 45432211110 000 0 000 0000
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
. .....+.+++.+||+.||++|||++++++.|+
T Consensus 226 ~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 A---------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred C---------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01124567888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-29 Score=220.30 Aligned_cols=228 Identities=26% Similarity=0.325 Sum_probs=159.3
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.......||+|+||.||+|.. .++..|++|.+..... ..+.+|+.+++.++|+||+++++++..++.+++|+||++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 344456899999999999994 4567899998865543 345677788999999999999999999999999999999
Q ss_pred CCCHHHHHhccCccc----cccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCccc
Q 045271 128 NKSLDFLLFDSTRSV----QLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~----~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++|..++....... ........+++.++.+.|+ +.++|+|||++........ ..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence 999999887542211 1222334456666666443 3589999999876532221 12
Q ss_pred cccccCCccccccccccCC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 185 NRVVGTYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
....|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......... .+.......... +.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~-~~------ 234 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKVGMFKIHPE-IP------ 234 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----HhhhhhhccCCC-CC------
Confidence 2345788999999987653 788999999999999999999998642211100 000000000000 00
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
......+.+|+.+||+.+|.+|||+.+++..
T Consensus 235 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 --ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0112345678889999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=223.89 Aligned_cols=226 Identities=23% Similarity=0.342 Sum_probs=163.0
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-----CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-----SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||.|+||.||+|.. .++..||+|.+... ..+.+..|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588899999999999999995 45788999998543 223456778899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+++++|.+++..... ..........+++.++.+.|+. .++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--L 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--c
Confidence 999999988865332 1222233444566666665432 269999999876642211 1
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......... .. ........ ..
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~-~~------ 224 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL------KI-CQGYFAPI-SP------ 224 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------HH-hcccCCCC-CC------
Confidence 223468889999999988889999999999999999999999986432211100 00 00000000 00
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+++.+||+.+|++|||+.+++..
T Consensus 225 --~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 --NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011245678889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=221.52 Aligned_cols=226 Identities=23% Similarity=0.321 Sum_probs=163.7
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 123 (338)
+|++++.||.|+||.||++.. .++..||+|.+..... +.+..++.+++.++||||+++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999994 5678899998864321 234556778999999999999998764 45689999
Q ss_pred ecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcC-----C------------------CCeEEeeeccceec
Q 045271 124 EYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDH-----K------------------MNPKISDFGMARVF 175 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~-----~------------------~~vkL~Dfg~a~~~ 175 (338)
||+++++|..++.... ......+....+++.++.+.| + +.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999998886531 122233445566777777777 3 34899999999876
Q ss_pred CCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. ......... +
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~~-~ 230 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL---AS----KIKEGKFRR-I 230 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH---HH----HHhcCCCCC-C
Confidence 43221 12235688999999999988899999999999999999999999865331111 00 001111100 0
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.......+.+++.+||+.||++|||+.+|++.
T Consensus 231 --------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 --------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01112345678889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=220.60 Aligned_cols=230 Identities=24% Similarity=0.382 Sum_probs=164.1
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|+||.||+|.. .++..|++|.+..... ..+..+..+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999995 4678899999865433 2456677789999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc--c
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN--T 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~--~ 184 (338)
+++++|.+++..... ..........+++.++.+.|+ +.+||+|||++........... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 999999999876532 223333444556666665443 4589999999887643222111 1
Q ss_pred cccccCCccccccccccCC---CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYALEGL---FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~---~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....++..|+|||++.+.. ++.++||||||+++|+|++|..||....... ........ ..... +...
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~~~~-~~~~--- 230 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGA-GHKPP-IPDS--- 230 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhc-CCCCC-CCcc---
Confidence 1346788999999998766 8899999999999999999999986432111 11111000 00000 1110
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+++.+||+.||.+|||+.+++.
T Consensus 231 ---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 ---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111223457888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=226.53 Aligned_cols=242 Identities=20% Similarity=0.238 Sum_probs=160.6
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC--CEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~~l 121 (338)
.++|++.+.||+|+||.||+|.. .++..||+|.+..... .....|+.+++.++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46899999999999999999995 4588999999864322 1245678899999999999999998754 56899
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+. ++|..++..... ..........+++.+|.+.|+ +.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-- 162 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-- 162 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--
Confidence 999995 578777654322 222334455566776666543 458999999998764321
Q ss_pred ccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhhccCCcc
Q 045271 182 ANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLWCEGNAQ 252 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~ 252 (338)
.......++..|+|||++.+ ..++.++||||+||++|+|++|..||......+......... +........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 11122345778999999876 458899999999999999999999987433222111111000 000000000
Q ss_pred ccc--C-ccccc-ccc-HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 ELM--D-PVLKE-SFI-LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~~--~-~~~~~-~~~-~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+ . ..... ... ......+.++|.+||++||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0 00000 000 001234567899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=220.30 Aligned_cols=230 Identities=24% Similarity=0.320 Sum_probs=168.0
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++.+.||+|++|.||+|... +++.|++|.+..... ..+..+...++.++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999955 588999999865532 3456667788899999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC-C------------------CeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK-M------------------NPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~-~------------------~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+++++|..++.... ......+....+++.++.+.|+ . .++|+|||++......... ..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--cc
Confidence 99999999987532 2333334555567777777776 3 4899999999876432221 12
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||............. . ........ ... .
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~-~~~~~~~~-~~~----~--- 226 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---A-ICDGPPPS-LPA----E--- 226 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---H-HhcCCCCC-CCc----c---
Confidence 3467889999999988889999999999999999999999986543211111110 0 00011000 000 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01234566888899999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=233.15 Aligned_cols=178 Identities=25% Similarity=0.272 Sum_probs=136.0
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC-----
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG----- 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~----- 116 (338)
...++|++.+.||+|+||.||+|.. .++..||+|.+.... ......++.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4568999999999999999999994 468899999986432 12344677889999999999999998643
Q ss_pred -CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCC
Q 045271 117 -NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 117 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~ 177 (338)
...|+||||+. ++|...+... ...........+++.++.++|. +.+||+|||++.....
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999994 5777766543 2222333445556666666543 4589999999987532
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
. .......++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 171 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 171 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred C---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 1 1122346788999999999989999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=224.38 Aligned_cols=226 Identities=20% Similarity=0.198 Sum_probs=165.5
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
+|++.+.||.|+||.||+|... ++..||+|.+.... .+.+.+|.++++.++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999954 58889999986432 2345667778999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcc-CccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDS-TRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|+.+++|..++... ............++++++.+.|+ +.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 99999999988765 33333344455567777766554 458999999988753321 122
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||............. .... .... .. .
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~-~~~~-~~--------~ 223 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET-ADVL-YP--------A 223 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc-cccc-Cc--------c
Confidence 3568889999999988889999999999999999999999987543211111100 0000 0000 00 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTM--SSVVF 294 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~--~~vl~ 294 (338)
.....+.+++.+||+.||.+||++ .|++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 111455678889999999999999 76653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=225.25 Aligned_cols=231 Identities=23% Similarity=0.307 Sum_probs=168.9
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
...+.|++...||+|.+|.||+|... ++..|++|.+.... ......+..+++.++|+||+++++.+...+..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34567999999999999999999965 67889999987544 3445667788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|.+++.... ...........+++.++.+.|+ +.++|+|||++....... ...
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~ 173 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKR 173 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhh
Confidence 999999999998764 2333334455667777776553 358999999887553221 112
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||........... .. ........ ..
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~~~~-----~~-- 239 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------IT-TKGIPPLK-----NP-- 239 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hcCCCCCc-----ch--
Confidence 234578899999999888899999999999999999999999864322111000 00 00000000 00
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001124567888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=226.07 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=162.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC--CEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 122 (338)
++|++.+.||+|.||.||+|... +++.+++|.++.... ....+|..+++.++||||+++++++... +.+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999954 578899999864322 1234677889999999999999999877 889999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||++ ++|..++..... ..........+++.+|.++|+ +.++|+|||++....... .
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--K 161 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--c
Confidence 99996 588887765432 223334455567777666553 458999999998764321 1
Q ss_pred cccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------Hhhhcc-----
Q 045271 183 NTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCE----- 248 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~----- 248 (338)
......++..|+|||.+.+.. ++.++||||+||++|+|++|..||......+........ +..+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 122345788999999987654 689999999999999999999998754322111111000 000000
Q ss_pred -CCcccccCccccccccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 -GNAQELMDPVLKESFILE-ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 -~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..........+....... ....+.+++.+||+.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000000 1234567889999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=234.22 Aligned_cols=245 Identities=20% Similarity=0.231 Sum_probs=162.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC-----CEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG-----NEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~~~ 119 (338)
.++|++.++||+|+||.||+|.. .++..||+|.+..... .....|..+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999994 5688999999853221 2345577889999999999999987654 358
Q ss_pred EEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
++|+||+. +++..++...............+++.++.+.|+ +.+||+|||++.........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 99999994 688777765544444444555567777666543 45899999999765322211
Q ss_pred c-cccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc--
Q 045271 182 A-NTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP-- 257 (338)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 257 (338)
. ......|+..|+|||.+.+ ..++.++||||+||++|+|++|..||..........................+...
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 1 1123468899999998765 46889999999999999999999998643221110000000000000000000000
Q ss_pred -----ccc--ccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 258 -----VLK--ESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 258 -----~~~--~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
... ..... .....+.++|.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000 112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=242.80 Aligned_cols=182 Identities=19% Similarity=0.251 Sum_probs=129.4
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcC--CcEEEEE------------------EeccC--CcccHHHHHHHHHhcC
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLND--DKEIAVK------------------RLSRS--SGQGLQEFKNLIAKLQ 102 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK------------------~~~~~--~~~~~~~~~~~l~~l~ 102 (338)
....+.++|++++.||+|+||.||+|.... +...++| .+... ....+..|+.+++.++
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 335567899999999999999999987432 1112222 11111 1123556788999999
Q ss_pred CCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHhccCcc------ccccHHHHHHHHHHhhhcC----------------
Q 045271 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRS------VQLDWNRRMCIINGIARDH---------------- 160 (338)
Q Consensus 103 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~~~---------------- 160 (338)
||||+++++++.+.+..|+|++++ .++|..++...... ......+..+++.+|.++|
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 999999999999999999999999 45666655432211 1112234455666666655
Q ss_pred --CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCc
Q 045271 161 --KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 161 --~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
++.+||+|||++..+..... .......||..|+|||++.+..|+.++|||||||++|||++|..++.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 34589999999987643221 12224579999999999999899999999999999999999886443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=221.28 Aligned_cols=229 Identities=21% Similarity=0.287 Sum_probs=149.0
Q ss_pred ceecccCCeeEEEEEEcCCc---EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 57 NKLGEGGFGPVYKGVLNDDK---EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~---~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.||+|+||.||+|...++. .+++|.+..... ..+..+..+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999844433 356676654322 23555666788899999999999999999999999999999
Q ss_pred CHHHHHhccCcc-ccc----cHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 130 SLDFLLFDSTRS-VQL----DWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 130 ~L~~~l~~~~~~-~~~----~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+|..++...... ... ......+++.+|.+.|+ +.++|+|||++..............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999988654221 111 12334456667666553 3489999999864321111111223
Q ss_pred cccCCcccccccccc-------CCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 187 VVGTYGYMAPEYALE-------GLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~-------~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
..++..|+|||++.. ..++.++|||||||++|+|++ |..||......+..... . ........++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~-~~~~~~~~~~~ 233 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------I-KDQQVKLFKPQ 233 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H-hhcccccCCCc
Confidence 567889999998853 235789999999999999997 45676432221111100 0 11111112221
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
+... ....+.+++..|| .||++|||+++|++.|.
T Consensus 234 ~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111 1123455777899 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=248.33 Aligned_cols=237 Identities=29% Similarity=0.349 Sum_probs=170.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc--C------CcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN--D------DKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCL 114 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~--~------~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~ 114 (338)
...++..+.+.||+|.||.|++|... . ...||||.++.... +.+..|..+++.+ .|+||+.+++++.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33445567779999999999999822 1 33589999875433 3566677777776 4999999999999
Q ss_pred eCCEEEEEEecCCCCCHHHHHhccC-----------------ccccccHHHHHHHHHHhhhcCC----------------
Q 045271 115 EGNELLLICEYMPNKSLDFLLFDST-----------------RSVQLDWNRRMCIINGIARDHK---------------- 161 (338)
Q Consensus 115 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~~~~~~i~~~~~---------------- 161 (338)
....+++|+|||..|+|..+++... ......+....|++.|+.++.+
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 9999999999999999999998776 2222335566778888776433
Q ss_pred --CCeEEeeeccceecCCCCCCccccccc--cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCccccccccc
Q 045271 162 --MNPKISDFGMARVFGGNQSEANTNRVV--GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQ 236 (338)
Q Consensus 162 --~~vkL~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~ 236 (338)
..+||+|||+|+........... ... -+..|||||.+....|+.++|||||||+|||+++ |..||+.......
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~- 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE- 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH-
Confidence 34899999999976433332211 112 2456999999999999999999999999999998 8888865221111
Q ss_pred chhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.. ... ...-+...+..+..+.+++|+.||+.+|++||+|.++.+.|+...
T Consensus 531 -l~----~~l---------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 -LL----EFL---------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -HH----HHH---------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 01 001 111111112222345678999999999999999999999998843
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=224.82 Aligned_cols=238 Identities=23% Similarity=0.281 Sum_probs=159.3
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++++.||.|++|.||+|... ++..||||.+..... ..+..|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999954 578899998864321 3456788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+. ++|..++..... ..........+++.++.+.| ++.+||+|||++........ ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence 95 678777754322 22223344455666666644 34589999999876532211 12
Q ss_pred cccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC-----------Ccc
Q 045271 185 NRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG-----------NAQ 252 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 252 (338)
....++..|+|||++.+.. ++.++|||||||++|+|++|..||............ ........ ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhCCCChhhhhhhhHHHHHH
Confidence 2235678899999887654 688999999999999999999998643221110000 00000000 000
Q ss_pred cccCcccccc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 ELMDPVLKES---FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+....... ........+.+++.+||+.||.+|||+++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 00001123567899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=216.14 Aligned_cols=230 Identities=26% Similarity=0.371 Sum_probs=167.1
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC--CEEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG--NELLLIC 123 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 123 (338)
+|.+.+.||+|++|.||+|... ++..|++|.+.... .+.+..+...++.++||||+++++.+... +.+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999965 68889999986554 34566777889999999999999999988 8999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++++|.+++..... .....+....+++.++.++| ++.++|+|||.+............
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99999999998876532 22223344455666666544 356899999999876443221112
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ......+.............
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-------- 227 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPEIPE-------- 227 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcCCCc--------
Confidence 33568889999999988889999999999999999999999986543 01111111110001111110
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+|+.+||+.||++||++.+++..
T Consensus 228 -~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 -HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 112356678889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=225.48 Aligned_cols=224 Identities=25% Similarity=0.324 Sum_probs=157.5
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+.|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+..|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35799999999999999999995 4688899998854321 2355677789999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+. |++.+++..... ..........+++.++.+.|+ +.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 99995 666665543222 222223344456666666553 4589999999876421
Q ss_pred cccccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 183 NTNRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....++..|+|||++. ...++.++||||||+++|+|++|..||........ ..... ........
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~-~~~~~~~~---- 235 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDSPTLS---- 235 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHh-cCCCCCCC----
Confidence 12346788999999885 34588999999999999999999999854321110 00000 00000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.......+.+++.+||+.||++|||+.+|+..
T Consensus 236 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 ----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00112346778889999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=226.93 Aligned_cols=179 Identities=26% Similarity=0.370 Sum_probs=133.8
Q ss_pred CCCCCceecccCCeeEEEEEEc---CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeC--CEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEG--NELL 120 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~~ 120 (338)
+|++.++||+|+||.||+|... .+..||+|.+.... ......++.+++.++||||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5888999999999999999954 47889999987632 23456677889999999999999999987 8899
Q ss_pred EEEecCCCCCHHHHHhccCc------cccccHHHHHHHHHHhhhcC----------------------CCCeEEeeeccc
Q 045271 121 LICEYMPNKSLDFLLFDSTR------SVQLDWNRRMCIINGIARDH----------------------KMNPKISDFGMA 172 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~i~~~~----------------------~~~vkL~Dfg~a 172 (338)
+||||++ +++..++..... .....+....+++.+|.+.| ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 466555543221 11223344556666666533 456999999999
Q ss_pred eecCCCCC-CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccc
Q 045271 173 RVFGGNQS-EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYL 231 (338)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~ 231 (338)
........ ........++..|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 87533221 1112234678899999988764 58899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=223.16 Aligned_cols=227 Identities=21% Similarity=0.280 Sum_probs=162.9
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.|...+.||+|++|.||++.. .++..+++|.+..... +.+.+++.+++.++||||+++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455668999999999999994 5678899998854332 235567778899999999999999999999999999999
Q ss_pred CCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 128 NKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
+++|.+++...............+++.++.+.|+ +.++|+|||.+....... .......|
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~ 177 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVG 177 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccC
Confidence 9999998876433333334455556666666443 458999999887653221 11223468
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+..|+|||++.+..++.++|||||||++|+|++|..||............ .... ........ ....
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~~~~~--~~~~ 243 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------RDNL-----PPKLKNLH--KVSP 243 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-------HhcC-----CCCCcccc--cCCH
Confidence 89999999998888999999999999999999999998642211110000 0000 00010000 0113
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 270 KRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+.+|+.+||+.||++|||+.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 4677888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=236.97 Aligned_cols=218 Identities=22% Similarity=0.246 Sum_probs=149.9
Q ss_pred ecccCCeeEEEEEE-cCCcEEEEEEeccCCc---c---cHHHHHHHHHhc---CCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 59 LGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---Q---GLQEFKNLIAKL---QHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 59 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~---~~~~~~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
||+|+||.||+|.. .++..||+|.+..... . ....+..++... +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999995 4588899999854321 1 112233344433 799999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|+|...+..... ..........+++.+|.+.|+ +.+||+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCccCccC
Confidence 999888765433 223334445567777776543 45899999998754221 122234679
Q ss_pred CCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 190 TYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 190 t~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
|..|+|||++.+. .++.++|||||||++|+|++|..||......+....+. .... ...... ..
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~-~~~~~~--------~~ 222 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA-------FGKV-RFPKNV--------LS 222 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH-------cCCC-CCCCcc--------CC
Confidence 9999999999765 48999999999999999999999986533221111110 0000 001000 01
Q ss_pred HHHHHHHhhccCCCCCCCC----CHHHHHH
Q 045271 269 LKRIHIGLLCVQEDPADRP----TMSSVVF 294 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rp----s~~~vl~ 294 (338)
..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 2345688899999999998 5677765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=222.40 Aligned_cols=240 Identities=25% Similarity=0.286 Sum_probs=160.8
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
+|++.+.||.|++|.||+|... ++..||||.+.... ......|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999964 57889999986442 234456778899999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 127 PNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 127 ~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+ ++|..++..... ..........+++.++.+.|+ +.++|+|||++........ ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 157 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TF 157 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cc
Confidence 6 578777755432 222223344556666666543 4589999999976532111 11
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC------CcccccCc
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG------NAQELMDP 257 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 257 (338)
....++..|+|||++.+. .++.++|||||||++|+|++|..||......+............... ........
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 224568889999998764 47889999999999999999999987543221111110000000000 00000000
Q ss_pred ccccc------ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKES------FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~------~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..... ........+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00011234568899999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=223.81 Aligned_cols=237 Identities=23% Similarity=0.272 Sum_probs=159.9
Q ss_pred CCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 53 FSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
|++.+.||.|.+|.||+|.. .++..||+|.+.... ......|+.+++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999995 468899999886432 123556788999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
.++|..++.... ...........+++.+|.++|+ +.++|+|||++........ ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~ 157 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYT 157 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccC
Confidence 468888876543 2223334455566777666543 4589999999976532211 112
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC-----------Cccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG-----------NAQE 253 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~ 253 (338)
...++..|+|||++.+. .++.++|||||||++|+|++|..||............ ........ ....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI--FRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChHHhhhhhhchhhhh
Confidence 23567889999988765 5789999999999999999999998643221110000 00000000 0000
Q ss_pred ccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........ .........+.+++.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 000011134667899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=222.90 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=190.0
Q ss_pred CCCChhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHH--hcCCCceeeeeeEEEeC
Q 045271 39 PLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIA--KLQHKNLVRLLGCCLEG 116 (338)
Q Consensus 39 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~--~l~hpnIv~~~~~~~~~ 116 (338)
.-.|+-......+...+.+.||+|.||.||+|.+ .|..||||++.........+|.++.+ .|+|+||+.+++.-..+
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 3456667788888999999999999999999998 57789999998888888888888775 57999999999987643
Q ss_pred ----CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC--------------------------CCCeEE
Q 045271 117 ----NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH--------------------------KMNPKI 166 (338)
Q Consensus 117 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~--------------------------~~~vkL 166 (338)
.++|+|.+|-+.|+|.+++..........+..++.++.||+|+| ++...|
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 36899999999999999998877766667777778888888865 234789
Q ss_pred eeeccceecCCCC--CCccccccccCCccccccccccCC----C-Cc-ccchHhHhHHHHHHHhCC----------CCCc
Q 045271 167 SDFGMARVFGGNQ--SEANTNRVVGTYGYMAPEYALEGL----F-SV-KSDVFSFGVLLLEIISGR----------KDTR 228 (338)
Q Consensus 167 ~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~-~~-~~DiWSlGv~l~el~~g~----------~Pf~ 228 (338)
+|+|+|....... .....+..+||..|||||++...- | +. .+||||||.++||++-.. .||+
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998765432 123344568999999999997532 3 23 499999999999997532 4666
Q ss_pred ccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 229 FYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.....+.. .....+..........++..... -+.+..+.++|+.||..||.-|.||--|-+.|.+...
T Consensus 438 d~Vp~DPs--~eeMrkVVCv~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPS--FEEMRKVVCVQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCC--HHHHhcceeecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 43322221 11122222222222222222222 2445567789999999999999999999988887653
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=221.80 Aligned_cols=231 Identities=20% Similarity=0.268 Sum_probs=160.1
Q ss_pred CCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 045271 53 FSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN------ 117 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~------ 117 (338)
|++.+.||+|+||.||+|... ++..||||.+..... +....|..+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677899999999999999843 357899999865432 23456778899999999999999886532
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccc
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMA 172 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a 172 (338)
..++++||+.+|+|..++..... ..........+++.++.+.|+ +.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34789999999999877643211 111224445566677766553 45899999999
Q ss_pred eecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
................++..|++||.+.+..++.++|||||||++|+|++ |..||......+. .... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~---~~~~~~ 234 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYL---IKGNRL 234 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHH---HcCCcC
Confidence 86532221111222345678999999988889999999999999999999 8888764322111 0000 000000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.. .......+.+++.+||+.+|++|||+.+++..|+..
T Consensus 235 ~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 KQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011123567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=222.80 Aligned_cols=240 Identities=21% Similarity=0.220 Sum_probs=161.2
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC--CEEEEEEe
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG--NELLLICE 124 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e 124 (338)
|++.+.||.|+||.||+|... +++.+|+|.+.... ......++.+++.++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999965 47889999987542 12355677889999999999999999987 89999999
Q ss_pred cCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++ ++|..++.... ...........+++.++.++| ++.++|+|||++......... ..
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DY 158 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cc
Confidence 996 58887776542 222333445556666666644 345899999999876433211 11
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc--------cc
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE--------LM 255 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 255 (338)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||.......................... ..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 223567889999987754 578999999999999999999999865432211111100000000000000 00
Q ss_pred CccccccccH----H--HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFIL----E--ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~----~--~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......... . ....+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 0 1335678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=224.83 Aligned_cols=241 Identities=23% Similarity=0.269 Sum_probs=159.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++.+.||+|.+|.||+|... +++.||+|.+..... ..+..++.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999954 678899998854321 345667889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcc---ccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCCc
Q 045271 125 YMPNKSLDFLLFDSTRS---VQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|++ ++|...+...... .........+++.++.+.|+. .+||+|||++....... .
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--R 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--c
Confidence 995 5776666443221 112223445677777765532 37999999997653211 1
Q ss_pred cccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH-----Hhhhcc-CCcccc-
Q 045271 183 NTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT-----WKLWCE-GNAQEL- 254 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~- 254 (338)
......++..|+|||++.+. .++.++||||+||++|+|++|..||......+........ ...+.. ......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 11234568899999998764 5789999999999999999999998643221111000000 000000 000000
Q ss_pred --cCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 255 --MDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 255 --~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....... .........+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000011224567889999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=215.14 Aligned_cols=227 Identities=25% Similarity=0.355 Sum_probs=165.6
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
+|++.+.||+|++|.||++... ++..+++|.+..... .....+...++.++|+||+++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4888999999999999999964 678899999865543 446677788999999999999999999999999999999
Q ss_pred CCCHHHHHhccC--ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDST--RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|.+++.... ...........+++.++.+.|+ +.++|+|||.+........ ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTM 157 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccce
Confidence 999999887652 2222333344456666665443 4589999999987643221 2345
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||............. .......... . ..
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~-----~--~~ 223 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------TNGPPGLRNP-----E--KW 223 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------hcCCCCcCcc-----c--cc
Confidence 68889999999988888999999999999999999999986432111110000 0111111100 0 01
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+.+++.+||+.||.+|||+.++++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2345678889999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=230.85 Aligned_cols=246 Identities=19% Similarity=0.230 Sum_probs=163.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhc-CCCceeeeeeEEEe--CCE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKL-QHKNLVRLLGCCLE--GNE 118 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l-~hpnIv~~~~~~~~--~~~ 118 (338)
.+.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+..+++.+ +||||+++++++.. +..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678999999999999999999954 57789999875321 12345577788999 99999999999864 346
Q ss_pred EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+++||||++ ++|..++...............+++.+|.++|+ +.+||+|||++........
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 899999996 688888765432322333455566777766554 4589999999986643221
Q ss_pred C---ccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh--------hcc
Q 045271 181 E---ANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL--------WCE 248 (338)
Q Consensus 181 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 248 (338)
. .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||......+........... ...
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1 12223568889999998865 45788999999999999999999998643221111110000000 000
Q ss_pred CCcccccCccccc------cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKE------SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
............. .........+.+++.+||+.||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0000000000000 000001235677899999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=221.82 Aligned_cols=239 Identities=19% Similarity=0.210 Sum_probs=156.7
Q ss_pred CCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc----cHHHHHHHHHhc-CCCceeeeeeEEEeC--CEEEEEEe
Q 045271 53 FSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ----GLQEFKNLIAKL-QHKNLVRLLGCCLEG--NELLLICE 124 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~e 124 (338)
|++.++||+|+||.||+|.. .++..||+|.+...... ....+..+++.+ +|+||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999994 46788999988653221 122455566666 499999999999987 88999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
|++ +++...+..... ..........+++.++.++|. +.+||+|||++..+..... ..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~---~~ 156 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPP---YT 156 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCC---cC
Confidence 996 577666654322 223334455567777766543 4589999999987632221 12
Q ss_pred ccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccCCccc-cc
Q 045271 186 RVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEGNAQE-LM 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~ 255 (338)
...++..|+|||.+.. ..++.++|||||||++|+|++|..||......+........ ........... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3467889999998754 45788999999999999999999999653221110000000 00000000000 00
Q ss_pred Cccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 256 DPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 256 ~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...... .........+.+++.+||+.||++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0001123467789999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=222.79 Aligned_cols=229 Identities=22% Similarity=0.303 Sum_probs=154.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|+..+.||+|+||.||++.. .++..||+|.+..... ..+..+..++..+. |+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3677788999999999999995 4578899999864322 23445666677775 9999999999999999999999
Q ss_pred cCCCCCHHHHHh---c---cCccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCC
Q 045271 125 YMPNKSLDFLLF---D---STRSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 125 ~~~~g~L~~~l~---~---~~~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
|+. +++..+.. . .............+++.++.+.|. +.++|+|||++..+....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 985 45543321 1 111222233444556666666542 348999999997653221
Q ss_pred CCccccccccCCccccccccccC---CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 180 SEANTNRVVGTYGYMAPEYALEG---LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
......|+..|+|||++.+. .++.++|||||||++|+|++|..||.... ......... .......
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~--- 230 (288)
T cd06616 163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV-VKGDPPI--- 230 (288)
T ss_pred ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh-cCCCCCc---
Confidence 11234678899999999876 58899999999999999999999986432 000000000 0000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+...........+.+|+.+||+.||++|||+.+|+.
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 --LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred --CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111112335677888999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=221.53 Aligned_cols=239 Identities=23% Similarity=0.256 Sum_probs=162.0
Q ss_pred CCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 53 FSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
|++.+.||+|++|.||+|.. .+++.+++|.+..... .....+..+++.++|+||+++++++.+++.+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999995 4678899999865432 24556777889999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 127 PNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 127 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+ +++..++..... ..........+++.++.+.|. +.++|+|||.+....... .....
T Consensus 81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~ 157 (283)
T cd05118 81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTH 157 (283)
T ss_pred C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccC
Confidence 6 577777765422 222334455566777666543 458999999998764332 11222
Q ss_pred cccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC---------
Q 045271 187 VVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD--------- 256 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 256 (338)
..++..|+|||.+.+. .++.++|+||+|+++|+|++|..||......+......................
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4577889999999876 688999999999999999999999864332111111000000000000000000
Q ss_pred --c-ccc-ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 --P-VLK-ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 --~-~~~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ... ..........+.+|+.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 000 0001112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=231.05 Aligned_cols=244 Identities=19% Similarity=0.206 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeC---------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEG--------- 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~--------- 116 (338)
..+|++.+.||.|+||.||+|.. .+++.||+|.+..... ....+++.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999995 4578899999865432 3456678889999999999999876543
Q ss_pred -----CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccc
Q 045271 117 -----NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMA 172 (338)
Q Consensus 117 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a 172 (338)
...++||||++ ++|..++...............+++.++.+.|+. .++|+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35799999995 6888887655444444555566777777665532 3799999999
Q ss_pred eecCCCCCCc-cccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh-----
Q 045271 173 RVFGGNQSEA-NTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL----- 245 (338)
Q Consensus 173 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~----- 245 (338)
..+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||................+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 7653211111 1122357889999998765 45888999999999999999999999643221111000000000
Q ss_pred --hccCCcccccC-ccccccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 --WCEGNAQELMD-PVLKESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 --~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........... ......... .....+.+|+.+||+.||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000 000000001 11234668999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=222.86 Aligned_cols=245 Identities=22% Similarity=0.260 Sum_probs=161.0
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN---- 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~---- 117 (338)
...++|++.+.||+|+||.||+|... +++.||+|.+..... .....|..+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999964 578899999864321 23456778899999999999999987654
Q ss_pred ------EEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeecc
Q 045271 118 ------ELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGM 171 (338)
Q Consensus 118 ------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~ 171 (338)
.+++|+||+++ ++..++..... ..........+++.+|.++|+ +.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999965 66666554322 223334455567777776553 4589999999
Q ss_pred ceecCCCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
+........ .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.......................
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 163 ARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred cccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 986632221 111223457789999988754 578999999999999999999999864322111111110000000000
Q ss_pred ccccc--------C------ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 251 AQELM--------D------PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 251 ~~~~~--------~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...+. + ....... ......+.+++.+||+.||.+|||+.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 0 0000000 0012346788899999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=218.85 Aligned_cols=220 Identities=25% Similarity=0.310 Sum_probs=154.1
Q ss_pred ecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||+|+||.||+|.. .+++.||+|.+.... ......+..+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 457889999885422 12334577889999999999999999999999999999999999
Q ss_pred HHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccC
Q 045271 132 DFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGT 190 (338)
Q Consensus 132 ~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt 190 (338)
.+++..... ..........+++.++.+.|. +.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 988865432 222223344556666666543 4589999999876532 1112234678
Q ss_pred CccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
..|+|||++.+..++.++|||||||++|+|++|..||............... .. ..... .. ......
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--~~~~~-~~--------~~~~~~ 224 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TL--EMAVE-YP--------DKFSPE 224 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--cc--ccccc-CC--------ccCCHH
Confidence 8999999998888999999999999999999999998643321111111000 00 00000 00 001224
Q ss_pred HHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 271 RIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
+.+++.+||+.||.+|| ++.+++.
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56788899999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=218.91 Aligned_cols=223 Identities=19% Similarity=0.166 Sum_probs=153.8
Q ss_pred ceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---cc---HHHHHH-HHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QG---LQEFKN-LIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~---~~~~~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.. .+++.||+|.+..... .. ...+.. +....+|+||+++++++..++.+++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999995 4578899999864321 11 112222 33456899999999999999999999999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
++|..++..... ..........+++.++.+.|+ +.++|+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999998865432 323334445567777776554 3589999999876422 223467
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+..|+|||.+.+..++.++||||||+++|+|++|..||............. .......... ......
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~ 222 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-----SRRINWPEEV--------KEFCSP 222 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----hcccCCCCcc--------cccCCH
Confidence 889999999988888999999999999999999999986432211100000 0000000000 001123
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 270 KRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.+.+++.+||+.||++|||+.++.+.|.-
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 45678889999999999987655555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=218.57 Aligned_cols=220 Identities=20% Similarity=0.245 Sum_probs=158.7
Q ss_pred ecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||.|+||.||+|... +++.||+|.+..... +.+..+..+++.++||||+++++.+.+++.+++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999954 478899999864321 3456677788999999999999999999999999999999999
Q ss_pred HHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 132 DFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 132 ~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
.+++..... ..........+++.++.+.|+ +.++|+|||++....... ......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999876433 222233344457777776553 458999999998764321 1223468889
Q ss_pred cccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHH
Q 045271 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRI 272 (338)
Q Consensus 193 y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
|+|||.+.+..++.++|+||||+++|+|++|..||........ .... ....... .... .......+.
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~~~~~~~-~~~~--------~~~~~~~~~ 224 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYN---DILKGNG-KLEF--------PNYIDKAAK 224 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHH---HHhccCC-CCCC--------CcccCHHHH
Confidence 9999999888899999999999999999999999865432110 0000 0000000 0000 001123567
Q ss_pred HHHhhccCCCCCCCCC-----HHHHHH
Q 045271 273 HIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 273 ~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
++|.+||+.||++||| ++|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7889999999999999 888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=230.76 Aligned_cols=246 Identities=20% Similarity=0.247 Sum_probs=163.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC-----CE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG-----NE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~~ 118 (338)
.++|.+.+.||+|+||.||+|.. .++..||||.+.... ......+..+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45899999999999999999994 568899999886431 22345677789999999999999988643 35
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
.++|+||+. ++|..++..... ..........+++.++.++|+ +.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999994 788877765432 223334455567777766554 458999999998653221
Q ss_pred CCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhhccCC
Q 045271 180 SEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLWCEGN 250 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~ 250 (338)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||................ .......
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 12223467889999998875 458899999999999999999999986532211100000000 0000000
Q ss_pred cccccCcccccc------ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhc
Q 045271 251 AQELMDPVLKES------FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM--LAT 298 (338)
Q Consensus 251 ~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~--L~~ 298 (338)
............ ........+.+++.+||+.||++|||+.++++. ++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000000000 000122346789999999999999999999964 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=219.17 Aligned_cols=224 Identities=25% Similarity=0.344 Sum_probs=164.2
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.++||+|+||.||++. ..+++.+|+|.+.... ......+..+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58899999999999999998 4467889999986432 12344566788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+++++|..++.... ......+....+++.++.+.|+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99999998886521 1222334455567777666554 35899999999876432
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .... ........
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~~~-------- 221 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL------RYKV-QRGKYPPI-------- 221 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-hcCCCCCC--------
Confidence 12234678899999999988899999999999999999999999864322111 0000 00111110
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.......+.+++.+||+.||++|||+.+++..
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01222346778889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-31 Score=257.30 Aligned_cols=235 Identities=23% Similarity=0.285 Sum_probs=172.6
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.-+|....+||.|.||.||.|. ..+|.-.|+|.+.-.. ...+.+|..++..++|||+|+++++-.+++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3478888999999999999999 5557778999875322 234677888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCccc-cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC--CCc
Q 045271 124 EYMPNKSLDFLLFDSTRSV-QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ--SEA 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~--~~~ 182 (338)
|||.+|+|.+++....... ...-..-.+++.|++++| ++-+|++|||.|..+.... ...
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999999999987654322 222334445667766654 4558999999999875432 112
Q ss_pred cccccccCCccccccccccCC---CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGL---FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~---~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
......||+.|||||++.+.. ...++||||+|||+.||+||+.||.... ......+....... +.++..
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-----ne~aIMy~V~~gh~-Pq~P~~-- 1465 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-----NEWAIMYHVAAGHK-PQIPER-- 1465 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-----chhHHHhHHhccCC-CCCchh--
Confidence 234568999999999998643 5678999999999999999999997432 22222222222221 111111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
-...-.+|+.+||+.||++|.++.|+++.--..
T Consensus 1466 -------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1466 -------LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred -------hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 122457799999999999999999998865543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=228.56 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=175.2
Q ss_pred CChhHHHHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEec--cCC--------cccHHHHHHHHHhcCCCceeee
Q 045271 41 FPLDLIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLS--RSS--------GQGLQEFKNLIAKLQHKNLVRL 109 (338)
Q Consensus 41 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~--~~~--------~~~~~~~~~~l~~l~hpnIv~~ 109 (338)
.++.....+.++|-++.+||+|+|+.||+|. .....-||+|+-. ++. .+...+|..+.+.|+||.||++
T Consensus 453 SQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 453 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred hhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 3455666777899999999999999999999 4446678888753 221 1335566778999999999999
Q ss_pred eeEEE-eCCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC-----------------------CCCe
Q 045271 110 LGCCL-EGNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH-----------------------KMNP 164 (338)
Q Consensus 110 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~-----------------------~~~v 164 (338)
|++|. +.+.+|-|+|||+|.+|+.+++.... +......+.++++.++.|+. .+.+
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 99997 56789999999999999999987654 33445667777888877633 2348
Q ss_pred EEeeeccceecCCCCCC-----ccccccccCCccccccccccC----CCCcccchHhHhHHHHHHHhCCCCCcccccccc
Q 045271 165 KISDFGMARVFGGNQSE-----ANTNRVVGTYGYMAPEYALEG----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG 235 (338)
Q Consensus 165 kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~ 235 (338)
||+|||+++.+.+.... .......||.+|++||++.-+ ..+.|+||||+||++|+.+.|+.||.....++.
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 99999999987543222 223446899999999999743 378999999999999999999999986544332
Q ss_pred cchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 236 QSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. +... .............+.. ...+.+||++||++.-++|....++..
T Consensus 693 I--LqeN-TIlkAtEVqFP~KPvV--------sseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 I--LQEN-TILKATEVQFPPKPVV--------SSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred H--Hhhh-chhcceeccCCCCCcc--------CHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1 1111 1111111222222211 224567999999999999998887753
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=221.91 Aligned_cols=241 Identities=21% Similarity=0.208 Sum_probs=156.8
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcC-CCceeeeeeEEEeCCE-----
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNE----- 118 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~----- 118 (338)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999995 4688899998754322 33566778888885 6999999999987655
Q ss_pred EEEEEecCCCCCHHHHHhccCc------cccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccce
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR------SVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMAR 173 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~ 173 (338)
+|+||||+++ +|..++..... ..........+++.+|.++| ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999974 78777654322 11223334455666666544 3458999999998
Q ss_pred ecCCCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (338)
.+.... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........................
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 160 AFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 653211 112223567889999988764 57899999999999999999999987532211110000000000000000
Q ss_pred cc--------cCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 EL--------MDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~--------~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. ....... .........+.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000 000011234677899999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=217.81 Aligned_cols=232 Identities=20% Similarity=0.144 Sum_probs=162.3
Q ss_pred HhcCCCCC-ceecccCCeeEEEEE-EcCCcEEEEEEeccCCcccHHHHHHH-HHhcCCCceeeeeeEEEe----CCEEEE
Q 045271 49 ATRNFSNE-NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNL-IAKLQHKNLVRLLGCCLE----GNELLL 121 (338)
Q Consensus 49 ~~~~y~~~-~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~-l~~l~hpnIv~~~~~~~~----~~~~~l 121 (338)
+.++|.+. ++||-|-.|.|..|. ..++..+|+|++.... ..++|.++ +..-.|||||.++++|++ ...+.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 45678774 699999999999999 4568889999986543 34455543 345579999999999875 457889
Q ss_pred EEecCCCCCHHHHHhccCcc---ccccHHHHHHHHHHhhhcCCC---------------------CeEEeeeccceecCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRS---VQLDWNRRMCIINGIARDHKM---------------------NPKISDFGMARVFGG 177 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~~~~---------------------~vkL~Dfg~a~~~~~ 177 (338)
|||.+.||.|..-+..++.. ......+..++..++.|+|+. .+||+|||+|+...
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~- 215 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ- 215 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC-
Confidence 99999999998888765541 112223334455555554432 38999999998642
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
......+.|-|++|.|||++..++|+..+|+||+||++|-|++|.+||+........ .+.+...........++
T Consensus 216 --~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais----pgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 216 --EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKRRIRTGQYEFPEP 289 (400)
T ss_pred --CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC----hhHHhHhhccCccCCCh
Confidence 233455678899999999999999999999999999999999999999865432221 11111101111111111
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....-.....++|+.+|..+|.+|.|+.+++.
T Consensus 290 -----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 290 -----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11112234567888899999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=215.77 Aligned_cols=226 Identities=20% Similarity=0.287 Sum_probs=165.9
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||.|+||.||++... ++..|++|.+..... .....+.++++.++|||++++.+.+...+.+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999954 578899999864322 3456677889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+++++|..++.... ...........+++.++.+.|+ +.++|+|||.+....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 99999998887642 2223334455566666666543 568999999998764322 1
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||......... . .. .......+..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~---~~-~~~~~~~~~~------ 225 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA---L---KI-LKGQYPPIPS------ 225 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH---H---HH-hcCCCCCCCC------
Confidence 223357888999999998888999999999999999999999998643311110 0 00 0001111100
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+++.+||..||.+|||+.++++.
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111245678889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=222.99 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=163.4
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEe-CCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLE-GNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~-~~~~~ 120 (338)
...++|++.+.||.|+||.||+|. ..+++.||+|.+.... ...+..+..+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 356789999999999999999999 4468899999875321 2345667889999999999999999875 56789
Q ss_pred EEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 121 LICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+||||+ +++|..++...............+++.++.+.|+ +.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999999 6788888765443333334445566666666543 4589999999875421
Q ss_pred cccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccCCccc
Q 045271 183 NTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEGNAQE 253 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 253 (338)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||............... .......+...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 1123467888999998876 46899999999999999999999998653321110000000 00000000000
Q ss_pred ccCccc-cccccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 254 LMDPVL-KESFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 254 ~~~~~~-~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.+.... ....... ....+.++|.+||+.||++|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0001111 12356778999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=221.88 Aligned_cols=227 Identities=22% Similarity=0.273 Sum_probs=164.6
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+..+++.++ ||||+++++++.+.+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999995 468899999986522 133455667888888 99999999999999999999
Q ss_pred EecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC--
Q 045271 123 CEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE-- 181 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~-- 181 (338)
|||+.+++|.+++.... ...........+++.++.++|+ +.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999998887653 2333344555566766665443 45899999998866432211
Q ss_pred ----------------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh
Q 045271 182 ----------------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 182 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
.......++..|+|||++.+..++.++|+||||+++|++++|..||........ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~ 235 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-----FQKIL 235 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHH
Confidence 112234678899999999888899999999999999999999999874431110 00000
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTM----SSVVF 294 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~----~~vl~ 294 (338)
. ....+.. .....+.+|+.+||+.||.+|||+ .+++.
T Consensus 236 ~----~~~~~~~--------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 K----LEYSFPP--------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred h----cCCCCCC--------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0000000 012345678889999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=221.59 Aligned_cols=226 Identities=25% Similarity=0.319 Sum_probs=157.7
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
..|+..+.||+|+||.||++.. .++..||+|.+..... ..+..++.+++.++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3478889999999999999994 4578899999864322 23455677889999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||++ |++.+++....... ........+++.++.+.|+ +.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 9996 56766664433222 2223344556666666543 4589999999875421
Q ss_pred ccccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 184 TNRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||.......... ....... .. ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~~-~~-----~~ 245 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNES-PT-----LQ 245 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHHhccC-CC-----CC
Confidence 12346888999999974 3468899999999999999999999986432111100 0000000 00 00
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.......+.+++.+||+.||.+|||+.+++..+..
T Consensus 246 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 246 ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00111235678889999999999999999975544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=222.83 Aligned_cols=238 Identities=21% Similarity=0.193 Sum_probs=154.5
Q ss_pred ceeccc--CCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEG--GFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G--~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
..||.| +||+||++.+ .+++.||+|.+..... +.+.++..+++.++||||++++++|..++.+++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999995 5688999999864321 3455667778889999999999999999999999999999
Q ss_pred CCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCCCCc-----
Q 045271 129 KSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQSEA----- 182 (338)
Q Consensus 129 g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~~~~----- 182 (338)
+++..++..... ..........+++.+|.+.|+. .++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 999988875421 2222234555677777776653 37888887543321111000
Q ss_pred cccccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------------Hhhh
Q 045271 183 NTNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------------WKLW 246 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------------~~~~ 246 (338)
......++..|+|||++.+. .++.++|||||||++|+|++|..||............... ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 00112345679999999864 4789999999999999999999998753221110000000 0000
Q ss_pred c----------------cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 247 C----------------EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 247 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ...........+...........+.+|+++||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 00000000011111112223446788999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=223.90 Aligned_cols=245 Identities=20% Similarity=0.230 Sum_probs=160.3
Q ss_pred HhcCCCC-CceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc-----------------cHHHHHHHHHhcCCCceeee
Q 045271 49 ATRNFSN-ENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ-----------------GLQEFKNLIAKLQHKNLVRL 109 (338)
Q Consensus 49 ~~~~y~~-~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----------------~~~~~~~~l~~l~hpnIv~~ 109 (338)
+.++|.. .+.||.|+||.||+|.. .+++.||||.+...... .+.+|..+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3557765 46799999999999994 46889999988543221 24567788999999999999
Q ss_pred eeEEEeCCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeec
Q 045271 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFG 170 (338)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg 170 (338)
++++...+..++||||+. |+|..++..... ..........+++.++.+.|+ +.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999995 688887755322 222333444556666665443 458999999
Q ss_pred cceecCCCC------------CCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccc
Q 045271 171 MARVFGGNQ------------SEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS 237 (338)
Q Consensus 171 ~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~ 237 (338)
++....... .........++..|+|||++.+. .++.++|+|||||++|+|++|..||..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 997654110 00111123467889999998765 47899999999999999999999987543211111
Q ss_pred hhhHHHhhhccCCccc--------ccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 238 LLTYTWKLWCEGNAQE--------LMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+.............. ........ .........+.+++.+||+.||++|||+.|++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 0000000000000000 00000000 000011234668899999999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=226.15 Aligned_cols=242 Identities=19% Similarity=0.191 Sum_probs=167.5
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhcCC--C----ceeeeeeEEEeCC
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQH--K----NLVRLLGCCLEGN 117 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~h--p----nIv~~~~~~~~~~ 117 (338)
..+..+|++..++|+|+||.|-.|.. ..+..||||+++.... +...-|+.+|+.+++ | -+|.+.++|.-.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 45578999999999999999999994 4467899999876543 344556667777742 3 3888899999999
Q ss_pred EEEEEEecCCCCCHHHHHhccC-cccccc--HHHHHHHHHHhhhcCC---------------------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDST-RSVQLD--WNRRMCIINGIARDHK--------------------------------- 161 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~--~~~~~~~~~~i~~~~~--------------------------------- 161 (338)
+.|||+|.+ |-++.+++.... .+.+.. .....|+++.+.++|+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999998 778888887643 333322 2233355555555433
Q ss_pred -----CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc
Q 045271 162 -----MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236 (338)
Q Consensus 162 -----~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~ 236 (338)
..++|+|||.|.... ......+.|..|+|||++.+-.|+.++||||+||||+|+.+|..-|+.....+..
T Consensus 244 r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred ccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 238999999998742 2224578899999999999999999999999999999999999888765433321
Q ss_pred chhhHH--------------HhhhccCCcccccCccccc--------c--------ccHHHHHHHHHHHhhccCCCCCCC
Q 045271 237 SLLTYT--------------WKLWCEGNAQELMDPVLKE--------S--------FILEELLKRIHIGLLCVQEDPADR 286 (338)
Q Consensus 237 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~--------~--------~~~~~~~~~~~li~~cl~~dP~~R 286 (338)
...... .+.+..+ -.+.......+ . ..-.+...+++|++.||.+||.+|
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 111110 0000001 00000000000 1 112344568899999999999999
Q ss_pred CCHHHHHHH
Q 045271 287 PTMSSVVFM 295 (338)
Q Consensus 287 ps~~~vl~~ 295 (338)
+|+.|+|..
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=224.05 Aligned_cols=246 Identities=26% Similarity=0.320 Sum_probs=176.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHH--hcCCCceeeeeeEEEeCC----EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIA--KLQHKNLVRLLGCCLEGN----ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~--~l~hpnIv~~~~~~~~~~----~~~lv~ 123 (338)
....++++.||+|.||.||+|.. .++.||||++.....+.+..|..+.+ .+.|+||++++++-..+. .+++|+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 44667789999999999999997 45899999998877788888887776 468999999999887655 899999
Q ss_pred ecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC---------------------------CCeEEeeeccceecC
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK---------------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~---------------------------~~vkL~Dfg~a~~~~ 176 (338)
+|.+.|+|.++++.+..+....-.+...++.||+|+|. .+..|+|||+|..+.
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 99999999999998877766666667778899998774 237899999999886
Q ss_pred CCCCCccccccccCCccccccccccCC-CC-----cccchHhHhHHHHHHHhCCCCCcc-------ccccc----ccchh
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGL-FS-----VKSDVFSFGVLLLEIISGRKDTRF-------YLYEQ----GQSLL 239 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiWSlGv~l~el~~g~~Pf~~-------~~~~~----~~~~~ 239 (338)
...........+||.+|||||++.+.. +. ...||||+|.+||||+++..-++. .++.+ ....-
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 544444455579999999999998752 33 358999999999999987643321 11110 00000
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...........-+.+.+..... .....+.+.+..||..||+-|.||.=+.+++..+.
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 0000111111111111111111 22334556788899999999999999999888754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=217.97 Aligned_cols=239 Identities=13% Similarity=0.126 Sum_probs=152.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcCC----cEEEEEEeccCCcccHH--------------HHHHHHHhcCCCceeee
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLNDD----KEIAVKRLSRSSGQGLQ--------------EFKNLIAKLQHKNLVRL 109 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~--------------~~~~~l~~l~hpnIv~~ 109 (338)
...++|++.+.||+|+||.||+|....+ ..+|+|........... .+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999995443 34566653222111100 11123345689999999
Q ss_pred eeEEEeCC----EEEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------CCeEE
Q 045271 110 LGCCLEGN----ELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------MNPKI 166 (338)
Q Consensus 110 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL 166 (338)
++.+.... ..+++++++ ..++..++.... ...........+++.++.+.|+ +.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 99765433 447888887 456655554332 2222334455667777776554 45899
Q ss_pred eeeccceecCCCCCC-----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccc-cchhh
Q 045271 167 SDFGMARVFGGNQSE-----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG-QSLLT 240 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~-~~~~~ 240 (338)
+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876321111 111234699999999999998999999999999999999999999975522111 11111
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLA 297 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~ 297 (338)
.... ..+.......... ...+.+++..||+.+|++||++.++++.|+
T Consensus 248 ~~~~-------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFI-------KRLHEGKIKIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHH-------HHhhhhhhccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000 0000000000111 134567888899999999999999998764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=219.15 Aligned_cols=233 Identities=21% Similarity=0.275 Sum_probs=164.1
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.|+...+||+|+||.||++.. .++..||+|.+..... ..+..++.+++.++|+||+++++.+..++..++||||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 344457899999999999995 5688899998854322 235566778899999999999999999999999999999
Q ss_pred CCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccccc
Q 045271 128 NKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
+++|.+++...............+++.++.+.| ++.++|+|||++........ ......|
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~ 178 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG 178 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence 999998876544333333444455666666544 34589999999876543221 1223568
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
+..|+|||.+.+..++.++|+||+||++|+|++|..||.............. ........... ...
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~------~~~ 244 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--------NLPPKLKNLHK------VSP 244 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------hCCcccCCccc------CCH
Confidence 8899999999888899999999999999999999999864322111111000 00000000000 112
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH--HhhcCc
Q 045271 270 KRIHIGLLCVQEDPADRPTMSSVVF--MLATDT 300 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~ 300 (338)
.+.+++.+||+.||.+||++.+++. +|....
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 3456788899999999999999986 455433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=216.44 Aligned_cols=238 Identities=21% Similarity=0.281 Sum_probs=156.6
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHH---hcCCCceeeeeeEEEeCCE-----
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIA---KLQHKNLVRLLGCCLEGNE----- 118 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~---~l~hpnIv~~~~~~~~~~~----- 118 (338)
|++.+.||+|+||.||+|... +++.||+|.+..... .....+..+++ .++||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999965 488999999863322 12333444444 4469999999999988766
Q ss_pred EEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~ 177 (338)
++++|||++ ++|..++..... ..........+++.++.++|+ +.++|+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 578777754322 222334445556677766554 4589999999987632
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH-----hhhccCCc-
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW-----KLWCEGNA- 251 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~- 251 (338)
. .......++..|+|||++.+..++.++|+|||||++|+|++|..||......+......... ..+.....
T Consensus 160 ~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 160 E---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred C---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 2 11223457889999999998889999999999999999999998886533221111110000 00000000
Q ss_pred -ccccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 252 -QELMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 252 -~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......... .........+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 000112235568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=227.64 Aligned_cols=244 Identities=17% Similarity=0.264 Sum_probs=162.3
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe----CCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE----GNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~ 119 (338)
.++|++.+.||+|+||.||+|. ..++..||+|.+..... .....+..+++.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3689999999999999999999 45688999999865321 234567788999999999999998863 4578
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
++||||+ .++|..++..... ..........+++.++.++|+ +.+||+|||++........
T Consensus 84 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999999 5688888754432 223334455566777666543 4589999999976532221
Q ss_pred C--ccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccC
Q 045271 181 E--ANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEG 249 (338)
Q Consensus 181 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 249 (338)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||............... .......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 11123478889999999876 45889999999999999999999999654321111000000 0000000
Q ss_pred CcccccCccc-ccccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 250 NAQELMDPVL-KESFI-----LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 250 ~~~~~~~~~~-~~~~~-----~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......... ..... ......+.+++.+||+.||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000 00000 111345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=216.62 Aligned_cols=180 Identities=24% Similarity=0.358 Sum_probs=139.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-C----CcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEe-CC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-D----DKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLE-GN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~----~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~-~~ 117 (338)
....|+++..||+|+||.||+|... + ++.+|||+++... .....+|+.+++.++||||+.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3458999999999999999999622 2 2368999997552 2456778889999999999999999987 88
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc------ccccHHHHHHHHHHhhhcCC----------------------CCeEEeee
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS------VQLDWNRRMCIINGIARDHK----------------------MNPKISDF 169 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Df 169 (338)
.+++++||+ .-+|..+++.+..+ ......+..+++.|++|+|. +.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 66777777654332 22334556678899998664 46999999
Q ss_pred ccceecCCCCCCc-cccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 170 GMARVFGGNQSEA-NTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 170 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
|+++.+...-..- .....+-|.+|+|||.+.+.. |+.+.||||+||++.||++-.+-|..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999874322211 223356789999999999975 99999999999999999998876653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=226.65 Aligned_cols=246 Identities=20% Similarity=0.239 Sum_probs=164.8
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC-
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG- 116 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~- 116 (338)
..+....++|++.+.||+|+||.||+|.. .++..||+|++.... .....+++.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34566778999999999999999999994 568889999986432 12345577789999999999999988643
Q ss_pred -----CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccce
Q 045271 117 -----NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMAR 173 (338)
Q Consensus 117 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~ 173 (338)
+.++++++++ +++|..++...............+++.++.+.|+ +.+||+|||++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478899887 8899888765544434444555667777776554 458999999987
Q ss_pred ecCCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh--------
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK-------- 244 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-------- 244 (338)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 169 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 6421 1223467889999999876 4688999999999999999999999864322111000000000
Q ss_pred hhccCCcccccCcccc-ccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 245 LWCEGNAQELMDPVLK-ESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
................ ..... .....+.++|.+||+.||.+|||+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000 00000 012245689999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=216.74 Aligned_cols=220 Identities=23% Similarity=0.242 Sum_probs=150.7
Q ss_pred eecccCCeeEEEEEE-cCCcEEEEEEeccCCcc------cHHHHHH---HHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 58 KLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ------GLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 58 ~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~---~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.||+|+||.||++.. .++..+|+|.+...... ...++.. ++...+||||+.+++++..++.+++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 45788999988643211 1222222 3334579999999999999999999999999
Q ss_pred CCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccc
Q 045271 128 NKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 128 ~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
+++|..++..... ..........+++.++.+.| ++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999888765432 22333444555666666544 345899999998765321 122346
Q ss_pred cCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
|+..|+|||.+.+ ..++.++||||+||++|+|++|..||.......... .. ..... ....+. ...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~---~~~~~------~~~~~~----~~~ 222 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID---RMTLT------VNVELP----DSF 222 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HH---HHhhc------CCcCCc----ccc
Confidence 8999999999874 468999999999999999999999986432211110 00 00000 000000 011
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRP-----TMSSVVFM 295 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rp-----s~~~vl~~ 295 (338)
...+.+++.+||..||.+|| |+.++++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 23456788899999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=235.07 Aligned_cols=237 Identities=22% Similarity=0.330 Sum_probs=170.6
Q ss_pred CChhHHHHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc--ccHHHHHHHHHhc-CCCceeeeeeEEEe-
Q 045271 41 FPLDLIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG--QGLQEFKNLIAKL-QHKNLVRLLGCCLE- 115 (338)
Q Consensus 41 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l-~hpnIv~~~~~~~~- 115 (338)
++++......+.|++++.||.|.+|.||+++ .+++...|+|+...+.. +.+..+..+++.+ .|||++.++++|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445555667789999999999999999999 55677788888755443 3344455677665 69999999999863
Q ss_pred ----CCEEEEEEecCCCCCHHHHHhccCccccccH----HHHHHHHHHhhhcCC------------------CCeEEeee
Q 045271 116 ----GNELLLICEYMPNKSLDFLLFDSTRSVQLDW----NRRMCIINGIARDHK------------------MNPKISDF 169 (338)
Q Consensus 116 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~----~~~~~~~~~i~~~~~------------------~~vkL~Df 169 (338)
++++|+|||||.+|+.-++++... ...+.+ .+....+.|+.|+|+ +.|||+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 678999999999999999987654 322222 223335566666554 35999999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccC-----CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK 244 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 244 (338)
|++..+.. .-.+..+..||+.|||||++.-. .|+..+|+|||||+..||.-|.+|+.+...-.. .+.
T Consensus 168 GvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------LF~ 239 (953)
T KOG0587|consen 168 GVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFL 239 (953)
T ss_pred eeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------hcc
Confidence 99988742 23345567999999999999732 377889999999999999999999865432111 111
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. .. +.+.+. .......++.+||..||..|-.+||+..++++
T Consensus 240 Ip-----RN-PPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IP-----RN-PPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CC-----CC-CCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 00 111111 12345667889999999999999999999885
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=215.57 Aligned_cols=219 Identities=23% Similarity=0.246 Sum_probs=152.0
Q ss_pred eecccCCeeEEEEEE-cCCcEEEEEEeccCCcc------cHHHHH---HHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 58 KLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ------GLQEFK---NLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 58 ~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~---~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.||+|+||.||+|.. .+++.||+|.+...... ....+. ..++...||||+.+++.+.+.+.+++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999995 45789999998643211 112222 23445689999999999999999999999999
Q ss_pred CCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccc
Q 045271 128 NKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 128 ~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
+++|..++..... ..........+++.++.+.| ++.++|+|||++..+... ......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999888865432 22333445556777776654 345899999998765321 122357
Q ss_pred cCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
|+..|+|||++.+. .++.++||||+||++|+|++|..||............ ....... .. .... .
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~-~~-~~~~--------~ 222 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMA-VE-LPDS--------F 222 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhccC-CC-CCCc--------C
Confidence 89999999999755 6899999999999999999999998754221111110 0000000 00 0000 1
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
...+.+++.+||..||.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 23456678889999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=218.23 Aligned_cols=239 Identities=24% Similarity=0.265 Sum_probs=158.1
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEecC
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
|++.+.||+|++|.||+|... +++.|+||.+..... .....+...++.++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999964 477899999865432 12234566778888 999999999999999999999999
Q ss_pred CCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
+|+|...+.... ...........+++.++.++| ++.++|+|||++....... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYT 156 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---CcC
Confidence 888887776543 122233344445666665544 3458999999998763221 122
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH--------HHhh--hccCCcccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--------TWKL--WCEGNAQEL 254 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~ 254 (338)
...++..|+|||++.+. .++.++|+||||+++|+|++|..||.............. .+.. .........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 34678899999988654 578999999999999999999999864322111000000 0000 000000000
Q ss_pred cCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 255 MDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 255 ~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
....... .........+.+++.+||+.||++|||+.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 0000112346789999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=216.11 Aligned_cols=226 Identities=23% Similarity=0.299 Sum_probs=157.7
Q ss_pred CCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC--------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS--------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+|.+.++||+|+||.||++.... +..+++|.++... ......+..+++.++||||+++++.+.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999999543 3445555554211 11234566788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCCC
Q 045271 123 CEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
|||+++++|..++.... ...........+++.++.+.|+ +.++|+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence 99999999988875321 1222233444556677666554 3489999999977633221
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... ......
T Consensus 161 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~~~~~------- 224 (260)
T cd08222 161 --LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-EGPTPS------- 224 (260)
T ss_pred --cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-cCCCCC-------
Confidence 1223467889999999988888999999999999999999999985322111 000100 000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
........+.++|.+||+.||++||++.++++.
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 --LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011122356778999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=221.47 Aligned_cols=244 Identities=18% Similarity=0.219 Sum_probs=165.8
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC-
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN- 117 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~- 117 (338)
.+..+.++|++++.||+|+||.||+|. ..++..||||.+..... ..+..|..+++.++||||+++++++..+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 345567899999999999999999999 45688899999854321 23556778999999999999999987543
Q ss_pred -----EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeecccee
Q 045271 118 -----ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARV 174 (338)
Q Consensus 118 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~ 174 (338)
.+++||||+ +++|..++...............+++.++.+.|+ +.++|+|||++..
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999 7899888865544444445556677777776554 3489999999976
Q ss_pred cCCCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------Hhh
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKL 245 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~ 245 (338)
... ......++..|+|||++.+. .++.++|+||+||++|+|++|..||............... ...
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 521 12234678899999998763 5889999999999999999999998743221110000000 000
Q ss_pred hccCCcccccCcccccc-ccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 WCEGNAQELMDPVLKES-FIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
................. ... .....+.+++.+||+.||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000 000 01123568899999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=234.27 Aligned_cols=225 Identities=20% Similarity=0.306 Sum_probs=166.5
Q ss_pred CCCceecccCCeeEEEEEE-cCCcEEEEEEe-----ccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCE--EEEEE
Q 045271 54 SNENKLGEGGFGPVYKGVL-NDDKEIAVKRL-----SRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE--LLLIC 123 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~-----~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~ 123 (338)
+.-..||+|+|=+||+|.. .+|..||--.+ .+... +.+.+|+.+|+.|+|||||++|+++.+... +.+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3357899999999999995 34777764333 22333 567788999999999999999999997654 88999
Q ss_pred ecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcCCC---------------------CeEEeeeccceecCCCCCC
Q 045271 124 EYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDHKM---------------------NPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~~~---------------------~vkL~Dfg~a~~~~~~~~~ 181 (338)
|.+..|+|..|.+..... .......+.+++.||.|+|.. .|||+|+|+|.... .
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----K 198 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh----c
Confidence 999999999999776543 233456677899999998753 49999999998763 2
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|||||+.- ..|+..+||||||+.+.||+|+.+||........ .++.-..+.-+.
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~-------- 263 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPA-------- 263 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHH--------
Confidence 3344479999999999776 7799999999999999999999999875433222 111111111111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
+...-...+..+||.+||.. ..+|||+.|+|. +|..
T Consensus 264 sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11111123456789999999 999999999996 5555
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=213.02 Aligned_cols=229 Identities=22% Similarity=0.281 Sum_probs=160.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----c---ccHHHHHHHHHhcCCCceeeeeeEEEeC--CEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----G---QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NEL 119 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~ 119 (338)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... . ..+..|+.+++.++|+||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999994 458899999874321 1 2355677889999999999999998764 568
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+++|||+++++|.+++..... ..........+++.++.++|+ +.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999988865432 222233344566677666543 4589999999986532111
Q ss_pred -CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 -EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........++..|+|||++.+..++.++|+|||||++|+|++|..||........ .. ....... ...+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~-~~~~p~-- 232 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----IF-KIATQPT-KPMLPD-- 232 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----HH-HHHcCCC-CCCCCc--
Confidence 1112235688899999999888889999999999999999999999864321110 01 1110000 000111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+++.+||+ +|..|||+.+++.+
T Consensus 233 ------~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 233 ------GVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111345678888999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=216.70 Aligned_cols=235 Identities=19% Similarity=0.230 Sum_probs=162.8
Q ss_pred CCCCCceecccCCeeEEEEEE----cCCcEEEEEEeccCC-------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~ 119 (338)
+|++.+.||+|+||.||++.. .++..||||.+.... .+....|..+++.+ +||||+++++.+..++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999984 246789999886421 12345667788888 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
++||||+++++|...+..... ..........+++.+|.+.|+ +.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999999888765432 222223334456666666543 4589999999876532211
Q ss_pred CccccccccCCccccccccccCC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||......... ........ ... . ....
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~-~~~-~-~~~~- 233 (288)
T cd05583 161 -ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRIL-KSK-P-PFPK- 233 (288)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHH-ccC-C-CCCc-
Confidence 1122346888999999987665 788999999999999999999998632211110 01010000 000 0 0000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+++.+||+.||++|||+.++.+.|+..+
T Consensus 234 -------~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 234 -------TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred -------ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 01124567888999999999999998888777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=236.67 Aligned_cols=231 Identities=26% Similarity=0.323 Sum_probs=176.6
Q ss_pred CCCceecccCCeeEEEEEE-cCCc----EEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 54 SNENKLGEGGFGPVYKGVL-NDDK----EIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~-~~~~----~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
...++||+|+||+||+|.+ ..++ +||||++.... ...+.+++-.|..++|||++++++++.... +-||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458999999999999994 3343 48999885433 345666777889999999999999998654 789999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|++.|.|.++++.+.. ..........|+++|+.|++.. .+|+.|||+++.+.....+-..
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 9999999999987544 3344566777899999987653 3899999999987654444333
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....-.+.|||-|.+....|+.++|||||||++||++| |..|+......+....+..+.+ -+.
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR----------------Lsq 921 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER----------------LSQ 921 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc----------------CCC
Confidence 33445678999999999999999999999999999998 8889876665554443332221 122
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
+.-..+..+-+|.+||..|+..||+|+++...+.+.+-
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 23344566778889999999999999999887776654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=244.23 Aligned_cols=232 Identities=20% Similarity=0.243 Sum_probs=168.0
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEecc------CCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSR------SSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
....++|++++.||+|+||.|.++++ .+++.||+|.+.+ ....-+.+|..+|..-+.+=|++++-.|.+.+++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 34457999999999999999999995 5577889999865 2233467777788888888999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCccccccHHHHHH--HHHH------------------hhhcCCCCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING------------------IARDHKMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~--~~~~------------------i~~~~~~~vkL~Dfg~a~~~~~~~ 179 (338)
|+||||++||+|-.++.... ..+..|+.+.. +..+ +..+..|++||+|||.|..+.. +
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-D 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-C
Confidence 99999999999999998776 44555554432 2222 2224467899999999987743 2
Q ss_pred CCccccccccCCccccccccc----c-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc
Q 045271 180 SEANTNRVVGTYGYMAPEYAL----E-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (338)
........+|||-|.+||++. + +.|+..+|+||+||++|||+.|..||+....-+....+...... +.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-----l~-- 301 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-----LS-- 301 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-----cC--
Confidence 334445679999999999997 3 56999999999999999999999999876544443332211111 11
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPT---MSSVVF 294 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~vl~ 294 (338)
++....-+. .+.+||...+. +|+.|.. +.|+-.
T Consensus 302 FP~~~~VSe------eakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 302 FPDETDVSE------EAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCcccccCH------HHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 111111222 33445555554 6999998 888875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=223.85 Aligned_cols=246 Identities=21% Similarity=0.264 Sum_probs=165.9
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCC-----EEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN-----ELL 120 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 120 (338)
+|++.+.||+|++|.||+|... .++.||||.+.... .+.+..+..+++.++|+||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999954 48889999886532 234667788999999999999999998765 789
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||++ ++|..++..... ..........+++.+|.++|+ +.++|+|||++.........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 578877765432 222233455566677666543 45899999999876432210
Q ss_pred -ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh--------hccCCc
Q 045271 182 -ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL--------WCEGNA 251 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~ 251 (338)
.......++..|+|||++.+. .++.++|+|||||++|+|++|..||......+........... ......
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 112234678899999999887 7899999999999999999999999754432211111100000 000000
Q ss_pred ccccCccccc-cccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 252 QELMDPVLKE-SFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 252 ~~~~~~~~~~-~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...+...... .... .....+.+++.+||+.||.+|||+.+++. +++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000 0000 01234577899999999999999999996 3544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=219.09 Aligned_cols=237 Identities=18% Similarity=0.131 Sum_probs=152.6
Q ss_pred CCceecccCCeeEEEEEEcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 55 NENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.+.+|.|+++.|+++.. +++.||||++.... ...+..|+.+++.++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344444444444444433 68899999986441 134667778899999999999999999999999999999999
Q ss_pred CHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC-----Ccc
Q 045271 130 SLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS-----EAN 183 (338)
Q Consensus 130 ~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~-----~~~ 183 (338)
+|..++..... ..........+++.+|.++|+ +.+||+|||.+..+..... ...
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 99998875321 222223344567777777554 4589999998875532111 111
Q ss_pred ccccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhh-----------ccCC
Q 045271 184 TNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLW-----------CEGN 250 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-----------~~~~ 250 (338)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......... ........ ....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCC
Confidence 1224567789999998764 4889999999999999999999999753321110 00000000 0000
Q ss_pred ccc----ccCcc----ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 AQE----LMDPV----LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~~~----~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
... ..... ............+.+|+.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 00000 000011111235678999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=208.37 Aligned_cols=225 Identities=25% Similarity=0.348 Sum_probs=163.3
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+|++.+.||+|.+|.||++... +++.|++|.+..... +.+..++++++.++|||++++++++.+.+.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999954 577899999865432 3456677788999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++++|.+++..... .....+....+++.++.+.|+ +.++|+|||++......... ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccc
Confidence 999999988865422 222333444556666655443 45899999999876432221 223
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... . .+... ...... +...
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~-~~~~~-~~~~~~-~~~~-------- 222 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----A-LFRIV-QDDHPP-LPEG-------- 222 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----H-HHHHh-ccCCCC-CCCC--------
Confidence 567889999999888778899999999999999999999986432110 0 00000 000000 1110
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+++.+||+.||++|||+.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1124557888999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=217.54 Aligned_cols=222 Identities=26% Similarity=0.335 Sum_probs=154.3
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.|...+.||+|+||.||+|.. .++..|++|.+..... ..+..+..+++.++|||++++++++.+.+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 377788999999999999995 4578899999854322 234567778999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+. |++..++........ .......+++.++.+.|+ +.+||+|||++.... ..
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 995 566666654332221 222334456666665443 458999999986431 12
Q ss_pred cccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....|+..|+|||++. ...++.++|||||||++|+|++|..||.......... ... ..........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~-~~~~~~~~~~---- 243 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA-QNDSPTLQSN---- 243 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHH-hcCCCCCCcc----
Confidence 2356888999999985 3568889999999999999999999986432111100 000 0000110000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+|+.+||+.+|.+|||+.+++..
T Consensus 244 ----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 ----EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011235668889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=217.84 Aligned_cols=229 Identities=21% Similarity=0.321 Sum_probs=155.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCcc----cHHHHHHHH-HhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQ----GLQEFKNLI-AKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~l-~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++.+.||+|+||.||+|.+.. ++.||||.+...... ....+..++ +..+||||+++++++.++..+++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4589999999999999999999654 888999998654321 122233334 3445999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCc
Q 045271 124 EYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||+ .+++..++...... .........+++.++.+.|. +.+||+|||++..+.....
T Consensus 94 e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-- 170 (296)
T cd06618 94 ELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-- 170 (296)
T ss_pred ecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--
Confidence 998 55776666543222 22223455566777776653 3489999999876532211
Q ss_pred cccccccCCccccccccccCC----CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 183 NTNRVVGTYGYMAPEYALEGL----FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ..... ... ..........
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~-~~~~~~~~~~- 242 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KIL-QEEPPSLPPN- 242 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHh-cCCCCCCCCC-
Confidence 12235778899999987653 788999999999999999999998642111 00000 000 0111111000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
. .....+.+|+.+||+.||.+|||+.+++..
T Consensus 243 ~------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 E------GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C------CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 112245678889999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=224.71 Aligned_cols=247 Identities=19% Similarity=0.261 Sum_probs=161.4
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC---
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG--- 116 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~--- 116 (338)
++.+.++|.+...||+|+||.||+|.. .++..||+|.+.... ......++.+++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 345567999999999999999999995 468899999986432 12355677899999999999999998754
Q ss_pred ---CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceec
Q 045271 117 ---NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVF 175 (338)
Q Consensus 117 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~ 175 (338)
..+++|+||+. .+|..+... ............+++.++.+.| ++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIMGH-PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCCceEEEEecccc-cCHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 35699999994 567665421 2222333344455666666544 345899999998764
Q ss_pred CCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhh
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLW 246 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~ 246 (338)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||................ ...
T Consensus 168 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 21 1223467889999999876 458899999999999999999999997532211110000000 000
Q ss_pred ccCCcccccCcccc-ccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 247 CEGNAQELMDPVLK-ESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 247 ~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.............. ..... .....+.+|+.+||+.||++|||+.+++. +++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000000 00000 01224568899999999999999999994 46554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=217.92 Aligned_cols=225 Identities=27% Similarity=0.322 Sum_probs=156.0
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+.|+..+.||+|+||.||+|.. .++..+|+|.+..... ..+..++.+++.++|+|++++++++...+..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588889999999999999995 4577899998853211 2344677789999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+. |++..++........ .......+++.++.+.|. +.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 99995 677666643332222 222333456666665443 4589999999876532
Q ss_pred cccccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 183 NTNRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....++..|+|||.+. ...++.++|||||||++|+|++|..||.......... ... ........
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~---~~~~~~~~---- 235 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIA---QNESPALQ---- 235 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH----HHh---hcCCCCcC----
Confidence 12346788999999985 3457889999999999999999999985432111100 000 00000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.......+.+++.+||+.+|++|||+.+++...
T Consensus 236 ----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 011123356788899999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=214.27 Aligned_cols=227 Identities=21% Similarity=0.244 Sum_probs=160.2
Q ss_pred ecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||.|+||.||++... +++.+++|.+..... ..+..+..+++.++||||+++++.+..++.+|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 488999999864432 2455666788999999999999999999999999999999999
Q ss_pred HHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC------Cccccc
Q 045271 132 DFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS------EANTNR 186 (338)
Q Consensus 132 ~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~------~~~~~~ 186 (338)
..++..... ..........++++++.+.|+ +.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 998876432 333334455667777766543 4589999999875432211 012223
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||............ . ..... ......
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~~~~~--~~~~~~------ 225 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------L-NGKIE--WPEDVE------ 225 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h-cCCcC--CCcccc------
Confidence 46788999999998888999999999999999999999998643321111000 0 00000 000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+++.+||+.||.+|||+..+.+.|...+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 1234567888999999999999966666655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=213.82 Aligned_cols=229 Identities=22% Similarity=0.252 Sum_probs=158.4
Q ss_pred CCCCCceecccCCeeEEEEEE----cCCcEEEEEEeccCC-------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~ 119 (338)
+|++.+.||+|+||.||++.. .++..||+|.+.... .+....++.+++.+ +|+||+.+++.++.++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488899999999999999985 357889999986422 13355677788888 589999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
++||||+++++|.+++..... ..........+++.+|.+.|+ +.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999999988865432 222222233356666666543 4589999999976532221
Q ss_pred CccccccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 181 EANTNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.......|+..|+|||.+.+. .++.++||||||+++|+|++|..||............ ........ .. ...
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~--~~-~~~- 233 (290)
T cd05613 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE--PP-YPQ- 233 (290)
T ss_pred -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HHHhhccC--CC-CCc-
Confidence 112235688999999998754 4678999999999999999999998643221111111 10000000 00 000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
.....+.+++.+||+.||++|| ++.+++.
T Consensus 234 -------~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 234 -------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112345688889999999997 7777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=218.86 Aligned_cols=244 Identities=22% Similarity=0.257 Sum_probs=157.6
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC-------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG------- 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~------- 116 (338)
.++|++.++||+|+||.||+|.. .++..+|+|.+..... ....+|..+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46999999999999999999995 4578899998854321 2356678899999999999999987543
Q ss_pred -CEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceec
Q 045271 117 -NELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVF 175 (338)
Q Consensus 117 -~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~ 175 (338)
..+++||||+. +++...+..... ..........+++.+|.+.|+ +.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 35799999995 466665543322 222333444556666666553 45899999999765
Q ss_pred CCCCCCc---------cccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh
Q 045271 176 GGNQSEA---------NTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 176 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
....... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||..................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 3221111 11223567889999988764 5889999999999999999999998643322111111000000
Q ss_pred hccC------Cccccc--CccccccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 WCEG------NAQELM--DPVLKESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 ~~~~------~~~~~~--~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.... ...... .......... .....+.+|+.+||+.||.+|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 000000 0000000111 11134678999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=226.62 Aligned_cols=241 Identities=20% Similarity=0.233 Sum_probs=164.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCE---
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNE--- 118 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~--- 118 (338)
.+.++|++...||+|++|.||+|... ++..||+|.+.... ......++.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999954 57789999875421 1234457788999999999999998876554
Q ss_pred ---EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCC
Q 045271 119 ---LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 119 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~ 177 (338)
.++|+||+ +++|.+++...............+++.++.+.|+ +.++|+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 7799888876444444445555667777666553 4589999999986532
Q ss_pred CCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhhcc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLWCE 248 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 248 (338)
. .....++..|+|||++.+. .++.++|||||||++|+|++|..||................ .....
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 1 2234678899999998764 57899999999999999999999986433211111000000 00000
Q ss_pred CCcccccCccccc-cccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKE-SFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~-~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
............. .... .....+.+|+.+||+.||.+|||+.+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000 0000 11335678999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=215.42 Aligned_cols=239 Identities=24% Similarity=0.272 Sum_probs=162.0
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
|++.+.||+|.+|.||+|... +++.||+|.+.... .+....++.+++.++|+||+++++++.+.+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999954 48899999986542 123456777889999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--CccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 127 PNKSLDFLLFDS--TRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 127 ~~g~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+ ++|.+++... ............+++.+|.++| ++.++|+|||++........ ....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCc
Confidence 6 6898888765 2233333444455666666544 34589999999987632221 1223
Q ss_pred cccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH--------HHhhhccCC-cccccC
Q 045271 187 VVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--------TWKLWCEGN-AQELMD 256 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~ 256 (338)
..++..|+|||.+.+. .++.++|+|||||++|+|++|..||.............. .+....... ......
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567789999998876 789999999999999999999998865332111110000 000000000 000000
Q ss_pred ccccccc---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESF---ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....... .......+.+++.+||+.||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 0011335788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=193.57 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=160.7
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.|.-.++||+|+||+||+|+ ..++..||+|.+..+.. ....+|+.+++.++|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 57778999999999999999 55677899999865433 3467788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
| ..+|..+......... ......++++.|+.+ ..++.+||+|||+++.++-...+- .
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy--s 159 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--S 159 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee--e
Confidence 9 6777776654433222 222333445544443 335679999999998764322221 2
Q ss_pred ccccCCccccccccccCC-CCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCC---ccccc-----
Q 045271 186 RVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGN---AQELM----- 255 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 255 (338)
..+-|.+|++|.++.+.. |++..|+||.||++.|+.. |.+-|+.....++...+....-...... +..+.
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 346789999999999975 8999999999999999987 5555554333222221111100000000 11111
Q ss_pred ---CccccccccHHHH-HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 256 ---DPVLKESFILEEL-LKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 256 ---~~~~~~~~~~~~~-~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
......+...+.+ ..-.+++..+|.-+|.+|.+|+..++.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111111 123567888999999999999998863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=208.42 Aligned_cols=228 Identities=21% Similarity=0.315 Sum_probs=154.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccH-HHHH---H-HHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGL-QEFK---N-LIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~---~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++.+++..||.|+.|.||+++.. ++...|||.+.+..+... .++. . +++..++|.||+.+|+|..+..+++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 35667889999999999999954 477889999977655322 2221 1 3344458999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccccHH--HHHHHH-------------------HHhhhcCCCCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWN--RRMCII-------------------NGIARDHKMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~--~~~~~~-------------------~~i~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
.| ...++.+++....+.+..+. ....+. .||..+.++++||||||++..+-+...+
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 98 55566665544443332211 111122 4455577899999999999887443332
Q ss_pred ccccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 184 TNRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
....|.+.|||||-+.- ..|+..+|||||||+++||+||.+||......-. . ...... +.. +.+.
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe----~-ltkvln--~eP----P~L~ 316 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE----V-LTKVLN--EEP----PLLP 316 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH----H-HHHHHh--cCC----CCCC
Confidence 23478899999999863 3589999999999999999999999976332111 1 111111 011 2222
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.... ....+.+|+..||+.|+.+||...++|+.
T Consensus 317 ~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111 12234567777999999999999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=228.77 Aligned_cols=176 Identities=25% Similarity=0.382 Sum_probs=139.9
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC----CcccHHHHHHHHHhcCCCceeeeeeEEEeC------CEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS----SGQGLQEFKNLIAKLQHKNLVRLLGCCLEG------NELL 120 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~----~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~------~~~~ 120 (338)
.|...+.||+|+||.||+|+ ..+|..||||.+... ..+....|+++|++++|+|||+++++-+.. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 46667899999999999999 567999999998653 335677889999999999999999987653 3568
Q ss_pred EEEecCCCCCHHHHHhccCccccccHH----HHHHHHHHhhhcCCCC----------------------eEEeeecccee
Q 045271 121 LICEYMPNKSLDFLLFDSTRSVQLDWN----RRMCIINGIARDHKMN----------------------PKISDFGMARV 174 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~i~~~~~~~----------------------vkL~Dfg~a~~ 174 (338)
+|||||++|+|...+........+.-. ...++..|+.|+|..+ .||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999999765543333322 2223445565544322 69999999998
Q ss_pred cCCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
+++ ......+.||..|++||++.. +.|+.-+|.|||||++|+.+||..||...
T Consensus 174 l~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 853 334567899999999999984 78899999999999999999999998753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=215.87 Aligned_cols=240 Identities=20% Similarity=0.217 Sum_probs=173.4
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcCC------cEEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCL 114 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~------~~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~ 114 (338)
++....++++....+.+|+||.||.|.+.+. +.|-+|.++....+ .+..+..++..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 4445567888899999999999999986543 33566777655432 2444555677889999999999876
Q ss_pred e-CCEEEEEEecCCCCCHHHHHhccCc-----c----ccccHHHHHHHHHHhhhcCC------------------CCeEE
Q 045271 115 E-GNELLLICEYMPNKSLDFLLFDSTR-----S----VQLDWNRRMCIINGIARDHK------------------MNPKI 166 (338)
Q Consensus 115 ~-~~~~~lv~e~~~~g~L~~~l~~~~~-----~----~~~~~~~~~~~~~~i~~~~~------------------~~vkL 166 (338)
. ....+++++++.-|+|+.++..... . .......+.+++.++.|+|+ .++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 4 5678999999999999999973221 1 11122334456677777554 35899
Q ss_pred eeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhh
Q 045271 167 SDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
+|-.+++.+-..+.++.....-.+..||+||.+.+..|+.++|+|||||++|||+| |+.|+......+....+..+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99999998765555555545556789999999999999999999999999999998 88888654444443333322221
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
. .+..+..+++.+|..||+.+|++||++.|+...|.+--
T Consensus 518 a----------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 518 A----------------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred c----------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 1 11122334566777899999999999999999998743
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=219.66 Aligned_cols=227 Identities=24% Similarity=0.285 Sum_probs=163.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.-.+.|..-+.||+|+||.|+-|. ..+|+-+|.|.+.++. ......|.++|..++.+.||.+--+|+..+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 334578888999999999999999 4568889999885433 234566778999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~ 179 (338)
+||..|+||+|...|.+.+. ........+-.+++|+.+ |..++++|+|+|+|..++...
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999887766553 222233444455555554 556789999999999875433
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
. ....+||..|||||++.++.|+..+|+||+||++|||+.|+.||....-...... ..+... ....+..+.
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~-~~~~ey~~k-- 412 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTL-EDPEEYSDK-- 412 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHh-cchhhcccc--
Confidence 2 3334899999999999999999999999999999999999999974332221100 001000 000111111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMS 290 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 290 (338)
....+.+|.+.+|+.||++|...+
T Consensus 413 -------FS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 413 -------FSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -------cCHHHHHHHHHHHccCHHHhccCC
Confidence 112345566679999999998554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=216.10 Aligned_cols=223 Identities=22% Similarity=0.230 Sum_probs=160.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~ 119 (338)
....+|..+..||.|+||.|.++.. .+...+|||+++++. .+-...|.++|... +-|.+++++..|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 3345899999999999999999994 446678999987643 22234455566554 367899999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCccc-cccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSV-QLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~~ 180 (338)
|+||||+.+|+|...+++-++.. +.+...+..++-|+.+ +..+++||+|||+|+--- -.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~ 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FD 503 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc--cC
Confidence 99999999999988887655532 2233333344444443 445779999999997531 12
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.....++|||+-|+|||++.-.+|+.++|+|||||+||||+.|++||....-.+....+... +
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------n---------- 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------N---------- 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------c----------
Confidence 33345789999999999999999999999999999999999999999754332221111111 1
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTM 289 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 289 (338)
.+.+..-..+++++.+..|...|.+|...
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 11222233456677778999999999754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=224.74 Aligned_cols=223 Identities=20% Similarity=0.193 Sum_probs=162.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
+.+.|++...+|.|+|+.|..|.+ .+.+..++|.+.+...+...+....+..-+||||+++.+++.++.+.|+|||.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 567899999999999999999994 4577789999976633333333345566789999999999999999999999999
Q ss_pred CCCHHHHHhccCccccccHHHHHHHH------------------HHhhh-cCCCCeEEeeeccceecCCCCCCccccccc
Q 045271 128 NKSLDFLLFDSTRSVQLDWNRRMCII------------------NGIAR-DHKMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~~~~~~~~~~~------------------~~i~~-~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
++.+.+-+............+..+++ .||.+ +..++++|+|||.++..... ..+.|
T Consensus 400 g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~ 474 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPA 474 (612)
T ss_pred ccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccc
Confidence 99887777655544333322233333 33444 34566999999999876432 33456
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (338)
-|..|.|||++....|+.++||||||++||+|++|..||...+.+ ........ .......-.
T Consensus 475 ~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~-------------~~~~s~~vS 536 (612)
T KOG0603|consen 475 LTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQ-------------MPKFSECVS 536 (612)
T ss_pred hhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhc-------------CCccccccC
Confidence 788999999999889999999999999999999999999765544 11111110 000001112
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 269 LKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 269 ~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+.+|+.+||+.||.+||++.++..
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhcc
Confidence 24567888899999999999999974
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=207.19 Aligned_cols=216 Identities=25% Similarity=0.271 Sum_probs=156.4
Q ss_pred ecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 59 LGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 59 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
||.|+||.||++... +++.+|+|.+..... .....+..+++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 478899999865432 2456677889999999999999999999999999999999999
Q ss_pred HHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 132 DFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 132 ~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
.+++..... .....+....+++.++.+.|+ +.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 988865532 333334455567777666443 458999999998763321 11233567889
Q ss_pred cccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHH
Q 045271 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRI 272 (338)
Q Consensus 193 y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (338)
|+|||...+..++.++|+||||+++|+|++|..||........ ...... . ...+.... ...+.
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~--~~~~~~~~--------~~~l~ 221 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI------YEKILK-D--PLRFPEFL--------SPEAR 221 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHhc-C--CCCCCCCC--------CHHHH
Confidence 9999999888889999999999999999999999864322110 000000 0 00011111 23456
Q ss_pred HHHhhccCCCCCCCCCH---HHHH
Q 045271 273 HIGLLCVQEDPADRPTM---SSVV 293 (338)
Q Consensus 273 ~li~~cl~~dP~~Rps~---~~vl 293 (338)
+++.+||..||++|||+ .+++
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHH
Confidence 78889999999999999 5554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=207.08 Aligned_cols=239 Identities=19% Similarity=0.212 Sum_probs=165.2
Q ss_pred HHHhcCCCC-CceecccCCeeEEEEE-EcCCcEEEEEEeccCCc---ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEE
Q 045271 47 HEATRNFSN-ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG---QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 47 ~~~~~~y~~-~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~ 120 (338)
..+.+-|++ .++||+|+|+.|..|. ..++..+|||++.+... ....+|.+++.+. .|+||+.++++|+++..+|
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 345555666 4689999999999999 78899999999976533 3455566666555 5999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcCCC---------------------CeEEeeeccceecCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDHKM---------------------NPKISDFGMARVFGGN 178 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~~~---------------------~vkL~Dfg~a~~~~~~ 178 (338)
+|||.|.||.|...+..+... ..........++.++.++|+. -+||+||.++..+...
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999999999998777655443 233333444466666655543 2899999887544222
Q ss_pred CCC-----ccccccccCCccccccccc---cC--CCCcccchHhHhHHHHHHHhCCCCCccccccc-----ccchhhHHH
Q 045271 179 QSE-----ANTNRVVGTYGYMAPEYAL---EG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ-----GQSLLTYTW 243 (338)
Q Consensus 179 ~~~-----~~~~~~~gt~~y~aPE~~~---~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~-----~~~~~~~~~ 243 (338)
... ....+.+|+..|||||+.. +. .|+.++|.|||||++|-|++|.+||...-..+ +...-...
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ- 311 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ- 311 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH-
Confidence 221 2234568999999999875 22 48999999999999999999999998643211 11111000
Q ss_pred hhhccCCcccccCccccccc------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 244 KLWCEGNAQELMDPVLKESF------ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..++.....+.. .........+++..+|..|+.+|.++.+++.
T Consensus 312 --------~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 --------NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --------HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111111 1122335667888899999999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=220.76 Aligned_cols=232 Identities=19% Similarity=0.238 Sum_probs=168.5
Q ss_pred ChhHHHHHhcCCCCC--ceecccCCeeEEEEE-EcCCcEEEEEEecc-----CCcccHHHHHHHHHhcCCCceeeeeeEE
Q 045271 42 PLDLIHEATRNFSNE--NKLGEGGFGPVYKGV-LNDDKEIAVKRLSR-----SSGQGLQEFKNLIAKLQHKNLVRLLGCC 113 (338)
Q Consensus 42 ~~~~~~~~~~~y~~~--~~iG~G~~g~V~~~~-~~~~~~vavK~~~~-----~~~~~~~~~~~~l~~l~hpnIv~~~~~~ 113 (338)
.+++-..+..-|++. +.||+|.||+||-|. .++|+.||||++.+ +....++.|..||+.+.||.||.+.-.|
T Consensus 553 qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ 632 (888)
T KOG4236|consen 553 QIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF 632 (888)
T ss_pred hhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee
Confidence 333444455556663 799999999999999 45689999999854 3345688899999999999999999999
Q ss_pred EeCCEEEEEEecCCCCCHHHHH-hccCccc--cccHHHHHHHHHHhhhcCC---------------------CCeEEeee
Q 045271 114 LEGNELLLICEYMPNKSLDFLL-FDSTRSV--QLDWNRRMCIINGIARDHK---------------------MNPKISDF 169 (338)
Q Consensus 114 ~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~--~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Df 169 (338)
+..+.+++|||.+ .|+....+ ....... ........+++.++.|+|. +++|||||
T Consensus 633 ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 633 ETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred cCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence 9999999999999 55555544 3322222 2223344456666666554 35899999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc-chhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ-SLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~-~~~~~~~~~~~~ 248 (338)
|+|+.++. .......+||+.|+|||+++++.|+..-|+||+||++|.-+.|.+||.....-+.+ +...+. +.+
T Consensus 712 GfARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM---yPp 785 (888)
T KOG4236|consen 712 GFARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM---YPP 785 (888)
T ss_pred cceeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc---cCC
Confidence 99999853 23345679999999999999999999999999999999999999999753321111 111000 001
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
.+..+....+++||..+|+..-.+|.|....+
T Consensus 786 -------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 -------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11122233567888889999999999998765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=214.23 Aligned_cols=242 Identities=21% Similarity=0.234 Sum_probs=154.9
Q ss_pred CCCCCceecccCCeeEEEEEEc-C--CcEEEEEEeccCC-----cccHHHHHHHHHhc-CCCceeeeeeEEEe----CCE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-D--DKEIAVKRLSRSS-----GQGLQEFKNLIAKL-QHKNLVRLLGCCLE----GNE 118 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~--~~~vavK~~~~~~-----~~~~~~~~~~l~~l-~hpnIv~~~~~~~~----~~~ 118 (338)
+|++.+.||+|+||.||++... . +..||+|.+.... .+....|..+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999953 3 6789999886432 12345567778877 59999999987543 245
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
++++++|+. ++|...+..... ..........+++.++.+.|+ +.+||+|||++..+....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999984 688877754332 223334445566776666553 458999999998764222
Q ss_pred CC--ccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------Hhhhcc
Q 045271 180 SE--ANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCE 248 (338)
Q Consensus 180 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 248 (338)
.. .......|+..|+|||.+.+ ..++.++||||+||++|+|++|..||............... ......
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 11 11223578999999998876 46899999999999999999999998643211100000000 000000
Q ss_pred CCcccccCccccc-cccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKE-SFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~-~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
............. ..... ....+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00000 1234667899999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=229.38 Aligned_cols=124 Identities=21% Similarity=0.286 Sum_probs=98.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|+++++||+|+||.||+|... ++..||||++..... ..+..+..+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999965 578899999864321 3455667788899999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccce
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMAR 173 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~ 173 (338)
|||+.+++|..++..... .......+..+++.+|.++|. +.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998865332 223344555567777766553 458999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=230.57 Aligned_cols=233 Identities=25% Similarity=0.365 Sum_probs=164.1
Q ss_pred HHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC-----
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG----- 116 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~----- 116 (338)
.....+|+.++.||+|+||.||+++ .-+|..||||++.-... ..+.+|+.++..|+|||||+++..+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4567789999999999999999999 66899999999865432 3466788899999999999987653100
Q ss_pred --------------------------------------------------------------------------------
Q 045271 117 -------------------------------------------------------------------------------- 116 (338)
Q Consensus 117 -------------------------------------------------------------------------------- 116 (338)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CEEEEEEecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC
Q 045271 117 ----------------------------------NELLLICEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH 160 (338)
Q Consensus 117 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~ 160 (338)
-.+||-||||+...+.+++...... ....|....++++|++|.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1257788888877787777765553 5567778888999999977
Q ss_pred C------------------CCeEEeeeccceecC----------------CCCCCccccccccCCccccccccccCC---
Q 045271 161 K------------------MNPKISDFGMARVFG----------------GNQSEANTNRVVGTYGYMAPEYALEGL--- 203 (338)
Q Consensus 161 ~------------------~~vkL~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--- 203 (338)
+ .+|||+|||+|.... ........+..+||.-|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 5 359999999998621 001112334568999999999998654
Q ss_pred CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCC
Q 045271 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDP 283 (338)
Q Consensus 204 ~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP 283 (338)
|+.|+||||+||+++||+. ||...+ ........ ...+.++.. . ............+|++|++.||
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsM-----ERa~iL~~-LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSM-----ERASILTN-LRKGSIPEP--A----DFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchH-----HHHHHHHh-cccCCCCCC--c----ccccccchHHHHHHHHHhcCCC
Confidence 9999999999999999985 343211 11111111 112222221 0 1111222234568889999999
Q ss_pred CCCCCHHHHHH
Q 045271 284 ADRPTMSSVVF 294 (338)
Q Consensus 284 ~~Rps~~~vl~ 294 (338)
.+||||.|+|.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-29 Score=205.50 Aligned_cols=243 Identities=20% Similarity=0.263 Sum_probs=161.0
Q ss_pred cCCCCCceecccCCeeEEEEE-EcCCcEEEEEEecc-C----CcccHHHHHHHHHhcCCCceeeeeeEEEe--------C
Q 045271 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSR-S----SGQGLQEFKNLIAKLQHKNLVRLLGCCLE--------G 116 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~-~----~~~~~~~~~~~l~~l~hpnIv~~~~~~~~--------~ 116 (338)
..|+-..+||+|.||.||+|+ ..+++.||+|++-- . ......+++.+|..++|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 468888999999999999999 44577789876522 1 22345677889999999999999988753 3
Q ss_pred CEEEEEEecCCCCCHHHHHhccCccccc--cHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecC
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRSVQL--DWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFG 176 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~ 176 (338)
..+|+||.+| ..+|.-++.+......+ .......+++|+.+ +.++.+||+|||+++.+.
T Consensus 97 ~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 97 ATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred ceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 4589999999 56676666554222111 11222234444444 445679999999997664
Q ss_pred CCCC--CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 177 GNQS--EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 177 ~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
..+. .......+-|.+|++||.+.+. .|+++.|||+.||++.||.+|.+-++.....+....+....-...+..++.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 3222 2223334568999999999987 599999999999999999999987776555444444333222111111111
Q ss_pred -----cc-----Ccccccccc-HHH-------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 -----LM-----DPVLKESFI-LEE-------LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 -----~~-----~~~~~~~~~-~~~-------~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+. .+...+... .++ .....+++.++|.+||.+|+++.+++.
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11 111111100 111 114678999999999999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-28 Score=216.58 Aligned_cols=236 Identities=20% Similarity=0.245 Sum_probs=173.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCc-EEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDK-EIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~-~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
..+++++..||-|+||.|=++...... .+|+|.+++. ..++...|..+|...+.|.||++|-.|.+..++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 457788899999999999999854433 4788887543 234566677888899999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCcccc-ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQ-LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||-|-||.|..+++.++.... ......-|+++++.|+|. +=+||.|||+|+.+. ....
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---cCCc
Confidence 999999999999988766433 233445566666666554 448999999999884 3444
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.-++|||+.|.|||++.+...+.++|.||+||++|||++|.+||.....-...+.+..+. .....+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------d~i~~P-------- 641 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------DKIEFP-------- 641 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------hhhhcc--------
Confidence 567899999999999999999999999999999999999999997533222222221111 011111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHH---HHhhcCcccc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVV---FMLATDTITL 303 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl---~~L~~~~~~~ 303 (338)
........++|+++...+|.+|.. +.||- ++..-+|+++
T Consensus 642 -r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 642 -RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred -cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 111224567888889999999997 56664 3455556554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-29 Score=206.93 Aligned_cols=230 Identities=23% Similarity=0.305 Sum_probs=154.6
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHH-HHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKN-LIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++.+-+..||.|+||+|++..+ ..++..|||.+..... +.+..+.. +++.-+.||||++||++..++..||-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4566678999999999999995 4588899999965433 22233332 5567789999999999988888999999
Q ss_pred cCCCCCHHHHHhc------cCcccc-------------------ccHHHHHHHHHHhhhcCCCCeEEeeeccceecCCCC
Q 045271 125 YMPNKSLDFLLFD------STRSVQ-------------------LDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 125 ~~~~g~L~~~l~~------~~~~~~-------------------~~~~~~~~~~~~i~~~~~~~vkL~Dfg~a~~~~~~~ 179 (338)
.| .-+|+.+-+. ...+.. +.+.|+...-.||..+..+.+||||||+|..+-+
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 99 6666544321 111110 1111222233455567778899999999987632
Q ss_pred CCccccccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
....+.-.|...|||||-+... .|+.++|+||+|++|||+.||.+||...... .......-. +.. ..
T Consensus 221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv~-gdp----p~ 289 (361)
T KOG1006|consen 221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVVI-GDP----PI 289 (361)
T ss_pred -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHHc-CCC----Ce
Confidence 2222334688899999998743 4899999999999999999999998754321 111111111 111 11
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+.......-...+..|+--||..|-..||...++++
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1222222333445667788899999999999999885
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=197.44 Aligned_cols=200 Identities=14% Similarity=0.061 Sum_probs=140.5
Q ss_pred cCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHhccCc
Q 045271 62 GGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR 140 (338)
Q Consensus 62 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 140 (338)
|.+|.||++.. .+++.||+|.+..... ...+...+....||||+++++++.+.+.+++||||+++|+|.+++.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 81 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN 81 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC
Confidence 89999999994 5678899999865432 22333444556799999999999999999999999999999888755432
Q ss_pred -cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccccCCcccccccccc
Q 045271 141 -SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201 (338)
Q Consensus 141 -~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (338)
..........+++.++.+.|+ +.++|+|||.+...... .....++..|+|||.+.+
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGI 156 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCC
Confidence 222233444556666666554 45899999987654221 122355678999999988
Q ss_pred CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCC
Q 045271 202 GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQE 281 (338)
Q Consensus 202 ~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 281 (338)
..++.++|+||+||++|+|++|..|+........ ...... +.. .....+.+++.+||+.
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~~~~-~~~--------~~~~~~~~li~~~l~~ 215 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THTTLN-IPE--------WVSEEARSLLQQLLQF 215 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cccccC-Ccc--------cCCHHHHHHHHHHccC
Confidence 8899999999999999999999987643211000 000000 000 0112456788899999
Q ss_pred CCCCCCCH
Q 045271 282 DPADRPTM 289 (338)
Q Consensus 282 dP~~Rps~ 289 (338)
||++|||+
T Consensus 216 dp~~R~~~ 223 (237)
T cd05576 216 NPTERLGA 223 (237)
T ss_pred CHHHhcCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=198.57 Aligned_cols=228 Identities=20% Similarity=0.261 Sum_probs=157.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHH-hcCCCceeeeeeEEEeCCEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIA-KLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~-~l~hpnIv~~~~~~~~~~~~~ 120 (338)
...+|.++..||+|+|+.|.++++ .+.+.+|+|++++.- .+-.+.|..+.. ..+||.+|.++..|.....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 346899999999999999999994 456778999986531 233555655554 457999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhh------------------cCCCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIAR------------------DHKMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~------------------~~~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+|.||+++|+|...++..... ........-.+..++++ +..+++||+|+|+|+.-- ...
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--CCC
Confidence 999999999997766554332 21122222223333333 445679999999997532 223
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccch-hhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL-LTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
....++|||+.|.|||++.+..|+..+|+|++||+++||+.|+.||.....++.... ..+.+...... -++
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------qir 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------QIR 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--------ccc
Confidence 345678999999999999999999999999999999999999999986544443221 12222221111 111
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPT 288 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps 288 (338)
.+. .-..++-.+++.-|+.||.+|..
T Consensus 478 ipr--slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 IPR--SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ccc--eeehhhHHHHHHhhcCCcHHhcC
Confidence 100 01123344666689999999964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=201.79 Aligned_cols=93 Identities=19% Similarity=0.310 Sum_probs=70.4
Q ss_pred ChhHHHHHh-cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHhcC-----C---Cceeee
Q 045271 42 PLDLIHEAT-RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQ-----H---KNLVRL 109 (338)
Q Consensus 42 ~~~~~~~~~-~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~l~~l~-----h---pnIv~~ 109 (338)
|+.....+. .+|.+.++||.|.|++||+|.. .....||+|+++.. ..+....|+++|++++ | .+||++
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 334445666 7999999999999999999994 45667899998643 3345666778887763 3 479999
Q ss_pred eeEEEe----CCEEEEEEecCCCCCHHHHH
Q 045271 110 LGCCLE----GNELLLICEYMPNKSLDFLL 135 (338)
Q Consensus 110 ~~~~~~----~~~~~lv~e~~~~g~L~~~l 135 (338)
+|.|.. +.++|||+|++ |.+|..+|
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI 176 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLI 176 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHH
Confidence 999974 56899999999 55554444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=215.94 Aligned_cols=221 Identities=26% Similarity=0.319 Sum_probs=165.6
Q ss_pred CCceecccCCe-eEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 55 NENKLGEGGFG-PVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 55 ~~~~iG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
--+.+|.|+.| .||+|.. .++.||||.+-....+...+|+..|+.- +|||||++++.-.++.+.||..|.| ..+|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 34678999887 5699998 6779999998777777888898888765 5999999999999999999999999 89999
Q ss_pred HHHhccCc-cc----cccHHHHHHHHHHhhhcCCC-----------------------CeEEeeeccceecCCCCCC-cc
Q 045271 133 FLLFDSTR-SV----QLDWNRRMCIINGIARDHKM-----------------------NPKISDFGMARVFGGNQSE-AN 183 (338)
Q Consensus 133 ~~l~~~~~-~~----~~~~~~~~~~~~~i~~~~~~-----------------------~vkL~Dfg~a~~~~~~~~~-~~ 183 (338)
+++..... .. -..+....+++.|++|+|.. .++|+|||+|+.+...... .+
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r 670 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR 670 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc
Confidence 99977411 11 12355666788888887653 3799999999988654332 23
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhC-CCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG-RKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....||-.|+|||++.+..-+.++||+|+||++|+.++| .+||......+..... .......+..
T Consensus 671 ~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~~L~~----- 737 (903)
T KOG1027|consen 671 LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLVHLEP----- 737 (903)
T ss_pred ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccceeeecc-----
Confidence 4557899999999999988888899999999999999986 8899754333221100 0000000000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
...+ .+.+||.+|+.+||..||||.+||
T Consensus 738 -~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 -LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0111 667899999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=188.61 Aligned_cols=216 Identities=25% Similarity=0.278 Sum_probs=153.4
Q ss_pred CCeeEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHhc
Q 045271 63 GFGPVYKGVLN-DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFD 137 (338)
Q Consensus 63 ~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 137 (338)
+||.||+|... ++..+|+|.+.... .+.+..+.+.++.++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 48889999986543 34566777888999999999999999999999999999999999988865
Q ss_pred cC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccccCCccccccc
Q 045271 138 ST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198 (338)
Q Consensus 138 ~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 198 (338)
.. ......+....+++.++.+.| ++.++|+|||.+....... ......++..|+|||.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV 157 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence 44 222233344444555555533 3568999999998764322 2233567889999999
Q ss_pred cccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhc
Q 045271 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLC 278 (338)
Q Consensus 199 ~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 278 (338)
+.+..++.++||||||+++|+|++|..||..... ......... ..... ..... ......+.+++.+|
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~----~~~~~-~~~~~------~~~~~~~~~~i~~~ 224 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG----KPKPP-FPPPE------WKISPEAKDLIRKL 224 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh----ccCCC-Ccccc------ccCCHHHHHHHHHH
Confidence 9888889999999999999999999999864211 111111000 00000 00000 00113456788899
Q ss_pred cCCCCCCCCCHHHHHH
Q 045271 279 VQEDPADRPTMSSVVF 294 (338)
Q Consensus 279 l~~dP~~Rps~~~vl~ 294 (338)
|..||++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=208.18 Aligned_cols=250 Identities=18% Similarity=0.148 Sum_probs=171.1
Q ss_pred CChhHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhcC------CCceeeeee
Q 045271 41 FPLDLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQ------HKNLVRLLG 111 (338)
Q Consensus 41 ~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~------hpnIv~~~~ 111 (338)
+.+.....+-.+|.+....|+|-|++|..|.. ..+..||||+|.+... +.-..|+++|+.|+ --|+++++-
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 34445566777999999999999999999994 4477999999976543 33456778999886 348999999
Q ss_pred EEEeCCEEEEEEecCCCCCHHHHHhccCccccccH----HHHHHHHHHhhh------cC-------------CCCeEEee
Q 045271 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW----NRRMCIINGIAR------DH-------------KMNPKISD 168 (338)
Q Consensus 112 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~----~~~~~~~~~i~~------~~-------------~~~vkL~D 168 (338)
.|...+++|||||-+ .-+|..+++.-+....+.+ ....++..+|.+ +| +..+||||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 999999999999998 8899999987665433221 112222222211 11 23489999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH------
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT------ 242 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~------ 242 (338)
||.|.....+. .....-+..|.|||++.+.+|+...|+||+||+||||.||+.-|+.....++..+....
T Consensus 581 fGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 581 FGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred Ccccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99998764332 22345677899999999999999999999999999999999877765433332221111
Q ss_pred ---------HhhhccC--Cc----------------------ccccCccccc----cccHHHHHHHHHHHhhccCCCCCC
Q 045271 243 ---------WKLWCEG--NA----------------------QELMDPVLKE----SFILEELLKRIHIGLLCVQEDPAD 285 (338)
Q Consensus 243 ---------~~~~~~~--~~----------------------~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~ 285 (338)
...+-.. .+ ..+...+... ......+..+.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0000000 00 0000000000 112344556788999999999999
Q ss_pred CCCHHHHHHH
Q 045271 286 RPTMSSVVFM 295 (338)
Q Consensus 286 Rps~~~vl~~ 295 (338)
|.|..++|.+
T Consensus 737 Rit~nqAL~H 746 (752)
T KOG0670|consen 737 RITVNQALKH 746 (752)
T ss_pred cCCHHHHhcC
Confidence 9999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=211.29 Aligned_cols=243 Identities=17% Similarity=0.178 Sum_probs=140.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-C----CcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeE------EEeCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-D----DKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGC------CLEGN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~------~~~~~ 117 (338)
..++|++.+.||+|+||.||+|... + +..||+|++.......... ...++...+.++..+... ...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~-~e~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM-NERVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHH-HHHHHhhchhhHHHHHHhhhcccccccCC
Confidence 3468999999999999999999954 4 5789999876433221111 112222223333333222 23467
Q ss_pred EEEEEEecCCCCCHHHHHhccCcccc---------------------ccHHHHHHHHHHhhhcCC---------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQ---------------------LDWNRRMCIINGIARDHK--------------- 161 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------~~~~~~~~~~~~i~~~~~--------------- 161 (338)
.+++||||+++++|.+++........ .......+++.+|.+.|+
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 89999999999999988865421100 011234456666665442
Q ss_pred ----CCeEEeeeccceecCCCCCCccccccccCCccccccccccC----------------------CCCcccchHhHhH
Q 045271 162 ----MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG----------------------LFSVKSDVFSFGV 215 (338)
Q Consensus 162 ----~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiWSlGv 215 (338)
+.+||+|||+|+.+..... ......++++.|+|||.+... .++.++|||||||
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred eCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 4589999999986532211 122346789999999976432 2345679999999
Q ss_pred HHHHHHhCCCCCcccccccccchhh--HHHhhhccCCcccccCccccccccH--HHHHHHHHHHhhccCCCCCCCCCHHH
Q 045271 216 LLLEIISGRKDTRFYLYEQGQSLLT--YTWKLWCEGNAQELMDPVLKESFIL--EELLKRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 216 ~l~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~~~ 291 (338)
++|||+++..|+......-...... .....|....... ....+...... .......+|+.+||+.||++|||+.+
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 9999999776643211000000000 0000000000000 00000000000 00112457899999999999999999
Q ss_pred HHH
Q 045271 292 VVF 294 (338)
Q Consensus 292 vl~ 294 (338)
+++
T Consensus 447 ~L~ 449 (566)
T PLN03225 447 ALA 449 (566)
T ss_pred HhC
Confidence 996
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=211.41 Aligned_cols=233 Identities=21% Similarity=0.283 Sum_probs=162.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCccc---HHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG---LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
...++|++++.+|.|+||.||+++ ..+++..|+|.++-...+. .+.|+-+++..+||||+.+++.+...+.+|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 345699999999999999999999 6678888999997655443 456666788999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCccccccHH-HHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWN-RRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||.+|+|.++-+--+.-....++ .....++|+.|+| .+.+||+|||.+..+.. ...+.
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKR 169 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhhhh
Confidence 999999998766443322222221 2223445555544 35699999999987642 22334
Q ss_pred cccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
..+.||++|||||+.. .+.|+..+|||++|++..|+..-++|-....... .........+.+ +.++.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~qp--------p~lkD 239 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQP--------PTLKD 239 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCCC--------CcccC
Confidence 5689999999999986 4469999999999999999988777643322111 111111111111 11111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
... ....+-+|++.||..+|++|||++-+|.
T Consensus 240 k~k--ws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTK--WSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Ccc--chHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 1122345777799999999999987763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=201.66 Aligned_cols=184 Identities=22% Similarity=0.295 Sum_probs=138.9
Q ss_pred CCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
-|..++.||-|+||.|-+++..+ ...+|.|.+.+.. ....+.|..||..-+.+=||+||-.|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46678999999999999999544 5568999886532 2345677789999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcccc-ccHHHHHHHH------------------HHhhhcCCCCeEEeeeccceecCC--------
Q 045271 125 YMPNKSLDFLLFDSTRSVQ-LDWNRRMCII------------------NGIARDHKMNPKISDFGMARVFGG-------- 177 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~------------------~~i~~~~~~~vkL~Dfg~a~~~~~-------- 177 (338)
|++||++..++...+.... +.....-.+. .||+.|.++++||+|||+|.-+..
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999999888876655432 1111111122 233446678899999999964310
Q ss_pred CCCC--------------------------------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCC
Q 045271 178 NQSE--------------------------------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRK 225 (338)
Q Consensus 178 ~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~ 225 (338)
...+ ......+||+.|+|||++....|+..+|+||.|||||||+.|+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 0000 01123579999999999999999999999999999999999999
Q ss_pred CCcccccccc
Q 045271 226 DTRFYLYEQG 235 (338)
Q Consensus 226 Pf~~~~~~~~ 235 (338)
||......+.
T Consensus 870 pf~~~tp~~t 879 (1034)
T KOG0608|consen 870 PFLADTPGET 879 (1034)
T ss_pred CccCCCCCcc
Confidence 9986554443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=181.58 Aligned_cols=244 Identities=18% Similarity=0.267 Sum_probs=164.8
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHhcC-CCceeeeeeEEEeC--CEEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEG--NELLLIC 123 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~ 123 (338)
...++|++.+++|+|.|+.||.|. ..++..++||.++....+.+.+|+.+|+.|. ||||++++++..+. ....+|+
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 356799999999999999999999 5668889999999988899999999999987 99999999999875 4578999
Q ss_pred ecCCCCCHHHHHhccCcc------ccccHHHHHHHHHHhhh----------cCC-CCeEEeeeccceecCCCCCCccccc
Q 045271 124 EYMPNKSLDFLLFDSTRS------VQLDWNRRMCIINGIAR----------DHK-MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~----------~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
||+++.+...+....... .++..+...|+..||.| +|. ..++|+|+|+|.+...... .+-
T Consensus 115 E~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnV 191 (338)
T KOG0668|consen 115 EYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNV 191 (338)
T ss_pred hhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce---eee
Confidence 999988876655322111 01111222334444433 222 2489999999988643322 223
Q ss_pred cccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCccccccccc-chhh----------HHHh--hhccCCcc
Q 045271 187 VVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ-SLLT----------YTWK--LWCEGNAQ 252 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~-~~~~----------~~~~--~~~~~~~~ 252 (338)
.+.+.+|-.||.+.+- .|+..-|+|||||++..|+..+-||........+ ..+. +..+ ........
T Consensus 192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~ 271 (338)
T KOG0668|consen 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFE 271 (338)
T ss_pred eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHh
Confidence 4668889999999875 4899999999999999999999999754321111 1110 0000 00000000
Q ss_pred cccCc--------cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 ELMDP--------VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.++.. .+......-...+.++|+.++|.+|..+|+||+|++.
T Consensus 272 ~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 272 DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00000 0000000011235678888999999999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=200.60 Aligned_cols=175 Identities=22% Similarity=0.276 Sum_probs=141.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCc-----------ccHHHHHHHHHhcC---CCceeeeeeEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSG-----------QGLQEFKNLIAKLQ---HKNLVRLLGCCL 114 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-----------~~~~~~~~~l~~l~---hpnIv~~~~~~~ 114 (338)
..+|..++.+|+|+||.|++|.++. ...|+||.+.+... -..-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3479999999999999999999654 56789999865432 12446778888887 999999999999
Q ss_pred eCCEEEEEEecC-CCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCC------------------CeEEeeecccee
Q 045271 115 EGNELLLICEYM-PNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARV 174 (338)
Q Consensus 115 ~~~~~~lv~e~~-~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~ 174 (338)
+++++|++||-- ++-+|.+++..+.. ...+...+..|+..++.+.|+. -+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999985 34567777765443 4456677888888888887754 389999999987
Q ss_pred cCCCCCCccccccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCc
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
.. ......+.||..|.|||++.+.+|- ..-|||++||+||.++....||+
T Consensus 720 ~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 52 3334468999999999999999874 56899999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=192.95 Aligned_cols=238 Identities=16% Similarity=0.172 Sum_probs=140.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-----------------cCCcEEEEEEeccCCccc-----------------HHHH
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-----------------NDDKEIAVKRLSRSSGQG-----------------LQEF 94 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~-----------------~~~~ 94 (338)
..++|++.++||+|+||.||+|.. ..+..||||.+....... ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 366899999999999999999963 234569999986432211 1112
Q ss_pred HHHHHhcCCCc-----eeeeeeEEEe--------CCEEEEEEecCCCCCHHHHHhccCccc-------------------
Q 045271 95 KNLIAKLQHKN-----LVRLLGCCLE--------GNELLLICEYMPNKSLDFLLFDSTRSV------------------- 142 (338)
Q Consensus 95 ~~~l~~l~hpn-----Iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------- 142 (338)
..++..++|.+ +++++++|.. .+..++||||+++++|.+++.......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 33445555544 4677777653 356899999999999998886432110
Q ss_pred ------cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccccCCccccccc
Q 045271 143 ------QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198 (338)
Q Consensus 143 ------~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 198 (338)
........+++.++.+.| +..+||+|||++......... ......+++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 011123334555555544 345899999999754321111 1111234789999999
Q ss_pred cccCC--------------------CC--cccchHhHhHHHHHHHhCCC-CCccccccccc-c---hhhHHHhhhccCCc
Q 045271 199 ALEGL--------------------FS--VKSDVFSFGVLLLEIISGRK-DTRFYLYEQGQ-S---LLTYTWKLWCEGNA 251 (338)
Q Consensus 199 ~~~~~--------------------~~--~~~DiWSlGv~l~el~~g~~-Pf~~~~~~~~~-~---~~~~~~~~~~~~~~ 251 (338)
+.... |+ .+.||||+||++|+|++|.. ||......+.. . .....|+.......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 86432 22 24799999999999999875 55432111110 0 00001111111110
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDP---ADRPTMSSVVFM 295 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~Rps~~~vl~~ 295 (338)
..+......-...+|+.+||..+| .+|+|+.|+|.+
T Consensus 462 --------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 --------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 001001112345678888999766 789999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-24 Score=176.92 Aligned_cols=239 Identities=15% Similarity=0.204 Sum_probs=161.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCcc--cHHHHHHH-HHhcCCCceeeeeeE-EEeCCEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQ--GLQEFKNL-IAKLQHKNLVRLLGC-CLEGNELLLI 122 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~-l~~l~hpnIv~~~~~-~~~~~~~~lv 122 (338)
.+.+.|.+.+.||+|.||.+.+|+++. ...+++|.+.+.... ++.+|..- +-.-.|.||+..|++ |+..+.++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 345789999999999999999999655 556889988764432 22222211 112248999998874 6778899999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC--------------------CeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM--------------------NPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------------~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||++.|+|...+...+........+.-+++.+|.+.|+. ++||||||.....+.
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~----- 175 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT----- 175 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc-----
Confidence 9999999999888777666666666677777777776654 389999999876421
Q ss_pred cccccccCCcccccccccc---CC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 183 NTNRVVGTYGYMAPEYALE---GL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~---~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.....--+..|.+||++.. +. .++..|||.|||++|..++|++||+.....+. .-..+..|.......+++.
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccCccCchh
Confidence 1112234557999998863 32 46889999999999999999999985433222 2222333433333333332
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.-..+. .++.+.++-|+.+|++|--..++.++-...|
T Consensus 253 F~~fs~------~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 253 FNPFSE------KALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred hcccCH------HHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 222222 2333445689999999966666554444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=164.50 Aligned_cols=188 Identities=33% Similarity=0.520 Sum_probs=146.3
Q ss_pred ecccCCeeEEEEEEcC-CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHHH
Q 045271 59 LGEGGFGPVYKGVLND-DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDF 133 (338)
Q Consensus 59 iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~ 133 (338)
||+|.+|.||++.... ++.+++|.+..... +.+.++...++.+.|++|+++++++......+++||++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999644 88899999976654 567788889999999999999999999899999999999899999
Q ss_pred HHhcc--CccccccHHHHHHHHHHhhh------------------cC-CCCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 134 LLFDS--TRSVQLDWNRRMCIINGIAR------------------DH-KMNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 134 ~l~~~--~~~~~~~~~~~~~~~~~i~~------------------~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
++... .......+....+++.++.+ .. ...++|+|||.+........ ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCC
Confidence 98764 22222333333444444443 22 46789999999987632211 1223457788
Q ss_pred cccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHH
Q 045271 193 YMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKR 271 (338)
Q Consensus 193 y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (338)
|++||.+... .++.+.|+|++|+++++| ..+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~ 190 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PEL 190 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHH
Confidence 9999998877 788999999999999999 234
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHh
Q 045271 272 IHIGLLCVQEDPADRPTMSSVVFML 296 (338)
Q Consensus 272 ~~li~~cl~~dP~~Rps~~~vl~~L 296 (338)
.+++.+||+.||++||++.++++.|
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5677789999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-24 Score=179.75 Aligned_cols=249 Identities=19% Similarity=0.267 Sum_probs=165.2
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCC-----EEE
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN-----ELL 120 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 120 (338)
+.+--+-||-|+||.||.+. -++++.||+|++.... .+..-++.++|..++|.|++..+|+..... ++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 55667899999999999999 5679999999885432 345666778888999999999999887543 367
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCCC------------------eEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKMN------------------PKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~~------------------vkL~Dfg~a~~~~~~~~~ 181 (338)
++.|.+ ..+|..++..... +.........+++.|+.|+|.-+ +||+|||+++.....+.
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~- 211 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR- 211 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence 888888 6777766654332 33334556678888888876532 79999999986532222
Q ss_pred ccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH--------hhhccCCcc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------KLWCEGNAQ 252 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~ 252 (338)
......+-|.+|+|||++.+.. |+.++||||+||++.||+..+.-|+....-+....+.... +..+.+--.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2233446688999999999875 9999999999999999998887776443323222222110 000000000
Q ss_pred cccCccccc---------cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 253 ELMDPVLKE---------SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 253 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.++...... +.....-...+.+...+|..||++|.+..+.+..+-...-+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 001000000 00001111234555669999999999999999877665544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=175.65 Aligned_cols=174 Identities=25% Similarity=0.283 Sum_probs=133.3
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC-----CcccHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS-----SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGN------ 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~------ 117 (338)
..+|.-++.+|.|.- .|-.+. .-.+..||+|++... ...+..+|..++..++|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 447888899999988 666666 345788999987432 1234566777889999999999999998543
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC------------------CeEEeeeccceecCCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM------------------NPKISDFGMARVFGGNQ 179 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~------------------~vkL~Dfg~a~~~~~~~ 179 (338)
.+|+|||+| ..+|..++.. .........+..++++|+.|.|+. .+||.|||+|+.-.
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~--- 169 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED--- 169 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC---
Confidence 579999999 7888877762 222233345566777888776653 38999999998742
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
..-..+..+.+..|.|||++.+..|...+||||+||++.||++|..-|+.
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 22344556889999999999998899999999999999999999876663
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=165.33 Aligned_cols=176 Identities=28% Similarity=0.350 Sum_probs=135.6
Q ss_pred CCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 53 FSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
|.+.+.||.|.+|.||+|.... ++.+++|.+.... .+.+..+...++.++|+|++++++.+...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678999999999999999654 7889999987653 3456667778889999999999999998899999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|..++..... .....+....+++.++.+.| .+.++|+|||.+......... .....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 159 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTV 159 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccce
Confidence 9999998865442 22222333344555555433 356899999999876433211 12335
Q ss_pred ccCCcccccccc-ccCCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 188 VGTYGYMAPEYA-LEGLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 188 ~gt~~y~aPE~~-~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
.++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 678889999998 556688899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=177.96 Aligned_cols=184 Identities=23% Similarity=0.348 Sum_probs=140.1
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEE-c---CCcEEEEEEeccC-CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVL-N---DDKEIAVKRLSRS-SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~---~~~~vavK~~~~~-~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~ 118 (338)
.+....+.|.++.+||+|+|++||++.. . ....||+|.+... ....+..|.++|..+ .+.||+++.+.+...+.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3566778999999999999999999993 3 4567999998643 456788888888776 48999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCC-
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGN- 178 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~- 178 (338)
..+|+||++.....++...... ........+++.+|.+.|.. .-.|.|||+|......
T Consensus 110 v~ivlp~~~H~~f~~l~~~l~~--~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSLSL--AEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred eEEEecccCccCHHHHHhcCCH--HHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999999999999888866543 22333344555666665543 3689999998721000
Q ss_pred --------------C----------------CCc-----------cccccccCCccccccccccCC-CCcccchHhHhHH
Q 045271 179 --------------Q----------------SEA-----------NTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVL 216 (338)
Q Consensus 179 --------------~----------------~~~-----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~ 216 (338)
. ... ......||+.|+|||++...+ .++++||||.||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 000 001136899999999999875 7899999999999
Q ss_pred HHHHHhCCCCCccc
Q 045271 217 LLEIISGRKDTRFY 230 (338)
Q Consensus 217 l~el~~g~~Pf~~~ 230 (338)
+..++++.+||...
T Consensus 268 ~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKA 281 (418)
T ss_pred eehhhccccccccC
Confidence 99999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=162.53 Aligned_cols=180 Identities=21% Similarity=0.269 Sum_probs=125.4
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCcccH----HHHH-HHHHhcCCCceeeeeeEEEeCCEE
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGL----QEFK-NLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~----~~~~-~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
+....++...+..||+|+||.|-+.+ ..+|...|+|.+...-+... ..+. .+++...+|.+|.+|+.......+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 33445567778899999999999999 45677889999865443221 1122 234566799999999999888999
Q ss_pred EEEEecCCCCCHHHHHhc----cCc-cccccHHHHHHHHHHhhh-------------------cCCCCeEEeeeccceec
Q 045271 120 LLICEYMPNKSLDFLLFD----STR-SVQLDWNRRMCIINGIAR-------------------DHKMNPKISDFGMARVF 175 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~----~~~-~~~~~~~~~~~~~~~i~~-------------------~~~~~vkL~Dfg~a~~~ 175 (338)
|+.||.| ..+|+.+-+. ... .....-.++..+.+++.+ +..++||+||||++..+
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999999 6777655432 211 111111222233333333 44578999999999887
Q ss_pred CCCCCCccccccccCCcccccccccc----CCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALE----GLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
-+ ....+.-.|...|||||.+.. ..|+.++||||||+++.||.++++||..
T Consensus 200 ~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 32 111222467778999999863 3589999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-22 Score=167.90 Aligned_cols=232 Identities=22% Similarity=0.282 Sum_probs=156.5
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEec-----cCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLS-----RSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
...++.+|.+...|..|+|+++.+..| +|++. .....++.+|.-.|+.+.||||+.+++.|....++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 455677889999999999999665544 45442 223345667777789999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCCCeEEeeecc-----------ceecCCCC--CCccccccccC
Q 045271 127 PNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKMNPKISDFGM-----------ARVFGGNQ--SEANTNRVVGT 190 (338)
Q Consensus 127 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~~vkL~Dfg~-----------a~~~~~~~--~~~~~~~~~gt 190 (338)
+.|+|..++..... ........++.++.|++++|+....|--|-+ ...+.-.+ .........-.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~ 349 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYS 349 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccccccC
Confidence 99999999976544 2334566777889999998876533332222 11111000 00011122346
Q ss_pred CccccccccccCCC--C-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 191 YGYMAPEYALEGLF--S-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 191 ~~y~aPE~~~~~~~--~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+.||+||.++.++- + .++|+|||+|++|||.|...||.....-+.-. +....+.-.. +.+.+.
T Consensus 350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------kialeglrv~-ippgis------- 415 (448)
T KOG0195|consen 350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------KIALEGLRVH-IPPGIS------- 415 (448)
T ss_pred cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------hhhhcccccc-CCCCcc-------
Confidence 88999999997753 2 57999999999999999999997654322211 1111111111 111111
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.....+|.-|...||.+||.|..|+.+|+.+
T Consensus 416 -~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 416 -RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1122355559999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=157.20 Aligned_cols=155 Identities=14% Similarity=0.036 Sum_probs=101.5
Q ss_pred CCHHHHHhccC--ccccccHHHHHHHHHHhhhcCCC------------CeEEeeeccceecCCCCCCccccccccCCccc
Q 045271 129 KSLDFLLFDST--RSVQLDWNRRMCIINGIARDHKM------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYM 194 (338)
Q Consensus 129 g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~~------------~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 194 (338)
|+|.+++.... ......+....+++.++.+.|+. .+|+ ||++...... ...|++.|+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFM 71 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeeccc-------cCCCccccc
Confidence 67888887533 33444566667788888887753 3566 9988765321 125889999
Q ss_pred cccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHH
Q 045271 195 APEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHI 274 (338)
Q Consensus 195 aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (338)
|||++.+..|+.++|||||||++|||++|..||........ ............ ................+.++
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD-----DPRDRSNLESVSAARSFADF 144 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC-----CccccccHHHHHhhhhHHHH
Confidence 99999999999999999999999999999999864321111 000000000000 00000000011111247889
Q ss_pred HhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 275 GLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 275 i~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
+.+||+.||.+|||+.++++.+...
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=180.17 Aligned_cols=176 Identities=21% Similarity=0.217 Sum_probs=109.7
Q ss_pred hcCC-CceeeeeeEE-------EeCCEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCCCC------
Q 045271 100 KLQH-KNLVRLLGCC-------LEGNELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHKMN------ 163 (338)
Q Consensus 100 ~l~h-pnIv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~~~------ 163 (338)
.++| .||++++++| .....++++||++ +++|.+++..... ..........+++.+|.|.|..+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5888888887 2335678889988 7799999865432 22334455667888887766432
Q ss_pred ------------e-------------------EEeeeccceecCCCCC--------------CccccccccCCccccccc
Q 045271 164 ------------P-------------------KISDFGMARVFGGNQS--------------EANTNRVVGTYGYMAPEY 198 (338)
Q Consensus 164 ------------v-------------------kL~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~ 198 (338)
+ |++|||+++....... .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 3 4455555543210000 000111357889999999
Q ss_pred cccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhc
Q 045271 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLC 278 (338)
Q Consensus 199 ~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 278 (338)
+.+..|+.++|||||||+||||++|..|+.... .......... .... .........+++.+|
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHRV--------LPPQ-----ILLNWPKEASFCLWL 248 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHhh--------cChh-----hhhcCHHHHHHHHHh
Confidence 999999999999999999999999887754211 0000000000 0000 011122345677889
Q ss_pred cCCCCCCCCCHHHHHH
Q 045271 279 VQEDPADRPTMSSVVF 294 (338)
Q Consensus 279 l~~dP~~Rps~~~vl~ 294 (338)
|+.||.+|||+.||++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-19 Score=173.22 Aligned_cols=238 Identities=21% Similarity=0.243 Sum_probs=152.9
Q ss_pred hcCC-CCCceecccCCeeEEEEEE-cCCcEEEEEEeccC--Cccc-------HHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 50 TRNF-SNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS--SGQG-------LQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y-~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~-------~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
.+.| .....+|.|++|.|+.+.. ...+..+.|.+... ..+. +..|..+-..+.|||++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3445 4568999999998887773 33444444443210 1111 1222223356889999998888877666
Q ss_pred EEEEEecCCCCCHHHHHhcc-CccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDS-TRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
..-+||||++ +|..++... ............+++.|+.+.|. +.+||+|||.+..+.-..
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 998888775 23333444555667767666543 468999999987653322
Q ss_pred CC--ccccccccCCccccccccccCCCCcc-cchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 180 SE--ANTNRVVGTYGYMAPEYALEGLFSVK-SDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 180 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.. ......+|+-.|+|||++.+..|.+. .||||.||+++.|.+|++||......+..... ..+ .. -.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~---~~---~~ 544 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNY---SD---QR 544 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hcc---cc---cc
Confidence 22 34456799999999999999999865 89999999999999999999754333221100 000 00 00
Q ss_pred ccccccccHHHH--HHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 257 PVLKESFILEEL--LKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 257 ~~~~~~~~~~~~--~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
....+...+..+ .....+|.+||++||.+|.|+++|++ ++++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 001111111111 12356888899999999999999984 4444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.4e-15 Score=132.88 Aligned_cols=236 Identities=26% Similarity=0.291 Sum_probs=158.0
Q ss_pred CCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCC-ceeeeeeEEEeCCEEEEEEec
Q 045271 53 FSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHK-NLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e~ 125 (338)
|.+.+.||.|+||.||++... ..+++|.+..... .....+..+++.+.|+ +|+++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778899999999999999976 7788998854332 2355666788889988 799999999877888999999
Q ss_pred CCCCCHHHHHhccC----ccccccHHHHHHHHHHhhhcC------------------CC-CeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDST----RSVQLDWNRRMCIINGIARDH------------------KM-NPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~i~~~~------------------~~-~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+.++++..++.... ...........+++.++.+.| .. .++++|||.+..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 99999997776543 222233334444555544433 23 48999999998654332211
Q ss_pred ----cccccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccc-cccchhhHHHhhhccCCcccc
Q 045271 183 ----NTNRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYE-QGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 183 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 254 (338)
......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ............... .....
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 238 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASP 238 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccccc
Confidence 2345689999999999987 56888999999999999999999996543321 000111111110000 00000
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
...... ........+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 1112345567788999999999999887754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=146.16 Aligned_cols=197 Identities=21% Similarity=0.311 Sum_probs=132.0
Q ss_pred HHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCCC-------------
Q 045271 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHKM------------- 162 (338)
Q Consensus 98 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~~------------- 162 (338)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+........ ........++.|+.+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568899999999999999999999999999999999987443222 1223334477788887753
Q ss_pred ------CeEEeeeccceecCCCCCCccccccccCCccccccccccCC-------CCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 163 ------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-------FSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 163 ------~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
.+||+|||+.................-...|.|||.+.+.. .+.++||||||++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 38999999987653211111111123345799999998641 35679999999999999999999986
Q ss_pred cccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 230 YLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.........+... ... .....+.+.+.... +....++.++.+||..+|.+||++.+|-..++..-
T Consensus 161 ~~~~~~~~eii~~--~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 161 RNLVEDPDEIILR--VKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccCChHHHHHH--HHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 5443332111111 111 12222222222111 11114667888999999999999999987776644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-14 Score=132.43 Aligned_cols=238 Identities=22% Similarity=0.203 Sum_probs=157.9
Q ss_pred CCCCCceecccCCeeEEEEEEcCC--cEEEEEEeccCCc---ccHHHHHHHHHhcC----CCceeeeeeEE-EeCCEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDD--KEIAVKRLSRSSG---QGLQEFKNLIAKLQ----HKNLVRLLGCC-LEGNELLL 121 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~--~~vavK~~~~~~~---~~~~~~~~~l~~l~----hpnIv~~~~~~-~~~~~~~l 121 (338)
+|++.++||+|+||.||.|..... ..+|+|....... ..+..|..++..+. .+++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999995453 4788887654322 25677777777776 36899999988 47788899
Q ss_pred EEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC-----------------------CCeEEeeeccce--
Q 045271 122 ICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK-----------------------MNPKISDFGMAR-- 173 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~-----------------------~~vkL~Dfg~a~-- 173 (338)
||+.+ |.+|.++..... .+......++.+++.+|...|+ ..+.|.|||+|+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99999 999988875443 2223344455555555543332 348999999998
Q ss_pred ecCCCCCC----cc--ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc
Q 045271 174 VFGGNQSE----AN--TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC 247 (338)
Q Consensus 174 ~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 247 (338)
.+...... .. ...+.||..|+++.+..+...+.+.|+||++.++.+++.|..||..................
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~-- 255 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK-- 255 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh--
Confidence 33211111 11 12356999999999999999999999999999999999999999654432221111111000
Q ss_pred cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
..... ........... ++..+-..+..++|....+...|+.....
T Consensus 256 -----~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 256 -----LLTDR--FGDLKPEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -----hcccc--ccCCChHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00000 11111222222 33334558999999999998887765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=138.84 Aligned_cols=160 Identities=16% Similarity=0.119 Sum_probs=107.7
Q ss_pred ChhHHHHHhcCCCCCceecccCCeeEEEEEEc--CCcEEEEEEeccCC--------cccHHHHHHHHHhcCCCceee-ee
Q 045271 42 PLDLIHEATRNFSNENKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSS--------GQGLQEFKNLIAKLQHKNLVR-LL 110 (338)
Q Consensus 42 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~--------~~~~~~~~~~l~~l~hpnIv~-~~ 110 (338)
|.+....+.++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+|+++|+.++|+||+. ++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 44555667789999999999999999999854 46667999864321 223678889999999999985 44
Q ss_pred eEEEeCCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhc-------------------CCCCeEEeeecc
Q 045271 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARD-------------------HKMNPKISDFGM 171 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~-------------------~~~~vkL~Dfg~ 171 (338)
+ .+..|+||||+++++|... .... ......+++++|.+. .++.+||+|||+
T Consensus 89 ~----~~~~~LVmE~~~G~~L~~~-~~~~-----~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 89 A----TGKDGLVRGWTEGVPLHLA-RPHG-----DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred E----cCCcEEEEEccCCCCHHHh-Cccc-----hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 3 2457999999999999632 1111 012223334443332 234689999999
Q ss_pred ceecCCCCCCcc------ccccccCCccccccccccC------CCCcccchH
Q 045271 172 ARVFGGNQSEAN------TNRVVGTYGYMAPEYALEG------LFSVKSDVF 211 (338)
Q Consensus 172 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~DiW 211 (338)
|+.+........ .....+++.|+|||.+.-. ..+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 997643221111 1345788899999998743 234557777
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=120.07 Aligned_cols=187 Identities=19% Similarity=0.226 Sum_probs=137.4
Q ss_pred HhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccC-CcccHHHHHHHHHhcCC-CceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQH-KNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..+.|.++++||+|+||.+|+|. ...|..||||.-... ....+.-|..+.+.|.+ ..|..+..+..+..+-.+||+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 45689999999999999999999 677999999986543 33456677778888875 5677777777788888999999
Q ss_pred CCCCCHHHHHhccCcccccc--HHHHHHHHHHhhh---------------------cCCCCeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDSTRSVQLD--WNRRMCIINGIAR---------------------DHKMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~i~~---------------------~~~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+ |.+|.+++.-..+..... ...+.+++.-|.+ .|...+.|+|||+|+.+.+.....
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 9 999988876544432221 1222233332222 233458999999999875433211
Q ss_pred -----cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc
Q 045271 183 -----NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236 (338)
Q Consensus 183 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~ 236 (338)
......||..|.+--...+...+...|+=|+|.+|.+..-|..||+........
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 123468999999988888888899999999999999999999999976554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4e-16 Score=145.35 Aligned_cols=211 Identities=20% Similarity=0.227 Sum_probs=140.5
Q ss_pred ecccCCeeEEEEEE----cCCcEEEEEEeccCC-----cccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 59 LGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 59 iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+|+|+||.|++++. ..+.-+|+|.+++.. ......+..++...+ ||.++++...|+.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998873 235557888764321 123444556777776 99999999999999999999999999
Q ss_pred CCHHHHHhccCccccc-------------------cHHHHHHHHHHhhhcCCCCeEEeeeccceecCCCCCCcccccccc
Q 045271 129 KSLDFLLFDSTRSVQL-------------------DWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVG 189 (338)
Q Consensus 129 g~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~i~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~g 189 (338)
|++..-+......... ...++....+||..+..+++++.|||+++..- .. ...||
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v----~~--~~~cg 155 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV----KE--KIACG 155 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH----hh--hhccc
Confidence 9986655443322111 11111112456666778889999999998642 11 11289
Q ss_pred CCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHH
Q 045271 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269 (338)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (338)
|..|||||++. ....++|+||||+++++|++|..||..... ..+....+ ..+.....
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~-------------------~~Il~~~~--~~p~~l~~ 212 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM-------------------KRILKAEL--EMPRELSA 212 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH-------------------HHHhhhcc--CCchhhhH
Confidence 99999999988 457889999999999999999999874110 00011000 01111122
Q ss_pred HHHHHHhhccCCCCCCCCCH--HHHHHHhhc
Q 045271 270 KRIHIGLLCVQEDPADRPTM--SSVVFMLAT 298 (338)
Q Consensus 270 ~~~~li~~cl~~dP~~Rps~--~~vl~~L~~ 298 (338)
.+-+++.+++..+|..|.-. ..+.++++.
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 33456667888899999866 455555443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.7e-15 Score=129.56 Aligned_cols=177 Identities=20% Similarity=0.235 Sum_probs=113.2
Q ss_pred CCCceeeeeeEEEe---------------------------CCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHH
Q 045271 102 QHKNLVRLLGCCLE---------------------------GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIIN 154 (338)
Q Consensus 102 ~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 154 (338)
+|||||++..+|.+ +..+|+||.-. ..+|..++.....+.........++++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 49999999888753 13478999887 688988888777766666677777888
Q ss_pred HhhhcCCC----------------------CeEEeeeccceecCCC----CCCccccccccCCccccccccccCC-----
Q 045271 155 GIARDHKM----------------------NPKISDFGMARVFGGN----QSEANTNRVVGTYGYMAPEYALEGL----- 203 (338)
Q Consensus 155 ~i~~~~~~----------------------~vkL~Dfg~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~----- 203 (338)
++.|+|+. .+.++|||.|---... ......-...|.-..||||+...-+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 87775432 3799999987432110 0011112235777899999886321
Q ss_pred CC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCC
Q 045271 204 FS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQED 282 (338)
Q Consensus 204 ~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 282 (338)
.+ .|+|.|+.|.+.||++....||+.. +... ...+.+....++.+.+. -+ ....+++..+|+.|
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~r----Gem~--L~~r~Yqe~qLPalp~~-----vp----p~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKR----GEML--LDTRTYQESQLPALPSR-----VP----PVARQLVFDLLKRD 497 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCccccc----chhe--echhhhhhhhCCCCccc-----CC----hHHHHHHHHHhcCC
Confidence 23 5899999999999999999999751 1000 00111111111111111 00 12334666799999
Q ss_pred CCCCCCHHHHHH
Q 045271 283 PADRPTMSSVVF 294 (338)
Q Consensus 283 P~~Rps~~~vl~ 294 (338)
|.+|++..-...
T Consensus 498 pskRvsp~iAAN 509 (598)
T KOG4158|consen 498 PSKRVSPNIAAN 509 (598)
T ss_pred ccccCCccHHHh
Confidence 999999876544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-14 Score=122.14 Aligned_cols=183 Identities=21% Similarity=0.274 Sum_probs=138.8
Q ss_pred CCCCCceecccCCeeEEEEE-EcCCcEEEEEEecc-CCcccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSR-SSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~-~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
.|.++++||+|.||.++.|. .-.+..||||.-.. +..-.+..|.+..+.|. .++|..++-+-..+.+-.+|+|.+ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 79999999999999999999 66788999997543 33344666666777665 689999888888888889999999 9
Q ss_pred CCHHHHHhccCccccc--cHHHHHHHHHHhhhcCC-----------------------CCeEEeeeccceecCCCCCCc-
Q 045271 129 KSLDFLLFDSTRSVQL--DWNRRMCIINGIARDHK-----------------------MNPKISDFGMARVFGGNQSEA- 182 (338)
Q Consensus 129 g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~~~-----------------------~~vkL~Dfg~a~~~~~~~~~~- 182 (338)
.+|.++..-.++.... ...++.+++.-|.+.|. ..+.++|||+|+.+.+.....
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH 187 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH 187 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc
Confidence 9998887655543332 23344455544444332 127899999999875443221
Q ss_pred ----cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccc
Q 045271 183 ----NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG 235 (338)
Q Consensus 183 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~ 235 (338)
......||..||+--...+...+...|+=|+|-++++.+-|..||+.......
T Consensus 188 IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 188 IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 12346899999999988999999999999999999999999999997655443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.9e-14 Score=119.82 Aligned_cols=160 Identities=13% Similarity=0.112 Sum_probs=103.8
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCccc------------HHHHHHHHHhcCCCceeeeeeEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQG------------LQEFKNLIAKLQHKNLVRLLGCCL 114 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~l~~l~hpnIv~~~~~~~ 114 (338)
..+.++|.+++.||+|+||.||+... ++..+|||.+....... ..+|+..+..+.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999766 56789999996432211 356666788999999999999876
Q ss_pred eC--------CEEEEEEecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhh----------cCCCCeEEeeeccceec
Q 045271 115 EG--------NELLLICEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIAR----------DHKMNPKISDFGMARVF 175 (338)
Q Consensus 115 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~----------~~~~~vkL~Dfg~a~~~ 175 (338)
.. ...++||||++|.+|.++....... ..........+..|+.| ..++ ++|+|||.....
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence 43 3578999999999997764211000 00000001111112222 2334 999999987654
Q ss_pred CCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~ 222 (338)
. ..... ...+....|+.++|+||||+++..+..
T Consensus 185 ~----e~~a~----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 185 A----QRKAK----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred c----chhhH----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 1 11110 013445567789999999998876643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.3e-14 Score=137.72 Aligned_cols=228 Identities=17% Similarity=0.189 Sum_probs=140.7
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-ccHH------HHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-QGLQ------EFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~------~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
+|...+-||++.|=.|.+|++..|. |+||++.+... -.+. ++++ ...++|||++.+.-+.+.....|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777899999999999999987776 88999865442 1111 1122 456789999999888777777888989
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCCC------------------eEEeeeccceecCCCCCCcc-c
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKMN------------------PKISDFGMARVFGGNQSEAN-T 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~~------------------vkL~Dfg~a~~~~~~~~~~~-~ 184 (338)
|. ..+|.+-+..+.- .......++.+++.++..-|+.+ +.|+||..-+...-..+... .
T Consensus 102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 88 5666665543321 11223345556666666555433 57888866543321111111 0
Q ss_pred c----ccccCCcccccccccc----------CC-CCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhcc
Q 045271 185 N----RVVGTYGYMAPEYALE----------GL-FSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 185 ~----~~~gt~~y~aPE~~~~----------~~-~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
. +...-.+|+|||-+.. .. .+++.||+|+||++.||++ |.+||..... .. +..
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~a-----Yr~ 249 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LA-----YRS 249 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------Hh-----Hhc
Confidence 0 1122347999998853 12 5778999999999999998 6777752111 00 111
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
++ .......++.- +.....+++..|++.||.+|.||++.|+.-.+
T Consensus 250 ~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 GN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11 11111111110 01134557888999999999999999976444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-13 Score=134.60 Aligned_cols=203 Identities=17% Similarity=0.195 Sum_probs=117.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
..+|+.++.|..|+||.||.++++. .+.+|+| +.+.. ..++. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-lilRn---ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-LILRN---ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-hhhhc---cccccCCccee---------------------
Confidence 3589999999999999999999654 5568884 32211 11111 22333344443
Q ss_pred CCHHHHHhccCccccccHHHHHHHH------------HHhhhcCCCCeEEeeeccceecCCCC-------------CCcc
Q 045271 129 KSLDFLLFDSTRSVQLDWNRRMCII------------NGIARDHKMNPKISDFGMARVFGGNQ-------------SEAN 183 (338)
Q Consensus 129 g~L~~~l~~~~~~~~~~~~~~~~~~------------~~i~~~~~~~vkL~Dfg~a~~~~~~~-------------~~~~ 183 (338)
|+-..+++..+. ...........+ .++...+-+.+|++|||+.+...... .+..
T Consensus 136 gDc~tllk~~g~-lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~ 214 (1205)
T KOG0606|consen 136 GDCATLLKNIGP-LPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQ 214 (1205)
T ss_pred chhhhhcccCCC-CcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhh
Confidence 333333332211 111111111111 22222334679999999986431100 0111
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....|||+.|+|||++....|+..+|+|++|+++|+.+.|+.||..+...+...........|.... -..
T Consensus 215 dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d--------ea~-- 284 (1205)
T KOG0606|consen 215 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED--------EAL-- 284 (1205)
T ss_pred hccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC--------cCC--
Confidence 2345999999999999999999999999999999999999999986643332221111111111110 000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
..+..+++.++|+.+|.+|---...+
T Consensus 285 ----p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 285 ----PPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred ----CHHHHHHHHHHHHhChHhhcccchhh
Confidence 11234566679999999998443433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-12 Score=127.05 Aligned_cols=181 Identities=16% Similarity=0.170 Sum_probs=125.8
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcC---CCceeeeeeEEEeCCEEEE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ---HKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~---hpnIv~~~~~~~~~~~~~l 121 (338)
......+.|.|-+.||+|+||.||+|...+++.||||+=+....=.+--..+++..|+ -+.|+.+...+.-.+.-++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3344556889999999999999999998789999999865433211000112333333 3566666666666777899
Q ss_pred EEecCCCCCHHHHHhccCcccc-ccHHHHHHHHHHhhhcC-------------------------CCCeEEeeeccceec
Q 045271 122 ICEYMPNKSLDFLLFDSTRSVQ-LDWNRRMCIINGIARDH-------------------------KMNPKISDFGMARVF 175 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~i~~~~-------------------------~~~vkL~Dfg~a~~~ 175 (338)
|+||.+.|+|.+++........ +......+++.-|.+.| ...++|+|||.+-.+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999999999999974433222 22222223332222211 234899999998765
Q ss_pred CCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCC
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRK 225 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~ 225 (338)
..-.........++|-.+-.+|+..|.+|+..+|.|.++.+++.|+.|++
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 43333344455688889999999999999999999999999999999974
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.6e-13 Score=122.86 Aligned_cols=156 Identities=20% Similarity=0.275 Sum_probs=98.9
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHH----HHHHh------h---------hcCCCCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGI------A---------RDHKMNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~----~~~~i------~---------~~~~~~vkL~Dfg~a~~~~~~ 178 (338)
++||.|++|...+|.+++..........+..... +..++ + .-.+..+||+|||+.......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 5899999999999999997655544443333333 33222 1 122345999999998776432
Q ss_pred C----CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhC-CCCCcccccccccchhhHHHhhhccCCccc
Q 045271 179 Q----SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG-RKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 179 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
. .........||..||+||.+.+..|+.++||||||++|+|++.- ..++.-.. .......+.
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r~g~--- 476 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIRDGI--- 476 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhhcCC---
Confidence 2 12234456899999999999999999999999999999999872 22221000 000000111
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~v 292 (338)
+++ ....+-..-..|+.++|...|.+||++.++
T Consensus 477 -ip~-----~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 477 -IPP-----EFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -CCh-----HHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 110 011111223567788999999999966554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-11 Score=102.64 Aligned_cols=118 Identities=13% Similarity=0.028 Sum_probs=73.9
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCCc---c---------c-----------------HHHHHHHHHhcCCCce
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---Q---------G-----------------LQEFKNLIAKLQHKNL 106 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~---------~-----------------~~~~~~~l~~l~hpnI 106 (338)
...||+|++|.||+|...+|+.||||+++.... . . ...|...++.+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 578999999999999977899999999864321 0 1 1236677888877776
Q ss_pred eeeeeEEEeCCEEEEEEecCCCCCHHHHH-hccCccccccHHHHHHHHHHhhhc-C-----------------CCCeEEe
Q 045271 107 VRLLGCCLEGNELLLICEYMPNKSLDFLL-FDSTRSVQLDWNRRMCIINGIARD-H-----------------KMNPKIS 167 (338)
Q Consensus 107 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~i~~~-~-----------------~~~vkL~ 167 (338)
.....+. .. ..++||||++++++.... ...............+++.++.+. | ++.++|+
T Consensus 82 ~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~Li 159 (190)
T cd05147 82 PCPEPIL-LK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYII 159 (190)
T ss_pred CCCcEEE-ec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEEE
Confidence 4333222 22 238999999887765442 222222222222333344444433 2 3469999
Q ss_pred eeccceec
Q 045271 168 DFGMARVF 175 (338)
Q Consensus 168 Dfg~a~~~ 175 (338)
|||+|...
T Consensus 160 DFG~a~~~ 167 (190)
T cd05147 160 DVSQSVEH 167 (190)
T ss_pred EccccccC
Confidence 99999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.2e-11 Score=106.81 Aligned_cols=208 Identities=19% Similarity=0.218 Sum_probs=106.7
Q ss_pred CCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCc------ccHHHHHHHHHhcC----------CCceeeeeeE--
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSG------QGLQEFKNLIAKLQ----------HKNLVRLLGC-- 112 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~~~~~l~~l~----------hpnIv~~~~~-- 112 (338)
.+...+.||.|+++.||.+.+.. ++.+|+|++.-... +.+.++.-....+. |-.++.-++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 44567899999999999999654 78899998743221 11222211111111 1111111221
Q ss_pred -------EEeC---C-----EEEEEEecCCCCCHHHHHhc---cCcc-ccccHHHHH----HHHHHhh------------
Q 045271 113 -------CLEG---N-----ELLLICEYMPNKSLDFLLFD---STRS-VQLDWNRRM----CIINGIA------------ 157 (338)
Q Consensus 113 -------~~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~-~~~~~~~~~----~~~~~i~------------ 157 (338)
+... + +.+++|+-+ .++|..++.. .... .......++ ++..-++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1111 1 247788888 7888777642 1111 111121111 1121111
Q ss_pred ------hcCCCCeEEeeeccceecCCCCCCccccccccCCccccccccccC--------CCCcccchHhHhHHHHHHHhC
Q 045271 158 ------RDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG--------LFSVKSDVFSFGVLLLEIISG 223 (338)
Q Consensus 158 ------~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiWSlGv~l~el~~g 223 (338)
.+.++.++|+||+.....+.. ......+..|.+||..... .++.+.|.|++|+++|.|.++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 245678999999887764211 1112345679999977532 478899999999999999999
Q ss_pred CCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCC
Q 045271 224 RKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADR 286 (338)
Q Consensus 224 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 286 (338)
..||........... ..-.+. ..++. ...+|.++|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------------------~f~~C~-~~Pe~--v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------------------DFSRCR-DMPEP--VQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------------------GGTTSS----HH--HHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------------------cchhcC-CcCHH--HHHHHHHHccCCcccC
Confidence 999975432222111 011111 22222 2347778999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.5e-13 Score=128.43 Aligned_cols=232 Identities=19% Similarity=0.194 Sum_probs=150.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC--CcEEEEEEeccCCc-----ccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND--DKEIAVKRLSRSSG-----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~~-----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~l 121 (338)
...|.+.+-||+|+|+.|-...... ...+|.|.+..... .....+..+-+.+. |+|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4578888999999999999888533 33456666543321 12222333445555 9999999999999999999
Q ss_pred EEecCCCCCHHHHH-hccC--ccccccHHHHHHHHH-------------------HhhhcCCC-CeEEeeeccceecCC-
Q 045271 122 ICEYMPNKSLDFLL-FDST--RSVQLDWNRRMCIIN-------------------GIARDHKM-NPKISDFGMARVFGG- 177 (338)
Q Consensus 122 v~e~~~~g~L~~~l-~~~~--~~~~~~~~~~~~~~~-------------------~i~~~~~~-~vkL~Dfg~a~~~~~- 177 (338)
+++|..++++...+ .... ...........++.. ++.+++++ .++++|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999998777 3322 111111222222222 33334556 799999999988765
Q ss_pred CCCCcccccccc-CCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 178 NQSEANTNRVVG-TYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 178 ~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
..........+| ++.|+|||...+.. ..+..|+||.|+++..+++|..|+.........-..... .. .......
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~~~ 254 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS---NK-GRFTQLP 254 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc---cc-cccccCc
Confidence 333444445688 99999999999854 567899999999999999999998754433321111000 00 0000101
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
... ......+++.+++..+|..|.+.+++-
T Consensus 255 ~~~--------~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 255 WNS--------ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccc--------CChhhhhcccccccCCchhcccccccc
Confidence 111 111234566679999999999999875
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.8e-11 Score=98.36 Aligned_cols=120 Identities=17% Similarity=0.088 Sum_probs=76.1
Q ss_pred CCceecccCCeeEEEEEEcCCcEEEEEEeccCCcc-----------------------------cHHHHHHHHHhcCCCc
Q 045271 55 NENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQ-----------------------------GLQEFKNLIAKLQHKN 105 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------------~~~~~~~~l~~l~hpn 105 (338)
+...||+|++|.||+|...+|..||||.+...... ....|...+..+.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999768999999998654210 1134556777888888
Q ss_pred eeeeeeEEEeCCEEEEEEecCCCCCHHHH-HhccCccccccHHHHHHHHHHhhhcC------------------CCCeEE
Q 045271 106 LVRLLGCCLEGNELLLICEYMPNKSLDFL-LFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKI 166 (338)
Q Consensus 106 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL 166 (338)
+.....+.... .++||||++++++... +...............+++.++.+.| +++++|
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~~l 158 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKPYI 158 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCEEE
Confidence 75444433322 4899999988754332 33222221222233334444443332 456899
Q ss_pred eeeccceecC
Q 045271 167 SDFGMARVFG 176 (338)
Q Consensus 167 ~Dfg~a~~~~ 176 (338)
+|||++..+.
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05145 159 IDVSQAVELD 168 (190)
T ss_pred EEcccceecC
Confidence 9999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-09 Score=92.73 Aligned_cols=84 Identities=17% Similarity=0.255 Sum_probs=63.5
Q ss_pred CCCCceecccCCeeEEEEEEcCCcEEEEEEeccC---CcccHHHHHHHHHhc-----CCCceeeeeeEEEeCC---E-EE
Q 045271 53 FSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS---SGQGLQEFKNLIAKL-----QHKNLVRLLGCCLEGN---E-LL 120 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~l~~l-----~hpnIv~~~~~~~~~~---~-~~ 120 (338)
+.-.+.||+|+||.||. +......+||++... ..+...+|+.+++.+ +||||++++++++++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 333333478987643 334577888889888 6799999999998763 4 44
Q ss_pred EEEec--CCCCCHHHHHhcc
Q 045271 121 LICEY--MPNKSLDFLLFDS 138 (338)
Q Consensus 121 lv~e~--~~~g~L~~~l~~~ 138 (338)
+|+|| +.+++|.+++...
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~ 101 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC 101 (210)
T ss_pred EEecCCCCcchhHHHHHHcc
Confidence 89999 5579999999764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-09 Score=91.72 Aligned_cols=114 Identities=12% Similarity=0.148 Sum_probs=78.9
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++.||+|++|.||+|.. .+..+++|....... .....|..++..+.|+||.....++.+.+..++|||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 667788997643221 124456678888889998877777777778899999
Q ss_pred cCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccce
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMAR 173 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~ 173 (338)
|+++++|.+++..... .......+++..+.+.|. +.++|+|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCccc
Confidence 9999999988864322 222333344444444443 346677777664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-09 Score=94.68 Aligned_cols=122 Identities=14% Similarity=0.036 Sum_probs=77.1
Q ss_pred CCCCCceecccCCeeEEEEE--EcCCcEEEEEEeccCCc---------------------------ccHHHHHHHHHhcC
Q 045271 52 NFSNENKLGEGGFGPVYKGV--LNDDKEIAVKRLSRSSG---------------------------QGLQEFKNLIAKLQ 102 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~--~~~~~~vavK~~~~~~~---------------------------~~~~~~~~~l~~l~ 102 (338)
.|.+.+.||+|++|.||+|. ..++..||+|.+..... .....|...++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998 56789999999864321 01245666777776
Q ss_pred CCceeeeeeEEEeCCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCC------------------C
Q 045271 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKM------------------N 163 (338)
Q Consensus 103 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~------------------~ 163 (338)
+. ++.+..++... ..++||||+++++|......... ..........+++.++.+.|.. .
T Consensus 109 ~~-~i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~ 186 (237)
T smart00090 109 EA-GVPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGK 186 (237)
T ss_pred hc-CCCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCC
Confidence 52 33333333222 34899999988887654422211 1111224445566666655543 4
Q ss_pred eEEeeeccceec
Q 045271 164 PKISDFGMARVF 175 (338)
Q Consensus 164 vkL~Dfg~a~~~ 175 (338)
++|+|||.+...
T Consensus 187 i~LiDFg~a~~~ 198 (237)
T smart00090 187 VVIIDVSQSVEL 198 (237)
T ss_pred EEEEEChhhhcc
Confidence 788888877643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.1e-09 Score=89.87 Aligned_cols=170 Identities=13% Similarity=0.026 Sum_probs=103.3
Q ss_pred CCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--c-----cHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEec
Q 045271 54 SNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--Q-----GLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+...|+.|+||+|+++.. .+.+++.+.+..... . .+.+|+++|+.+. |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997765 667777776654433 2 3577889999995 4789998886 346999999
Q ss_pred CCCCCHHHHHhccCccccc--cHHHHHHHHHH-----------hhhcCCCCeEEeeeccceecCCCCCC----c--c---
Q 045271 126 MPNKSLDFLLFDSTRSVQL--DWNRRMCIING-----------IARDHKMNPKISDFGMARVFGGNQSE----A--N--- 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~-----------i~~~~~~~vkL~Dfg~a~~~~~~~~~----~--~--- 183 (338)
+.|.+|...........-. .......+..| |..+.++.++|+|||+|........- . .
T Consensus 80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ 159 (218)
T PRK12274 80 LAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRH 159 (218)
T ss_pred ecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence 9988886543221100000 00000111122 22234456999999999854321100 0 0
Q ss_pred --ccccccCCccccccccccC-CCC-cccchHhHhHHHHHHHhCCCCCc
Q 045271 184 --TNRVVGTYGYMAPEYALEG-LFS-VKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 184 --~~~~~gt~~y~aPE~~~~~-~~~-~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
......++.|++|+--.-. ..+ ...++.+.|+-+|.++|+..++-
T Consensus 160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0001235566666543322 334 34566688999999999987654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.4e-09 Score=87.63 Aligned_cols=110 Identities=14% Similarity=0.175 Sum_probs=74.1
Q ss_pred eecccCCeeEEEEEEcCCcEEEEEEeccCCc-----------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 58 KLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 58 ~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.||+|+||.||+|.+ ++..|++|....... .....|..+++.+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 567899998643211 22345677888888887655555555666779999999
Q ss_pred CCCCHHHHHhccCccccccHHHHHHHHHHhhhcC-----------------CCCeEEeeecccee
Q 045271 127 PNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH-----------------KMNPKISDFGMARV 174 (338)
Q Consensus 127 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-----------------~~~vkL~Dfg~a~~ 174 (338)
++++|..++..... ....+++..|.+.| ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence 99999888754321 33333444444433 34567777777654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.6e-09 Score=100.46 Aligned_cols=117 Identities=15% Similarity=0.196 Sum_probs=81.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEE-eccC-C---------cccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKR-LSRS-S---------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~-~~~~-~---------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
...|...+.||+|+||.||+|.+.... +++|. +.+. . .+....|.++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999875443 34443 2211 1 1235567788999999999888777777777
Q ss_pred EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC-----------------CCCeEEeeecccee
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH-----------------KMNPKISDFGMARV 174 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-----------------~~~vkL~Dfg~a~~ 174 (338)
.++||||+++++|.+++.. ......+++.++.+.| ++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~~-------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEG-------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHHH-------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCccccc
Confidence 8999999999999988751 1222333444444433 34588999998865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.4e-08 Score=85.52 Aligned_cols=115 Identities=17% Similarity=0.084 Sum_probs=74.8
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-------------------------ccHHHHHHHHHhcCCCc-
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-------------------------QGLQEFKNLIAKLQHKN- 105 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~l~~l~hpn- 105 (338)
-|.+.+.||+|+||.||+|...++..||||.+..... .....+..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4888999999999999999987899999998653220 01234455667777764
Q ss_pred -eeeeeeEEEeCCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhh------------------cCCCCeEE
Q 045271 106 -LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------------DHKMNPKI 166 (338)
Q Consensus 106 -Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~------------------~~~~~vkL 166 (338)
+...++ ....++||||+++++|..+... .........++.++.. +.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 333333 2445899999999998765431 1111222223332222 33566899
Q ss_pred eeeccceec
Q 045271 167 SDFGMARVF 175 (338)
Q Consensus 167 ~Dfg~a~~~ 175 (338)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3e-08 Score=93.03 Aligned_cols=229 Identities=21% Similarity=0.231 Sum_probs=142.5
Q ss_pred HHhcCCCCCceecc--cCCeeEEEEEE---cCCcEEEEEEeccCCc-----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGE--GGFGPVYKGVL---NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~--G~~g~V~~~~~---~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
.+...+.+.+.+|. |.+|.||.+.. .++..+|+|.-+.... .+-.++....+.+ .|+|.++.+..++..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34456778899999 99999999885 4467788887322111 1111222222233 489999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHH----HhhhcCCC-------------------CeEEeeecc
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIIN----GIARDHKM-------------------NPKISDFGM 171 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~----~i~~~~~~-------------------~vkL~Dfg~ 171 (338)
+..++-.|+| +.+|..+...... .....+........ ++.++|.. ..+++|||+
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 9999999999 5777776655443 22334445555555 66665543 378999999
Q ss_pred ceecCCCCCCcc---ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 172 ARVFGGNQSEAN---TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 172 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
...+........ .....|...|++||+ .+..++.+.||+|+|.++.+..++..++...... .|.....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r~ 340 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLRQ 340 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccccccc
Confidence 988754332111 112256778999995 4556789999999999999999887654321100 0000000
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+........ ..++-..+.+|++.||..|++++.++.
T Consensus 341 ---~~ip~e~~~~~-----s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 ---GYIPLEFCEGG-----SSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---ccCchhhhcCc-----chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00111111110 111112555699999999999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.3e-08 Score=78.01 Aligned_cols=78 Identities=15% Similarity=0.117 Sum_probs=62.6
Q ss_pred CCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHhcCC--CceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 55 NENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-QGLQEFKNLIAKLQH--KNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
+.+.||.|.++.||++.... ..+++|.+..... .....|...++.+.| .++.+++.++...+..+++|||++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45789999999999999744 7899998865432 456677778888876 5899999888887889999999988777
Q ss_pred HH
Q 045271 132 DF 133 (338)
Q Consensus 132 ~~ 133 (338)
..
T Consensus 81 ~~ 82 (155)
T cd05120 81 DE 82 (155)
T ss_pred cc
Confidence 54
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.1e-07 Score=86.05 Aligned_cols=160 Identities=16% Similarity=0.168 Sum_probs=98.6
Q ss_pred ceecccCCeeEEEEE-EcCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 57 NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
...+-+..+....|. ..++..|.|...+.... +...+-++-|+.++||||+++++.++..+.+|+|.|-+ -.|.
T Consensus 18 e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~ 95 (690)
T KOG1243|consen 18 EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLE 95 (690)
T ss_pred ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHH
Confidence 333444444222344 55688888888876655 33455567889999999999999999999999999986 3455
Q ss_pred HHHhccCccccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCccccccccCCcc
Q 045271 133 FLLFDSTRSVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGY 193 (338)
Q Consensus 133 ~~l~~~~~~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 193 (338)
.++..... .....-..+++.++.++| .+.-||++|.++....+... .......-..|
T Consensus 96 ~~lk~l~~--~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~ 171 (690)
T KOG1243|consen 96 TVLKELGK--EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESF 171 (690)
T ss_pred HHHHHhHH--HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcc
Confidence 55544331 111222334555555543 24568888887765432221 11111122245
Q ss_pred ccccccccCCCCcccchHhHhHHHHHHHhCC
Q 045271 194 MAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224 (338)
Q Consensus 194 ~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~ 224 (338)
..|+.+.... -..|.|-|||++++++.|.
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 6666443222 3469999999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.4e-07 Score=77.16 Aligned_cols=31 Identities=26% Similarity=0.325 Sum_probs=27.0
Q ss_pred CCceecccCCeeEEEEEEcCCcEEEEEEecc
Q 045271 55 NENKLGEGGFGPVYKGVLNDDKEIAVKRLSR 85 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~ 85 (338)
+.+.||+|+||.||+|...++..||||.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~ 31 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRT 31 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEec
Confidence 3578999999999999977889999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-07 Score=81.48 Aligned_cols=128 Identities=23% Similarity=0.331 Sum_probs=81.4
Q ss_pred HHhcCCCceeeeeeEEEeCC-----EEEEEEecCCCCCHHHHHhccCcc----ccccH-HHHHHHHHHhhhcCCCC----
Q 045271 98 IAKLQHKNLVRLLGCCLEGN-----ELLLICEYMPNKSLDFLLFDSTRS----VQLDW-NRRMCIINGIARDHKMN---- 163 (338)
Q Consensus 98 l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~-~~~~~~~~~i~~~~~~~---- 163 (338)
|-++-|.|||+++.++.+.+ ...++.||+..|++..+++.-... ....| ....+++.+|.++|...
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44567999999999987643 478999999999999999764332 12223 23456888888877542
Q ss_pred --------eEEeeeccceecCC-CCCC---------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCC
Q 045271 164 --------PKISDFGMARVFGG-NQSE---------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRK 225 (338)
Q Consensus 164 --------vkL~Dfg~a~~~~~-~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~ 225 (338)
+.+.--|+.+.-.. .+.. .......+-++|.|||.-..-..+.++|||+||+...+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 11111122111000 0000 00111245678999997665567789999999999999987753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.40 E-value=9.5e-07 Score=83.37 Aligned_cols=29 Identities=34% Similarity=0.412 Sum_probs=26.6
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEecc
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSR 85 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~ 85 (338)
+.||.|++|.||+|+..+|+.||||+.+.
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp 151 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRP 151 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCC
Confidence 67999999999999988999999999754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2e-07 Score=92.59 Aligned_cols=229 Identities=17% Similarity=0.162 Sum_probs=134.7
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.-.+.+.+++-+-+|.++.++.+.- ..+...++|..... ..........++-...+|.++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456778888889999999998883 33444444433211 1111111111222234577777666666788899
Q ss_pred EEEecCCCCCHHHHHhccCccc-c---ccHHHHHHHH---------------HHhhhcCCCCeEEeeeccceecCCC---
Q 045271 121 LICEYMPNKSLDFLLFDSTRSV-Q---LDWNRRMCII---------------NGIARDHKMNPKISDFGMARVFGGN--- 178 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~-~---~~~~~~~~~~---------------~~i~~~~~~~vkL~Dfg~a~~~~~~--- 178 (338)
+|++|+++++|...++...... . ..+....+-+ .++...+.+..+++|||.....+..
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999988877655211 1 1112222211 2222344566889999843322100
Q ss_pred ---------------------CC-C----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccc
Q 045271 179 ---------------------QS-E----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLY 232 (338)
Q Consensus 179 ---------------------~~-~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~ 232 (338)
.. . .......||+.|.+||.+.+......+|+|++|+++++.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00 0 012235789999999999999999999999999999999999999875544
Q ss_pred ccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 045271 233 EQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMS 290 (338)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 290 (338)
.+....+......|. .--...+...+ +++...+..+|.+|..+.
T Consensus 1041 q~~f~ni~~~~~~~p--------~g~~~~s~~aq------~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWP--------EGPEEGSYEAQ------DLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhccccCCCCCC--------CCccccChhhh------hhhhhhhccCchhccCcc
Confidence 333221111111110 01111122222 234447889999999887
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.8e-07 Score=88.34 Aligned_cols=36 Identities=25% Similarity=0.288 Sum_probs=30.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEecc
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSR 85 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~ 85 (338)
....|+. +.||.|++|.||+|+..+ |+.||||++..
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP 154 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRP 154 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCc
Confidence 3446776 799999999999999777 99999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.9e-05 Score=68.56 Aligned_cols=113 Identities=19% Similarity=0.143 Sum_probs=71.0
Q ss_pred ceec-ccCCeeEEEEEEcCCcEEEEEEeccCC----------------cccHHHHHHHHHhcCCCce--eeeeeEEEeC-
Q 045271 57 NKLG-EGGFGPVYKGVLNDDKEIAVKRLSRSS----------------GQGLQEFKNLIAKLQHKNL--VRLLGCCLEG- 116 (338)
Q Consensus 57 ~~iG-~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~l~~l~hpnI--v~~~~~~~~~- 116 (338)
..|| .|+.|+||.+... +..++||.+.... .....+|..++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 7888888888763 6678888774311 1234567788889988774 6666654432
Q ss_pred C---EEEEEEecCCC-CCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeecccee
Q 045271 117 N---ELLLICEYMPN-KSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARV 174 (338)
Q Consensus 117 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~ 174 (338)
. ..++|||++++ .+|.+++...... .....+++.+|.+.| ++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~----~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLS----EEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCC----HHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 23599999987 6888887543211 122233444444333 34588889988765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.4e-06 Score=82.70 Aligned_cols=174 Identities=17% Similarity=0.087 Sum_probs=115.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcCCCc-eeeeeeEEEeCCEEEEEEecCCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKN-LVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
...|.....+++|+++.+++.+....+....+.+... ....-++++|.+++||| .+..++.++.++..+++|+++.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3456666788999999999998544554445655443 34555677899999999 77788888778899999999977
Q ss_pred C-CHHHHHhccCcccccc--HHHHHHHHHHhhhcC-------------CCCeEEeeeccceecCCCCCCccccccccCCc
Q 045271 129 K-SLDFLLFDSTRSVQLD--WNRRMCIINGIARDH-------------KMNPKISDFGMARVFGGNQSEANTNRVVGTYG 192 (338)
Q Consensus 129 g-~L~~~l~~~~~~~~~~--~~~~~~~~~~i~~~~-------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 192 (338)
+ +............... ......-..+++++| +...++.||+....+.... ..+...+++.
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~ 395 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTRTM---KPRTAIGTPE 395 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcccccccccccccccccCCcccCccc---ccccCCCCCC
Confidence 7 2211110000000000 000000112222222 2457899999988764322 3445789999
Q ss_pred cccccccccCCCCcccchHhHhHHHHHHHhCCCCCc
Q 045271 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 193 y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
|+|||+...+.+..+.|.|+.|+-..+|.-|-+|-.
T Consensus 396 ~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 396 PLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999999999999999999999998888887776643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00014 Score=59.17 Aligned_cols=75 Identities=13% Similarity=0.044 Sum_probs=52.9
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCcee-eeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLV-RLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
++.|+.|.++.||++... +..|++|...... ......|..+++.+.+.+++ +++... ....++||||+++..+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 467899999999999864 7789999875543 23456677777777655543 444433 33457999999988875
Q ss_pred H
Q 045271 133 F 133 (338)
Q Consensus 133 ~ 133 (338)
.
T Consensus 80 ~ 80 (170)
T cd05151 80 T 80 (170)
T ss_pred c
Confidence 4
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.9e-05 Score=73.25 Aligned_cols=173 Identities=18% Similarity=0.098 Sum_probs=107.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE--cCCcEEEEEEeccCCcccH------HHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL--NDDKEIAVKRLSRSSGQGL------QEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~------~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
....+|..+..||.|.|+.|+.+.. .++..|++|.+.+...... .+.........|.+++.++..+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456888999999999999999884 3567889988765433222 2222122334589999998888877778
Q ss_pred EEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------C-CCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------K-MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~-~~vkL~Dfg~a~~~~~~~ 179 (338)
++-.|||.++++...+..... .....+....+++.++...| + +..+++|||+...+.-
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-- 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-- 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence 899999999887655421111 11112222223333333222 1 4467788887754211
Q ss_pred CCccccccccCCccc--cccccccCCCCcccchHhHhHHHHHHHhCCC
Q 045271 180 SEANTNRVVGTYGYM--APEYALEGLFSVKSDVFSFGVLLLEIISGRK 225 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~ 225 (338)
.. ....+.-.++ ++.......+..++|++|||..+.+..++..
T Consensus 420 -~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 420 -SS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred -ec--ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11 1112222344 4444445568899999999999999998864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00037 Score=59.25 Aligned_cols=107 Identities=12% Similarity=0.171 Sum_probs=72.7
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCC----cccHHHHHHHHHhcCC--CceeeeeeEEEeC---CEEEEEEecCC
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQH--KNLVRLLGCCLEG---NELLLICEYMP 127 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~h--pnIv~~~~~~~~~---~~~~lv~e~~~ 127 (338)
+.|+.|..+.||++...++..+++|...... ......|..+++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5789999999999997666789999875432 3457778888888765 3456666666543 35689999999
Q ss_pred CCCHHHHHhccCccccccHHHHHHHHHHhhhcCCCC
Q 045271 128 NKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMN 163 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 163 (338)
+.++...+...............+++..+...|+..
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 119 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVD 119 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 888866543111111122334556777787777754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0049 Score=57.95 Aligned_cols=100 Identities=22% Similarity=0.268 Sum_probs=70.6
Q ss_pred CeeEEEEE-EcCCcEEEEEEeccCCcc---cHHHHHHHHHhcCCCceeeeeeEEEe----CCEEEEEEecCCC-CCHHHH
Q 045271 64 FGPVYKGV-LNDDKEIAVKRLSRSSGQ---GLQEFKNLIAKLQHKNLVRLLGCCLE----GNELLLICEYMPN-KSLDFL 134 (338)
Q Consensus 64 ~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~ 134 (338)
-.+.|++. ..+|..|++|.++..... ......+.++++.|+|||++.++|.. +..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35668888 667999999999543332 23445678899999999999999873 4578999999875 456554
Q ss_pred HhccCc----------------cccccHHHHHHHHHHhhhcCCCC
Q 045271 135 LFDSTR----------------SVQLDWNRRMCIINGIARDHKMN 163 (338)
Q Consensus 135 l~~~~~----------------~~~~~~~~~~~~~~~i~~~~~~~ 163 (338)
-..... .....|....|+..+|...|+-+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG 413 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG 413 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC
Confidence 432211 22456888888888888777653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00097 Score=54.53 Aligned_cols=81 Identities=14% Similarity=0.154 Sum_probs=51.3
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEe-ccCC----------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRL-SRSS----------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~-~~~~----------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..+++|+-+.++.+.+.+ ..+++|.= .+.. ......|+.++..+.--.|..-.=++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999997633 33556642 2211 12234566667665433333333334466777899999
Q ss_pred CCCCCHHHHHhcc
Q 045271 126 MPNKSLDFLLFDS 138 (338)
Q Consensus 126 ~~~g~L~~~l~~~ 138 (338)
+++..|.+++...
T Consensus 81 I~G~~lkd~l~~~ 93 (204)
T COG3642 81 IEGELLKDALEEA 93 (204)
T ss_pred eCChhHHHHHHhc
Confidence 9999999888665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0015 Score=53.11 Aligned_cols=80 Identities=23% Similarity=0.306 Sum_probs=56.5
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEecc-CCcccHHHHHHHHHhcCCCceee-eeeEEEeCCEEEEEEecCCCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSR-SSGQGLQEFKNLIAKLQHKNLVR-LLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~~~~g 129 (338)
.....+.||+|.+|.||+|.+. +..+|+|+=.. +....+..|+++|..++-.++-. ++.+ +.-++.|||+.|-
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~ 97 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence 3445688999999999999984 45788887544 34466888888888887655543 3333 2234569999887
Q ss_pred CHHHHHh
Q 045271 130 SLDFLLF 136 (338)
Q Consensus 130 ~L~~~l~ 136 (338)
.|...-.
T Consensus 98 ~L~~~~~ 104 (201)
T COG2112 98 PLGKLEI 104 (201)
T ss_pred chhhhhh
Confidence 8876654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.011 Score=49.51 Aligned_cols=29 Identities=17% Similarity=0.132 Sum_probs=23.4
Q ss_pred CceecccCCeeEEEEEEcC-------CcEEEEEEec
Q 045271 56 ENKLGEGGFGPVYKGVLND-------DKEIAVKRLS 84 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~-------~~~vavK~~~ 84 (338)
...||.|.-+.||.|...+ +..+|||..+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r 37 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFK 37 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEe
Confidence 4679999999999998543 4689999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0019 Score=60.75 Aligned_cols=160 Identities=21% Similarity=0.207 Sum_probs=83.0
Q ss_pred HHHHHHHHhcCCCceeeeeeEEEe-CCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCCCeEEeeec
Q 045271 92 QEFKNLIAKLQHKNLVRLLGCCLE-GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFG 170 (338)
Q Consensus 92 ~~~~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~vkL~Dfg 170 (338)
....++++.+.|+|...++++... .....+|||++ +.++.+++..+... ..... +++ ..+.+..+.+| -
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~-~~s~~-----~~~--~~~~~~~~~td-~ 99 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK-DESLL-----AHG--VLHLNIIYITD-H 99 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc-hhhhc-----ccc--cceehhhhccc-c
Confidence 344568899999999999998764 23488999999 77887777654311 11000 111 12222233444 0
Q ss_pred cceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
++. .| |- +..+|+||||+|.++.++..|..-+......+.... ..+.+....
T Consensus 100 ~~t------------------~~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~---i~k~~~~d~ 151 (725)
T KOG1093|consen 100 FLT------------------KY--PS-----PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEI---LLKYYTDDQ 151 (725)
T ss_pred ccc------------------cC--CC-----CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHH---HHHhccCch
Confidence 000 00 10 112599999999999999988754432211111111 111111110
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 291 (338)
..... ........+.......+...|+...|..||...+
T Consensus 152 ~~~~~--a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 152 ELLST--AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred hHHHH--HHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 00000 0000111223334566778899999988876544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.026 Score=47.19 Aligned_cols=32 Identities=28% Similarity=0.385 Sum_probs=29.2
Q ss_pred cCCCCCceecccCC-eeEEEEEEcCCcEEEEEEe
Q 045271 51 RNFSNENKLGEGGF-GPVYKGVLNDDKEIAVKRL 83 (338)
Q Consensus 51 ~~y~~~~~iG~G~~-g~V~~~~~~~~~~vavK~~ 83 (338)
.+++.++.||.|.. |.||++.. .|+.+|+|.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf 69 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLF 69 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEe
Confidence 78999999999999 99999998 6679999994
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.022 Score=46.77 Aligned_cols=118 Identities=12% Similarity=0.091 Sum_probs=69.5
Q ss_pred CCceecccCCeeEEEEEEcCCcEEEEEEe-ccCC----------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 55 NENKLGEGGFGPVYKGVLNDDKEIAVKRL-SRSS----------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~-~~~~----------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.+..|-+|+-+.|+++.. .|+.+.||.= .+.. ......|++.|..+.--.|.--.=+|.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 568899999999999987 5666667752 2211 123445566665554333333333455666678999
Q ss_pred ecCCC-CCHHHHHhccCcccccc---HHHHHHHHHHhhhcCCCCeEEeeeccce
Q 045271 124 EYMPN-KSLDFLLFDSTRSVQLD---WNRRMCIINGIARDHKMNPKISDFGMAR 173 (338)
Q Consensus 124 e~~~~-g~L~~~l~~~~~~~~~~---~~~~~~~~~~i~~~~~~~vkL~Dfg~a~ 173 (338)
||+++ .++.+++.......... ......+-+.|..+|.+.+..+|+-.+.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSN 143 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSN 143 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccc
Confidence 99966 47788776544432222 2233345556666666655555554443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.022 Score=54.82 Aligned_cols=120 Identities=13% Similarity=0.072 Sum_probs=70.2
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCCccc-------------------------------------------HHH
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQG-------------------------------------------LQE 93 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------~~~ 93 (338)
.-|+.++-|.||+|+..+|+.||||+....-.+. +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999899999999974321110 111
Q ss_pred HHHHH----HhcCCCceeeeeeEEEe-CCEEEEEEecCCCCCHHHHH--hccCccccc-cHHHHHH--------------
Q 045271 94 FKNLI----AKLQHKNLVRLLGCCLE-GNELLLICEYMPNKSLDFLL--FDSTRSVQL-DWNRRMC-------------- 151 (338)
Q Consensus 94 ~~~~l----~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~-~~~~~~~-------------- 151 (338)
|+.-+ +.++...=+.+-.++.+ ...-.++|||+.|-.+.++. ...+..... ......+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaD 290 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHAD 290 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccC
Confidence 11111 12233444455555543 35568999999998887774 332222100 0001111
Q ss_pred -HHHHhhhcCCCCeEEeeeccceecC
Q 045271 152 -IINGIARDHKMNPKISDFGMARVFG 176 (338)
Q Consensus 152 -~~~~i~~~~~~~vkL~Dfg~a~~~~ 176 (338)
+.-||....++.+.+.|||+...+.
T Consensus 291 pHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 291 PHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CCccceEEecCCcEEEEcCcceecCC
Confidence 1123333455678999999987663
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.098 Score=54.16 Aligned_cols=178 Identities=19% Similarity=0.141 Sum_probs=102.8
Q ss_pred HHHHHhcCCCceeeeeeEEEeCCE----EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCCCC------
Q 045271 95 KNLIAKLQHKNLVRLLGCCLEGNE----LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHKMN------ 163 (338)
Q Consensus 95 ~~~l~~l~hpnIv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~~~------ 163 (338)
...+....|+|++.++.+-..... ..+..++|..-++...+..... .............+|+.+.|...
T Consensus 233 ~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L 312 (1351)
T KOG1035|consen 233 LESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVL 312 (1351)
T ss_pred HHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEE
Confidence 345677889999999988764322 2345667777777666654332 22223334455667777655421
Q ss_pred ---------------eEEe--eeccceecCCCCCCccccccccCCccccccccccCCCCc--ccchHhHhHHHHHHHhCC
Q 045271 164 ---------------PKIS--DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV--KSDVFSFGVLLLEIISGR 224 (338)
Q Consensus 164 ---------------vkL~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiWSlGv~l~el~~g~ 224 (338)
+..+ ||+..+.+..... ......+..|.++|......+.. ..|+|.+|..+..+..|.
T Consensus 313 ~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 313 SASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred ecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 2333 6655554432211 11223455688888777665544 479999999999999886
Q ss_pred CCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 225 KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 225 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.+-.. .......+...... ...+....|+..|+++|+++.+++...-...+
T Consensus 390 ~i~~~----------------------~~~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 390 DISEK----------------------SAVPVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ccccc----------------------ccchhhhhccccch----hhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 43110 00000111100000 12334456999999999999999976554333
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.011 Score=57.30 Aligned_cols=73 Identities=27% Similarity=0.357 Sum_probs=50.8
Q ss_pred HHHhhhcCCCCeEEeeeccceecCCCCCC-----c-cc-cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCC
Q 045271 153 INGIARDHKMNPKISDFGMARVFGGNQSE-----A-NT-NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRK 225 (338)
Q Consensus 153 ~~~i~~~~~~~vkL~Dfg~a~~~~~~~~~-----~-~~-~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~ 225 (338)
.+.+.....+..||+.|+.+....+.... . .. ........|.|||++.....+.++|++|+||++|.+..|..
T Consensus 128 p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk 207 (700)
T KOG2137|consen 128 PEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGK 207 (700)
T ss_pred hhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCc
Confidence 44555567788999999988765331110 0 00 01123457999999999778899999999999999985443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.25 Score=41.07 Aligned_cols=66 Identities=18% Similarity=0.201 Sum_probs=38.2
Q ss_pred eEEEEEEcCCcEEEEEEeccCC--------------c---------------ccHHHHHHHHHhcCCC--ceeeeeeEEE
Q 045271 66 PVYKGVLNDDKEIAVKRLSRSS--------------G---------------QGLQEFKNLIAKLQHK--NLVRLLGCCL 114 (338)
Q Consensus 66 ~V~~~~~~~~~~vavK~~~~~~--------------~---------------~~~~~~~~~l~~l~hp--nIv~~~~~~~ 114 (338)
.||.|...++..+|||...... . .....|.+.|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999863210 0 1134556677777644 455555442
Q ss_pred eCCEEEEEEecCC--CCCHHHHH
Q 045271 115 EGNELLLICEYMP--NKSLDFLL 135 (338)
Q Consensus 115 ~~~~~~lv~e~~~--~g~L~~~l 135 (338)
.-++||||++ +..+..+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~ 99 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK 99 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH
T ss_pred ---CCEEEEEecCCCccchhhHH
Confidence 2379999997 55555443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.18 Score=45.25 Aligned_cols=81 Identities=10% Similarity=0.031 Sum_probs=57.7
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccC-CcccHHHHHHHHHhcCC---CceeeeeeEEEe---CCEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQH---KNLVRLLGCCLE---GNELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~h---pnIv~~~~~~~~---~~~~~lv~e 124 (338)
...-.+.||.|..+.||.....++ .+.+|..+.. ....+..|...|+.+.- ..+.++++++.. .+..++|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 334467899999999999876455 4666775442 34577888888877753 356677776654 356899999
Q ss_pred cCCCCCHHH
Q 045271 125 YMPNKSLDF 133 (338)
Q Consensus 125 ~~~~g~L~~ 133 (338)
++++..+.+
T Consensus 94 ~i~G~~~~~ 102 (297)
T PRK10593 94 RLRGVSVEA 102 (297)
T ss_pred ccCCEecCC
Confidence 998887754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.39 Score=44.62 Aligned_cols=175 Identities=14% Similarity=0.107 Sum_probs=94.8
Q ss_pred CCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHH-HhcCCCceeeeeeEE------EeCC-EEEEEEec
Q 045271 54 SNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI-AKLQHKNLVRLLGCC------LEGN-ELLLICEY 125 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l-~~l~hpnIv~~~~~~------~~~~-~~~lv~e~ 125 (338)
....-||+|+.+.+|-.-. -+. .+.|+..............+| +.-.||-+-.=+.+= -++. -+.++|+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CCCccccCCccceeeecch-hhc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 4567899999999985431 111 234776654443322222233 223455433311110 0122 36788888
Q ss_pred CCCCC-HHHHHhc---cCccccccHHHHHHHHHHhhh----cCC----------CCeEEeeeccceecCCCCC-----Cc
Q 045271 126 MPNKS-LDFLLFD---STRSVQLDWNRRMCIINGIAR----DHK----------MNPKISDFGMARVFGGNQS-----EA 182 (338)
Q Consensus 126 ~~~g~-L~~~l~~---~~~~~~~~~~~~~~~~~~i~~----~~~----------~~vkL~Dfg~a~~~~~~~~-----~~ 182 (338)
+++.. +..+... ........|-..+-.+.+|+. .|. .+..++|-|....++.++. ..
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~ 171 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT 171 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCc
Confidence 85542 2333322 122334455555555555442 222 2355666666555433221 11
Q ss_pred cccccccCCccccccccccCC-----CCcccchHhHhHHHHHHHhC-CCCCccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGL-----FSVKSDVFSFGVLLLEIISG-RKDTRFY 230 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiWSlGv~l~el~~g-~~Pf~~~ 230 (338)
.....+|...|.+||.-.-.. -+...|-+.+|+++++++.| .+||...
T Consensus 172 ~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 172 LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 122357888999999654232 34668999999999999986 8898864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.13 Score=44.93 Aligned_cols=78 Identities=18% Similarity=0.197 Sum_probs=51.8
Q ss_pred CCCCceecccCCeeEEEEEEcCCcEEEEEEecc----------CC-------c--------ccHHHHHHHHHhcCCC--c
Q 045271 53 FSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSR----------SS-------G--------QGLQEFKNLIAKLQHK--N 105 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~----------~~-------~--------~~~~~~~~~l~~l~hp--n 105 (338)
+.++..||-|.-+.||.|....+.++|||.-.. .. . ...++|.+.|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 566789999999999999998999999996311 00 0 0123444566665433 3
Q ss_pred eeeeeeEEEeCCEEEEEEecCCCCCHHHH
Q 045271 106 LVRLLGCCLEGNELLLICEYMPNKSLDFL 134 (338)
Q Consensus 106 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 134 (338)
+.+-+++ +.-.+||||+.+-.|...
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~ 197 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL 197 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc
Confidence 4444443 456899999987666443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.61 E-value=0.32 Score=47.00 Aligned_cols=29 Identities=17% Similarity=0.319 Sum_probs=26.0
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEecc
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSR 85 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~ 85 (338)
+.||.-+.|.||+|+.++|..||||+-+.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P 195 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHP 195 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCc
Confidence 68899999999999988999999998643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=93.26 E-value=0.27 Score=50.63 Aligned_cols=107 Identities=12% Similarity=0.207 Sum_probs=65.2
Q ss_pred CceecccCCeeEEEEEEcCC---cEEEEEEeccC----CcccHHHHHHHHHhcC-CCce--eeeeeEEEeC---CEEEEE
Q 045271 56 ENKLGEGGFGPVYKGVLNDD---KEIAVKRLSRS----SGQGLQEFKNLIAKLQ-HKNL--VRLLGCCLEG---NELLLI 122 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~~~~~l~~l~-hpnI--v~~~~~~~~~---~~~~lv 122 (338)
++.|+.|.++.+|+.....+ ..+++|+.... ....+.+|..+++.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 67889999999999886543 36777775432 1235678888888885 6654 7777777654 457899
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMN 163 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 163 (338)
|||+++..+.+... .............+++..++.+|...
T Consensus 123 ME~v~G~~~~~~~~-~~~~~~~r~~l~~~l~~~La~LH~vd 162 (822)
T PLN02876 123 MEYLEGRIFVDPKL-PGVAPERRRAIYRATAKVLAALHSAD 162 (822)
T ss_pred EEecCCcccCCccC-CCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 99997654422100 00011111223344666666666643
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.042 Score=42.03 Aligned_cols=48 Identities=19% Similarity=0.273 Sum_probs=35.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHH
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI 98 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l 98 (338)
...++ ..-||.|+.|.||+|+..+|+.||||+.+..-.+.+..-..++
T Consensus 11 F~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~Dl~~l 58 (119)
T PF03109_consen 11 FDEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEADLRIL 58 (119)
T ss_pred HHHCC-cchhhheehhhheeeeecccchhhhhhcchHHHHHHHHHHHHH
Confidence 34444 4689999999999999988999999998765544443333333
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.5 Score=40.04 Aligned_cols=77 Identities=21% Similarity=0.258 Sum_probs=53.3
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccC-CcccHHHHHHHHHhcCCC--ceeeeeeEEE---eCCEEEEEEecCCCC
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQHK--NLVRLLGCCL---EGNELLLICEYMPNK 129 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~hp--nIv~~~~~~~---~~~~~~lv~e~~~~g 129 (338)
++.|+.|..+.||+....+ ..+++|..... .......+..+++.+... .+.+++.... .....+++|+++++.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 4678999999999999866 68999987554 334556666666666432 2445555332 334579999999888
Q ss_pred CHHH
Q 045271 130 SLDF 133 (338)
Q Consensus 130 ~L~~ 133 (338)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 8876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.019 Score=60.96 Aligned_cols=130 Identities=12% Similarity=-0.000 Sum_probs=85.3
Q ss_pred HHHhcCCCceeeeeeEEEe--CCEEEEEEecCCCCCHHHHHhccCccc-cccH--HHH-HHH-HHH---------hh---
Q 045271 97 LIAKLQHKNLVRLLGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSV-QLDW--NRR-MCI-ING---------IA--- 157 (338)
Q Consensus 97 ~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~--~~~-~~~-~~~---------i~--- 157 (338)
.++...|+++...+.-..+ ....+.+++|+..|.+...+..+.... .+.- ++. .++ ..+ +.
T Consensus 1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence 4455689999888776654 345689999999999988886543311 1111 111 111 100 00
Q ss_pred -----------hcCCCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCC
Q 045271 158 -----------RDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKD 226 (338)
Q Consensus 158 -----------~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~P 226 (338)
...+.++|++++|+.+... ..........+++.|++|+....-.++.++|+|..|+.+|+...|..+
T Consensus 1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred hhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence 1234468999999998321 111122335678899999987777889889999999999999888776
Q ss_pred Cc
Q 045271 227 TR 228 (338)
Q Consensus 227 f~ 228 (338)
|-
T Consensus 1440 fi 1441 (2724)
T KOG1826|consen 1440 FI 1441 (2724)
T ss_pred HH
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=91.62 E-value=0.69 Score=39.67 Aligned_cols=71 Identities=20% Similarity=0.214 Sum_probs=51.4
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCc--eeeeeeEEEeCCEEEEEEecCCCCC
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKN--LVRLLGCCLEGNELLLICEYMPNKS 130 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~g~ 130 (338)
..||.|..+.||+. .+..+++|...... .....+|.+.++.+..-+ +.+.+++..+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 67899999999984 35567788875432 345677777787765332 4566777777777889999997763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=90.40 E-value=2.8 Score=36.10 Aligned_cols=76 Identities=13% Similarity=0.130 Sum_probs=51.2
Q ss_pred eecccCC-eeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEecCCCCCHHHH
Q 045271 58 KLGEGGF-GPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEYMPNKSLDFL 134 (338)
Q Consensus 58 ~iG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 134 (338)
.|-.|.. +.||+.... +..+.+|............|..+++.+. +--+.+++++....+..++|||+++|..+...
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 3445555 788988753 3677888775443345667777776664 33455667766666678999999988888644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.15 E-value=2.3 Score=36.93 Aligned_cols=50 Identities=16% Similarity=0.115 Sum_probs=36.8
Q ss_pred CCCCCCChhHHHHHhcCCCCCc---eecccCCeeEEEEEEcCCcEEEEEEecc
Q 045271 36 QELPLFPLDLIHEATRNFSNEN---KLGEGGFGPVYKGVLNDDKEIAVKRLSR 85 (338)
Q Consensus 36 ~~~~~~~~~~~~~~~~~y~~~~---~iG~G~~g~V~~~~~~~~~~vavK~~~~ 85 (338)
+-+.......+..+..+..+.. .|.+|.-+.||+|...++..+|+|++..
T Consensus 30 ~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~ 82 (268)
T COG1718 30 EVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRT 82 (268)
T ss_pred hhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEeh
Confidence 3444555666777777777755 4556777899999987889999999854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.26 E-value=3.3 Score=38.78 Aligned_cols=81 Identities=12% Similarity=0.161 Sum_probs=52.5
Q ss_pred CceecccCCeeEEEEEEcCC-cEEEEEEecc------C----CcccHHHHHHHHHhcC---CCceeeeeeEEEeCCEEEE
Q 045271 56 ENKLGEGGFGPVYKGVLNDD-KEIAVKRLSR------S----SGQGLQEFKNLIAKLQ---HKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~-~~vavK~~~~------~----~~~~~~~~~~~l~~l~---hpnIv~~~~~~~~~~~~~l 121 (338)
.+.||.|.++.||++...++ +.++||.-.. . ..+....|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999997666 4899997421 1 1123444555565542 3456667766 3455789
Q ss_pred EEecCCCCC-HHHHHhcc
Q 045271 122 ICEYMPNKS-LDFLLFDS 138 (338)
Q Consensus 122 v~e~~~~g~-L~~~l~~~ 138 (338)
|||++++.. +...+...
T Consensus 109 VME~L~~~~~lr~~Ll~g 126 (401)
T PRK09550 109 VMEDLSDHKILRKGLIDG 126 (401)
T ss_pred EEecCCCccHHHHHHhcC
Confidence 999997644 44444433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=89.11 E-value=3.7 Score=36.20 Aligned_cols=117 Identities=13% Similarity=-0.009 Sum_probs=60.9
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCCc--------------ccHHHHHHHHHhcCCCc--eeeeeeEEEe-----
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--------------QGLQEFKNLIAKLQHKN--LVRLLGCCLE----- 115 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~l~~l~hpn--Iv~~~~~~~~----- 115 (338)
+.+-......|++... .|+.|.||....... .....|...+..+..-+ +...+.+.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445666655 566788997633221 12445555555443222 2223333332
Q ss_pred CCEEEEEEecCCCC-CHHHHHhccCc---cccccHHHHHHHHHHhhhcCCCCeEEeeecccee
Q 045271 116 GNELLLICEYMPNK-SLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKMNPKISDFGMARV 174 (338)
Q Consensus 116 ~~~~~lv~e~~~~g-~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~~vkL~Dfg~a~~ 174 (338)
...-++|+|++++. +|.+++..... ...........++..+..+|..++..+|+-.+..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~Ni 169 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHF 169 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhE
Confidence 23468999999775 78888753211 1111122333455556666666666666655443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=87.69 E-value=0.1 Score=49.30 Aligned_cols=71 Identities=24% Similarity=0.423 Sum_probs=53.6
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEEeC
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCLEG 116 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~~~ 116 (338)
......+++....+|.|+||+|+.+.. .++..+|||.+...... ...++..-+..+.|++|+++...|..+
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 566778999999999999999999994 44558899988543332 233344456788999999998888643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=87.31 E-value=2.9 Score=37.25 Aligned_cols=75 Identities=13% Similarity=0.149 Sum_probs=49.2
Q ss_pred CCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcC---CCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 54 SNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ---HKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+-.+.++-|..+.+|+.. .+++.+.||.-.......+..|..-|+.|. --.+.+++++....+.-++||||++.+
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 345788989999999887 577789999887666677888887777773 345777888877767779999998655
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=85.71 E-value=4.4 Score=35.97 Aligned_cols=76 Identities=14% Similarity=0.184 Sum_probs=48.4
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcCCCc--eeeeee------EEEeCCEEEEEEecCC
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKN--LVRLLG------CCLEGNELLLICEYMP 127 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpn--Iv~~~~------~~~~~~~~~lv~e~~~ 127 (338)
++.|..|....+|+... ++..+++|............+..+++.+.+-+ +.+.+. +....+..++|++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 56778888889999875 34578889876543445556666666654222 333322 1123456789999998
Q ss_pred CCCHH
Q 045271 128 NKSLD 132 (338)
Q Consensus 128 ~g~L~ 132 (338)
|..+.
T Consensus 98 G~~~~ 102 (296)
T cd05153 98 GEHLT 102 (296)
T ss_pred CCCCC
Confidence 87664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=85.40 E-value=1.9 Score=39.76 Aligned_cols=30 Identities=23% Similarity=0.294 Sum_probs=26.0
Q ss_pred CCceecccCCeeEEEEEEcCCcEEEEEEec
Q 045271 55 NENKLGEGGFGPVYKGVLNDDKEIAVKRLS 84 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~ 84 (338)
+-..|..|.-+.||++...+|..+|||+++
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYK 177 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYK 177 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEe
Confidence 346788899999999998899999999874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=83.51 E-value=15 Score=30.74 Aligned_cols=83 Identities=17% Similarity=0.241 Sum_probs=56.0
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCC-------------------cccHHHHHHHHHhc------CCCceeeee
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-------------------GQGLQEFKNLIAKL------QHKNLVRLL 110 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~~~~~~~~~~l~~l------~hpnIv~~~ 110 (338)
...||+|+.-.||.- ......+||++.... .....+|......+ .+.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 467999999888854 344456788876554 23334444333333 378999999
Q ss_pred eEEEeCCEEEEEEecCCC------CCHHHHHhccCc
Q 045271 111 GCCLEGNELLLICEYMPN------KSLDFLLFDSTR 140 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~ 140 (338)
|+.+..--..+|+|.+.+ -+|.+++.....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~ 119 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGL 119 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCc
Confidence 999988888999998632 347777755543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 338 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-124
Identities = 95/307 (30%), Positives = 138/307 (44%), Gaps = 41/307 (13%)
Query: 32 KVESQELPLFPLDLIHEATRNFSNE------NKLGEGGFGPVYKGVLNDDKEIAVKRLS- 84
+V F + T NF NK+GEGGFG VYKG + ++ +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 85 ---RSSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDS 138
++ + Q+F ++AK QH+NLV LLG +G++L L+ YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 139 TRSVQLDWNRRMCIINGIAR----------------------DHKMNPKISDFGMARVFG 176
+ L W+ R I G A D KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236
T+R+VGT YMAPE L G + KSD++SFGV+LLEII+G + Q
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--Q 241
Query: 237 SLLTYTWKLWCE-GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295
LL ++ E ++ +D + + + C+ E RP + V +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 296 LATDTIT 302
L T +
Sbjct: 301 LQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-120
Identities = 108/309 (34%), Positives = 153/309 (49%), Gaps = 41/309 (13%)
Query: 33 VESQELP--------LFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLS 84
V ++E P F L + A+ NFSN+N LG GGFG VYKG L D +AVKRL
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 85 RSSGQGLQ-EFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR 140
QG + +F+ +I+ H+NL+RL G C+ E LL+ YM N S+ L +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 141 S-VQLDWNRRMCIINGIAR-------------------------DHKMNPKISDFGMARV 174
S LDW +R I G AR D + + DFG+A++
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRK--DTRFYLY 232
+ T V GT G++APEY G S K+DVF +GV+LLE+I+G++ D
Sbjct: 184 MDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 233 EQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+ LL + L E + L+D L+ ++ EE+ + I + LLC Q P +RP MS V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 293 VFMLATDTI 301
V ML D +
Sbjct: 303 VRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 317 bits (816), Expect = e-108
Identities = 94/283 (33%), Positives = 147/283 (51%), Gaps = 28/283 (9%)
Query: 41 FPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---L 97
PL + EAT NF ++ +G G FG VYKGVL D ++A+KR + S QG++EF+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-LDWNRRMCIINGI 156
++ +H +LV L+G C E NE++LI +YM N +L L+ S + W +R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 157 AR----------------------DHKMNPKISDFGMARVF-GGNQSEANTNRVVGTYGY 193
AR D PKI+DFG+++ +Q+ +T V GT GY
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGY 207
Query: 194 MAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253
+ PEY ++G + KSDV+SFGV+L E++ R L + +L + + G ++
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
++DP L + E L K + C+ DRP+M V++ L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-74
Identities = 55/311 (17%), Positives = 110/311 (35%), Gaps = 62/311 (19%)
Query: 41 FPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---L 97
+ ++ + G FG V+K L + + +AVK Q + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 98 IAKLQHKNLVRLLGCCLEGN----ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
+ ++H+N+++ +G G +L LI + SL L + + WN I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIA 127
Query: 154 NGIAR--------------------------------DHKMNPKISDFGMARVFGGNQSE 181
+AR + + I+DFG+A F +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 182 ANTNRVVGTYGYMAPEYALEGL-----FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236
+T+ VGT YMAPE + ++ D+++ G++L E+ S + E
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY-- 245
Query: 237 SLLTYTWKLWCEGNAQEL--------MDPVLKESFILEELLKRI-HIGLLCVQEDPADRP 287
+L + ++ + +++ PVL++ + + + C D R
Sbjct: 246 -MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 288 TMSSVVFMLAT 298
+ V +
Sbjct: 305 SAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-59
Identities = 65/324 (20%), Positives = 111/324 (34%), Gaps = 69/324 (21%)
Query: 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN--LIAKLQHKNL 106
N +G G +G VYKG L++ + +AVK S ++ Q KN + ++H N+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI 69
Query: 107 VRLLGCCLEGN-----ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--- 158
R + E LL+ EY PN SL L T DW + + + R
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLA 125
Query: 159 ----------------------------DHKMNPKISDFGMARVFGGN------QSEANT 184
+ ISDFG++ GN + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 185 NRVVGTYGYMAPEYALEGLFSV--------KSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236
VGT YMAPE LEG ++ + D+++ G++ EI D +
Sbjct: 186 ISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE-SVPE 243
Query: 237 SLLTYTWKLWCEGNAQELMD--------PVLKESFILEELLKRIHIGLL--CVQEDPADR 286
+ + ++ +++ P E++ L R + C +D R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 287 PTMSSVVFMLATDTITLLQPTQPA 310
T +A + + +
Sbjct: 304 LTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 59/272 (21%), Positives = 115/272 (42%), Gaps = 51/272 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKN---LIAKLQHKNLVRLL 110
+ K+G G FG V++ + ++AVK L + + EF ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------ 158
G + L ++ EY+ SL LL S QLD RR+ + +A+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 159 ------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
D K K+ DFG++R+ + ++ GT +MAPE + +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF--I 264
KSDV+SFGV+L E+ + ++ + + + + + +
Sbjct: 219 KSDVYSFGVILWELATLQQ-----PWG-NLNPAQVVAAV-----GFKCKRLEIPRNLNPQ 267
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ +++ C +P RP+ ++++ +L
Sbjct: 268 VAAIIEG------CWTNEPWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 63/279 (22%), Positives = 99/279 (35%), Gaps = 54/279 (19%)
Query: 56 ENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLG 111
LG+G FG K + + + +K L R + + F ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------- 158
+ L I EY+ +L ++ Q W++R+ IA
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 159 ---------DHKMNPKISDFGMARVFGGNQSEANTNR------------VVGTYGYMAPE 197
N ++DFG+AR+ +++ R VVG +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 198 YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
+ K DVFSFG++L EII YL L G P
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------RGFLDRYCPP 246
Query: 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
SF + R C DP RP+ + L
Sbjct: 247 NCPPSFF--PITVR------CCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-44
Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 48/272 (17%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKN---LIAKLQHKNLVRLL 110
++G G FG VYKG + D +AVK L+ + + Q LQ FKN ++ K +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 111 GCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIAR----------- 158
G L ++ ++ SL L + + + + I AR
Sbjct: 87 GYSTAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 159 -----------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE---YALEGLF 204
KI DFG+A ++ G+ +MAPE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264
S +SDV++FG++L E+++G+ Y + + L + K
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ-----LPYSNINNRDQIIEMV----GRGSLSPDLSKVRSN 253
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ +KR+ C+++ +RP+ ++ +
Sbjct: 254 CPKRMKRLM--AECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-43
Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 68/285 (23%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-------LQEFKN---LIAKLQHK 104
E ++G+GGFG V+KG + D +A+K L +G QEF+ +++ L H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARD----H 160
N+V+L G N ++ E++P L L D ++ + W+ ++ ++ IA
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 161 KMNP-------------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
NP K++DFG+++ S + + ++G + +MA
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMA 194
Query: 196 PE--YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253
PE A E ++ K+D +SF ++L I++G Y Y + + + +E
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---------FINMIREE 245
Query: 254 LMDPVLKESF--ILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ P + E L +++ C DP RP S +V L
Sbjct: 246 GLRPTIPEDCPPRLRNVIEL------CWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-43
Identities = 66/281 (23%), Positives = 108/281 (38%), Gaps = 64/281 (22%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRL----SRSSGQGLQEFKN---LIAKLQHKNLVR 108
E +G GGFG VY+ E+AVK Q ++ + L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARD----HKMNP 164
L G CL+ L L+ E+ L+ +L ++ + + IAR H
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 165 -----------------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
KI+DFG+AR + + G Y +MA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMA 182
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255
PE +FS SDV+S+GVLL E+++G + G L + + A +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEV-----PFR-GIDGLAVAYGVAMNKLALPIP 236
Query: 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ +L++ C DP RP+ ++++ L
Sbjct: 237 STCPEP---FAKLMED------CWNPDPHSRPSFTNILDQL 268
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-43
Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 55/271 (20%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGC 112
E +G G FG V K K++A+K++ S + F ++++ H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKWRA-KDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARD----HKMNP---- 164
CL N + L+ EY SL +L + M ++ H M P
Sbjct: 70 CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 165 ------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
KI DFG A + + G+ +MAPE +S
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQ-GQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
K DVFS+G++L E+I+ RK +++ G W + G L+ + K +
Sbjct: 183 KCDVFSWGIILWEVITRRK-----PFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP---I 233
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
E L+ R C +DP+ RP+M +V ++
Sbjct: 234 ESLMTR------CWSKDPSQRPSMEEIVKIM 258
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 60/276 (21%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKN---LIAKLQHKNLVRLL 110
KL E G ++KG +I VK L S + ++F + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 111 GCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---------- 158
G C LI +MP SL +L + T V +D ++ + +AR
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEP 132
Query: 159 --------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-- 202
D M +IS + F + + ++APE AL+
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKKP 184
Query: 203 --LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260
+D++SF VLL E+++ + S + K+ EG + +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV-----PFA-DLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ +L+K C+ EDPA RP +V +L
Sbjct: 239 H---VSKLMKI------CMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 56/279 (20%), Positives = 107/279 (38%), Gaps = 57/279 (20%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRL--SRSSGQGLQEFKN---LIAKLQHKNLVRLL 110
+G+G FG VY G + + +A++ + R + L+ FK + +H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------------- 157
G C+ L +I ++L ++ D + LD N+ I I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 158 RD--------HKMNPKISDFGMARVFGGNQSEANTNR---VVGTYGYMAPE--------- 197
+D I+DFG+ + G Q+ ++ G ++APE
Sbjct: 154 KDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 198 YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
+ FS SDVF+ G + E+ + ++ Q W++ G L
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREW-----PFK-TQPAEAIIWQM-GTGMKPNLSQI 266
Query: 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ + + ++L C + +RPT + ++ ML
Sbjct: 267 GMGKE--ISDILLF------CWAFEQEERPTFTKLMDML 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 61/309 (19%), Positives = 103/309 (33%), Gaps = 80/309 (25%)
Query: 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN-----LIAKLQHK 104
R+ + +G+G +G V++G + +AVK S + + + L+H+
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQG-ENVAVKIFSS---RDEKSWFRETELYNTVMLRHE 62
Query: 105 NLVRLLGCCLEGN----ELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIAR- 158
N++ + + +L LI Y SL D+L + LD + I+ IA
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASG 117
Query: 159 -----------------------------DHKMNPKISDFGMARVF--GGNQSEANTNRV 187
I+D G+A + NQ + N
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 188 VGTYGYMAPE------YALEGLFSVKSDVFSFGVLLLEIISGRKDTR--------FYLYE 233
VGT YMAPE + D+++FG++L E+ FY
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 234 QGQSLLTYTWKLWCEGN------AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRP 287
K+ C + DP L L +L+K C ++P+ R
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS---LAKLMKE------CWYQNPSARL 288
Query: 288 TMSSVVFML 296
T + L
Sbjct: 289 TALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 56/305 (18%), Positives = 102/305 (33%), Gaps = 82/305 (26%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN-----LIAKLQHKNLVRLL 110
++G+G +G V+ G +++AVK + ++H+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWRG-EKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 111 GCCLEGN----ELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIAR------- 158
++G +L LI +Y N SL D+L +S LD + +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 159 -----------------------DHKMNPKISDFGMARVF--GGNQSEANTNRVVGTYGY 193
I+D G+A F N+ + N VGT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 194 MAPEYALEGLFSV-------KSDVFSFGVLLLEIISGRKDTR--------FYLYEQGQSL 238
M PE L+ + +D++SFG++L E+ ++
Sbjct: 213 MPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 239 LTYTWKLWCEGN------AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
++ C + D L++ + +L+ C +PA R T V
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQ---MGKLMTE------CWAHNPASRLTALRV 322
Query: 293 VFMLA 297
LA
Sbjct: 323 KKTLA 327
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 69/315 (21%), Positives = 113/315 (35%), Gaps = 75/315 (23%)
Query: 36 QELPLFPLD--LIHEATRNFSNENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSG 88
+ L P D + H+ R LGEG FG V + + +AVK L +G
Sbjct: 16 EVLFQGPGDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG 73
Query: 89 -QGLQEFK---NLIAKLQHKNLVRLLGCCLEGNE--LLLICEYMPNKSL-DFLLFDSTRS 141
Q +K +++ L H+++++ GCC + L L+ EY+P SL D+L
Sbjct: 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PR 128
Query: 142 VQLDWNRRMCIINGIA-------------RD---------HKMNPKISDFGMARVFGGNQ 179
+ + + I RD + KI DFG+A+
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
Query: 180 SEANTNRVVGTYG-----YMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYE 233
V G + APE E F SDV+SFGV L E+++
Sbjct: 189 EYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244
Query: 234 QGQSLLTYTWKLWCEGNAQELMDPVLKESFILE----------ELLKRIHIGLLCVQEDP 283
+ + L + +L+ L L+K C + +
Sbjct: 245 LELIGIAQG-----QMTVLRLTE-LLERGERLPRPDKCPAEVYHLMKN------CWETEA 292
Query: 284 ADRPTMSSVVFMLAT 298
+ RPT +++ +L T
Sbjct: 293 SFRPTFENLIPILKT 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 71/312 (22%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSGQGLQEFK---NLIAKLQHKNLV 107
++LG+G FG V + + +AVK+L S ++F+ ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 108 RLLGCCLEGNE--LLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------- 157
+ G L L+ EY+P+ L DFL +LD +R + + I
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLG 144
Query: 158 ------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPE 197
RD + + KI+DFG+A++ ++ VV G + APE
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPE 200
Query: 198 YALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256
+ +FS +SDV+SFGV+L E+ + K L L++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS-----CSPSAEFLRMMGCERDVPALSRLLE 255
Query: 257 PVLKESFILE----------ELLKRIHIGLLCVQEDPADRPTMSSVVFML---ATDTITL 303
+L+E L EL+K C P DRP+ S++ L + +
Sbjct: 256 -LLEEGQRLPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
Query: 304 LQPTQPAFSVGR 315
A G+
Sbjct: 309 ETHAFTAHPEGK 320
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 53/283 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSGQGLQEFK---NLIAKLQHKNLV 107
+LG+G FG V + ++ +AVK+L S+ + L++F+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 108 RLLGCCLEGNE--LLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------- 157
+ G C L LI EY+P SL D+L ++D + + + I
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 158 ------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPE 197
RD ++ KI DFG+ +V ++ V G + APE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPE 187
Query: 198 YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
E FSV SDV+SFGV+L E+ + + ++ E + + L++
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLIE- 243
Query: 258 VLKESFILEELL---KRIH-IGLLCVQEDPADRPTMSSVVFML 296
+LK + L I+ I C + RP+ + +
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 65/275 (23%), Positives = 101/275 (36%), Gaps = 58/275 (21%)
Query: 56 ENKLGEGGFGPVYKGVLN-DDKEIAVKRL-SRSSGQGLQEFK---NLIAKLQHKNLVRLL 110
++G G FG V+ G L D+ +AVK +F ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---------RD 159
G C + + ++ E + L +++ +M G+ RD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDV 210
K KISDFGM+R A+ + APE G +S +SDV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 211 FSFGVLLLEIIS-GR--------KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261
+SFG+LL E S G + TR ++ E+G L C LM
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPE---LCPDAVFRLM------ 348
Query: 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
C +P RP+ S++ L
Sbjct: 349 --------------EQCWAYEPGQRPSFSTIYQEL 369
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 65/289 (22%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSGQGLQEFK---NLIAKLQHKNLV 107
+LG+G FG V + ++ +AVK+L S+ + L++F+ ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 108 RLLGCCLEGNE--LLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------- 157
+ G C L LI EY+P SL D+L ++D + + + I
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 158 ------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPE 197
RD ++ KI DFG+ +V ++ V G + APE
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPE 218
Query: 198 YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
E FSV SDV+SFGV+L E+ + + ++ E + + L++
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLIE- 274
Query: 258 VLKESFILE----------ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+LK + L ++ C + RP+ + +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTE------CWNNNVNQRPSFRDLALRV 317
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 51/304 (16%), Positives = 101/304 (33%), Gaps = 82/304 (26%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN-----LIAKLQHKNLVRLL 110
+ +G+G FG V++G +E+AVK S + + + L+H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKWRG-EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 111 GCCLEGN----ELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIAR------- 158
+ N +L L+ +Y + SL D+L + + + A
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 159 -----------------------DHKMNPKISDFGMARVF--GGNQSEANTNRVVGTYGY 193
I+D G+A + + N VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 194 MAPEYALEGLFSV-------KSDVFSFGVLLLEIISGRKDTR--------FYLYEQGQSL 238
MAPE L+ ++ ++D+++ G++ EI +Y
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 239 LTYTWKLWCEGN------AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+ K+ CE + L+ + ++++ C + A R T +
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRV---MAKIMRE------CWYANGAARLTALRI 327
Query: 293 VFML 296
L
Sbjct: 328 KKTL 331
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 62/285 (21%), Positives = 112/285 (39%), Gaps = 57/285 (20%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRL-SRSSGQGLQEFK---NLIAKLQHKNL 106
LGEG FG V + + + +AVK L S G + + K ++ L H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 107 VRLLGCCLE--GNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------ 157
V+ G C E GN + LI E++P+ SL ++L +++ +++ I
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 158 -------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAP 196
RD + KI DFG+ + ++ V + AP
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAP 198
Query: 197 EYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255
E ++ F + SDV+SFGV L E+++ D+ T+ L+
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM-----TVTRLV 253
Query: 256 DPVLKESFILEELL---KRIH-IGLLCVQEDPADRPTMSSVVFML 296
+ LKE L ++ + C + P++R + +++
Sbjct: 254 N-TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 35/195 (17%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
+LG G FG V G ++A+K + + EF ++ L H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------------RD 159
C + + +I EYM N L L + Q MC + RD
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK--DVCEAMEYLESKQFLHRD 145
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVK 207
+ K+SDFG++R ++ ++ G+ + PE + FS K
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSK 201
Query: 208 SDVFSFGVLLLEIIS 222
SD+++FGVL+ EI S
Sbjct: 202 SDIWAFGVLMWEIYS 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 36/199 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
++G G FG V+ G + ++A+K + R ++F ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------------RD 159
CLE + L+ E+M + L L + MC+ + RD
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL--DVCEGMAYLEEACVIHRD 129
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVK 207
K+SDFGM R +Q ++T GT + +PE +S K
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSK 185
Query: 208 SDVFSFGVLLLEIIS-GRK 225
SDV+SFGVL+ E+ S G+
Sbjct: 186 SDVWSFGVLMWEVFSEGKI 204
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 36/199 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
+LG G FG V G ++AVK + + EF + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------------RD 159
C + + ++ EY+ N L L + ++ MC + RD
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY--DVCEGMAFLESHQFIHRD 129
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVK 207
+ K+SDFGM R +Q ++ GT + APE +S K
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSK 185
Query: 208 SDVFSFGVLLLEIIS-GRK 225
SDV++FG+L+ E+ S G+
Sbjct: 186 SDVWAFGILMWEVFSLGKM 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 78/295 (26%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRL-SRSSGQGLQEFKN---LIAKLQHKN 105
+LGE FG VYKG L + +A+K L ++ G +EF++ L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSL-DFL------------LFDSTRSVQLDWNRRMCI 152
+V LLG + L +I Y + L +FL D T L+ + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 153 INGIA-------------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT 190
+ IA +D K+N KISD G+ R A +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-----YAADYYKLLG 188
Query: 191 YG-----YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245
+MAPE + G FS+ SD++S+GV+L E+ +Y +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF------------------SYGLQP 230
Query: 246 WCEGNAQELMDPVLKESFILEELL---KRIH-IGLLCVQEDPADRPTMSSVVFML 296
+C + Q++++ + + +L ++ + + C E P+ RP + L
Sbjct: 231 YCGYSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 54/216 (25%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNL 106
+ +LGEG FG V+ + +AVK L + ++F+ L+ LQH+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 107 VRLLGCCLEGNELLLICEYMPNKSL-DFL------------LFDSTRSVQLDWNRRMCII 153
V+ G C +G+ L+++ EYM + L FL +L ++ + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 154 NGIA-------------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTY 191
+ IA RD + KI DFGM+R + R VG +
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV----YSTDYYR-VGGH 194
Query: 192 G-----YMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+M PE + F+ +SDV+SFGV+L EI +
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 46/208 (22%)
Query: 56 ENKLGEGGFGPVYKGVL----NDDKEIAVKRL-SRSSGQGLQEFK---NLIAKLQHKNLV 107
E +G G G V G L D +A+K L + + + ++F +++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
RL G G +++ EYM N SL FL T Q + + ++ G+
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG------YMAPEY 198
RD + K+SDFG++RV + A T T G + APE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEA 225
Query: 199 ALEGLFSVKSDVFSFGVLLLEIIS-GRK 225
FS SDV+SFGV++ E+++ G +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRL-SRSSGQGLQEF---KNLIAKLQHKNL 106
LG G FG VYKG+ + E +A+K L +S + +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
RLLG CL + + LI + MP L + + ++ + C+ IA
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYLEDR 136
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPEYA 199
RD + KI+DFG+A++ G + E + G +MA E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESI 191
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS-GRK 225
L +++ +SDV+S+GV + E+++ G K
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 41/199 (20%)
Query: 56 ENKLGEGGFGPVYKGVLNDDK-EIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLG 111
++KLG G +G VY+GV +AVK L + ++EF ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 112 CCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------------- 157
C +I E+M +L D+L ++ + + I+
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 158 RD---------HKMNPKISDFGMARVFGGNQSEANTN-----RVVGTYGYMAPEYALEGL 203
RD K++DFG++R+ G+ A+ + + APE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNK 188
Query: 204 FSVKSDVFSFGVLLLEIIS 222
FS+KSDV++FGVLL EI +
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 76/313 (24%), Positives = 134/313 (42%), Gaps = 77/313 (24%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRL-SRSSGQGLQEFK---NLIAKLQHKNL 106
+ +G G FG VYKG+L +A+K L + + + +F ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 107 VRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA-------- 157
+RL G + +++I EYM N +L FL + + + + ++ GIA
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 158 -----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG------YMAPE 197
RD + K+SDFG++RV + T T G + APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTAPE 220
Query: 198 YALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256
F+ SDV+SFG+++ E+++ G + Y W+L + E+M
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER--------------PY-WEL----SNHEVMK 261
Query: 257 PVLKESFILEELL---KRIH-IGLLCVQEDPADRPTMSSVVFML-----ATDTITLLQPT 307
+ + F L + I+ + + C Q++ A RP + +V +L A D++ L
Sbjct: 262 AI-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
Query: 308 QPAFSVGRVKSPS 320
P S+ R+ S S
Sbjct: 321 DPRVSI-RLPSTS 332
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 74/299 (24%), Positives = 117/299 (39%), Gaps = 88/299 (29%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNL 106
+ +LGEG FG V+ ++ +AVK L +S Q+F+ L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 107 VRLLGCCLEGNELLLICEYMPNKSL-DFL-----------LFDSTRSVQLDWNRRMCIIN 154
VR G C EG LL++ EYM + L FL + L + + + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 155 GIA-------------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG 192
+A RD + KI DFGM+R + + R VG
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGGRT 220
Query: 193 -----YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC 247
+M PE L F+ +SDV+SFGV+L EI TY + W
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF------------------TYGKQPWY 262
Query: 248 EGNAQELMDPVLKESFILE----------ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ + E +D + + LE +++ C Q +P R ++ V L
Sbjct: 263 QLSNTEAIDCI-TQGRELERPRACPPEVYAIMRG------CWQREPQQRHSIKDVHARL 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 37/196 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
+LG G FG V+ G N ++AVK L + F NL+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA-------------R 158
+ + +I EYM N SL DFL + ++L N+ + + IA R
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 159 D---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSV 206
D ++ KI+DFG+AR+ N+ A G + APE G F++
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTFTI 189
Query: 207 KSDVFSFGVLLLEIIS 222
KSDV+SFG+LL EI++
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 61/194 (31%), Positives = 87/194 (44%), Gaps = 33/194 (17%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
E KLG G FG V+ N ++AVK + + ++ F N++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCI-----------INGIARD- 159
+ + +I E+M SL DFL D L N I RD
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 160 --------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEGLFSVKS 208
+ KI+DFG+ARV N+ A G + APE G F++KS
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKS 366
Query: 209 DVFSFGVLLLEIIS 222
DV+SFG+LL+EI++
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 27/192 (14%)
Query: 56 ENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLG 111
++KLG G +G VY+GV +AVK L + ++EF ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 112 CCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCI-----------INGIARD 159
C +I E+M +L D+L + + V M N I R+
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDV 210
K++DFG++R+ G+ A+ + APE FS+KSDV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDV 402
Query: 211 FSFGVLLLEIIS 222
++FGVLL EI +
Sbjct: 403 WAFGVLLWEIAT 414
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 38/204 (18%)
Query: 56 ENKLGEGGFGPVYKGVLN----DDKEIAVKRL-SRSSGQGLQEFK---NLIAKLQHKNLV 107
+ +G G FG V G L + +A+K L + + ++F +++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA---------- 157
RL G + ++++ EYM N SLD L Q + + ++ GIA
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEG 202
RD + K+SDFG+ RV + A T R G + +PE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYR 225
Query: 203 LFSVKSDVFSFGVLLLEIIS-GRK 225
F+ SDV+S+G++L E++S G +
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 67/281 (23%), Positives = 102/281 (36%), Gaps = 64/281 (22%)
Query: 56 ENKLGEGGFGPVYKGVLNDDK----EIAVKRL---SRSSGQGLQEFK---NLIAKLQHKN 105
KLG+G FG V +G + +AVK L S + + +F N + L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------- 157
L+RL G L + ++ E P SL L L R + +A
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES 139
Query: 158 -----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYAL 200
RD + KI DFG+ R N + + APE
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLK 197
Query: 201 EGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259
FS SD + FGV L E+ + G++ W N +++ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP-------------------WIGLNGSQILHKID 238
Query: 260 KESFIL---EELLKRIH-IGLLCVQEDPADRPTMSSVVFML 296
KE L E+ + I+ + + C P DRPT ++ L
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 61/218 (27%)
Query: 56 ENKLGEGGFGPVYKGVLNDDK--------EIAVKRLSRSSGQGLQEFK---NLIAKLQHK 104
LG+G F ++KGV + E+ +K L ++ + F ++++KL HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------- 157
+LV G C+ G+E +L+ E++ SLD L + + + W + +A
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK--QLAAAMHFLE 130
Query: 158 ------RD-----------------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY- 193
+ + K+SD G++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQE 179
Query: 194 ----MAPEYALEG-LFSVKSDVFSFGVLLLEIIS-GRK 225
+ PE ++ +D +SFG L EI S G K
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 74/290 (25%), Positives = 111/290 (38%), Gaps = 74/290 (25%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRL-SRSSGQGLQEFKN---LIAKLQHKN 105
LG G FG VY+G ++ ++AVK L S Q +F +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSL-DFLL---FDSTRSVQLDWNRRMCIINGIA---- 157
+VR +G L+ ++ E M L FL ++ L + + IA
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 158 ---------RD------------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY--- 193
RD KI DFGMAR + A+ R G
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAMLPV 209
Query: 194 --MAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGN 250
M PE +EG+F+ K+D +SFGVLL EI S G Y +S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPY---PSKS------------- 250
Query: 251 AQELMDPVLKESFILE---ELLKRIH-IGLLCVQEDPADRPTMSSVVFML 296
QE+++ V ++ ++ I C Q P DRP + ++ +
Sbjct: 251 NQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 58/193 (30%), Positives = 86/193 (44%), Gaps = 35/193 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQG--LQEFKNLIAKLQHKNLVRLLGCC 113
+G+G FG V G ++AVK + + L E +++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVI 255
Query: 114 LEGNELL-LICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCI-----------INGIARD- 159
+E L ++ EYM SL D+L + D + + N + RD
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 160 --------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY--MAPEYALEGLFSVKSD 209
K+SDFG+ + EA++ + G APE E FS KSD
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 210 VFSFGVLLLEIIS 222
V+SFG+LL EI S
Sbjct: 369 VWSFGILLWEIYS 381
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 81/294 (27%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE---IAVKRL-SRSSGQGLQEFK---NLIAKL-QHKNLV 107
++ +GEG FG V K + D A+KR+ +S ++F ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFL------------LFDSTRSVQLDWNRRMCIIN 154
LLG C L L EY P+ +L DFL ++ + L + +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 155 GIA-------------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG 192
+A RD KI+DFG++R Q V T G
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY----VKKTMG 201
Query: 193 -----YMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLW 246
+MA E +++ SDV+S+GVLL EI+S G +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------------------Y 242
Query: 247 CEGNAQELMDPVLKESFILE---ELLKRIH-IGLLCVQEDPADRPTMSSVVFML 296
C EL + L + + LE ++ + C +E P +RP+ + ++ L
Sbjct: 243 CGMTCAELYE-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 61/211 (28%), Positives = 85/211 (40%), Gaps = 49/211 (23%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRL-SRSSGQGLQEFKN---LIAKLQHKN 105
LG G FG VY+G ++ ++AVK L S Q +F +I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSL-DFLL---FDSTRSVQLDWNRRMCIINGIA---- 157
+VR +G L+ ++ E M L FL ++ L + + IA
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 158 ---------RD------------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY--- 193
RD KI DFGMAR + A R G
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAMLPV 250
Query: 194 --MAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
M PE +EG+F+ K+D +SFGVLL EI S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 64/292 (21%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
E KLG+G FG V+ G N +A+K L + + F ++ KL+H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA-------------R 158
E + ++ EYM SL DFL ++ + ++L M IA R
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA--QIASGMAYVERMNYVHR 387
Query: 159 D---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
D + K++DFG+AR+ N+ A + APE AL G F++KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 446
Query: 210 VFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK-------LWCEGNAQELMDPVLKES 262
V+SFG+LL E+ + K Y + +L + C + +LM
Sbjct: 447 VWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM------- 497
Query: 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVG 314
C +++P +RPT + L T+P + G
Sbjct: 498 -------------CQCWRKEPEERPTFEYLQAFL----EDYFTSTEPQYQPG 532
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 51/211 (24%)
Query: 57 NKLGEGGFGPVYKGVLND------DKEIAVKRL-SRSSGQGLQEFKN---LIAKLQHKNL 106
+LG+G FG VY+GV + +A+K + +S + EF N ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 107 VRLLGCCLEGNELLLICEYMPNKSL-DFL------LFDSTRSVQLDWNRRMCIINGIA-- 157
VRLLG +G L+I E M L +L + ++ ++ + + IA
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 158 -----------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN-----RVVGTY 191
RD KI DFGM R ++ + R
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----- 205
Query: 192 GYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+M+PE +G+F+ SDV+SFGV+L EI +
Sbjct: 206 -WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 45/207 (21%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSG-QGLQEFK---NLIAKLQHKNL 106
LG G FG V+KGV + E + +K + SG Q Q I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
VRLLG C + L L+ +Y+P SL + ++ + IA
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIAKGMYYLEEH 134
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPEYA 199
R+ +++DFG+A + + + + +MA E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESI 189
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS-GRK 225
G ++ +SDV+S+GV + E+++ G +
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 46/207 (22%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE---IAVKRL-SRSSGQGLQEFK---NLIAKLQHKNLVR 108
+ +LG G FG V +GV K+ +A+K L + +E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 109 LLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA---------- 157
L+G C L+L+ E L FL+ + ++ + +++ ++
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG------YMAPEYA 199
RD ++ KISDFG+++ G + S + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS-GRK 225
FS +SDV+S+GV + E +S G+K
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 80/333 (24%), Positives = 119/333 (35%), Gaps = 101/333 (30%)
Query: 34 ESQELPLFPLDLIHEATR-NFSNENKLGEGGFGPVYKGVLNDDKE------IAVKRL-SR 85
+ L L P L E R N +GEG FG V++ +AVK L
Sbjct: 29 QRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE 88
Query: 86 SSGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFL------- 134
+S +F+ L+A+ + N+V+LLG C G + L+ EYM L +FL
Sbjct: 89 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 135 -------------LFDSTRSVQLDWNRRMCIINGIA-------------RD--------- 159
S L ++CI +A RD
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208
Query: 160 HKMNPKISDFGMAR-VFGGNQSEANTN-----RVVGTYGYMAPEYALEGLFSVKSDVFSF 213
M KI+DFG++R ++ + +A+ N R +M PE ++ +SDV+++
Sbjct: 209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAY 262
Query: 214 GVLLLEIIS-------GRKDTRFYLY-EQGQSLL--TYTWKLWCEGNAQELMDPVLKESF 263
GV+L EI S G Y G L C LM
Sbjct: 263 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN-----CPLELYNLM-------- 309
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
LC + PADRP+ S+ +L
Sbjct: 310 ------------RLCWSKLPADRPSFCSIHRIL 330
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 72/289 (24%), Positives = 106/289 (36%), Gaps = 80/289 (27%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRLSR-SSGQGLQEFKN---LIAKLQHKNLV 107
+G G FG VY G L D+ AVK L+R + + +F ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 108 RLLGCCLEGNE-LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
LLG CL L++ YM + L + + T + + + +A
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLASK 147
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG------YMAPEY 198
RD K K++DFG+AR + V G +MA E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMALES 203
Query: 199 ALEGLFSVKSDVFSFGVLLLEIIS-GRK--------DTRFYLYEQGQSLL--TYTWKLWC 247
F+ KSDV+SFGVLL E+++ G D YL QG+ LL Y C
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEY-----C 257
Query: 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
E+M L C RP+ S +V +
Sbjct: 258 PDPLYEVM--------------------LKCWHPKAEMRPSFSELVSRI 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 60/290 (20%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
E KLG+G FG V+ G N +A+K L + + F ++ KL+H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 113 CLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA-------------R 158
E + ++ EYM SL DFL ++ + ++L M IA R
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA--QIASGMAYVERMNYVHR 304
Query: 159 D---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
D + K++DFG+AR+ N+ A + APE AL G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 210 VFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKL----WCEGNAQELMDPVLKESFI 264
V+SFG+LL E+ + GR + + + +++ C + +LM
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM--------- 414
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVG 314
C +++P +RPT + L T+P + G
Sbjct: 415 -----------CQCWRKEPEERPTFEYLQAFL----EDYFTSTEPQYQPG 449
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 65/226 (28%)
Query: 56 ENKLGEGGFGPVYKGVL------NDDKEIAVKRL-SRSSGQGLQEFK---NLIAKLQHKN 105
LGEG FG V K +AVK L +S L++ N++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSL-DFL--------------------LFDSTRSVQL 144
+++L G C + LLLI EY SL FL D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 145 DWNRRMCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSE 181
+ I+ RD KISDFG++R V+ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 182 ANTN-----RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ + +MA E + +++ +SDV+SFGVLL EI++
Sbjct: 208 KRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE-----IAVKRL-SRSSGQGLQEF---KNLIAKLQHKNL 106
LG G FG VYKG+ + E +A+K L +S + +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
RLLG CL + + LI + MP L + + ++ + C+ IA
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYLEDR 136
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPEYA 199
RD + KI+DFG+A++ G + E + G +MA E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESI 191
Query: 200 LEGLFSVKSDVFSFGVLLLEIIS-GRK 225
L +++ +SDV+S+GV + E+++ G K
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 56/217 (25%)
Query: 56 ENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHK 104
LG G FG V + + ++AVK L ++ + E K + QH+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSL-DFL----------LFDSTRSVQLDWNRRMCII 153
N+V LLG C G +L+I EY L +FL + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 154 NGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN----- 185
+ +A RD + KI DFG+AR + + N
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ +MAPE + +++V+SDV+S+G+LL EI S
Sbjct: 231 K------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 48/208 (23%)
Query: 56 ENKLGEGGFGPVYKGVLNDDK---EIAVKRL--SRSSGQGLQEFK---NLIAKLQHKNLV 107
+ +LG G FG V KG K +AVK L + E N++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
R++G C +L+ E L +L ++ + + +++ ++
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG------YMAPEY 198
RD + KISDFG+++ +++ + APE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 199 ALEGLFSVKSDVFSFGVLLLEIIS-GRK 225
FS KSDV+SFGVL+ E S G+K
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 86/296 (29%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRLSR--SSGQGLQEFKN---LIAKLQHKNL 106
LGEG FG V +G L + +AVK + SS + ++EF + + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 107 VRLLGCCLEGN-----ELLLICEYMPNKSL-DFLLF--DSTRSVQLDWNRRMCIINGIA- 157
+RLLG C+E + + ++I +M L +LL+ T + + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 158 ------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN-----RVVGT 190
RD M ++DFG+++ ++ G+ +
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---- 214
Query: 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-------GRKDTRFYLY-EQGQSLL--T 240
++A E + +++ KSDV++FGV + EI + G ++ Y Y G L
Sbjct: 215 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272
Query: 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
C E+M C + DP DRPT S + L
Sbjct: 273 D-----CLDELYEIM--------------------YSCWRTDPLDRPTFSVLRLQL 303
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 42/200 (21%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGC 112
+G+G FG V G ++AVK + + Q F +++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 113 CLEGNE-LLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA------------- 157
+E L ++ EYM SL D+L + D + + +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNNFVH 140
Query: 158 RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGY--MAPEYALEGLFSV 206
RD K+SDFG+ + EA++ + G APE E FS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 207 KSDVFSFGVLLLEIIS-GRK 225
KSDV+SFG+LL EI S GR
Sbjct: 194 KSDVWSFGILLWEIYSFGRV 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 33/199 (16%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRLSRSSGQG-----LQEFKNLIAKLQHKNL 106
+ +G+G FG VY G D + A+K LSR + L+E L+ L H N+
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG-LLMRGLNHPNV 84
Query: 107 VRLLGCCLEGNE-LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA------ 157
+ L+G L ++ YM + L + R+ + + G+
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTY--GYMAPEYALEGL 203
RD K++DFG+AR + + + A E
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 204 FSVKSDVFSFGVLLLEIIS 222
F+ KSDV+SFGVLL E+++
Sbjct: 205 FTTKSDVWSFGVLLWELLT 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 67/306 (21%), Positives = 111/306 (36%), Gaps = 97/306 (31%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE--------IAVKRLSRSSGQG-----LQEFKNLIAKLQ 102
LGEG FG V + +AVK L + + + E + + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLL------------FDSTRSVQLDWNRR 149
HKN++ LLG C + L +I EY +L ++L + Q+ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 150 MCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN- 185
+ +A RD KI+DFG+AR + + + TN
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 186 ----RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240
+ +MAPE + +++ +SDV+SFGVL+ EI + G Y G
Sbjct: 220 RLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---Y---PGIP--- 264
Query: 241 YTWKLWCEGNAQELMDPVLKESFILE----------ELLKRIHIGLLCVQEDPADRPTMS 290
+EL +LKE ++ +++ C P+ RPT
Sbjct: 265 ----------VEELFK-LLKEGHRMDKPANCTNELYMMMRD------CWHAVPSQRPTFK 307
Query: 291 SVVFML 296
+V L
Sbjct: 308 QLVEDL 313
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 64/282 (22%), Positives = 104/282 (36%), Gaps = 66/282 (23%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRLSR-SSGQGLQEFKN---LIAKLQHKNLV 107
+G G FG VY G L D+ AVK L+R + + +F ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 108 RLLGCCLEGNE-LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
LLG CL L++ YM + L + + T + + + +A
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLASK 211
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYG------YMAPEY 198
RD K K++DFG+AR + + V G +MA E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKWMALES 267
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
F+ KSDV+SFGVLL E+ +T + + N ++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWEL------------------MTRGAPPYPDVNTFDITV-Y 308
Query: 259 LKESFILE---ELLKRIH-IGLLCVQEDPADRPTMSSVVFML 296
L + L ++ + L C RP+ S +V +
Sbjct: 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 67/306 (21%), Positives = 111/306 (36%), Gaps = 97/306 (31%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE--------IAVKRLSRSSGQG-----LQEFKNLIAKLQ 102
LGEG FG V + +AVK L + + + E + + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLL------------FDSTRSVQLDWNRR 149
HKN++ LLG C + L +I EY +L ++L + Q+ +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 150 MCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN- 185
+ +A RD KI+DFG+AR + + + TN
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 186 ----RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240
+ +MAPE + +++ +SDV+SFGVL+ EI + G Y G
Sbjct: 266 RLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---Y---PGIP--- 310
Query: 241 YTWKLWCEGNAQELMDPVLKESFILE----------ELLKRIHIGLLCVQEDPADRPTMS 290
+EL +LKE ++ +++ C P+ RPT
Sbjct: 311 ----------VEELFK-LLKEGHRMDKPANCTNELYMMMRD------CWHAVPSQRPTFK 353
Query: 291 SVVFML 296
+V L
Sbjct: 354 QLVEDL 359
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 64/223 (28%)
Query: 56 ENKLGEGGFGPVYKGVL--------NDDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQ 102
LGEG FG V N ++AVK L + + + E + + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIING------ 155
HKN++ LLG C + L +I EY +L ++L + R L+++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 156 --------IA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANT 184
+A RD KI+DFG+AR + + + T
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 185 N-----RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
N + +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 252 NGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 52/213 (24%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRL--SRSSGQGLQEFKN---LIAKLQHKNL 106
LG+G FG V + L + +AVK L + ++EF + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 107 VRLLGCCLEG------NELLLICEYMPNKSL-DFLLF--DSTRSVQLDWNRRMCIINGIA 157
+L+G L ++I +M + L FLL L + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 158 -------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN-----RVVG 189
RD M ++DFG++R ++ G+ +
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK--- 204
Query: 190 TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
++A E + L++V SDV++FGV + EI++
Sbjct: 205 ---WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 37 ELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKE---IAVKRL-SRSSGQGLQ 92
EL L L + + +LG G FG V +GV K+ +A+K L + +
Sbjct: 324 ELKDKKLFLKRDNLL--IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381
Query: 93 EFK---NLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNR 148
E ++ +L + +VRL+G C L+L+ E L FL+ + ++ +
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSN 437
Query: 149 RMCIINGIA-------------RD---------HKMNPKISDFGMARVFGGNQSEANTNR 186
+++ ++ R+ ++ KISDFG+++ G + S
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR- 496
Query: 187 VVGT---YGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRK 225
+ APE FS +SDV+S+GV + E +S G+K
Sbjct: 497 -SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 55/221 (24%), Positives = 78/221 (35%), Gaps = 60/221 (27%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHK 104
LG G FG V + +AVK L S+ + E K L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSL-DFL--------------LFDSTRSVQLDWNRR 149
N+V LLG C G L+I EY L +FL + LD
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 150 MCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN- 185
+ +A RD H KI DFG+AR + + N
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 186 ----RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ +MAPE +++ +SDV+S+G+ L E+ S
Sbjct: 208 RLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 41/204 (20%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRLSR-SSGQGLQEFK---NLIAKLQHKNLV 107
LGEG FG VY+GV + K +AVK + + ++F ++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA---------- 157
+L+G E +I E P L L + S+++ + I
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLESIN 133
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGT---YGYMAPEYALEG 202
RD K+ DFG++R + T +M+PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMSPESINFR 189
Query: 203 LFSVKSDVFSFGVLLLEIIS-GRK 225
F+ SDV+ F V + EI+S G++
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 46/203 (22%), Positives = 77/203 (37%), Gaps = 39/203 (19%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRL-SRSSGQGLQEFK---NLIAKLQHKNLV 107
+GEG FG V++G+ + +A+K + +S ++F + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA---------- 157
+L+G E N + +I E L L S+ L ++
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY--QLSTALAYLESKR 136
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTY--GYMAPEYALEGL 203
RD K+ DFG++R + G +MAPE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 204 FSVKSDVFSFGVLLLEIIS-GRK 225
F+ SDV+ FGV + EI+ G K
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVK 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 59/219 (26%)
Query: 57 NKLGEGGFGPVYKGVLNDDKE------IAVKRL-SRSSGQGLQEFK---NLIAKL-QHKN 105
LG G FG V + + +AVK L ++ + ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 106 LVRLLGCCL-EGNELLLICEYMPNKSL-DFL------------LFDSTRSVQLDWNRRMC 151
+V LLG C G L++I E+ +L +L + L +C
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 152 IINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSEANTN--- 185
+A RD K KI DFG+AR ++ +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 186 --RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
+ +MAPE + +++++SDV+SFGVLL EI S
Sbjct: 213 PLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 57/226 (25%), Positives = 83/226 (36%), Gaps = 65/226 (28%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE------IAVKRLSRSSGQG-----LQEFKNLIAKLQHK 104
LG G FG V + +AVK L + + E K + H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSL-DFL-------------------LFDSTRSVQL 144
N+V LLG C + LI EY L ++L L + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 145 DWNRRMCIINGIA-------------RD---------HKMNPKISDFGMAR-VFGGNQSE 181
+ +C +A RD H KI DFG+AR + +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 182 ANTN-----RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS 222
N + +MAPE EG++++KSDV+S+G+LL EI S
Sbjct: 230 VRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 36/198 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRL-SRSSGQGLQEFK---NLIAKLQHKNLV 107
+GEG FG V++G+ + +A+K + +S ++F + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
+L+G E N + +I E L FL R LD + ++
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
RD K+ DFG++R + + + +MAPE F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRF 569
Query: 205 SVKSDVFSFGVLLLEIIS 222
+ SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEILM 587
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 45/271 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRL---SRSSGQGLQEFKN---LIAKLQHK 104
NF E K+G G F VY+ L D +A+K++ + + L+ +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-------LDWNRRMCI----- 152
N+++ +E NEL ++ E L ++ + + + ++C
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 153 -INGIA-RDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201
+ RD K K+ D G+ R F + A++ +VGT YM+PE E
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHE 210
Query: 202 GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261
++ KSD++S G LL E+ + + F Y +L + K+ + + L P
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSP--F--YGDKMNLYSLCKKI-EQCDYPPL--PSDHY 263
Query: 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
S L +L+ C+ DP RP ++ V
Sbjct: 264 SEELRQLVNM------CINPDPEKRPDVTYV 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 61/268 (22%)
Query: 58 KLGEGGFGPVYKGVLNDD-KEIAVK--RLSRSSGQGLQEFKN---LIAKLQHKNLVRLLG 111
++G G F VYKG+ + E+A + + + Q FK ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 112 CCL----EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMNP- 164
++L+ E M + +L L + +++ R C I+ G+ H P
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 165 --------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
KI D G+A + S A V+GT +MAPE E +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA--VIGTPEFMAPEMYEEK-Y 206
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA----QELMDPVLK 260
DV++FG+ +LE+ + Y Q + + ++ G ++ P +K
Sbjct: 207 DESVDVYAFGMCMLEMATSE---YPYSECQNAAQI---YRRVTSGVKPASFDKVAIPEVK 260
Query: 261 ESFILEELLKRIHIGLLCVQEDPADRPT 288
E I C++++ +R +
Sbjct: 261 E-II-----------EGCIRQNKDERYS 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 66/289 (22%), Positives = 97/289 (33%), Gaps = 50/289 (17%)
Query: 27 LRGKKKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRL-- 83
RG+ Q P ++F ++LG G +G V+K +D + AVKR
Sbjct: 33 FRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS 92
Query: 84 ----SRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDST 139
+ + L E + QH VRL EG L L E SL
Sbjct: 93 PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG 151
Query: 140 RSVQLD--WNRRMCIINGIA---------RD---------HKMNPKISDFGMARVFGGNQ 179
S+ W + +A D + K+ DFG+ G
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TA 210
Query: 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL 239
G YMAPE L+G + +DVFS G+ +LE+ + L G+
Sbjct: 211 GAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME-----LPHGGEG-- 260
Query: 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT 288
W+ +G L S L +L ++ DP R T
Sbjct: 261 ---WQQLRQGYLPPEFTAGL--SSELRSVLVM------MLEPDPKLRAT 298
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 60/283 (21%), Positives = 106/283 (37%), Gaps = 69/283 (24%)
Query: 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRL 109
+F +G GGFG V+K D K +KR+ ++ + +E K +AKL H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK-ALAKLDHVNIVHY 69
Query: 110 LGC----------------CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
GC + L + E+ +L+ + + R +LD + +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELF 128
Query: 154 NGIA-------------RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTY 191
I RD K KI DFG+ +++ R GT
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTL 185
Query: 192 GYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251
YM+PE + + D+++ G++L E++ T F +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAF----ETSKFF------------ 228
Query: 252 QELMDPVLKESF--ILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+L D ++ + F + LL++ + + P DRP S +
Sbjct: 229 TDLRDGIISDIFDKKEKTLLQK------LLSKKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 57/291 (19%), Positives = 95/291 (32%), Gaps = 69/291 (23%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKN 105
+F LG GGFG V++ D K I + + + ++E K +AKL+H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPG 64
Query: 106 LVRLLGCCLEGNE------------LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
+VR LE N L + + ++L + + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 154 NGIA-------------RDHK---------MNPKISDFGMARVFGGNQSEANTNRV---- 187
IA RD K K+ DFG+ ++ E
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 188 ------VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241
VGT YM+PE +S K D+FS G++L E++ F Q
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPF----STQMERVR 235
Query: 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
T L +++ + P +RP ++
Sbjct: 236 TLTDVRNLKFPPLFTQKYPC---EYVMVQD------MLSPSPMERPEAINI 277
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 65/264 (24%), Positives = 106/264 (40%), Gaps = 55/264 (20%)
Query: 59 LGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQGLQEFK---NLIAKLQHKNLVRLLGCCL 114
LG+G +G VY G ++ IA+K + + Q L L+HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 115 EGNELLLICEYMPNKSLDFLL------FDSTRSVQLDWNRRMCIINGIA---------RD 159
E + + E +P SL LL + ++ I+ G+ RD
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ--ILEGLKYLHDNQIVHRD 147
Query: 160 HK-----MNP-----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE---YALEGLFSV 206
K +N KISDFG ++ G T GT YMAPE G +
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG-YGK 204
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF--I 264
+D++S G ++E+ +G+ FY + Q+ + +K+ G + P + ES
Sbjct: 205 AADIWSLGCTIIEMATGKPP--FYELGEPQAAM---FKV---GMFKVH--PEIPESMSAE 254
Query: 265 LEELLKRIHIGLLCVQEDPADRPT 288
+ + + C + DP R
Sbjct: 255 AKAFILK------CFEPDPDKRAC 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 58/268 (21%), Positives = 106/268 (39%), Gaps = 45/268 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHKN 105
+ K+GEG FG +D KEI + R+S + + ++A ++H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR-----SVQLDWNRRMCI------IN 154
+V+ E L ++ +Y L + LDW ++C+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 155 GIA-RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
I RD K ++ DFG+ARV A +GT Y++PE +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPY 202
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264
+ KSD+++ G +L E+ + + F S+ K+ G+ + S+
Sbjct: 203 NNKSDIWALGCVLYELCTLKHA--FE----AGSMKNLVLKI-ISGSFPPVSLHY---SYD 252
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSV 292
L L+ + + +P DRP+++S+
Sbjct: 253 LRSLVSQ------LFKRNPRDRPSVNSI 274
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 42/270 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGL-QEFKNLIAKLQHKNLVRLL 110
+F ++ LG G G + + D++++AVKR+ +E + L +H N++R
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-IINGIA---------RDH 160
+ + E +++ + L+ + +G+A RD
Sbjct: 85 CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144
Query: 161 K--------------MNPKISDFGMARVFGGNQSE-ANTNRVVGTYGYMAPEY---ALEG 202
K + ISDFG+ + + + + V GT G++APE +
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
+ D+FS G + +IS + G+SL L + L P E
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGS--HPF----GKSLQRQANILLGACSLDCL-HPEKHED 257
Query: 263 FILEELLKRIHIGLLCVQEDPADRPTMSSV 292
I EL+++ + DP RP+ V
Sbjct: 258 VIARELIEK------MIAMDPQKRPSAKHV 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 56/284 (19%), Positives = 104/284 (36%), Gaps = 67/284 (23%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIA---KLQHKN 105
R +S ++G GG V++ + + A+K ++ Q L ++N IA KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 106 L--VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---- 157
+RL + + ++ E N L +S+ + ++ +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDL-NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 158 -----RD--------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL- 203
D K+ DFG+A + + + VGT YM PE A++ +
Sbjct: 146 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMS 204
Query: 204 -----------FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL------TYTWKLW 246
S KSDV+S G +L + G+ T F S L + +
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMS 290
++ + L+ ++LK C++ DP R ++
Sbjct: 263 ------DIPEKDLQ------DVLKC------CLKRDPKQRISIP 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 63/278 (22%), Positives = 103/278 (37%), Gaps = 54/278 (19%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIAKLQHK 104
++ +G G +G K D KE+ ++ + Q L NL+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 105 NLVRLLGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQ-------LDW--------- 146
N+VR ++ L ++ EY L ++ T+ Q L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 147 ---NRRMCIINGIARDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYM 194
R + RD K N K+ DFG+AR+ + S A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254
+PE ++ KSD++S G LL E+ + F S K+ EG + +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PF----TAFSQKELAGKI-REGKFRRI 236
Query: 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
E L E++ R + RP++ +
Sbjct: 237 PYRYSDE---LNEIITR------MLNLKDYHRPSVEEI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-21
Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 67/284 (23%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIA---KLQHKN 105
R +S ++G GG V++ + + A+K ++ Q L ++N IA KLQ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 106 L--VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---- 157
+RL + + ++ E N L +S+ + ++ +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDL-NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 158 -----RD--------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL- 203
D K+ DFG+A + + + VG YM PE A++ +
Sbjct: 174 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232
Query: 204 -----------FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL------TYTWKLW 246
S KSDV+S G +L + G+ T F S L + +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMS 290
++ + L+ ++LK C++ DP R ++
Sbjct: 291 ------DIPEKDLQ------DVLKC------CLKRDPKQRISIP 316
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 55/283 (19%), Positives = 101/283 (35%), Gaps = 65/283 (22%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS--SGQGLQEFKNLIA---KLQHKN 105
R +S ++G GG V++ + + A+K ++ Q L ++N IA KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 106 L--VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---- 157
+RL + + ++ E N L +S+ + ++ +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDL-NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 158 -----RD--------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------- 197
D K+ DFG+A + + + VGT YM PE
Sbjct: 127 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 198 ----YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL------TYTWKLWC 247
+ S KSDV+S G +L + G+ T F S L + +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNHEIEFP- 243
Query: 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMS 290
++ + L+ ++LK C++ DP R ++
Sbjct: 244 -----DIPEKDLQ------DVLKC------CLKRDPKQRISIP 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 64/305 (20%), Positives = 107/305 (35%), Gaps = 70/305 (22%)
Query: 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNL 106
+++ KLGEGGF V L+D A+KR+ Q +E + + H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 107 VRLLGCCLE----GNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIA---- 157
+RL+ CL +E L+ + +L + + + L ++ + ++ GI
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 158 ---------RD---------HKMNPKISDFGMARVFG---GNQSEANTN----RVVGTYG 192
RD + P + D G +A T T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 193 YMAPEYALEGLFSV--------KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK 244
Y APE LFSV ++DV+S G +L ++ G + Q +
Sbjct: 209 YRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPY--DMVFQKGDSVALA 259
Query: 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304
+ Q + + S L +LL + DP RP + ++ L L
Sbjct: 260 V----QNQLSIPQSPRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQLE-----AL 304
Query: 305 QPTQP 309
QP P
Sbjct: 305 QPPAP 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-20
Identities = 59/290 (20%), Positives = 101/290 (34%), Gaps = 60/290 (20%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG-----QGLQEFKNLIAKLQHKNL 106
F ++LG G G V+K + A K + Q ++E + L + +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNSPYI 93
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA------- 157
V G E+ + E+M SLD +L + ++ +I G+
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD + K+ DFG++ S AN+ VGT YM+PE +S
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMSPERLQGTHYS 208
Query: 206 VKSDVFSFGVLLLEIISGR---------KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256
V+SD++S G+ L+E+ GR + + + + G
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 257 PVLKESFILEELLKRI---HIGLL---------------CVQEDPADRPT 288
+ + ELL I L C+ ++PA+R
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 42/202 (20%), Positives = 75/202 (37%), Gaps = 28/202 (13%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQGLQEFKNLIAKLQHKNL 106
E +++ ++G G FG V++ AVK++ + ++E A L +
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEEL-VACAGLSSPRI 112
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA------- 157
V L G EG + + E + SL L+ + D + G+
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 158 --RDHK----------MNPKISDFGMARVF---GGNQSEANTNRVVGTYGYMAPEYALEG 202
D K + DFG A G +S + + GT +MAPE +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
K D++S ++L +++G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGC 253
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 57/289 (19%), Positives = 90/289 (31%), Gaps = 75/289 (25%)
Query: 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG------QGLQEFKNLIAKLQ 102
T F K+G G FG V+K V D I A+KR + L+E Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ-------LDWNRRMC---- 151
H ++VR E + +L+ EY SL + ++ R + D ++
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 152 ------II-------------NGIAR------------DHKMNPKISDFGMARVFGGNQS 180
++ I +K+ KI D G Q
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 181 EANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL 239
E G ++A E E K+D+F+ + ++ L G
Sbjct: 190 E------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPRNGDQ-- 236
Query: 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPT 288
W +G + S ELLK + + DP RP+
Sbjct: 237 ---WHEIRQGRLPRIPQ---VLSQEFTELLK------VMIHPDPERRPS 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 66/293 (22%)
Query: 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG---LQEFKNLIAKLQHKN 105
+F LG+G FG V K D + A+K++ + + L E L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQY 63
Query: 106 LVRLLGCCLEGNE-------------LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC- 151
+VR LE L + EY N +L L+ + Q D R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 152 -IINGIA---------RD---------HKMNPKISDFGMARVF------------GGNQS 180
I+ ++ RD N KI DFG+A+ S
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 181 EANTNRVVGTYGYMAPE-YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL 239
N +GT Y+A E G ++ K D++S G++ E+I E+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----FSTGMERVN--- 236
Query: 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
K + + D + + +++++ L+ DP RP ++
Sbjct: 237 --ILKKLRSVSIEFPPDFDDNKMKVEKKIIRL----LIDH--DPNKRPGARTL 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 43/198 (21%), Positives = 84/198 (42%), Gaps = 28/198 (14%)
Query: 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLI---AKLQHKN 105
+ ++ K+G+G G VY + + A+++++ + N I + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN 163
+V L L G+EL ++ EY+ SL ++ + + +C + + H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 164 P------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
K++DFG QS+ +T +VGT +MAPE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 194
Query: 206 VKSDVFSFGVLLLEIISG 223
K D++S G++ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIA---KLQHKN 105
+ K+GEG G V AVK + Q + N + QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLD--WNRRMC--IINGIARDHK 161
+V + L G EL ++ E++ +L D V+L+ +C ++ +A H
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 162 MNP------------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
K+SDFG + + + +VGT +MAPE L
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 204 FSVKSDVFSFGVLLLEIISG 223
++ + D++S G++++E++ G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 30 KKKVESQELPLFPLDLIHEA------TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKR 82
+ V+ + P L + E F KLGEG +G VYK + + +I A+K+
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 83 LSRSSGQGLQEFKNLI---AKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDST 139
+ LQE I + ++V+ G + +L ++ EY S+ ++
Sbjct: 62 VPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 140 RSVQLDWNRRMC--IINGIARDHKMN------------------PKISDFGMARVFGGNQ 179
+++ D + + G+ H M K++DFG+A
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179
Query: 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG 223
++ NT V+GT +MAPE E ++ +D++S G+ +E+ G
Sbjct: 180 AKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLI---AKLQHKNLVR 108
+ +LG+G FG VYK + + A K + S + L+++ I A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING---------IA 157
LLG +L ++ E+ P ++D ++ + R + + +C ++ I
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 158 RDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE-----YALEGL 203
RD K + +++DFG++ + ++ +GT +MAPE +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTP 198
Query: 204 FSVKSDVFSFGVLLLEIISG 223
+ K+D++S G+ L+E+
Sbjct: 199 YDYKADIWSLGITLIEMAQI 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-18
Identities = 45/202 (22%), Positives = 76/202 (37%), Gaps = 38/202 (18%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLL 110
+LG G +G V K +I AVKR+ + + L + + + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 111 GCCLEGNELLLICEYMPNKSLDFLL---FDSTRSVQLDWNRRMC--IING---------- 155
G ++ + E M + SLD D +++ D ++ I+
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 156 IARD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE----YALEG 202
I RD K+ DFG + G + + G YMAPE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
+SVKSD++S G+ ++E+ R
Sbjct: 189 GYSVKSDIWSLGITMIELAILR 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 67/314 (21%), Positives = 99/314 (31%), Gaps = 77/314 (24%)
Query: 34 ESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGL-Q 92
+P F L +E LG G G V + +AVKR+
Sbjct: 2 RIANIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM 57
Query: 93 EFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFL----LFDSTRSVQLDWNR 148
E K L H N++R L + E D + + D +Q ++N
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 149 RMC---IINGIA---------RDHK----------------------MNPKISDFGMARV 174
I +G+A RD K + ISDFG+ +
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 175 FGGNQS--EANTNRVVGTYGYMAPEYALEGLFSV-------KSDVFSFGVLLLEIIS--- 222
QS N N GT G+ APE E D+FS G + I+S
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 223 ---GRKDTRFYLYEQGQ-SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLC 278
G K +R +G SL ++ E+ +L+ + ++
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHD---------RSLIAEA---TDLISQ----MID 281
Query: 279 VQEDPADRPTMSSV 292
DP RPT V
Sbjct: 282 H--DPLKRPTAMKV 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 40/199 (20%), Positives = 76/199 (38%), Gaps = 36/199 (18%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLG 111
++G G G V+K + AVK++ RS + L + ++ +V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING----------IARD 159
+ ++ + E M + L + +M I+ I RD
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE-----YALEGLFS 205
+ K+ DFG + G + +R G YMAPE + +
Sbjct: 151 VKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 206 VKSDVFSFGVLLLEIISGR 224
+++DV+S G+ L+E+ +G+
Sbjct: 208 IRADVWSLGISLVELATGQ 226
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 54/290 (18%), Positives = 98/290 (33%), Gaps = 66/290 (22%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVK-----RLSRSSGQGLQEFKNLIAKLQHKNLVRLLG 111
LG+G V++G A+K R ++EF+ L KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL-KKLNHKNIVKLFA 74
Query: 112 C--CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN--RRM--CIINGIA-------- 157
+LI E+ P SL +L + + + L + + ++ G+
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 158 -RD-------------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------ 197
R+ + K++DFG AR ++ + + + GT Y+ P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYERAV 191
Query: 198 --YALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL-------LTYTWKLWCE 248
+ + D++S GV +G F +E + +T
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGS--LPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 249 GNAQELMDPVLKE---------SFILEELLKRIHIGLLCVQEDPADRPTM 289
G + P+ S L+ LL + +L D
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA--DQEKCWGF 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 60/311 (19%), Positives = 100/311 (32%), Gaps = 85/311 (27%)
Query: 30 KKKVESQELPLFPLDLIHEATRNFSN----ENKLGEGGFGPVYKGV-LNDDKEIAVKRLS 84
+ +L P I + S KLG G +G V E A+K +
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 85 RS--SGQGLQEFKNLIA---KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDST 139
++ S + +A L H N+++L + L+ E L FD
Sbjct: 72 KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FD-- 125
Query: 140 RSVQLDWN-----RRMC--IINGIARDHKMN---------------------PKISDFGM 171
+ + +++G+ HK N KI DFG+
Sbjct: 126 EIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185
Query: 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231
+ VF + +GT Y+APE L + K DV+S GV+L +++G F
Sbjct: 186 SAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP--PFGG 239
Query: 232 YEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE------------LLKRIHIGLLCV 279
QE++ V K + + L+K+ +L
Sbjct: 240 -----------------QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ----MLQF 278
Query: 280 QEDPADRPTMS 290
D R +
Sbjct: 279 --DSQRRISAQ 287
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 43/210 (20%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSG-----QGLQEFKNLIAKLQHKN 105
+ + ++G G +G V K V +I AVKR+ + Q L + ++
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQL----DWNRRMC--IING---- 155
+V+ G + + E M + S D + + ++ +
Sbjct: 83 IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 156 ------IARD---------HKMNPKISDFGMARVFGGN--QSEANTNRVVGTYGYMAPE- 197
I RD N K+ DFG++ G S A T G YMAPE
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTR-DAGCRPYMAPER 196
Query: 198 ---YALEGLFSVKSDVFSFGVLLLEIISGR 224
A + V+SDV+S G+ L E+ +GR
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 59/279 (21%), Positives = 94/279 (33%), Gaps = 54/279 (19%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGL-----QEFKNLIAKLQHKNLVRLL- 110
+LG GGFG V + + + +++A+K+ + E + + KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM-KKLNHPNVVSARE 79
Query: 111 -----GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQL--DWNRRM--CIINGIA---- 157
+ LL EY L L L R + I + +
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 158 -----RD------------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
RD ++ KI D G A+ VGT Y+APE
Sbjct: 140 NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTE--FVGTLQYLAPELLE 196
Query: 201 EGLFSVKSDVFSFGVLLLEIISGR-------KDTRFYLYEQGQSLLTYTWKLWCEGNAQ- 252
+ ++V D +SFG L E I+G + +++ + +S G +
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256
Query: 253 --ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTM 289
L P S IL L+R +L R T
Sbjct: 257 SSVLPTPN-HLSGILAGKLERWLQCML--MWHQRQRGTD 292
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 46/209 (22%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVK-----RLSRSSGQGLQEFKNLIAKLQHKNLVRLLG 111
LG+G V++G A+K R ++EF+ L KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL-KKLNHKNIVKLFA 74
Query: 112 C--CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN--RRM--CIINGIA-------- 157
+LI E+ P SL +L + + + L + + ++ G+
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 158 -RD-------------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------ 197
R+ + K++DFG AR + + + + GT Y+ P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 198 --YALEGLFSVKSDVFSFGVLLLEIISGR 224
+ + D++S GV +G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQG-LQEFKNLI---AKLQHKNLV 107
F+ K+G+G FG V+KG+ N +++ A+K + + +++ + I ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII-------------N 154
+ G L+ +L +I EY+ S D LD + I+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 155 GIARDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
I RD K K++DFG+A Q + NT VGT +MAPE + +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYD 197
Query: 206 VKSDVFSFGVLLLEIISG 223
K+D++S G+ +E+ G
Sbjct: 198 SKADIWSLGITAIELARG 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 61/306 (19%), Positives = 104/306 (33%), Gaps = 86/306 (28%)
Query: 36 QELPLFPLDLIHEATRNFSN----ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS---S 87
L P + +T FS+ + LG+G FG V +E AVK +S+
Sbjct: 7 DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66
Query: 88 GQGLQEFKNLIA---KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQL 144
+ + +L H N+++L + L+ E L FD +
Sbjct: 67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD--EIISR 120
Query: 145 DWN-----RRMC--IINGIARDHKMN---------------------PKISDFGMARVFG 176
R+ +++GI HK +I DFG++ F
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236
++ +GT Y+APE L G + K DV+S GV+L ++SG F
Sbjct: 181 ASKK---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC--PPFN------ 228
Query: 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEE------------LLKRIHIGLLCVQEDPA 284
N +++ V K + E L+++ +L P+
Sbjct: 229 -----------GANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK----MLTY--VPS 271
Query: 285 DRPTMS 290
R +
Sbjct: 272 MRISAR 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLI------AKLQ 102
+ FS+ ++G G FG VY + E+ A+K++S S Q ++++++I KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IING----- 155
H N ++ GC L + L+ EY + D LL + +Q + + G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 156 ----IARDHKM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE---YA 199
I RD K K+ DFG A + AN+ VGT +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAM 225
Query: 200 LEGLFSVKSDVFSFGVLLLEIISG 223
EG + K DV+S G+ +E+
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAER 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 46/265 (17%), Positives = 83/265 (31%), Gaps = 73/265 (27%)
Query: 58 KLGEGGFGPVYKG---VLNDDKEIAVKRLSRSSGQGLQE-FKN---LIAKLQHKNLVRLL 110
+ GG G +Y + + + + +K L S Q +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 111 -----GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------- 157
++ EY+ +SL +L + + I
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS 200
Query: 158 -----RDHKMNP----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
D K P K+ D G + GT G+ APE
Sbjct: 201 IGLVYNDLK--PENIMLTEEQLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-RT 251
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
+V +D+++ G L + G+ + +G ++ DPVLK
Sbjct: 252 GPTVATDIYTVGRTLAALTLDL------PTRNGRYV---------DGLPED--DPVLKTY 294
Query: 263 FILEELLKRIHIGLLCVQEDPADRP 287
LL+R + DP R
Sbjct: 295 DSYGRLLRR------AIDPDPRQRF 313
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 27/223 (12%), Positives = 62/223 (27%), Gaps = 44/223 (19%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGV------LNDDKEIAVKRLSRSSGQGLQEFKNLIA 99
++ + LGEG F VY+ + ++ +K ++ L+
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 100 KLQ---HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLL--FDSTRSVQLDWNRRM---- 150
+L+ ++ L N +L+ E +L + + +T + +
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 151 CIINGIARDHKMN-------P----------------------KISDFGMARVFGGNQSE 181
++ I + H P + D G +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
T G+ E ++ + D F + ++ G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 63/323 (19%), Positives = 108/323 (33%), Gaps = 96/323 (29%)
Query: 29 GKKKVESQELPLFPLDLIHEATRNFSN----ENKLGEGGFGPVYKGV-LNDDKEIAVKRL 83
G++ + Q + + P + + KLG G +G V N E A+K +
Sbjct: 10 GRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVI 69
Query: 84 SRS-------------SGQGLQEFKNLIA---KLQHKNLVRLLGCCLEGNELLLICEYMP 127
+S + +E N I+ L H N+++L + L+ E+
Sbjct: 70 KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129
Query: 128 NKSLDFLLFDSTRSVQLDWN------RRMCII---------NGIA-RDHK---------- 161
L F+ + + M I + I RD K
Sbjct: 130 GGEL----FE--QIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 162 --MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLE 219
+N KI DFG++ F + +GT Y+APE L+ ++ K DV+S GV++
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYI 239
Query: 220 IISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE------------ 267
++ G F N Q+++ V K + +
Sbjct: 240 LLCGY--PPFG-----------------GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 268 LLKRIHIGLLCVQEDPADRPTMS 290
L+K +L D R T
Sbjct: 281 LIKL----MLTY--DYNKRCTAE 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 47/197 (23%), Positives = 80/197 (40%), Gaps = 35/197 (17%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN-------LIAKLQHKNLVRL 109
KLG GG VY + ++A+K + + +E ++L H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------------ 157
+ E + L+ EY+ +L + L + + N I
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 158 -RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
RD K ++ KI DFG+A+ S TN V+GT Y +PE A
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 208 SDVFSFGVLLLEIISGR 224
+D++S G++L E++ G
Sbjct: 193 TDIYSIGIVLYEMLVGE 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 60/284 (21%), Positives = 98/284 (34%), Gaps = 87/284 (30%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKNLIA---KLQHKNLVRL 109
LG+G FG V K +E AVK ++++ + + KL H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFD--------STRSVQLDWNRRMC--IINGIARD 159
+ + ++ E L FD S R+ + +GI
Sbjct: 87 FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDA-----ARIIKQVFSGITYM 137
Query: 160 HKMN---------------------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
HK N KI DFG++ F N +GT Y+APE
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE- 193
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
L G + K DV+S GV+L ++SG FY N +++ V
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGT--PPFY-----------------GKNEYDILKRV 234
Query: 259 LKESFILEE------------LLKRIHIGLLCVQEDPADRPTMS 290
+ + L+++ +L P+ R T +
Sbjct: 235 ETGKYAFDLPQWRTISDDAKDLIRK----MLTF--HPSLRITAT 272
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 40/221 (18%)
Query: 35 SQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSS------ 87
++E+P +D + R + LG+GGF ++ D KE+ A K + +S
Sbjct: 1 AKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 58
Query: 88 -GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW 146
+ E L H+++V G + + + ++ E +SL L +++
Sbjct: 59 REKMSMEISIH-RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPE 116
Query: 147 NRRMC--IINGIA---------RD---------HKMNPKISDFGMARVFGGNQSEANTNR 186
R I+ G RD + KI DFG+A + E + R
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGER 171
Query: 187 ---VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
+ GT Y+APE + S + DV+S G ++ ++ G+
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 47/300 (15%), Positives = 88/300 (29%), Gaps = 94/300 (31%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ----HKNLVRLL 110
L EGGF VY+ + +E A+KRL + + + + ++ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 111 GCCL-------EGNELLLICEYMPNKSLDFLLFDSTRSVQ-------LDWNRRMCIINGI 156
G L+ + L S L + C +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQL-VEFLKKMESRGPLSCDTVLKIFYQTC--RAV 149
Query: 157 A-----------RDHK---------MNPKISDFGMARVFGGNQSEANTNR---------- 186
RD K K+ DFG A + + +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 187 VVGTYGYMAPEYALEGLFSV--------KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL 238
T Y PE + + K D+++ G +L + + F + +
Sbjct: 210 RNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPF----EDGAK 258
Query: 239 L-----TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
L Y+ P + + L++ +Q +P +R +++ VV
Sbjct: 259 LRIVNGKYSIP------------PHDTQYTVFHSLIRA------MLQVNPEERLSIAEVV 300
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 3e-14
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 35/202 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRL---SRSSG---QGLQEFKNLIAKLQHKN 105
+ K+GEG +G VYK + + +A+KR+ + G ++E L+ +L H N
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS-LLKELHHPN 80
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGIA---- 157
+V L+ L L+ E+M D L ++ ++ G+A
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 158 -----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EG 202
RD K++DFG+AR F G + T+ VV T Y AP+ +
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSK 195
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
+S D++S G + E+I+G+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 43/199 (21%), Positives = 67/199 (33%), Gaps = 45/199 (22%)
Query: 58 KLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIA---KLQHKNLVR 108
+G+G F V + + + K + V + + S G ++ K + L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-----------------RMC 151
LL L ++ E+M L R C
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 152 IINGIA-RDHK------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
N I RD K K+ FG+A G + A VGT +MAPE
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEV 204
Query: 199 ALEGLFSVKSDVFSFGVLL 217
+ DV+ GV+L
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 5e-14
Identities = 48/202 (23%), Positives = 83/202 (41%), Gaps = 32/202 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRL---SRSSG---QGLQEFKNLIAKLQHK 104
+ K+GEG +G V+K + EI A+KR+ G L+E L+ +L+HK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHK 61
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA----- 157
N+VRL +L L+ E+ + L + + + ++ G+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGL 203
RD K+++FG+AR F G + VV T Y P+ L
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 204 FSVKSDVFSFGVLLLEIISGRK 225
+S D++S G + E+ + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGR 200
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 45/197 (22%), Positives = 79/197 (40%), Gaps = 38/197 (19%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLL 110
LG+GGF ++ D KE+ A K + +S + E L H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH-RSLAHQHVVGFH 107
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---------RD 159
G + + + ++ E +SL L +++ R I+ G RD
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNR---VVGTYGYMAPEYALEGLFSVK 207
+ KI DFG+A + E + R + GT Y+APE + S +
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 208 SDVFSFGVLLLEIISGR 224
DV+S G ++ ++ G+
Sbjct: 222 VDVWSIGCIMYTLLVGK 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 37/200 (18%)
Query: 56 ENKLGEGGFGPVYKG---VLNDDKEIAVKRLSR--SSGQGLQE-FKN---LIAKLQHKNL 106
+G GG G VY+ V ++ +A+K +S SS + + +LQ ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--------- 157
V + +L + + L +L L R + I+ I
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA 153
Query: 158 ----RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
RD K ++ + DFG+A + VGT YMAPE E
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHA 212
Query: 205 SVKSDVFSFGVLLLEIISGR 224
+ ++D+++ +L E ++G
Sbjct: 213 TYRADIYALTCVLYECLTGS 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 48/204 (23%), Positives = 79/204 (38%), Gaps = 43/204 (21%)
Query: 58 KLGEGGFGPVYKGVLND---DKEIAVKRLSRSSGQGLQEFKN-------LIAKLQHKNLV 107
LG GG V+ D +++AVK L R+ F A L H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 108 RLL--GCCLEGNELL--LICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------ 157
+ G L ++ EY+ +L ++ + R + +I
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS 132
Query: 158 -------RDHK-----MNP----KISDFGMARVFGGNQSE-ANTNRVVGTYGYMAPEYAL 200
RD K ++ K+ DFG+AR + + T V+GT Y++PE A
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 201 EGLFSVKSDVFSFGVLLLEIISGR 224
+SDV+S G +L E+++G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 34/204 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQG-----LQEFKNLIAKLQHKN 105
F KLG G + VYKG+ A+K + S +G ++E L+ +L+H+N
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS-LMKELKHEN 64
Query: 106 LVRLLGCCLEGNELLLICEYMPN--KSLDFLLFDSTRSVQLDWNRRMC----IINGIA-- 157
+VRL N+L L+ E+M N K L+ N ++ G+A
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 158 -------RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL- 200
RD K +N K+ DFG+AR F G ++ VV T Y AP+ +
Sbjct: 125 HENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRAPDVLMG 182
Query: 201 EGLFSVKSDVFSFGVLLLEIISGR 224
+S D++S G +L E+I+G+
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 31/200 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQ------GLQEFKNLIAKLQHKN 105
+ K+GEG +G VYK N + A+K++ ++E ++ +L+H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSN 61
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA------ 157
+V+L L+L+ E++ + L LL ++ + ++NGIA
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 158 ---RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGLF 204
RD K +N KI+DFG+AR F G T+ +V T Y AP+ + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178
Query: 205 SVKSDVFSFGVLLLEIISGR 224
S D++S G + E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 35/202 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQG-----LQEFKNLIAKLQHKN 105
+ +KLGEG + VYKG + A+K + +G ++E L+ L+H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHAN 61
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGIA---- 157
+V L L L+ EY+ D + ++ + ++ G+A
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 158 -----RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EG 202
RD K +N K++DFG+AR ++ N VV T Y P+ L
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 203 LFSVKSDVFSFGVLLLEIISGR 224
+S + D++ G + E+ +GR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 50/279 (17%), Positives = 94/279 (33%), Gaps = 79/279 (28%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-LQEFKNLIA---KLQHKNLVRLLGC 112
KLG G FG V+ + E +K +++ Q +++ + I L H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-----------------RMCIING 155
+ + + ++ E L + S Q
Sbjct: 89 FEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 156 IA-RDHK------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
+ +D K KI DFG+A +F ++ + GT YMAPE +
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFKR 200
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
+ K D++S GV++ +++G F + +E+ +
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGC--LPFT-----------------GTSLEEVQQKATYKE 241
Query: 263 FILEE-----------LLKRIHIGLLCVQEDPADRPTMS 290
LLK+ +L DP RP+ +
Sbjct: 242 PNYAVECRPLTPQAVDLLKQ----MLTK--DPERRPSAA 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 47/192 (24%), Positives = 73/192 (38%), Gaps = 40/192 (20%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKNLIA---KLQHKNLVRLLG 111
LG+G FG V K +E AVK ++++ + + KL H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFD-------------STRSVQLDWNRRMCIINGIA- 157
+ + ++ E L FD + Q+ + I
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 158 RDHK------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD K + KI DFG++ F N +GT Y+APE L G +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYD 200
Query: 206 VKSDVFSFGVLL 217
K DV+S GV+L
Sbjct: 201 EKCDVWSAGVIL 212
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 51/198 (25%), Positives = 76/198 (38%), Gaps = 41/198 (20%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIA---KLQHKNLV 107
S LG G FG V+K A K + + +E KN I+ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN------RRMC--IINGIARD 159
+L N+++L+ EY+ LFD R + +N I GI
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFD--RIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 160 HKMN-------P-------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA 199
H+M P KI DFG+AR + + GT ++APE
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVV 260
Query: 200 LEGLFSVKSDVFSFGVLL 217
S +D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 41/218 (18%), Positives = 73/218 (33%), Gaps = 33/218 (15%)
Query: 30 KKKVESQELPLFPLDLIHEATRNFSN----ENKLGEGGFGPVYKGVLND-DKEIAVKRLS 84
+ + + + +LG G FG V++ A K +
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191
Query: 85 RSSGQGLQEFKNLIA---KLQHKNLVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTR 140
+ + I L+H LV L + NE+++I E+M L + + + +
Sbjct: 192 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 141 SVQLDWNRRMC-IINGIARDHKMN-------P-------------KISDFGMARVFGGNQ 179
+ + M + G+ H+ N P K+ DFG+ Q
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLL 217
+ GT + APE A +D++S GVL
Sbjct: 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 32/201 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSS------GQGLQEFKNLIAKLQHK 104
+ N +GEG +G V K D I A+K+ S ++E K L+ +L+H+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK-LLKQLRHE 84
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA----- 157
NLV LL C + L+ E++ + ++ L + ++ IINGI
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 158 ----RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGL 203
RD K ++ K+ DFG AR E + V T Y APE + +
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPELLVGDVK 201
Query: 204 FSVKSDVFSFGVLLLEIISGR 224
+ DV++ G L+ E+ G
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGE 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 3e-13
Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 37/197 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLL 110
LG+G F VY+ A+K + + + + E K +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH-CQLKHPSILELY 77
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---------RD 159
+ N + L+ E N ++ L + + + R II G+ RD
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137
Query: 160 ---------HKMNPKISDFGMARVFGGNQSEANTNR---VVGTYGYMAPEYALEGLFSVK 207
MN KI+DFG+A Q + + + GT Y++PE A ++
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 208 SDVFSFGVLLLEIISGR 224
SDV+S G + ++ GR
Sbjct: 193 SDVWSLGCMFYTLLIGR 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 57/306 (18%), Positives = 107/306 (34%), Gaps = 81/306 (26%)
Query: 36 QELPLFPL-DLIHEATRNFSNE----NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ 89
Q + + + +H + F++ +G G + + + + E AVK + +S
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 90 GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQL----- 144
+E + L+ QH N++ L +G + ++ E M L D + ++
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE----LLD--KILRQKFFSE 115
Query: 145 -DWNRRMCII---------NGIA-RDHKMNP---------------KISDFGMARVFGGN 178
+ + + I G+ RD K P +I DFG A+
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLK--PSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL 238
T T ++APE + D++S GVLL +++G T F
Sbjct: 174 NGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY--TPFANG------ 223
Query: 239 LTYTWKLWCEGNAQELMDPVLKESFILE------------ELLKRIHIGLLCVQEDPADR 286
+ +E++ + F L +L+ + +L V DP R
Sbjct: 224 --------PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSK----MLHV--DPHQR 269
Query: 287 PTMSSV 292
T + V
Sbjct: 270 LTAALV 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 49/296 (16%), Positives = 90/296 (30%), Gaps = 74/296 (25%)
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIA------------------ 99
L +G F + D+K A+K+ +S + ++F
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 100 --KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC------ 151
++++ + G +E+ +I EYM N S+ + + ++ +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI-LKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 152 ----IINGIA----------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVV 188
++N + RD K+SDFG + +
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSR 211
Query: 189 GTYGYMAPEYALEGLFSV---KSDVFSFGVLLLEIISGR-----KDTRFYLYEQ-GQSLL 239
GTY +M PE S K D++S G+ L + K + L+ +
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 240 TYTWKLWCEGNAQELMDPVLKESFILEE---LLKRIHIGLLCVQEDPADRPTMSSV 292
Y +F+ E LK L +PA+R T
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL----FLRK--NPAERITSEDA 320
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 36/209 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLS-RSSGQGLQEFKNLI---AKLQHKNL 106
++ + +G G V KE A+KR++ + E I ++ H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 107 VRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMCIINGIARD------ 159
V + +EL L+ + + S+ D + + I I R+
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 160 --HKMNP------------------KISDFGM-ARVFGGNQSEANTNR--VVGTYGYMAP 196
HK +I+DFG+ A + G N R VGT +MAP
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 197 EYALEGL-FSVKSDVFSFGVLLLEIISGR 224
E + + K+D++SFG+ +E+ +G
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-13
Identities = 56/278 (20%), Positives = 94/278 (33%), Gaps = 85/278 (30%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIA---KLQHKNLVRLLGCC 113
+G G +G V V A K++ + + + FK I L H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 114 LEGNELLLICEYMPNKSLDFLLFD--------STRSVQLDWNRRMC--IINGIA------ 157
+ ++ L+ E L F+ R+ +++ +A
Sbjct: 76 EDNTDIYLVMELCTGGEL----FERVVHKRVFRESDA-----ARIMKDVLSAVAYCHKLN 126
Query: 158 ---RDHK------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
RD K K+ DFG+A F + VGT Y++P+ LEG
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ-VLEG 182
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
L+ + D +S GV++ ++ G F E+M + + +
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY--PPFS-----------------APTDSEVMLKIREGT 223
Query: 263 FILEE------------LLKRIHIGLLCVQEDPADRPT 288
F E L++R LL P R T
Sbjct: 224 FTFPEKDWLNVSPQAESLIRR----LLTK--SPKQRIT 255
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 38/206 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLS-RSSGQG-----LQEFKNLIAKLQHK 104
+ KLGEG +G VYK + E A+KR+ +G ++E L+ +LQH+
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS-LLKELQHR 93
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA----- 157
N++ L + L LI EY L + D V + + +ING+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 158 ----RDHK-----MNP---------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA 199
RD K ++ KI DFG+AR F G T+ ++ T Y PE
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWYRPPEIL 209
Query: 200 L-EGLFSVKSDVFSFGVLLLEIISGR 224
L +S D++S + E++
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 34 ESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQ 92
++ L L + + F +G G +G VYKG ++ A+K + +G +
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEE 65
Query: 93 EFKNLIAKL----QHKNLVRLLGCCLEG------NELLLICEYMPNKSL-DFLLFDSTRS 141
E K I L H+N+ G ++ ++L L+ E+ S+ D + +
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 125
Query: 142 VQLDWNRRMC--IING---------IARDHK---------MNPKISDFGMARVFGGNQSE 181
++ +W +C I+ G I RD K K+ DFG++
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 182 ANTNRVVGTYGYMAPE-----YALEGLFSVKSDVFSFGVLLLEIISG 223
NT +GT +MAPE + + KSD++S G+ +E+ G
Sbjct: 186 RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 40/205 (19%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSS-GQG-----LQEFKNLIAKLQHK 104
+ K+GEG +G V+K D +I A+K+ S L+E + ++ +L+H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR-MLKQLKHP 62
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA----- 157
NLV LL L L+ EY + ++ L R V + + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 158 ----RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
RD K + K+ DFG AR+ G S+ + V T Y +PE L
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPEL----LV 175
Query: 205 SVKS-----DVFSFGVLLLEIISGR 224
DV++ G + E++SG
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 41/192 (21%), Positives = 67/192 (34%), Gaps = 41/192 (21%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIA---KLQHKNLVRLLGCC 113
+LG G FG V++ V + K ++ KN I+ +L H L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN------RRMC--IINGIARDHKMN-- 163
+ E++LI E++ LFD R D+ G+ H+ +
Sbjct: 118 EDKYEMVLILEFLSGGE----LFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 164 -----P-------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
P KI DFG+A ++ T + APE
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVG 228
Query: 206 VKSDVFSFGVLL 217
+D+++ GVL
Sbjct: 229 FYTDMWAIGVLG 240
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 34/323 (10%), Positives = 62/323 (19%), Gaps = 73/323 (22%)
Query: 31 KKVESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQ 89
V Q L+ + R L G V+ + ++ A+K + +
Sbjct: 42 ATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 90 GLQEFKNL------IAKLQHKNLVRLLGCC--------------------------LEGN 117
E + L A+L ++
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 118 ELLLICEYMP---NKSLDFLLFDSTRSVQLDWNRRMCII------------NGIA-RDHK 161
LL+ L F + G+
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221
Query: 162 ---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL--EGLFSVKSDV 210
+ D G Y E+ F+ +
Sbjct: 222 PDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 211 FSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270
+ G+ + + F L G L G ++ L+
Sbjct: 277 WQLGLSIYRVWCLF--LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334
Query: 271 RIHIGLLCVQEDPADRPTMSSVV 293
R L D R +
Sbjct: 335 R----FLNF--DRRRRLLPLEAM 351
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 25/144 (17%), Positives = 44/144 (30%), Gaps = 28/144 (19%)
Query: 159 DHKMNPKISDFGMARVFGGNQSEANTN----------RVVGTYGYMAPEYALEGLFSVKS 208
K+ DFG+ ++ E VGT YM+PE +S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 209 DVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEEL 268
D+FS G++L E++ Q L + +
Sbjct: 258 DIFSLGLILFELLYSFST---------QMERVRIITDVRNLKFPLLFTQKYPQ---EHMM 305
Query: 269 LKRIHIGLLCVQEDPADRPTMSSV 292
++ + P +RP + +
Sbjct: 306 VQD------MLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 9e-05
Identities = 27/107 (25%), Positives = 40/107 (37%), Gaps = 9/107 (8%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQH 103
+F +G GGFG V++ N DD A+KR+ + + ++E K L AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL-AKLEH 63
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM 150
+VR LE E D S +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV 110
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 47/206 (22%), Positives = 81/206 (39%), Gaps = 47/206 (22%)
Query: 50 TRNFSNE----NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKNLIA--- 99
+ FS+ +LG+G F V + V E A K ++ S + Q+ +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 100 KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW-----NRRMC--I 152
KLQH N+VRL E + L+ + + L F+ V ++ I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FE--DIVAREFYSEADASHCIQQI 114
Query: 153 INGIARDHKMN-------P--------------KISDFGMARVFGGNQSEANTNRVVGTY 191
+ IA H P K++DFG+A +++ + GT
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTP 171
Query: 192 GYMAPEYALEGLFSVKSDVFSFGVLL 217
GY++PE + +S D+++ GV+L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 46/217 (21%), Positives = 91/217 (41%), Gaps = 54/217 (24%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN----LIAKLQH 103
+ ++N +G G FG V++ L + E+A+K++ + + FKN ++ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91
Query: 104 KNLVRLLGCCLEGNE------LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC------ 151
N+V L + L L+ EY+P +++ + Q +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQ-TMPMLLIKLYMYQ 149
Query: 152 IINGIA---------RDHK-----MNP-----KISDFGMARVFGGNQSEANTNRVVGTYG 192
++ +A RD K ++P K+ DFG A++ E N + + Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY- 206
Query: 193 YMAPEYALEGLF-----SVKSDVFSFGVLLLEIISGR 224
Y APE +F + D++S G ++ E++ G+
Sbjct: 207 YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 48/214 (22%), Positives = 84/214 (39%), Gaps = 47/214 (21%)
Query: 42 PLDLIHEATRNFSNE----NKLGEGGFGPVYKGVLNDD-KEIAVKRLSRS--SGQGLQEF 94
+ + A+ FS+ +LG+G F V + V E A K ++ S + Q+
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 95 KNLIA---KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW----- 146
+ KLQH N+VRL E + L+ + + L F+ V ++
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FE--DIVAREFYSEAD 129
Query: 147 NRRMC--IINGIARDHKMN-------P--------------KISDFGMARVFGGNQSEAN 183
I+ IA H P K++DFG+A +++
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--- 186
Query: 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLL 217
+ GT GY++PE + +S D+++ GV+L
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 68/272 (25%), Positives = 98/272 (36%), Gaps = 69/272 (25%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQ-----EFKNLIAKLQHKNLVRLLGC 112
LGEG +G V V ++ +AVK + E L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFYGH 73
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IINGIA----- 157
EGN L EY LFD R + M ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFD--RIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------Y 198
RD + N KISDFG+A VF N E N++ GT Y+APE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
+ DV+S G++L +++G L S + W E P
Sbjct: 185 H-----AEPVDVWSCGIVLTAMLAG------ELPWDQPSDSCQEYSDWKEKKTYLN--PW 231
Query: 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMS 290
K LL +I L +P+ R T+
Sbjct: 232 KKIDSAPLALLHKI----LVE--NPSARITIP 257
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 58 KLGEGGFGPVYKGV---LNDDKEIAVKRLSRS--SGQGLQEFKNLIAKLQHKNLVRLLGC 112
K+G G +G VYK DDK+ A+K++ + S +E L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-ALLRELKHPNVISLQKV 86
Query: 113 CLEGNE--LLLICEYMPN---KSLDFLLFDSTRSVQLDWNRRMC------IINGIA---- 157
L + + L+ +Y + + F + R M I++GI
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 158 -----RD-------------HKMNPKISDFGMARVFGG-NQSEANTNRVVGTYGYMAPEY 198
RD + KI+D G AR+F + A+ + VV T+ Y APE
Sbjct: 147 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 206
Query: 199 AL-EGLFSVKSDVFSFGVLLLEIISGR 224
L ++ D+++ G + E+++
Sbjct: 207 LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 6e-12
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 39/207 (18%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEI-AVK--RLSRSSGQ-------GLQEFKNLIAK 100
+ + + LGEG F VYK + +I A+K +L S L+E K L+ +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQE 68
Query: 101 LQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGI 156
L H N++ LL + + L+ ++M D + S+ L + + G+
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 157 A---------RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
RD K ++ K++DFG+A+ F G+ + A T++VV T Y APE
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPEL 183
Query: 199 AL-EGLFSVKSDVFSFGVLLLEIISGR 224
++ V D+++ G +L E++
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 69/274 (25%), Positives = 99/274 (36%), Gaps = 73/274 (26%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQ-----EFKNLIAKLQHKNLVRLLGC 112
LGEG +G V V ++ +AVK + E L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFYGH 73
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IINGIA----- 157
EGN L EY LFD R + M ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFD--RIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 158 ----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------Y 198
RD + N KISDFG+A VF N E N++ GT Y+APE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL--YEQGQSLLTYTWKLWCEGNAQELMD 256
+ DV+S G++L +++G L + S Y W E
Sbjct: 185 H-----AEPVDVWSCGIVLTAMLAG------ELPWDQPSDSCQEY--SDWKEKKTYLN-- 229
Query: 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMS 290
P K LL +I L +P+ R T+
Sbjct: 230 PWKKIDSAPLALLHKI----LVE--NPSARITIP 257
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 43/302 (14%), Positives = 79/302 (26%), Gaps = 67/302 (22%)
Query: 53 FSNENKLGEG--GFGPVYKGVLNDDKEI-AVKR--LSRSSGQGLQEFKNLI---AKLQHK 104
+ +G+G V E V+R L S + + + + H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII----------- 153
N+V + NEL ++ +M S L+ + ++ I+
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 154 -NG-IARDHKM---------NPKISDFGMARVFGGNQSEANT-----NRVVGTYGYMAPE 197
G + R K +S + V +++PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 198 YALEGL--FSVKSDVFSFGVLLLEIISGR----------------KDTRFYLYEQGQSLL 239
+ L + KSD++S G+ E+ +G T L +
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265
Query: 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGL-------------LCVQEDPADR 286
A + L S C+Q +P R
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325
Query: 287 PT 288
P+
Sbjct: 326 PS 327
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 32/207 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLLG 111
LGEG F V A+K L + + ++++++L H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 112 CCLEGNELLLICEYMPNKSLDFLL-----FDSTRS--------VQLDWNRRMCII----- 153
+ +L Y N L + FD T + L++ II
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 154 --NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVF 211
N I + M+ +I+DFG A+V +A N VGT Y++PE E SD++
Sbjct: 158 PEN-ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 212 SFGVLLLEIISG----RKDTRFYLYEQ 234
+ G ++ ++++G R + ++++
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQK 243
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 58/291 (19%), Positives = 99/291 (34%), Gaps = 69/291 (23%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ----HKNLVRLL 110
E+ LGEG V + L +E AVK + + G + L H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ----LDWNRRMCII---------NGIA 157
E + L+ E M S+ + L+ + + + GIA
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 158 -RDHK------MNP------KISDFGMARVFGGNQSEANTNR-----VVGTYGYMAPEYA 199
RD K +P KI DF + N + + G+ YMAPE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-V 192
Query: 200 LEGLFSV------KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253
+E + D++S GV+L ++SG F + S + C
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGY--PPF--VGRCGSDCGWDRGEACPACQNM 248
Query: 254 LMDPVLKESFILE------------ELLKRIHIGLLCVQEDPADRPTMSSV 292
L + + + + +L+ + LL D R + + V
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISK----LLVR--DAKQRLSAAQV 293
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 39/194 (20%), Positives = 72/194 (37%), Gaps = 38/194 (19%)
Query: 58 KLGEGGFGPVYKGVLNDD------KEIAVKRLS-RSSGQGLQEFKNLIA---KLQHKNLV 107
+LG G F V K K I ++ G +E + ++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC-IINGIARDHKMN-- 163
L +++LI E + L DFL + S + + + I++G+ H
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTKKIA 137
Query: 164 -----P---------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
P K+ DFG+A + GT ++APE
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEP 194
Query: 204 FSVKSDVFSFGVLL 217
+++D++S GV+
Sbjct: 195 LGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 39/194 (20%), Positives = 73/194 (37%), Gaps = 38/194 (19%)
Query: 58 KLGEGGFGPVYKGVLNDD------KEIAVKRL-SRSSGQGLQEFKNLIA---KLQHKNLV 107
+LG G F V K K I ++ + G +E + ++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 108 RLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC-IINGIARDHKMN-- 163
L +++LI E + L DFL + S + + + I++G+ H
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTKKIA 137
Query: 164 -----P---------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
P K+ DFG+A + GT ++APE
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEP 194
Query: 204 FSVKSDVFSFGVLL 217
+++D++S GV+
Sbjct: 195 LGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 44/220 (20%), Positives = 76/220 (34%), Gaps = 64/220 (29%)
Query: 45 LIHEATRNFSNE----NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKNL 97
+ F+ E +LG+G F V + V + +E A ++ S + Q+ +
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 98 IA---KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--- 151
L+H N+VRL E LI + + L F+ +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FE-----------DIVARE 105
Query: 152 -------------IINGIARDHKMN-------P--------------KISDFGMARVFGG 177
I+ + H+M P K++DFG+A G
Sbjct: 106 YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLL 217
Q GT GY++PE + + D+++ GV+L
Sbjct: 166 EQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 42/194 (21%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIA---KLQHKNLVRLLG 111
LG G F V+ K A+K + +S +N IA K++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW-----NRRMC--IINGIARDHKMN- 163
L+ + + L FD R ++ + +++ + H+
Sbjct: 74 IYESTTHYYLVMQLVSGGEL----FD--RILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 164 ------P--------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
P I+DFG++++ + GT GY+APE +
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKP 183
Query: 204 FSVKSDVFSFGVLL 217
+S D +S GV+
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRL---SRSSG---QGLQEFKNLIAKLQHK 104
+ K+G+G FG V+K + A+K++ + G L+E K ++ L+H+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHE 76
Query: 105 NLVRLLGCCLE--------GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCI---- 152
N+V L+ C + L+ ++ D S V+ + +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 153 INGIA---------RDHK-----MNP----KISDFGMARVFGGNQSEAN---TNRVVGTY 191
+NG+ RD K + K++DFG+AR F ++ TNRVV T
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192
Query: 192 GYMAPEYAL-EGLFSVKSDVFSFGVLLLEIISGR 224
Y PE L E + D++ G ++ E+ +
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 68/279 (24%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCC 113
+ LGEG F K V ++ AVK +S+ Q+ + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQ------LDWNRRMCII---------NGIA- 157
+ L+ E + L F+ R + + + M + G+
Sbjct: 76 HDQLHTFLVMELLNGGEL----FE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 158 RDHK------MNP------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD K + KI DFG AR+ + T T Y APE + +
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYD 187
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
D++S GV+L ++SG+ F +++ + + A E+M + K F
Sbjct: 188 ESCDLWSLGVILYTMLSGQ--VPFQSHDRSLTCTS----------AVEIMKKIKKGDFSF 235
Query: 266 EE------------LLKRIHIGLLCVQEDPADRPTMSSV 292
E L++ LL V DP R MS +
Sbjct: 236 EGEAWKNVSQEAKDLIQG----LLTV--DPNKRLKMSGL 268
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 57/217 (26%)
Query: 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKN----LIAKLQHK 104
++++ +G G FG VY+ L D E+ A+K++ + + FKN ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 105 NLVRLLGCCLEGNE------LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-----II 153
N+VRL E L L+ +Y+P +++ + +R+ Q + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 154 NGIA---------RDHK-----MNP-----KISDFGMARVFGGNQSEANTNRVVGTYGYM 194
+A RD K ++P K+ DFG A+ + E N + + Y Y
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YR 223
Query: 195 APE-------YALEGLFSVKSDVFSFGVLLLEIISGR 224
APE Y + DV+S G +L E++ G+
Sbjct: 224 APELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 40/192 (20%), Positives = 65/192 (33%), Gaps = 42/192 (21%)
Query: 58 KLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIA---KLQHKNLVRLLGCC 113
LG G FG V++ V K+ K + G K I+ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN------RRMC--IINGIARDHKMN-- 163
EL++I E++ + F+ R + + + H N
Sbjct: 71 ESMEELVMIFEFISGLDI----FE--RINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 164 -----P-------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
P KI +FG AR N + Y APE + S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 206 VKSDVFSFGVLL 217
+D++S G L+
Sbjct: 182 TATDMWSLGTLV 193
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 8e-11
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 44/212 (20%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRL---SRSSGQG------LQEFKNL--IA 99
+ ++G G +G VYK A+K + + G G ++E L +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 100 KLQHKNLVRLLGCCL-----EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--- 151
+H N+VRL+ C ++ L+ E++ ++ L L D L
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 127
Query: 152 -IINGIA---------RDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYG 192
+ G+ RD K + K++DFG+AR++ + T VV T
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLW 184
Query: 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
Y APE L+ ++ D++S G + E+ +
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 29/357 (8%), Positives = 80/357 (22%), Gaps = 89/357 (24%)
Query: 1 QVLQFLRSREGRTGDDDDDEGYSYSILRGKKKVESQELPLFPLDLIHEATRNFSNENKLG 60
++ + RT + + + + P + E R LG
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVST---SLWNTGQPFRVESELGERPRTLVRGTVLG 87
Query: 61 EGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNL---------------------- 97
+ + + V + K +
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 98 ------IAKLQHKNLVRLLGCCLEGNELLLICEY--MPNKS------LDFLLFDSTRSVQ 143
++ +++ L+ ++ ++ + P + LL S+
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 144 LDWNRRMCIINGIA-------------RDHK---------MNPKISDFGMARVFGGNQSE 181
L + R+ + + + ++ F G +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-ASAV 266
Query: 182 ANTNRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236
+ R A L + D ++ G+ + I
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNT------ 318
Query: 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
+ A + + + + + ++ + G L + DR +
Sbjct: 319 -----------DDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQAM 362
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 42/210 (20%)
Query: 52 NFSNENKLGEGGFGPVYKG--VLNDDKEIAVKRL---SRSSG---QGLQEFKNL--IAKL 101
+ ++GEG +G V+K + N + +A+KR+ + G ++E L +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 102 QHKNLVRLLGCC-----LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----I 152
+H N+VRL C +L L+ E++ ++ L L D + +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQL 129
Query: 153 INGIA---------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYM 194
+ G+ RD K++DFG+AR++ + T+ VV T Y
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV-TLWYR 186
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIISGR 224
APE L+ ++ D++S G + E+ +
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 28/112 (25%), Positives = 39/112 (34%), Gaps = 12/112 (10%)
Query: 56 ENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHK 104
LG G FG V + + +AVK L + + E K LI H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 105 NLVRLLGCCL-EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIING 155
N+V LLG C G L++I E+ +L L + G
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 10/69 (14%)
Query: 159 DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYG-----YMAPEYALEGLFSVKSDVFSF 213
K KI DFG+AR + + V +MAPE + +++++SDV+SF
Sbjct: 227 SEKNVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 281
Query: 214 GVLLLEIIS 222
GVLL EI S
Sbjct: 282 GVLLWEIFS 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 48/197 (24%), Positives = 77/197 (39%), Gaps = 36/197 (18%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLI------AKLQHKNLVRL 109
LG+G FG VY K I A+K L ++ + L + L+H N++RL
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----IINGIA-------- 157
G + + LI EY P ++ L ++ D R + N ++
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVI 131
Query: 158 -RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVK 207
RD KI+DFG + ++ + GT Y+ PE + K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 208 SDVFSFGVLLLEIISGR 224
D++S GVL E + G+
Sbjct: 188 VDLWSLGVLCYEFLVGK 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 40/199 (20%), Positives = 71/199 (35%), Gaps = 48/199 (24%)
Query: 58 KLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQE-FKNLIA---KLQHKNLV 107
+LG G F V K K I +RLS S +E + + +++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW-----NRRMC--IINGIARDH 160
L +++LI E + L FD + + + I++G+ H
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FD--FLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 161 KMN-------P---------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
P K+ DFG+A + GT ++APE
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 182
Query: 199 ALEGLFSVKSDVFSFGVLL 217
+++D++S GV+
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 35/201 (17%), Positives = 70/201 (34%), Gaps = 49/201 (24%)
Query: 58 KLGEGGFGPVYKGVLNDD-KEIAVKRLSRSSGQGLQEFK-----------NLIAKLQHKN 105
LG G G V K++A++ +S+ + ++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFD---STRSVQLDWNRRMC--IINGIARDH 160
++++ + + ++ E M L FD + ++ + ++ + H
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 161 KMN-------P--------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE-- 197
+ P KI+DFG +++ G + GT Y+APE
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVL 313
Query: 198 -YALEGLFSVKSDVFSFGVLL 217
++ D +S GV+L
Sbjct: 314 VSVGTAGYNRAVDCWSLGVIL 334
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 43/236 (18%), Positives = 82/236 (34%), Gaps = 53/236 (22%)
Query: 28 RGKKKVESQELPLFPLDLIHEATRNFSNE----NKLGEGGFGPVYKGVLNDD-KEIAVKR 82
+G + + Q + A + F + + +G G V + V E AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 83 LSRSSGQG------------LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKS 130
+ ++ + +E L H +++ L+ + + L+ + M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 131 LDFLLFDS-TRSVQL--DWNRRMC--IINGIARDHKMN-------P-----------KIS 167
L FD T V L R + ++ ++ H N P ++S
Sbjct: 187 L----FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS 242
Query: 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPE------YALEGLFSVKSDVFSFGVLL 217
DFG + + + GT GY+APE + + D+++ GV+L
Sbjct: 243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 32/196 (16%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRL------SRSSGQGLQEFKNLIAKLQHKNLVRLLG 111
LG GGFG V+ + ++ A K+L R QG K ++AK+ + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 112 CCLEGNELLLICEYMPNKSLDF-LLFDSTRSVQLDWNRRM----CIINGIARDHKMN--- 163
+L L+ M + + + + R + I++G+ H+ N
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 164 ----P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS 208
P +ISD G+A Q++ GT G+MAPE L +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSV 370
Query: 209 DVFSFGVLLLEIISGR 224
D F+ GV L E+I+ R
Sbjct: 371 DYFALGVTLYEMIAAR 386
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 42/196 (21%), Positives = 75/196 (38%), Gaps = 38/196 (19%)
Query: 56 ENKLGEGGFGPVYKGVLNDD------KEIAVKRL-SRSSGQGLQEFKNLIA---KLQHKN 105
+LG G F V K K I +R S G ++ + ++ ++QH N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSL-DFLLFDSTRSVQLDWNRRMC-IINGIARDHKMN 163
++ L +++LI E + L DFL + + + + + I+NG+ H +
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLT-EEEATEFLKQILNGVYYLHSLQ 134
Query: 164 -------P---------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201
P KI DFG+A + GT ++APE
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNY 191
Query: 202 GLFSVKSDVFSFGVLL 217
+++D++S GV+
Sbjct: 192 EPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 47/225 (20%), Positives = 80/225 (35%), Gaps = 51/225 (22%)
Query: 35 SQELPLFPLDLIHEATRNFSN-----ENKLGEGGFGPVYKGVLNDD-KEIAVK--RLSRS 86
S + L +L ++ NF+N +LG G F V + + +E A K + R
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 87 SGQGLQEFKNLIAKLQ----HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSV 142
E + IA L+ ++ L +E++LI EY + F +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS--LCL 121
Query: 143 QLDWNR---RMC------IINGIARDHKMN-------P--------------KISDFGMA 172
I+ G+ H+ N P KI DFGM+
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLL 217
R G ++GT Y+APE + +D+++ G++
Sbjct: 182 RKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 33/195 (16%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRL------SRSSGQGLQEFKNLIAKLQHKNLVRLLG 111
LG+GGFG V + ++ A K+L R K ++ K+ + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM----CIINGIARDHKMN---- 163
+ L L+ M L F ++ ++ R + I G+ H+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 164 ---P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
P +ISD G+A Q+ VGT GYMAPE ++ D
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 210 VFSFGVLLLEIISGR 224
++ G LL E+I+G+
Sbjct: 368 WWALGCLLYEMIAGQ 382
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 53/275 (19%), Positives = 95/275 (34%), Gaps = 79/275 (28%)
Query: 58 KLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGLQEFKNLIA---KLQHKNLVRLLGCC 113
+LG G VY+ K A+K L ++ + + + I +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDW-----NRRMC--IINGIARDHKMN--- 163
E+ L+ E + L FD R V+ + I+ +A H+
Sbjct: 118 ETPTEISLVLELVTGGEL----FD--RIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171
Query: 164 ----P--------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
P KI+DFG++++ V GT GY APE +
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYG 228
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
+ D++S G++ ++ G F + E Q + +L +
Sbjct: 229 PEVDMWSVGIITYILLCGF--EPF----------------YDERGDQFMFRRILNCEYYF 270
Query: 266 EE------------LLKRIHIGLLCVQEDPADRPT 288
L+++ L+ + DP R T
Sbjct: 271 ISPWWDEVSLNAKDLVRK----LIVL--DPKKRLT 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 37/242 (15%), Positives = 71/242 (29%), Gaps = 76/242 (31%)
Query: 58 KLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQGLQEFKNLIA---KLQHKNLVR 108
+G+G +G V + N K + ++ + + + ++ K + KL H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 109 LLGC------------CLEGNELL-LICEYMPNKSLDFLLFDSTRSVQLDWNRRMC---- 151
L G LL + ++ + + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 152 ------------------------IINGIARDHKMN--------------------PKIS 167
I + + H K+
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 168 DFGMARVFGGNQSEANT--NRVVGTYGYMAPEYALEGL---FSVKSDVFSFGVLLLEIIS 222
DFG+++ F + GT ++APE L + K D +S GVLL ++
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 223 GR 224
G
Sbjct: 272 GA 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 38/203 (18%), Positives = 68/203 (33%), Gaps = 53/203 (26%)
Query: 58 KLGEGGFGPVYKGVLNDD-KEIAVKRLSRSSGQGLQE--------FKNLIA---KLQHKN 105
LG G G V K++A+K +S+ + I KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQL-----DWNRRMC--IINGIAR 158
++++ + + ++ E M L FD + V + ++ +
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FD--KVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 159 DHKMN-------P--------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197
H+ P KI+DFG +++ G + GT Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPE 186
Query: 198 ---YALEGLFSVKSDVFSFGVLL 217
++ D +S GV+L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 41/197 (20%), Positives = 62/197 (31%), Gaps = 46/197 (23%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCC- 113
+ LG G G V + ++ A+K L S QE + ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASGGPHIVCILDVYE 92
Query: 114 ---LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN-------RRMC--IINGIARDHK 161
LL+I E M L F R + + I I H
Sbjct: 93 NMHHGKRCLLIIMECMEGGEL----FS--RIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 162 MN-------P--------------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
N P K++DFG A+ N T Y+APE
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLG 202
Query: 201 EGLFSVKSDVFSFGVLL 217
+ D++S GV++
Sbjct: 203 PEKYDKSCDMWSLGVIM 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 35/329 (10%), Positives = 74/329 (22%), Gaps = 99/329 (30%)
Query: 36 QELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEF 94
P + E R LG+ + + V +
Sbjct: 58 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 117
Query: 95 KNL-------------------------------IAKLQHKNLVRLLGCCLEGNELLLIC 123
K + + Q K ++R+ + L
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 124 EYMPNKS-----LDFLLFDSTRSVQLDWNRRMCIINGIAR-------------------- 158
Y +S + LL S+ L + R+ + + R
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237
Query: 159 --DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-----------EGLFS 205
D + ++ F G + G+ PE L +
Sbjct: 238 VLDQRGGVFLTGFEHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL-WCEGNAQELMDPVLKESFI 264
D ++ G+++ I L + A + + +
Sbjct: 292 FSFDAWALGLVIYWIWCAD--------------------LPITKDAALGGSEWIFRSCKN 331
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSVV 293
+ + ++ + G L DR +
Sbjct: 332 IPQPVRALLEGFLRY--PKEDRLLPLQAM 358
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 44/200 (22%), Positives = 74/200 (37%), Gaps = 36/200 (18%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSS----GQGLQEFKNLIA---KLQHKNLVRLL 110
LGEG +G V + + AVK L + G K I +L+HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 111 G--CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWN--RRMC--IINGIA------- 157
E ++ ++ EY + + DS + +I+G+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 158 --RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA--LEGLF 204
+D KIS G+A ++ G+ + PE A L+
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 205 SVKSDVFSFGVLLLEIISGR 224
K D++S GV L I +G
Sbjct: 191 GFKVDIWSAGVTLYNITTGL 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 43/203 (21%), Positives = 67/203 (33%), Gaps = 50/203 (24%)
Query: 58 KLGEGGFGPVYKGVLNDD-KEIAVKRLSRSSGQGL---------QEFKNLIAKLQ----H 103
LG G V + + KE AVK + + G + + L+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDS-----------TRSV--QLDWNRRM 150
N+++L L+ + M L FD TR + L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 151 CIINGIA-RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE--- 197
I RD K MN K++DFG + + V GT Y+APE
Sbjct: 140 LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIE 196
Query: 198 ---YALEGLFSVKSDVFSFGVLL 217
+ + D++S GV++
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 49/199 (24%), Positives = 75/199 (37%), Gaps = 44/199 (22%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRS----SGQGLQ---EFKNLIAKLQHKNLVRLL 110
LG+G FG VY +K I A+K L +S G Q E + + L+H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ-SHLRHPNILRMY 80
Query: 111 GCCLEGNELLLICEYMPNKSLDFLL-----FDSTRSVQLDWNRRMC--IINGIA------ 157
+ + L+ E+ P L L FD RS + + +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS------ATFMEELADALHYCHERK 134
Query: 158 ---RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD +K KI+DFG + + + GT Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHD 190
Query: 206 VKSDVFSFGVLLLEIISGR 224
K D++ GVL E + G
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 49/236 (20%), Positives = 81/236 (34%), Gaps = 67/236 (28%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNL------IA---KLQHK--NL 106
LG GGFG VY G+ ++D+ +A+K + + E N + K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IINGI 156
+RLL + +LI E P D LFD + + ++ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFD-----FITERGALQEELARSFFWQVLEAV 162
Query: 157 A---------RD----------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE 197
RD ++ K+ DFG + GT Y PE
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 218
Query: 198 YALEGLFS-VKSDVFSFGVLL-------------LEIISGRKDTRFYLYEQGQSLL 239
+ + + V+S G+LL EII G+ R + + Q L+
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 44/201 (21%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKN---LVR 108
+G GGFG VY D ++ A+K L + + Q + +++ + + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM----CIINGIARDHKMN- 163
+ ++L I + M L + L ++ II G+ H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 164 ------P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL--- 203
P +ISD G+A F + + VGT+GYMAPE +G+
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYD 369
Query: 204 FSVKSDVFSFGVLLLEIISGR 224
S D FS G +L +++ G
Sbjct: 370 SSA--DWFSLGCMLFKLLRGH 388
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 50/224 (22%), Positives = 84/224 (37%), Gaps = 65/224 (29%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRS-------------------SGQGLQEFKNLI 98
+G+G +G V ND+ A+K LS+ + G + + I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 99 A----------KLQHKNLVRLLGCCLEG---NELLLICEYMPNKSLDFLLFDSTRSVQLD 145
KL H N+V+L+ L+ + L ++ E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLS 135
Query: 146 WN--RRMC--IINGIA---------RD---------HKMNPKISDFGMARVFGGNQSEAN 183
+ R +I GI RD + KI+DFG++ F G+ + +
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 184 TNRVVGTYGYMAPE--YALEGLFS-VKSDVFSFGVLLLEIISGR 224
VGT +MAPE +FS DV++ GV L + G+
Sbjct: 196 N--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 55/221 (24%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRL---SRSSGQGLQEFKNLIAKLQH 103
+ F E G+G FG V G +A+K++ R + LQ + +A L H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-DLAVLHH 78
Query: 104 KNLVRLLGCCLEGNE-------LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----- 151
N+V+L E L ++ EY+P +L + R +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 152 IINGIA-----------RDHK-----MNP-----KISDFGMARVFGGNQSEANTNRVVGT 190
+I I RD K +N K+ DFG A+ + SE N +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSR 195
Query: 191 YGYMAPE-------YALEGLFSVKSDVFSFGVLLLEIISGR 224
Y Y APE Y + D++S G + E++ G
Sbjct: 196 Y-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 44/210 (20%), Positives = 73/210 (34%), Gaps = 56/210 (26%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLI-------------AKLQHK 104
LG+GGFG V+ G L D ++A+K + R+ G + + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IIN 154
++RLL +L+ E P + D LFD + ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITE-----KGPLGEGPSRCFFGQVVA 150
Query: 155 GIA---------RD----------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
I RD + K+ DFG + GT Y
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSP 206
Query: 196 PEYALEGLFS-VKSDVFSFGVLLLEIISGR 224
PE+ + + + V+S G+LL +++ G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 38/197 (19%), Positives = 63/197 (31%), Gaps = 45/197 (22%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLG--- 111
LG G G V + ++ A+K L +E + Q ++VR++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWRASQCPHIVRIVDVYE 125
Query: 112 -CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR-----------------RMCII 153
LL++ E + L F R +
Sbjct: 126 NLYAGRKCLLIVMECLDGGEL----FS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 154 NGIA-RDHK------MNP------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
IA RD K + K++DFG A+ + S T Y+APE
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLG 236
Query: 201 EGLFSVKSDVFSFGVLL 217
+ D++S GV++
Sbjct: 237 PEKYDKSCDMWSLGVIM 253
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 40/219 (18%), Positives = 73/219 (33%), Gaps = 62/219 (28%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKNL---------IA 99
+S + LG G FG V+ V +KE+ VK + + E L ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 100 KLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-------- 151
+++H N++++L L+ E + LD LF +D + R+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLD--LFA-----FIDRHPRLDEPLASYIF 136
Query: 152 --IINGIAR------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTY 191
+++ + K+ DFG A + GT
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTI 193
Query: 192 GYMAPEYALEGLFSVKS------DVFSFGVLLLEIISGR 224
Y APE + +++S GV L ++
Sbjct: 194 EYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 48/206 (23%), Positives = 73/206 (35%), Gaps = 58/206 (28%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQ---EFKNLIAKLQHKNLVRLLGCCL 114
+G G FG + +AVK + R + E N L+H N+VR L
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSLRHPNIVRFKEVIL 86
Query: 115 EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM----------CIINGIA------- 157
L +I EY L ++ R R +++G++
Sbjct: 87 TPTHLAIIMEYASGGEL----YE--RICN---AGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 158 --RDHK-----------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------Y 198
RD K KI DFG ++ + S+ + VGT Y+APE Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYIAPEVLLRQEY 194
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGR 224
+DV+S GV L ++ G
Sbjct: 195 D-----GKIADVWSCGVTLYVMLVGA 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 48/207 (23%), Positives = 77/207 (37%), Gaps = 59/207 (28%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLG 111
+G+G F V + +E+A+K + ++ + +E + + L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM-KILNHPNIVKLFE 81
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IINGIA---- 157
L LI EY +FD + + RM I++ +
Sbjct: 82 VIETEKTLYLIMEYASGGE----VFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 158 -----RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
RD MN KI+DFG + F + G Y APE L
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPE-----L 184
Query: 204 FS------VKSDVFSFGVLLLEIISGR 224
F + DV+S GV+L ++SG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 31/288 (10%), Positives = 76/288 (26%), Gaps = 76/288 (26%)
Query: 58 KLGEGGFGPVYKGVLND---DKEIAVKRLSRSSG---QGLQEFKN---LIAKLQHKNLVR 108
G ++ + D D+++A+ + LQE + ++++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA----------- 157
+L L++ E++ SL + + + +A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 158 --RDHK-MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFG 214
++S G V+ M + + D+ G
Sbjct: 151 ALSIDHPSRVRVSIDGDV--------------VLAYPATMPDA-------NPQDDIRGIG 189
Query: 215 VLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI-------LEE 267
L ++ R G + ++ ++ + I +
Sbjct: 190 ASLYALLVNRWPLPEAGVRSGLAPA-----------ERDTAGQPIEPADIDRDIPFQISA 238
Query: 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAFSVGR 315
+ R VQ D R S+++ ++ T +
Sbjct: 239 VAAR------SVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEA 279
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 47/213 (22%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSR------SSGQGLQEFKNLIAK 100
+ + N +G G G V +A+K+LSR + + +E L+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKC 117
Query: 101 LQHKNLVRLL------GCCLEGNELLLICEYMP-------NKSLD-----FLLFDSTRSV 142
+ HKN++ LL E ++ L+ E M LD +LL+ +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 143 QLDWNRRMCIINGIARDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTY 191
+ + I RD K P KI DFG+AR G S T VV T
Sbjct: 178 KHLHSA-----GIIHRDLK--PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TR 227
Query: 192 GYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
Y APE L + D++S G ++ E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 43/205 (20%), Positives = 79/205 (38%), Gaps = 37/205 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLLG 111
+G G FG V L + ++ A+K L++ E ++++ K + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR--RMCIINGIARDHKMN------ 163
+ N L L+ +Y L LL + + R ++ I H+++
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 164 -P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKS--- 208
P +++DFG + ++ VGT Y++PE L+ + K
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPE-ILQAMEGGKGRYG 259
Query: 209 ---DVFSFGVLLLEIISGRKDTRFY 230
D +S GV + E++ G T FY
Sbjct: 260 PECDWWSLGVCMYEMLYGE--TPFY 282
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 39/207 (18%), Positives = 75/207 (36%), Gaps = 39/207 (18%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRS-------SGQGLQEFKNLIAKLQHKNLVRLL 110
+G G F V + ++ A+K +++ +E ++++ + + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE-RDVLVNGDRRWITQLH 127
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN----- 163
+ N L L+ EY L LL + + R I+ I H++
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 164 --P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE-------YALEGL 203
P +++DFG + + VGT Y++PE G
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFY 230
+ + D ++ GV E+ G+ T FY
Sbjct: 247 YGPECDWWALGVFAYEMFYGQ--TPFY 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 38/198 (19%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLLG 111
+G+G FG V ND K++ A+K +++ E ++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 112 CCLEGNELLLICEYMPNKSLDFLL-----FDSTRS--------VQLDWNRRMCII----- 153
+ ++ ++ + + L + L F + LD+ + II
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 154 --NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-----FSV 206
N I D + I+DF +A + + GT YMAPE F+V
Sbjct: 143 PDN-ILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAV 198
Query: 207 KSDVFSFGVLLLEIISGR 224
D +S GV E++ GR
Sbjct: 199 --DWWSLGVTAYELLRGR 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 40/225 (17%), Positives = 77/225 (34%), Gaps = 56/225 (24%)
Query: 46 IHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQE--FKNLI-AK-- 100
+H ++ + + G +G V GV ++ +A+KR+ + G + K
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 101 ---------LQHKNLVRLLGCCL-----EGNELLLICEYMPNKSLDFLLFDSTRSVQLDW 146
H N++ L + ++L L+ E M L ++
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVI 131
Query: 147 NRRMC------IING---------IARDHKMNP-----------KISDFGMARVFGGNQS 180
+ + I+ G + RD P I DF +AR
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLH--PGNILLADNNDITICDFNLARED--TAD 187
Query: 181 EANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGR 224
T+ V Y APE ++ F+ D++S G ++ E+ + +
Sbjct: 188 ANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 54/214 (25%), Positives = 83/214 (38%), Gaps = 49/214 (22%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSR------SSGQGLQEFKNLIAK 100
+ + N +G G G V + +A+K+LSR + + +E L+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKC 80
Query: 101 LQHKNLVRLL------GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII- 153
+ HKN++ LL E ++ ++ E M D L + +LD R ++
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHERMSYLLY 134
Query: 154 ------------NGIARDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGT 190
I RD K P KI DFG+AR G S T VV T
Sbjct: 135 QMLCGIKHLHSAGIIHRDLK--PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-T 189
Query: 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
Y APE L + D++S G ++ E+I G
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 52/222 (23%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQG----LQEFKNLIAKLQ 102
+ + + LG GG G V+ V ND + +A+K++ + Q L+E K +I +L
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLD 66
Query: 103 HKNLVRLL--------------GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNR 148
H N+V++ G E N + ++ EYM + L + L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEH 121
Query: 149 RMCII-------------NGIARDHK-----MNP-----KISDFGMARVFGGNQSEAN-- 183
+ N + RD K +N KI DFG+AR+ + S
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 184 TNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGR 224
+ +V T Y +P L ++ D+++ G + E+++G+
Sbjct: 182 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 46/215 (21%), Positives = 79/215 (36%), Gaps = 53/215 (24%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLLG 111
LG G FG V + A+K L + L++ K ++ + LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 112 CCLEGNELLLICEYMPNKSLDFLL-----FDSTRSVQLDWNRRM---CII--------NG 155
+ + L ++ EY+ + L F + R I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVLTFEYLHSLD 161
Query: 156 IA-RDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
+ RD K P +++DFG A+ G T + GT +APE L
Sbjct: 162 LIYRDLK--PENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKG 214
Query: 204 FSVKSDVFSFGVLLLEIISGR----KDTRFYLYEQ 234
++ D ++ GVL+ E+ +G D +YE+
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 60/208 (28%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRS-------SGQGLQEFKNLIAKLQHKNLVRLL 110
LG G FG V G ++AVK L+R G+ +E +NL +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRHPHIIKLY 77
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IINGIA--- 157
+ ++ EY+ LFD + + R+ I++ +
Sbjct: 78 QVISTPTDFFMVMEYVSGGE----LFD-----YICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 158 ------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE----- 197
RD MN KI+DFG++ + + T G+ Y APE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT--SCGSPNYAAPEVISGR 185
Query: 198 -YALEGLFSVKSDVFSFGVLLLEIISGR 224
YA G + D++S GV+L ++ G
Sbjct: 186 LYA--GP---EVDIWSCGVILYALLCGT 208
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 38/214 (17%), Positives = 81/214 (37%), Gaps = 43/214 (20%)
Query: 43 LDLIHEATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-------LQEF 94
+ ++ KLG G + V++ + + +++++ VK L + L+
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENL 87
Query: 95 KNLIAKLQHKNLVRLLGCCLEGNE--LLLICEYMPNKSLDFLLFDSTRS-VQ-------- 143
+ N++ L + L+ E++ N L T ++
Sbjct: 88 RG------GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 141
Query: 144 -LDWNRRMCIINGIARDHK-----MNP-----KISDFGMARVFGGNQSEANTNRVVGTYG 192
LD+ M I++ RD K ++ ++ D+G+A + Q RV Y
Sbjct: 142 ALDYCHSMGIMH---RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRY- 195
Query: 193 YMAPEYALEGLFSVKS-DVFSFGVLLLEIISGRK 225
+ PE ++ S D++S G +L +I ++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 14/101 (13%), Positives = 32/101 (31%), Gaps = 5/101 (4%)
Query: 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEAN 183
+ + + K+ KI+D G A + +E
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-- 252
Query: 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR 224
+ T Y + E + ++ +D++S + E+ +G
Sbjct: 253 ---DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 61/208 (29%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLL 110
LGEG FG V +++A+K +SR + +E L L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRHPHIIKLY 75
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC----------IINGIA--- 157
+++++ EY + LFD + +RM II I
Sbjct: 76 DVITTPTDIVMVIEYAGGE-----LFD-----YIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 158 ------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE----- 197
RD +N KI+DFG++ + T+ G+ Y APE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPEVINGK 182
Query: 198 -YALEGLFSVKSDVFSFGVLLLEIISGR 224
YA + DV+S G++L ++ GR
Sbjct: 183 LYA-----GPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 50/203 (24%)
Query: 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLL 110
LG G FG V G ++AVK L+R G+ +E +NL +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRHPHIIKLY 82
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFD---STRSVQLDWNRRMC--IINGIA-------- 157
+++ ++ EY+ LFD + +RR+ I++G+
Sbjct: 83 QVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 158 -RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE------YALE 201
RD MN KI+DFG++ + + T+ G+ Y APE YA
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISGRLYA-- 193
Query: 202 GLFSVKSDVFSFGVLLLEIISGR 224
+ D++S GV+L ++ G
Sbjct: 194 ---GPEVDIWSSGVILYALLCGT 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 46/213 (21%), Positives = 84/213 (39%), Gaps = 47/213 (22%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSR------SSGQGLQEFKNLIAK 100
E + + +G G +G V V +A+K+L R + + +E + L+
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKH 80
Query: 101 LQHKNLVRLL------GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII- 153
++H+N++ LL + + L+ +M L + +L +R ++
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVY 135
Query: 154 ------------NGIARDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYG 192
I RD K +N KI DFG+AR + V T
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVTRW 190
Query: 193 YMAPEYALE-GLFSVKSDVFSFGVLLLEIISGR 224
Y APE L ++ D++S G ++ E+I+G+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 47/215 (21%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSRSSGQG-----LQEFKNLIAKL 101
+ ++N + +GEG +G V N +K +A+K++S Q L+E K ++ +
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRF 82
Query: 102 QHKNLVRLLGCCL-----EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII--- 153
+H+N++ + + ++ ++ + M + L+ ++ L + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 154 ----------NGIARDHKMNP-----------KISDFGMARVFGGNQSEAN--TNRVVGT 190
N + RD K P KI DFG+ARV + T V T
Sbjct: 138 LRGLKYIHSANVLHRDLK--PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-T 194
Query: 191 YGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGR 224
Y APE L ++ D++S G +L E++S R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 36/203 (17%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLS------RSSGQGLQEFKNLIAKLQHKNLVRLLG 111
+G G FG V +++ A+K LS RS E ++++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN------ 163
+ L ++ EYMP L L+ S V W R ++ + H M
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194
Query: 164 -P-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPE----YALEGLFSVK 207
P K++DFG + VGT Y++PE +G + +
Sbjct: 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 208 SDVFSFGVLLLEIISGRKDTRFY 230
D +S GV L E++ G T FY
Sbjct: 254 CDWWSVGVFLYEMLVGD--TPFY 274
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSR------SSGQGLQEFKNLIAK 100
E + + + +G G +G V + E +A+K+LSR + + +E L+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKH 79
Query: 101 LQHKNLVRLL------GCCLEGNELLLICEYMP------------NKSLDFLLFDSTRSV 142
+QH+N++ LL + L+ +M + + +L++
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY------ 133
Query: 143 QLDWNRRMCII---NGIARDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGT 190
Q+ + + I + RD K +N KI DFG+AR + V T
Sbjct: 134 QM--LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVT 186
Query: 191 YGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGR 224
Y APE L ++ D++S G ++ E+++G+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 8e-05
Identities = 46/213 (21%), Positives = 84/213 (39%), Gaps = 49/213 (23%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLLG 111
LG G FG V+ + A+K L + L++ + +++ + H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 112 CCLEGNELLLICEYMPNKSLDFLL-----FDSTRSV----QLDWNRRMCII-----NGIA 157
+ ++ +I +Y+ L LL F + + ++ + I
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKDII 128
Query: 158 -RDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD K P KI+DFG A+ T + GT Y+APE ++
Sbjct: 129 YRDLK--PENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYN 181
Query: 206 VKSDVFSFGVLLLEIISGR----KDTRFYLYEQ 234
D +SFG+L+ E+++G YE+
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 2e-04
Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 12/131 (9%)
Query: 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVR 108
T K+GEG FG V++ + D +A+K ++ + + ++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISD 168
EL L+ + N++ F+ +S VQ + + A DH + K S
Sbjct: 77 SK-------ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL----KAWDHYNSTKGSA 125
Query: 169 FGMARVFGGNQ 179
F +Q
Sbjct: 126 NDRPDFFKDDQ 136
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKE-IAVKRLSR------SSGQGLQEFKNLIAK 100
E + N + +G G +G V +AVK+LSR + + +E + L+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKH 84
Query: 101 LQHKNLVRLL------GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII- 153
++H+N++ LL E N++ L+ M D L + + +L + +I
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKLTDDHVQFLIY 139
Query: 154 ------------NGIARDHK-----MNP----KISDFGMARVFGGNQSEANTNRVVGTYG 192
+ I RD K +N KI DFG+AR + V T
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-----VATRW 194
Query: 193 YMAPEYALE-GLFSVKSDVFSFGVLLLEIISGR 224
Y APE L ++ D++S G ++ E+++GR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 35/245 (14%), Positives = 79/245 (32%), Gaps = 67/245 (27%)
Query: 7 RSREGRTGDDDDDEGYSYSILRGKKKVESQELPLFPLDLIHEAT----RNFSNENKLGEG 62
+ + + S S G+++ + + + + +G G
Sbjct: 5 EAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTG 64
Query: 63 GFGPVYKGVLNDDKE-IAVKRLSRSSGQGLQEFKNLI-AK-----------LQHKNLVRL 109
+G V + +K +A+K++ R F++LI K L H ++V++
Sbjct: 65 SYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 110 L-----GCCLEGNELLLICEYMPN------KSLDFLLFDSTRSV--QLDWNRRMCIINGI 156
L + +EL ++ E + ++ +L +++ ++ G+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN--------LLVGV 169
Query: 157 A---------RDHKMNP-----------KISDFGMARVFGGNQSEANTNRVVGTYGYMAP 196
RD K P K+ DFG+AR ++ + + M
Sbjct: 170 KYVHSAGILHRDLK--PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 197 EYALE 201
Sbjct: 228 VTFPH 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 29/193 (15%)
Query: 59 LGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEF------KNLIAKLQHKNLVRLLG 111
LG+G FG V A+K L + E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 112 CCLEGNELLLICEYMPNKSLDFLL-----FDSTRS------VQLDWNRRMCIINGIARDH 160
+ L + EY L F L F R+ + + N + RD
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 161 KM---------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVF 211
K+ + KI+DFG+ + G + A GT Y+APE + + D +
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 333
Query: 212 SFGVLLLEIISGR 224
GV++ E++ GR
Sbjct: 334 GLGVVMYEMMCGR 346
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 6e-04
Identities = 23/147 (15%), Positives = 46/147 (31%), Gaps = 36/147 (24%)
Query: 4 QFLRSREGRTGDDDDDEGYSYSILRG---KKKVESQELPLFP---LDLIHEATRNFSNEN 57
++ + + Y YS + G K + + LF LD F E
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHI-GHHLKNIEHPERMTLFRMVFLDF------RFL-EQ 505
Query: 58 KLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGN 117
K+ G + + L + L+ +K I RL+ N
Sbjct: 506 KIRHDSTAWNASGSILNT-------LQQ-----LKFYKPYICD-NDPKYERLV------N 546
Query: 118 ELLLICEYMPNKSLDFLLFDSTRSVQL 144
+L +++P + + T +++
Sbjct: 547 AIL---DFLPKIEENLICSKYTDLLRI 570
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 338 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.83 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.76 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.5 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.09 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.83 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.68 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 95.15 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 94.14 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.96 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 92.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 91.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 90.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 88.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 86.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 85.63 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 83.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 81.49 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=340.26 Aligned_cols=235 Identities=26% Similarity=0.365 Sum_probs=175.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|.+.+.||+|+||.||+|++. ++..||||+++.... +.+.+|+++|+.++|||||++++++.+++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357889999999999999999853 366799999975443 34667888999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccC--------------ccccccHHHHHHHHHHhhhcCC------------------CCeEEee
Q 045271 121 LICEYMPNKSLDFLLFDST--------------RSVQLDWNRRMCIINGIARDHK------------------MNPKISD 168 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~D 168 (338)
+|||||++|+|.+++.... ........+..+++.|+.|+|+ +.+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 9999999999999997542 1222334566678888887654 4589999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhc
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWC 247 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 247 (338)
||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |..||......+.......
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~------ 245 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ------ 245 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH------
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------
Confidence 999987643332222334579999999999999999999999999999999998 8999976443222111111
Q ss_pred cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
+....... .....+.+||.+||+.||++||||.+|+++|+...
T Consensus 246 -~~~~~~p~---------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 246 -GRVLQRPR---------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp -TCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111110 01124567888999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=340.11 Aligned_cols=232 Identities=26% Similarity=0.327 Sum_probs=175.4
Q ss_pred cCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.+++++++||+|+||.||+|.+. ++..||||.++.... +.+.+|+.+++.++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46778899999999999999853 356799999965432 34677889999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeE
Q 045271 121 LICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPK 165 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vk 165 (338)
+|||||++|+|.+++..... .......+..+++.|+.|+|+ +.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 99999999999999965321 111224456678888887653 4599
Q ss_pred EeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHh
Q 045271 166 ISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWK 244 (338)
Q Consensus 166 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~ 244 (338)
|+|||+|+.+...+........+||+.|||||++.+..|+.++|||||||++|||+| |..||......+......
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~---- 261 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR---- 261 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH----
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 999999987644333333445689999999999999999999999999999999998 899997544322211111
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
........+ .....+.+||.+||+.||++||||.||+++|+.
T Consensus 262 ---~~~~~~~p~---------~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 262 ---NRQVLPCPD---------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ---TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---cCCCCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111111111 112245678889999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=340.70 Aligned_cols=235 Identities=29% Similarity=0.370 Sum_probs=169.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|.+.++||+|+||.||+|++. ++..||||+++.... +.+.+|+++|+.++|||||++++++.+.+.+|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357788899999999999999864 367799999975543 34667888999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc----------------cccccHHHHHHHHHHhhhcCC------------------CCeEE
Q 045271 121 LICEYMPNKSLDFLLFDSTR----------------SVQLDWNRRMCIINGIARDHK------------------MNPKI 166 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL 166 (338)
||||||++|+|.+++..... .......+..+++.|+.|+|+ +.+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 99999999999999976432 112234556677888877553 45999
Q ss_pred eeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhh
Q 045271 167 SDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |+.||......+.......+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g--- 276 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG--- 276 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT---
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence 99999987643333333345689999999999999999999999999999999999 89999754432221111111
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.. ..... .....+.+||.+||+.||++||||.||+++|+...
T Consensus 277 ---~~-~~~p~---------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 277 ---RE-LERPR---------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ---CC-CCCCT---------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CC-CCCcc---------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 00 00000 01124567888999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=344.02 Aligned_cols=226 Identities=19% Similarity=0.262 Sum_probs=166.7
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++++.||+|+||.||+|++ .+++.||||++..... +.+.+|+.+++.++|||||++++++++++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999995 4588999999965432 346778899999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcc---ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDSTRS---VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||++|+|.+++...... ......+..+++.+|.|.| ++.+||+|||+|+.+.. ....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVEL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--Cccc
Confidence 99999999998654322 2233445667777777644 45699999999987521 1122
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|||||++.+..|+.++|||||||++|||++|..||......+....+. . ....... . .
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~-~~~~~~~-~--~--- 248 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII------S-GSFPPVS-L--H--- 248 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------H-TCCCCCC-T--T---
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------c-CCCCCCC-c--c---
Confidence 345689999999999999999999999999999999999999997543322211111 0 1111100 0 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+||.+||+.||++|||+.|+++
T Consensus 249 ---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 249 ---YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1124567888999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=335.90 Aligned_cols=233 Identities=21% Similarity=0.267 Sum_probs=180.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS---SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+.|+++++||+|+||.||+|.+. +++.||||++... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999964 6889999999543 335578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
|++|+|.+++............+..+++.+|.|.| ++.+||+|||+|+.+... .......
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCC
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CCccccc
Confidence 99999999998766655556666777888877754 456999999999987422 2234457
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+||+.|||||++.+..|+.++|||||||++|||++|..||......+....+.. .. ...+..... .
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~~-~~~~~~~~~------~ 296 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-------NL-PPRLKNLHK------V 296 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SS-CCCCSCGGG------S
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------CC-CCCCCcccc------C
Confidence 999999999999999999999999999999999999999975432221111110 00 000000000 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...+.+||.+||+.||++|||+.|+++ ++..
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 124567888999999999999999986 4544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=334.43 Aligned_cols=226 Identities=20% Similarity=0.233 Sum_probs=175.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|++ .+++.||||++.+. ..+.+.+|+++|+.++|||||+++++|++.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 45889999999642 2345778899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||++|+|.+++..... ..........+++.+|.|.| ++.+||+|||+|+.+.........
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 99999999999876533 33344455567777777644 456999999999987544444445
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|||||++.+..|+.++||||+||++|+|++|..||......+....+.. ... . +...+
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~~~-~-~p~~~----- 257 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------LEY-D-FPEKF----- 257 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCC-C-CCTTC-----
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCC-C-CCccc-----
Confidence 568999999999999999999999999999999999999999975432221111110 010 0 11111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
...+.+|+.+||+.||++|||+.|++
T Consensus 258 ---s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 ---FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12456788899999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.44 Aligned_cols=233 Identities=21% Similarity=0.266 Sum_probs=180.9
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS---SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+.|+++++||+|+||.||+|.+ .+++.||||++... ..+.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35799999999999999999995 45889999999643 234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
|++|+|.+++............+..+++.||.|+| ++.+||+|||+|+.+.. ........
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~ 307 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSL 307 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBCCC
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcccccc
Confidence 99999999998766665566667777888887755 45699999999998642 22334467
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+||+.|||||++.+..|+.++|||||||++|||++|..||......+....+.. .. ...+......
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~~-~~~~~~~~~~------ 373 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-------NL-PPRLKNLHKV------ 373 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SC-CCCCSCTTSS------
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------CC-CCCCcccccC------
Confidence 999999999999999999999999999999999999999975432222111110 00 0000000011
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...+.+||.+||+.||++|||+.|+|+ +|..
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 124567888899999999999999986 4544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=331.13 Aligned_cols=236 Identities=18% Similarity=0.158 Sum_probs=176.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.|++.++||+|+||.||+|++ .+++.||||+++... ...+|+.+++.++|||||++++++.+++.+|||||||++|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 4688899999999999999995 458899999997543 2346888999999999999999999999999999999999
Q ss_pred CHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------C-CeEEeeeccceecCCCCCC---ccccc
Q 045271 130 SLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------M-NPKISDFGMARVFGGNQSE---ANTNR 186 (338)
Q Consensus 130 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~-~vkL~Dfg~a~~~~~~~~~---~~~~~ 186 (338)
+|.+++..... .......+..+++.+|.|.|+ + .+||+|||+|+.+...... .....
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~ 215 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCc
Confidence 99999976543 334445566678888887553 3 4999999999876432211 11234
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.+||+.|||||++.+..|+.++|||||||++|||++|.+||...........+... ......+. ..
T Consensus 216 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~-~~-------- 281 (336)
T 4g3f_A 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-----PPPIREIP-PS-------- 281 (336)
T ss_dssp CCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-----CCGGGGSC-TT--------
T ss_pred cccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-----CCCchhcC-cc--------
Confidence 68999999999999999999999999999999999999999754433322211111 00111111 11
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
....+.+|+.+||+.||++|||+.|+++.|......
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 112356688889999999999999999988765543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=326.39 Aligned_cols=237 Identities=21% Similarity=0.311 Sum_probs=167.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.+++++.++||+|+||.||+|.+. ..||||+++.... +.+.+|+.+++.++|||||++++++.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 457889999999999999999864 3699999864322 346678889999999999999998864 56899999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||++|+|.+++..... .......+..+++.||.|+|+ +.+||+|||+|+...........
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 9999999999965433 223344566678888888654 34899999999876433333334
Q ss_pred cccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
...+||+.|||||++.+ ..|+.++|||||||++|||+||..||......... ..................
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~----- 264 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVGRGYASPDLSKLYK----- 264 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHTTCCCCCSTTSCT-----
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCCCcccccc-----
Confidence 45789999999999964 35899999999999999999999999753321111 111111111111111110
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+||.+||+.||++||||.||++.|+...
T Consensus 265 ----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 265 ----NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ----TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 01124567888999999999999999998887654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.56 Aligned_cols=229 Identities=20% Similarity=0.276 Sum_probs=160.1
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|.. .+++.||||++.+.. ...+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999994 568899999986432 23467888999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||| +|+|.+++.... ...........+++.+|.|.| ++++||+|||+|+.... ...
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CCc
Confidence 9999 688888776543 333344555667777777644 45699999999987532 222
Q ss_pred ccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
....+||+.|||||++.+..| +.++||||+||++|+|++|..||...........+. .... . ++..+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~-------~~~~-~-~p~~~--- 235 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS-------NGVY-T-LPKFL--- 235 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCC-C-CCTTS---
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCC-C-CCCCC---
Confidence 345789999999999998876 579999999999999999999997543222111111 0100 0 11111
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
...+.+|+.+||+.||++|||+.|+++ +++..
T Consensus 236 -----s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 236 -----SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp -----CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred -----CHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 123567888999999999999999996 56543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=333.41 Aligned_cols=242 Identities=25% Similarity=0.324 Sum_probs=177.7
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCc----ccHHHHHHHHHhcCC-CceeeeeeE
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSG----QGLQEFKNLIAKLQH-KNLVRLLGC 112 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~~~l~~l~h-pnIv~~~~~ 112 (338)
+.+....++|++++.||+|+||.||+|.+.. ++.||||.+..... ..+..|+.+|+.++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444556899999999999999999999533 25699999975443 235667788888865 899999999
Q ss_pred EEe-CCEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC-------------
Q 045271 113 CLE-GNELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------- 161 (338)
Q Consensus 113 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------- 161 (338)
|.. ++.+++|||||++|+|.++++.... .......+..+++.|+.|+|+
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 876 4678999999999999999975432 111233455678888887553
Q ss_pred -----CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccc
Q 045271 162 -----MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQG 235 (338)
Q Consensus 162 -----~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~ 235 (338)
+.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |..||......+.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4599999999987754433334445689999999999999999999999999999999998 8999975432221
Q ss_pred cchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 236 QSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
. ..... .+......+. ....+.++|.+||+.||++||||.+|+++|+...
T Consensus 297 ~--~~~i~----~g~~~~~p~~---------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 297 F--CRRLK----EGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp H--HHHHH----HTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HHHHH----cCCCCCCCcc---------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1 11110 1110111110 1124567888999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=321.94 Aligned_cols=247 Identities=23% Similarity=0.233 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHH--HHHhcCCCceeeeeeEEEeCC----EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN--LIAKLQHKNLVRLLGCCLEGN----ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~l~~l~hpnIv~~~~~~~~~~----~~~lv~ 123 (338)
.++|.+.++||+|+||.||+|.+ +++.||||++..........+.+ .+..++|||||++++++.+++ .+||||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 35788899999999999999998 68899999997655444444444 345789999999999998653 689999
Q ss_pred ecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC--------------------------CCeEEeeeccceecCC
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK--------------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~--------------------------~~vkL~Dfg~a~~~~~ 177 (338)
|||++|+|.+++...............+++.||.|.|. +.+||+|||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 99999999999987766555556667778888887663 3489999999987643
Q ss_pred CCCC--ccccccccCCccccccccccC------CCCcccchHhHhHHHHHHHhCCCCCccccccccc--------chhhH
Q 045271 178 NQSE--ANTNRVVGTYGYMAPEYALEG------LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ--------SLLTY 241 (338)
Q Consensus 178 ~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~--------~~~~~ 241 (338)
.... ......+||+.|||||++.+. .|+.++|||||||++|||+||..||......+.. .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3221 122345899999999999764 3678999999999999999998876543221110 00000
Q ss_pred HHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.............++.. ....+....+.+||.+||+.||++||||.||++.|+...
T Consensus 241 ~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00111111111111111 111233445678999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=315.60 Aligned_cols=223 Identities=23% Similarity=0.314 Sum_probs=162.4
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe----CCEEEEE
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE----GNELLLI 122 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~lv 122 (338)
|++.++||+|+||.||+|.+. ++..||+|.+..... +.+.+|+.+++.++|||||+++++|.+ .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999954 578899999864321 346778899999999999999999975 3568999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||||++|+|.+++..... ..........+++.||.|.|+ +.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~---- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---- 183 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC----
Confidence 999999999999976433 223334455667777766442 458999999997542
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......+||+.|||||++.+ .|+.++|||||||++|||++|..||........ .. ...........++..
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~-~~i~~~~~~~~~~~~-- 254 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IY-RRVTSGVKPASFDKV-- 254 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HH-HHHTTTCCCGGGGGC--
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HH-HHHHcCCCCCCCCcc--
Confidence 223445789999999998865 699999999999999999999999964321111 00 011111111111110
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+|+.+||+.||++|||+.|+++
T Consensus 255 ------~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 ------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0123567888999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=321.34 Aligned_cols=225 Identities=20% Similarity=0.231 Sum_probs=164.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
++|++++.||+|+||.||+|+.. +++.||||++.+.. ......|+.+++.++|||||++++++++++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999853 35689999986432 2345667888999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||||++|+|.+++..... ..........+++.+|.|.| ++.+||+|||+|+.... ...
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEK 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CCc
Confidence 9999999999999876543 33334445566777777644 45699999999986532 222
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|||||++.+..|+.++||||+||++|||++|..||......+....+.. ... . +...+
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------~~~-~-~p~~~--- 249 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-------AKL-G-MPQFL--- 249 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC-C-CCTTS---
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc-------CCC-C-CCCcC---
Confidence 33457899999999999999999999999999999999999999975433222111110 000 0 11111
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTM-----SSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~vl~ 294 (338)
...+.+|+.+||+.||++|||+ +|+++
T Consensus 250 -----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 250 -----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1245678889999999999985 67774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=312.77 Aligned_cols=228 Identities=23% Similarity=0.306 Sum_probs=157.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN------ 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~------ 117 (338)
+.++|++++.||+|+||.||+|++ .+++.||||++..... +.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 345799999999999999999995 4688999999865433 34567888999999999999999997544
Q ss_pred ------EEEEEEecCCCCCHHHHHhccCccccc----cHHHHHHHHHHhhhcC------------------CCCeEEeee
Q 045271 118 ------ELLLICEYMPNKSLDFLLFDSTRSVQL----DWNRRMCIINGIARDH------------------KMNPKISDF 169 (338)
Q Consensus 118 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~----~~~~~~~~~~~i~~~~------------------~~~vkL~Df 169 (338)
.+|+|||||++|+|.+++......... ...+..+++.||.|.| ++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 379999999999999999866543332 2345567777777754 356999999
Q ss_pred ccceecCCCCCC----------ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchh
Q 045271 170 GMARVFGGNQSE----------ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL 239 (338)
Q Consensus 170 g~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~ 239 (338)
|+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||..... .....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHHH
Confidence 999876432211 11234589999999999999999999999999999999995 6643210 00000
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. . ....... + ..........+|+.+||+.||++|||+.|+++
T Consensus 238 ~---~-~~~~~~p----~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 T---D-VRNLKFP----P-----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H---H-HHTTCCC----H-----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---H-HhcCCCC----C-----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 0001100 0 01111223467889999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=308.07 Aligned_cols=181 Identities=23% Similarity=0.326 Sum_probs=142.4
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCC-cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSS-GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~ 120 (338)
+.+.++|+++++||+|+||.||+|+.. +++.||||.+.... .....+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 346688999999999999999999853 35689999986543 34466778888877 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+|||||++|+|.+++.. ...........+++.+|.|.|+ +.+||+|||+|+........
T Consensus 97 lvmE~~~g~~L~~~~~~--l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS--LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EEEECCCCCCHHHHHTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred EEEeCCCcccHHHHHcC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 99999999999998853 3333445556677777776543 45899999999865322110
Q ss_pred --------------------------ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 182 --------------------------ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 182 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
......+||+.|+|||++.+. .|+.++||||+||++|||++|..||..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 112335799999999999886 489999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.23 Aligned_cols=229 Identities=20% Similarity=0.222 Sum_probs=174.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++++.||+|+||.||+|.. .+++.||+|.+..... +.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999995 4688999999865432 3467788999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC--------------------CCeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK--------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~--------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|++|+|.+++..... ..........+++.+|.|+|+ +.+||+|||+|+.+.. ...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---TSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---CCc
Confidence 999999998865432 233344555667777776442 4689999999998742 223
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|||||++.+..|+.++||||+||++|+|++|..||......+....+... ...... ....
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~-----~~~~~~---~~~~--- 381 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-----DWNMDD---SAFS--- 381 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-----CCCCCS---GGGT---
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC-----CCCCCc---cccc---
Confidence 34568999999999999999999999999999999999999999754332221111100 000000 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+||.+||+.||.+|||+.|+|+
T Consensus 382 --~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 --GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01124567899999999999999999997
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.25 Aligned_cols=247 Identities=17% Similarity=0.224 Sum_probs=170.7
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe------CCE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE------GNE 118 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~------~~~ 118 (338)
++|++++.||+|+||.||+|++ .+++.||||++..... ....+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 4688999999965432 235578899999999999999999864 367
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
+|||||||+ |+|..++..... .......+..+++.||.|.| ++.+||+|||+|+.+....
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 899999995 778888865432 33344556667787777755 3569999999998763321
Q ss_pred --CCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc---
Q 045271 180 --SEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE--- 253 (338)
Q Consensus 180 --~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 253 (338)
........+||+.|||||++.+. .|+.++||||+||++|||++|.+||......+....+..............
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 12233457999999999999876 579999999999999999999999976443322222211100000000000
Q ss_pred -----ccCccc-cccccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 254 -----LMDPVL-KESFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 254 -----~~~~~~-~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...... ....... ....+++|+.+||++||++||||.|+|+ +++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 000000 0000011 1124678999999999999999999986 4544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=316.08 Aligned_cols=226 Identities=23% Similarity=0.231 Sum_probs=166.9
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHH---HHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEF---KNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~---~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
++|++++.||+|+||.||+|++. +++.||||++.+.. .....++ ..+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999954 58899999995421 1223333 34556678999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+|||||+||+|..++..... ..........+++.||.|.|+ +.+||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~---- 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC----
Confidence 99999999999999876543 333444556677777777554 5699999999987642
Q ss_pred ccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......+||+.|||||++.+ ..|+.++||||+||++|||++|.+||................ ..... +...+
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~----~p~~~- 417 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVE----LPDSF- 417 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCC----CCTTS-
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCC----CCccC-
Confidence 22345799999999999975 579999999999999999999999997543322211111110 00000 11111
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
...+.+||.+||+.||.+|++ +.||++
T Consensus 418 -------S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 418 -------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 124567888999999999998 788874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.75 Aligned_cols=256 Identities=32% Similarity=0.499 Sum_probs=194.9
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+....++|++.+.||+|+||.||+|...++..||||.+..... +.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456789999999999999999999987889999999865443 345667778889999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-----cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR-----SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
||||+++|+|.+++..... .....+....+++.+|.+.| ++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999988865432 11223344555666666644 346899999999875433
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.............+..............+..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 32222334578999999999999999999999999999999999999997655444443333332333333444444444
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
+...........+.+++.+||+.||++|||+.++++.|+...
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 444455666677888999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=290.18 Aligned_cols=263 Identities=37% Similarity=0.543 Sum_probs=200.5
Q ss_pred CCCCChhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEE
Q 045271 38 LPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCC 113 (338)
Q Consensus 38 ~~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~ 113 (338)
...++...+....++|++.+.||+|+||.||+|...++..||||.+..... ..+..|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345677888889999999999999999999999977889999999865432 2467788889999999999999999
Q ss_pred EeCCEEEEEEecCCCCCHHHHHhccCcc-----ccccHHHHHHHHHHhhhcCCC---------------------CeEEe
Q 045271 114 LEGNELLLICEYMPNKSLDFLLFDSTRS-----VQLDWNRRMCIINGIARDHKM---------------------NPKIS 167 (338)
Q Consensus 114 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~~~~~---------------------~vkL~ 167 (338)
.+.+..++||||+.+|+|.+++...... .........+++.+|.+.|+. .+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 9999999999999999999999765432 122344455566666665543 58999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccc--cchhhHHHhh
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG--QSLLTYTWKL 245 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~--~~~~~~~~~~ 245 (338)
|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987643222 223345699999999999988899999999999999999999999964332222 1222222222
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
..........+..+...........+.+++.+||+.||.+|||+.+|+++|+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 23334445555555555666777788899999999999999999999999998543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.64 Aligned_cols=247 Identities=20% Similarity=0.202 Sum_probs=178.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCccc--HHHHHHHHHhcCCCceeeeeeEEEeCC----EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQG--LQEFKNLIAKLQHKNLVRLLGCCLEGN----ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~ 123 (338)
.++|++++.||+|+||.||+|... ++.||||++....... ...|+.+++.++||||+++++++.+.. .+++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 458999999999999999999874 7889999996544333 333555678899999999999998743 479999
Q ss_pred ecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC----------------------------CeEEeeeccceec
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM----------------------------NPKISDFGMARVF 175 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~----------------------------~vkL~Dfg~a~~~ 175 (338)
||+++|+|.+++...............+++.++.++|+. .+||+|||++..+
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 999999999999876655555566677788888887764 5899999999877
Q ss_pred CCCCCCccccccccCCccccccccccC-----CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH---------
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEG-----LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--------- 241 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--------- 241 (338)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||..............
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 544333333446799999999999873 466789999999999999999999975432221111100
Q ss_pred HHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.............+.... ........+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000111111111111 11123345678999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.91 Aligned_cols=230 Identities=20% Similarity=0.286 Sum_probs=173.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
..++|++.+.||+|+||.||+|.. .+++.||||.+.... .+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999994 568899999985432 2346677889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|+++|+|.+++...............+++.++.+.| ++.+||+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 175 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCC
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCC
Confidence 999999999997765554455556666777776644 4569999999998764322 22334
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
..||+.|+|||++.+..++.++|||||||++|+|++|..||............. .... .... .. ..
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~~~-~~~~-----~~--~~ 241 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNGT-PELQ-----NP--EK 241 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHCS-CCCS-----CG--GG
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC-CCCC-----Cc--cc
Confidence 689999999999999999999999999999999999999996433211111100 0000 0000 00 00
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123567888999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.57 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=167.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
..++|++.+.||+|+||.||+|.. .+..||||.+..... ..+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999987 678899999865432 23556788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCC--------------------CCeEEeeeccceecCCCC
Q 045271 124 EYMPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHK--------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~--------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
||+++|+|.+++..... .....+....+++.+|.+.|+ +.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST- 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-
Confidence 99999999999976542 222334455567777766554 35899999999764321
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........||+.|+|||++.+..++.++|||||||++|+|++|..||......+...... . ........ ..
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-----~-~~~~~~~~-~~- 263 (309)
T 3p86_A 193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-----F-KCKRLEIP-RN- 263 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-----H-SCCCCCCC-TT-
T ss_pred -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----h-cCCCCCCC-cc-
Confidence 112234579999999999999999999999999999999999999997543222111110 0 00000100 00
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
....+.+|+.+||+.||.+|||+.++++.|+.......
T Consensus 264 -------~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 264 -------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred -------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 11235678889999999999999999999998765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=273.70 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=176.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHh--cCCCceeeeeeEEEe----CCEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAK--LQHKNLVRLLGCCLE----GNELLLI 122 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~--l~hpnIv~~~~~~~~----~~~~~lv 122 (338)
+.++|++++.||+|+||.||+|.. +++.||||.+..........+.+++.. ++||||+++++++.. ...+++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 457899999999999999999998 688899999976655555666666665 799999999998764 3568999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC--------C------------------CCeEEeeeccceecC
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH--------K------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~--------~------------------~~vkL~Dfg~a~~~~ 176 (338)
|||+++|+|.+++..........+....+++.++.+.| + +.+||+|||++....
T Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 164 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164 (301)
T ss_dssp ECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred hhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecc
Confidence 99999999999997665555555666777888888877 2 358999999998764
Q ss_pred CCCCCc--cccccccCCccccccccccC------CCCcccchHhHhHHHHHHHhC----------CCCCcccccccccch
Q 045271 177 GNQSEA--NTNRVVGTYGYMAPEYALEG------LFSVKSDVFSFGVLLLEIISG----------RKDTRFYLYEQGQSL 238 (338)
Q Consensus 177 ~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiWSlGv~l~el~~g----------~~Pf~~~~~~~~~~~ 238 (338)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..||...........
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~ 244 (301)
T 3q4u_A 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244 (301)
T ss_dssp TTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred cccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchh
Confidence 322211 12234799999999999876 456799999999999999999 777754332222111
Q ss_pred hhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 239 LTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
. ............. +.. ..........+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 245 ~-~~~~~~~~~~~~~-~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 245 D-MRKVVCVDQQRPN-IPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp H-HHHHHTTSCCCCC-CCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred h-hhHHHhccCCCCC-CCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 1111110111111 110 011122344577899999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=283.84 Aligned_cols=235 Identities=26% Similarity=0.321 Sum_probs=173.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEc--------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN--------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
.++|++++.||+|+||.||+|... ++..||||.+..... ..+..|..+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 234699999975433 2356777889999 899999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcC------------------C
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDH------------------K 161 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~------------------~ 161 (338)
+.+|+||||+++|+|.+++..... ..........+++.+|.++| +
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 999999999999999999876432 11122334556777766644 4
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
+.+||+|||++..+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+......
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 5699999999987654333233334567889999999999999999999999999999999 999987543322211111
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
......... .....+.++|.+||+.||.+|||+.|+++.|+...
T Consensus 320 -------~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 320 -------EGHRMDKPA---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -------TTCCCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------cCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000000000 11124567888999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=280.75 Aligned_cols=232 Identities=25% Similarity=0.300 Sum_probs=170.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+.++|++++.||+|+||.||+|... +++.||||.+.... .+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4579999999999999999999965 68889999985432 245778888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||++|+|.+++..... ..........+++.+|.++| ++.+||+|||++..+.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999999988865432 23334455566777766644 356999999999865332222233
Q ss_pred cccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... .. . +...... .....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~--~---~~~~~~~--~~~~~---- 232 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--D---WKEKKTY--LNPWK---- 232 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH--H---HHTTCTT--STTGG----
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH--H---Hhccccc--CCccc----
Confidence 45689999999999988775 77899999999999999999999653321110 00 0 0000000 00000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+|+.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 233 --KIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01123457888999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=272.46 Aligned_cols=249 Identities=17% Similarity=0.164 Sum_probs=176.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCC--EEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN--ELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 122 (338)
.++|++.+.||+|+||.||+|... +++.||||++.... .+...+|+.+++.++||||+++++++...+ .+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 468999999999999999999965 48899999986532 234567888999999999999999998754 78999
Q ss_pred EecCCCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCC----------------------CCeEEeeeccceecC
Q 045271 123 CEYMPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~~~ 176 (338)
|||+++++|.+++..... .....+....+++.+|.+.|+ +.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999999976543 223334455567777666442 238999999998764
Q ss_pred CCCCCccccccccCCccccccccc--------cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYAL--------EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
... ......||..|+|||++. +..++.++|||||||++|+|++|..||....................+
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 322 223457999999999986 467899999999999999999999999753322221111111111111
Q ss_pred CC-cc---cccC-------c-cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 249 GN-AQ---ELMD-------P-VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 249 ~~-~~---~~~~-------~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.. .. .... . .............+.+++.+||+.||++|||+.|+++...+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 00 00 0000 0 00111223334456779999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=282.20 Aligned_cols=230 Identities=18% Similarity=0.212 Sum_probs=171.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---------ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
+.++|++++.||+|+||.||+|... ++..||+|.+..... +.+..|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999954 588899999865432 346778889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CC----CeEEeeeccceec
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KM----NPKISDFGMARVF 175 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~----~vkL~Dfg~a~~~ 175 (338)
+++||||+++|+|.+++..... ..........+++.+|.+.| ++ .+||+|||++..+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999999865432 22333445556666666543 22 5899999999876
Q ss_pred CCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+. ..... +
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-------~~~~~--~ 237 (361)
T 2yab_A 170 EDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------AVSYD--F 237 (361)
T ss_dssp CTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTCCC--C
T ss_pred CCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hcCCC--C
Confidence 432 22334689999999999999899999999999999999999999997543222111110 00000 0
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0001124567888999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=277.19 Aligned_cols=225 Identities=22% Similarity=0.267 Sum_probs=170.2
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++++.||+|+||.||+|.+ .+++.||||++..... +.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 56899999999999999999996 5688999999865422 23567788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++|+|.+++..... ..........+++.++.+.| ++.+||+|||++..... ....
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~ 170 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKL 170 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS---SCGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC---CCcc
Confidence 99999999998865433 33334455566777766644 45699999999976532 2233
Q ss_pred cccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
...+||+.|+|||++.+..++ .++||||+||++|+|++|..||......+....... .... +...
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~~~--~p~~----- 236 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR-------GKYR--IPFY----- 236 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCC--CCTT-----
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC--CCCC-----
Confidence 456899999999999988765 789999999999999999999975433222111110 0000 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ---~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 237 ---MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1123567888899999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=272.85 Aligned_cols=242 Identities=15% Similarity=0.092 Sum_probs=177.6
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.++|++.+.||+|+||.||+|.. .+++.||||.+... ....+..|..+++.+ +||||+++++++.+++..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 46899999999999999999995 56888999998643 345678889999999 9999999999999999999999999
Q ss_pred CCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcCC------------------CC-----eEEeeeccceecCCCCCC
Q 045271 127 PNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDHK------------------MN-----PKISDFGMARVFGGNQSE 181 (338)
Q Consensus 127 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~~------------------~~-----vkL~Dfg~a~~~~~~~~~ 181 (338)
+++|.+++.... ...........+++.+|.++|+ +. +||+|||++..+......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 999999987532 2333344555667777776443 22 999999999876432221
Q ss_pred c-----cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 182 A-----NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 182 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........................
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~--- 243 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV--- 243 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH---
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH---
Confidence 1 12346899999999999999999999999999999999999999976432222111111100000000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
+. .. .. .+.+++.+||+.||.+||++.+|++.|+....+
T Consensus 244 --~~-~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 244 --LC-EN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp --HT-TT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --Hh-cc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00 00 01 566788899999999999999999999866544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=276.71 Aligned_cols=235 Identities=18% Similarity=0.173 Sum_probs=174.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+.++|++.+.||+|+||.||+|... ++..||+|.+..... ..+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578999999999999999999964 577899999865433 3466788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC--------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH--------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~--------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|++|+|.+++..... .....+....+++.++.+.| ++.+||+|||++..+... ..
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---Cc
Confidence 999999999876532 22334455566777766533 456999999999876422 22
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.............. .... +... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------~~~~--~~~~----~ 226 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-------AEYT--FDEE----A 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------TCCC--CCHH----H
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc-------CCCC--CChh----h
Confidence 3346799999999999998899999999999999999999999975432221111100 0000 0000 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.......+.+|+.+||+.||.+|||+.|+++ ++...
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 0001124567889999999999999999996 55543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.99 Aligned_cols=260 Identities=33% Similarity=0.436 Sum_probs=186.9
Q ss_pred CCCCCChhHHHHHhcCCCCC------ceecccCCeeEEEEEEcCCcEEEEEEeccCC-------cccHHHHHHHHHhcCC
Q 045271 37 ELPLFPLDLIHEATRNFSNE------NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-------GQGLQEFKNLIAKLQH 103 (338)
Q Consensus 37 ~~~~~~~~~~~~~~~~y~~~------~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l~h 103 (338)
....+....+....++|... +.||+|+||.||+|.. ++..||||.+.... .+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34556777888888877766 9999999999999986 67889999986432 2346677889999999
Q ss_pred CceeeeeeEEEeCCEEEEEEecCCCCCHHHHHhccCcc----ccccHHHHHHHHHHhhhcC------------------C
Q 045271 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRS----VQLDWNRRMCIINGIARDH------------------K 161 (338)
Q Consensus 104 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~i~~~~------------------~ 161 (338)
|||+++++++.+.+..++||||+++++|.+++...... ....+....+++.+|.+.| +
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA 169 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999999988643322 2222344455666666544 3
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~ 241 (338)
+.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..............
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence 4699999999987643322222334578999999998765 588999999999999999999999976443322221111
Q ss_pred HHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
... .........++..+. .........+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 249 ~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 249 EIE-DEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHH-TTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred Hhh-hhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 110 111112222222222 223344456778999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=272.94 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=169.9
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+.++|+++++||+|+||.||+|...+++.||+|.+..... ....+|+.+++.++||||+++++++.+.+.+++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34579999999999999999999988899999999864332 3456788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||++ ++|..++...... .........+++.+|.++| ++.+||+|||++....... .
T Consensus 98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 174 (311)
T 3niz_A 98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--R 174 (311)
T ss_dssp EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C
T ss_pred EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--c
Confidence 99996 5777776654332 2233444556777766644 4569999999998764221 2
Q ss_pred cccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc------
Q 045271 183 NTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM------ 255 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 255 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............................
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 2233578999999999987 468999999999999999999999997543332221111110000000000000
Q ss_pred C---ccccccc----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 256 D---PVLKESF----ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 256 ~---~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
. ....... .......+.+|+.+||+.||++|||+.|+++ ++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 0 0000000 0001124578899999999999999999996 4544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.44 Aligned_cols=232 Identities=22% Similarity=0.222 Sum_probs=171.1
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
..+.++|++.+.||+|+||.||+|... ++..||+|.+..... +.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 355678999999999999999999954 588999999965432 34567888999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGN 178 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~ 178 (338)
+||||+.+|+|.+.+..... ..........+++.+|.+.|+ ..+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999999888865432 223334455567777666442 24899999999876422
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||............. ...... ....
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------~~~~~~-~~~~ 253 (362)
T 2bdw_A 185 ---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------AGAYDY-PSPE 253 (362)
T ss_dssp ---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCCC-CTTG
T ss_pred ---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hCCCCC-Cccc
Confidence 22334689999999999999899999999999999999999999996533211111110 000000 0000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. .....+.+|+.+||+.||++|||+.++++
T Consensus 254 ~~-----~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 254 WD-----TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GG-----GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc-----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 01124567888999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=269.51 Aligned_cols=238 Identities=25% Similarity=0.349 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 358999999999999999999964 588899998865433 3456778899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc---
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA--- 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~--- 182 (338)
+++|+|.+++..... ..........+++.+|.+.| ++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 999999999976433 22233445566777777654 3469999999998763322111
Q ss_pred ---------cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH--HHhhhccCCc
Q 045271 183 ---------NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--TWKLWCEGNA 251 (338)
Q Consensus 183 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~ 251 (338)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP-- 246 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCT--
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCC--
Confidence 01145799999999999999999999999999999999999998875433222111100 00000000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
. .+ ..+.+++.+||+.||++|||+.++++.|+......
T Consensus 247 ------~--~~------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 247 ------N--CP------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ------T--CC------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------C--CC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 01 12456788899999999999999999998866543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=285.40 Aligned_cols=232 Identities=20% Similarity=0.172 Sum_probs=170.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+.++|++++.||+|+||.||+|.. .+++.||+|.+..... +.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 5677899999999999999999995 4678899999865432 345678889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
|||||.+|+|.+.+..... ..........+++.+|.+.| ++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999888765433 22333445556777766643 2459999999998764322
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
......+||+.|+|||++.+..|+.++||||+||++|+|++|..||.............. ...........
T Consensus 168 --~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~~ 238 (444)
T 3soa_A 168 --QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-------GAYDFPSPEWD 238 (444)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCCCCTTTTT
T ss_pred --ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------CCCCCCccccc
Confidence 222346899999999999998999999999999999999999999965432221111110 00000000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ....+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~------~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 239 T------VTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T------SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c------CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 1124567888899999999999999996
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=284.72 Aligned_cols=235 Identities=24% Similarity=0.319 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++.+.||+|+||.||+|.+. ++..||||.+..... ..+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467889999999999999999965 688899999865432 345678889999999999999999999899999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++|+|.+++..... ..........+++.++.++| ++.+||+|||+++...........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 9999999999875432 22233445556777776644 456999999999865322111111
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||++.+..++.++|||||||++|||++ |..||......+...... ... .......
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~-~~~~~~~----- 339 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGG-RLPCPEL----- 339 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTC-CCCCCTT-----
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC-CCCCCCC-----
Confidence 12235678999999998899999999999999999998 999987543322111111 000 0000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+||.+||+.||++|||+.+|++.|+...
T Consensus 340 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 340 ---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1123567888999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=273.26 Aligned_cols=226 Identities=20% Similarity=0.194 Sum_probs=169.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|+.. +++.||+|.+.+. .......|..+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 358999999999999999999954 5888999998642 223466778899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++|+|..++..... ..........+++.+|.++| ++.+||+|||+++.... ....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCCc
Confidence 999999999988865432 23333444556666666544 45699999999986422 1222
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ..... +...
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-------~~~~~--~p~~----- 227 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIR--FPRT----- 227 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC--CCTT-----
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCC--CCCC-----
Confidence 345689999999999999999999999999999999999999996533221111110 00000 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+|+.+||+.||++|| ++.+|++
T Consensus 228 ---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 112456788889999999999 8999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=269.33 Aligned_cols=229 Identities=28% Similarity=0.398 Sum_probs=162.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|.+. +..||||.+..... +.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 458999999999999999999974 78899999864322 3456778899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC-----------------------------CCCeEEeeeccce
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH-----------------------------KMNPKISDFGMAR 173 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-----------------------------~~~vkL~Dfg~a~ 173 (338)
|||+++++|..++..........+....+++.++.+.| ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999987655544445555666666666543 2348999999998
Q ss_pred ecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ ........ ...
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~~ 233 (271)
T 3dtc_A 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMNK-LAL 233 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTSC-CCC
T ss_pred cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcCC-CCC
Confidence 653221 2235789999999999998999999999999999999999999965332111 00111010 000
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
.... .....+.+++.+||+.||.+|||+.++++.|+.
T Consensus 234 ~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 234 PIPS--------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCc--------ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0100 011245678888999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=275.39 Aligned_cols=230 Identities=21% Similarity=0.227 Sum_probs=168.7
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC--------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS--------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
+.++|++.+.||+|+||.||+|.. .+++.||||.+... ..+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999995 45889999998532 234567888899999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccce
Q 045271 120 LLICEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMAR 173 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~ 173 (338)
|+|||||++++|.+.+.... ...........+++.+|.+.|+ ..+||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999999987775432 1222334455567777776442 228999999998
Q ss_pred ecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... .......
T Consensus 182 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i----~~~~~~~ 251 (351)
T 3c0i_A 182 QLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI----IKGKYKM 251 (351)
T ss_dssp ECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH----HHTCCCC
T ss_pred EecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH----HcCCCCC
Confidence 764322 222345799999999999999999999999999999999999999975321 000000 0000000
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. ... ......+.+|+.+||+.||++|||+.++++
T Consensus 252 ~~-~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NP-RQW-----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CH-HHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cc-ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000 001124567888999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=266.19 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=176.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++++.||+|+||.||+|...++..||+|.+.... .+.+..|+.+++.++||||+++++++.+.+.+++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 46899999999999999999998888889999997543 3456778889999999999999999999999999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|.+++..... .....+....+++.++.+.| ++.+||+|||++........ ......
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~ 165 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGT 165 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCC
Confidence 9999999876433 22333445556666666544 45699999999987643221 112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.+|..|+|||++.+..++.++||||||+++|+|++ |..||............... . . ...+..
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------~--~-~~~~~~------- 229 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG------H--R-LYRPHL------- 229 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------C--C-CCCCTT-------
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC------C--C-CCCCCc-------
Confidence 56778999999998899999999999999999999 99998654332221111100 0 0 000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
....+.+++.+||+.||.+|||+.++++.|+....+
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 012356688889999999999999999999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=268.72 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=175.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.+.||+|+||.||+|...++..||+|.+.... .+.+.+|..+++.++||||+++++++.+.+.+++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35899999999999999999998888899999997543 3457788889999999999999999999999999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|.+++..... .....+....+++.++.+.|+ +.+||+|||++....... .......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 167 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGT 167 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccccCc
Confidence 9999999976443 222334455567777666443 458999999997653211 1112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.++..|+|||++.+..++.++||||+||++|+|++ |..||......+....... . ........
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-------~-~~~~~~~~-------- 231 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------G-FRLYKPRL-------- 231 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------T-CCCCCCTT--------
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-------C-ccCCCCCc--------
Confidence 56778999999998999999999999999999999 9999865432221111110 0 00000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
....+.+++.+||+.||++|||+.++++.|+....
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 01235668888999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.25 Aligned_cols=256 Identities=22% Similarity=0.280 Sum_probs=179.3
Q ss_pred CCChhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHh--cCCCceeeeeeEEEeC-
Q 045271 40 LFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAK--LQHKNLVRLLGCCLEG- 116 (338)
Q Consensus 40 ~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~--l~hpnIv~~~~~~~~~- 116 (338)
..+......+.++|++++.||+|+||.||+|... +..||||.+..........+.+++.. ++||||+++++++...
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3455666677789999999999999999999974 88999999976555545555555544 4899999999999887
Q ss_pred ---CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC--------------------------CeEEe
Q 045271 117 ---NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM--------------------------NPKIS 167 (338)
Q Consensus 117 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------------------~vkL~ 167 (338)
..+++||||+++|+|.+++..........+....+++.+|.+.|.. .+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999776555555556666777777776643 48999
Q ss_pred eeccceecCCCCCCc--cccccccCCccccccccccCCCCcc------cchHhHhHHHHHHHhC----------CCCCcc
Q 045271 168 DFGMARVFGGNQSEA--NTNRVVGTYGYMAPEYALEGLFSVK------SDVFSFGVLLLEIISG----------RKDTRF 229 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiWSlGv~l~el~~g----------~~Pf~~ 229 (338)
|||++..+....... ......||+.|+|||++.+..++.+ +|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764322211 1224579999999999988766554 9999999999999999 555543
Q ss_pred cccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 230 YLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.......... ................... .......+.+|+.+||+.||++|||+.+|++.|+....
T Consensus 265 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 265 LVPSDPSYED--MREIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TSCSSCCHHH--HHHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCchhh--hHHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 2222111110 0010111111111111111 11334456789999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=273.00 Aligned_cols=230 Identities=18% Similarity=0.223 Sum_probs=170.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC---------cccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS---------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
+.++|++.+.||+|+||.||+|... ++..||+|.+.... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999964 58889999986532 2346778889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------C----CeEEeeeccceec
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------M----NPKISDFGMARVF 175 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~----~vkL~Dfg~a~~~ 175 (338)
+++||||+++++|.+++..... ..........+++.+|.+.|+ + .+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999999865432 223344455567777666442 2 5899999999876
Q ss_pred CCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+........ ......
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-----~~~~~~-- 238 (326)
T 2y0a_A 169 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-----NYEFED-- 238 (326)
T ss_dssp CTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT-----CCCCCH--
T ss_pred CCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc-----CCCcCc--
Confidence 4221 223457999999999999889999999999999999999999999654322211111000 000000
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.... .....+.+|+.+||+.||++|||+.++++
T Consensus 239 -~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 239 -EYFS-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HHHT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cccc-----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 01123567888999999999999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=279.40 Aligned_cols=231 Identities=18% Similarity=0.187 Sum_probs=172.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEecc------CCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSR------SSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|++. +++.||+|++.+ .....+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999965 478899999854 2334577888999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||||++|+|..++...............+++.+|.++| ++.+||+|||+|+...... ....
T Consensus 148 ~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~ 226 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRC 226 (410)
T ss_dssp ECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEEC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccc
Confidence 99999999999987665444444455556676666644 4569999999998764221 1123
Q ss_pred cccccCCccccccccccCC----CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 185 NRVVGTYGYMAPEYALEGL----FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~----~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...........+....... . +.....
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----~--~p~~~~ 299 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-----T--FPDDND 299 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-----C--CCTTCC
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc-----c--CCCccc
Confidence 3568999999999998765 8899999999999999999999997543322211111110000 0 000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~ 294 (338)
. ...+.+|+.+||+.+|.+ ||++.||++
T Consensus 300 ~------s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 300 I------SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp C------CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred c------cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1 123566888899999988 999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=263.64 Aligned_cols=245 Identities=16% Similarity=0.149 Sum_probs=180.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..++|++.+.||+|+||.||+|.. .+++.||||.+... ....+.+|..+++.+ +|+|++++++++.+....++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 346899999999999999999995 56888999998643 345677888888888 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCCC------------------C-----eEEeeeccceecCCCCC
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHKM------------------N-----PKISDFGMARVFGGNQS 180 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~~------------------~-----vkL~Dfg~a~~~~~~~~ 180 (338)
+ +++|.+++..... ..........+++.++.+.|+. . +||+|||++........
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 9999999975433 3334455666677777765532 2 99999999987643322
Q ss_pred C-----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 181 E-----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 181 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||............................
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 246 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHH
Confidence 1 11234679999999999999999999999999999999999999997643222211111111110011111111
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.. ....+.+++.+||+.||++|||+.+|++.|+......
T Consensus 247 ~~---------~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 247 AG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp TT---------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hh---------CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00 1124567888899999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=274.72 Aligned_cols=234 Identities=18% Similarity=0.207 Sum_probs=168.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEec
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+.++|++.+.||+|+||.||+|... +++.||||.+...... ..+|..++..+ +||||+++++++.+++.+|+||||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45678999999999999999999964 5788999999765543 34555666665 899999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC----------------------CCeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|++|+|.+.+..... ..........+++.+|.+.|+ +.+||+|||++....... .
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~ 175 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--G 175 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--C
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--C
Confidence 999999988865432 233334455566666665432 138999999998764322 2
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||............... . ...... .....
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~-~~~~~~-~~~~~--- 247 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---G-SGKFSL-SGGYW--- 247 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---H-HCCCCC-CSTTT---
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---c-cCCccc-Ccccc---
Confidence 233468999999999998888999999999999999999999999753221111111111 0 011000 00000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+|+.+||+.||++|||+.++++
T Consensus 248 --~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 248 --NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001124567888999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=281.82 Aligned_cols=237 Identities=27% Similarity=0.336 Sum_probs=172.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++++.||+|+||.||+|.+. ++..||||.+..... .....|+.+++.++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999943 355799999864322 2355677889999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc--------cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeec
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--------SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFG 170 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg 170 (338)
++|||||++|+|.+++..... .....+....+++.+|.++|+ ..+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 999999999999999876432 111223455566666666432 238999999
Q ss_pred cceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
+++.+.............||+.|+|||++.+..++.++|||||||++|+|++ |..||............. . .
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~------~-~ 302 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------S-G 302 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------T-T
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------c-C
Confidence 9975432222222334568899999999999999999999999999999998 999987543222111111 0 0
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
...... . .....+.+|+.+||+.||.+|||+.+|++.|+.....
T Consensus 303 ~~~~~~-~--------~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRMDPP-K--------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCCCC-T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCC-c--------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 000000 0 0112356788899999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=278.93 Aligned_cols=230 Identities=18% Similarity=0.199 Sum_probs=171.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
+.++|++++.||+|+||.||+|... +++.||+|.+..... ..+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4578999999999999999999954 578899999865432 346678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC--------------------CCCeEEeeeccceecCCCCCCc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH--------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~--------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|+.+|+|.+++..... ..........+++.+|.++| .+.+||+|||++...... .
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---E 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---S
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC---c
Confidence 9999999998875432 22334445556777766643 245999999999876422 2
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+...... . ...... .....
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~--~~~~~~---~~~~~-- 275 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK---R--CDWEFD---EDAFS-- 275 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H--CCCCCC---SSTTT--
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH---h--CCCCCC---ccccc--
Confidence 2234579999999999999999999999999999999999999997543211111110 0 000000 00000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+|+.+||+.||.+|||+.++++
T Consensus 276 ---~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 276 ---SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 01124567888999999999999999996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=281.87 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=174.9
Q ss_pred ChhHHHHHhcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeee
Q 045271 42 PLDLIHEATRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLL 110 (338)
Q Consensus 42 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~ 110 (338)
.........++|++++.||+|+||.||+|.+ .+++.||||.+..... ..+..|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444555678999999999999999999983 2346799999975433 2356777888888 789999999
Q ss_pred eEEEeCC-EEEEEEecCCCCCHHHHHhccCc-------------------------------------------------
Q 045271 111 GCCLEGN-ELLLICEYMPNKSLDFLLFDSTR------------------------------------------------- 140 (338)
Q Consensus 111 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------- 140 (338)
+++.+.+ .+++|||||++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 58999999999999999876432
Q ss_pred ------------------cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 141 ------------------SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 141 ------------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
.....+....+++.+|.+.|+ +.+||+|||++............
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 111123344566777766543 45899999999876433333333
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....||+.|+|||++.+..++.++|||||||++|+|++ |..||............ . . ..........
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--~-~---~~~~~~~~~~------ 320 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--L-K---EGTRMRAPDY------ 320 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH--H-H---HTCCCCCCTT------
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH--H-H---cCCCCCCCCC------
Confidence 44578899999999999999999999999999999998 99998754322211100 0 0 0000000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+++.+||+.||.+|||+.+++++|+...
T Consensus 321 ---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 321 ---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1123567888899999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.69 Aligned_cols=240 Identities=26% Similarity=0.350 Sum_probs=174.8
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~ 117 (338)
...++|++++.||+|+||.||+|... ++..||||.+..... ..+.+|+.+++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999964 247799999875432 34567888999999999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccC-------------------------ccccccHHHHHHHHHHhhhcCC-----------
Q 045271 118 ELLLICEYMPNKSLDFLLFDST-------------------------RSVQLDWNRRMCIINGIARDHK----------- 161 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~-------------------------~~~~~~~~~~~~~~~~i~~~~~----------- 161 (338)
.+++||||+++|+|.+++.... ......+....+++.++.+.|+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 9999999999999999987632 1112233455567777776543
Q ss_pred -------CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccc
Q 045271 162 -------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYE 233 (338)
Q Consensus 162 -------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~ 233 (338)
+.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 4589999999986533222222234567889999999998899999999999999999999 99998754322
Q ss_pred cccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 234 QGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
+..... .......... .....+.+++.+||+.||.+|||+.++++.|+......
T Consensus 284 ~~~~~~-------~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 284 EVIYYV-------RDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHH-------HTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHHHH-------hCCCcCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 211110 0111111110 01124567888999999999999999999999877543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.52 Aligned_cols=233 Identities=19% Similarity=0.262 Sum_probs=165.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++++.||+|+||.||+|+.. +++.||+|++.+.. ......|..+++.+ +||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999965 46789999986532 23356677777665 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||||++|+|..++..... ..........+++.+|.++| ++.+||+|||+|+.... ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~~ 208 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGD 208 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--CCC
Confidence 9999999999988875432 33333444556666666543 45699999999985321 222
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccc--hhhHHHhhhccCCcccccCcccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS--LLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......... ............... +...
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~-- 284 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRS-- 284 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--CCTT--
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--CCCc--
Confidence 3445789999999999999999999999999999999999999996432211100 000010111011100 0010
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTM------SSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~vl~ 294 (338)
....+.+|+.+||+.||.+||++ .||++
T Consensus 285 ------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 285 ------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ------SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ------CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 11245678889999999999996 56664
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=267.49 Aligned_cols=256 Identities=23% Similarity=0.256 Sum_probs=186.3
Q ss_pred CCCChhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHh--cCCCceeeeeeEEEeC
Q 045271 39 PLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAK--LQHKNLVRLLGCCLEG 116 (338)
Q Consensus 39 ~~~~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~--l~hpnIv~~~~~~~~~ 116 (338)
...+......+.++|++.+.||+|+||.||+|.. +++.||||.+..........+.++++. ++||||+++++++...
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3456677778889999999999999999999998 588999999976665666677777776 7899999999999876
Q ss_pred C----EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC--------C------------------CCeEE
Q 045271 117 N----ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH--------K------------------MNPKI 166 (338)
Q Consensus 117 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~--------~------------------~~vkL 166 (338)
+ .+++||||+++|+|.+++..........+....+++.++.+.| + +.+||
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 5 7999999999999999997765555555666777888877776 2 35899
Q ss_pred eeeccceecCCCCCCc--cccccccCCccccccccccC------CCCcccchHhHhHHHHHHHhC----------CCCCc
Q 045271 167 SDFGMARVFGGNQSEA--NTNRVVGTYGYMAPEYALEG------LFSVKSDVFSFGVLLLEIISG----------RKDTR 228 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiWSlGv~l~el~~g----------~~Pf~ 228 (338)
+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999998764322111 12345799999999999876 334789999999999999999 66775
Q ss_pred ccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 229 FYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
........... .. ...........+.... ........+.+++.+||+.||++|||+.+|++.|+...
T Consensus 269 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 269 DLVPSDPSVEE-MR-KVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTSCSSCCHHH-HH-HHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCcCcccHHH-HH-HHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 43322211111 01 1111111111111110 11233445677899999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=277.60 Aligned_cols=240 Identities=26% Similarity=0.298 Sum_probs=176.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc--------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN--------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCL 114 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~ 114 (338)
...++|++.+.||+|+||.||+|... .+..||||.+..... ..+.+|+.+++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34568999999999999999999952 224699999975433 3356677888888 8999999999999
Q ss_pred eCCEEEEEEecCCCCCHHHHHhccC-----------------ccccccHHHHHHHHHHhhhcC-----------------
Q 045271 115 EGNELLLICEYMPNKSLDFLLFDST-----------------RSVQLDWNRRMCIINGIARDH----------------- 160 (338)
Q Consensus 115 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~~~~~~i~~~~----------------- 160 (338)
+++.+++||||+++|+|.+++.... ...........+++.+|.++|
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 9999999999999999999997643 122233445556777766644
Q ss_pred -CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccch
Q 045271 161 -KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSL 238 (338)
Q Consensus 161 -~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~ 238 (338)
++.+||+|||++................+|..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 45699999999987644332233334567889999999999999999999999999999999 9999875433221111
Q ss_pred hhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 239 LTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.. ........ . . ....+.+|+.+||+.||++|||+.+|++.|+......
T Consensus 306 ~~-------~~~~~~~~-~--~------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 306 LK-------EGHRMDKP-S--N------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HH-------TTCCCCCC-S--S------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HH-------cCCCCCCC-c--c------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11 00000000 0 0 1124566888899999999999999999998876443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=273.43 Aligned_cols=237 Identities=25% Similarity=0.306 Sum_probs=170.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++.+.||+|+||.||+|.+. .+..||||.+..... ..+.+|+.+++.++||||+++++++.+++.+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457999999999999999999964 234599999975432 345667889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++|+|.+++..... ..........+++.+|.+.| ++.+||+|||++.........
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 9999999999999865432 22233444555666666544 456999999999876432211
Q ss_pred c-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 A-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
. ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.............. ..... ...
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------~~~~~--~~~-- 277 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE------GYRLP--APM-- 277 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT------TCCCC--CCT--
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------CCCCC--CCC--
Confidence 1 1222356778999999998899999999999999999999 9999865433221111110 00000 000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+|+.+||+.||.+|||+.+|++.|+.....
T Consensus 278 ------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 278 ------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0112456688889999999999999999999986543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=270.09 Aligned_cols=228 Identities=21% Similarity=0.221 Sum_probs=163.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----------------------------cccHHHHHHHHH
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----------------------------GQGLQEFKNLIA 99 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------------------------~~~~~~~~~~l~ 99 (338)
.++|++.+.||+|+||.||+|.. .++..||||.+.... .+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999995 457789999986432 134667888999
Q ss_pred hcCCCceeeeeeEEEe--CCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC-----------------
Q 045271 100 KLQHKNLVRLLGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH----------------- 160 (338)
Q Consensus 100 ~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~----------------- 160 (338)
.++||||+++++++.+ .+.+++||||+++++|..++...............+++.+|.+.|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999986 578999999999999987665444343444555566777766644
Q ss_pred -CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCC---CCcccchHhHhHHHHHHHhCCCCCccccccccc
Q 045271 161 -KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL---FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236 (338)
Q Consensus 161 -~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~ 236 (338)
++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp TTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 4569999999998764322 2223457999999999998764 478899999999999999999999653221110
Q ss_pred chhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ... ...... ..... ....+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~------~~~-~~~~~~--~~~~~------~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 250 S------KIK-SQALEF--PDQPD------IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H------HHH-HCCCCC--CSSSC------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H------HHh-cccCCC--CCccc------cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 0 000 000000 00000 1123566888899999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=271.37 Aligned_cols=236 Identities=28% Similarity=0.365 Sum_probs=174.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++.+.||+|+||.||+|... ++..||||.+..... ..+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 568999999999999999999852 346799999865432 3456678889999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc-------------------------cccccHHHHHHHHHHhhhcC--------------
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-------------------------SVQLDWNRRMCIINGIARDH-------------- 160 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~i~~~~-------------- 160 (338)
++||||+++++|.+++..... .....+....+++.+|.+.|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 999999999999999876432 11223345556777766644
Q ss_pred ----CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccc
Q 045271 161 ----KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQG 235 (338)
Q Consensus 161 ----~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~ 235 (338)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 34599999999987644333222334467888999999999899999999999999999999 9999875433221
Q ss_pred cchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 236 QSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
..... ......... .....+.+++.+||+.||++|||+.++++.|+....
T Consensus 262 ~~~~~-------~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 FNLLK-------TGHRMERPD---------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHH-------TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhh-------cCCcCCCCc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 000000000 011245678888999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=266.62 Aligned_cols=234 Identities=23% Similarity=0.319 Sum_probs=171.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++++.||+|+||.||+|.+.++..||+|.+.... .+.+.+|..+++.++||||+++++++.+.+.+++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 55899999999999999999998888899999997543 3456778889999999999999999999999999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|.+++..... .....+....+++.++.+.| ++.+||+|||++....... .......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 181 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGS 181 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTST
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCC
Confidence 9999999876322 22333445556666666544 3569999999997653211 1112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.+|+.|+|||++.+..++.++|||||||++|+|++ |..||............... .........
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~------- 246 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRLYRPHLA------- 246 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--------CCCCCCTTC-------
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc--------cCCCCCCcC-------
Confidence 56778999999998899999999999999999998 99998754332221111100 000000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...+.+++.+||+.||.+|||+.++++.|+...
T Consensus 247 -~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 247 -SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 123566888899999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=273.32 Aligned_cols=256 Identities=23% Similarity=0.229 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHH--HhcCCCceeeeeeEEEe-----CCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI--AKLQHKNLVRLLGCCLE-----GNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l--~~l~hpnIv~~~~~~~~-----~~~~~lv 122 (338)
.++|++++.||+|+||.||+|.. ++..||||++..........+..++ +.++||||+++++.+.. ...+++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 46899999999999999999987 6789999999765555444454443 35899999999986543 3367999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC---------------------------CeEEeeeccceec
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM---------------------------NPKISDFGMARVF 175 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~---------------------------~vkL~Dfg~a~~~ 175 (338)
||||++|+|.+++...............+++.+|.++|.. .+||+|||++..+
T Consensus 91 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence 9999999999999776655444555666788888777644 4899999999876
Q ss_pred CCCCC------CccccccccCCcccccccccc-------CCCCcccchHhHhHHHHHHHhCCCCCccccccccc-chhhH
Q 045271 176 GGNQS------EANTNRVVGTYGYMAPEYALE-------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ-SLLTY 241 (338)
Q Consensus 176 ~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~-~~~~~ 241 (338)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 43211 111223579999999999987 35678999999999999999998776543221111 11000
Q ss_pred H----------HhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccCCCCC
Q 045271 242 T----------WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQ 308 (338)
Q Consensus 242 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~~~~~ 308 (338)
. ............+.... .........+.+||.+||+.||++|||+.|+++.|+.......++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred ccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 0 00000000000111111 11122334577889999999999999999999999987766555433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=274.86 Aligned_cols=231 Identities=22% Similarity=0.233 Sum_probs=161.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.++|++++.||+|+||.||+|... +++.||||.+.... .....+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 468999999999999999999965 68889999997543 345678888999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------C--CeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------M--NPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~--~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++|+|..++..... ..........+++.+|.+.|+ + .+||+|||+++... ......
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~---~~~~~~ 175 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPK 175 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---ccCCCC
Confidence 99999988865432 333445556667777766442 2 39999999997532 122223
Q ss_pred ccccCCccccccccccCCCCcc-cchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVK-SDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~-~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
..+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.............. ... .... .+......
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--~~~-~~~~--~~~~~~~~--- 247 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ--RIL-SVKY--SIPDDIRI--- 247 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH--HHH-TTCC--CCCTTSCC---
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH--HHh-cCCC--CCCCcCCC---
Confidence 4579999999999988887655 8999999999999999999975433222111111 100 0000 00010011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+|+.+||+.||++|||+.|+++
T Consensus 248 ---s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 248 ---SPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ---CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 124567888999999999999999995
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=274.15 Aligned_cols=232 Identities=18% Similarity=0.142 Sum_probs=159.5
Q ss_pred HhcCCCCC-ceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHH-HhcCCCceeeeeeEEEe----CCEEEE
Q 045271 49 ATRNFSNE-NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLI-AKLQHKNLVRLLGCCLE----GNELLL 121 (338)
Q Consensus 49 ~~~~y~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l-~~l~hpnIv~~~~~~~~----~~~~~l 121 (338)
..++|.+. +.||+|+||.||+|... ++..||||.+... ....+|+.++ +..+||||+++++++.. .+.+|+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45677776 68999999999999954 5788999998643 3455566554 56789999999999876 567899
Q ss_pred EEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCC
Q 045271 122 ICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGG 177 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~ 177 (338)
|||||++|+|.+++.... ........+..+++.+|.++| ++.+||+|||+++....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999999997643 223334445556777766644 45699999999987532
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||................. ...... ...
T Consensus 217 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~~~-~~~ 289 (400)
T 1nxk_A 217 ---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEF-PNP 289 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCCCC-CTT
T ss_pred ---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCcccC-CCc
Confidence 2223356899999999999988999999999999999999999999975433221111100000 000000 000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. . .....+.+||.+||+.||++|||+.++++
T Consensus 290 ~~--~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 290 EW--S---EVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TT--T---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc--c---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 01124567889999999999999999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=271.11 Aligned_cols=236 Identities=20% Similarity=0.195 Sum_probs=152.0
Q ss_pred cCCCC---CceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSN---ENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~---~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++ .+.||+|+||.||+|... +++.||||.+.........+|+.+++.+. ||||+++++++.+.+..|+||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 34555 378999999999999964 58889999998766667778888888887 99999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------C---CeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------M---NPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~---~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+++|+|.+++..... ..........+++.++.++|+ + .+||+|||++...... ...
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 165 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQP 165 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCc
Confidence 999999998876532 333344555667777776442 1 5899999999865322 222
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......................... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 3345789999999999999999999999999999999999999975432211111111111111111000 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0011234667888999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=270.81 Aligned_cols=231 Identities=19% Similarity=0.253 Sum_probs=171.0
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|.+ .++..||||.+... ....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999995 56889999998532 224567888899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+ +|+|.+++.... ...........+++.++.+.| ++.+||+|||++..... ...
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~~~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNF 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---SBT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---Ccc
Confidence 9999 678877765433 233334455556777666643 45699999999986532 222
Q ss_pred ccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.............. ....+...
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~---------~~~~~p~~---- 230 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS---------CVYVMPDF---- 230 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS---------SCCCCCTT----
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---------CCCCCccc----
Confidence 345689999999999998876 6899999999999999999999975433222111100 00000000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDTI 301 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~~ 301 (338)
....+.+|+.+||+.||.+|||+.|+++ ++....+
T Consensus 231 ----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 231 ----LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 1123567888999999999999999985 5655433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=263.66 Aligned_cols=227 Identities=22% Similarity=0.271 Sum_probs=170.1
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
|+..+.||+|+||.||+|... +++.||||.+..... +.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 777789999999999999965 688999999865433 3456778889999999999999999999999999999999
Q ss_pred CCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccccC
Q 045271 129 KSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVVGT 190 (338)
Q Consensus 129 g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt 190 (338)
++|.+++...............+++.++.+.| ++.+||+|||++....... .......||
T Consensus 127 ~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt 204 (321)
T 2c30_A 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGT 204 (321)
T ss_dssp CBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSC
T ss_pred CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCC
Confidence 99999987655444445556666777666644 4569999999998764321 222346899
Q ss_pred CccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHH
Q 045271 191 YGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLK 270 (338)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (338)
+.|+|||++.+..++.++|||||||++|+|++|..||............ . ..... .+.... .....
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~------~-~~~~~-----~~~~~~--~~~~~ 270 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------R-DSPPP-----KLKNSH--KVSPV 270 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HSSCC-----CCTTGG--GSCHH
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h-cCCCC-----CcCccc--cCCHH
Confidence 9999999999999999999999999999999999999653321111100 0 00000 000000 01123
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 271 RIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 271 ~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
+.+++.+||+.||++|||+.++++.
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 5668888999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=273.19 Aligned_cols=232 Identities=21% Similarity=0.243 Sum_probs=157.8
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+.++|++.+.||+|+||.||+|... +++.||||.+.... .+.+..|+.+++.++||||+++++++.+.+.+++||||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 35678999999999999999999965 47789999987543 34566788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+++++|.+++..... ..........+++.++.+.| ++.+||+|||++..... ...
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~~ 206 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVL 206 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc---ccc
Confidence 999999988865433 22333445556666666533 45699999999986532 122
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. ......... .......
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----~~i~~~~~~-~~~~~~~--- 276 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF----RRILNCEYY-FISPWWD--- 276 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH----HHHHTTCCC-CCTTTTT---
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH----HHHHhCCCc-cCCchhh---
Confidence 2346799999999999998999999999999999999999999864332111 00 000011000 0000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+|+.+||+.||++|||+.++++
T Consensus 277 --~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 277 --EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01124567888999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=270.66 Aligned_cols=236 Identities=24% Similarity=0.315 Sum_probs=168.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcE----EEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKE----IAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~----vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|++++.||+|+||.||+|.+. ++.. ||+|.+.... .....++..+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 358999999999999999999954 3443 7888774332 234567778899999999999999986 45689
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
+||||+.+|+|.+++..... ..........+++.+|.+.| ++.+||+|||+++.......
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 99999999999999876532 33334445566777777644 35699999999987654333
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........|+..|+|||++.+..++.++|||||||++|+|++ |..||................ ........
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~---- 242 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----RLAQPQIC---- 242 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----BCCCCTTB----
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----CCCCCCcC----
Confidence 333344578889999999998999999999999999999999 999997543322211111100 00000001
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
+ ..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 243 --~------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 243 --T------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --C------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --c------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1234577889999999999999999999887643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=270.63 Aligned_cols=238 Identities=25% Similarity=0.333 Sum_probs=174.7
Q ss_pred HhcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~ 117 (338)
..++|++.+.||+|+||.||+|.. .++..||||.+..... +.+.+|..+++.+ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356899999999999999999984 2356799999975432 3456777888999 9999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-------------------cccccHHHHHHHHHHhhhcC------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-------------------SVQLDWNRRMCIINGIARDH------------------ 160 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~~~i~~~~------------------ 160 (338)
..++||||+++|+|.+++..... .....+....+++.+|.+.|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 99999999999999999876532 22223445556677766644
Q ss_pred CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchh
Q 045271 161 KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLL 239 (338)
Q Consensus 161 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~ 239 (338)
++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......... .
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~ 258 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--Y 258 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--H
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH--H
Confidence 34589999999987643332222334567889999999999999999999999999999999 99998754322111 1
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
....... ...... .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 259 ~~~~~~~-----~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 KMIKEGF-----RMLSPE--------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHTC-----CCCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCC-----CCCCcc--------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1010000 000000 011245678889999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.02 Aligned_cols=229 Identities=26% Similarity=0.402 Sum_probs=166.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----------ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... +.+.+|..+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999995 4688899999854322 34567788899999999999999997655
Q ss_pred EEEEEecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCCCC-------------------------eEEeeecc
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHKMN-------------------------PKISDFGM 171 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~~~-------------------------vkL~Dfg~ 171 (338)
++||||+++|+|.+.+...... ....+....+++.++.+.|+.+ +||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6999999999998888655432 2233445556777776655433 89999999
Q ss_pred ceecCCCCCCccccccccCCccccccccc--cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYAL--EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
+.... .......||+.|+|||++. ...++.++|||||||++|+|++|..||............... . .
T Consensus 176 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~----~ 245 (287)
T 4f0f_A 176 SQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR-E----E 245 (287)
T ss_dssp CBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH-H----S
T ss_pred ccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh-c----c
Confidence 97542 1233467999999999984 456889999999999999999999999754322211111100 0 0
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
......... ....+.+++.+||+.||.+|||+.++++.|+.
T Consensus 246 ~~~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 GLRPTIPED--------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCCcc--------cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 001001110 11245678888999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=275.06 Aligned_cols=177 Identities=24% Similarity=0.285 Sum_probs=142.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHhcC-----CCceeeeeeEEEeCCEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQ-----HKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~-----hpnIv~~~~~~~~~~~~ 119 (338)
.+.++|+++++||+|+||.||+|.. .+++.||||.+.... ......|..+++.+. ||||+++++++...+.+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 4467999999999999999999996 457889999986432 234556777888876 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------------------------
Q 045271 120 LLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------------------------ 160 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------------------------ 160 (338)
++||||+ +++|.+++..... ..........+++.+|.++|
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999 9999998876542 22233445556666666533
Q ss_pred -------CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 161 -------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 161 -------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 45689999999987532 123457899999999999999999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=273.02 Aligned_cols=244 Identities=25% Similarity=0.291 Sum_probs=168.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~ 119 (338)
.++|++++.||+|+||.||+|++ .++..||||.+..... ..+.+|+.+++.++||||+++++++.. ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 2577899999875543 345678889999999999999999864 3568
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++|+|.+++..... ..........+++.++.+.| ++.+||+|||++.......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 999999999999999876543 22233445556777766654 3459999999998764322
Q ss_pred CC-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccc-------cc-hhh-HHHhhhccC
Q 045271 180 SE-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG-------QS-LLT-YTWKLWCEG 249 (338)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~-------~~-~~~-~~~~~~~~~ 249 (338)
.. .......++..|+|||++.+..++.++|||||||++|+|++|..||........ .. ... .........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 11 112234567789999999999999999999999999999999998864321100 00 000 000000000
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.... . .......+.+++.+||+.||++|||+.++++.|+.....
T Consensus 249 ~~~~-~--------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 249 GRLP-R--------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CCCC-C--------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCC-C--------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000 0 001113456788899999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=272.44 Aligned_cols=248 Identities=17% Similarity=0.128 Sum_probs=173.6
Q ss_pred ChhHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--------cccHHHHHHHHHhcCCCceeeeeeE
Q 045271 42 PLDLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--------GQGLQEFKNLIAKLQHKNLVRLLGC 112 (338)
Q Consensus 42 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~~l~~l~hpnIv~~~~~ 112 (338)
+...+..+.++|++.+.||+|+||.||+|.. .++..||+|.+.... .+.+..|+.+++.++||||++++++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 3445667788999999999999999999995 457789999985431 2346678889999999999999999
Q ss_pred EEeCCEEEEEEecCCCCCHHHHHhccCc-----------------------------------------cccccHHHHHH
Q 045271 113 CLEGNELLLICEYMPNKSLDFLLFDSTR-----------------------------------------SVQLDWNRRMC 151 (338)
Q Consensus 113 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------~~~~~~~~~~~ 151 (338)
+.+.+.+++|||||++|+|.+++..... .....+....+
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 9999999999999999999998852110 01112234456
Q ss_pred HHHHhhhcC------------------CC--CeEEeeeccceecCCCCCCc--cccccccCCcccccccccc--CCCCcc
Q 045271 152 IINGIARDH------------------KM--NPKISDFGMARVFGGNQSEA--NTNRVVGTYGYMAPEYALE--GLFSVK 207 (338)
Q Consensus 152 ~~~~i~~~~------------------~~--~vkL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~ 207 (338)
++.++.++| ++ .+||+|||++..+....... ......||+.|+|||++.+ ..++.+
T Consensus 177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 666666643 22 69999999998763222111 2234579999999999975 578999
Q ss_pred cchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCC
Q 045271 208 SDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRP 287 (338)
Q Consensus 208 ~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp 287 (338)
+|||||||++|+|++|..||......+...... ... ... ..... ......+.+|+.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~------~~~-~~~-~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL------NKK-LCF-ENPNY-----NVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-CCT-TSGGG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH------hcc-ccc-CCccc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999997543222111110 000 000 00000 00112456788899999999999
Q ss_pred CHHHHHH--HhhcCccc
Q 045271 288 TMSSVVF--MLATDTIT 302 (338)
Q Consensus 288 s~~~vl~--~L~~~~~~ 302 (338)
|+.++++ +++.....
T Consensus 324 s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 324 DAMRALQHPWISQFSDK 340 (345)
T ss_dssp CHHHHHHSHHHHTTSSC
T ss_pred CHHHHhcChhhccChHh
Confidence 9999986 56654433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=267.12 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=169.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
+.++|++++.||+|+||.||+|.. .++..||+|.+..... +.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 356899999999999999999995 4578899999854322 235567778899999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||||+++++|.+++..... ..........+++.++.+.| ++.+||+|||++....... ..
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LT 167 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-cc
Confidence 9999999999999876432 33334445556666666544 4569999999997653221 11
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... ...... ....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~~~~~~-~~~~-- 237 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-SVPNVT-TDVR-- 237 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-CCCCHH-HHSC--
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-cCCCcc-hhcc--
Confidence 223457999999999999999999999999999999999999999753321110 000000 000000 0000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCccc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRP-TMSSVVFMLATDTIT 302 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~vl~~L~~~~~~ 302 (338)
......+.+++.+||+.||.+|| ++.++.+.|+.....
T Consensus 238 --~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 238 --KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred --cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00112356688889999999999 899999999886544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=283.57 Aligned_cols=238 Identities=27% Similarity=0.340 Sum_probs=176.0
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
....++|++.+.||+|+||.||+|.+..+..||||.++... .+.+.+|+.+++.++||||+++++++. .+.+++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 34456889999999999999999998888899999997543 345677888999999999999999986 567899999
Q ss_pred cCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 125 YMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|+++|+|.+++.... ...........+++.+|.++| ++.+||+|||+++...... ...
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~ 341 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 341 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eec
Confidence 999999999997542 222233445566777777654 3469999999998653211 111
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....++..|+|||++....++.++|||||||++|||++ |..||......+........ .... ...
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------~~~~--~~~----- 408 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG------YRMP--RPE----- 408 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT------CCCC--CCT-----
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------CCCC--CCC-----
Confidence 122356778999999998899999999999999999999 99999754332221111110 0000 000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+||.+||+.||++|||+.+|++.|+.....
T Consensus 409 ---~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 409 ---NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0112456788899999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=280.40 Aligned_cols=229 Identities=26% Similarity=0.302 Sum_probs=171.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeCC-EEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN-ELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~ 127 (338)
.++|++.+.||+|+||.||+|.+. +..||||.++... .+.+.+|+.+++.++||||+++++++...+ .+++||||++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 467889999999999999999974 6789999997543 345778889999999999999999987655 7999999999
Q ss_pred CCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+|+|.+++..... ..........+++.++.++| ++.+||+|||+++..... ...
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~ 345 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 345 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccC
Confidence 9999999976543 22233445566777777644 346999999999864211 122
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||++.+..++.++|||||||++|||++ |..||......+.......+ .. .. ...
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------~~-~~-~p~-------- 409 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------YK-MD-APD-------- 409 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT------CC-CC-CCT--------
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------CC-CC-CCC--------
Confidence 357889999999999999999999999999999998 99999754432221111100 00 00 000
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.++|.+||+.||++|||+.++++.|+...
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01124567888999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=265.80 Aligned_cols=223 Identities=20% Similarity=0.245 Sum_probs=169.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|... +++.||+|.+.+. ..+...+|..+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 458999999999999999999964 6889999998643 224456778889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++|+|..++..... ..........+++.+|.++| ++.+||+|||++..... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----c
Confidence 999999999999876433 22333445556777776654 35699999999987532 2
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .. .... +...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~-~~~~--~p~~----- 225 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LN-AELR--FPPF----- 225 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-CCCC--CCTT-----
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CCCC--CCCC-----
Confidence 23468999999999999999999999999999999999999999653321111111 00 0000 0010
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+++.+||+.||.+|| ++.++++
T Consensus 226 ---~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 012456788889999999999 8999984
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=274.16 Aligned_cols=227 Identities=22% Similarity=0.246 Sum_probs=163.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~ 120 (338)
..++|++++.||+|+||.||+|+.. +++.||||++.+. .......|..+++.+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999954 5788999998643 223355667778776 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+|||||++|+|..++..... ..........+++.+|.++| ++.+||+|||+|+.... ..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~ 178 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NG 178 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--CC
Confidence 99999999999988865433 33333445556666666544 45699999999975421 12
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+....+.. .... +...
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~~~~--~p~~--- 246 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------DEVV--YPTW--- 246 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCC--CCTT---
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCCC--CCCC---
Confidence 223456899999999999988899999999999999999999999975433222111110 0000 0110
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTM------SSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~vl~ 294 (338)
....+.+|+.+||+.||.+||++ .++++
T Consensus 247 -----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 -----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11235678889999999999999 78875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=273.99 Aligned_cols=239 Identities=25% Similarity=0.297 Sum_probs=173.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCC----cccHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSS----GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~ 117 (338)
..++|++.+.||+|+||.||+|... ++..||||.+.... ...+..|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3568999999999999999999952 34579999986432 24467788899999 8999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc------------------------ccccHHHHHHHHHHhhhcC-------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS------------------------VQLDWNRRMCIINGIARDH------------- 160 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~i~~~~------------- 160 (338)
.+++||||+++|+|.+++...... ....+....+++.+|.++|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 999999999999999999765321 1122345556777766654
Q ss_pred -----CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCccccccc
Q 045271 161 -----KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQ 234 (338)
Q Consensus 161 -----~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~ 234 (338)
++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 34589999999987643322222334567889999999999999999999999999999998 999987543221
Q ss_pred ccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 235 GQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
... .... ... ...... .....+.+|+.+||+.||.+|||+.++++.|+.....
T Consensus 283 ~~~--~~~~----~~~-~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 283 NFY--KLIQ----NGF-KMDQPF--------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHH--HHHH----TTC-CCCCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHH--HHHh----cCC-CCCCCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111 0000 000 000000 0112456688889999999999999999999886543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.48 Aligned_cols=239 Identities=19% Similarity=0.249 Sum_probs=162.2
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++++.||+|+||.||+|... +++.||||.+..... ....+|+.+++.++||||+++++++.+++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 58999999999999999999964 578899999864432 335567888999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++ ++...+.... ...........+++.++.+.| ++.+||+|||++....... ...
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccc
Confidence 9965 5544443322 222333445556777766644 4569999999998764222 222
Q ss_pred cccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc------ccccC-
Q 045271 185 NRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA------QELMD- 256 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~- 256 (338)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .............. ....+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcccccc
Confidence 3457899999999998776 89999999999999999999888643221111 01100000000000 00000
Q ss_pred --------ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 --------PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 --------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..............+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000000111234567888999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=273.46 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=175.7
Q ss_pred hcCC-CCCceecccCCeeEEEEEEc-----CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe--CC
Q 045271 50 TRNF-SNENKLGEGGFGPVYKGVLN-----DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GN 117 (338)
Q Consensus 50 ~~~y-~~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~ 117 (338)
.++| ++++.||+|+||.||++.+. +++.||||.+..... ..+.+|+.+++.++||||+++++++.+ ..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3355 99999999999999988642 567899999976532 335678889999999999999999987 46
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
.+++||||+++|+|.+++..........+....+++.+|.+.| ++.+||+|||++.......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 8999999999999999998766555555556666777766644 3469999999998764322
Q ss_pred CC-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc------chhh--HHHhhhccCC
Q 045271 180 SE-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ------SLLT--YTWKLWCEGN 250 (338)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~------~~~~--~~~~~~~~~~ 250 (338)
.. .......++..|+|||++.+..++.++|||||||++|+|++|..||......... .... ..........
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 21 1123346788899999999989999999999999999999999998643211000 0000 0000000000
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
.. .........+.+|+.+||+.||++|||+.++++.|+.......
T Consensus 269 -~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 269 -RL--------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp -CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CC--------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 00 0000111345678889999999999999999999998765543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=268.48 Aligned_cols=242 Identities=24% Similarity=0.272 Sum_probs=153.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|+||.||+|.. .++..||+|.+..... ....+|+.+++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999994 4588899999864332 346678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC-------ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 125 YMPNKSLDFLLFDST-------RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
|++ |+|.+++.... ...........+++.+|.+.| ++.+||+|||++.......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 996 68888876432 112222334446777766644 4569999999998764221
Q ss_pred CCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc------c
Q 045271 180 SEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA------Q 252 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~ 252 (338)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+............ .
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 163 --NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp --CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred --ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 122345789999999999874 6899999999999999999999999754332221111100000000000 0
Q ss_pred c---ccCc--------cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 E---LMDP--------VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~---~~~~--------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. .+.. .+...........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000 0000000001124678899999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=272.37 Aligned_cols=229 Identities=21% Similarity=0.242 Sum_probs=167.3
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~ 118 (338)
....++|++++.||+|+||.||+|+.. +++.||||.+.+. .......|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345679999999999999999999964 5788999998643 223355566677665 99999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
+|+||||+++|+|..++.... ...........+++.+|.++| ++.+||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-
Confidence 999999999999999887533 233334445556666666544 456999999999864221
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+.. .... +...
T Consensus 172 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-----~~~~----~p~~- 240 (345)
T 1xjd_A 172 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPF----YPRW- 240 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----CCCC----CCTT-
T ss_pred -CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-----CCCC----CCcc-
Confidence 2223457899999999999999999999999999999999999999975432221111110 0000 1111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMS-SVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~vl~ 294 (338)
....+.+|+.+||+.||++||++. +|++
T Consensus 241 -------~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 241 -------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -------SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112456788899999999999997 7763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=270.75 Aligned_cols=238 Identities=23% Similarity=0.309 Sum_probs=157.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-Cc---EEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEE-
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DK---EIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL- 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~---~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~- 119 (338)
.++|++++.||+|+||.||+|.... +. .||||.+.... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4589999999999999999999544 32 79999986532 23456777889999999999999999876654
Q ss_pred -----EEEEecCCCCCHHHHHhccC-------ccccccHHHHHHHHHHhhhcC------------------CCCeEEeee
Q 045271 120 -----LLICEYMPNKSLDFLLFDST-------RSVQLDWNRRMCIINGIARDH------------------KMNPKISDF 169 (338)
Q Consensus 120 -----~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Df 169 (338)
++||||+.+|+|.+++.... ......+....+++.++.+.| ++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999886432 222233445556777766644 356999999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
|++................+++.|+|||++.+..++.++|||||||++|+|++ |..||............. .
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~ 254 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-------G 254 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------T
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-------c
Confidence 99987643322222233456788999999999999999999999999999999 899987543322111110 0
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
........ .....+.+|+.+||+.||++|||+.++++.|+......
T Consensus 255 ~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 255 GNRLKQPP---------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TCCCCCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCCCC---------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000 01124567888999999999999999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=284.85 Aligned_cols=236 Identities=28% Similarity=0.366 Sum_probs=175.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..++|++.+.||+|+||.||+|.+.. +..||||.+.... .+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 34578889999999999999999654 7789999997543 34567788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++|+|.+++..... .....+....+++.+|.++|+ +.+||+|||+++...... ....
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~ 376 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 376 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeec
Confidence 999999999975332 222233445567777776553 458999999998764321 1112
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||++.+..++.++|||||||++|||++ |..||......+...... ... .. . ..
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~---~~-~-~~------- 441 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDY---RM-E-RP------- 441 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTC---CC-C-CC-------
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC---CC-C-CC-------
Confidence 23456778999999999999999999999999999999 999987543322111111 000 00 0 00
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
......+.+||.+||+.||++|||+.+|++.|+....
T Consensus 442 -~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0011245678889999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=264.33 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=163.6
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++++.||+|+||.||+|...+++.||+|++..... ....+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999987799999999864332 3456788889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++ ++|..++..... ..........+++.++.+.| ++.+||+|||++....... ....
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 158 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYT 158 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccc
Confidence 96 588888765432 22233445556777766644 4569999999998653211 1223
Q ss_pred ccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc---ccc--cCccc
Q 045271 186 RVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA---QEL--MDPVL 259 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~ 259 (338)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||......+................. ... .+...
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 35789999999999765 5899999999999999999999999754322211111100000000000 000 00000
Q ss_pred c-------ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 K-------ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~-------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000001124567888999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=269.00 Aligned_cols=230 Identities=21% Similarity=0.291 Sum_probs=166.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN----- 117 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~----- 117 (338)
.+.++|++++.||+|+||.||+|... +++.||||++..... +.+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 35678999999999999999999965 688999999864332 34667888999999999999999986543
Q ss_pred ----------------------------------------------------EEEEEEecCCCCCHHHHHhccCccccc-
Q 045271 118 ----------------------------------------------------ELLLICEYMPNKSLDFLLFDSTRSVQL- 144 (338)
Q Consensus 118 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~- 144 (338)
.+++|||||++++|.+++.........
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 389999999999999999876544333
Q ss_pred ---cHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC----------ccccccccCCcc
Q 045271 145 ---DWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE----------ANTNRVVGTYGY 193 (338)
Q Consensus 145 ---~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y 193 (338)
.+....+++.+|.+.| ++.+||+|||++......... ......+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 2445566777776644 456999999999876433211 112335799999
Q ss_pred ccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHH
Q 045271 194 MAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIH 273 (338)
Q Consensus 194 ~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (338)
+|||++.+..++.++|||||||++|+|++|..|+.... ..... ....... .........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~----~~~~~~~---------~~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITD----VRNLKFP---------LLFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHH----HHTTCCC---------HHHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHH----hhccCCC---------cccccCChhHHH
Confidence 99999999999999999999999999999876642110 00000 0000000 001111224467
Q ss_pred HHhhccCCCCCCCCCHHHHHHH
Q 045271 274 IGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 274 li~~cl~~dP~~Rps~~~vl~~ 295 (338)
|+.+||+.||++|||+.|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 8899999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=270.53 Aligned_cols=228 Identities=18% Similarity=0.227 Sum_probs=168.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|... +++.||+|.+... ....+..|..+++.++||||++++++|.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999954 4778999998542 223466788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+.+|+|..++..... ..........+++.+|.++| ++.+||+|||++..+.. ...
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---~~~ 170 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQ 170 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---TCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC---CCc
Confidence 999999999999876533 22233445556677766644 45699999999987642 223
Q ss_pred ccccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 184 TNRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||................. ... . ....
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~-~-~p~~-- 242 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVV-T-YPSA-- 242 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCC-C-CCTT--
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----ccc-C-CCCc--
Confidence 345789999999999974 3589999999999999999999999974332222111111100 000 0 0000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPT-MSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~vl~ 294 (338)
....+.+|+.+||+.||.+||+ +.+|+.
T Consensus 243 ------~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 ------WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1124567888999999999998 777764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=278.51 Aligned_cols=184 Identities=25% Similarity=0.340 Sum_probs=133.2
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcC-CCceeeeeeEEEeCC--
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQ-HKNLVRLLGCCLEGN-- 117 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~-- 117 (338)
....++|++++.||+|+||.||+|.. .+++.||||++..... ....+|..+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 45678999999999999999999995 4688999999854321 23445667888887 999999999998544
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
.+|+|||||+ ++|..++...............+++.+|.+.| ++.+||+|||+|+.+....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 7899999995 78988887654444444455566777777654 3569999999998753211
Q ss_pred -------------------CCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccc
Q 045271 180 -------------------SEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231 (338)
Q Consensus 180 -------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~ 231 (338)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234589999999999987 578999999999999999999999997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=267.57 Aligned_cols=233 Identities=20% Similarity=0.258 Sum_probs=165.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++++.||+|+||.||+|+.. +++.||+|++.+... .....|..+++.+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 358999999999999999999965 577899999975432 2245666777776 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||||+++|+|..++.... ...........+++.+|.++| ++.+||+|||+++.... ...
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~~~ 165 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGD 165 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--TTC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--CCC
Confidence 999999999998886543 233333445556666666543 45699999999986421 122
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc--chhhHHHhhhccCCcccccCcccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ--SLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ................ +...
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~-- 241 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRS-- 241 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--CCTT--
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--CCCC--
Confidence 234568999999999999999999999999999999999999999642211110 0000000111011100 0110
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTM------SSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~vl~ 294 (338)
....+.+|+.+||+.||.+||++ .+++.
T Consensus 242 ------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 242 ------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11245678888999999999996 67764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=258.51 Aligned_cols=245 Identities=18% Similarity=0.153 Sum_probs=172.6
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHhcCCCceeeeeeEE-EeCCEEEEEEe
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQHKNLVRLLGCC-LEGNELLLICE 124 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e 124 (338)
.+.++|++.+.||+|+||.||+|.. .+++.||||.+... .......|..+++.++|++++..+..+ ...+..++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4567999999999999999999995 56788999987543 345678888899999988877766655 67788999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCCCC
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|+ +++|.+++..... ..........+++.++.+.| ++.+||+|||++.........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 99 9999999874332 33334445556666666533 345899999999876433221
Q ss_pred -----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 182 -----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 182 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.............................
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 244 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhc
Confidence 122346799999999999999999999999999999999999999976443333222221111111111000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
. ....+.+++.+||+.||++|||+.+|++.|+.....
T Consensus 245 ~---------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 245 G---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp T---------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred c---------CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0 012456788889999999999999999999886654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.27 Aligned_cols=238 Identities=27% Similarity=0.372 Sum_probs=171.7
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
...++|++.+.||+|+||.||+|.+..+..||||.+.... .+.+.+|+.+++.++||||+++++++.+ +.+++||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3456789999999999999999998888889999997543 3457788899999999999999999876 678999999
Q ss_pred CCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++|+|.+++.... ...........+++.+|.++|+ +.+||+|||+++....... ...
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 338 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 338 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecc
Confidence 99999999986431 2223344555667777776543 4589999999987642211 112
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....... .... ....
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------~~~~--~~~~------ 404 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------GYRM--PCPP------ 404 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------TCCC--CCCT------
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------CCCC--CCCC------
Confidence 23456788999999999999999999999999999999 9999875433221111110 0000 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.....+.+||.+||+.||++|||+.+|++.|+......
T Consensus 405 --~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 405 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11124567888999999999999999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=267.67 Aligned_cols=223 Identities=20% Similarity=0.179 Sum_probs=168.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|... +++.||||.+... .......|..+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 358999999999999999999964 5889999998543 223456678889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++|+|..++..... ..........+++.+|.++| ++.+||+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----
Confidence 999999999998875432 33333445556666666544 456999999999876321
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. ..... +...
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-------~~~~~--~p~~----- 260 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-------SGKVR--FPSH----- 260 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC--CCTT-----
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH-------cCCCC--CCCC-----
Confidence 234689999999999999999999999999999999999999997543221111111 01100 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
....+.+++.+||+.||.+||+ +.+|++
T Consensus 261 ---~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 ---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1124567888899999999998 899985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=273.35 Aligned_cols=250 Identities=17% Similarity=0.159 Sum_probs=175.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCC--EEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGN--ELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 122 (338)
.++|++.+.||+|+||.||+|... +++.||||.+.... .+...+|..+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 468999999999999999999965 48899999986532 234567888999999999999999998754 78999
Q ss_pred EecCCCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCC----------------------CCeEEeeeccceecC
Q 045271 123 CEYMPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~~~ 176 (338)
||||++|+|.+++..... .....+....+++.+|.+.|+ +.+||+|||++....
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999999976543 223334455567777666442 238999999998763
Q ss_pred CCCCCccccccccCCcccccccccc--------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALE--------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
.. .......||..|+|||++.+ ..++.++|||||||++|+|++|..||....................+
T Consensus 168 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 168 DD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred CC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 22 22334679999999999875 46788999999999999999999999753322221111111111000
Q ss_pred CC-cc---cccC-------c-cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 249 GN-AQ---ELMD-------P-VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 249 ~~-~~---~~~~-------~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.. .. .... . .............+.+++.+||+.||++|||+.++++.++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00 00 0000 0 001111233344566799999999999999999999888776553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.62 Aligned_cols=237 Identities=25% Similarity=0.311 Sum_probs=173.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEc--------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN--------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
.++|++.+.||+|+||.||+|... ++..||||.+..... ..+.+|..+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 568999999999999999999963 456799999875432 2355677788888 899999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcC------------------C
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDH------------------K 161 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~------------------~ 161 (338)
+.+++||||+++|+|.+++..... .....+....+++.+|.+.| +
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 999999999999999999976532 11122344556666666544 4
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
+.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......+......
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 5699999999987644332222333467788999999998889999999999999999999 999987543222111111
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
. ....... . .....+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 274 ~-------~~~~~~~-~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 274 E-------GHRMDKP-A--------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H-------TCCCCCC-T--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-------CCCCCCC-c--------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0000000 0 0112356688889999999999999999999886543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=277.18 Aligned_cols=232 Identities=21% Similarity=0.286 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|.+. +++.||||.+.... ...+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999964 68899999986432 23567788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++|+|.+++..... ..........+++.+|.+.|+ +++||+|||++...... ..
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---CC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc---cc
Confidence 999999999999875432 233344556667777777553 46999999999876422 22
Q ss_pred ccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ . .... . ....+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-~~~~-~-~p~~~--- 239 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI------C-DGIF-Y-TPQYL--- 239 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH------H-TTCC-C-CCTTC---
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH------h-cCCc-C-CCccC---
Confidence 345689999999999998875 68999999999999999999999754322111111 0 0000 0 00000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDTI 301 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~~ 301 (338)
...+.+|+.+||+.||.+|||+.++++ ++....+
T Consensus 240 -----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 240 -----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred -----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 124567888999999999999999996 6665443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=265.57 Aligned_cols=243 Identities=20% Similarity=0.226 Sum_probs=163.9
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--------cccHHHHHHHHHhc---CCCceeeeeeEEEe
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--------GQGLQEFKNLIAKL---QHKNLVRLLGCCLE 115 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~~l~~l---~hpnIv~~~~~~~~ 115 (338)
...++|++++.||+|+||.||+|.. .+++.||||.+.... .....+|..+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467999999999999999999994 568889999986322 12345565555544 59999999999987
Q ss_pred CC-----EEEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeee
Q 045271 116 GN-----ELLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDF 169 (338)
Q Consensus 116 ~~-----~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Df 169 (338)
.. .+++||||+. ++|..++..... ..........+++.++.+.| ++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 5899999995 699888876542 22333445566777776644 346999999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
|++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus 165 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 165 GLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99976532 222334689999999999999999999999999999999999999997543322221111110000000
Q ss_pred Cccccc---Cccc--cccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 250 NAQELM---DPVL--KESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 250 ~~~~~~---~~~~--~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...... .... ...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 0000 000000 11124567889999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=272.25 Aligned_cols=181 Identities=15% Similarity=0.156 Sum_probs=142.7
Q ss_pred hcCCCCCceeccc--CCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEG--GFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++++.||+| +||.||+|... +++.||||.+..... ..+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4589999999999 99999999965 688999999965431 345668889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC-
Q 045271 122 ICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ- 179 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~- 179 (338)
|||||++|+|.+++.... ...........+++.+|.++| ++.+||+|||.+.......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999999999999987542 222233445556777776644 4569999999986542111
Q ss_pred ----CCccccccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 180 ----SEANTNRVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 180 ----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 1111223478999999999987 57999999999999999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=261.92 Aligned_cols=234 Identities=26% Similarity=0.362 Sum_probs=165.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
.++|++.+.||+|+||.||+|.+ .++.||||.+.... .+.+..|+.+++.++||||+++++++. +..++||||+++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 35799999999999999999997 46789999986543 244667888999999999999999886 447999999999
Q ss_pred CCHHHHHhccCccc----cccHHHHHHHHHHhhhcCC---------------------CC-eEEeeeccceecCCCCCCc
Q 045271 129 KSLDFLLFDSTRSV----QLDWNRRMCIINGIARDHK---------------------MN-PKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 129 g~L~~~l~~~~~~~----~~~~~~~~~~~~~i~~~~~---------------------~~-vkL~Dfg~a~~~~~~~~~~ 182 (338)
|+|.+++....... ...+....+++.++.+.|. +. +||+|||++.....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----- 158 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----- 158 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----
Confidence 99999997654321 2223444566677766554 12 69999999976521
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+.... .........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~----- 228 (307)
T 2eva_A 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHN-GTRPPLIKN----- 228 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHT-TCCCCCBTT-----
T ss_pred ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhc-CCCCCcccc-----
Confidence 12234689999999999998999999999999999999999999864322111 11111110 000111100
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccCC
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQ 305 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~~ 305 (338)
....+.+++.+||+.||.+|||+.++++.|+........
T Consensus 229 ----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 229 ----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 012356688889999999999999999999987655443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.09 Aligned_cols=235 Identities=21% Similarity=0.197 Sum_probs=171.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+.++|++.+.||+|+||.||+|... ++..||+|.+..... ..+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999954 578899999865432 3355678899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
|||+++++|...+..... ..........+++.++.+.|+ ..+||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 999999999877755432 333334455566666666442 23899999999876422
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ............
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 233 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA-------GAYDYPSPEWDT 233 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCCCCCTTTTTT
T ss_pred -ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh-------ccccCCchhhcc
Confidence 222345799999999999999999999999999999999999999965332221111110 000000000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
....+.+|+.+||+.||++|||+.|+++ ++...
T Consensus 234 ------~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 234 ------VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp ------SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ------cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 0123567888899999999999999985 55543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=264.66 Aligned_cols=230 Identities=18% Similarity=0.201 Sum_probs=170.2
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---------ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
+.++|++.+.||+|+||.||+|... ++..||+|.+..... +.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4568999999999999999999964 588899999865332 336778889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CC----CeEEeeeccceec
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KM----NPKISDFGMARVF 175 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~----~vkL~Dfg~a~~~ 175 (338)
+++||||+++++|.+++..... .....+....+++.+|.+.| ++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999999875432 22333445556666666543 22 5899999999876
Q ss_pred CCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+...... .... ..
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~--~~ 237 (321)
T 2a2a_A 170 EDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------SVSY--DF 237 (321)
T ss_dssp CTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTCC--CC
T ss_pred Ccc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hccc--cc
Confidence 432 12234579999999999999899999999999999999999999996543221111100 0000 00
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...... .....+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 238 DEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Chhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 01123567888999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=265.06 Aligned_cols=246 Identities=24% Similarity=0.261 Sum_probs=172.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEE--eCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCL--EGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~--~~~~~~ 120 (338)
++|++++.||+|+||.||+|.+ .++..||||.+..... ..+.+|+.+++.++||||+++++++. +.+.++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5899999999999999999984 3567899999976543 33677888999999999999999987 456799
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
+||||+++++|.+++..... .....+....+++.+|.+.| ++.+||+|||++........
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 99999999999999875332 33334445556777766644 34589999999987643222
Q ss_pred C-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc--------chhhHHHhhhccCCc
Q 045271 181 E-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ--------SLLTYTWKLWCEGNA 251 (338)
Q Consensus 181 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~ 251 (338)
. .......||..|+|||++.+..++.++|||||||++|+|++|..||......... ...............
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC
Confidence 1 1122346788899999999999999999999999999999999998643221000 000000000000000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccCC
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQ 305 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~~ 305 (338)
. .........+.+|+.+||+.||++|||+.++++.|+..+.....
T Consensus 263 ~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 263 L---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred C---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 0 00011122456788889999999999999999999998765543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=261.45 Aligned_cols=235 Identities=26% Similarity=0.345 Sum_probs=174.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++.+.||+|+||.||+|...++..||+|.+.... .+.+.+|..+++.++||||+++++++.+.+.+++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35899999999999999999998888899999997543 3456778889999999999999999999999999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
+++|.+++..... .....+....+++.++.+.| ++.+||+|||++....... .......
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 165 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGT 165 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccccc
Confidence 9999999876432 22333445556777766644 3458999999997653211 1112234
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
.++..|+|||++.+..++.++||||||+++|+|++ |..||............. .. ........
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-------~~-~~~~~~~~-------- 229 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TG-FRLYKPRL-------- 229 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TT-CCCCCCTT--------
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-------cC-CcCCCCcc--------
Confidence 56788999999998889999999999999999999 899986533221111110 00 00000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
....+.+++.+||+.||++|||+.++++.|+....
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11235668888999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=273.14 Aligned_cols=236 Identities=24% Similarity=0.339 Sum_probs=161.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++.+.||+|+||.||+|... .+..||||.++.... ..+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999954 466799999865432 345677889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++|+|.+++...... .........+++.+|.++| ++.+||+|||++.........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999999999765332 2223445556677666644 356899999999876432211
Q ss_pred c-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 A-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||............. . ......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~---~-----~~~~~~---- 271 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---E-----GYRLPP---- 271 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH---T-----TEECCC----
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-----CCCCCC----
Confidence 1 1112345678999999999999999999999999999998 999986543222111110 0 000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 272 ----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 272 ----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 00111245678889999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=263.17 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=163.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++++.||+|+||.||+|... +++.||||++..... ....+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999964 488899999865433 23456778999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++++|..++..... ..........+++.++.+.| ++.+||+|||++....... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--ccc
Confidence 99999999888765432 22333445556666666644 4568999999998764222 122
Q ss_pred cccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccCCc---c
Q 045271 185 NRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEGNA---Q 252 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~---~ 252 (338)
....||..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ...+..... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 34578999999999986 56899999999999999999999999754332221111100 000000000 0
Q ss_pred cccCccccccc---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 ELMDPVLKESF---ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000 0011123567889999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=279.17 Aligned_cols=234 Identities=22% Similarity=0.222 Sum_probs=170.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS-----SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+.++|++++.||+|+||.||+|... +++.||||++... ....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 56678999999999999999999964 6889999998532 23456778889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
|||||.+|+|.+.+..... ..........+++.+|.+.|+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 9999999999887755432 333344555567777666442 35999999999765322
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
......+||+.|+|||++.+ .|+.++||||+||++|+|++|..||......+....... ...........
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~~ 247 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-------GKYAFDLPQWR 247 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCCCSCSGGGG
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCCCCCcccC
Confidence 22334579999999999876 589999999999999999999999975432221111110 00000000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
. ....+.+|+.+||+.||.+|||+.++++ ++..
T Consensus 248 ~------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 248 T------ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp G------SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred C------CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0 1124567888999999999999999996 4544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=256.30 Aligned_cols=245 Identities=18% Similarity=0.153 Sum_probs=175.7
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEE-EeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCC-LEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e~ 125 (338)
..++|++.+.||+|+||.||+|.. .+++.||||.+.... ...+..|..+++.++|++++..+..+ ...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 356899999999999999999995 568899999986443 35577888899999998876666655 567889999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCCCCc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+ +++|.+++..... ..........+++.++.+.| ++.+||+|||++..........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 9 9999999874332 33334445556666666533 4559999999998764332211
Q ss_pred -----cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 183 -----NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 183 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..............................
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 245 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTT
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhh
Confidence 123457999999999999999999999999999999999999999864433222222111111000000000000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
....+.+++.+||+.||++|||+.+|++.|+......
T Consensus 246 ---------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 246 ---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ---------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0123567888999999999999999999999876544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=280.39 Aligned_cols=233 Identities=21% Similarity=0.213 Sum_probs=167.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+.++|++++.||+|+||.||+|... ++..||+|++.... ...+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999964 57889999986432 34567788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||||.+|+|.+.+..... ..........+++.+|.+.|+ ..+||+|||++......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 999999999887755432 333344555667777776542 23899999999876432
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......+||+.|+|||++. ..|+.++||||+||++|+|++|..||......+........ .... ......
T Consensus 193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------~~~~-~~~~~~ 262 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-------KYTF-DSPEWK 262 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------CCCC-CSGGGT
T ss_pred -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CCCC-Cchhcc
Confidence 2233467999999999876 46999999999999999999999999754332221111110 0000 000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.....+.+|+.+||+.||.+|||+.++++ ++..
T Consensus 263 -----~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 263 -----NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -----cCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 01123567888999999999999999984 4444
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=266.85 Aligned_cols=235 Identities=24% Similarity=0.370 Sum_probs=166.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCc----EEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDK----EIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|++++.||+|+||.||+|.+. ++. .||+|.+.... ...+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357999999999999999999954 343 35888775332 234667888999999999999999998755 78
Q ss_pred EEEecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+|+||+.+|+|.+++...... ....+....+++.+|.+.|+ +.+||+|||+++.......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 899999999999998764432 22334455667777776553 4589999999987654333
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........+|..|+|||++.+..++.++|||||||++|+|++ |..||............... .... ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------~~~~--~~--- 241 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ERLP--QP--- 241 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------CCCC--CC---
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC------CCCC--CC---
Confidence 333334467889999999999999999999999999999999 99999754332221111100 0000 00
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
......+.+++.+||+.||++|||+.++++.|+....
T Consensus 242 -----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 -----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111245678889999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=274.10 Aligned_cols=232 Identities=17% Similarity=0.203 Sum_probs=169.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEecc------CCcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSR------SSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|+++++||+|+||.||+|+... ++.||+|++.+ .....+.+|..+++.++||||++++++|.+.+.+|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 4789999999999999999999654 67899999854 2234477888899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||||++|+|..++..... ..........+++.+|.+.| ++.+||+|||+|+....... .
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 231 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 231 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-c
Confidence 999999999999976322 22233344455666666533 46699999999987643221 2
Q ss_pred cccccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 183 NTNRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.....+||+.|+|||++. ...|+.++|||||||++|||++|..||......+....+....... ......
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~-- 306 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF---QFPTQV-- 306 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---CCCSSC--
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc---cCCccc--
Confidence 223468999999999997 4568999999999999999999999997543322222111110000 000000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPAD--RPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~vl~ 294 (338)
.. ....+.+||.+||+.+|++ ||++.|+++
T Consensus 307 -~~------~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 307 -TD------VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -CC------SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -cc------CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00 1124567888899998888 999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=264.68 Aligned_cols=230 Identities=19% Similarity=0.272 Sum_probs=162.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCC--CceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQH--KNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~h--pnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|...++..||||.+..... +.+.+|+.+++.++| |||+++++++.+++.+++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 457999999999999999999987888999999864432 335677888999976 9999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCCCCccc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+ .+++|.+++..... ..........+++.+|.+.|. +.+||+|||++............
T Consensus 88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC---------
T ss_pred EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccC
Confidence 995 58899998876433 222334555667777777553 45899999999876433222223
Q ss_pred cccccCCcccccccccc-----------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 185 NRVVGTYGYMAPEYALE-----------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~-----------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .......... ....
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~-~~~~ 240 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDP-NHEI 240 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCT-TSCC
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcC-Cccc
Confidence 34689999999999865 56889999999999999999999999642211 1111111100 0000
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...... ...+.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~--------~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 241 EFPDIP--------EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCCCCS--------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcccC--------CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 011100 123567888899999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=266.23 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=164.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcE----EEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKE----IAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~----vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|++++.||+|+||.||+|.+. ++.. ||+|.+.... ...+.+|+.+++.++||||+++++++...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 358999999999999999999954 3443 5777774332 234667888999999999999999998755 78
Q ss_pred EEEecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+|+||+.+|+|.+++...... ....+....+++.+|.+.|+ +.+||+|||++........
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999999998764332 23334455667777776543 4589999999987643332
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
........+|..|+|||++.+..++.++|||||||++|+|++ |..||............... .. .. ...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~------~~-~~-~~~-- 242 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ER-LP-QPP-- 242 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------CC-CC-CCT--
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------CC-CC-CCc--
Confidence 222333456788999999999999999999999999999999 99999754332221111100 00 00 000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 243 ------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 243 ------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0112356788899999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=259.26 Aligned_cols=229 Identities=21% Similarity=0.260 Sum_probs=163.4
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.+.++|++.+.||+|+||.||+|.. .++..||+|.+..... +.+..|+.+++.++||||+++++++.+.+..++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3456899999999999999999995 4578899999865432 4567788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecC
Q 045271 123 CEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFG 176 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~ 176 (338)
|||+++|+|.+.+... ............+++.+|.++| ++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998887542 1222333445556666666533 2458999999997653
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.. .......||+.|+|||++. ..++.++|||||||++|+|++|..||............. ...........
T Consensus 179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~ 249 (285)
T 3is5_A 179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-----YKEPNYAVECR 249 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCC--C
T ss_pred Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-----cCCcccccccC
Confidence 22 2223457899999999875 568899999999999999999999997543222111111 10111000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ....+.+|+.+||+.||++|||+.|+++
T Consensus 250 ------~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 250 ------P---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------C---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ------c---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0123457888999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=280.34 Aligned_cols=235 Identities=21% Similarity=0.233 Sum_probs=169.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC----------------cccHHHHHHHHHhcCCCceeeee
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS----------------GQGLQEFKNLIAKLQHKNLVRLL 110 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~----------------~~~~~~~~~~l~~l~hpnIv~~~ 110 (338)
.+.++|+++++||+|+||.||+|... ++..||||.+.... ...+..|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35679999999999999999999964 57789999986432 23456788899999999999999
Q ss_pred eEEEeCCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEee
Q 045271 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISD 168 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~D 168 (338)
+++.+.+.+++|||||++|+|.+.+..... ..........+++.+|.+.|+ ..+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999887765432 333344555667777776442 1489999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
||++...... ......+||+.|+|||++. ..|+.++||||+||++|+|++|..||......+.......
T Consensus 193 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------- 261 (504)
T 3q5i_A 193 FGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK------- 261 (504)
T ss_dssp CTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------
T ss_pred CCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------
Confidence 9999876432 2233467999999999876 4689999999999999999999999975433222111110
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
............ ....+.+|+.+||+.||.+|||+.|+++ ++...
T Consensus 262 ~~~~~~~~~~~~------~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 262 GKYYFDFNDWKN------ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCCCCHHHHTT------SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCCCCccccCC------CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 000000000000 1124567888999999999999999985 55553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=264.13 Aligned_cols=226 Identities=22% Similarity=0.268 Sum_probs=161.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE----cCCcEEEEEEeccCC-------cccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
.++|++++.||+|+||.||+|+. .+++.||+|++.... ......|..+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999996 468899999986532 2335667889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
+|+||||+++++|..++..... ..........+++.+|.+.| ++.+||+|||++......
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 174 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD- 174 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC-
Confidence 9999999999999988865432 22233344556666666543 356999999999754221
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. .... +...
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-----~~~~----~p~~- 243 (327)
T 3a62_A 175 -GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-----CKLN----LPPY- 243 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----TCCC----CCTT-
T ss_pred -CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----CCCC----CCCC-
Confidence 1223346899999999999998999999999999999999999999975432221111100 0000 0000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+|+.+||+.||.+|| ++.++++
T Consensus 244 -------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 244 -------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 112456788899999999999 7888886
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=263.65 Aligned_cols=240 Identities=15% Similarity=0.177 Sum_probs=169.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcC-CCceeeeeeEEEe--CCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLE--GNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~ 125 (338)
.++|++++.||+|+||.||+|.. .+++.||||.+.....+.+.+|+.+++.++ ||||+++++++.+ ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 36899999999999999999995 568899999998777777888999999997 9999999999987 6778999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------C-CeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------M-NPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~-~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+.+++|..++.. ...........+++.+|.++|+ + .+||+|||++....... ....
T Consensus 115 ~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 189 (330)
T 3nsz_A 115 VNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNV 189 (330)
T ss_dssp CCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCS
T ss_pred cCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---cccc
Confidence 999999988854 2223334455566777666442 2 58999999998764322 2334
Q ss_pred cccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccc-hh-h---------HHHh----------
Q 045271 187 VVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS-LL-T---------YTWK---------- 244 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~-~~-~---------~~~~---------- 244 (338)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .. . ....
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence 578999999999987 568999999999999999999999995322111000 00 0 0000
Q ss_pred hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..........................+.+|+.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000000000111234677899999999999999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=271.82 Aligned_cols=229 Identities=19% Similarity=0.269 Sum_probs=162.9
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcC--CCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQ--HKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|....+..||||.+..... ..+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46999999999999999999977788999999865432 34567788888886 599999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCCCCcccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
| +.+++|.+++..... ..........+++.+|.+.|+ +.+||+|||++..+..........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~ 214 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKD 214 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------C
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCC
Confidence 9 558899998876542 222334455677888777654 458999999998764322222234
Q ss_pred ccccCCcccccccccc-----------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc
Q 045271 186 RVVGTYGYMAPEYALE-----------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-----------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (338)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .......... .....
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~~-~~~~~ 288 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDP-NHEIE 288 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHCT-TSCCC
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhCc-cccCC
Confidence 4689999999999875 36889999999999999999999999643211 0001111110 00000
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..... ...+.+|+.+||+.||.+|||+.|+++
T Consensus 289 ~~~~~--------~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 289 FPDIP--------EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCS--------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccc--------hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11100 124567888999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=271.27 Aligned_cols=231 Identities=21% Similarity=0.233 Sum_probs=162.5
Q ss_pred CCCC--CceecccCCeeEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSN--ENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~--~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.|.+ .+.||+|+||.||+|.. .++..||+|.+.... .+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3444 56899999999999995 458899999997643 24466788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC--------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH--------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~--------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
+++++|.+++..... ..........+++.+|.++| .+.+||+|||++....... .
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 999999888765432 22223344456666666543 2458999999998764322 2
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+... .+ .. .....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~---~~---~~~~~---- 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--RW---DL---EDEEF---- 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CC---CS---CSGGG----
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cC---CC---Chhhh----
Confidence 23457999999999999888999999999999999999999999754322211111100 00 00 00000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
......+.+|+.+||+.||.+|||+.|+++ ++..
T Consensus 313 -~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 313 -QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 001124567889999999999999999996 5544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=272.76 Aligned_cols=232 Identities=16% Similarity=0.159 Sum_probs=169.2
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
..++|++++.||+|+||.||+|+.. +++.||||++.+. ....+.+|..++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3578999999999999999999964 6889999998642 23457788889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++|+|..++..... ..........+++.+|.+.| ++.+||+|||+++.......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~- 217 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT- 217 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-
Confidence 9999999999999876432 22233444556666666544 45699999999987643221
Q ss_pred ccccccccCCccccccccc-------cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYAL-------EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (338)
......+||+.|+|||++. +..|+.++|||||||++|||++|..||......+....+........ ...
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p~- 293 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS---LPL- 293 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---CC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC---CCc-
Confidence 1223468999999999997 35689999999999999999999999975433222111111100000 000
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADR---PTMSSVVF 294 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~~vl~ 294 (338)
.... ....+.+||.+||+ ||.+| |++.||++
T Consensus 294 ~~~~--------~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 294 VDEG--------VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---C--------CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cccC--------CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000 11245678889999 99998 59999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=265.27 Aligned_cols=238 Identities=17% Similarity=0.191 Sum_probs=169.1
Q ss_pred CChhHHHHHhcCCCCC-ceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhc-CCCceeeeeeE
Q 045271 41 FPLDLIHEATRNFSNE-NKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKL-QHKNLVRLLGC 112 (338)
Q Consensus 41 ~~~~~~~~~~~~y~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l-~hpnIv~~~~~ 112 (338)
+.+.....+.++|.+. +.||+|+||.||+|... +++.||+|.+.... ...+..|..+++.+ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3445667778899998 89999999999999954 58899999986432 23455667777777 56999999999
Q ss_pred EEeCCEEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC---------------------CCCeEEee
Q 045271 113 CLEGNELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH---------------------KMNPKISD 168 (338)
Q Consensus 113 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~D 168 (338)
+.+.+.+++||||+.+|+|..++.... ......+....+++.+|.++| .+.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999999988875431 122233445556666666533 35699999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ..
T Consensus 178 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~----~~ 250 (327)
T 3lm5_A 178 FGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----NV 250 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CC
T ss_pred CccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc----cc
Confidence 9999876322 1223457999999999999999999999999999999999999999654322211111100 00
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........ .....+.+|+.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 DYSEETFS---------SVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCTTTTT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCchhhc---------ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00000000 01123566888899999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=276.73 Aligned_cols=241 Identities=21% Similarity=0.197 Sum_probs=161.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEG------ 116 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~------ 116 (338)
..++|++++.||+|+||.||+|... +++.||||++.... .....+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999954 57889999996532 23455777899999999999999999754
Q ss_pred CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
..+|+||||+++ ++...+... ...........+++.+|.+.| ++.+||+|||+++....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~~-l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC------
T ss_pred CeEEEEEeCCCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC-
Confidence 467999999965 465555432 222333445556777776644 35699999999987632
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH---------------
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW--------------- 243 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------------- 243 (338)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+....+....
T Consensus 217 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 222344689999999999999999999999999999999999999997643222211111000
Q ss_pred hhhcc-------CCcccccCcccc-cccc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 244 KLWCE-------GNAQELMDPVLK-ESFI--LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 244 ~~~~~-------~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+.. ......+...+. .... ......+.+|+.+||++||++|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000001111000 0000 111345788999999999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=270.43 Aligned_cols=239 Identities=27% Similarity=0.346 Sum_probs=173.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcC-C-----cEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLND-D-----KEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~ 116 (338)
...++|++.+.||+|+||.||+|.... + ..||+|.+..... ..+..|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999999543 2 3699999875432 3456778889999 899999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc---------------cccccHHHHHHHHHHhhhcCC------------------CC
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR---------------SVQLDWNRRMCIINGIARDHK------------------MN 163 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~~~~~i~~~~~------------------~~ 163 (338)
+.+++||||+++|+|.+++..... .....+....+++.+|.+.|+ +.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 999999999999999998865321 222234455567777776553 34
Q ss_pred eEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHH
Q 045271 164 PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYT 242 (338)
Q Consensus 164 vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~ 242 (338)
+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......... ...
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~~~ 280 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--KLV 280 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--HHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--HHH
Confidence 89999999986643322222333467889999999999999999999999999999998 888986543221111 100
Q ss_pred HhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 243 WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.... ....... ....+.+++.+||+.||.+|||+.+|++.|+....
T Consensus 281 ~~~~-----~~~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 281 KDGY-----QMAQPAF--------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHTC-----CCCCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCC-----CCCCCCC--------CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 0000 0000000 01245668888999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=267.18 Aligned_cols=227 Identities=22% Similarity=0.213 Sum_probs=166.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccC------CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRS------SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~ 120 (338)
..++|++++.||+|+||.||+|.... ++.||||.+.+. .......|..+++.+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45689999999999999999999654 678999998643 223355666677766 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+++|+|..++..... ..........+++.+|.++| ++.+||+|||+++.... ..
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 175 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DG 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--CC
Confidence 99999999999998875432 33334445556666666544 45699999999986421 12
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. ..... +...
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------~~~~~--~p~~--- 243 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNVA--YPKS--- 243 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC--CCTT---
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH-------hCCCC--CCCC---
Confidence 22345689999999999999999999999999999999999999997543221111111 00000 0010
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
....+.+|+.+||+.||.+||+ +.+|++
T Consensus 244 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 244 -----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1124567888999999999995 578875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=256.01 Aligned_cols=233 Identities=22% Similarity=0.318 Sum_probs=172.7
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEe----------
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLE---------- 115 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~---------- 115 (338)
..+.++|++++.||+|+||.||+|... +++.||+|.+.... ....+|..+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356678999999999999999999965 68899999997544 456778889999999999999998864
Q ss_pred ------CCEEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEee
Q 045271 116 ------GNELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISD 168 (338)
Q Consensus 116 ------~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~D 168 (338)
...+++||||+++++|.+++.... ......+....+++.++.+.| ++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 345899999999999999986532 222233445556777766644 34589999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.... ... .....
T Consensus 166 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~----~~~~~ 233 (284)
T 2a19_B 166 FGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFF----TDLRD 233 (284)
T ss_dssp CTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHH----HHHHT
T ss_pred chhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHH----HHhhc
Confidence 99998764322 2234578999999999999899999999999999999999998864211 000 00001
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
......+ ...+.+++.+||+.||.+|||+.++++.|........
T Consensus 234 ~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 GIISDIF------------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TCCCTTS------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccccC------------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111101 1234568888999999999999999999988665443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=266.38 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=173.4
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG 116 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~ 116 (338)
....++|++.+.||+|+||.||+|... ++..||||.+..... ..+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344678999999999999999999853 366799999865433 2355677888999999999999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc-----------cccccHHHHHHHHHHhhhcC------------------CCCeEEe
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR-----------SVQLDWNRRMCIINGIARDH------------------KMNPKIS 167 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~ 167 (338)
+..++||||+++|+|.+++..... .....+....+++.+|.+.| ++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 999999999999999998865321 22223344556666666544 3569999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhh
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------- 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-------
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH-------
Confidence 9999986532222222233467889999999999899999999999999999999 88888654322111110
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.......... .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 254 ~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0111111000 011235668888999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=257.96 Aligned_cols=228 Identities=23% Similarity=0.282 Sum_probs=168.2
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC--CEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 122 (338)
.++|++.+.||+|+||.||+|.+. +..||||.+..... +.+.+|+.+++.++||||+++++++.+. +.+++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 458999999999999999999984 78899999865432 2355666778888999999999999876 788999
Q ss_pred EecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCCC--------------------CeEEeeeccceecCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHKM--------------------NPKISDFGMARVFGGNQ 179 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~~--------------------~vkL~Dfg~a~~~~~~~ 179 (338)
|||+++|+|.+++..... .....+....+++.+|.+.|+. .++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 999999999999987543 3334455666788888877753 36888888765421
Q ss_pred CCccccccccCCccccccccccCCCCc---ccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSV---KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
.....||+.|+|||++.+..++. ++|||||||++|+|++|..||.......... .......... ..
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~-~~ 233 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALEGLRPT-IP 233 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHSCCCCC-CC
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhcCCCCC-CC
Confidence 12346899999999998776554 7999999999999999999997533221111 1110111111 11
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.. ....+.+++.+||+.||++|||+.++++.|+...
T Consensus 234 ~~--------~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 234 PG--------ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC--------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 10 1123567888899999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=265.71 Aligned_cols=243 Identities=25% Similarity=0.320 Sum_probs=174.1
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeE
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGC 112 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~ 112 (338)
.......++|++.+.||+|+||.||+|.. .+++.||||.+..... ..+.+|..+++.+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444567999999999999999999984 2356799999975433 2355677788888 69999999999
Q ss_pred EEeCC-EEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC-------------
Q 045271 113 CLEGN-ELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------- 161 (338)
Q Consensus 113 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------- 161 (338)
+...+ .+++||||+++++|.+++..... .....+....+++.++.+.|+
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87654 58999999999999999976542 112233445566777666443
Q ss_pred -----CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccc
Q 045271 162 -----MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQG 235 (338)
Q Consensus 162 -----~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~ 235 (338)
+.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 4589999999987643333233334567889999999999999999999999999999998 9999865432211
Q ss_pred cchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 236 QSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
. .... . ........ .. ....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 260 ~--~~~~-~---~~~~~~~~-~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 F--CRRL-K---EGTRMRAP-DY--------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp H--HHHH-H---HTCCCCCC-TT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHHh-c---cCccCCCC-CC--------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 0000 0 00000000 00 11235668888999999999999999999987553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=258.78 Aligned_cols=229 Identities=22% Similarity=0.318 Sum_probs=166.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-C-------cEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-D-------KEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
.++|++.+.||+|+||.||+|.... + ..||+|.+..... +.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4589999999999999999999433 3 4699999865433 346677889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CC--------eEEeeec
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MN--------PKISDFG 170 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~--------vkL~Dfg 170 (338)
.++||||+++|+|.+++..... .....+....+++.+|.++|+ +. +||+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 9999999999999999976543 222334455567777776442 22 8999999
Q ss_pred cceecCCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
++.... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..|+........ .... .....
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~~---~~~~~ 235 (289)
T 4fvq_A 167 ISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQF---YEDRH 235 (289)
T ss_dssp SCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHH---HHTTC
T ss_pred cccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHHH---hhccC
Confidence 986542 1123468889999999987 6789999999999999999996554432211111 0000 00001
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
...... + ..+.+|+.+||+.||++|||+.++++.|+....
T Consensus 236 ~~~~~~------~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QLPAPK------A------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CCCCCS------S------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCCCCC------C------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111101 1 124567888999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=267.76 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=165.6
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|++++.||+|+||.||+|... +++.||||.+..... ....+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999965 688899999864332 1334577889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 126 MPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++ |+|..++....... ........+++.+|.+.| ++.+||+|||++...... .....
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 158 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYD 158 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccccc
Confidence 95 68888776544322 223344456666666644 456999999999865322 11223
Q ss_pred ccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC--------
Q 045271 186 RVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD-------- 256 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 256 (338)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+......................
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 3578999999999987 4689999999999999999999999976443322211111100000000000000
Q ss_pred -ccccccc----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcccc
Q 045271 257 -PVLKESF----ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDTITL 303 (338)
Q Consensus 257 -~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~~~~ 303 (338)
....... .......+.+|+.+||+.||++|||+.|+++ ++.......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 0000000 0001124567899999999999999999996 666655443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=259.37 Aligned_cols=236 Identities=30% Similarity=0.400 Sum_probs=173.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
..++|++++.||+|+||.||+|...++..||+|.+.... .+.+..|+.+++.++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 346899999999999999999998888889999986543 345677888999999999999999986 45689999999
Q ss_pred CCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++++|.+++.... ......+....+++.+|.+.| ++.+||+|||++........ ....
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 168 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TARE 168 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCT
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-cccc
Confidence 9999999986532 222333445556676666544 34699999999987643221 1122
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...++..|+|||++.+..++.++|||||||++|+|++ |..||......+...... . . .......
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~----~-~~~~~~~------- 233 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---R----G-YRMVRPD------- 233 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T----T-CCCCCCT-------
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh---c----c-cCCCCcc-------
Confidence 3456788999999998889999999999999999999 899986543222111110 0 0 0000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+++.+||+.||++|||+.++++.|+.....
T Consensus 234 -~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0112456788889999999999999999999886644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.30 Aligned_cols=227 Identities=23% Similarity=0.331 Sum_probs=170.9
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.+.|++++.||+|+||.||+|.. .+++.||||.+.... ...+.+++.+++.++||||+++++++.+.+.+++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45799999999999999999995 458889999986443 2446677888999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 125 YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|+++++|.+++...............+++.++.+.| ++.+||+|||++....... .....
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 178 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--cccCc
Confidence 999999999987654444444555566776666543 4569999999998764322 12234
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
..|+..|+|||++.+..++.++|||||||++|+|++|..||........... .. ...... +....
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~~-----~~~~~--- 243 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------IP-KNNPPT-----LEGNY--- 243 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HH-HSCCCC-----CCSSC---
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH------hh-cCCCCC-----Ccccc---
Confidence 5789999999999999999999999999999999999999864322111100 00 000000 11111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+|+.+||+.||.+|||+.++++
T Consensus 244 -~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 244 -SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp -CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 123566888899999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.21 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=168.8
Q ss_pred hcCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC--CE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~ 118 (338)
.+.|++++.||+|+||.||+|.+ .+++.||+|.+..... ..+.+|..+++.++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45799999999999999999983 3577899999864432 4467788899999999999999999876 67
Q ss_pred EEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
+++||||+++++|.+++..... .....+....+++.++.+.| ++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999999999999854432 22333445556777776654 345899999999876433
Q ss_pred CCC-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccc--------cccchhhHHHhhhccC
Q 045271 179 QSE-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYE--------QGQSLLTYTWKLWCEG 249 (338)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~~ 249 (338)
... .......||..|+|||++.+..++.++|||||||++|+|++|..|+...... ................
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 221 1223356788899999999999999999999999999999999886532110 0000000000000000
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.... .. ......+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 260 ~~~~-~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 260 KRLP-CP--------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp CCCC-CC--------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-CC--------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000 00 01112456788899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=263.47 Aligned_cols=223 Identities=18% Similarity=0.235 Sum_probs=169.3
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----------cccHHHHHHHHHhcCCCceeeeeeEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----------GQGLQEFKNLIAKLQHKNLVRLLGCCL 114 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------~~~~~~~~~~l~~l~hpnIv~~~~~~~ 114 (338)
..+.++|++++.||+|+||.||+|.. .+++.||||.+.... ...+..|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35677999999999999999999995 457889999986542 234567888999999999999999999
Q ss_pred eCCEEEEEEecCCCC-CHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeecccee
Q 045271 115 EGNELLLICEYMPNK-SLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARV 174 (338)
Q Consensus 115 ~~~~~~lv~e~~~~g-~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~ 174 (338)
+.+.+++||||+..| +|..++..... ..........+++.+|.++| ++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999776 99888876533 33333445556777766644 45699999999987
Q ss_pred cCCCCCCccccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 180 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------------------ 238 (335)
T 3dls_A 180 LERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE------------------ 238 (335)
T ss_dssp CCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT------------------
T ss_pred CCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh------------------
Confidence 6432 22334679999999999998876 7899999999999999999999864211000
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
........ ....+.+|+.+||+.||++|||+.++++.
T Consensus 239 ---~~~~~~~~--~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ---AAIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TCCCCSSC--CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hccCCCcc--cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 11235678888999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.75 Aligned_cols=225 Identities=23% Similarity=0.211 Sum_probs=157.5
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCccc------HHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQG------LQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
..+.++|+++++||+|+||.||+|... +++.||||++....... ..++..+.+..+||||+++++++.+++.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 345578999999999999999999965 68899999986533211 12222233445899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+ +++|..++..... .....+....+++.+|.++|+ +.+||+|||++......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999999 7788887765433 222334455567777776543 45899999999876322
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .......... ..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~----~~ 273 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGYLPP----EF 273 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTCCCH----HH
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccCCCc----cc
Confidence 22234579999999998876 7899999999999999999997665432110 0000000000 00
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......+.+|+.+||+.||++|||+.++++
T Consensus 274 ----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 ----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0001134567888999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=257.93 Aligned_cols=232 Identities=25% Similarity=0.308 Sum_probs=168.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+.++|++++.||+|+||.||+|... ++..||||.+..... +.+.+|..+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999964 688999999864332 34667788899999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++++|.+++..... ..........+++.++.+.| ++.+||+|||++............
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99999999888765322 22333445556666666543 456999999999865322222223
Q ss_pred cccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....|+..|+|||++.+..+ +.++|||||||++|+|++|..||......... .. . +..... .......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~--~---~~~~~~--~~~~~~~--- 233 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--D---WKEKKT--YLNPWKK--- 233 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HH--H---HHTTCT--TSTTGGG---
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HH--H---hhhccc--ccCchhh---
Confidence 34678999999999988765 77899999999999999999999653321110 00 0 000000 0000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+++.+||+.||.+|||+.|+++
T Consensus 234 ---~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 234 ---IDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1123456888899999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=272.12 Aligned_cols=242 Identities=19% Similarity=0.172 Sum_probs=174.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHhcCC-CceeeeeeEEEeCCEEEEEEecC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQH-KNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.++|+++++||+|+||.||+|.. .+++.||||++... ....+..|..+++.+.| ++|..+..++...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 46899999999999999999995 56889999987643 34567788889999987 55666666677888999999999
Q ss_pred CCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCCCCc-
Q 045271 127 PNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQSEA- 182 (338)
Q Consensus 127 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~~~~- 182 (338)
+++|.+++.... ......+.+..+++.+|.++| .+.+||+|||+++.+.......
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 999999987433 233334455556777766643 4558999999998765332211
Q ss_pred ----cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 183 ----NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 183 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
......||..|+|||++.+..++.++|||||||++|+|++|..||..........................+...
T Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~- 243 (483)
T 3sv0_A 165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRG- 243 (483)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTT-
T ss_pred cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcC-
Confidence 122468999999999999999999999999999999999999999764432222111111111101111111110
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
....+.+|+.+||+.||++||++.+|++.|+....
T Consensus 244 --------~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 244 --------YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp --------SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 01245678889999999999999999998887643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=266.03 Aligned_cols=237 Identities=27% Similarity=0.339 Sum_probs=167.7
Q ss_pred HhcCCCCCceecccCCeeEEEEEE------cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
..++|++++.||+|+||.||+|.+ .++..||||.+..... ..+..|..+++.++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356899999999999999999983 2466899999864332 235567788999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc--------cccccHHHHHHHHHHhhhcCC---------------------CCeEEeee
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR--------SVQLDWNRRMCIINGIARDHK---------------------MNPKISDF 169 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Df 169 (338)
.++||||+++++|.+++..... .....+....+++.++.++|+ ..+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 9999999999999999976532 111233445566666665432 24899999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
|++................|++.|+|||++.+..++.++|||||||++|+|++ |..||............. .
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~ 260 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-------S 260 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------T
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-------c
Confidence 99976533222222334567889999999999899999999999999999998 989986543221111110 0
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
..... ... .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 261 ~~~~~-~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 261 GGRMD-PPK--------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TCCCC-CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC-CCC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00000 000 011235668888999999999999999999887654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.98 Aligned_cols=238 Identities=21% Similarity=0.331 Sum_probs=158.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++.++||+|+||.||+|... ..||+|.+..... +.+.+|+.+++.++||||++++++. ..+.+++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 568999999999999999999853 3599999864432 3356778899999999999999965 5567899999
Q ss_pred cCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+.+++|.+++....... ...+....+++.+|.+.| ++.+||+|||++............
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 999999999886543322 223344556666666544 345999999999765432222233
Q ss_pred cccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....||+.|+|||++. +..++.++|||||||++|+|++|..||......... ...... ............
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~- 252 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGR----GSLSPDLSKVRS- 252 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHH----TSCCCCTTSSCT-
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcc----cccCcchhhccc-
Confidence 3457899999999987 556889999999999999999999999753322111 111111 011110110000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.....+.+|+.+||+.||.+|||+.++++.|+....
T Consensus 253 ----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 253 ----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011245678888999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=272.45 Aligned_cols=232 Identities=19% Similarity=0.217 Sum_probs=160.9
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----------cccHHHHHHHHHhcCCCceeeeeeEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----------GQGLQEFKNLIAKLQHKNLVRLLGCCL 114 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------~~~~~~~~~~l~~l~hpnIv~~~~~~~ 114 (338)
..+.++|++.+.||+|+||.||+|.. .+++.||||.+.... ...+..|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678999999999999999999995 457899999986432 124678889999999999999999985
Q ss_pred eCCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccc
Q 045271 115 EGNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMA 172 (338)
Q Consensus 115 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a 172 (338)
.+.+++||||+++|+|.+++..... ..........+++.+|.++|+ ..+||+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4568999999999999887765432 223334455667777776442 23999999999
Q ss_pred eecCCCCCCccccccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
..... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||......... ..... ..
T Consensus 290 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~----~~ 360 (419)
T 3i6u_A 290 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT----SG 360 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHH----TT
T ss_pred eecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHh----cC
Confidence 87532 222334689999999999864 56889999999999999999999999753222111 10000 00
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.... ..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 361 ~~~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYNF-IPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCC-CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-Cchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 00000 001124567888999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=269.03 Aligned_cols=242 Identities=18% Similarity=0.192 Sum_probs=162.9
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEe-----------
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLE----------- 115 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~----------- 115 (338)
...++|++++.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4567899999999999999999995 5688999999865433 33468889999999999999999854
Q ss_pred ---------------------------CCEEEEEEecCCCCCHHHHHhc-----cCccccccHHHHHHHHHHhhhcCC--
Q 045271 116 ---------------------------GNELLLICEYMPNKSLDFLLFD-----STRSVQLDWNRRMCIINGIARDHK-- 161 (338)
Q Consensus 116 ---------------------------~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~~~~i~~~~~-- 161 (338)
...+++||||++ |+|...+.. .............+++.++.+.|+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 334899999996 677666643 122223334455667777776543
Q ss_pred -----------------CCeEEeeeccceecCCCCCCccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhC
Q 045271 162 -----------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISG 223 (338)
Q Consensus 162 -----------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g 223 (338)
+.+||+|||++..+.... ......||+.|+|||++.+.. ++.++||||+||++|+|++|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 459999999998764322 223457899999999998764 89999999999999999999
Q ss_pred CCCCcccccccccchhhHHH------------hhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 045271 224 RKDTRFYLYEQGQSLLTYTW------------KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 224 ~~Pf~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 291 (338)
..||......+....+.... ..+........................+.+|+.+||++||.+|||+.|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99997643322211111000 000000000000000000000011224678889999999999999999
Q ss_pred HHH
Q 045271 292 VVF 294 (338)
Q Consensus 292 vl~ 294 (338)
+++
T Consensus 319 ~l~ 321 (383)
T 3eb0_A 319 AMA 321 (383)
T ss_dssp HHT
T ss_pred Hhc
Confidence 984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.07 Aligned_cols=234 Identities=18% Similarity=0.212 Sum_probs=169.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
+.++|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4568999999999999999999954 68899999987543 2346678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhc---------------------CCCCeEEeeeccceecCCCCCCc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARD---------------------HKMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~---------------------~~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|+++++|.+++..... ..........+++.++.+. .++.+||+|||++..... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~ 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----G 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC----B
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC----C
Confidence 9999999888765432 2233344455566665543 245689999999875421 1
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.............. .... .......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~~~-~~~~~~~-- 232 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE-------GYYE-FESPFWD-- 232 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------CCCC-CCTTTTT--
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CCCC-CCccccc--
Confidence 22345789999999999999999999999999999999999999865332211111100 0000 0000000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.....+.+|+.+||+.||++|||+.++++ ++...
T Consensus 233 ---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 233 ---DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 01124567888999999999999999995 56553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=257.46 Aligned_cols=230 Identities=17% Similarity=0.183 Sum_probs=167.6
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.+.++|++.+.||+|+||.||+|.... +..||+|.+.... .+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 356789999999999999999999644 6789999986533 345677888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCCCC
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||+++++|.+++..... ..........+++.++.+.| ++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--- 162 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---
Confidence 99999999888765433 33334445556666665533 345899999999876422
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.............. ...........
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~-- 232 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE-------GTFTFPEKDWL-- 232 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCCCCHHHHT--
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CCCCCCchhhh--
Confidence 223345799999999988654 89999999999999999999999975432211111100 00000000000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+++.+||+.||++|||+.++++
T Consensus 233 ----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 ----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01124567888999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.68 Aligned_cols=229 Identities=22% Similarity=0.260 Sum_probs=169.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|... +++.||+|.+... .......|..+++.++||||+++++++.+.+.+|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999964 6889999998542 223456788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|||+++|+|..++..... ..........+++.+|.++| ++.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--- 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--- 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC---
Confidence 999999999998876432 22233444556666666644 456999999999876422
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||................. ..... +...
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~----~p~~--- 411 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEE----YSER--- 411 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCC----CCTT---
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-ccccc----CCcc---
Confidence 222345899999999999998999999999999999999999999975432211111111100 00000 0000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+|+.+||+.||.+|| ++.||++
T Consensus 412 -----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 412 -----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 112456788889999999999 7899985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=282.46 Aligned_cols=238 Identities=27% Similarity=0.371 Sum_probs=175.7
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
...++|++.++||+|+||.||+|.+..+..||||++.... .+.+.+|+.+++.++||||+++++++.+ +.+++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3456788999999999999999998888889999997543 2457788899999999999999999876 678999999
Q ss_pred CCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+.+|+|.+++.... ......+.+..+++.+|.++|. +.+||+|||+++...... ....
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~ 421 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTAR 421 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTT
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecc
Confidence 99999999986431 2223344555667777776553 358999999997653211 1111
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||++.+..++.++|||||||++|||++ |..||......+....... .... ....
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~------~~~~--~~~~------ 487 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------GYRM--PCPP------ 487 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT------TCCC--CCCT------
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------CCCC--CCCC------
Confidence 22356788999999999999999999999999999999 8999875433221111110 0000 0000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.....+.+||.+||+.||++|||+.+|++.|+......
T Consensus 488 --~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 488 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred --CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 01124567888999999999999999999999876544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=259.23 Aligned_cols=236 Identities=27% Similarity=0.363 Sum_probs=174.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... +.+..|..+++.++||||+++++++.+.+.+++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 35689999999999999999999654 77899999975543 3466788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 126 MPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++++|.+++..... .....+....+++.++.+.| ++.+||+|||++........ ...
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~ 169 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAH 169 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccc
Confidence 999999999875332 22222344455666666544 34599999999986542221 222
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++..|+|||++.+..++.++||||||+++|+|++ |..||............... . ... ...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~---~----~~~-~~~------ 235 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---Y----RME-RPE------ 235 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---C----CCC-CCT------
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---C----CCC-CCC------
Confidence 33467788999999998999999999999999999999 99998754332221111100 0 000 000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.....+.+|+.+||+.||.+|||+.++++.|+....
T Consensus 236 --~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 236 --GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 011245678888999999999999999999987553
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=257.87 Aligned_cols=233 Identities=21% Similarity=0.252 Sum_probs=158.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++.+.||+|+||.||+|.... +..||+|.+..... +.+.+|..+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999999643 34589999865432 23556778899999999999999984 567899
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++++|.+++..... .....+....+++.++.+.| ++.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY- 171 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc-
Confidence 9999999999999875542 22233444556777766644 34589999999987643221
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+...... ...... ...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~~~~-~~~--- 240 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLP-MPP--- 240 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCCC-CCT---
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCCCCC-CCC---
Confidence 11223456788999999998899999999999999999997 999987543322111110 000000 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+++.+||+.||++|||+.++++.|+...
T Consensus 241 -----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 241 -----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01124566888999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=261.21 Aligned_cols=242 Identities=22% Similarity=0.304 Sum_probs=163.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
...++|++.+.||+|+||.||+|.. .++..||||.+..... ..+.+|+.+++.++||||+++++++...+.++
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3456899999999999999999995 5688999999864321 23556778899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCC
Q 045271 121 LICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGG 177 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~ 177 (338)
+||||+++++|.+++... .......+....+++.++.+.| ++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999888642 1222233445556666666543 45699999999986532
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ........ ..........
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 261 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIE-QCDYPPLPSD 261 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHHHH-TTCSCCCCTT
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHHhh-cccCCCCccc
Confidence 21 11223578999999999999999999999999999999999999986432211 11111110 0111110000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
. ....+.+++.+||+.||++|||+.+|++.|+.......
T Consensus 262 -----~---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 262 -----H---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -----T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -----c---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0 11235568888999999999999999999988765443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=279.86 Aligned_cols=234 Identities=21% Similarity=0.210 Sum_probs=171.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.+.++|++.+.||+|+||.||+|... +++.||||++.... ...+.+|+.+++.++||||+++++++.+.+.++
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34568999999999999999999964 68899999985432 234677888999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
+|||||.+|+|.+.+..... ..........+++.+|.+.| ++.+||+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999888865443 22233445556677766644 345899999999876322
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
......+||+.|+|||++.+ .|+.++||||+||++|+|++|..||......+....... ..........
T Consensus 183 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~ 251 (484)
T 3nyv_A 183 ---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTFELPQW 251 (484)
T ss_dssp ---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCCCCSGGG
T ss_pred ---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CCCCCCCccc
Confidence 22334579999999999876 689999999999999999999999975432221111110 0000000000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
. .....+.+|+.+||+.||.+|||+.++++ ++..
T Consensus 252 ~------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 252 K------KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp G------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred c------cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 0 01124567888999999999999999995 5544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=261.84 Aligned_cols=240 Identities=18% Similarity=0.180 Sum_probs=162.0
Q ss_pred HhcCCCCC-ceecccCCeeEEEEE-EcCCcEEEEEEeccCCc---ccHHHHHHHHHh-cCCCceeeeeeEEEeCCEEEEE
Q 045271 49 ATRNFSNE-NKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG---QGLQEFKNLIAK-LQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 49 ~~~~y~~~-~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~~l~~-l~hpnIv~~~~~~~~~~~~~lv 122 (338)
+.+.|++. +.||+|+||.||+|. ..+++.||||.+..... ....+|+.+++. ++||||+++++++.+.+.+++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45689885 789999999999999 45688999999965433 345667777777 5799999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------C---CeEEeeeccceecCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------M---NPKISDFGMARVFGGNQS 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~---~vkL~Dfg~a~~~~~~~~ 180 (338)
|||+++++|.+++..... ..........+++.+|.+.|+ + .+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999998865432 333344455567777766442 2 289999999876532111
Q ss_pred -----CccccccccCCcccccccccc-----CCCCcccchHhHhHHHHHHHhCCCCCcccccccccch--------hhHH
Q 045271 181 -----EANTNRVVGTYGYMAPEYALE-----GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL--------LTYT 242 (338)
Q Consensus 181 -----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~--------~~~~ 242 (338)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 111223469999999999975 4588999999999999999999999975432211000 0000
Q ss_pred HhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 243 WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......... ...... ......+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~i~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGKYE-FPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCCCC-CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccCcc-cCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000000000 000000 001124567888999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=262.77 Aligned_cols=245 Identities=14% Similarity=0.119 Sum_probs=164.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCCcc--------------cHHHHHHHHHhcCCCceeeeee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSGQ--------------GLQEFKNLIAKLQHKNLVRLLG 111 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--------------~~~~~~~~l~~l~hpnIv~~~~ 111 (338)
.++|++.+.||+|+||.||+|... .+..||||.+...... ...++...++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999965 5667999998654321 1234445677889999999999
Q ss_pred EEEe----CCEEEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CC--CeEE
Q 045271 112 CCLE----GNELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KM--NPKI 166 (338)
Q Consensus 112 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~--~vkL 166 (338)
++.. .+.+++||||+ +++|.+++.... ......+....+++.+|.++| ++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 77899999999 999999987543 233334455566777766643 23 7999
Q ss_pred eeeccceecCCCCC-----CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH
Q 045271 167 SDFGMARVFGGNQS-----EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY 241 (338)
Q Consensus 167 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~ 241 (338)
+|||+++.+..... ........||..|+|||++.+..++.++|||||||++|+|++|..||........... .
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~--~ 272 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ--T 272 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH--H
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH--H
Confidence 99999987632211 1111345799999999999999999999999999999999999999964221111100 0
Q ss_pred HHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
........ ............ .....+.+++.+||+.||++|||+.+|++.|+....
T Consensus 273 ~~~~~~~~-~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDE-LPQSVLKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHT-TTHHHHHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhccc-ccHHHHhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 00000000 000000000000 011245668888999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=264.85 Aligned_cols=235 Identities=18% Similarity=0.246 Sum_probs=169.6
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----------ccHHHHHHHHHhc-CCCceeeee
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----------QGLQEFKNLIAKL-QHKNLVRLL 110 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~l~~l-~hpnIv~~~ 110 (338)
.....+.++|++.+.||+|+||.||+|... +++.||||++..... ..+..|..+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344667788999999999999999999965 688999999865431 2345667788888 799999999
Q ss_pred eEEEeCCEEEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeecc
Q 045271 111 GCCLEGNELLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGM 171 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~ 171 (338)
+++...+..++||||+++++|.+++.... ...........+++.+|.+.| ++.+||+|||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999999999999886542 222333445556666666533 45699999999
Q ss_pred ceecCCCCCCccccccccCCcccccccccc------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhh
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALE------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKL 245 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 245 (338)
+..+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 247 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~----- 318 (365)
T 2y7j_A 247 SCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM----- 318 (365)
T ss_dssp CEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred ccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----
Confidence 9876432 22334689999999999863 358899999999999999999999996432211111100
Q ss_pred hccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 WCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........ +... .....+.+|+.+||+.||++|||+.++++
T Consensus 319 --~~~~~~~~-~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 --EGQYQFSS-PEWD-----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HTCCCCCH-HHHS-----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --hCCCCCCC-cccc-----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000 0000 00123567888999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=255.52 Aligned_cols=228 Identities=22% Similarity=0.308 Sum_probs=167.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|... ++..||+|.+... ....+.++..+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 458999999999999999999954 4668999998542 223466778889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++++|..++..... ..........+++.++.++|. +.+||+|||++..... ..
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----cc
Confidence 999999999988865432 223344555667777766553 4599999999865422 12
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||.............. ...... ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~----~~----- 229 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----VEFTFP----DF----- 229 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----TCCCCC----TT-----
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-----CCCCCC----Cc-----
Confidence 2345789999999999998899999999999999999999999975433222111110 000000 00
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
....+.+|+.+||+.||.+|||+.|+++ ++..
T Consensus 230 ---~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 230 ---VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp ---SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred ---CCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 1123456888899999999999999996 4544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=256.64 Aligned_cols=234 Identities=19% Similarity=0.224 Sum_probs=168.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC---------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS---------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++++.||+|+||.||+|... +++.||+|.+.... .+.+.+|..+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999965 58899999986432 23467788899999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC------------------C----CeEEeeeccceecC
Q 045271 120 LLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK------------------M----NPKISDFGMARVFG 176 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~------------------~----~vkL~Dfg~a~~~~ 176 (338)
++||||+++++|.+++.... ...........+++.++.+.|. + .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999886533 2333344555566666665432 2 58999999998763
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||............. ..... ..
T Consensus 164 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~--~~ 231 (283)
T 3bhy_A 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-------AVNYD--FD 231 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TTCCC--CC
T ss_pred CCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-------hcccC--Cc
Confidence 221 2234578999999999998899999999999999999999999987543221111000 00000 00
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.... ......+.+|+.+||+.||++|||+.++++ +++..
T Consensus 232 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 232 EEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred chhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 0000 001123567888999999999999999996 45543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=275.18 Aligned_cols=226 Identities=20% Similarity=0.184 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|.. .++..||||.+.... ......|..+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 458899999986421 12344566777888999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
|||+++|+|..++..... ..........+++.+|.++|+ +.+||+|||+|+.... ...
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--CCc
Confidence 999999999888865432 223334445566666666553 3589999999975422 122
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+.. .... +...
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------~~~~--~p~~---- 371 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------EEIR--FPRT---- 371 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCC--CCTT----
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh-------CCCC--CCcc----
Confidence 23456899999999999999999999999999999999999999965432221111110 0000 0000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+|+.+||+.||.+|| |+.|+++
T Consensus 372 ----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 ----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 012456788899999999999 9999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=260.13 Aligned_cols=234 Identities=26% Similarity=0.315 Sum_probs=169.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcE--EEEEEeccCC----cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKE--IAVKRLSRSS----GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~--vavK~~~~~~----~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.+.||+|+||.||+|.. .++.. +|+|.+.... ...+..|..+++.+ +||||+++++++.+.+.+++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5899999999999999999994 44554 4899886432 24467788889999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhccC-----------------ccccccHHHHHHHHHHhhhcCC------------------CCeEEe
Q 045271 123 CEYMPNKSLDFLLFDST-----------------RSVQLDWNRRMCIINGIARDHK------------------MNPKIS 167 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~ 167 (338)
|||+++++|.+++.... ......+....+++.+|.+.|+ +.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999999987653 2222334455567777776543 358999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhh
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
|||++..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 185 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~------ 255 (327)
T 1fvr_A 185 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 255 (327)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG------
T ss_pred ccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh------
Confidence 9999974321 111223456789999999998889999999999999999998 999996543222111110
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
...... ... .....+.+|+.+||+.||.+|||+.++++.|+......
T Consensus 256 -~~~~~~-~~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 -QGYRLE-KPL--------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -GTCCCC-CCT--------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -cCCCCC-CCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 000000 000 01124567888999999999999999999998866543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=255.85 Aligned_cols=242 Identities=17% Similarity=0.163 Sum_probs=163.8
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
....++|++.+.||+|+||.||+|... +++.||+|.+..... +.+.+|+.+++.++||||+++++++.+++.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 445679999999999999999999964 578899999865432 3356677888999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
++||||+++++|.+++.... ...........+++.++.+.| ++.+||+|||++........
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999999987543 233334455556666666543 45699999999976532211
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||........ .................+
T Consensus 190 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~- 261 (309)
T 2h34_A 190 -TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM------GAHINQAIPRPSTVRPGI- 261 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH------HHHHHSCCCCGGGTSTTC-
T ss_pred -ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH------HHHhccCCCCccccCCCC-
Confidence 122345789999999999998999999999999999999999999975432211 000000000000000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCcccc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRP-TMSSVVFMLATDTITL 303 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~vl~~L~~~~~~~ 303 (338)
+ ..+.+++.+||+.||++|| |+.++++.|+......
T Consensus 262 -~------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 262 -P------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -C------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -C------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1 1345678889999999999 9999999999866543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=262.52 Aligned_cols=245 Identities=12% Similarity=0.082 Sum_probs=173.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC---------CcEEEEEEeccCCcccHHHHHHHHHhcCCCceee------------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND---------DKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVR------------ 108 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~------------ 108 (338)
.++|++.+.||+|+||.||+|.... +..||||.+... ..+.+|..+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 4689999999999999999999653 678999998654 56778889999999999988
Q ss_pred ---eeeEEEe-CCEEEEEEecCCCCCHHHHHhcc---CccccccHHHHHHHHHHhhhcCC------------------C-
Q 045271 109 ---LLGCCLE-GNELLLICEYMPNKSLDFLLFDS---TRSVQLDWNRRMCIINGIARDHK------------------M- 162 (338)
Q Consensus 109 ---~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~i~~~~~------------------~- 162 (338)
+++++.. ++.+++||||+ +++|.+++... .......+....+++.+|.++|+ +
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCC
Confidence 5677766 78899999999 99999999764 22333445566667777776542 3
Q ss_pred -CeEEeeeccceecCCCCCC-----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccccc
Q 045271 163 -NPKISDFGMARVFGGNQSE-----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQ 236 (338)
Q Consensus 163 -~vkL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~ 236 (338)
.+||+|||++..+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 277 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence 6999999999865322111 1123357999999999999989999999999999999999999999754311111
Q ss_pred chhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 237 SLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.......+. ................ ...+.+|+.+||+.||++|||+.+|++.|+......
T Consensus 278 --~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 278 --IMKQKQKFV-DKPGPFVGPCGHWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp --HHHHHHHHH-HSCCCEECTTSCEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHhcc-CChhhhhhhccccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 111111110 1111111111110000 123566788899999999999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=264.59 Aligned_cols=243 Identities=25% Similarity=0.301 Sum_probs=163.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQ-----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++++.||+|+||.||+|... +++.||||.+...... ...+|..+++.++||||+++++++.+.+.+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 458999999999999999999964 4888999998654332 2456778999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+++++|..+..... ...........+++.++.++| ++.+||+|||++....... ...
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 181 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 181 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--ccc
Confidence 9999998888765433 222333445556666666543 4569999999997653221 122
Q ss_pred cccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccC-Ccccc
Q 045271 185 NRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEG-NAQEL 254 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~ 254 (338)
....|+..|+|||++.+. .++.++|||||||++|+|++|..||......+........ ...+... .....
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 345789999999999876 6899999999999999999999999754322211111000 0000000 00000
Q ss_pred cCccccccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 255 MDPVLKESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 255 ~~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..+........ .....+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000 11234677889999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=252.91 Aligned_cols=230 Identities=20% Similarity=0.243 Sum_probs=171.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|... ++..||+|.+... ....+.+|..+++.++||||+++++++.+.+.+++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999965 4678999998532 224567788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++++|.+++..... ..........+++.++.+.| ++.+||+|||++...... .
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----R 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS----C
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc----c
Confidence 999999999988865432 23334455556777776654 346899999999765321 2
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||............ . ..... +...
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~-~~~~~--~~~~----- 234 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI------V-NVDLK--FPPF----- 234 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H-TTCCC--CCTT-----
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH------h-ccccC--CCCc-----
Confidence 23457899999999999989999999999999999999999999653322111100 0 00000 0010
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCc
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDT 300 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~ 300 (338)
....+.+++.+||+.||.+|||+.++++ ++....
T Consensus 235 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 235 ---LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ---CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 1123567888999999999999999995 666543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=257.71 Aligned_cols=228 Identities=25% Similarity=0.349 Sum_probs=149.5
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
...++|++.+.||+|+||.||+|.. .+++.||||.+.... ...+.+|..+++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 3456899999999999999999995 568899999985432 244667888899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
+||||+++++|..++..... .....+....+++.++.+.| ++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 99999999999999876433 22333445556777766644 4569999999998763221
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......+...... .... . ...
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~-~-~~~--- 233 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------LADY-E-MPS--- 233 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------SSCC-C-CCT---
T ss_pred -CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------hccc-C-Ccc---
Confidence 11223578999999999998889999999999999999999999997543222111000 0000 0 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.....+.+++.+||+.||++|||+.++++
T Consensus 234 -----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 -----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01124567888999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=261.56 Aligned_cols=233 Identities=19% Similarity=0.240 Sum_probs=172.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
...++|++.+.||+|+||.||+|... +++.||+|.+.... .+.+..|+.+++.++||||+++++++.+.+.++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34568999999999999999999965 46789999986542 234566778899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+.+++|.+++.... ......+....+++.+|.++| ++.+||+|||++.......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence 9999999999998886543 233334455566777766644 3569999999998763221
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||......+...... ..... +....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~----~~~~~-- 264 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYS----IPKHI-- 264 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----HTCCC----CCTTS--
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-----cCCCC----CCccC--
Confidence 22234578999999999999889999999999999999999999997543222111100 00000 00000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
...+.+|+.+||+.||++|||+.++++ ++...
T Consensus 265 ------~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 265 ------NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 123456888999999999999999995 55543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=265.07 Aligned_cols=243 Identities=21% Similarity=0.239 Sum_probs=163.2
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
....++|++++.||+|+||.||+|.. .+++.||||.+..... ....+|+.+++.++||||+++++++.+.+.++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34567999999999999999999995 4678899999864332 23557888999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-----------------------CCeEEeeeccceecC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-----------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-----------------------~~vkL~Dfg~a~~~~ 176 (338)
+||||++ |+|.+++..... ..........+++.+|.++|+ +.+||+|||++....
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999996 688888865432 233334455667777766442 228999999998763
Q ss_pred CCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC-----
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN----- 250 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 250 (338)
... .......||..|+|||++.+. .++.++|||||||++|+|++|..||.......................
T Consensus 189 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 189 IPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred Ccc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 221 122335789999999999875 489999999999999999999999975432221111110000000000
Q ss_pred ----cccccCccccccccHH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 ----AQELMDPVLKESFILE------ELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ----~~~~~~~~~~~~~~~~------~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........ . ..... ....+.+|+.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKF-R-GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCC-C-CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhh-c-cccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 0 00011 1134578999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=265.71 Aligned_cols=233 Identities=19% Similarity=0.241 Sum_probs=157.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcc------cHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQ------GLQEFKNLIAKLQHKNLVRLLGCCLEGN---- 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~l~~l~hpnIv~~~~~~~~~~---- 117 (338)
+.++|++.+.||+|+||.||+|.. .+++.||||.+...... .+.+|..+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999995 56788999999754322 2455666777889999999999987643
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
..|+||||+++++|.+++..... .....+....+++.+|.+.| ++.+||+|||++..+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 45999999999999999865432 33334445556676666644 456999999999866432
Q ss_pred CCC-ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 179 QSE-ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......... .
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~----~ 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP----P 239 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC----H
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCCC----c
Confidence 211 1223357899999999999999999999999999999999999999653321110 0100000000 0
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
..... .....+.+|+.+||+.||++||++.+++.
T Consensus 240 ~~~~~---~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 240 SARHE---GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHST---TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ccccC---CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00000 01123556888899999999998777663
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=261.47 Aligned_cols=245 Identities=21% Similarity=0.246 Sum_probs=164.0
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--------cccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
...++|++++.||+|+||.||+|.. .+++.||||.+.... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999995 458899999986422 1345678889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
+++||||+. ++|..++..... ..........+++.++.+.| ++.+||+|||++..+...
T Consensus 87 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCS-EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCC-CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999996 488888765543 23333455556777766644 356999999999876322
Q ss_pred CCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc---c
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE---L 254 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 254 (338)
. ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+....+.............. .
T Consensus 166 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 N--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp C--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred c--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 2 223345789999999999765 489999999999999999999999875432222111111000000000000 0
Q ss_pred cCcc---ccccccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 255 MDPV---LKESFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 255 ~~~~---~~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.+.. ........ ....+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00000111 11346778899999999999999999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=259.56 Aligned_cols=237 Identities=24% Similarity=0.315 Sum_probs=160.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC--
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN-- 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-- 117 (338)
..++|++.+.||+|+||.||+|... ++..||+|.+..... ..+..|+.+++.++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3568999999999999999999843 234799999864422 23566778899999999999999998654
Q ss_pred ---EEEEEEecCCCCCHHHHHhccC-------ccccccHHHHHHHHHHhhhcCC------------------CCeEEeee
Q 045271 118 ---ELLLICEYMPNKSLDFLLFDST-------RSVQLDWNRRMCIINGIARDHK------------------MNPKISDF 169 (338)
Q Consensus 118 ---~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Df 169 (338)
..++||||+.+++|..++.... ......+....+++.+|.+.|+ +.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999999999999884321 1223344555667777776553 45999999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
|++................+++.|+|||++.+..++.++|||||||++|+|++ |..||............. .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~ 264 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-------H 264 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------T
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-------c
Confidence 99987643222222233467889999999999999999999999999999999 888886543322111110 0
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
........ .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 265 ~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 GHRLKQPE---------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TCCCCCBT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCc---------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000000 011245678889999999999999999999988653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=267.39 Aligned_cols=223 Identities=19% Similarity=0.214 Sum_probs=158.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHH-HHhcCCCceeeeeeEEEeCCEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNL-IAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~-l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
..++|++++.||+|+||.||+|+.. ++..||||++.+... .....+..+ ++.++||||+++++++.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3568999999999999999999965 477899999965432 112223333 46678999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+++|+|..++..... ..........+++.+|.++| ++.+||+|||+++..... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~ 193 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--N 193 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC--C
Confidence 99999999999988875432 22233344556666666543 456999999999764221 2
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||......+....+. ..... +...+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------~~~~~--~~~~~-- 262 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-------NKPLQ--LKPNI-- 262 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH-------HSCCC--CCSSS--
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------hcccC--CCCCC--
Confidence 22345789999999999999999999999999999999999999997543222111110 00000 01101
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMS 290 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 290 (338)
...+.+|+.+||+.||.+||++.
T Consensus 263 ------~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 263 ------TNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ------CHHHHHHHHHHcccCHHhCCCCC
Confidence 12356788889999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=266.64 Aligned_cols=242 Identities=19% Similarity=0.221 Sum_probs=164.3
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC------C
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG------N 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~------~ 117 (338)
.++|++++.||+|+||.||+|.. .+++.||||++..... ....+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 56899999999999999999995 4688999999854322 2355778899999999999999999865 3
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
.+|+||||+ +++|..++...............+++.+|.+.| ++.+||+|||+++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-- 180 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 180 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc--
Confidence 469999999 899999987655444444555666777777644 35699999999987532
Q ss_pred CCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhh--------ccC-
Q 045271 180 SEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLW--------CEG- 249 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~~- 249 (338)
.....++|+.|+|||++.+ ..++.++||||+||++|+|++|..||......+....+....... ...
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 1234578999999999987 679999999999999999999999997543322211111000000 000
Q ss_pred ------CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 250 ------NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 250 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
........... .........+.+|+.+||+.||.+|||+.++++ +++.
T Consensus 258 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 00000000000 000011234667888999999999999999997 4544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=255.05 Aligned_cols=237 Identities=24% Similarity=0.344 Sum_probs=171.5
Q ss_pred hcCCCCCc-eecccCCeeEEEEEEc---CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNEN-KLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~-~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|.+.+ .||+|+||.||+|... ++..||||.+..... +.+.+|+.+++.++||||+++++++ ..+.+++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677777 9999999999999853 466799999976432 3356778899999999999999999 4566899
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++++|.+++..... .....+....+++.+|.+.| ++.+||+|||++.........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999999999865432 22334455566777776654 345899999999876432221
Q ss_pred -ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 -ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+...... ...... ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~~~~-~~~-- 236 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRME-CPP-- 236 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCCC-CCT--
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCCcCC-CCC--
Confidence 11223456889999999998889999999999999999998 999986543222111110 000000 000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.....+.+++.+||+.||++|||+.++++.|+......
T Consensus 237 ------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 237 ------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01124566888899999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=267.47 Aligned_cols=245 Identities=18% Similarity=0.200 Sum_probs=163.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeCC------EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEGN------ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~------~~~lv~ 123 (338)
..+|++++.||+|+||.||+|....+..||+|++..... ...+|..+++.++||||+++++++...+ .+++||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 457999999999999999999987777899998865432 3346888999999999999999996533 388999
Q ss_pred ecCCCCCHHHHHhc----cCccccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCC
Q 045271 124 EYMPNKSLDFLLFD----STRSVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 124 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
||++++.+..+... .............+++.+|.+.| ++.+||+|||+++......
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~- 196 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE- 196 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-
Confidence 99976544433321 12222233344556677666643 4568999999998763222
Q ss_pred CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH------------Hhhhc
Q 045271 181 EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT------------WKLWC 247 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~------------~~~~~ 247 (338)
......||+.|+|||++.+. .|+.++|||||||++|+|++|..||...........+... ...+.
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 197 --PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp --CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred --CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 22345789999999999876 5899999999999999999999999764432221111100 00000
Q ss_pred cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.......................+.+|+.+||++||.+|||+.|+++ ++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 00000000000000000011235678899999999999999999996 3544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=253.30 Aligned_cols=236 Identities=19% Similarity=0.279 Sum_probs=166.2
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
....++|++++.||+|+||.||+|... ++..||||.+.... ...+.+++.+++.++||||+++++++...+.+++|||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 455678999999999999999999964 48899999986543 3557778889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|.+++.... ......+....+++.++.+.| ++.+||+|||++....... ...
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKR 182 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCB
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--ccc
Confidence 999999999886322 233333445556666666543 4569999999998764321 122
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ...... ... . ....
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~-~~~-~----~~~~- 249 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPTNP-PPT-F----RKPE- 249 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC-CCC-C----SSGG-
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCC-Ccc-c----CCcc-
Confidence 34578999999999999899999999999999999999999986432211100 000000 000 0 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.....+.+|+.+||+.||.+|||+.++++ ++..
T Consensus 250 -~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 250 -LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp -GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 01124567888899999999999999985 4444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=262.35 Aligned_cols=177 Identities=25% Similarity=0.330 Sum_probs=139.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|+||.||+|... ++..||+|.+..... ..+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 458999999999999999999965 578899999875432 335567778889999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|.+++..... ..........+++.++.++| ++.+||+|||++..... ...
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~ 187 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMA 187 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HC-
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc----ccc
Confidence 9999999999876432 22223334445555554433 45699999999875421 122
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3457899999999999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=260.98 Aligned_cols=244 Identities=18% Similarity=0.222 Sum_probs=166.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe--------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE-------- 115 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~-------- 115 (338)
.++|++++.||+|+||.||+|.. .+++.||||++..... ....+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999996 5688999999854332 245678889999999999999999987
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceec
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVF 175 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~ 175 (338)
.+.+++||||+. ++|...+..... ..........+++.+|.++| ++.+||+|||++..+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 456899999996 566666654332 22333445556677766644 456999999999876
Q ss_pred CCCCC--CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcc
Q 045271 176 GGNQS--EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252 (338)
Q Consensus 176 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (338)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.........................
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 42221 1222345789999999999864 58999999999999999999999997543322221111111000000000
Q ss_pred c--------ccCccccccccHHH-------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 E--------LMDPVLKESFILEE-------LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~--------~~~~~~~~~~~~~~-------~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. .............. ...+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 00000000111111 123678999999999999999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=272.11 Aligned_cols=229 Identities=24% Similarity=0.309 Sum_probs=167.5
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|+.. +++.||+|++.+. .......|..+++.++||||+++++++.+.+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999964 5889999998543 2234567888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 124 EYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
||+++|+|..++.... ...........+++.+|.++| ++.+||+|||++..+....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~- 343 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ- 343 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-
Confidence 9999999999886543 122223344556676666644 4569999999998764322
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||............ ..... .... . +...
T Consensus 344 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~~i~-~~~~-~-~p~~-- 415 (543)
T 3c4z_A 344 -TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRVL-EQAV-T-YPDK-- 415 (543)
T ss_dssp -CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HHHHH-HCCC-C-CCTT--
T ss_pred -cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HHHHh-hccc-C-CCcc--
Confidence 2223458999999999999999999999999999999999999999754221111111 11111 0000 0 0000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTM-----SSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~vl~ 294 (338)
....+.+|+.+||+.||.+||++ .+|+.
T Consensus 416 ------~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 416 ------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11245668888999999999965 67774
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=254.09 Aligned_cols=233 Identities=23% Similarity=0.295 Sum_probs=165.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ..+.+|..+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4689999999999999999998533 23589999875432 345667888999999999999999875 45689
Q ss_pred EEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
||||+++++|.+++..... .....+....+++.++.+.| ++.+||+|||++........
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 168 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY- 168 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc-
Confidence 9999999999999875432 22233444556777766644 34589999999986543221
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||............... .. .. ....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~------~~-~~-~~~~-- 238 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG------DR-LP-KPDL-- 238 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT------CC-CC-CCTT--
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC------CC-CC-CCCC--
Confidence 11223456788999999998899999999999999999998 99998643332211111100 00 00 0000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+++.+||+.||++|||+.++++.|+...
T Consensus 239 ------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 239 ------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0123566888899999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=257.41 Aligned_cols=233 Identities=22% Similarity=0.266 Sum_probs=167.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~l 121 (338)
.++|++++.||+|+||.||+|... +++.||+|.+..... +.+..|..+++.++||||+++++++.+ .+.+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999964 588899999865432 335667788999999999999998864 578999
Q ss_pred EEecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcC-----------------------CCCeEEeeeccce
Q 045271 122 ICEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDH-----------------------KMNPKISDFGMAR 173 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~-----------------------~~~vkL~Dfg~a~ 173 (338)
||||+++++|.+++.... ......+....+++.+|.+.| ++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999886532 222233444455555555433 3459999999997
Q ss_pred ecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||......+...... ......
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-------~~~~~~ 235 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKFRR 235 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCCC
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-------hccccc
Confidence 65321 111223578999999999999899999999999999999999999987543221111110 011111
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
... .....+.+++.+||+.||.+|||+.+|++.+....
T Consensus 236 ~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 236 IPY---------RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred CCc---------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 100 01124566888899999999999999998776544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=261.75 Aligned_cols=244 Identities=20% Similarity=0.181 Sum_probs=159.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN------ 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~------ 117 (338)
.++|++++.||+|+||.||+|... +++.||||++..... ....+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999954 578899999865322 23556778899999999999999998654
Q ss_pred EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
.+++||||++ ++|...+... ...........+++.++.+.| ++.+||+|||++......
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~- 180 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 180 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred ceEEEEEcCC-CCHHHHHhhc-cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-
Confidence 7899999995 5777776532 222333445556777766644 456999999999865321
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH---------------Hh
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT---------------WK 244 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~---------------~~ 244 (338)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||............... ..
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred --cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 1223457899999999999999999999999999999999999999754321111100000 00
Q ss_pred hh-------ccCCcccccCcccccc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 245 LW-------CEGNAQELMDPVLKES---FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 245 ~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.+ ................ ........+.+|+.+||+.||++|||+.|+++ ++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 0000000011100000 01112345778999999999999999999996 5554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=255.40 Aligned_cols=236 Identities=26% Similarity=0.323 Sum_probs=168.6
Q ss_pred hcCCCCCc-eecccCCeeEEEEEE---cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNEN-KLGEGGFGPVYKGVL---NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~-~iG~G~~g~V~~~~~---~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|++.+ .||+|+||.||+|.. ..++.||||.+..... +.+..|..+++.++||||+++++++ ..+.++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45888888 999999999999963 2357799999865432 3456778899999999999999999 567789
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+++++|.+++..... .....+....+++.++.+.|+ +.+||+|||++.........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999999999876432 223334555667777776543 45899999999876432221
Q ss_pred c-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 A-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+...... ...... ...
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~-~~~-- 243 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMG-CPA-- 243 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC-CCT--
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC-CCC--
Confidence 1 1122346788999999998889999999999999999999 999987543322111110 000000 000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 244 ------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 244 ------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0112456688889999999999999999999886644
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=254.45 Aligned_cols=233 Identities=20% Similarity=0.212 Sum_probs=166.8
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------------cccHHHHHHHHHhcC-CCceeeeee
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------------GQGLQEFKNLIAKLQ-HKNLVRLLG 111 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~~~~~l~~l~-hpnIv~~~~ 111 (338)
...+.++|++.+.||+|+||.||+|... +++.||||.+.... .+....|..+++.+. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999999964 57889999986543 123446667888885 999999999
Q ss_pred EEEeCCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccc
Q 045271 112 CCLEGNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMA 172 (338)
Q Consensus 112 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a 172 (338)
++.+.+.+++||||+++++|.+++..... .....+....+++.++.+.| ++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999875432 33334455556666666543 456999999999
Q ss_pred eecCCCCCCccccccccCCccccccccc------cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhh
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYAL------EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
...... .......|++.|+|||++. ...++.++|||||||++|+|++|..||.............
T Consensus 172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------ 242 (298)
T 1phk_A 172 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM------ 242 (298)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------
T ss_pred hhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh------
Confidence 876422 2233457899999999985 3468899999999999999999999986433211111110
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......... . ......+.+++.+||+.||.+|||+.++++
T Consensus 243 -~~~~~~~~~~-~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 -SGNYQFGSPE-W-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HTCCCCCTTT-G-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -cCCcccCccc-c-----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000000000 0 001123567888899999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=258.09 Aligned_cols=233 Identities=12% Similarity=0.059 Sum_probs=172.1
Q ss_pred HHhcCCCCCceecccCCeeEEEEE------EcCCcEEEEEEeccCCcccHHHHHHHHHhcC---CCceeeeeeEEEeCCE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV------LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ---HKNLVRLLGCCLEGNE 118 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~---hpnIv~~~~~~~~~~~ 118 (338)
...++|++.+.||+|+||.||+|. ..+++.||||.+..........+..+++.++ |+||+.+++++...+.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345689999999999999999993 4567889999998777667777777887777 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhcc------CccccccHHHHHHHHHHhhhcC-----------------------------CCC
Q 045271 119 LLLICEYMPNKSLDFLLFDS------TRSVQLDWNRRMCIINGIARDH-----------------------------KMN 163 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~~~~i~~~~-----------------------------~~~ 163 (338)
.++|||||++|+|.+++... .........+..+++.+|.+.| ++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence 99999999999999998642 1222334555666777766533 467
Q ss_pred eEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH
Q 045271 164 PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW 243 (338)
Q Consensus 164 vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 243 (338)
+||+|||+|..+............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------- 294 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------- 294 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------
Confidence 9999999998654323333344568999999999999999999999999999999999999998543211100
Q ss_pred hhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCcc
Q 045271 244 KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRP-TMSSVVFMLATDTI 301 (338)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~vl~~L~~~~~ 301 (338)
........... ....+++..||+.+|.+|+ ++.++.+.|+....
T Consensus 295 -----------~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 -----------PEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -----------ECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----------echhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00111111111 1234577779999999995 77777777776443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=262.24 Aligned_cols=222 Identities=27% Similarity=0.331 Sum_probs=161.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+.|++++.||+|+||.||+|.. .++..||||.+..... ..+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4689999999999999999995 5688899999865432 23567788999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 124 EYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||+. |++.+++..... ..........+++.+|.+.| ++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9996 677776643322 22233445556666766644 35699999999976521
Q ss_pred ccccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 184 TNRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||......... ....... .......
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~-~~~~~~~--- 276 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-SPALQSG--- 276 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-CCCCCCT---
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-CCCCCCC---
Confidence 22357999999999985 457899999999999999999999998653321111 0111010 0000000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ....+.+|+.+||+.||++|||+.++++
T Consensus 277 --~---~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 277 --H---WSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --T---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --C---CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0123456888899999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=264.86 Aligned_cols=177 Identities=20% Similarity=0.236 Sum_probs=138.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHhc------CCCceeeeeeEEEeCCEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG--QGLQEFKNLIAKL------QHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~l~~l------~hpnIv~~~~~~~~~~~~ 119 (338)
...+|++++.||+|+||.||+|... ++..||||.+..... .....|+.+++.+ +|+||+++++++...+.+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3568999999999999999999954 478899999965432 3345566666655 678999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCC--eEEeeeccceecC
Q 045271 120 LLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMN--PKISDFGMARVFG 176 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~--vkL~Dfg~a~~~~ 176 (338)
++||||+. ++|.+++.... ...........+++.+|.++| ++. +||+|||++....
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99999994 78888876543 222333445556777766644 233 9999999997642
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~ 231 (338)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||....
T Consensus 254 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 254 Q-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp C-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 2 2234589999999999999999999999999999999999999997543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=261.59 Aligned_cols=253 Identities=17% Similarity=0.189 Sum_probs=158.1
Q ss_pred hHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCC---
Q 045271 44 DLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGN--- 117 (338)
Q Consensus 44 ~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~--- 117 (338)
.......++|++.+.||+|+||.||+|.. .++..||||.+..... .....+.+.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45567778999999999999999999996 4588999999865432 34555666778889999999999997533
Q ss_pred ----EEEEEEecCCCCCHHHHHhc----c-CccccccHHHHHHHHHHhhhcC---------------------CCCeEEe
Q 045271 118 ----ELLLICEYMPNKSLDFLLFD----S-TRSVQLDWNRRMCIINGIARDH---------------------KMNPKIS 167 (338)
Q Consensus 118 ----~~~lv~e~~~~g~L~~~l~~----~-~~~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~ 167 (338)
.+++||||+++ +|...+.. . ............+++.++.+.| ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 38899999965 44433321 1 1122223445556777776666 3459999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH----
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT---- 242 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~---- 242 (338)
|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...............
T Consensus 175 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 999998764322 223457899999999997654 899999999999999999999999764332221111100
Q ss_pred ----HhhhccCC--cccccCcccc-----ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCc
Q 045271 243 ----WKLWCEGN--AQELMDPVLK-----ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDT 300 (338)
Q Consensus 243 ----~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~ 300 (338)
........ .......... ..........+.+|+.+||+.||.+|||+.|+++ ++++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00000000 0000000000 0000112345678999999999999999999996 455533
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=261.76 Aligned_cols=248 Identities=16% Similarity=0.146 Sum_probs=169.0
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCcccH--------------HHHHHHHHhcCCCceee
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQGL--------------QEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~--------------~~~~~~l~~l~hpnIv~ 108 (338)
..++|++.+.||+|+||.||+|.+.. ++.||||.+........ ..+...++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999999654 36799999865542211 11222345678999999
Q ss_pred eeeEEEeC----CEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC--------------------CC
Q 045271 109 LLGCCLEG----NELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH--------------------KM 162 (338)
Q Consensus 109 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~--------------------~~ 162 (338)
+++++... ...++||||+ +++|.+++..... ..........+++.+|.++| ++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5589999999 9999999876432 23333445556676666533 45
Q ss_pred CeEEeeeccceecCCCCCC-----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccc
Q 045271 163 NPKISDFGMARVFGGNQSE-----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS 237 (338)
Q Consensus 163 ~vkL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~ 237 (338)
.+||+|||+++.+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~- 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY- 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH-
Confidence 6999999999876422111 1113356999999999999999999999999999999999999999753221111
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.... ..........+++..+..... ...+.+|+..||+.||.+|||+.+|++.|+......
T Consensus 271 -~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 271 -VRDS-KIRYRENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp -HHHH-HHHHHHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHHH-HHHhhhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1000 000011112222211111111 124566888899999999999999999998876554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=258.87 Aligned_cols=236 Identities=24% Similarity=0.334 Sum_probs=163.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCC-----cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDD-----KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
.++|++.+.||+|+||.||+|..... ..||||.+..... ..+.+|+.+++.++||||+++++++.+.+.++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 35788899999999999999995432 3599999875432 23556778899999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
+||||+++++|.+++..... .....+....+++.+|.+.| ++.+||+|||++........
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999999999999876432 22233445556666666544 45699999999987643221
Q ss_pred Cc-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 181 EA-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+...... ...... ...
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~------~~~~~~--~~~- 273 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN------DGFRLP--TPM- 273 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCCC--CCT-
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------CCCcCC--Ccc-
Confidence 11 1122346778999999998899999999999999999999 999986543221111110 000000 000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.....+.+++.+||+.||++|||+.++++.|+....
T Consensus 274 -------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 274 -------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp -------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011235668888999999999999999999987553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=254.58 Aligned_cols=239 Identities=25% Similarity=0.304 Sum_probs=165.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcCC----cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEE-eCCEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLNDD----KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCL-EGNEL 119 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~-~~~~~ 119 (338)
...+|++.+.||+|+||.||+|..... ..||+|.+..... +.+.+|..+++.++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 345799999999999999999995332 2489999875433 33567778999999999999999864 55678
Q ss_pred EEEEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++|+|.+++....... ...+....+++.++.+.| ++.+||+|||++.......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999999997644322 223344456666666544 3469999999998653322
Q ss_pred C--CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhC-CCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 180 S--EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG-RKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 180 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
. ........+|+.|+|||++.+..++.++|||||||++|+|++| .+||............. . .. .....
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---~----~~-~~~~~ 254 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---Q----GR-RLLQP 254 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH---T----TC-CCCCC
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---c----CC-CCCCC
Confidence 1 1112234677889999999999999999999999999999994 55554322211111100 0 00 00000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
... ...+.+++.+||+.||++|||+.++++.|+......
T Consensus 255 ~~~--------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 255 EYC--------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ccC--------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 123567888899999999999999999998866543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=268.58 Aligned_cols=239 Identities=20% Similarity=0.205 Sum_probs=161.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeC------CEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEG------NELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~------~~~~lv 122 (338)
..+|++++.||+|+||.||+|.+. +++.||||++.... ....+|+++++.++||||++++++|... ..+++|
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 347999999999999999999964 58899999986543 2344688899999999999999998542 246799
Q ss_pred EecCCCCCHHHHHhc-----cCccccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCC
Q 045271 123 CEYMPNKSLDFLLFD-----STRSVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGN 178 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~ 178 (338)
|||+++ ++..++.. .............+++.+|.++|+. .+||+|||+++.+...
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 999965 55555432 1122223344556777777775542 3799999999876322
Q ss_pred CCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH--------HhhhccC
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------WKLWCEG 249 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 249 (338)
. .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||......+....+... .... ..
T Consensus 211 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~-~~ 286 (420)
T 1j1b_A 211 E---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM-NP 286 (420)
T ss_dssp C---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH-CS
T ss_pred C---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-Ch
Confidence 1 22345789999999999875 6999999999999999999999999764322211111100 0000 00
Q ss_pred CcccccCccccccc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 250 NAQELMDPVLKESF-----ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 250 ~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......-+.+.... .......+.+|+.+||++||.+|||+.|+++
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000000000 0011235678899999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=258.26 Aligned_cols=237 Identities=19% Similarity=0.200 Sum_probs=166.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEe----CCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLE----GNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~l 121 (338)
.++|++++.||+|+||.||+|.. .+++.||||.+..... +.+.+|..+++.++||||+++++++.. .+..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45899999999999999999995 5688999999865432 345677889999999999999999873 347899
Q ss_pred EEecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 122 ICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
||||+.+|+|.+++... .......+....+++.+|.+.| ++.+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999999888652 1223334455566777776644 356999999998764211
Q ss_pred CCCc-------cccccccCCccccccccccCC---CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 179 QSEA-------NTNRVVGTYGYMAPEYALEGL---FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 179 ~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||............... .
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~---- 262 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-N---- 262 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-C----
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-c----
Confidence 1100 011235789999999987654 689999999999999999999998643221111111000 0
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
... .... ......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 263 -~~~--~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 -QLS--IPQS------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -C----CCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -cCC--CCcc------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 0000 001124567888899999999999999999999854
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=279.76 Aligned_cols=235 Identities=25% Similarity=0.335 Sum_probs=165.2
Q ss_pred CCCCCc-eecccCCeeEEEEEEc---CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 52 NFSNEN-KLGEGGFGPVYKGVLN---DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 52 ~y~~~~-~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++.+.+ .||+|+||.||+|.+. ++..||||.++... .+.+.+|+.+++.++||||+++++++.. +.+++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 334444 7999999999999853 34569999997542 2446778889999999999999999976 5689999
Q ss_pred ecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC-c
Q 045271 124 EYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE-A 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~-~ 182 (338)
|||++|+|.+++..... ..........+++.+|.++|+ +.+||+|||+++.+...... .
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 99999999999865433 222334455667777776553 45899999999865322211 1
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.. ..... ...
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-------~~~~~-~p~---- 562 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKRME-CPP---- 562 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-------TCCCC-CCT----
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCCCC-CCC----
Confidence 1122345688999999998999999999999999999998 9999975433221111110 00000 000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcccc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITL 303 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~ 303 (338)
.....+.+||.+||+.||++|||+.+|++.|+..+...
T Consensus 563 ----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 563 ----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01134567888999999999999999999999876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=254.75 Aligned_cols=229 Identities=26% Similarity=0.313 Sum_probs=163.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEeC-CEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLEG-NELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~ 127 (338)
.++|++.+.||+|+||.||+|.. .+..||||.+.... .+.+.+|+.+++.++||||+++++++... +.+++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 46899999999999999999987 47889999987543 34567788899999999999999987654 57899999999
Q ss_pred CCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+++|.+++..... .....+....+++.++.+.| ++.+||+|||++...... ...
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~ 173 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 173 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccC
Confidence 9999998865432 22223445556666666543 456999999998765321 122
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||++.+..++.++|||||||++|+|++ |..||......+...... ...... ...
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~~-~~~-------- 237 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMD-APD-------- 237 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTCCCC-CCT--------
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCCCCC-Ccc--------
Confidence 467889999999998899999999999999999998 999987543322111110 000000 000
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+++.+||+.||++|||+.++++.|+...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 01123566888899999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=259.49 Aligned_cols=234 Identities=21% Similarity=0.224 Sum_probs=167.2
Q ss_pred hcCCCCCceecccCCeeEEEEEE----cCCcEEEEEEeccC-------CcccHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRS-------SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGN 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~ 117 (338)
.++|++++.||+|+||.||+|+. .+++.||||++... .......|..+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999996 36789999998542 223455677788888 6999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
.+++||||+++++|.+++..... ..........+++.+|.++| ++.+||+|||++..+...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999998875432 22233344456677766644 456999999999875321
Q ss_pred CCCccccccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
. .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||................... ... ..
T Consensus 213 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~----~~ 286 (355)
T 1vzo_A 213 E-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPP----YP 286 (355)
T ss_dssp G-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCC----CC
T ss_pred C-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCC----CC
Confidence 1 1223346799999999999863 47899999999999999999999997543222211111110000 000 00
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhh
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVFMLA 297 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~~L~ 297 (338)
. .....+.+|+.+||+.||.+|| |+.++++..-
T Consensus 287 ~--------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 287 Q--------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred c--------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0 0112345688889999999999 9999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=263.33 Aligned_cols=252 Identities=17% Similarity=0.221 Sum_probs=165.9
Q ss_pred hhHHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--------------ccHHHHHHHHHhcCCCceee
Q 045271 43 LDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--------------QGLQEFKNLIAKLQHKNLVR 108 (338)
Q Consensus 43 ~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~l~~l~hpnIv~ 108 (338)
........++|++.+.||+|+||.||+|....+..||||.+..... +.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3466778899999999999999999999987899999999854221 34567888999999999999
Q ss_pred eeeEEEe-----CCEEEEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCC
Q 045271 109 LLGCCLE-----GNELLLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMN 163 (338)
Q Consensus 109 ~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~ 163 (338)
+++++.. ...+|+||||+. |+|...+..... ..........+++.++.++| ++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9999854 346899999996 677777765432 22233445556666666644 456
Q ss_pred eEEeeeccceecCCCCCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH
Q 045271 164 PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT 242 (338)
Q Consensus 164 vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~ 242 (338)
+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+........
T Consensus 173 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 173 ITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999754321 22234578999999999987 57899999999999999999999999754322221111100
Q ss_pred H----------------hhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 243 W----------------KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 243 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
. ..+.............. .........+.+|+.+||+.||.+|||+.|+++ +++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 00000000000000000 000011224567889999999999999999996 45544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=258.86 Aligned_cols=231 Identities=19% Similarity=0.193 Sum_probs=163.6
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----------cccHHHHHHHHHhcCCCceeeeeeEEEe
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----------GQGLQEFKNLIAKLQHKNLVRLLGCCLE 115 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~~~~~l~~l~hpnIv~~~~~~~~ 115 (338)
.+.++|++.+.||+|+||.||+|... +++.||||.+.... ...+..|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45678999999999999999999954 57889999986432 1246778889999999999999999976
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccce
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMAR 173 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~ 173 (338)
.+ +++||||+++++|.+++..... ..........+++.+|.+.|. ..+||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 55 8999999999999888765432 222334455567777666442 239999999998
Q ss_pred ecCCCCCCccccccccCCccccccccc---cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYAL---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
.... ........||+.|+|||++. ...++.++|||||||++|+|++|..||......... ...... .....
T Consensus 166 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~-~~~~~ 239 (322)
T 2ycf_A 166 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS-GKYNF 239 (322)
T ss_dssp ECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHHH-TCCCC
T ss_pred eccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHHh-Ccccc
Confidence 7632 12223457899999999974 456899999999999999999999999753322111 100000 00000
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...... .....+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~---------~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 240 IPEVWA---------EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cchhhh---------hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 01124567888999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=259.16 Aligned_cols=237 Identities=19% Similarity=0.148 Sum_probs=147.0
Q ss_pred HHhcCCCCCc-eecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEe----CCEEEE
Q 045271 48 EATRNFSNEN-KLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLE----GNELLL 121 (338)
Q Consensus 48 ~~~~~y~~~~-~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~l 121 (338)
.+.++|++++ .||+|+||.||+|... +++.||||.+... .....+....++.++||||+++++++.. ...+++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 3567899965 6999999999999965 5889999998653 2333444456788899999999999976 456899
Q ss_pred EEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCC
Q 045271 122 ICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~ 177 (338)
||||+++|+|.+++.... ......+....+++.++.++|+ +.+||+|||++.....
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999999999997653 2333344555667777766442 3489999999987532
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ...... .....
T Consensus 184 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~-~~~~~ 255 (336)
T 3fhr_A 184 ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR---IRLGQY-GFPNP 255 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCTT
T ss_pred ----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh---hhcccc-ccCch
Confidence 1223457899999999998888999999999999999999999999654322211100000 000000 00000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.. ......+.+|+.+||+.||++|||+.|+++ ++..
T Consensus 256 ~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 256 EW-----SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp TS-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hh-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 00 001124567888899999999999999997 5554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.26 Aligned_cols=238 Identities=24% Similarity=0.279 Sum_probs=167.2
Q ss_pred CCCCCceecccCCeeEEEEEEcC-Cc---EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE-EEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLND-DK---EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL-LLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~-~~---~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~-~lv 122 (338)
.|++.+.||+|+||.||+|.+.. +. .||+|.+..... +.+.+|..+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56677999999999999999433 33 689999875433 3355777899999999999999999876554 999
Q ss_pred EecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC--C
Q 045271 123 CEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ--S 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~--~ 180 (338)
|||+.+|+|.+++....... ...+....+++.++.+.| ++.+||+|||++....... .
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 99999999999997644322 223344456777766644 3469999999997653221 1
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
........++..|+|||.+.+..++.++|||||||++|+|++|..|+........ ....... ... .. ...
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~---~~~-~~-~~~--- 251 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLAQ---GRR-LP-QPE--- 251 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHHT---TCC-CC-CCT---
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhhc---CCC-CC-CCc---
Confidence 1122335678899999999999999999999999999999996665432221111 1111000 000 00 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
.....+.+++.+||+.||.+|||+.++++.|+.......
T Consensus 252 -----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 252 -----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -----cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011245678889999999999999999999998765544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=265.92 Aligned_cols=241 Identities=17% Similarity=0.148 Sum_probs=165.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHhcC--------CCceeeeeeEEE--
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQ--------HKNLVRLLGCCL-- 114 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~--------hpnIv~~~~~~~-- 114 (338)
.+.++|+++++||+|+||.||+|.. .+++.||||++.... .....+|+.+++.++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4467999999999999999999995 457789999996543 234566777777774 788999999998
Q ss_pred --eCCEEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCCC---------------------------
Q 045271 115 --EGNELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHKM--------------------------- 162 (338)
Q Consensus 115 --~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~~--------------------------- 162 (338)
+...+++||||+ ++++...+.... ...........+++.+|.++|..
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 456899999999 555554443322 22333444555677776665532
Q ss_pred -----------------------------------------CeEEeeeccceecCCCCCCccccccccCCcccccccccc
Q 045271 163 -----------------------------------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201 (338)
Q Consensus 163 -----------------------------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (338)
.+||+|||++..... ......||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcC
Confidence 699999999987632 1233578999999999999
Q ss_pred CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH---HHhhhcc---------CCcccccC---------ccc-
Q 045271 202 GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY---TWKLWCE---------GNAQELMD---------PVL- 259 (338)
Q Consensus 202 ~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~~---------~~~- 259 (338)
..++.++|||||||++|+|++|..||.............. ....... ......+. ...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999975432221110000 0000000 00000000 000
Q ss_pred ---------cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 ---------KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ---------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...........+.+|+.+||+.||++|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00112344456788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.25 Aligned_cols=231 Identities=19% Similarity=0.236 Sum_probs=170.7
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
..++|++.+.||+|+||.||+|... +++.||+|.+.... .+.+..|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3568999999999999999999965 47789999986432 1335667788999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 122 ICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||||+++++|.+++.... ...........+++.++.+.| ++.+||+|||++....... .
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--c
Confidence 999999999998886543 233334455556777766644 3569999999998763221 2
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......+..... ..... . ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-~-~~~~---- 237 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNEY-S-IPKH---- 237 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTCC-C-CCTT----
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hhccC-C-Cccc----
Confidence 223457899999999999888999999999999999999999999754322211100 00000 0 0000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
....+.+++.+||+.||++|||+.|+++ ++..
T Consensus 238 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 238 ----INPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ----cCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 0123556888899999999999999996 4544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=262.47 Aligned_cols=243 Identities=24% Similarity=0.298 Sum_probs=169.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-----cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeC--CEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-----NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEG--NEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~--~~~ 119 (338)
.++|++++.||+|+||.||+|.. .++..||||.+..... ..+.+|+.+++.++||||+++++++... ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45799999999999999999984 3577899999976543 2456788899999999999999998754 378
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++++|.+++..... .....+....+++.+|.+.| ++.+||+|||++.......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999999999999876532 22233444556777766644 3458999999998764322
Q ss_pred CCc-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccccccc------cc--chhh-HHHhhhccC
Q 045271 180 SEA-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ------GQ--SLLT-YTWKLWCEG 249 (338)
Q Consensus 180 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~------~~--~~~~-~~~~~~~~~ 249 (338)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||......- .. .... .........
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 211 1223456778999999999889999999999999999999998876321100 00 0000 000000000
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
.... .. ......+.++|.+||+.||++|||+.++++.|+....
T Consensus 280 ~~~~-~~--------~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 280 GRLP-RP--------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp CCCC-CC--------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-CC--------CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000 00 0111345678889999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.27 Aligned_cols=225 Identities=23% Similarity=0.313 Sum_probs=160.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe----CCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE----GNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~ 120 (338)
+.|++.+.||+|+||.||+|.. .++..||+|.+..... +.+.+|..+++.++||||+++++++.. ...++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4588889999999999999995 4577899999864321 335667788999999999999999875 45689
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
+||||+++++|.+++..... .....+....+++.++.+.| ++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~- 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-
Confidence 99999999999999876332 22333444555666665543 34589999999975422
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||......... . ...............
T Consensus 185 ---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~-~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----Y-RRVTSGVKPASFDKV 254 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----H-HHHTTTCCCGGGGGC
T ss_pred ---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----H-HHHhccCCccccCCC
Confidence 22234578999999998764 5899999999999999999999999643221110 0 000011000001000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+|+.+||+.||.+|||+.++++
T Consensus 255 --------~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 255 --------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0123567888999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=259.99 Aligned_cols=180 Identities=21% Similarity=0.254 Sum_probs=140.4
Q ss_pred HHHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHhcC-CC-----ceeeeeeEEEeC
Q 045271 46 IHEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG--QGLQEFKNLIAKLQ-HK-----NLVRLLGCCLEG 116 (338)
Q Consensus 46 ~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~l~~l~-hp-----nIv~~~~~~~~~ 116 (338)
...+.++|++.+.||+|+||.||+|... +++.||||++..... .....+..+++.++ |+ +|+++++++...
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 3445679999999999999999999954 577899999975432 23445666666664 44 499999999999
Q ss_pred CEEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC----------------------CCCeEEeeecc
Q 045271 117 NELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH----------------------KMNPKISDFGM 171 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~----------------------~~~vkL~Dfg~ 171 (338)
+.+++||||++ ++|.+++.... ...........+++.+|.++| ++.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999999995 68988886543 223334455566777777665 23489999999
Q ss_pred ceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccc
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~ 231 (338)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 208 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 208 SCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 987632 1234578999999999999999999999999999999999999997543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.91 Aligned_cols=249 Identities=20% Similarity=0.218 Sum_probs=171.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC-----CEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG-----NEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~~~ 119 (338)
.++|++++.||+|+||.||+|... ++..||||.+..... ..+.+|+.+++.++||||+++++++... ..+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999954 577899999864332 3456788899999999999999999754 468
Q ss_pred EEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
++||||+. |+|..++...............+++.+|.++| ++.+||+|||++.........
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 99999995 68988887665554455556667777777644 346999999999876422211
Q ss_pred -ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc----
Q 045271 182 -ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM---- 255 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 255 (338)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+................
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 112345899999999987654 58999999999999999999999997644333222111000000000000000
Q ss_pred -----CccccccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 256 -----DPVLKESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 256 -----~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.......... .....+.+|+.+||+.||++|||+.|+++ +++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000000000 01124677899999999999999999996 45443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=250.54 Aligned_cols=234 Identities=19% Similarity=0.187 Sum_probs=162.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-------cccHHHHHHHHHhcCCCceeeeeeEEE--eCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-------GQGLQEFKNLIAKLQHKNLVRLLGCCL--EGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~l~~l~hpnIv~~~~~~~--~~~~ 118 (338)
+.++|++++.||+|+||.||+|.. .++..||+|.+.... ...+.+|..+++.++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 467999999999999999999995 457889999986432 234667888999999999999999984 4567
Q ss_pred EEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCC
Q 045271 119 LLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGG 177 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~ 177 (338)
+++||||+.++ |.+++.... ......+....+++.++.+.| ++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999766 655554322 222233445556666666644 45689999999987643
Q ss_pred CCCCccccccccCCccccccccccCC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
...........|+..|+|||++.+.. ++.++|||||||++|+|++|..||............. .... . +
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-------~~~~-~-~ 232 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-------KGSY-A-I 232 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HCCC-C-C
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh-------cCCC-C-C
Confidence 32233333457899999999998653 4789999999999999999999997533221111100 0000 0 0
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCc
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDT 300 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~ 300 (338)
.. . ....+.+|+.+||+.||.+|||+.++++ ++....
T Consensus 233 ~~--~------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 233 PG--D------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CS--S------SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CC--c------cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 00 0 1123456888899999999999999995 555543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=265.35 Aligned_cols=173 Identities=20% Similarity=0.319 Sum_probs=121.8
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe-----CCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE-----GNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~-----~~~ 118 (338)
.++|++++.||+|+||.||+|.. .+++.||||++..... +.+.+|+.+++.++||||+++++++.. .+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999995 4688899999865322 345678889999999999999999954 357
Q ss_pred EEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
+|+||||+ +++|..++..... ..........+++.+|.++| ++.+||+|||+|+......
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 99999998 6888888876532 22333445556777777644 3569999999998763221
Q ss_pred CC-------------------------ccccccccCCccccccccc-cCCCCcccchHhHhHHHHHHHhC
Q 045271 180 SE-------------------------ANTNRVVGTYGYMAPEYAL-EGLFSVKSDVFSFGVLLLEIISG 223 (338)
Q Consensus 180 ~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiWSlGv~l~el~~g 223 (338)
.. ......+||+.|+|||++. +..|+.++|||||||++|||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 10 1123457899999999875 55699999999999999999994
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=264.85 Aligned_cols=237 Identities=26% Similarity=0.335 Sum_probs=157.9
Q ss_pred CCCCCceecccCCeeEEEEEEc--CC--cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEE-eCCEEEEE
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN--DD--KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCL-EGNELLLI 122 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~-~~~~~~lv 122 (338)
.|++.+.||+|+||.||+|... ++ ..||+|.+..... ..+.+|..+++.++||||+++++++. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677899999999999999953 22 3589998864332 23556677888999999999999875 45678999
Q ss_pred EecCCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC-
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE- 181 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~- 181 (338)
|||+++|+|.+++........ .......+++.+|.+.| ++.+||+|||+++.+......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 999999999999976543222 23344456777766644 456999999999865322211
Q ss_pred -ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 -ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......++..|+|||++.+..++.++|||||||++|+|++ |.+||......+...... . ... ...+
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~---~---~~~---~~~p-- 318 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---Q---GRR---LLQP-- 318 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH---T---TCC---CCCC--
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH---c---CCC---CCCC--
Confidence 11223457788999999999999999999999999999999 666765433222111110 0 000 0000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
.. ....+.++|.+||+.||++|||+.++++.|+.......
T Consensus 319 --~~---~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 319 --EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 11235678889999999999999999999998765443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=261.91 Aligned_cols=180 Identities=25% Similarity=0.375 Sum_probs=125.6
Q ss_pred hcCCCC-CceecccCCeeEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEEE
Q 045271 50 TRNFSN-ENKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLLI 122 (338)
Q Consensus 50 ~~~y~~-~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~lv 122 (338)
.+.|++ .++||+|+||.||+|.+. ++..||||.+.... .....+|+.+++.++||||+++++++.. ...+++|
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 345776 458999999999999965 46789999997543 3457788899999999999999999965 6789999
Q ss_pred EecCCCCCHHHHHhccC----------ccccccHHHHHHHHHHhhhcC----------------------CCCeEEeeec
Q 045271 123 CEYMPNKSLDFLLFDST----------RSVQLDWNRRMCIINGIARDH----------------------KMNPKISDFG 170 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~~~~i~~~~----------------------~~~vkL~Dfg 170 (338)
|||+. ++|..++.... ........+..+++.+|.++| ++.+||+|||
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 99995 67766664321 122223445556666666533 3469999999
Q ss_pred cceecCCCCC-CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 171 MARVFGGNQS-EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 171 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
++..+..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9987642211 1223346899999999999875 5899999999999999999999999643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=248.36 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=162.1
Q ss_pred CCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.|.....||+|+||.||+|.. .++..||||.+..... +.+.+|..+++.++||||+++++++.+.+.+++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455567999999999999995 4577899999865433 346677889999999999999999999999999999999
Q ss_pred CCCHHHHHhccCcccc----ccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 128 NKSLDFLLFDSTRSVQ----LDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~----~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
+++|.+++........ .......+++.+|.+.| ++.+||+|||++....... ...
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~ 180 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCT 180 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Ccc
Confidence 9999999876532222 22334455666666533 4569999999998764321 122
Q ss_pred cccccCCccccccccccCC--CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 185 NRVVGTYGYMAPEYALEGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~--~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
....|+..|+|||++.+.. ++.++|||||||++|+|++|..||......... . ...... ....... . .
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~-~~~~~~--~~~~~~~-~----~ 250 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--M-FKVGMF--KVHPEIP-E----S 250 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--H-HHHHHH--CCCCCCC-T----T
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--H-Hhhccc--ccccccc-c----c
Confidence 3457899999999997654 889999999999999999999998643211110 0 000000 0000000 0 0
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+++.+||+.||++|||+.++++
T Consensus 251 ----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 ----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1123556888899999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=252.87 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=165.0
Q ss_pred HhcCCCCCceecccCCeeEEEEEE--cCCcEEEEEEeccCC-----cccHHHHHHHHHhc---CCCceeeeeeEEE----
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL--NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKL---QHKNLVRLLGCCL---- 114 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l---~hpnIv~~~~~~~---- 114 (338)
..++|++++.||+|+||.||+|.. .+++.||+|.+.... .....+|..+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 356899999999999999999997 357789999985322 23455666666555 8999999999987
Q ss_pred -eCCEEEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccc
Q 045271 115 -EGNELLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMA 172 (338)
Q Consensus 115 -~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a 172 (338)
....+++||||+. |+|.+++..... ..........+++.++.+.| ++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 4567899999996 799888865432 22333445556666666543 456999999999
Q ss_pred eecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh-----hhc
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK-----LWC 247 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-----~~~ 247 (338)
..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||................. .+.
T Consensus 168 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 168 RIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 76531 1223345789999999999999999999999999999999999999975432221111110000 000
Q ss_pred cCC-c-ccccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 248 EGN-A-QELMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 248 ~~~-~-~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
... . ...+...... .........+.+|+.+||+.||.+|||+.++++ ++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 000 0 0000000000 000001123567888999999999999999995 4544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=262.18 Aligned_cols=236 Identities=21% Similarity=0.251 Sum_probs=151.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG------ 116 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~------ 116 (338)
..++|++++.||+|+||.||+|.. .++..||||++..... ....+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 346999999999999999999995 4578899999865322 3355678899999999999999999754
Q ss_pred CEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
..+++|||++ +++|..++...............+++.+|.+.| ++.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 5689999999 789988887654444444555666777777644 35699999999986532
Q ss_pred CCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..........
T Consensus 185 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~----g~p~~~~~~~ 256 (367)
T 2fst_X 185 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV----GTPGAELLKK 256 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH----CSCCHHHHTT
T ss_pred ----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh----CCCCHHHHHH
Confidence 1234578999999999987 578999999999999999999999997543322211111000 0000000000
Q ss_pred c------------cc-ccccHHH-----HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 V------------LK-ESFILEE-----LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~------------~~-~~~~~~~-----~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. .. ....... ...+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 00 0001111 124677899999999999999999996
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.92 Aligned_cols=235 Identities=20% Similarity=0.311 Sum_probs=162.3
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHhc-CCCceeeeeeEEEe------C
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--GQGLQEFKNLIAKL-QHKNLVRLLGCCLE------G 116 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~l~~l-~hpnIv~~~~~~~~------~ 116 (338)
....++|++++.||+|+||.||+|.. .+++.||||.+.... ...+..+..+++.+ +||||+++++++.. .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34567899999999999999999996 468889999986433 34566777888888 79999999999987 4
Q ss_pred CEEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceec
Q 045271 117 NELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVF 175 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~ 175 (338)
+.+++||||+++++|.+++.... ...........+++.+|.++| ++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 68999999999999999987542 222223445556666666644 456999999999865
Q ss_pred CCCCCCccccccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 176 GGNQSEANTNRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
... ........|++.|+|||++. +..++.++|||||||++|+|++|..||......... ..... ..
T Consensus 180 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~ 250 (326)
T 2x7f_A 180 DRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR-NP 250 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SC
T ss_pred CcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HHhhc-Cc
Confidence 321 11223457899999999997 456899999999999999999999998643321111 00000 00
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
......... ...+.+|+.+||+.||.+|||+.++++ ++..
T Consensus 251 ~~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 251 APRLKSKKW--------SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp CCCCSCSCS--------CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred cccCCcccc--------CHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 111111000 124566888899999999999999986 4543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=259.05 Aligned_cols=233 Identities=19% Similarity=0.157 Sum_probs=149.2
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcC-CCceeeeeeEEE--------eC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQ-HKNLVRLLGCCL--------EG 116 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~-hpnIv~~~~~~~--------~~ 116 (338)
..+|++.+.||+|+||.||+|.+ .+++.||||.+..... ..+..|..+++.+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34899999999999999999995 4688999999855443 23456677888885 999999999994 34
Q ss_pred CEEEEEEecCCCCCHHHHHhcc----CccccccHHHHHHHHHHhhhcCC--------------------CCeEEeeeccc
Q 045271 117 NELLLICEYMPNKSLDFLLFDS----TRSVQLDWNRRMCIINGIARDHK--------------------MNPKISDFGMA 172 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~~~~i~~~~~--------------------~~vkL~Dfg~a 172 (338)
..+++||||+ .|+|.+++... .......+....+++.+|.++|. +.+||+|||++
T Consensus 107 ~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 4589999999 57888877542 12223344555567777766553 35899999999
Q ss_pred eecCCCCCCc----------cccccccCCcccccccc---ccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchh
Q 045271 173 RVFGGNQSEA----------NTNRVVGTYGYMAPEYA---LEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL 239 (338)
Q Consensus 173 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~ 239 (338)
.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--- 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--- 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---
Confidence 8764322111 11134689999999998 4567899999999999999999999998643221110
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
. . ....... ...+ ..+.+|+.+||+.||.+|||+.++++.|+.....
T Consensus 263 ~---~-----~~~~~~~--~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 263 N---G-----KYSIPPH--DTQY------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------CCCCTT--CCSS------GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c---C-----cccCCcc--cccc------hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0 0000000 0001 1135678889999999999999999999887653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=262.65 Aligned_cols=179 Identities=21% Similarity=0.327 Sum_probs=135.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC-----C
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG-----N 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~ 117 (338)
+.++|++++.||+|+||.||+|... +++.||||++..... ..+.+|+.+++.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3569999999999999999999954 577899999965322 3456788899999999999999999865 5
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
.+|+||||+ +++|..++..... ..........+++.+|.++| ++.+||+|||+|+.....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 799999999 5799988876532 33334455566777777644 356999999999876432
Q ss_pred CCC--------------------ccccccccCCccccccccc-cCCCCcccchHhHhHHHHHHHhCCCCCc
Q 045271 179 QSE--------------------ANTNRVVGTYGYMAPEYAL-EGLFSVKSDVFSFGVLLLEIISGRKDTR 228 (338)
Q Consensus 179 ~~~--------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiWSlGv~l~el~~g~~Pf~ 228 (338)
... ......+||+.|+|||++. +..|+.++|||||||++|||++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 211 1124568999999999875 5569999999999999999998665554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=262.37 Aligned_cols=228 Identities=21% Similarity=0.235 Sum_probs=162.8
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCCCC
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPNKS 130 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 130 (338)
+|++.+.||+|+||.|+.....+++.||||.+.........+|..+++.+ +||||+++++++.+.+.+|+|||||. |+
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 68889999999999977555668899999999776666778888999988 79999999999999999999999994 79
Q ss_pred HHHHHhccCcccc--ccHHHHHHHHHHhhhcCCC-----------------------CeEEeeeccceecCCCCC-Cccc
Q 045271 131 LDFLLFDSTRSVQ--LDWNRRMCIINGIARDHKM-----------------------NPKISDFGMARVFGGNQS-EANT 184 (338)
Q Consensus 131 L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~~-----------------------~vkL~Dfg~a~~~~~~~~-~~~~ 184 (338)
|.+++........ .......+++.+|.++|+. .+||+|||+|..+..... ....
T Consensus 104 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~ 183 (432)
T 3p23_A 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183 (432)
T ss_dssp HHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----------
T ss_pred HHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeec
Confidence 9988876543222 3345666777777765431 367999999987642211 1223
Q ss_pred cccccCCcccccccccc---CCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 185 NRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
...+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||........ . ........ ...
T Consensus 184 ~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~---~~~~~~~~-~~~----- 250 (432)
T 3p23_A 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----N---ILLGACSL-DCL----- 250 (432)
T ss_dssp --CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----H---HHTTCCCC-TTS-----
T ss_pred cccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----H---HHhccCCc-ccc-----
Confidence 34679999999999984 457889999999999999999 8888853221111 0 00000000 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.........+.+|+.+||+.||.+|||+.+|++
T Consensus 251 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 -HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 011122334567899999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=263.08 Aligned_cols=230 Identities=12% Similarity=-0.031 Sum_probs=148.2
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhc--CCCceeeee-------eEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKL--QHKNLVRLL-------GCCL 114 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l--~hpnIv~~~-------~~~~ 114 (338)
..|++.+.||+|+||.||+|.+. +++.||||++..... +.+.+|..+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999954 678899999976442 2344554334433 699988755 5554
Q ss_pred eC-----------------CEEEEEEecCCCCCHHHHHhccCcccccc--------HHHHHHHHHHhhhcC---------
Q 045271 115 EG-----------------NELLLICEYMPNKSLDFLLFDSTRSVQLD--------WNRRMCIINGIARDH--------- 160 (338)
Q Consensus 115 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~--------~~~~~~~~~~i~~~~--------- 160 (338)
.. ..+|+|||||+ |+|.+++.......... +....+++.+|.++|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999997 99999997643332222 233367777777654
Q ss_pred ---------CCCeEEeeeccceecCCCCCCccccccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCCcc
Q 045271 161 ---------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDTRF 229 (338)
Q Consensus 161 ---------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf~~ 229 (338)
++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 35699999999987531 1113456799999999987 6799999999999999999999999976
Q ss_pred cccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 230 YLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
........... ......................+.+||.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGSWKR--------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTCCCB--------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccchhh--------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 53221110000 0000000000000000011234567888999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=245.15 Aligned_cols=232 Identities=20% Similarity=0.269 Sum_probs=162.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++.+.||+|+||.||+|... +++.||||.+.... ...+.+++.+++.++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999965 68899999985432 23466778889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|||+++++|.+++..... ..........+++.+|.+.| ++.+||+|||++...... ..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC---cc
Confidence 999999999998865432 22333445555666666533 456999999999865322 12
Q ss_pred ccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....|++.|+|||++.+..+ +.++||||||+++|+|++|..||............. ... .. .....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~-~~-~~~~~--- 234 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-------GGV-FY-IPEYL--- 234 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC-CC-CCTTS---
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-------cCc-cc-Cchhc---
Confidence 234578999999999988765 689999999999999999999986533221111100 000 00 00000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDTI 301 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~~ 301 (338)
...+.+++.+||+.||++|||+.++++ ++....+
T Consensus 235 -----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 235 -----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp -----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred -----CHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 123556888899999999999999996 4655443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=255.72 Aligned_cols=240 Identities=20% Similarity=0.272 Sum_probs=151.2
Q ss_pred HHhcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
...++|++.+.||+|+||.||+|. ..++..||||.+.... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 446799999999999999999999 4468899999885432 23345666777888999999999999999999999
Q ss_pred EecCCCCCHHHHHhcc---------CccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceec
Q 045271 123 CEYMPNKSLDFLLFDS---------TRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVF 175 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~ 175 (338)
|||+++++|.+++... .......+....+++.++.+.| ++.+||+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999999988641 1222233445556666666544 456999999998765
Q ss_pred CCCCC---CccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 176 GGNQS---EANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 176 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~----~~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQ----NDP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HHT----SSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---Hhc----cCC
Confidence 32211 111233578999999999876 4689999999999999999999999975432221100 000 000
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...................+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000000001123566888899999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=246.11 Aligned_cols=222 Identities=21% Similarity=0.215 Sum_probs=162.4
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~ 120 (338)
.+.++|++++.||+|+||.||+|... +++.||||.+..... ....++...+..+ +||||+++++++.+.+.++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 45678999999999999999999965 688999999875422 2244455566777 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccC-----ccccccHHHHHHHHHHhhhcCC----------------------------------
Q 045271 121 LICEYMPNKSLDFLLFDST-----RSVQLDWNRRMCIINGIARDHK---------------------------------- 161 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~~~---------------------------------- 161 (338)
+||||+++++|.+++.... ......+....+++.+|.+.|+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999987532 2333345556667777666432
Q ss_pred ---CCeEEeeeccceecCCCCCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccc
Q 045271 162 ---MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS 237 (338)
Q Consensus 162 ---~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~ 237 (338)
..+||+|||++...... ....||..|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred CCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 24799999999876321 124689999999999876 567899999999999999999876542211
Q ss_pred hhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 238 LLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. ............. ....+.+++.+||+.||++|||+.++++
T Consensus 237 -~~----~~~~~~~~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -WH----EIRQGRLPRIPQV---------LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HH----HHHTTCCCCCSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH----HHHcCCCCCCCcc---------cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 0111111111110 0123566888899999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=254.15 Aligned_cols=243 Identities=21% Similarity=0.251 Sum_probs=169.6
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
......++|++.+.||+|+||.||+|.... .||+|.+.... .+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334446799999999999999999998744 59999986432 23456677788999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCC-
Q 045271 120 LLICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQ- 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~- 179 (338)
++||||+++++|.+++..... .....+....+++.++.+.|+ +.+||+|||++.......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC-------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccc
Confidence 999999999999999976542 333345556667777776543 458999999987542211
Q ss_pred --CCccccccccCCcccccccccc---------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 180 --SEANTNRVVGTYGYMAPEYALE---------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 180 --~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~- 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW------QMGT- 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH------HHHT-
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------Hhcc-
Confidence 1112233468999999999974 347889999999999999999999997543221111 1100
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
......... ..+. .+.+++.+||+.||++|||+.++++.|+.......
T Consensus 258 ~~~~~~~~~--~~~~------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 258 GMKPNLSQI--GMGK------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp TCCCCCCCS--SCCT------THHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCCCCCCcC--CCCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 001111100 1111 24567788999999999999999999999776543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=254.55 Aligned_cols=240 Identities=18% Similarity=0.180 Sum_probs=166.7
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-c-CCcEEEEEEeccCCc--ccHHHHHHHHHhcCCC------ceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-N-DDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHK------NLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hp------nIv~~~~~~~~~~~ 118 (338)
+.++|++++.||+|+||.||+|.. . ++..||||.+..... .....|..+++.++|+ +|+++++++.+.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 456999999999999999999996 3 577899999865432 3456677777777654 59999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcC-----------------------------------
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDH----------------------------------- 160 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~----------------------------------- 160 (338)
+++||||+ +++|.+++..... ..........+++.+|.+.|
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999999 8899888866542 22233445556777766643
Q ss_pred --CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccch
Q 045271 161 --KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL 238 (338)
Q Consensus 161 --~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~ 238 (338)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp ESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 33589999999987532 12345789999999999998999999999999999999999999975433222111
Q ss_pred hhHHHhhhcc------CCccc--------------------ccCcccc-ccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 045271 239 LTYTWKLWCE------GNAQE--------------------LMDPVLK-ESFILEELLKRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 239 ~~~~~~~~~~------~~~~~--------------------~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 291 (338)
.......... ..... ....... ..........+.+|+.+||+.||.+|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 1100000000 00000 0000000 0001122345678999999999999999999
Q ss_pred HHH
Q 045271 292 VVF 294 (338)
Q Consensus 292 vl~ 294 (338)
+++
T Consensus 326 ll~ 328 (339)
T 1z57_A 326 ALK 328 (339)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=260.46 Aligned_cols=239 Identities=18% Similarity=0.215 Sum_probs=167.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--------------------ccHHHHHHHHHhcCCCceeee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--------------------QGLQEFKNLIAKLQHKNLVRL 109 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~l~~l~hpnIv~~ 109 (338)
.++|++++.||+|+||.||+|.. +++.||||.+..... ..+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 56999999999999999999999 889999999853211 556778889999999999999
Q ss_pred eeEEEeCCEEEEEEecCCCCCHHHH------Hhcc---CccccccHHHHHHHHHHhhhcCC-------------------
Q 045271 110 LGCCLEGNELLLICEYMPNKSLDFL------LFDS---TRSVQLDWNRRMCIINGIARDHK------------------- 161 (338)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~---~~~~~~~~~~~~~~~~~i~~~~~------------------- 161 (338)
++++.+.+.+++||||+++++|.++ +... .......+....+++.++.+.|+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999887 4431 11222334455567777776654
Q ss_pred CCeEEeeeccceecCCCCCCccccccccCCccccccccccC-CCCc-ccchHhHhHHHHHHHhCCCCCcccccc-cccch
Q 045271 162 MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-LFSV-KSDVFSFGVLLLEIISGRKDTRFYLYE-QGQSL 238 (338)
Q Consensus 162 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiWSlGv~l~el~~g~~Pf~~~~~~-~~~~~ 238 (338)
+.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|+|++|..||...... +....
T Consensus 189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 35899999999876322 23345789999999999887 6776 999999999999999999999753321 10000
Q ss_pred hhHHHhhhccCCcccccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 239 LTYTWKLWCEGNAQELMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.......+ +............. .........+.+|+.+||+.||.+|||+.++++
T Consensus 265 i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 IRTKNIEY-PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HTSCCCCC-CCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCcCC-ccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 00000000000000 000111224567888999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=276.49 Aligned_cols=227 Identities=22% Similarity=0.216 Sum_probs=167.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~ 120 (338)
..++|++++.||+|+||.||+|... +++.||||++.+. .......|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999954 5778999998642 223345566677665 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+||||+++|+|..++..... .......+..+++.+|.++| ++.+||+|||+|+..... .
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--G 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--T
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC--C
Confidence 99999999999998876432 33334445566777776644 456999999999864322 2
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||......+....+ . ..... +...
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~-~~~~~--~p~~--- 564 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------M-EHNVA--YPKS--- 564 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-SSCCC--CCTT---
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------H-hCCCC--CCcc---
Confidence 2234578999999999999999999999999999999999999999754322211111 1 11100 1111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTM-----SSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~vl~ 294 (338)
....+.+|+.+||+.||++||++ .||++
T Consensus 565 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 -----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11245678889999999999998 78874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.36 Aligned_cols=230 Identities=19% Similarity=0.300 Sum_probs=160.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
..++|++++.||+|+||.||+|... ++..||+|.+..... ..+..++.+++.++||||+++++++.+.+.+++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999965 478899999865433 345667788999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|+++++|..++..... ..........+++.++.+.| ++.+||+|||++..... .....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 174 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKR 174 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HHHC-
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--ccccc
Confidence 9999999988865322 33333445556666666544 45699999998754311 01112
Q ss_pred cccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 185 NRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
....|+..|+|||++. +..++.++|||||||++|+|++|..||.......... ..... ........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-~~~~~~~~-- 245 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKS-DPPTLLTP-- 245 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-CCCCCSSG--
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHhcc-CCcccCCc--
Confidence 2357899999999984 5678999999999999999999999987543211110 00000 00000000
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+++.+||+.||++|||+.++++
T Consensus 246 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 246 -----SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001123567888899999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=275.47 Aligned_cols=227 Identities=26% Similarity=0.303 Sum_probs=161.4
Q ss_pred ceecccCCeeEEEEEEc---CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
+.||+|+||.||+|.+. .++.||||.++.... +.+.+|+.+++.++||||+++++++.. +.+++|||||.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999743 356799999965332 346778889999999999999999964 558899999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC-ccccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE-ANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~-~~~~~~~ 188 (338)
|+|.+++..... .......+..+++.+|.++|. +.+||+|||+++.+...... .......
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 999999875432 222334555667777776543 45899999999876432211 1122335
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+|..|+|||++.+..++.++|||||||++|||++ |..||......+........ ...... . ..
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------~~~~~p-~--------~~ 597 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------ERMGCP-A--------GC 597 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CCCCCC-T--------TC
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------CCCCCC-C--------CC
Confidence 6788999999999999999999999999999998 99999754432221111110 000000 0 01
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...+.+||.+||+.||++|||+.+|++.|+...
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 134567888999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=261.35 Aligned_cols=231 Identities=23% Similarity=0.232 Sum_probs=160.7
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEEecCCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLICEYMPNK 129 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~g 129 (338)
+.|.+.+.||+|+||+||.+...+++.||||.+.....+....|+.+++.+ +||||+++++++.+.+.+++|||||+ |
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 355667889999999998777778999999998766556667788888765 89999999999999999999999994 7
Q ss_pred CHHHHHhccCcccc--------ccHHHHHHHHHHhhhcCC-------------------------------CCeEEeeec
Q 045271 130 SLDFLLFDSTRSVQ--------LDWNRRMCIINGIARDHK-------------------------------MNPKISDFG 170 (338)
Q Consensus 130 ~L~~~l~~~~~~~~--------~~~~~~~~~~~~i~~~~~-------------------------------~~vkL~Dfg 170 (338)
+|.+++........ ..+....+++.+|.++|+ ..+||+|||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99999876543211 123456677777776442 258999999
Q ss_pred cceecCCCCCCc--cccccccCCcccccccccc-------CCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhh
Q 045271 171 MARVFGGNQSEA--NTNRVVGTYGYMAPEYALE-------GLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLT 240 (338)
Q Consensus 171 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~ 240 (338)
++.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....... ..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~ 249 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----SN 249 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----HH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----HH
Confidence 998764322111 1234579999999999976 568999999999999999999 999986432211 00
Q ss_pred HHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 241 YTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...... .... ............+.+|+.+||+.||.+|||+.+|++
T Consensus 250 i~~~~~---~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIRGIF---SLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTCC---CCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCC---Cccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 000000 0000 011111223345678999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=249.20 Aligned_cols=233 Identities=22% Similarity=0.212 Sum_probs=168.8
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
....+.++|++++.||+|+||.||+|... +++.||||.+.... ...+.+|..+++.++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34667789999999999999999999965 68889999985432 2346678889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecC
Q 045271 119 LLLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~ 176 (338)
+++||||+++++|.+.+.... ......+....+++.++.++|. ..+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999988775433 2333344455566666665332 258999999997653
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
... ......|++.|+|||++.+. ++.++||||||+++|+|++|..||......+...... .........
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~ 244 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-------TGKYAFDLP 244 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCCCCSG
T ss_pred CCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCCCCch
Confidence 221 22234688999999988764 8999999999999999999999987543221111100 000000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.... ....+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~------~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 QWRT------ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhh------cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 1123567888899999999999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=248.86 Aligned_cols=231 Identities=20% Similarity=0.271 Sum_probs=149.8
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCccc-----HHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++++.||+|+||.||+|.. .+++.||+|.+....... ..++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999995 468889999986543221 223334567789999999999999999999999
Q ss_pred ecCCCCCHHHHHhc-----cCccccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCC
Q 045271 124 EYMPNKSLDFLLFD-----STRSVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 124 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
||++ |+|.+++.. .............+++.++.+.| ++.+||+|||++......
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 163 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD- 163 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc-
Confidence 9996 577666643 12222233345555666665544 346999999999876322
Q ss_pred CCccccccccCCcccccccc----ccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 180 SEANTNRVVGTYGYMAPEYA----LEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
.......||+.|+|||++ .+..++.++|||||||++|+|++|..||........ ... ....... ....
T Consensus 164 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~---~~~~~~~-~~~~ 235 (290)
T 3fme_A 164 --VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLK---QVVEEPS-PQLP 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHH---HHHHSCC-CCCC
T ss_pred --ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHH---HHhccCC-CCcc
Confidence 122234789999999996 455689999999999999999999999964221111 000 0010110 1101
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
... ....+.+++.+||+.||++|||+.++++ +++.
T Consensus 236 ~~~--------~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 236 ADK--------FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccc--------CCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 000 1123567888899999999999999986 4443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=257.87 Aligned_cols=249 Identities=21% Similarity=0.228 Sum_probs=168.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeC-----CE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEG-----NE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~~ 118 (338)
+.++|++.+.||+|+||.||+|... +++.||||.+..... ....+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4568999999999999999999965 578899999964332 2345678899999999999999988754 67
Q ss_pred EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
.++||||+. ++|..++...............+++.+|.+.| ++.+||+|||++........
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 899999995 78988887655444445556666777776644 34699999999987642211
Q ss_pred Cc--------cccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc-cCC
Q 045271 181 EA--------NTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC-EGN 250 (338)
Q Consensus 181 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~ 250 (338)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 10 1223578999999998875 6789999999999999999999999975433221111100000000 000
Q ss_pred ccc--------ccCcccc-ccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 251 AQE--------LMDPVLK-ESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 251 ~~~--------~~~~~~~-~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
... ....... ..... .....+.+|+.+||+.||++|||+.++++ +++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 0000000 00000 11224567889999999999999999986 4544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=255.47 Aligned_cols=248 Identities=20% Similarity=0.237 Sum_probs=162.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-CcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEE-----------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCL----------- 114 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~----------- 114 (338)
.++|++++.||+|+||.||+|.... ++.||+|.+..... +.+.+|..+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999654 88899999865443 34566778999999999999999873
Q ss_pred ---eCCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccc
Q 045271 115 ---EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMA 172 (338)
Q Consensus 115 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a 172 (338)
+.+.+++||||+. |+|.+++...............+++.++.+.| ++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 3468899999996 79999887655444444555666777776644 235899999999
Q ss_pred eecCCCCC-CccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc---
Q 045271 173 RVFGGNQS-EANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC--- 247 (338)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--- 247 (338)
........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||....................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 86532211 112233467899999998876 5789999999999999999999999975432221111110000000
Q ss_pred ----cCCcccccCcccc-ccccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 248 ----EGNAQELMDPVLK-ESFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 248 ----~~~~~~~~~~~~~-~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
............. ..... .....+.+|+.+||+.||++|||+.++++ ++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 0000000000000 00000 01234677899999999999999999985 5543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=252.84 Aligned_cols=237 Identities=25% Similarity=0.290 Sum_probs=160.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc--CCc--EEEEEEeccCC------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN--DDK--EIAVKRLSRSS------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~--~~~--~vavK~~~~~~------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++++.||+|+||.||+|.+. ++. .||||.+.... .+.+.+|..+++.++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 458999999999999999999843 233 58999886432 134567778899999999999999998755 8
Q ss_pred EEEEecCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
++||||+++++|.+++.... ...........+++.++.+.| ++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 89999999999999887543 222333445556777766644 3458999999998764332
Q ss_pred CCc-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 180 SEA-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 180 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+... ....... ......
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~-~~~~~~ 248 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGE-RLPRPE 248 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCC-CCCCCT
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHccCC-CCCCCc
Confidence 211 1223467788999999998889999999999999999999 999986543221111 1000000 000000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 249 --------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 249 --------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --------CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0112456788889999999999999999999986643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.96 Aligned_cols=236 Identities=19% Similarity=0.261 Sum_probs=163.0
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcC--CCceeeeeeEEEeCCEEE
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQ--HKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~--hpnIv~~~~~~~~~~~~~ 120 (338)
...++|++++.||+|+||.||+|...++..||||.+..... +.+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 34568999999999999999999987888999999864432 34566777888887 599999999999999999
Q ss_pred EEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCCCCc
Q 045271 121 LICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
+|||+ .+++|.+++..... ..........+++.+|.+.|+ +.+||+|||++..........
T Consensus 105 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 105 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--------
T ss_pred EEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccc
Confidence 99994 58899988875432 222334455667777776553 358999999998764332222
Q ss_pred cccccccCCcccccccccc-----------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCc
Q 045271 183 NTNRVVGTYGYMAPEYALE-----------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNA 251 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (338)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....... ....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~-~~~~ 257 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII-DPNH 257 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH-CTTS
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHH-hccc
Confidence 2234578999999999875 468889999999999999999999986432111 0000111 0100
Q ss_pred ccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 252 QELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
........ ...+.+++.+||+.||.+|||+.++++ +++.
T Consensus 258 ~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 258 EIEFPDIP--------EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCCCCCCS--------CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred ccCCcccc--------hHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 00011000 123566888899999999999999985 4443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=261.94 Aligned_cols=217 Identities=12% Similarity=0.070 Sum_probs=154.5
Q ss_pred hcCCCCCceecccCCeeEEEEE-EcCCcEEEEEEeccCCc------ccHHHHH---HHHHhcCCCceeeee-------eE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG------QGLQEFK---NLIAKLQHKNLVRLL-------GC 112 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~---~~l~~l~hpnIv~~~-------~~ 112 (338)
.++|++.+.||+|+||.||+|. ..+++.||||++..... +.+.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3679999999999999999999 45688999999864321 3355666 345566899999998 66
Q ss_pred EEeCC-----------------EEEEEEecCCCCCHHHHHhccCccc--------cccHHHHHHHHHHhhhcC-------
Q 045271 113 CLEGN-----------------ELLLICEYMPNKSLDFLLFDSTRSV--------QLDWNRRMCIINGIARDH------- 160 (338)
Q Consensus 113 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~~~~~~i~~~~------- 160 (338)
+.+.+ ..|+||||+ +|+|.+++....... ...+....+++.+|.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66543 278999999 689999987543221 122335566777777644
Q ss_pred -----------CCCeEEeeeccceecCCCCCCccccccccCCccccccccccC-----------CCCcccchHhHhHHHH
Q 045271 161 -----------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG-----------LFSVKSDVFSFGVLLL 218 (338)
Q Consensus 161 -----------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiWSlGv~l~ 218 (338)
++.+||+|||++.... ......+| +.|+|||++.+. .++.++|||||||++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 4569999999998642 12334577 999999999887 8999999999999999
Q ss_pred HHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 219 EIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 219 el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+|++|..||............ ....... ...+.+||.+||+.||++|||+.++++
T Consensus 305 elltg~~Pf~~~~~~~~~~~~---------------~~~~~~~------~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWI---------------FRSCKNI------PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCSGGG---------------GSSCCCC------CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccchhhh---------------hhhccCC------CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999654322221111 0000000 123566888899999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=252.05 Aligned_cols=243 Identities=17% Similarity=0.199 Sum_probs=165.5
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHhcC-----------CCceeeeeeEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQ-----------HKNLVRLLGCCLE 115 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~-----------hpnIv~~~~~~~~ 115 (338)
.++|++++.||+|+||.||+|.. .+++.||||.+.... ......|..+++.++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 45899999999999999999995 567889999986442 234556666776665 8999999999986
Q ss_pred CC----EEEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCCC-------------------------C
Q 045271 116 GN----ELLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHKM-------------------------N 163 (338)
Q Consensus 116 ~~----~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~~-------------------------~ 163 (338)
.+ .+++||||+ +++|.+++.... ...........+++.+|.++|.. .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 44 789999999 899998886532 22233344556677777766643 4
Q ss_pred eEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccch---hh
Q 045271 164 PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL---LT 240 (338)
Q Consensus 164 vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~---~~ 240 (338)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ..
T Consensus 177 ~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 177 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 79999999987632 12335789999999999999999999999999999999999999975432111100 00
Q ss_pred HHHhh------------------hccCCcccccCccc----------cccccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 045271 241 YTWKL------------------WCEGNAQELMDPVL----------KESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292 (338)
Q Consensus 241 ~~~~~------------------~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~v 292 (338)
..... +........+.... ...........+.+|+.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 00000 00000000000000 001123344567789999999999999999999
Q ss_pred HH--Hhhc
Q 045271 293 VF--MLAT 298 (338)
Q Consensus 293 l~--~L~~ 298 (338)
++ ++..
T Consensus 332 l~hp~f~~ 339 (373)
T 1q8y_A 332 VNHPWLKD 339 (373)
T ss_dssp HTCGGGTT
T ss_pred hhChhhhc
Confidence 96 4444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=251.61 Aligned_cols=230 Identities=22% Similarity=0.316 Sum_probs=138.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCccc-----HHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQG-----LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++++.||+|+||.||+|... +++.||||.+....... ..++..+++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468999999999999999999964 68889999997543221 222233567789999999999999999999999
Q ss_pred ecCCCCCHHHHHhc------cCccccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCC
Q 045271 124 EYMPNKSLDFLLFD------STRSVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 124 e~~~~g~L~~~l~~------~~~~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
||++ ++|..++.. .............+++.++.+.| ++.+||+|||++......
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 9996 577766652 22222233344455555555433 346999999999865322
Q ss_pred CCCccccccccCCcccccccc----ccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc
Q 045271 179 QSEANTNRVVGTYGYMAPEYA----LEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (338)
. ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......... . .. .........
T Consensus 180 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~---~~-~~~~~~~~~ 250 (327)
T 3aln_A 180 I---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--L---TQ-VVKGDPPQL 250 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCCCCC
T ss_pred c---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--H---HH-HhcCCCCCC
Confidence 1 12234789999999998 4556899999999999999999999999743211000 0 00 000000000
Q ss_pred cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
... ........+.+|+.+||+.||++|||+.++++
T Consensus 251 ~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 SNS-----EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-----SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCc-----ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 00001124567888899999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=272.19 Aligned_cols=236 Identities=21% Similarity=0.232 Sum_probs=167.4
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
....++|++.+.||+|+||.||+|.+.. +..||||.+..... +.+.+|+.+++.++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3345689999999999999999999643 34689998865433 34566778899999999999999985 466
Q ss_pred EEEEEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
+++||||+++|+|.+++....... ...+....+++.+|.+.| ++.+||+|||++......
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 899999999999999987554322 223344556777777654 345899999999876432
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
.. .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....... ... .. ...
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~------~~~-~~-~~~ 615 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------GER-LP-MPP 615 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH------TCC-CC-CCT
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc------CCC-CC-CCc
Confidence 21 11223456789999999998899999999999999999997 9999875432221111110 000 00 000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+||.+||+.||++|||+.++++.|+...
T Consensus 616 --------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 616 --------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01124567888999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=257.48 Aligned_cols=235 Identities=20% Similarity=0.246 Sum_probs=161.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEE---
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL--- 119 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~--- 119 (338)
+.++|.+.+.||+|+||.||+|... +++.||||.+..... ....+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4569999999999999999999954 578899999965432 3355677889999999999999999876654
Q ss_pred ---EEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 120 ---LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 120 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
++||||+. ++|..++... ...........+++.+|.++| ++.+||+|||++.....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGME-FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eeEEEEEcccc-ccHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99999995 7887776432 333334445556676666644 45699999999986532
Q ss_pred CCCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+......... ..........
T Consensus 197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~ 268 (371)
T 4exu_A 197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT----GVPGTEFVQK 268 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH----CCCCHHHHTT
T ss_pred ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh----CCCcHHHHHH
Confidence 1234578999999999987 678999999999999999999999997543222111111000 0000000000
Q ss_pred ------------cccc-cccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 ------------VLKE-SFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ------------~~~~-~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.... .... .....+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 0000 01234677889999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=247.96 Aligned_cols=231 Identities=25% Similarity=0.355 Sum_probs=155.9
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEe----------
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLE---------- 115 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~---------- 115 (338)
+.++|++++.||+|+||.||+|.. .+++.||||.+..... ..+.+|..+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999995 4688999999864322 345677888999999999999998865
Q ss_pred ---CCEEEEEEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccc
Q 045271 116 ---GNELLLICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMA 172 (338)
Q Consensus 116 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a 172 (338)
.+.+++||||+++++|.+++....... ...+....+++.++.+.| ++.+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 356899999999999999997544322 223345556676666644 456999999999
Q ss_pred eecCCCCC------------CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchh
Q 045271 173 RVFGGNQS------------EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLL 239 (338)
Q Consensus 173 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~ 239 (338)
........ ........|+..|+|||++.+. .++.++|||||||++|+|++ ||...... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~~~~ 238 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--VNIL 238 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--HHHH
Confidence 76532110 1112345789999999999865 68999999999999999998 44321110 0000
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ... ... .. +..... ......+.+++.+||+.||.+|||+.++++
T Consensus 239 ~---~~~-~~~-~~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 239 K---KLR-SVS-IE-FPPDFD----DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H---HHH-STT-CC-CCTTCC----TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H---hcc-ccc-cc-cCcccc----ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 000 000 00 011111 111123456888899999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=250.45 Aligned_cols=244 Identities=18% Similarity=0.175 Sum_probs=165.4
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CC-cEEEEEEeccCC--cccHHHHHHHHHhcCCCc------eeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DD-KEIAVKRLSRSS--GQGLQEFKNLIAKLQHKN------LVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~-~~vavK~~~~~~--~~~~~~~~~~l~~l~hpn------Iv~~~~~~~~~~~ 118 (338)
+.++|++++.||+|+||.||+|... ++ ..||+|.+.... ......|+.+++.++|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4579999999999999999999964 34 579999986532 234556777787776655 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC-----------------------------------
Q 045271 119 LLLICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH----------------------------------- 160 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~----------------------------------- 160 (338)
+++||||+ ++++...+.... ...........+++.+|.+.|
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999999 566655554432 222333445566777766644
Q ss_pred --CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccch
Q 045271 161 --KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL 238 (338)
Q Consensus 161 --~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~ 238 (338)
.+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 34579999999986422 12345799999999999999999999999999999999999999975433221111
Q ss_pred hhHHHhhhc------cCCcccccCccc---------------------cccccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 045271 239 LTYTWKLWC------EGNAQELMDPVL---------------------KESFILEELLKRIHIGLLCVQEDPADRPTMSS 291 (338)
Q Consensus 239 ~~~~~~~~~------~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 291 (338)
......... ............ ...........+.+|+.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 110000000 000000000000 00011122345678999999999999999999
Q ss_pred HHH--Hhhc
Q 045271 292 VVF--MLAT 298 (338)
Q Consensus 292 vl~--~L~~ 298 (338)
+++ ++..
T Consensus 331 ~l~hp~f~~ 339 (355)
T 2eu9_A 331 ALLHPFFAG 339 (355)
T ss_dssp HTTSGGGGG
T ss_pred HhcChhhcC
Confidence 984 4544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=247.39 Aligned_cols=226 Identities=21% Similarity=0.327 Sum_probs=165.2
Q ss_pred ChhHHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC---------cccHHHHHHHHHhcC--CCceeee
Q 045271 42 PLDLIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---------GQGLQEFKNLIAKLQ--HKNLVRL 109 (338)
Q Consensus 42 ~~~~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~~l~~l~--hpnIv~~ 109 (338)
+......+.++|++.+.||+|+||.||+|.. .++..||||.+.... ...+..|..+++.++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 4455566778999999999999999999995 457889999986432 234566788888886 5999999
Q ss_pred eeEEEeCCEEEEEEecCCC-CCHHHHHhccCc-cccccHHHHHHHHHHhhhc-------------------CCCCeEEee
Q 045271 110 LGCCLEGNELLLICEYMPN-KSLDFLLFDSTR-SVQLDWNRRMCIINGIARD-------------------HKMNPKISD 168 (338)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~-------------------~~~~vkL~D 168 (338)
++++.+.+.+++|||++.+ ++|.+++..... ..........+++.+|.+. .++.+||+|
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999999975 899988865432 2233344555677766653 345699999
Q ss_pred eccceecCCCCCCccccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc
Q 045271 169 FGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC 247 (338)
Q Consensus 169 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 247 (338)
||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .. .
T Consensus 194 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~------~ 257 (320)
T 3a99_A 194 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II------R 257 (320)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------H
T ss_pred Cccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh------c
Confidence 9999876422 2234578999999999987765 6889999999999999999999864211 00 0
Q ss_pred cCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 248 EGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
... ...... ...+.+|+.+||+.||++|||+.+|++
T Consensus 258 -~~~--~~~~~~--------~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 -GQV--FFRQRV--------SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -CCC--CCSSCC--------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccc--cccccC--------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 123567888999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=245.18 Aligned_cols=223 Identities=19% Similarity=0.269 Sum_probs=155.7
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---------ccHHHHHHHHHhc----CCCceeeee
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---------QGLQEFKNLIAKL----QHKNLVRLL 110 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~l~~l----~hpnIv~~~ 110 (338)
....+.++|++.+.||+|+||.||+|.. .+++.||||.+..... .....+..+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4456678999999999999999999994 5678899999865421 2344567777777 899999999
Q ss_pred eEEEeCCEEEEEEec-CCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhc-------------------CCCCeEEeee
Q 045271 111 GCCLEGNELLLICEY-MPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARD-------------------HKMNPKISDF 169 (338)
Q Consensus 111 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~-------------------~~~~vkL~Df 169 (338)
+++...+..++|||+ +.+++|.+++.... ......+....+++.+|.+. .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 78999999887543 23333344555566666653 3456999999
Q ss_pred ccceecCCCCCCccccccccCCccccccccccCCCC-cccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhcc
Q 045271 170 GMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS-VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248 (338)
Q Consensus 170 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 248 (338)
|++...... ......|+..|+|||++.+..+. .++|||||||++|+|++|..||..... . ..
T Consensus 185 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~--~~----- 247 (312)
T 2iwi_A 185 GSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------I--LE----- 247 (312)
T ss_dssp SSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H--HH-----
T ss_pred chhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------H--hh-----
Confidence 999876422 22345789999999999877664 589999999999999999999863210 0 00
Q ss_pred CCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
... . +... ....+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~-~-~~~~--------~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 AEL-H-FPAH--------VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TCC-C-CCTT--------SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hcc-C-Cccc--------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 0000 1123567888999999999999999997
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=244.76 Aligned_cols=228 Identities=20% Similarity=0.296 Sum_probs=143.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQ-----GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.++|++++.||+|+||.||+|... +++.||||.+...... ...++..+++.++||||+++++++.+.+.+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 458999999999999999999964 6889999999754332 2233344678889999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCc
Q 045271 124 EYMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||+ ++.+..+..... ...........+++.++.+.| ++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--- 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---
Confidence 999 666666654322 222233344455565555543 3469999999997653221
Q ss_pred cccccccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 183 NTNRVVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
......|++.|+|||++. ...++.++|||||||++|+|++|..||........ ... ..... .... ...
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~-~~~~-~~~ 252 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---KVLQE-EPPL-LPG 252 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---HHHHS-CCCC-CCS
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---HHhcc-CCCC-CCc
Confidence 223357899999999995 45688999999999999999999999864321111 111 00000 0000 000
Q ss_pred cccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 258 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.... ...+.+|+.+||+.||.+|||+.++++
T Consensus 253 ~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 HMGF------SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSCC------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCC------CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0001 123556888899999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=251.07 Aligned_cols=236 Identities=19% Similarity=0.242 Sum_probs=159.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE-----
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE----- 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~----- 118 (338)
.++|.+.+.||+|+||.||+|.. .+++.||||.+..... ....+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999995 4588899999865432 235567788999999999999999987643
Q ss_pred -EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCC
Q 045271 119 -LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~ 179 (338)
+++||||+. ++|..++... ...........+++.+|.++| ++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-- 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGLK-FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-- 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred eEEEEecccc-CCHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC--
Confidence 599999995 6887766432 233333445556666666544 45699999999976421
Q ss_pred CCccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh--------------
Q 045271 180 SEANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK-------------- 244 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-------------- 244 (338)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+..........
T Consensus 179 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 1234578999999999987 5789999999999999999999999975432221111100000
Q ss_pred --hhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 245 --LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.+.. ........... .........+.+|+.+||+.||++|||+.++++
T Consensus 256 ~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 256 AKSYIQ-SLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHH-TSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHH-hCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000000000 000011234567888999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=265.21 Aligned_cols=243 Identities=20% Similarity=0.159 Sum_probs=160.7
Q ss_pred HHhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe------C
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE------G 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~------~ 116 (338)
...++|++.+.||+|+||.||+|.. .++..||||.+..... ..+..|+.+++.++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3457999999999999999999995 4588899999865422 335668889999999999999998765 6
Q ss_pred CEEEEEEecCCCCCHHHHHhccCc----cccccHHHHHHHHHHhhhcCCC---------------------CeEEeeecc
Q 045271 117 NELLLICEYMPNKSLDFLLFDSTR----SVQLDWNRRMCIINGIARDHKM---------------------NPKISDFGM 171 (338)
Q Consensus 117 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~~~~~---------------------~vkL~Dfg~ 171 (338)
+..++|||||++|+|..++..... .....+....+++.++.+.|+. .+||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 678999999999999999976432 2333445556677777765432 289999999
Q ss_pred ceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccch-h-hHHHh---hh
Q 045271 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL-L-TYTWK---LW 246 (338)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~-~-~~~~~---~~ 246 (338)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... . ..... ..
T Consensus 171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9876422 223346899999999999999999999999999999999999999964311100000 0 00000 00
Q ss_pred ccCCcccccCccccc--cccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 247 CEGNAQELMDPVLKE--SFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
........+...+.. .........+.+|+.+||++||++|||+.+++
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000000000000 01111233567788999999999999997743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=232.80 Aligned_cols=231 Identities=14% Similarity=0.068 Sum_probs=160.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
+.++|++.+.||+|+||.||+|... +++.||||.+..... ..+.++..+++.++||||+++++++.+.+.+|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3468999999999999999999965 488899999975433 345667778899999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCCCeEEeeeccceecCCCCCCccccccccCCcccccccccc
Q 045271 122 ICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (338)
||||+++++|.+++.... .......+..+++.+|.+.|+.++...|.-....+-..+. ....++..|++|
T Consensus 109 v~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g----~~kl~~~~~~~~----- 178 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG----DVVLAYPATMPD----- 178 (286)
T ss_dssp EEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS----CEEECSCCCCTT-----
T ss_pred EEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC----CEEEEeccccCC-----
Confidence 999999999999986543 2223345566788999998877665555543332211111 112345567665
Q ss_pred CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCC
Q 045271 202 GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQE 281 (338)
Q Consensus 202 ~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 281 (338)
++.++|||||||++|+|++|..||............... . ...... . .... . .....+.+|+.+||+.
T Consensus 179 --~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~---~-~~~~~~-~-~~~~-~---~~~~~l~~li~~~l~~ 246 (286)
T 3uqc_A 179 --ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD---T-AGQPIE-P-ADID-R---DIPFQISAVAARSVQG 246 (286)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC---T-TSCBCC-H-HHHC-T---TSCHHHHHHHHHHHCT
T ss_pred --CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH---h-ccCCCC-h-hhcc-c---CCCHHHHHHHHHHccc
Confidence 689999999999999999999999754332211000000 0 000000 0 0000 0 0112356788899999
Q ss_pred CCCCCCCHHHHHHHhhcCccc
Q 045271 282 DPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 282 dP~~Rps~~~vl~~L~~~~~~ 302 (338)
||++| |+.++++.|+.....
T Consensus 247 dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 247 DGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSSCC-CHHHHHHHHHHHHC-
T ss_pred CCccC-CHHHHHHHHHHHhcc
Confidence 99999 999999999986644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=260.84 Aligned_cols=220 Identities=17% Similarity=0.221 Sum_probs=159.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEc--CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE---
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLN--DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE--- 118 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~--- 118 (338)
.+.++|++.+.||+|+||.||+|.+. +++.||||.+..... .....|..+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34579999999999999999999964 578899999865432 234567778899999999999999987654
Q ss_pred --EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC-----------------CCeEEeeeccceecCCCC
Q 045271 119 --LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARVFGGNQ 179 (338)
Q Consensus 119 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~~~~~~ 179 (338)
.|+||||+++++|.+++.. .........+..+++.+|.+.|+ ..+||+|||++......
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC-
T ss_pred ceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC-
Confidence 7999999999999887754 33333445556667777776553 35899999999876322
Q ss_pred CCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 180 SEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
....||+.|+|||++.+.. +.++|||||||++|+|++|..||........ .
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~------- 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P------- 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C-------
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c-------
Confidence 3357999999999987654 8899999999999999999887653211100 0
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhhc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPT-MSSVVFMLAT 298 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~vl~~L~~ 298 (338)
...........+.+|+.+||+.||.+||+ ++++...|..
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00111112234567889999999999995 4555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=229.80 Aligned_cols=213 Identities=16% Similarity=0.110 Sum_probs=147.3
Q ss_pred HhcCCCCC-ceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHH-HhcCCCceeeeeeEEEe----CCEEEE
Q 045271 49 ATRNFSNE-NKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLI-AKLQHKNLVRLLGCCLE----GNELLL 121 (338)
Q Consensus 49 ~~~~y~~~-~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l-~~l~hpnIv~~~~~~~~----~~~~~l 121 (338)
+.++|.++ +.||+|+||.||+|.. .+++.||+|.+... ....++..++ +.++||||+++++++.. ...+++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 45678887 7899999999999995 56889999998643 3445566555 77799999999999987 678999
Q ss_pred EEecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCC
Q 045271 122 ICEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGG 177 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~ 177 (338)
||||+++|+|.+++.... ......+....+++.++.+.| ++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999999999987653 233334455566777776644 3458889998886531
Q ss_pred CCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCc
Q 045271 178 NQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257 (338)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
+..++.++|||||||++|+|++|..||............ .......
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-----------~~~~~~~ 217 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-----------KTRIRMG 217 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-----------CCSSCTT
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-----------HHHHhhc
Confidence 244788999999999999999999999643221110000 0000000
Q ss_pred ccccccc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 258 VLKESFI--LEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 258 ~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
....... ......+.+|+.+||+.||.+|||+.|+++ ++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 0000000 001234567888999999999999999996 5544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=235.90 Aligned_cols=215 Identities=13% Similarity=0.065 Sum_probs=142.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHhcCC-Cce---------ee-----
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS------GQGLQEFKNLIAKLQH-KNL---------VR----- 108 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~l~~l~h-pnI---------v~----- 108 (338)
..|...+.||+|+||.||+|.+ .++..||||++.... .+.+.+|..+++.+.| .|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3577889999999999999994 468899999986322 2345667777777766 221 11
Q ss_pred -------eeeEEEe-----CCEEEEEEecCCCCCHHHHHhcc------Cc--cccccHHHHHHHHHHhhhcC--------
Q 045271 109 -------LLGCCLE-----GNELLLICEYMPNKSLDFLLFDS------TR--SVQLDWNRRMCIINGIARDH-------- 160 (338)
Q Consensus 109 -------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~------~~--~~~~~~~~~~~~~~~i~~~~-------- 160 (338)
+..++.. ...++++|+++ +++|.+++... .. .....+....+++.+|.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 23467888877 78998888421 11 11122334456777776644
Q ss_pred ----------CCCeEEeeeccceecCCCCCCccccccccCCcccccccc----------ccCCCCcccchHhHhHHHHHH
Q 045271 161 ----------KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYA----------LEGLFSVKSDVFSFGVLLLEI 220 (338)
Q Consensus 161 ----------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiWSlGv~l~el 220 (338)
++.+||+|||+++.... .....+| +.|+|||++ .+..++.++|||||||++|+|
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 45699999999987532 1334577 999999999 555688999999999999999
Q ss_pred HhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 221 ISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 221 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
++|..||........... .+......+ ..+.+||.+||+.||++|||+.+++
T Consensus 311 ltg~~Pf~~~~~~~~~~~---------------~~~~~~~~~------~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEW---------------IFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHSSCCCCTTGGGSCSGG---------------GGSSCCCCC------HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHCCCCCCCcchhhhHHH---------------HHhhcccCC------HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999975432222111 111000111 2456788899999999999987775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=230.30 Aligned_cols=221 Identities=13% Similarity=0.069 Sum_probs=150.7
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----------ccHHHHHHHHHhcC---------CCceeee
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----------QGLQEFKNLIAKLQ---------HKNLVRL 109 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~l~~l~---------hpnIv~~ 109 (338)
.++|++++.||+|+||.||+|+. +++.||||.+..... +.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 678999999965432 44667777877775 6666666
Q ss_pred eeEE-----------------Ee-------------CCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhc
Q 045271 110 LGCC-----------------LE-------------GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARD 159 (338)
Q Consensus 110 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 159 (338)
.+++ .+ .+.+|+|||||++|++...+...............+++.+|.+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 6654 32 67899999999999665555443334444555666677776665
Q ss_pred C-------------------CC--------------------CeEEeeeccceecCCCCCCccccccccCCccccccccc
Q 045271 160 H-------------------KM--------------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200 (338)
Q Consensus 160 ~-------------------~~--------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 200 (338)
| ++ .+||+|||+|+.... ...+||+.|+|||++.
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGC
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhc
Confidence 5 22 799999999987632 1347999999999998
Q ss_pred cCCCCcccchHhHhHH-HHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhcc
Q 045271 201 EGLFSVKSDVFSFGVL-LLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCV 279 (338)
Q Consensus 201 ~~~~~~~~DiWSlGv~-l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 279 (338)
+.. +.++||||+|++ .++++.|..||........ . .......... ...............+.+|+.+||
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~---~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--L---TDKMLKQMTF----KTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--H---HHHHHHTCCC----SSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--H---HHhhhhhhcc----CcccchhhhhhcCHHHHHHHHHHh
Confidence 776 889999998777 7788889988753211000 0 0000000000 000001111223446788999999
Q ss_pred CCCCCCCCCHHHHH
Q 045271 280 QEDPADRPTMSSVV 293 (338)
Q Consensus 280 ~~dP~~Rps~~~vl 293 (338)
++| |+.|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 987 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-21 Score=188.19 Aligned_cols=163 Identities=12% Similarity=0.005 Sum_probs=102.1
Q ss_pred ecccCCeeEEEEE-EcCCcEEEEEEeccCCc-------------ccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEEE
Q 045271 59 LGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-------------QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 59 iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-------------~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
.+.|.+|.+..++ .-.|..+++|.+..... ..+.+|+++|+.+ +|+||+++++++++++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555555 44577899999865321 2366778899998 6999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
||++|++|.+++........ ..+..+++.+|.+.| ++++||+|||+|+..... .....
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~--~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~ 397 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDR--EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPT 397 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCH--HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSH
T ss_pred ecCCCCcHHHHHHhCCCCCH--HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Ccccc
Confidence 99999999999987654322 234556776666643 567999999999876422 22334
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCC
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKD 226 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~P 226 (338)
..+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 398 t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 398 NLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 57899999999988764 56789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-19 Score=173.34 Aligned_cols=166 Identities=14% Similarity=0.108 Sum_probs=118.4
Q ss_pred CCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 54 SNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
...+.||+|+||.||+|.. .+..+++|....... +.+.+|..+++.++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467999999999999954 577889988643221 2246788899999999999666666677788999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC----------------CeEEeeeccceecCCCCCCc----
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM----------------NPKISDFGMARVFGGNQSEA---- 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~----------------~vkL~Dfg~a~~~~~~~~~~---- 182 (338)
|||+++++|.+++.. ......+++.+|.+.|+. .+||+|||+++.........
T Consensus 418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~~~kL~DFGla~~~~~~~~~~~~~~ 490 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYIIDFGLGKISNLDEDKAVDLI 490 (540)
T ss_dssp EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESSSEEECCCTTCEECCCHHHHHHHHH
T ss_pred EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECCeEEEEECccCEECCCccccccchh
Confidence 999999999999865 335556666666664422 68999999999863221111
Q ss_pred -cccccccCCcccccccccc--CCCCcccchHhHhHHHHHHHhCCCCC
Q 045271 183 -NTNRVVGTYGYMAPEYALE--GLFSVKSDVFSFGVLLLEIISGRKDT 227 (338)
Q Consensus 183 -~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWSlGv~l~el~~g~~Pf 227 (338)
.....+||+.|||||++.. ..|+..+|+||.++-..+...++.+|
T Consensus 491 ~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 491 VFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1235689999999999987 56888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3e-14 Score=125.71 Aligned_cols=138 Identities=15% Similarity=-0.005 Sum_probs=97.6
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC---------------------cccHHHHHHHHHhcCCCceeee
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS---------------------GQGLQEFKNLIAKLQHKNLVRL 109 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~l~~l~hpnIv~~ 109 (338)
..|.+++.||+|+||.||+|...++..||||.+.... ...+..|..+++.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 4456669999999999999999678899999985322 123567778889888 5 677
Q ss_pred eeEEEeCCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC-----------------CCCeEEeeeccc
Q 045271 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH-----------------KMNPKISDFGMA 172 (338)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-----------------~~~vkL~Dfg~a 172 (338)
++++.. +..|+||||+++++|.+ +.. ........+++.++.+.| ++.+||+|||+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a 239 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQS 239 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCCC
Confidence 776544 55699999999999987 421 222345555666655533 456899999998
Q ss_pred eecCCCCCCccccccccCCcccccccccc----------CCCCcccchHhH
Q 045271 173 RVFGGNQSEANTNRVVGTYGYMAPEYALE----------GLFSVKSDVFSF 213 (338)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DiWSl 213 (338)
... ..++|||.+.. ..|+..+|+|.+
T Consensus 240 ~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 240 VEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred eEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 642 34688988753 346666777754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.6e-10 Score=100.37 Aligned_cols=117 Identities=13% Similarity=0.021 Sum_probs=78.4
Q ss_pred CCCCceecccCCeeEEEEEE-cCCcE--EEEEEeccCCc---------------------------ccHHHHHHHHHhcC
Q 045271 53 FSNENKLGEGGFGPVYKGVL-NDDKE--IAVKRLSRSSG---------------------------QGLQEFKNLIAKLQ 102 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~---------------------------~~~~~~~~~l~~l~ 102 (338)
|++.+.||+|+||.||+|.. .++.. ||||++..... .....|..+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999996 67888 99998743211 13556777888888
Q ss_pred CCce--eeeeeEEEeCCEEEEEEecCCC-C----CHHHHHhccCccccccHHHHHHHHHHhhhcC-CC------------
Q 045271 103 HKNL--VRLLGCCLEGNELLLICEYMPN-K----SLDFLLFDSTRSVQLDWNRRMCIINGIARDH-KM------------ 162 (338)
Q Consensus 103 hpnI--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-~~------------ 162 (338)
|+++ ..+++. +..++||||+.+ | .|.++.... ..........+++.++.+.| ..
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL--KELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG--GGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc--ChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 7764 333332 346899999942 3 676664321 12233445556666666655 32
Q ss_pred ----CeEEeeeccceec
Q 045271 163 ----NPKISDFGMARVF 175 (338)
Q Consensus 163 ----~vkL~Dfg~a~~~ 175 (338)
.++|+|||+|...
T Consensus 203 Ll~~~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MYIDKVYFIDMGQAVTL 219 (258)
T ss_dssp EESSSEEECCCTTCEET
T ss_pred EEcCcEEEEECcccccC
Confidence 5789999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.67 E-value=3.7e-09 Score=96.32 Aligned_cols=111 Identities=12% Similarity=-0.024 Sum_probs=65.5
Q ss_pred CCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----------------ccHHHHHHHHHhcCCCceeeeeeEEEe
Q 045271 53 FSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----------------QGLQEFKNLIAKLQHKNLVRLLGCCLE 115 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~l~~l~hpnIv~~~~~~~~ 115 (338)
|+++..||+|++|.||+|...+|+.||||+++.... .....+.++.....|+|+.++++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 899999999999999999988899999998743210 001112222222334444444322111
Q ss_pred ------CCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCCCeEEee
Q 045271 116 ------GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKMNPKISD 168 (338)
Q Consensus 116 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~vkL~D 168 (338)
.+..++||||++++.|..+... ........+++.+|.+.|..++..+|
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~-----~~~~~l~~qll~~l~~lH~~gIVHrD 230 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV-----PDPASLYADLIALILRLAKHGLIHGD 230 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC-----SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc-----HHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 1123799999998888654321 22334445666676665544433333
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00016 Score=62.14 Aligned_cols=110 Identities=12% Similarity=-0.022 Sum_probs=81.0
Q ss_pred HHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEecc---CCcccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEE
Q 045271 47 HEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSR---SSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 47 ~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 122 (338)
....+.|++...++.|+.+.||++.. .+..+++|.... .....+..|..+++.+. +.++.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34567899999999999999999975 367899999864 34456888888888885 67788899999988999999
Q ss_pred EecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC
Q 045271 123 CEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK 161 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 161 (338)
|||++|.++...+.. .........++...+...|.
T Consensus 89 ~e~i~G~~l~~~~~~----~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 89 MSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EECCSSEEHHHHCCT----TTCHHHHHHHHHHHHHHHHH
T ss_pred EEecCCeehhhccCC----cccHHHHHHHHHHHHHHHhC
Confidence 999999998765321 11112333445555555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00053 Score=58.40 Aligned_cols=106 Identities=12% Similarity=0.050 Sum_probs=71.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcCCCc--eeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKN--LVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~ 127 (338)
..+|.+....+.|..+.||++...++..+++|.........+..|..+++.+.+.+ +.+++++...++..++||||++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34555544445667799999987667789999976654456778888888776444 5568888887778999999999
Q ss_pred CCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC
Q 045271 128 NKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM 162 (338)
Q Consensus 128 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 162 (338)
|.++. ... ........++...+...|..
T Consensus 99 G~~l~--~~~-----~~~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 99 GQDLL--SSH-----LAPAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp SEETT--TSC-----CCHHHHHHHHHHHHHHHTTS
T ss_pred CcccC--cCc-----CCHhHHHHHHHHHHHHHhCC
Confidence 88884 211 01113334455556666654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=95.15 E-value=0.028 Score=50.31 Aligned_cols=77 Identities=14% Similarity=0.306 Sum_probs=55.7
Q ss_pred CCCceecccCCeeEEEEEEcCCcEEEEEEec--cC----CcccHHHHHHHHHhcC--CCceeeeeeEEEeC---CEEEEE
Q 045271 54 SNENKLGEGGFGPVYKGVLNDDKEIAVKRLS--RS----SGQGLQEFKNLIAKLQ--HKNLVRLLGCCLEG---NELLLI 122 (338)
Q Consensus 54 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~--~~----~~~~~~~~~~~l~~l~--hpnIv~~~~~~~~~---~~~~lv 122 (338)
..++.|+.|.++.||+.... +..+++|... .. ....+.+|..+++.+. +..+.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999998864 4678888765 22 2346778888888887 45578888888765 347899
Q ss_pred EecCCCCCH
Q 045271 123 CEYMPNKSL 131 (338)
Q Consensus 123 ~e~~~~g~L 131 (338)
|||+++..+
T Consensus 120 me~v~G~~l 128 (359)
T 3dxp_A 120 MEFVSGRVL 128 (359)
T ss_dssp EECCCCBCC
T ss_pred EEecCCeec
Confidence 999988766
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=94.14 E-value=0.13 Score=45.12 Aligned_cols=75 Identities=17% Similarity=0.118 Sum_probs=58.0
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcC---CCceeeeeeEEEeCCEEEEEEecCCCCCH
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ---HKNLVRLLGCCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 131 (338)
.+.|+.|....+|+... ++..+++|.........+..|...|+.+. ...+.+++.+....+..++||||+++..+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 56899999999999875 46788899876554455677777777663 35677888887777889999999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.96 E-value=0.26 Score=41.84 Aligned_cols=84 Identities=14% Similarity=0.111 Sum_probs=58.9
Q ss_pred CCCCCceecccCCe-eEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 52 NFSNENKLGEGGFG-PVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 52 ~y~~~~~iG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
.|+. +.+..|..| .||+.... ++..+++|.-.......+..|...|+.+. +--+-+++.++.+++..++|||++++
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 4443 344555554 68987743 45678899876554455677777887764 23366778888888999999999999
Q ss_pred CCHHHHHh
Q 045271 129 KSLDFLLF 136 (338)
Q Consensus 129 g~L~~~l~ 136 (338)
.++.....
T Consensus 105 ~~~~~~~~ 112 (272)
T 4gkh_A 105 KTAFQVLE 112 (272)
T ss_dssp EEHHHHHH
T ss_pred cccccccc
Confidence 88876653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=92.95 E-value=0.29 Score=42.18 Aligned_cols=76 Identities=14% Similarity=0.133 Sum_probs=52.8
Q ss_pred CCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCC---ceeeeeeEEEeCCEEEEEEec
Q 045271 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHK---NLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hp---nIv~~~~~~~~~~~~~lv~e~ 125 (338)
...-++.+|.|..+.||+....+|+.|++|....... ..+..|...|+.+.-. -+.+++.+ +. -++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence 3444678999999999999998999999998654322 3467788888877432 23344443 22 3789999
Q ss_pred CCCCCH
Q 045271 126 MPNKSL 131 (338)
Q Consensus 126 ~~~g~L 131 (338)
+..+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.23 E-value=0.33 Score=43.90 Aligned_cols=72 Identities=10% Similarity=0.156 Sum_probs=46.2
Q ss_pred CceecccCCeeEEEEEEc-CCcEEEEEEeccC----------CcccHHHHHHHHHhcCC--Cc-eeeeeeEEEeCCEEEE
Q 045271 56 ENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS----------SGQGLQEFKNLIAKLQH--KN-LVRLLGCCLEGNELLL 121 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~~l~~l~h--pn-Iv~~~~~~~~~~~~~l 121 (338)
.+.||.|..+.||++... ++..++||..... ..+....|..+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999743 4678999975421 11234567777776632 33 3345543 3455689
Q ss_pred EEecCCCC
Q 045271 122 ICEYMPNK 129 (338)
Q Consensus 122 v~e~~~~g 129 (338)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=88.70 E-value=1.6 Score=35.94 Aligned_cols=89 Identities=10% Similarity=0.052 Sum_probs=43.7
Q ss_pred CCHHHHHhccCc--cccccHHHHHHHHHHhhhcC---CCC--------eEEeeeccceecCCCCCCccccccccCCcccc
Q 045271 129 KSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH---KMN--------PKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195 (338)
Q Consensus 129 g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~---~~~--------vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 195 (338)
-+|.+++..... .....|+...+.+..+.... ... +.|.--|...+.. .........+.|
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-------~~s~~~~~~~~~ 105 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-------AADDAGEPPPVA 105 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-------C-----------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-------ccccccccCCCC
Confidence 357777765444 44556777777666655431 111 2222222222110 000012335778
Q ss_pred ccccccCCCCcccchHhHhHHHHHHHhCCC
Q 045271 196 PEYALEGLFSVKSDVFSFGVLLLEIISGRK 225 (338)
Q Consensus 196 PE~~~~~~~~~~~DiWSlGv~l~el~~g~~ 225 (338)
||... ...+.+.-|||+|+++|..+--..
T Consensus 106 pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 106 GKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred hhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 88653 334577889999999999986443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=86.17 E-value=1.7 Score=37.62 Aligned_cols=75 Identities=12% Similarity=0.003 Sum_probs=52.1
Q ss_pred CceecccCCeeEEEEEEcCCcEEEEEEeccC-CcccHHHHHHHHHhcCCC---ceeeeeeEEE-eCCEEEEEEecCCCCC
Q 045271 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQHK---NLVRLLGCCL-EGNELLLICEYMPNKS 130 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~e~~~~g~ 130 (338)
++.++.|....||+. +..+++|..... ....+..|..+++.+.+. .+.+++.+.. ..+..++|||+++|..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 567889999999987 567888885322 124567788888888753 2445555553 3445789999999888
Q ss_pred HHHH
Q 045271 131 LDFL 134 (338)
Q Consensus 131 L~~~ 134 (338)
+...
T Consensus 100 l~~~ 103 (306)
T 3tdw_A 100 LGED 103 (306)
T ss_dssp CHHH
T ss_pred Cchh
Confidence 7653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=85.63 E-value=0.67 Score=41.04 Aligned_cols=78 Identities=9% Similarity=0.029 Sum_probs=53.0
Q ss_pred Ccee-cccCCeeEEEEEEc-------CCcEEEEEEeccCC------cccHHHHHHHHHhcCC---CceeeeeeEEEeC--
Q 045271 56 ENKL-GEGGFGPVYKGVLN-------DDKEIAVKRLSRSS------GQGLQEFKNLIAKLQH---KNLVRLLGCCLEG-- 116 (338)
Q Consensus 56 ~~~i-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~------~~~~~~~~~~l~~l~h---pnIv~~~~~~~~~-- 116 (338)
.+.| +.|..+.+|+.... ++..+++|...... ......|..+++.+.. ..+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88999999988753 25678888764322 2456777777766642 3466677766554
Q ss_pred -CEEEEEEecCCCCCHHH
Q 045271 117 -NELLLICEYMPNKSLDF 133 (338)
Q Consensus 117 -~~~~lv~e~~~~g~L~~ 133 (338)
+..++||||++|..+..
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999998877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=83.29 E-value=2.1 Score=37.25 Aligned_cols=73 Identities=12% Similarity=0.193 Sum_probs=41.4
Q ss_pred ceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhc-----CCCceeeee-e--EEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKL-----QHKNLVRLL-G--CCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l-----~hpnIv~~~-~--~~~~~~~~~lv~e~~~~ 128 (338)
+.|+.|..+.||++...++ .+++|..... ......+..+++.+ ..|.++... + +....+..++||+|++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 4566677899999986444 5889988652 22333344444433 234444421 1 22356778999999987
Q ss_pred CCH
Q 045271 129 KSL 131 (338)
Q Consensus 129 g~L 131 (338)
..+
T Consensus 116 ~~~ 118 (346)
T 2q83_A 116 RPF 118 (346)
T ss_dssp BCC
T ss_pred ccC
Confidence 654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=81.49 E-value=6.2 Score=34.00 Aligned_cols=90 Identities=11% Similarity=0.076 Sum_probs=52.2
Q ss_pred CChhHHHHHhcCCCC-----CceecccCCeeEEEEEEcCCcEEEEEEeccC-CcccHHHHHHHHHhcC-----CCceeee
Q 045271 41 FPLDLIHEATRNFSN-----ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQ-----HKNLVRL 109 (338)
Q Consensus 41 ~~~~~~~~~~~~y~~-----~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~-----hpnIv~~ 109 (338)
++.+.+......|.+ ++.|+.|....+|+....++ .+++|..... ....+..+..+++.+. -|.++..
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 344555566666765 34567788899999986544 6889988652 3445566666665543 2333322
Q ss_pred e-e--EEEeCCEEEEEEecCCCCCH
Q 045271 110 L-G--CCLEGNELLLICEYMPNKSL 131 (338)
Q Consensus 110 ~-~--~~~~~~~~~lv~e~~~~g~L 131 (338)
. + +....+..+++|+|++|..+
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~ 110 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWL 110 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCC
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCC
Confidence 1 1 12234667999999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 338 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 9e-56
Identities = 52/273 (19%), Positives = 109/273 (39%), Gaps = 42/273 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVR 108
+ ++G G FG VYKG + D + + ++ + Q LQ FKN ++ K +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---------- 158
+G +L ++ ++ SL L + + + + I A+
Sbjct: 69 FMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 159 ------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL---EGL 203
+ KI DFG+A V ++ G+ +MAPE +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
+S +SDV++FG++L E+++G+ Y + + + + +L
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQL-----PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
++ L+ C+++ +RP ++ +
Sbjct: 241 AMKRLMAE------CLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-51
Identities = 76/270 (28%), Positives = 115/270 (42%), Gaps = 44/270 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVR 108
+LG G FG V+ G N ++AVK L + S F L+ +LQH+ LVR
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA----------- 157
L + + +I EYM N SL L ++L N+ + + IA
Sbjct: 73 LYAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 158 --RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
RD + ++ KI+DFG+AR+ N+ A + APE G F++
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTI 189
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266
KSDV+SFG+LL EI++ + + G + L ++ P E
Sbjct: 190 KSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNLE---RGYRMVRP----DNCPE 237
Query: 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
EL + LC +E P DRPT + +L
Sbjct: 238 EL---YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-50
Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 44/270 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVR 108
+ ++G G FG V+ G + ++A+K + + ++F ++ KL H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---------- 158
L G CLE + L+ E+M + L + T+ + + +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 159 ------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
K+SDFGM R +Q ++ + +PE +S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSS 181
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266
KSDV+SFGVL+ E+ S K + + +S + L P L + + +
Sbjct: 182 KSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVEDI---STGFRLYKPRLASTHVYQ 233
Query: 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
I C +E P DRP S ++ L
Sbjct: 234 -------IMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 58/271 (21%), Positives = 105/271 (38%), Gaps = 44/271 (16%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLV 107
++ + +LG G FG V G ++A+K + S EF ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--------- 158
+L G C + + +I EYM N L L + + + + + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 159 -------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
+ + K+SDFG++R ++ ++ + PE + FS
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFS 179
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
KSD+++FGVL+ EI S K + + + T + +G L P
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP-YERFTNSE-----TAEHIAQG--LRLYRP----HLAS 227
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
E++ I C E +RPT ++ +
Sbjct: 228 EKV---YTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-49
Identities = 68/294 (23%), Positives = 111/294 (37%), Gaps = 52/294 (17%)
Query: 34 ESQELPLFPLDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDK----EIAVKRLSRSSGQ 89
Q + + P LI +F +G G FG VY G L D+ AVK L+R +
Sbjct: 16 AVQHVVIGPSSLIV----HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 90 G-LQEFKN---LIAKLQHKNLVRLLGCCLEG-NELLLICEYMPNKSLDFLLFDSTRSVQL 144
G + +F ++ H N++ LLG CL L++ YM + L + + T + +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 129
Query: 145 DWNRRMCIINGIA-----------RDHKM---------NPKISDFGMARVFGGNQSEANT 184
+ RD K++DFG+AR + ++
Sbjct: 130 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 185 NR--VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT 242
N+ +MA E F+ KSDV+SFGVLL E+++ + T
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDIT 244
Query: 243 WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L + L+ P + + L + L C RP+ S +V +
Sbjct: 245 VYLL---QGRRLLQP----EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (415), Expect = 6e-49
Identities = 61/301 (20%), Positives = 120/301 (39%), Gaps = 65/301 (21%)
Query: 41 FPLDLIHEATRNFSNE---------NKLGEGGFGPVYKGVLNDDKE----IAVKRLSRS- 86
F + +EA R F+ E +G G FG V G L + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 87 SGQGLQEFKN---LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ 143
+ + ++F + ++ + H N++ L G + +++I E+M N SLD F Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 144 LDWNRRMCIINGIAR----------------------DHKMNPKISDFGMARVFGGNQSE 181
+ + ++ GIA + + K+SDFG++R + S+
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 182 ANTNRVVG---TYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL 238
+G + APE F+ SDV+S+G+++ E +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE------------------V 226
Query: 239 LTYTWKLWCEGNAQELMDPVLKES---FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295
++Y + + + Q++++ + ++ ++ + L C Q+D RP +V
Sbjct: 227 MSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 296 L 296
L
Sbjct: 287 L 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-47
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 44/284 (15%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVR 108
+ E KLG+G FG V+ G N +A+K L + + F ++ KL+H+ LV+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---------- 158
L + ++ EYM SL L T + + + IA
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMNY 134
Query: 159 ------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
+ K++DFG+AR+ N+ A + APE AL G F++
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTI 193
Query: 207 KSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266
KSDV+SFG+LL E+ + + Y + +L G + L
Sbjct: 194 KSDVWSFGILLTELTTKGR--VPYPGMVNREVL----DQVERGYRMPCPPECPES---LH 244
Query: 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPA 310
+L+ + C +++P +RPT + L + QP
Sbjct: 245 DLMCQ------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-47
Identities = 49/290 (16%), Positives = 97/290 (33%), Gaps = 54/290 (18%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNL--IAKLQHKNLVRLLGCC 113
+ +G+G FG V++G +E+AVK S + + L+H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 114 LEGN----ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR----------- 158
+ N +L L+ +Y + SL L + + + A
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 159 -------------------DHKMNPKISDFGMARVF--GGNQSEANTNRVVGTYGYMAPE 197
I+D G+A + + N VGT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 198 YALEGL------FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQ----GQSLLTYTWKLWC 247
+ + ++D+++ G++ EI + Q + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 248 EGNAQELMDPVLKESFILEELLKRIH-IGLLCVQEDPADRPTMSSVVFML 296
+ ++ + P + + E L+ + I C + A R T + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (402), Expect = 3e-47
Identities = 63/271 (23%), Positives = 111/271 (40%), Gaps = 44/271 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGVLND-DKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLV 107
+ + ++KLG G +G VY+GV +AVK L + + ++EF ++ +++H NLV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--------- 158
+LLG C +I E+M +L L + R ++ + + I+
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 135
Query: 159 -------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
K++DFG++R+ G+ A+ + APE FS
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFS 194
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
+KSDV++FGVLL EI + Y + EL++ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVY-------------ELLEKDYRMERPE 239
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
K + C Q +P+DRP+ + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-47
Identities = 58/286 (20%), Positives = 110/286 (38%), Gaps = 48/286 (16%)
Query: 56 ENKLGEGGFGPVYKGVLNDDK---EIAVKRLSRSSGQG-LQEFKN---LIAKLQHKNLVR 108
+ +LG G FG V +GV K ++A+K L + + + +E ++ +L + +VR
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 109 LLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---------- 158
L+G C + L+L+ E L L + ++ + +++ ++
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 159 ------------DHKMNPKISDFGMARVFGGNQSEAN-TNRVVGTYGYMAPEYALEGLFS 205
++ KISDFG+++ G + S + + APE FS
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
+SDV+S+GV + E +S + + Y +G ++ +G E E L
Sbjct: 191 SRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVM----AFIEQGKRMECPPECPPE---L 241
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLLQPTQPAF 311
L+ C DRP +V + +L +
Sbjct: 242 YALMSD------CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-46
Identities = 56/277 (20%), Positives = 112/277 (40%), Gaps = 49/277 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRSSGQG-LQEFKN---LIAKLQ 102
+ + +G G FG VYKG+L +A+K L + +F ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---- 158
H N++RL G + +++I EYM N +LD L + + + + + ++ GIA
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKY 125
Query: 159 ------------------DHKMNPKISDFGMARVFGGNQSEANT-NRVVGTYGYMAPEYA 199
+ + K+SDFG++RV + T + + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 200 LEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259
F+ SDV+SFG+++ E+++ + + L + ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAINDGF 230
Query: 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ ++ + + C Q++ A RP + +V +L
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-46
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 50/272 (18%)
Query: 56 ENKLGEGGFGPVYKGVLND---DKEIAVKRLSRSSGQG--LQEFKN---LIAKLQHKNLV 107
+ +LG G FG V KG K +AVK L + E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--------- 158
R++G C E +L+ E L+ L + + + +++ ++
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 127
Query: 159 -------------DHKMNPKISDFGMARVFGGNQSEANTN-RVVGTYGYMAPEYALEGLF 204
+ KISDFG+++ +++ + APE F
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264
S KSDV+SFGVL+ E S + + Y +G + + +G +E
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQ--KPYRGMKGSEVT----AMLEKGERMGCPAGCPRE--- 238
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ +L+ C D +RP ++V L
Sbjct: 239 MYDLMNL------CWTYDVENRPGFAAVELRL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-46
Identities = 65/272 (23%), Positives = 104/272 (38%), Gaps = 50/272 (18%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLV 107
+ +G+G FG V G ++AVK + + Q F ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 108 RLLGCCLEG-NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR-------- 158
+LLG +E L ++ EYM SL L RSV L + + +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 122
Query: 159 --------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
K+SDFG+ + ++ + + + APE E F
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKF 177
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264
S KSDV+SFG+LL EI S + Y + ++ +G + D
Sbjct: 178 STKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVV----PRVEKGYKMDAPDGCPPA--- 228
Query: 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ E++K C D A RP+ + L
Sbjct: 229 VYEVMKN------CWHLDAAMRPSFLQLREQL 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-45
Identities = 64/281 (22%), Positives = 98/281 (34%), Gaps = 54/281 (19%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDDK----EIAVKRLSR---SSGQGLQEFKN---LIAK 100
++ KLG+G FG V +G + +AVK L S + + +F +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 101 LQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA--- 157
L H+NL+RL G L + ++ E P SL L L R +
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 158 -----------------RDHKMNPKISDFGMARVFGGNQSE-ANTNRVVGTYGYMAPEYA 199
+ KI DFG+ R N + + APE
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 200 LEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259
FS SD + FGV L E + TY + W N +++ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 228
Query: 260 KESFIL---EELLKRI-HIGLLCVQEDPADRPTMSSVVFML 296
KE L E+ + I ++ + C P DRPT ++ L
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-45
Identities = 58/311 (18%), Positives = 109/311 (35%), Gaps = 77/311 (24%)
Query: 43 LDLIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGL-QEFKN---L 97
++L + +F ++LG G G V+K + A K + + + +
Sbjct: 1 MELKDD---DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA 157
+ + +V G E+ + E+M SLD +L + R + + +
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVI 114
Query: 158 --------------RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYM 194
RD K K+ DFG++ + N VGT YM
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM 170
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIISGR-----------------------KDTRFYL 231
+PE +SV+SD++S G+ L+E+ GR +T
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 232 YEQGQSLLTYTWKLWCEGNAQELMDPVLKE----------SFILEELLKRIHIGLLCVQE 281
G+ L +Y EL+D ++ E S ++ + + C+ +
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK------CLIK 284
Query: 282 DPADRPTMSSV 292
+PA+R + +
Sbjct: 285 NPAERADLKQL 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 7e-45
Identities = 62/276 (22%), Positives = 106/276 (38%), Gaps = 56/276 (20%)
Query: 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLI------AKLQ 102
+ FS+ ++G G FG VY + + + +A+K++S S Q ++++++I KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---- 158
H N ++ GC L + L+ EY + D L L + +G +
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 159 ------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
K+ DFG A + A N VGT +MAPE L
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 201 ---EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
EG + K DV+S G+ +E+ + + +L + + L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL-----YHIAQNESPALQSG 237
Query: 258 VLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
E F + C+Q+ P DRPT ++
Sbjct: 238 HWSEYFR--NFVDS------CLQKIPQDRPTSEVLL 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 1e-44
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 68/298 (22%)
Query: 52 NFSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSGQGLQ-EFKN---LIAKL 101
N +GEG FG V++ +AVK L + +Q +F+ L+A+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTR--------------------- 140
+ N+V+LLG C G + L+ EYM L+ L +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 141 SVQLDWNRRMCIINGIAR----------------------DHKMNPKISDFGMARVFGGN 178
L ++CI +A M KI+DFG++R
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSL 238
+M PE ++ +SDV+++GV+L EI S + Y + +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL--QPYYGMAHEEV 251
Query: 239 LTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ +GN + E ++ LC + PADRP+ S+ +L
Sbjct: 252 I----YYVRDGNILACPENCPLEL---------YNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 63/269 (23%), Positives = 100/269 (37%), Gaps = 45/269 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQE-FKN---LIAKLQHKNL 106
++ LGEG +G V V ++ +AVK + E K + L H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR-------- 158
V+ G EGN L EY L + + + +
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGI 122
Query: 159 --------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
D + N KISDFG+A VF N E N++ GT Y+APE F
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 205 -SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
+ DV+S G++L +++G L S + W E + ++P K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE------LPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDS 234
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSV 292
LL + + E+P+ R T+ +
Sbjct: 235 APLALLHK------ILVENPSARITIPDI 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-44
Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 54/284 (19%)
Query: 52 NFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRS-SGQGLQEFKN---LIAKL 101
+ +LG+G FG VY+GV + +A+K ++ + S + EF N ++ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLF-------DSTRSVQLDWNRRMCIIN 154
++VRLLG +G L+I E M L L ++ ++ + +
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 155 GIAR----------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYG 192
IA KI DFGM R + +
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 193 YMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252
+M+PE +G+F+ SDV+SFGV+L EI + + + Y + +L + EG
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQVL----RFVMEGGLL 254
Query: 253 ELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ D + +C Q +P RP+ ++ +
Sbjct: 255 DKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-43
Identities = 52/278 (18%), Positives = 101/278 (36%), Gaps = 57/278 (20%)
Query: 51 RNFSNENKLGEGGFGPVYKGVLNDD-KEIAVKRLSRS--SGQGLQEFKN---LIAKLQHK 104
R + ++G G F VYKG+ + E+A L + Q FK ++ LQH
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 105 NLVRLLGCCLE----GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR-- 158
N+VR ++L+ E M + +L L R + I +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGL 125
Query: 159 -----------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
+ KI D G+A + + V+GT +MA
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMA 181
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255
PE E + DV++FG+ +LE+ + + + + ++ G
Sbjct: 182 PEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI----YRRVTSGVKPASF 234
Query: 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
D V ++E+++ C++++ +R ++ ++
Sbjct: 235 DKVAIPE--VKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-43
Identities = 73/305 (23%), Positives = 104/305 (34%), Gaps = 63/305 (20%)
Query: 41 FPLDLIHEATRN-FSNENKLGEGGFGPVYKGVL------NDDKEIAVKRLSRSSGQG--- 90
P D E RN S LG G FG V + + +AVK L S+
Sbjct: 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71
Query: 91 --LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRS------- 141
+ E K L H N+V LLG C G L+I EY L L S
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 142 --------VQLDWNRRMCIINGIA-------------RDHK---------MNPKISDFGM 171
+ LD + +A RD KI DFG+
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 172 ARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYL 231
AR + + +MAPE +++ +SDV+S+G+ L E+ S
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS-----S 246
Query: 232 YEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSS 291
G + + +K+ EG +L E+ I C DP RPT
Sbjct: 247 PYPGMPVDSKFYKMIKEG------FRMLSPEHAPAEM---YDIMKTCWDADPLKRPTFKQ 297
Query: 292 VVFML 296
+V ++
Sbjct: 298 IVQLI 302
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-42
Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 54/278 (19%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS--GQGLQEFKN---LIAKLQHKN 105
++ +G G +G K +D K + K L S Q + L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 106 LVRLLGCCLE--GNELLLICEYMPNKSLDFLLFDSTRSVQ-LDWNRRMCIINGIAR---- 158
+VR ++ L ++ EY L ++ T+ Q LD + ++ +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 159 -----------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
D K N K+ DFG+AR+ + S A VGT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255
PE ++ KSD++S G LL E+ + F + Q + EG + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQKE-----LAGKIREGKFRRIP 235
Query: 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
E L E++ R + RP++ ++
Sbjct: 236 YRYSDE---LNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-42
Identities = 63/288 (21%), Positives = 106/288 (36%), Gaps = 61/288 (21%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD---KEIAVKRLSR-SSGQGLQEFKNLIAKL----QH 103
+ ++ +GEG FG V K + D + A+KR+ +S ++F + L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLL-------------FDSTRSVQLDWNRRM 150
N++ LLG C L L EY P+ +L L ++ + L + +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 151 CIINGIAR----------------------DHKMNPKISDFGMARVFGGNQSEANTNRVV 188
+AR KI+DFG++R G +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 187
Query: 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCE 248
+MA E +++ SDV+S+GVLL EI+S G + KL
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEKLP-- 240
Query: 249 GNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L P +E+ + C +E P +RP+ + ++ L
Sbjct: 241 -QGYRLEKP----LNCDDEV---YDLMRQCWREKPYERPSFAQILVSL 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-42
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 53/271 (19%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRS---SGQGLQEFKN---LIAKLQHK 104
+F LG+G FG VY K I A+K L ++ + + + + L+H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------ 158
N++RL G + + LI EY P ++ L ++ D R I +A
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH 123
Query: 159 ----------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
KI+DFG + ++ + GT Y+ PE
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGR 179
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
+ K D++S GVL E + G+ +E TY E + + +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGK-----PPFEANTYQETYKRISRVEFTFPDFVTEGAR-- 232
Query: 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVV 293
+L+ R ++ +P+ RP + V+
Sbjct: 233 ----DLISR------LLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-42
Identities = 51/267 (19%), Positives = 104/267 (38%), Gaps = 49/267 (18%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGC 112
+LG+G FG VYK + + A K + S + L+++ ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 113 CLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR-------------- 158
N L ++ E+ ++D ++ + R L ++ +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 159 --------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-----EGLFS 205
+ K++DFG++ ++ +GT +MAPE + + +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYD 193
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
K+DV+S G+ L+E+ + +L + L P + S
Sbjct: 194 YKADVWSLGITLIEMAEIE---PPHHELNPMRVL----LKIAKSEPPTLAQPS-RWSSNF 245
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSV 292
++ LK+ C++++ R T S +
Sbjct: 246 KDFLKK------CLEKNVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-42
Identities = 67/311 (21%), Positives = 103/311 (33%), Gaps = 68/311 (21%)
Query: 41 FPLDLIHEATR-NFSNENKLGEGGFGPVYKGVLNDD------KEIAVKRLSRSSGQG--- 90
+ DL E R N LG G FG V ++AVK L +
Sbjct: 26 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85
Query: 91 --LQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQ----- 143
+ E K + H+N+V LLG C + LI EY L L
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 144 ---------------LDWNRRMCIINGIAR----------------------DHKMNPKI 166
L + +C +A+ H KI
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205
Query: 167 SDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKD 226
DFG+AR + + +MAPE EG++++KSDV+S+G+LL EI
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----- 260
Query: 227 TRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADR 286
+ G + +KL G + +E + +++ C D R
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEE---IYIIMQS------CWAFDSRKR 311
Query: 287 PTMSSVVFMLA 297
P+ ++ L
Sbjct: 312 PSFPNLTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 45/273 (16%)
Query: 53 FSNENKLGEGGFGPVYKGVLNDDKE-----IAVKRLSRS-SGQGLQEFKN---LIAKLQH 103
F LG G FG VYKG+ + E +A+K L + S + +E + ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA---- 157
++ RLLG CL + LI + MP L + + ++ + C I G+
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 158 -----RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
RD + KI+DFG+A++ G + E + +MA E L +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
++ +SDV+S+GV + E+++ + Y + + +G +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEIS----SILEKGERLPQPPICTID-- 241
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ ++ + C D RP ++
Sbjct: 242 -VYMIMVK------CWMIDADSRPKFRELIIEF 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 52/269 (19%), Positives = 107/269 (39%), Gaps = 46/269 (17%)
Query: 50 TRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKN 105
+ ++ K+G+G G VY + + +E+A+++++ + N ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------- 158
+V L L G+EL ++ EY+ SL ++ ++ D + + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 159 ---------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
+ K++DFG QS+ +T +VGT +MAPE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
+ K D++S G++ +E+I G Y ++ L + + G + L F
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE-----PPY-LNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+ L R C+ D R + +
Sbjct: 247 R--DFLNR------CLDMDVEKRGSAKEL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 9e-41
Identities = 68/292 (23%), Positives = 98/292 (33%), Gaps = 61/292 (20%)
Query: 52 NFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSGQG-----LQEFKNLIAK 100
LG G FG V + + +AVK L + + E K LI
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 101 LQHKNLVRLLGCCLE-GNELLLICEYMPNKSLDFLLF-------------DSTRSVQLDW 146
H N+V LLG C + G L++I E+ +L L + L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 147 NRRMCIINGIAR----------------------DHKMNPKISDFGMARVFGGNQSEANT 184
+C +A+ K KI DFG+AR +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK 244
+MAPE + +++++SDV+SFGVLL EI S G + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCR 248
Query: 245 LWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
EG D E L C +P+ RPT S +V L
Sbjct: 249 RLKEGTRMRAPDYTTPEM---------YQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-38
Identities = 51/273 (18%), Positives = 91/273 (33%), Gaps = 49/273 (17%)
Query: 56 ENKLGEGGFGPVYKGVLNDDKE----IAVKRLSRSSGQGLQE-FKN---LIAKLQHKNLV 107
+GEG FG V++G+ + +A+K + ++E F + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--------- 158
+L+G E + +I E L L S LD + ++
Sbjct: 72 KLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKR 128
Query: 159 -------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
K+ DFG++R + ++ +MAPE F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFT 187
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
SDV+ FGV + EI+ + G + L
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNCPPT---L 238
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298
L+ + C DP+ RP + + L+T
Sbjct: 239 YSLMTK------CWAYDPSRRPRFTELKAQLST 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-38
Identities = 52/270 (19%), Positives = 90/270 (33%), Gaps = 53/270 (19%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG------LQEFKNLIAKLQHK 104
+F LGEG F V L +E A+K L + + ++++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------- 157
V+L + +L Y N L + D I
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 158 ------RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
RD K M+ +I+DFG A+V +A N VGT Y++PE E
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
SD+++ G ++ ++++G + GN + ++K
Sbjct: 186 SACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKIIKLE 226
Query: 263 FILEELLKRIHIGLL--CVQEDPADRPTMS 290
+ E L+ + D R
Sbjct: 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 68/293 (23%), Positives = 102/293 (34%), Gaps = 63/293 (21%)
Query: 52 NFSNENKLGEGGFGPVYKGVL--------NDDKEIAVKRLSRSSGQG-----LQEFKNLI 98
LGEG FG V N ++AVK L + + + E + +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 99 AKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLF-------------DSTRSVQLD 145
+HKN++ LLG C + L +I EY +L L QL
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 146 WNRRMCIINGIAR----------------------DHKMNPKISDFGMARVFGGNQSEAN 183
+ +AR KI+DFG+AR
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW 243
T +MAPE + +++ +SDV+SFGVLL EI + Y + L +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEEL----F 247
Query: 244 KLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
KL EG+ + E L +++ C P+ RPT +V L
Sbjct: 248 KLLKEGHRMDKPSNCTNE---LYMMMRD------CWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (340), Expect = 2e-37
Identities = 53/278 (19%), Positives = 96/278 (34%), Gaps = 43/278 (15%)
Query: 42 PLDLIHEAT-RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN--- 96
P+++ H+ ++ +LG G FG V++ A K + + +
Sbjct: 16 PVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ 75
Query: 97 LIAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IIN 154
++ L+H LV L + NE+++I E+M L + D + D +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 155 GIARDHKMNP--------------------KISDFGMARVFGGNQSEANTNRVVGTYGYM 194
G+ H+ N K+ DFG+ QS GT +
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFA 192
Query: 195 APEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254
APE A +D++S GVL ++SG + T C+ N +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSCDWNMDDS 247
Query: 255 MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
+ E + +++ + DP R T+
Sbjct: 248 AFSGISEDGK--DFIRK------LLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (324), Expect = 2e-35
Identities = 47/267 (17%), Positives = 90/267 (33%), Gaps = 49/267 (18%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQE-FKN---LIAKLQHKNLVRLL 110
+ LG G F V K +A+K +++ + +G + +N ++ K++H N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 111 GCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------------ 158
G L LI + + L + + +I +
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 159 -------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
D ISDFG++++ + GT GY+APE + +S
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYS 187
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
D +S GV+ ++ G + + L E + +S
Sbjct: 188 KAVDCWSIGVIAYILLCGY-----PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK- 241
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSV 292
+ ++ +++DP R T
Sbjct: 242 -DFIRH------LMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-35
Identities = 57/305 (18%), Positives = 97/305 (31%), Gaps = 56/305 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQG-------LQEFKNLIAKLQH 103
+F LG+G FG V+ + A+K L + + E + L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR----- 158
L + L + EY+ L + + + D +R I
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119
Query: 159 -----------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201
D + KI+DFGM + ++ NT GT Y+APE L
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLG 177
Query: 202 GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261
++ D +SFGVLL E++ G+ + + ++ K
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ-----SPFHGQDEEELFHSIRMDNPFYPRWLEKEAK- 231
Query: 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVV----FMLATDTITLLQPTQPAFSVGRVK 317
+LL + +P R + + + L + +VK
Sbjct: 232 -----DLLVK------LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 280
Query: 318 SPSDL 322
SP D
Sbjct: 281 SPFDC 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 129 bits (325), Expect = 3e-35
Identities = 44/263 (16%), Positives = 89/263 (33%), Gaps = 46/263 (17%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCC 113
+LG G FG V++ V + K ++ KN ++ +L H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--------------- 158
+ E++LI E++ L + + ++ + +
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 153
Query: 159 ---------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
+ KI DFG+A ++ T + APE +D
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 210 VFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269
+++ GVL ++SG + F + + T + + + D S ++ +
Sbjct: 211 MWAIGVLGYVLLSGL--SPFAGEDDLE-----TLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 270 KRIHIGLLCVQEDPADRPTMSSV 292
K +Q++P R T+
Sbjct: 264 KN------LLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-33
Identities = 44/263 (16%), Positives = 88/263 (33%), Gaps = 47/263 (17%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---LIAKLQHKNLVRLLGCC 113
LG G FG V++ V + K K + + G K ++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR--------------- 158
EL++I E++ + + +T + +L+ + ++ +
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 159 ---------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSD 209
KI +FG AR N + Y APE + S +D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 210 VFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEELL 269
++S G L+ ++SG + + + E E + + + +
Sbjct: 186 MWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM--DFV 238
Query: 270 KRIHIGLLCVQEDPADRPTMSSV 292
R + ++ R T S
Sbjct: 239 DR------LLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 3e-33
Identities = 44/271 (16%), Positives = 83/271 (30%), Gaps = 39/271 (14%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-LQEFKNLIAKLQHKNLVRLLGCC 113
K+G G FG +Y G + +E+A+K + L + +Q + + C
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 114 LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIARDHKMN-------- 163
+ ++ + SL+ L +R L + +I+ I H N
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 131
Query: 164 -------------PKISDFGMARVFGGNQSEAN-----TNRVVGTYGYMAPEYALEGLFS 205
I DFG+A+ + ++ + + GT Y + L S
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
+ D+ S G +L+ G + + + + L E
Sbjct: 192 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE---F 248
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
L C D+P S + +
Sbjct: 249 ATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-33
Identities = 59/284 (20%), Positives = 100/284 (35%), Gaps = 47/284 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLL 110
++++ +G G FG VY+ L D E+ A+K++ + +E + ++ KL H N+VRL
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ-IMRKLDHCNIVRLR 79
Query: 111 GCCLEGNE------LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------- 157
E L L+ +Y+P S L + +
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 158 ------RDHK----------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE 201
RD K K+ DFG A+ + + + + Y APE
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFG 196
Query: 202 GL-FSVKSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEGNAQ--E 253
++ DV+S G +L E++ G+ L E + L T T + E N E
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 254 LMDPVLKESFILEELLKRIHIGLL-----CVQEDPADRPTMSSV 292
P +K + R + ++ P R T
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (306), Expect = 1e-32
Identities = 65/268 (24%), Positives = 99/268 (36%), Gaps = 48/268 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDD-KEIAVKRLSRS---SGQGLQEFKN------LIAKL 101
+FS +G GGFG VY D K A+K L + QG N L++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 102 QHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM-CIINGIA--- 157
+V + ++L I + M L + L + D II G+
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 158 ------RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
RD K + +ISD G+A F + + VGT+GYMAPE +G
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG 180
Query: 203 L-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261
+ + +D FS G +L +++ G + Q ++ + A EL D E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGH-----SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 262 SFILEELLKRIHIGLLCVQEDPADRPTM 289
L LL+ +Q D R
Sbjct: 236 ---LRSLLEG------LLQRDVNRRLGC 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-32
Identities = 53/293 (18%), Positives = 104/293 (35%), Gaps = 56/293 (19%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSS------GQGLQEFKN---LIAKLQHKNLV 107
+LG G F V K + + A K + + G ++ + ++ ++QH N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM--CIINGIARDHKM--- 162
L +++LI E + L F S+ + I+NG+ H +
Sbjct: 77 TLHEVYENKTDVILILELVAGGEL-FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 135
Query: 163 -------------------NPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
KI DFG+A + GT ++APE
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEP 192
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
+++D++S GV+ ++SG ++ T N + + S
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFEDEYFSNTSA 245
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVV---FMLATDTITLLQP--TQPAF 311
+ ++ ++R + +DP R T+ + ++ DT L + P F
Sbjct: 246 LAKDFIRR------LLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (298), Expect = 4e-32
Identities = 51/270 (18%), Positives = 92/270 (34%), Gaps = 50/270 (18%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG---LQEFKN---LIAKLQHKN 105
+ LG GG V+ L +++AVK L + F+ A L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 106 LVRLLGCCLE----GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA---- 157
+V + G ++ EY+ +L ++ + R + +I
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 125
Query: 158 ---------RDHK---------MNPKISDFGMARVFG-GNQSEANTNRVVGTYGYMAPEY 198
RD K K+ DFG+AR S T V+GT Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 199 ALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
A +SDV+S G +L E+++G + + + +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGE-----PPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 259 LKESFILEELLKRIHIGLLCVQEDPADRPT 288
L L+ ++ + + ++P +R
Sbjct: 241 LSAD--LDAVVLK------ALAKNPENRYQ 262
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 116 bits (291), Expect = 4e-31
Identities = 61/278 (21%), Positives = 100/278 (35%), Gaps = 39/278 (14%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEIAVK--RLSRSSGQGLQEFKN---LIAKLQHKNL 106
+ K+GEG +G VYK N + A+K RL + ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 107 VRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-IINGIARDHKMN-- 163
V+L L+L+ E++ L + + ++NGIA H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 164 ----------------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGLFSV 206
KI+DFG+AR FG + + T Y AP+ + +S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYST 180
Query: 207 KSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP--VL 259
D++S G + E+++G L + L T K W DP +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 260 KESFILEELLKRIHIGLL-----CVQEDPADRPTMSSV 292
E E LK + + ++ DP R T
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-31
Identities = 51/278 (18%), Positives = 90/278 (32%), Gaps = 46/278 (16%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEI-AVKRLSRSSGQGLQEFK--------NLIAKLQHKNLV 107
+ LGEG F VYK + +I A+K++ ++ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 108 RLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII-------------- 153
LL + + L+ ++M + +S M +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 154 -----NGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVK 207
N + D K++DFG+A+ FG V T Y APE ++ V
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 208 SDVFSFGVLLLEIISGR--------KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259
D+++ G +L E++ D ++E + W C
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 260 KESFILEELLKRIHIGLL-----CVQEDPADRPTMSSV 292
L + LL +P R T +
Sbjct: 242 GIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 6e-31
Identities = 50/266 (18%), Positives = 96/266 (36%), Gaps = 52/266 (19%)
Query: 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFK------NLIAKLQH 103
++F LG G FG V+ ++ + A+K L + L++ + +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 104 KNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII---------- 153
++R+ G + ++ +I +Y+ L LL S R +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 154 NGIARDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLF 204
+ I RD K + KI+DFG A+ + GT Y+APE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPY 178
Query: 205 SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264
+ D +SFG+L+ E+++G + + N + + +L
Sbjct: 179 NKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKILNAELR 219
Query: 265 LEELLKRIHIGLL--CVQEDPADRPT 288
LL + D + R
Sbjct: 220 FPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-31
Identities = 51/288 (17%), Positives = 99/288 (34%), Gaps = 43/288 (14%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-LQEFKN---LIAKLQ 102
+ ++N + +GEG +G V + +A+K++S Q Q ++ + +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 103 HKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR---- 158
H+N++ + + Y+ + L+ ++ L + + I R
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 159 ------------------DHKMNPKISDFGMARVFGGNQSEANT-NRVVGTYGYMAPEYA 199
+ + KI DFG+ARV + V T Y APE
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 200 LEGLFSVKS-DVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253
L KS D++S G +L E++S R K L L + + + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 254 LMDPVLKESFILEELLKRIH-------IGLL--CVQEDPADRPTMSSV 292
+ +L + R+ + LL + +P R +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 60/280 (21%), Positives = 103/280 (36%), Gaps = 41/280 (14%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVK--RLSRSSGQGLQEFKN---LIAKLQHKN 105
NF K+GEG +G VYK + +A+K RL + L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCI--INGIA------ 157
+V+LL N+L L+ E++ F+ + + L + + G+A
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 158 ---RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPE-YALEGLF 204
RD K K++DFG+AR FG V T Y APE +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYY 180
Query: 205 SVKSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259
S D++S G + E+++ R L+ ++L T +W + P
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 260 KE--SFILEELLKRIHIGLL-----CVQEDPADRPTMSSV 292
+ +++ + + DP R + +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-30
Identities = 56/289 (19%), Positives = 106/289 (36%), Gaps = 48/289 (16%)
Query: 49 ATRNFSNENKLGEGGFGPVYKG--VLNDDKEIAVKRLSRSSGQGLQEFKNL--------I 98
A + + ++GEG +G V+K + N + +A+KR+ +G+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 99 AKLQHKNLVRLLGCCLEG-----NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII 153
+H N+VRL C +L L+ E++ +L V + + M
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 154 ----------NGIA-RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGY 193
+ + RD K K++DFG+AR++ + VV T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWY 181
Query: 194 MAPEYALEGLFSVKSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCE 248
APE L+ ++ D++S G + E+ + L + + + W
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 249 GNAQELMDPVLKESFILEELLKRIHIGLL-----CVQEDPADRPTMSSV 292
A K + +E+ + I C+ +PA R + S
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (285), Expect = 3e-30
Identities = 54/283 (19%), Positives = 93/283 (32%), Gaps = 61/283 (21%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQG-------------LQEFKNL 97
N+ + LG G V + + KE AVK + + G L+E L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 98 IAKLQHKNLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA 157
H N+++L L+ + M L L T V L I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 158 R----------------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
D MN K++DFG + + V GT Y+A
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLA 177
Query: 196 PEYALEGL------FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG 249
PE + + + D++S GV++ +++G + + +L ++ G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLML--RMIMSG 230
Query: 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSV 292
N Q S +++L+ R + P R T
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEA 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-29
Identities = 49/269 (18%), Positives = 91/269 (33%), Gaps = 61/269 (22%)
Query: 58 KLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKN---------LIAKLQ--HKN 105
LG GGFG VY G+ ++D+ +A+K + + E N L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC--IINGIA------ 157
++RLL + +LI E F ++Q + R ++ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 158 -------------RDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL-EGL 203
++ K+ DFG + + GT Y PE+
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 204 FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263
+ V+S G+LL +++ G +E + ++ Q +
Sbjct: 187 HGRSAAVWSLGILLYDMVCGD-----IPFEHDEEII----------RGQVFFRQRVSSEC 231
Query: 264 ILEELLKRIHIGLLCVQEDPADRPTMSSV 292
L++ C+ P+DRPT +
Sbjct: 232 Q--HLIRW------CLALRPSDRPTFEEI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (279), Expect = 3e-29
Identities = 44/277 (15%), Positives = 89/277 (32%), Gaps = 41/277 (14%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG-QGLQEFKNLIAKLQHKNLVRL 109
++ ++GEG FG +++G L +++++A+K R S L++ L +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 110 LGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII-----------NGIAR 158
+ + ++ + SL+ LL R + + + R
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 125
Query: 159 DHKM--------------NPKISDFGMARVFGGNQSEAN-----TNRVVGTYGYMAPEYA 199
D K + DFGM + + ++ + + GT YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 200 LEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259
L S + D+ + G + + + G QG T K G ++
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSL------PWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFML 296
+ EE K +H P + +
Sbjct: 240 LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-27
Identities = 51/293 (17%), Positives = 101/293 (34%), Gaps = 53/293 (18%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHK 104
+ K+G+G FG V+K +++A+K++ + L+E K L L+H+
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-QLLKHE 69
Query: 105 NLVRLLGCCLEG--------NELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCII--- 153
N+V L+ C + L+ ++ + L + + R M ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 154 ----------------NGIARDHKMNPKISDFGMARVFGGNQSEANTNR--VVGTYGYMA 195
+ K++DFG+AR F ++ V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 196 PEYAL-EGLFSVKSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEG 249
PE L E + D++ G ++ E+ + + L Q + T ++W
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 250 NAQELMDPVLKESFILEELLKRIHIGLL----------CVQEDPADRPTMSSV 292
+ EL + + ++ R+ + + DPA R
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-27
Identities = 45/267 (16%), Positives = 87/267 (32%), Gaps = 44/267 (16%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCC- 113
LG G G V + ++ A+K L + +E + Q ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYE 75
Query: 114 ---LEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------------- 157
LL++ E + L + D I+ I
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 158 RDHK------------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFS 205
RD K K++DFG A+ + S T Y+APE +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYD 191
Query: 206 VKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265
D++S GV++ ++ G + G ++ G + + S +
Sbjct: 192 KSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 266 EELLKRIHIGLLCVQEDPADRPTMSSV 292
+ L++ ++ +P R T++
Sbjct: 249 KMLIRN------LLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-25
Identities = 58/311 (18%), Positives = 95/311 (30%), Gaps = 63/311 (20%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFK------NLIAKLQHK 104
+F LG+G FG V + A+K L + E ++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIAR------ 158
L L + L + EY L F L +R R I
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH 122
Query: 159 ----------------DHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
D + KI+DFG+ + G A GT Y+APE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
+ D + GV++ E++ GR + + + L + +L E
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR-------------------LPFYNQDHERLFELILMEE 221
Query: 263 FILEELLKRIHIGLL--CVQEDPADRPTMSSVV--------FMLATDTITLLQPTQPAFS 312
L LL +++DP R F L+ + ++Q
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF 281
Query: 313 VGRVKSPSDLK 323
+V S D +
Sbjct: 282 KPQVTSEVDTR 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 1e-23
Identities = 53/279 (18%), Positives = 97/279 (34%), Gaps = 39/279 (13%)
Query: 52 NFSNENKLGEGGFGPVYKGVLNDDKEI-AVK--RLSRSSGQGLQEFKN---LIAKLQHKN 105
+ K+GEG +G V+K + EI A+K RL L+ +L+HKN
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 106 LVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRM-CIINGIA------- 157
+VRL +L L+ E+ + + + ++ G+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 158 --RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSV 206
RD K K+++FG+AR FG + VV + L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYST 181
Query: 207 KSDVFSFGVLLLEIISGR------KDTRFYLYEQGQSLLTYTWKLWCEGN--AQELMDPV 258
D++S G + E+ + D L + L T T + W P+
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 259 LKESFILEELLKRIHIGLL-----CVQEDPADRPTMSSV 292
+ L ++ +++ ++ +P R +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 3e-23
Identities = 56/284 (19%), Positives = 102/284 (35%), Gaps = 49/284 (17%)
Query: 53 FSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKN---LIAKLQHKNL 106
+ + +G G +G V V ++A+K+L R S + L+ ++H+N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 107 VRLLGCCLEGNELLLICE-YMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA-------- 157
+ LL L + Y+ + L + +L +R ++ +
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 158 -----RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGL 203
RD K KI DFG+AR Q+++ V T Y APE L +
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWM 194
Query: 204 -FSVKSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDP 257
++ D++S G ++ E+I+G+ D L E + T + + E +
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 258 VLK----ESFILEELLKRIH---IGLL--CVQEDPADRPTMSSV 292
+ E +L + LL + D R T
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.0 bits (230), Expect = 3e-22
Identities = 45/284 (15%), Positives = 99/284 (34%), Gaps = 46/284 (16%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGL-QEFKNLIAKLQHKNLVRL 109
++ KLG G + V++ + + +++++ VK L + + +E K L N++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 110 LGCCLEGNE--LLLICEYMPNKSLD------------FLLFDSTRSVQL-----DWNRRM 150
+ L+ E++ N F +++ +++ +R +
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDV 155
Query: 151 CIINGIARDHKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALE-GLFSVKSD 209
N + ++ D+G+A + Q N V + + PE ++ ++ D
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLD 212
Query: 210 VFSFGVLLLEIISGR------KDTRFYLYEQGQSLLTYTWKLWCEGNAQEL--------- 254
++S G +L +I + D L + L T + + EL
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272
Query: 255 -MDPVLKESFILEELLKRIH---IGLL--CVQEDPADRPTMSSV 292
E F+ E + + L ++ D R T
Sbjct: 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 3e-21
Identities = 54/312 (17%), Positives = 109/312 (34%), Gaps = 55/312 (17%)
Query: 52 NFSNENKLGEGGFGPVYKGVL----NDDKEIAVKRLSRSS----GQGLQEFKN---LIAK 100
NF LG G +G V+ + K A+K L +++ + + + ++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 101 LQHK-NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC-IINGIAR 158
++ LV L +L LI +Y+ L L R + + + I+ +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 159 DHKMN------------------PKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYAL 200
HK+ ++DFG+++ F +++E GT YMAP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVR 203
Query: 201 EGL--FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258
G D +S GVL+ E+++G + + ++ + + +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVDGEKNSQAEISRRILKSEPPYPQEM- 259
Query: 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVV--------FMLATDTITLLQPTQPA 310
S + ++L++R + +DP R F + L PA
Sbjct: 260 ---SALAKDLIQR------LLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310
Query: 311 FSVGRVKSPSDL 322
++ D+
Sbjct: 311 PFKPVIRDELDV 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 1e-20
Identities = 55/287 (19%), Positives = 105/287 (36%), Gaps = 49/287 (17%)
Query: 48 EATRNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKN---LIAKL 101
E + N + +G G +G V +AVK+LSR S + L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 102 QHKNLVRLLGCCLEGNEL-----LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGI 156
+H+N++ LL L + + ++ L+ ++ + I+ G+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 157 A---------RDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEY 198
RD K KI DFG+AR + T Y APE
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEI 189
Query: 199 ALEGL-FSVKSDVFSFGVLLLEIISGR-----KDTRFYLYEQGQSLLTYTWKLWCEGNAQ 252
L + ++ D++S G ++ E+++GR D L + + T +L + +++
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 253 ELMDPVLKESFILEELLKRIHIG-------LL--CVQEDPADRPTMS 290
+ + + + + + IG LL + D R T +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (216), Expect = 3e-20
Identities = 54/295 (18%), Positives = 91/295 (30%), Gaps = 56/295 (18%)
Query: 51 RNFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRS--SGQGLQEFKN---LIAKLQHK 104
+ + N +G G G V D+ +A+K+LSR + + L+ + HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 105 NLVRLLGCCL------EGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMC------- 151
N++ LL E ++ L+ E M + + +M
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 152 IINGIARDHK---------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
I RD K KI DFG+AR G + V T Y APE L
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM 193
Query: 203 LFSVKSDVFSFGVLLLEIISGR--------KDTRFYLYEQGQSLLTYTWKLWCEGNAQEL 254
+ D++S G ++ E++ + D + EQ + K +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 255 MDPVLKESFILEELLKRIHIGLL-----------------CVQEDPADRPTMSSV 292
+ +L + DPA R ++
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.4 bits (213), Expect = 1e-19
Identities = 56/307 (18%), Positives = 99/307 (32%), Gaps = 62/307 (20%)
Query: 52 NFSNENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSGQGLQEFK------NLIAKLQHK 104
F LG G FG V A+K L + L++ + ++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 105 NLVRLLGCCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIA------- 157
LV+L + + L ++ EY+ + L R I
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH 158
Query: 158 ------RD---------HKMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEG 202
RD + +++DFG A+ G + GT +APE L
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSK 213
Query: 203 LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262
++ D ++ GVL+ E+ +G + Q + Y + + LK
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGY-----PPFFADQPIQIYEKIVSGKVRFPSHFSSDLK-- 266
Query: 263 FILEELLKRIHIGLLCVQEDPADR-----PTMSSVV---FMLATDTITLLQPTQPAFSVG 314
+LL+ +Q D R ++ + + TD I + Q A +
Sbjct: 267 ----DLLRN------LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316
Query: 315 RVKSPSD 321
+ K P D
Sbjct: 317 KFKGPGD 323
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.1 bits (183), Expect = 9e-16
Identities = 29/209 (13%), Positives = 71/209 (33%), Gaps = 40/209 (19%)
Query: 56 ENKLGEGGFGPVYKGV-LNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGC 112
KLG G F V+ + ++ +A+K + + ++ L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 113 CLE---------------GNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRR--MCIING 155
G ++++ E + L + R + L + ++ ++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 156 IA----------RDHK----------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMA 195
+ D K + +A + + + + T Y +
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 196 PEYALEGLFSVKSDVFSFGVLLLEIISGR 224
PE L + +D++S L+ E+I+G
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 5e-13
Identities = 31/192 (16%), Positives = 58/192 (30%), Gaps = 35/192 (18%)
Query: 57 NKLGEGGFGPVYKGVLNDDKEIAVK--RLSRSSGQ--------GLQEFKNLIA---KLQH 103
+GEG V+ E VK ++ +S + G F L + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 104 KNLVRLLGCC----LEGNELLLICEYMPNKSLDFLLFDSTRSV------QLDWNRRMCII 153
+ L +L G ++ E + K L + ++ V ++ I+
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 154 NG-----IARDHKMNPKISDFGMARVFGGNQSEANTNR-VVGTYGYMAPEYALEGLFSVK 207
+G + I DF + G R V Y + Y +
Sbjct: 126 HGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RTE 179
Query: 208 SDVFSFGVLLLE 219
D+ S +L+
Sbjct: 180 KDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 338 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.45 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 94.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.04 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=320.41 Aligned_cols=229 Identities=19% Similarity=0.260 Sum_probs=176.8
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.++|++++.||+|+||.||+|.. .++..||||++.... .+.+.+|+.+++.++|||||++++++.+.+.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999994 568899999986433 24467888999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRV 187 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 187 (338)
|++|+|..++...............+++.||.|+| ++++||+|||+|+.+.... ......
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTM 176 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCC
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cccccc
Confidence 99999999887766555556667778888888755 3569999999999864322 223456
Q ss_pred ccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 188 VGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
+||+.|+|||++.+..|+.++|||||||++|+|++|..||............ ............. .
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~--------~ 242 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTPELQNPEK--------L 242 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCSCCCSSGGG--------S
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCCCCCCCCccc--------C
Confidence 8999999999999999999999999999999999999999653322211111 0000000000000 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+||.+||+.||++|||+.|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 124567888999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=321.95 Aligned_cols=231 Identities=25% Similarity=0.294 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|+||.||+|.+ .+++.||||.+.... .+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 56899999999999999999996 458899999986432 2457788999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
||++|+|.+++..... ..........+++.+|.+.| ++.+||+|||+|+.+..........
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9999999998865432 33344556667887777754 3569999999998764333333344
Q ss_pred ccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 186 RVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
..+||+.|||||++.+..+ +.++||||+||++|+|++|.+||......... ..... ..... ......
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~-----~~~~~--~~~~~~---- 231 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKTY--LNPWKK---- 231 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHH-----TTCTT--STTGGG----
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHh-----cCCCC--CCcccc----
Confidence 5789999999999988876 57899999999999999999999643321111 00000 00000 000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+|+.+||+.||++|||+.|+++
T Consensus 232 --~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 232 --IDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1124557888999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=317.47 Aligned_cols=233 Identities=26% Similarity=0.344 Sum_probs=166.4
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
++|++++.||+|+||.||+|.+.++..||||++.... .+.+.+|+++++.++|||||++++++.+.+.+++|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 4789999999999999999998888899999997543 24567888999999999999999999999999999999999
Q ss_pred CCHHHHHhccCccc--cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTRSV--QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
|+|.+++....... ........+++.||.+.|. +.+||+|||+++....... .......
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~ 163 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTK 163 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-eeeccee
Confidence 99999887654332 3344566778888877553 4599999999987643222 1223357
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHhC-CCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISG-RKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
||+.|+|||++.+..|+.++|||||||++|||+++ .+||......+........ .. ...+.. .
T Consensus 164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------~~---~~~p~~-------~ 227 (263)
T d1sm2a_ 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------FR---LYKPRL-------A 227 (263)
T ss_dssp -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT------CC---CCCCTT-------S
T ss_pred cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc------CC---CCCccc-------c
Confidence 89999999999999999999999999999999995 4444332221111111110 00 000100 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...+.+||.+||+.||++|||++||++.|+...
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 124567888999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=312.23 Aligned_cols=231 Identities=25% Similarity=0.346 Sum_probs=178.2
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
++|+++++||+|+||.||+|+++++..||||.++.... +.+.+|+.+++.++||||+++++++.+.+.+++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 58999999999999999999998888999999976433 4577888999999999999999999999999999999999
Q ss_pred CCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccccc
Q 045271 129 KSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 188 (338)
|+|..++....... ...+....+++.|+.++| ++.+||+|||+++.+..... .......
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~ 162 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSK 162 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccC
Confidence 99998876554432 234455667888877754 35699999999987643222 2223457
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
||+.|+|||++.+..|+.++|||||||++|||+| |..||......+....+... .. ...+.. .
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~------~~---~~~p~~-------~ 226 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------LR---LYRPHL-------A 226 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT------CC---CCCCTT-------C
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC------CC---CCCccc-------c
Confidence 8999999999999999999999999999999998 89998765433322211110 00 011100 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
...+.+||.+||+.||++||||.+|++.|.+
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1245678889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=315.05 Aligned_cols=227 Identities=22% Similarity=0.317 Sum_probs=174.4
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|++. ++..||+|++.+. ....+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 5788999998532 2234667889999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||++|+|..++..... ..........+++.||.+.| ++.+||+|||+|..... ...
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~~~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRR 161 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----CCC
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----Ccc
Confidence 99999999998875433 43445556667888887755 34699999999986532 223
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+...... .... .++..+
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~--~~p~~~----- 227 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------RVEF--TFPDFV----- 227 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TTCC--CCCTTS-----
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC--CCCccC-----
Confidence 34689999999999999999999999999999999999999997543222111110 0100 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...+.+|+.+||+.||++|||+.|+++ +|.+
T Consensus 228 ---s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 228 ---TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 124567888999999999999999996 5543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=321.99 Aligned_cols=234 Identities=18% Similarity=0.207 Sum_probs=162.1
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+.+.|++++.||+|+||.||+|++. +++.||||.+.... ...+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999964 57889999986533 234567888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC---------------------CCCeEEeeeccceecCCCCCC
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH---------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~---------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|||++|+|.+++..... ..........+++.+|.+.| ++.+||+|||+|+.... .
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---G 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---C
Confidence 99999999998876433 33444556667777777644 34599999999986532 2
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
......+||+.|||||++.+..|+.++|||||||++|+|++|..||......+....+. ...... ......
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-------~~~~~~-~~~~~~- 234 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL-------KAEYEF-DSPYWD- 234 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------TTCCCC-CTTTTT-
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh-------ccCCCC-CCcccc-
Confidence 22345689999999999999999999999999999999999999997543222111111 011000 000000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.....+.+|+.+||+.||++|||+.|+++ +++.
T Consensus 235 ----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 235 ----DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ----CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 01124567888999999999999999997 4543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=313.24 Aligned_cols=237 Identities=20% Similarity=0.309 Sum_probs=167.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|++++.||+|+||.||+|++. ..||||+++.... +.+.+|+.+++.++|||||++++++. .+.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 468999999999999999999853 3699999864322 34567888999999999999999875 456899999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||++|+|.+++..... .......+..+++.||.++| ++.+||+|||+|+...........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9999999999865433 22333455667888887755 356999999999876433333334
Q ss_pred cccccCCccccccccccC---CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYALEG---LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~---~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
....||+.|||||++.+. .|+.++|||||||++|||++|..||......... ...................
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~---- 237 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRGYLSPDLSKVRSN---- 237 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHTSCCCCGGGSCTT----
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCCcchhcccc----
Confidence 456899999999999743 5899999999999999999999999754322111 1111111111111111110
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+||.+||+.||++||||.||++.|+.+.
T Consensus 238 -----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 238 -----CPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1124567888999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=317.64 Aligned_cols=226 Identities=20% Similarity=0.232 Sum_probs=168.9
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|.. .+++.||||++.+. ..+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999996 46889999998532 2245678888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||++|+|.+++..... ..........+++.+|.+.| ++.+||+|||+|+.+.........
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999888765433 33344555667777777754 456999999999987533333334
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|+|||++.+..|+.++||||+||++|+|++|..||......+....+ . .... . +...+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~-~~~~-~-~p~~~----- 233 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------I-KLEY-D-FPEKF----- 233 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-TTCC-C-CCTTC-----
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------H-cCCC-C-CCccC-----
Confidence 4568999999999999999999999999999999999999999753322111111 0 1110 0 11111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVV 293 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl 293 (338)
...+.+||.+||+.||++|||++|++
T Consensus 234 ---s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 234 ---FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12456788999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=315.25 Aligned_cols=229 Identities=18% Similarity=0.202 Sum_probs=173.6
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC---------cccHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---------GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++++.||+|+||.||+|++ .+++.||||++.+.. .+.+.+|+.+++.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999996 468899999986432 13467788999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC----------------------CCeEEeeeccceecC
Q 045271 120 LLICEYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK----------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~----------------------~~vkL~Dfg~a~~~~ 176 (338)
|+|||||++|+|.+++.... ...........+++.||.++|+ ..+||+|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999987643 3334445566778888887553 248999999998863
Q ss_pred CCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
. ........||+.|+|||++.+..|+.++|||||||++|+|++|..||......+....+.. ..........
T Consensus 169 ~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~~~ 240 (293)
T d1jksa_ 169 F---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-----VNYEFEDEYF 240 (293)
T ss_dssp T---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-----TCCCCCHHHH
T ss_pred C---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh-----cCCCCCchhc
Confidence 2 2223346899999999999999999999999999999999999999975432221111100 0000000000
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
......+.+||.+||+.||++|||+.|+++
T Consensus 241 --------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 241 --------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001124567899999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-43 Score=321.42 Aligned_cols=231 Identities=20% Similarity=0.231 Sum_probs=174.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
..++|++++.||+|+||.||+|+. .++..||||++..... +.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 356899999999999999999995 4688999999965443 345678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC--ccccccHHHHHHHHHHhhhcC--------------------CCCeEEeeeccceecCCCCCCc
Q 045271 125 YMPNKSLDFLLFDST--RSVQLDWNRRMCIINGIARDH--------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~~~--------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||++|+|.+++.... ........+..+++.+|.++| ++.+||+|||+|+.+... .
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---S
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---c
Confidence 999999999885443 233344556667787777644 245999999999886432 2
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|||||++.+..|+.++|||||||++|+|++|..||......+....+.. ....... ....
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-----~~~~~~~---~~~~-- 250 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-----CDWNMDD---SAFS-- 250 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----TCCCSCC---GGGG--
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCCCCCc---cccc--
Confidence 23456899999999999999999999999999999999999999975432221111110 0001000 0000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
.....+.+||.+||+.||++|||+.|+++.
T Consensus 251 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 ---GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011245678889999999999999999973
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=312.67 Aligned_cols=227 Identities=22% Similarity=0.276 Sum_probs=162.9
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe--CCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE--GNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~--~~~~~l 121 (338)
.++|++++.||+|+||.||+|+. .+++.||||.+..... +.+.+|+++++.++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999995 4588899999865432 235667888999999999999999865 456899
Q ss_pred EEecCCCCCHHHHHhcc-----CccccccHHHHHHHHHHhhhcC-----------------------CCCeEEeeeccce
Q 045271 122 ICEYMPNKSLDFLLFDS-----TRSVQLDWNRRMCIINGIARDH-----------------------KMNPKISDFGMAR 173 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~~~~i~~~~-----------------------~~~vkL~Dfg~a~ 173 (338)
|||||++|+|.+++... .......+....+++.+|.+.| ++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988642 1233344555566666665543 3469999999998
Q ss_pred ecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccc
Q 045271 174 VFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQE 253 (338)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (338)
.+... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||......+....+ .......
T Consensus 163 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-------~~~~~~~ 233 (269)
T d2java1 163 ILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHTCCCC
T ss_pred ecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH-------HcCCCCC
Confidence 76422 22234568999999999999999999999999999999999999999754322211111 1111111
Q ss_pred ccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 254 LMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
+... . ...+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~---~------s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYR---Y------SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTT---S------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc---c------CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1110 0 124567888999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=320.98 Aligned_cols=177 Identities=25% Similarity=0.332 Sum_probs=144.0
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
.++|+++++||+|+||.||+|+. .++..||+|+++.... ..+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999996 4578899999865432 345677789999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC-------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH-------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||++|+|.+++..... ..........+++.||.|.| ++++||+|||+|+.+. ....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~----~~~~ 160 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMA 160 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----HHTC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC----CCcc
Confidence 9999999999875433 32333445556777766654 3469999999998752 1223
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY 230 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~ 230 (338)
...+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4568999999999999999999999999999999999999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=314.70 Aligned_cols=228 Identities=20% Similarity=0.248 Sum_probs=170.7
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
+.|++++.||+|+||.||+|++ .++..||||++..... +.+.+|+++++.++|||||++++++.+.+.+++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5799999999999999999996 4578899999865433 45678889999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 127 PNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 127 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
++|+|..++..... ..........+++.||.+.| ++++||+|||+|..... .......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccccccc
Confidence 99999998765433 33344556667888877754 35699999999976521 1122334
Q ss_pred cccCCccccccccc-----cCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 187 VVGTYGYMAPEYAL-----EGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 187 ~~gt~~y~aPE~~~-----~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
.+||+.|+|||++. +..|+.++|||||||++|+|++|..||......+...... .. .......
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~------~~-~~~~~~~----- 237 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------KS-EPPTLAQ----- 237 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH------HS-CCCCCSS-----
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH------cC-CCCCCCc-----
Confidence 68999999999985 4468999999999999999999999997543222111111 00 0000000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
. ......+.+||.+||+.||++|||+.|+++
T Consensus 238 ~--~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 P--SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp G--GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 001124567888999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=320.78 Aligned_cols=234 Identities=25% Similarity=0.317 Sum_probs=171.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC-C-----cEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCCE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND-D-----KEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~ 118 (338)
.++|++++.||+|+||.||+|++.. + ..||+|.+..... ..+.+|..+++.+ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4689999999999999999999533 2 2589998854322 3456677788777 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc------------------------cccccHHHHHHHHHHhhhcC--------------
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR------------------------SVQLDWNRRMCIINGIARDH-------------- 160 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~------------------------~~~~~~~~~~~~~~~i~~~~-------------- 160 (338)
+++|||||++|+|.+++..... ..........+++.||.++|
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 9999999999999999976432 11223345566777777654
Q ss_pred ----CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccc
Q 045271 161 ----KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQG 235 (338)
Q Consensus 161 ----~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~ 235 (338)
++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ |..||........
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 35599999999987644333333345678999999999999999999999999999999997 8999875433221
Q ss_pred cchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 236 QSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
... .... ..... ... .....+.+||.+||+.||++|||+.||+++|.-
T Consensus 276 ~~~--~~~~----~~~~~-~p~--------~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 276 FYK--LIQN----GFKMD-QPF--------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHH--HHHT----TCCCC-CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHhc----CCCCC-CCC--------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 111 1100 00000 000 011245678889999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=310.25 Aligned_cols=231 Identities=29% Similarity=0.395 Sum_probs=170.8
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS--GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++++.||+|+||.||+|.+.++..||||++.... .+.+.+|+.+++.++|||||++++++.+ +.+++|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 46899999999999999999998888899999996543 3457788899999999999999998754 56799999999
Q ss_pred CCCHHHHHhccC---ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDST---RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+|+|.+++.... ........+..+++.||.++| ++.+||+|||+|+.+..... .....
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~ 169 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREG 169 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc-ccccc
Confidence 999998775433 222334455666777777754 35699999999998743222 22334
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCccc-ccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFY-LYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..||+.|+|||++.+..|+.++|||||||++|||+||..|+... ...+...... ... ...... .
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-------~~~-~~~~p~-----~-- 234 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGY-RMVRPD-----N-- 234 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC-CCCCCT-----T--
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hcC-CCCCcc-----c--
Confidence 57899999999999999999999999999999999966554432 2111111110 000 000000 0
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLAT 298 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~ 298 (338)
....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 235 -~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 -CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11245678889999999999999999998876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-43 Score=318.89 Aligned_cols=238 Identities=18% Similarity=0.162 Sum_probs=178.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG---QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
..++|++++.||+|+||.||+|.. .+++.||||++..... ..+.+|+.+++.++|||||+++++|.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 356899999999999999999995 4688999999875443 345678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC--------------------CCCeEEeeeccceecCCCCCCc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH--------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~--------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||++|+|.+.+..... .......+..+++.+|.+.| .+.+||+|||+|..+.. ..
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DE 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TS
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC---CC
Confidence 9999999888765543 33344556667887777644 35699999999998743 22
Q ss_pred cccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccc
Q 045271 183 NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKES 262 (338)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
.....+||+.|+|||++.+..|+.++||||+||++|+|++|..||......+....+... .......... .
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~--~-- 254 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-----DWEFDEDAFS--S-- 254 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-----CCCCCSSTTT--T--
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCCCccccc--C--
Confidence 234468999999999999999999999999999999999999999754332221111100 0000000000 0
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCccc
Q 045271 263 FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDTIT 302 (338)
Q Consensus 263 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~~~ 302 (338)
....+.+||.+||+.||.+|||+.|+++ +++.....
T Consensus 255 ----~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 255 ----VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 1124567889999999999999999997 46654443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-44 Score=314.71 Aligned_cols=235 Identities=26% Similarity=0.328 Sum_probs=174.5
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.++|++.+.||+|+||.||+|.+. ++..||||+++.+.. +.+.+|+.+++.++|||||++++++.+++.+++|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 458999999999999999999965 477899999875433 44678889999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCc---cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 127 PNKSLDFLLFDSTR---SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 127 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++|+|..++..... .......+..+++.||.+.|+ +.+||+|||+|+....... ....
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~ 174 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHA 174 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEET
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-eeec
Confidence 99999998865322 222234455678888887654 4599999999987643222 2223
Q ss_pred ccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 186 RVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
...|++.|+|||++.+..|+.++|||||||++|||++|..||........ ...... ........ ..
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~----~~~~~~~~-~~------- 240 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE----KDYRMERP-EG------- 240 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH----TTCCCCCC-TT-------
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHh----cCCCCCCC-cc-------
Confidence 34688999999999999999999999999999999997776643221111 111110 11000101 00
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
....+.+||.+||+.||++|||+.||++.|+...
T Consensus 241 -~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 241 -CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1124567888999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=301.25 Aligned_cols=223 Identities=23% Similarity=0.319 Sum_probs=162.4
Q ss_pred CCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe----CCEEEEE
Q 045271 53 FSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE----GNELLLI 122 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~----~~~~~lv 122 (338)
|++.++||+|+||.||+|.+. ++..||+|.+..... +.+.+|+++++.++|||||++++++.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999964 577899999864321 345678889999999999999999875 4568999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCCCC
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
||||++|+|.+++..... ..........+++.||.++|+ +.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~---- 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---- 166 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC----
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc----
Confidence 999999999998876432 333334556677777776543 348999999997642
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......+||+.|||||++.+ .|+.++|||||||++|+|++|..||........ . . ...........++..
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~---~-~~i~~~~~~~~~~~~-- 237 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---Y-RRVTSGVKPASFDKV-- 237 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---H-HHHTTTCCCGGGGGC--
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H---H-HHHHcCCCCcccCcc--
Confidence 222345689999999998865 599999999999999999999999964321111 0 0 011111111111110
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
....+.+||.+||+.||++|||+.|+++
T Consensus 238 ------~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 ------AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0113567888999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-43 Score=311.10 Aligned_cols=234 Identities=23% Similarity=0.305 Sum_probs=162.8
Q ss_pred cCCCCCceecccCCeeEEEEEEcC-Cc---EEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND-DK---EIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~-~~---~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.++||+|+||.||+|.+.. ++ .||||.+..... +.+.+|+.+|+.++|||||++++++.+.+.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 578889999999999999999643 32 488998865433 2456788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCcc--ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCc
Q 045271 123 CEYMPNKSLDFLLFDSTRS--VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEA 182 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~ 182 (338)
||||++|+|..++...... .........+++.||.|+| ++.+||+|||+|+.+.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 9999999999988765432 2233455667888877754 3569999999998764322211
Q ss_pred ---cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 183 ---NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 183 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
......||+.|||||++.+..|+.++|||||||++|||+| |..||......+...... ...... .
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~------~~~~~~--~--- 254 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE------QDYRLP--P--- 254 (299)
T ss_dssp ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCCC--C---
T ss_pred eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCCCCC--C---
Confidence 1122457899999999999999999999999999999998 899987544322211111 000000 0
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.......+.+||.+||+.||++|||+.||++.|+...
T Consensus 255 -----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 255 -----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0011224567888999999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=306.21 Aligned_cols=235 Identities=24% Similarity=0.319 Sum_probs=173.1
Q ss_pred cCCCCCc-eecccCCeeEEEEEEc---CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNEN-KLGEGGFGPVYKGVLN---DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~-~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|.+.+ +||+|+||.||+|.+. ++..||||.++.... +.+.+|+++++.++|||||++++++.+ +.+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4677777 4999999999999853 244699999965432 345678889999999999999999875 568999
Q ss_pred EecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC-
Q 045271 123 CEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE- 181 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~- 181 (338)
||||++|+|.+++..... ..........+++.||.+.|+ +.+||+|||+|+.+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999999999998765433 333445566778888887654 45899999999987543322
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .+.......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~~~~~p~---- 235 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRMECPP---- 235 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCCCCCT----
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCCCCC----
Confidence 22234578999999999999999999999999999999998 899997543322211111 111111111
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
.....+.+||.+||+.||++||||.+|++.|+..+..
T Consensus 236 -----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 -----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0112456788899999999999999999999876543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=306.18 Aligned_cols=238 Identities=26% Similarity=0.370 Sum_probs=170.4
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 127 (338)
.++|++++.||+|+||.||+|++.++..||||+++.... +.+.+|+.+++.++|||||++++++.+ +.+++|||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 468999999999999999999988888899999965543 457788889999999999999999854 56889999999
Q ss_pred CCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+|+|..++.... ...........+++.++.++|. +.+||+|||+|+.+..... .....
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~ 173 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG 173 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-eeecc
Confidence 999988876432 2333445566677777777553 4599999999987643222 22233
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILE 266 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
..||+.|+|||++.+..++.++|||||||++|||++|..||........ ....... . ........
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~----~-~~~~~~~~-------- 238 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER----G-YRMPCPPE-------- 238 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT----T-CCCCCCTT--------
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHh----c-CCCCCCcc--------
Confidence 5789999999999999999999999999999999997766543322111 1111100 0 00001111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccccC
Q 045271 267 ELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTITLL 304 (338)
Q Consensus 267 ~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~~~ 304 (338)
....+.+|+.+||+.||++|||+.+|+++|+.......
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 11245678889999999999999999999998654433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-43 Score=310.78 Aligned_cols=223 Identities=26% Similarity=0.328 Sum_probs=167.1
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
+.|+.++.||+|+||.||+|+. .+++.||||++..... +.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999995 4577899999865432 23567888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
|||.+|++..++.... ...........+++.||.+.| ++.+||+|||+|..... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence 9999999877665433 333444566677888877755 34599999999986421 2
Q ss_pred cccccCCcccccccccc---CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccc
Q 045271 185 NRVVGTYGYMAPEYALE---GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKE 261 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~---~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (338)
...+||+.|||||++.+ ..|+.++|||||||++|||++|..||......+... .... ...........
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~-~~~~~~~~~~~-- 239 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NESPALQSGHW-- 239 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH-SCCCCCSCTTS--
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHh-CCCCCCCCCCC--
Confidence 34689999999999974 358999999999999999999999996533221111 1111 11111111100
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 262 SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 262 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...+.+||.+||+.||++|||+.|+++
T Consensus 240 ------s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 240 ------SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 124567888999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=300.72 Aligned_cols=226 Identities=26% Similarity=0.317 Sum_probs=163.7
Q ss_pred ceecccCCeeEEEEEEcC---CcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEecCCC
Q 045271 57 NKLGEGGFGPVYKGVLND---DKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEYMPN 128 (338)
Q Consensus 57 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 128 (338)
++||+|+||.||+|.+.. ++.||||+++.... +.+.+|+.+++.++|||||++++++.+ +.+++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998543 35799999864332 346678889999999999999999965 457899999999
Q ss_pred CCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCc-cccccc
Q 045271 129 KSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEA-NTNRVV 188 (338)
Q Consensus 129 g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~-~~~~~~ 188 (338)
|+|.+++..... ..........+++.||.+.|+ +.+||+|||+++.+....... ......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 999999876442 333445566678888887654 458999999998764332221 223357
Q ss_pred cCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccHHH
Q 045271 189 GTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFILEE 267 (338)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (338)
||+.|+|||++.+..|+.++|||||||++|||++ |..||......+...... .+...... .. .
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~~~~~p-~~--------~ 235 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCP-AG--------C 235 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCCCC-TT--------C
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------cCCCCCCC-cc--------c
Confidence 8999999999999999999999999999999998 899997543322111111 11101100 00 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 268 LLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 268 ~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
...+.+||.+||+.||++|||+.+|+++|+.-
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 12456788899999999999999999888764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=306.81 Aligned_cols=226 Identities=20% Similarity=0.198 Sum_probs=173.4
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|+. .+++.||||++.+. ......+|..+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35899999999999999999995 56889999998643 224466788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||||++|+|..++...... .........+++.||.|.| ++.+||+|||+|+..... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC--Ccc
Confidence 9999999999888765443 2334555567777777644 467999999999875322 223
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..|+.++||||+||++|||++|.+||......+....... ... . +...+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------~~~-~-~p~~~---- 228 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EEI-R-FPRTL---- 228 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC-C-CCTTS----
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------CCC-C-CCccC----
Confidence 3457899999999999999999999999999999999999999976443222111110 110 0 01111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
...+.+||.+||+.||.+|++ +.|+++
T Consensus 229 ----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 124567888999999999995 888886
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=308.64 Aligned_cols=235 Identities=19% Similarity=0.167 Sum_probs=177.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQ--GLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
+.++|++++.||+|+||.||+|.+. +++.||||.+.....+ .+.+|+++|+.++|||||+++++|.+.+.+|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4678999999999999999999964 5778999999765433 356788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC--------------------CCeEEeeeccceecCCCCCCcc
Q 045271 126 MPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK--------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~--------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
|++|+|.+++..... ..........+++.||.++|+ ..+||+|||++..... ...
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc---CCc
Confidence 999999999976543 333445566678888877553 3589999999987632 222
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....++|+.|+|||.+.+..|+.++||||+||++|+|++|..||......+....+... ..........
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~------ 228 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-----EYTFDEEAFK------ 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----CCCCCHHHHT------
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCCChhhcc------
Confidence 33467899999999999999999999999999999999999999754322211111000 0000000000
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.....+.+|+.+||+.||.+|||+.|+++ ++...
T Consensus 229 --~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 229 --EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 01124567899999999999999999997 45543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=299.57 Aligned_cols=228 Identities=25% Similarity=0.295 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHhcCCCceeeeeeEEEe-CCEEEEEEecCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-GQGLQEFKNLIAKLQHKNLVRLLGCCLE-GNELLLICEYMP 127 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~ 127 (338)
.++|++++.||+|+||.||+|.+ .+..||||+++.+. .+.+.+|+.+++.++||||+++++++.+ .+.+++||||++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 35788999999999999999998 46789999996543 3557788899999999999999999865 456899999999
Q ss_pred CCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCccccc
Q 045271 128 NKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 128 ~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+|+|.+++.... ........+..+++.++.+.|+ +.+||+|||+++.... ....
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~ 159 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDT 159 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-----CCcc
Confidence 999999986543 2333345566678888877553 4589999999986532 1233
Q ss_pred cccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCccccccccH
Q 045271 187 VVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFIL 265 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (338)
..++..|+|||++.+..++.++|||||||++|||++ |.+||......+...... ........ ..
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~~~~~~~-~~------- 224 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAP-DG------- 224 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTCCCCCC-TT-------
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCCCCC-cc-------
Confidence 568899999999999999999999999999999998 677776543332211111 01001111 10
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 266 EELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 266 ~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
....+.+|+.+||+.||.+||||.+|+++|+..
T Consensus 225 -~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 225 -CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112456788899999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-42 Score=304.20 Aligned_cols=236 Identities=26% Similarity=0.354 Sum_probs=173.8
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCE
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNE 118 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~ 118 (338)
..++|++++.||+|+||.||+|++. ++..||||++..... +.+.+|+.+++.++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999953 245799999865433 346778889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhccCc-------------------------cccccHHHHHHHHHHhhhcCC------------
Q 045271 119 LLLICEYMPNKSLDFLLFDSTR-------------------------SVQLDWNRRMCIINGIARDHK------------ 161 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~i~~~~~------------ 161 (338)
.++||||+.+|+|.+++..... .......+..+++.|+.+.|+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 9999999999999998864321 111234455567777777553
Q ss_pred ------CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCC-CCCccccccc
Q 045271 162 ------MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR-KDTRFYLYEQ 234 (338)
Q Consensus 162 ------~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~-~Pf~~~~~~~ 234 (338)
+.+||+|||+|+...............|++.|+|||++.+..|+.++|||||||++|||++|. +||......+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 458999999998764333333344567899999999999999999999999999999999986 5665443322
Q ss_pred ccchhhHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 235 GQSLLTYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
...... .......... ....+.+||.+||+.||++||||.||+++|+.+.
T Consensus 251 ~~~~v~-------~~~~~~~p~~---------~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYVR-------DGNILACPEN---------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHH-------TTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHH-------cCCCCCCCcc---------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 211111 1111111110 1124567889999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=301.70 Aligned_cols=235 Identities=23% Similarity=0.345 Sum_probs=163.6
Q ss_pred cCCCCCceecccCCeeEEEEEEcCC-----cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDD-----KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
+.|++.++||+|+||.||+|.+... ..||||.+..... ..+.+|+.+++.++|||||++++++.+.+.+++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999995442 3589999865433 235678889999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|||||.++++.+++....... ........+++.|+.++| ++.+||+|||+++.+......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999999988876554322 233445566777777754 456999999999876432221
Q ss_pred -ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 -ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.+..|+.++|||||||++|||++|..||........ ...... .+.... ...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~----~~~~~~-~~~--- 236 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN----DGFRLP-TPM--- 236 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH----TTCCCC-CCT---
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHh----ccCCCC-Cch---
Confidence 122335689999999999999999999999999999999997666543221111 111110 000000 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+||.+||+.||++||||.||++.|+...
T Consensus 237 -----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 237 -----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp -----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 01124567888999999999999999999998644
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-41 Score=298.08 Aligned_cols=229 Identities=21% Similarity=0.216 Sum_probs=171.1
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------------ccHHHHHHHHHhcC-CCceeeeeeEEEe
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------------QGLQEFKNLIAKLQ-HKNLVRLLGCCLE 115 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------------~~~~~~~~~l~~l~-hpnIv~~~~~~~~ 115 (338)
.++|++++.||+|+||+||+|+. .+++.||||++..... +...+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57999999999999999999995 4688899999865432 13556778889987 9999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecC
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFG 176 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~ 176 (338)
.+.+|+|||||++|+|.+++..... ..........+++.+|.+.| ++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999999965443 33444556667888877755 4569999999999874
Q ss_pred CCCCCccccccccCCcccccccccc------CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALE------GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN 250 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (338)
.. ......+||..|+|||++.+ ..++.++||||+||++|+|++|..||...........+. ...
T Consensus 162 ~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~-------~~~ 231 (277)
T d1phka_ 162 PG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-------SGN 231 (277)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTC
T ss_pred CC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-------hCC
Confidence 32 22344689999999999963 347889999999999999999999997543222111111 111
Q ss_pred cccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 251 AQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...........+ ..+.+|+.+||+.||.+|||+.||++
T Consensus 232 ~~~~~~~~~~~s------~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 YQFGSPEWDDYS------DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCCTTTGGGSC------HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCC------HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 110011111111 24567888999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=298.77 Aligned_cols=232 Identities=22% Similarity=0.249 Sum_probs=161.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEcC----CcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLND----DKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.++|++++.||+|+||.||+|.+.. +..||||.+..... +.+.+|+.+++.++|||||++++++. .+.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999999643 23588998865433 23567888999999999999999996 467899
Q ss_pred EEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
|||||++|+|..++....... ........+++.||.+.|+ +.+||+|||+|+.+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~- 163 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY- 163 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc-
Confidence 999999999998876554332 3344556678888887554 4599999999987643221
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.+||......+....... ..... +...
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-------~~~~~-~~~~-- 233 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERLP-MPPN-- 233 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCCCC-CCTT--
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCCCC-CCCC--
Confidence 22334578999999999999999999999999999999998 8888875543322111111 11011 1111
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
....+.+||.+||+.||++|||+.||++.|+..
T Consensus 234 ------~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 234 ------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112456788899999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=305.31 Aligned_cols=231 Identities=17% Similarity=0.124 Sum_probs=167.5
Q ss_pred hcCCCCCc-eecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHH-HhcCCCceeeeeeEEEe----CCEEEEE
Q 045271 50 TRNFSNEN-KLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLI-AKLQHKNLVRLLGCCLE----GNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~-~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l-~~l~hpnIv~~~~~~~~----~~~~~lv 122 (338)
.++|+++. .||+|+||.||+|++ .+++.||||++... ....+|+.++ +..+|||||+++++|.+ .+.+|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 56899876 599999999999995 56889999998643 4456677665 55689999999999976 4678999
Q ss_pred EecCCCCCHHHHHhccC---ccccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCC
Q 045271 123 CEYMPNKSLDFLLFDST---RSVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGN 178 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~ 178 (338)
||||++|+|.+++.... .+.........+++.||.+.|+ +.+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 99999999999997643 2333445666678888877553 34899999999876432
Q ss_pred CCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||............. .........
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~~~------ 235 (335)
T d2ozaa1 168 ---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQYE------ 235 (335)
T ss_dssp ---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS------
T ss_pred ---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCCCC------
Confidence 22345689999999999999999999999999999999999999997543222111000 000000000
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
............+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000111235678899999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-41 Score=301.61 Aligned_cols=223 Identities=20% Similarity=0.249 Sum_probs=171.1
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
.++|++++.||+|+||.||+|++ .+++.||||++.+. ..+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35799999999999999999996 45889999998532 224567788899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCccc-cccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTRSV-QLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||||.+|+|..++....... ........+++.++.+.|+ +.+||+|||+|+.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 99999999988887655432 2233455577777777554 5699999999988632 2
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|||||++.+..|+.++||||+||++|+|++|..||......+....+. . .... +...+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~-~~~~--~p~~~---- 224 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------N-AELR--FPPFF---- 224 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------H-CCCC--CCTTS----
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH------c-CCCC--CCCCC----
Confidence 234689999999999999999999999999999999999999997543222111111 0 1100 11111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
...+.+++.+||+.||.+|+ |++++++
T Consensus 225 ----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 ----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12356788889999999996 9999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=301.10 Aligned_cols=247 Identities=23% Similarity=0.246 Sum_probs=172.0
Q ss_pred hcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHH--HhcCCCceeeeeeEEEeCC----EEEEEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLI--AKLQHKNLVRLLGCCLEGN----ELLLIC 123 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l--~~l~hpnIv~~~~~~~~~~----~~~lv~ 123 (338)
.++|.+.+.||+|+||.||+|++ ++..||||++..........+.+++ +.++|||||++++++.+.+ .+|+||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 35788899999999999999997 6789999999765544444444433 5679999999999998643 689999
Q ss_pred ecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC--------------------------CCeEEeeeccceecCC
Q 045271 124 EYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK--------------------------MNPKISDFGMARVFGG 177 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~--------------------------~~vkL~Dfg~a~~~~~ 177 (338)
|||++|+|..+++.........+....+++.|+.+.|. +.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999999987665555555666777777776543 4599999999987743
Q ss_pred CCCC--ccccccccCCccccccccccCC------CCcccchHhHhHHHHHHHhCCCCCcccccccccc--------hhhH
Q 045271 178 NQSE--ANTNRVVGTYGYMAPEYALEGL------FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS--------LLTY 241 (338)
Q Consensus 178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~--------~~~~ 241 (338)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.......... ....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 3221 1233468999999999987642 6778999999999999999988775432221110 0000
Q ss_pred HHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 242 TWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.............+.. ..........+.++|.+||+.||++|||+.||++.|+...
T Consensus 241 ~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 241 MRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111111100111 1111223345678999999999999999999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=297.75 Aligned_cols=242 Identities=19% Similarity=0.193 Sum_probs=165.6
Q ss_pred CCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 55 NENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 55 ~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
.+++||+|+||+||+|+. .+++.||||++..... ..+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999995 5688999999854321 2466788999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|.++++..+...... ..........+++.+|.+.| ++.+||+|||+|+..... ......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence 988877766654332 33334455667888877754 356999999999865322 222334
Q ss_pred cccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccc----cCccc--
Q 045271 187 VVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQEL----MDPVL-- 259 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-- 259 (338)
.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||......+....+............... .....
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 6899999999998765 5899999999999999999999999754332221111110000000000000 00000
Q ss_pred cccccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 260 KESFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 260 ~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
....... ....+.+|+.+||++||++||||.|+|+ +|++
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0000111 1135678999999999999999999996 4543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-41 Score=299.72 Aligned_cols=233 Identities=24% Similarity=0.385 Sum_probs=166.7
Q ss_pred cCCCCCceecccCCeeEEEEEEcC-Cc----EEEEEEeccCC----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND-DK----EIAVKRLSRSS----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLL 121 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~-~~----~vavK~~~~~~----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~l 121 (338)
.+|+++++||+|+||.||+|.+.. ++ .||+|.+.... .+.+.+|+.+++.++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 369999999999999999999543 43 58899886432 23467788899999999999999999865 4677
Q ss_pred EEecCCCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCC
Q 045271 122 ICEYMPNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 122 v~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
++||+.+|+|.+.+........ .......+++.||.++|+ +.+||+|||+|+.+......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 8889889999887776544332 234456678888887653 45899999999876543333
Q ss_pred ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcccc
Q 045271 182 ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLK 260 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (338)
.......||+.|+|||++.++.|+.++|||||||++|||+| |..||......+.......+ ... . ...
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~------~~~-~-~p~--- 236 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ERL-P-QPP--- 236 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT------CCC-C-CCT---
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------CCC-C-CCc---
Confidence 33344578999999999999999999999999999999998 78888654433322111111 000 0 000
Q ss_pred ccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 045271 261 ESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDT 300 (338)
Q Consensus 261 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~ 300 (338)
.....+.+|+.+||+.||.+|||+.||++.|....
T Consensus 237 -----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 237 -----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 01124567888999999999999999999887653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=302.56 Aligned_cols=225 Identities=22% Similarity=0.261 Sum_probs=167.8
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHH-HHhcCCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEFKNL-IAKLQHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~-l~~l~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++++.||+|+||+||+|.+. +++.||||++.+.. ......+..+ .+.++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 58999999999999999999964 58889999996421 1223333344 4578999999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCcc
Q 045271 123 CEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEAN 183 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~ 183 (338)
||||++|+|..++..... ..........+++.||.|.| .+++||+|||+|+..... ...
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--ccc
Confidence 999999999999876543 33344556667888877754 356999999999865322 222
Q ss_pred ccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccccccc
Q 045271 184 TNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESF 263 (338)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+....+.. .... +...+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-----~~~~----~p~~~---- 226 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPF----YPRWL---- 226 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----CCCC----CCTTS----
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc-----CCCC----CCccC----
Confidence 3446899999999999999999999999999999999999999975433222111110 0000 11111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 045271 264 ILEELLKRIHIGLLCVQEDPADRPTMS-SVVF 294 (338)
Q Consensus 264 ~~~~~~~~~~li~~cl~~dP~~Rps~~-~vl~ 294 (338)
...+.+|+.+||+.||++|||+. ++++
T Consensus 227 ----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 ----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12356788899999999999996 7764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-41 Score=305.66 Aligned_cols=227 Identities=23% Similarity=0.225 Sum_probs=166.1
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCC------cccHHHH---HHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSS------GQGLQEF---KNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~---~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++++.||+|+||.||+|+.. +++.||||++.+.. .....++ ..+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 358999999999999999999964 58899999985321 1122233 4456677899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 120 LLICEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
|+|||||++|+|..++...... .........+++.||.+.| ++.+||+|||+|+.+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-- 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC--
Confidence 9999999999999998765432 2344555567787777754 356999999999876422
Q ss_pred CccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 181 EANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||......+...... .. ...... ....+
T Consensus 161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~--~~~~~~-~~~~~ 232 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MT--LTMAVE-LPDSF 232 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HS--SSCCCC-CCSSS
T ss_pred --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc--ccCCCC-CCCCC
Confidence 2334689999999999975 468999999999999999999999997543322211111 00 000000 11111
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPT-----MSSVVF 294 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~vl~ 294 (338)
...+.+||.+||+.||++||| |+|+++
T Consensus 233 --------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 233 --------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 123567888999999999999 789885
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=297.90 Aligned_cols=233 Identities=25% Similarity=0.277 Sum_probs=161.0
Q ss_pred cCCCCCceecccCCeeEEEEEEc-C-C--cEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-D-D--KEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~-~--~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~ 120 (338)
++|++++.||+|+||.||+|++. . + ..||||++..... +.+.+|+.+++.++||||+++++++.+ +.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999843 2 2 2589998864321 345677889999999999999999975 4678
Q ss_pred EEEecCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC
Q 045271 121 LICEYMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 121 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~ 180 (338)
+|||||++|++.+.+..... ..........+++.|+.|.|. +.+||+|||+++.+.....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999887765433 223334556678888887654 3489999999998744332
Q ss_pred Cc-cccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchhhHHHhhhccCCcccccCcc
Q 045271 181 EA-NTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPV 258 (338)
Q Consensus 181 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (338)
.. ......|+..|+|||++.+..++.++|||||||++|||++ |..||......+... ............ .
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~------~i~~~~~~~~~~-~- 238 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGERLPRP-E- 238 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCCCCCCC-T-
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH------HHHhCCCCCCCc-c-
Confidence 22 2233467889999999999999999999999999999998 899987543322211 111111100100 0
Q ss_pred ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 259 LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 259 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
.. ...+.+|+.+||+.||++||||.+|++.|+++
T Consensus 239 ----~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 ----DC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 12356788899999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=296.75 Aligned_cols=232 Identities=25% Similarity=0.289 Sum_probs=167.1
Q ss_pred cCCCCCceecccCCeeEEEEEEcC-Cc--EEEEEEeccCC----cccHHHHHHHHHhc-CCCceeeeeeEEEeCCEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLND-DK--EIAVKRLSRSS----GQGLQEFKNLIAKL-QHKNLVRLLGCCLEGNELLLI 122 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~----~~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 122 (338)
++|++.+.||+|+||.||+|.+.. +. .||||.+.... .+.+.+|+.+++.+ +|||||++++++.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 589999999999999999999544 43 47788875432 23567888899988 799999999999999999999
Q ss_pred EecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC------------------CCeEEe
Q 045271 123 CEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK------------------MNPKIS 167 (338)
Q Consensus 123 ~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~ 167 (338)
||||++|+|.+++..... ..........+++.|+.+.|+ +.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 999999999999865421 112234456677888777554 348999
Q ss_pred eeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCC-CCcccccccccchhhHHHhhh
Q 045271 168 DFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRK-DTRFYLYEQGQSLLTYTWKLW 246 (338)
Q Consensus 168 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~-Pf~~~~~~~~~~~~~~~~~~~ 246 (338)
|||+|+.... ........||..|+|||.+.+..|+.++|||||||++|||++|.. ||......+......
T Consensus 170 DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~------ 240 (309)
T d1fvra_ 170 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240 (309)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG------
T ss_pred cccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH------
Confidence 9999986532 112234578999999999999999999999999999999999764 564433222111111
Q ss_pred ccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 247 CEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
. ........ . ....+.+||.+||+.||++|||+.+|++.|+....
T Consensus 241 ~-~~~~~~~~---~------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 Q-GYRLEKPL---N------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp G-TCCCCCCT---T------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h-cCCCCCCc---c------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 00000000 0 11245678889999999999999999998887553
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-41 Score=297.63 Aligned_cols=235 Identities=27% Similarity=0.320 Sum_probs=167.5
Q ss_pred HhcCCCCCceecccCCeeEEEEEEcC-C-------cEEEEEEeccCCcc----cHHHHHHHHHhc-CCCceeeeeeEEEe
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLND-D-------KEIAVKRLSRSSGQ----GLQEFKNLIAKL-QHKNLVRLLGCCLE 115 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~----~~~~~~~~l~~l-~hpnIv~~~~~~~~ 115 (338)
..++|++++.||+|+||.||+|+... + ..||||+++..... ....|...+..+ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 35699999999999999999999432 2 36899998655432 233444556555 89999999999999
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcC------------------
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDH------------------ 160 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~------------------ 160 (338)
++.+++|||||.+|+|.+++..... ..........+++.||.|.|
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 9999999999999999999975532 22233455667777777755
Q ss_pred CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHh-CCCCCcccccccccchh
Q 045271 161 KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIIS-GRKDTRFYLYEQGQSLL 239 (338)
Q Consensus 161 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~-g~~Pf~~~~~~~~~~~~ 239 (338)
++.+||+|||+++...............|++.|+|||++.++.|+.++|||||||++|||++ |.+||......+.....
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i 250 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 34589999999987754443334445678999999999999999999999999999999998 68787654432211111
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
..+...... .. ....+.+||.+||+.||++||||.||++.|+..
T Consensus 251 -------~~~~~~~~p-~~--------~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 251 -------KEGHRMDKP-SN--------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -------HTTCCCCCC-SS--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HcCCCCCCC-cc--------chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111111111 10 012356788899999999999999999999765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-40 Score=300.10 Aligned_cols=222 Identities=20% Similarity=0.166 Sum_probs=170.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC------CcccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS------SGQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLIC 123 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 123 (338)
++|++++.||+|+||.||+|++ .+++.||||++.+. ..+.+.+|+.+|+.++|||||++++++.+.+.+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999996 46889999998532 2234667888999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhccC-ccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 124 EYMPNKSLDFLLFDST-RSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 124 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||+.+|+|..++.... ...........+++.+|.++| ++.+||+|||+|+.+.. ..
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-----~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----CB
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----cc
Confidence 9999999988886543 333344456667777777654 45699999999998632 22
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
...+||+.|||||++.+..|+.++|||||||++|+|++|..||...........+ .. .... +...
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~-~~~~--~p~~------ 260 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------VS-GKVR--FPSH------ 260 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CCCC--CCTT------
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------hc-CCCC--CCcc------
Confidence 3468999999999999999999999999999999999999999754322111111 10 0000 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 045271 265 LEELLKRIHIGLLCVQEDPADRP-----TMSSVVF 294 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~ 294 (338)
....+.+|+.+||+.||.+|+ |+.++++
T Consensus 261 --~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112356788889999999995 9999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-41 Score=299.45 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=171.3
Q ss_pred HhcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCc----ccHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSG----QGLQEFKNLIAKL-QHKNLVRLLGCCLEGN 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~~l~~l-~hpnIv~~~~~~~~~~ 117 (338)
..++|++.+.||+|+||.||+|.+. +++.||||+++.... ..+.+|..+++.+ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3468999999999999999999852 345799999975433 2345666778877 6999999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-------------------cccccHHHHHHHHHHhhhcC------------------
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-------------------SVQLDWNRRMCIINGIARDH------------------ 160 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~~~i~~~~------------------ 160 (338)
.+++|||||++|+|..++..... ..........+++.|+.++|
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 99999999999999999865432 11223345566777777654
Q ss_pred CCCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCC-Ccccccccccchh
Q 045271 161 KMNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKD-TRFYLYEQGQSLL 239 (338)
Q Consensus 161 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~P-f~~~~~~~~~~~~ 239 (338)
++.+|++|||+++..............+||+.|+|||++.+..++.++|||||||++|||+++..| |..........
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~-- 258 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH--
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence 345899999999877544333334456899999999999999999999999999999999995444 43322211111
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
..... + ....... .....+.+||.+||+.||++||||.+|++.|+..
T Consensus 259 ~~i~~----~-~~~~~~~--------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 KMIKE----G-FRMLSPE--------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHH----T-CCCCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc----C-CCCCCcc--------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11100 0 0000100 0112456788899999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-41 Score=296.85 Aligned_cols=237 Identities=24% Similarity=0.305 Sum_probs=160.3
Q ss_pred HHhcCCCCCceecccCCeeEEEEEEcC------CcEEEEEEeccCCcc----cHHHHHHHHHh-cCCCceeeeeeEEEeC
Q 045271 48 EATRNFSNENKLGEGGFGPVYKGVLND------DKEIAVKRLSRSSGQ----GLQEFKNLIAK-LQHKNLVRLLGCCLEG 116 (338)
Q Consensus 48 ~~~~~y~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~----~~~~~~~~l~~-l~hpnIv~~~~~~~~~ 116 (338)
...++|+++++||+|+||.||+|.+.. ++.||||+++..... ....+..++.. .+|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999532 357999998654332 22333344444 4789999999988754
Q ss_pred -CEEEEEEecCCCCCHHHHHhccCc-----------------cccccHHHHHHHHHHhhhcCC-----------------
Q 045271 117 -NELLLICEYMPNKSLDFLLFDSTR-----------------SVQLDWNRRMCIINGIARDHK----------------- 161 (338)
Q Consensus 117 -~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~----------------- 161 (338)
+.+++|||||++|+|.+++..... ..........+++.||.|.|+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 568999999999999999875432 112234455677888877553
Q ss_pred -CCeEEeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCC-CCCcccccccccchh
Q 045271 162 -MNPKISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR-KDTRFYLYEQGQSLL 239 (338)
Q Consensus 162 -~~vkL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~-~Pf~~~~~~~~~~~~ 239 (338)
+.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||........ ..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence 459999999998765444434444568999999999999999999999999999999999875 56654322211 11
Q ss_pred hHHHhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 045271 240 TYTWKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATD 299 (338)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~ 299 (338)
..... +......+. ....+.+||.+||+.||++|||+.||+++|+..
T Consensus 248 ~~~~~----~~~~~~~~~---------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 248 RRLKE----GTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHH----TCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc----CCCCCCCcc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 111111110 112456788899999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-40 Score=292.13 Aligned_cols=236 Identities=19% Similarity=0.214 Sum_probs=165.6
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG------QGLQEFKNLIAKLQHKNLVRLLGCCLEGN---- 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~l~~l~hpnIv~~~~~~~~~~---- 117 (338)
+.++|++++.||+|+||.||+|.+ .+++.||||++..... ..+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 356899999999999999999995 5688999999965432 23567788999999999999999998643
Q ss_pred EEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~ 178 (338)
.+|+|||||++++|..++..... ..........+++.+|.+.|+ +.++|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 48999999999999988765433 333445566678888777554 45899999998765322
Q ss_pred CC-CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccC-CcccccC
Q 045271 179 QS-EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEG-NAQELMD 256 (338)
Q Consensus 179 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (338)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+.. ....... .......
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIPPSARH 238 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCCGGGTS
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCCCCchhc
Confidence 21 22234468999999999999999999999999999999999999999753322111 1111111 0000011
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRP-TMSSVVFMLAT 298 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~vl~~L~~ 298 (338)
..+ ...+.+|+.+||+.||++|| |+++++..|..
T Consensus 239 ~~~--------s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 239 EGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSC--------CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCC--------CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 100 12356688889999999999 89999887764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=296.59 Aligned_cols=236 Identities=25% Similarity=0.353 Sum_probs=173.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc------CCcEEEEEEeccCCcc----cHHHHHHHHHhcCCCceeeeeeEEEeCCEE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN------DDKEIAVKRLSRSSGQ----GLQEFKNLIAKLQHKNLVRLLGCCLEGNEL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~ 119 (338)
.++|++++.||+|+||.||+|.+. ++..||||+++..... .+.+|+.+++.++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 358899999999999999999853 2457999999754332 356778899999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhccCc-----------cccccHHHHHHHHHHhhhcC------------------CCCeEEeeec
Q 045271 120 LLICEYMPNKSLDFLLFDSTR-----------SVQLDWNRRMCIINGIARDH------------------KMNPKISDFG 170 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg 170 (338)
++|||||++|+|..++..... ..........+++.|+.++| ++++||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecc
Confidence 999999999999998864321 11122345556777777644 4569999999
Q ss_pred cceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCC-CCCcccccccccchhhHHHhhhccC
Q 045271 171 MARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGR-KDTRFYLYEQGQSLLTYTWKLWCEG 249 (338)
Q Consensus 171 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~ 249 (338)
+|+.+.............||+.|+|||.+.+..++.++|||||||++|||++|. +||......+...... ..
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-------~~ 251 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------EG 251 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------TT
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hC
Confidence 998764333333334457899999999999999999999999999999999985 6665433222211111 11
Q ss_pred CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 250 NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
......+. ....+.++|.+||+.||++|||+.+|+++|+....
T Consensus 252 ~~~~~p~~---------~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCccc---------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111110 01246678889999999999999999999988644
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=289.28 Aligned_cols=222 Identities=21% Similarity=0.327 Sum_probs=166.5
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC---------cccHHHHHHHHHhcC--CCceeeeeeEEEeCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS---------GQGLQEFKNLIAKLQ--HKNLVRLLGCCLEGN 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~~l~~l~--hpnIv~~~~~~~~~~ 117 (338)
.++|++.+.||+|+||.||+|+. .++..||||++.... ...+..|+.+++.++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999995 468899999986432 123557888998887 899999999999999
Q ss_pred EEEEEEecCCC-CCHHHHHhccC-ccccccHHHHHHHHHHhhhcCC-------------------CCeEEeeeccceecC
Q 045271 118 ELLLICEYMPN-KSLDFLLFDST-RSVQLDWNRRMCIINGIARDHK-------------------MNPKISDFGMARVFG 176 (338)
Q Consensus 118 ~~~lv~e~~~~-g~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~~~~-------------------~~vkL~Dfg~a~~~~ 176 (338)
.+++||||+.+ +++..++.... ...........+++.+|.+.|+ +.+||+|||+|....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999965 57777765443 3334445566778888777443 458999999998753
Q ss_pred CCCCCccccccccCCccccccccccCCC-CcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCccccc
Q 045271 177 GNQSEANTNRVVGTYGYMAPEYALEGLF-SVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELM 255 (338)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (338)
. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||..... .... .. .+
T Consensus 163 ~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~-----~~----~~ 223 (273)
T d1xwsa_ 163 D----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-----QV----FF 223 (273)
T ss_dssp S----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-----CC----CC
T ss_pred c----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc-----cc----CC
Confidence 2 22345689999999999987765 6779999999999999999999964210 0000 00 01
Q ss_pred CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 256 DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...+ ...+.+|+.+||+.||++|||+.|+++ +++.
T Consensus 224 ~~~~--------s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 224 RQRV--------SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp SSCC--------CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CCCC--------CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1111 123567888999999999999999986 4543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=289.51 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=168.3
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|++++.||+|+||.||+|.+ .+++.||||+++... .+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999995 568899999985432 2346678899999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCc--cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccc
Q 045271 125 YMPNKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANT 184 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~ 184 (338)
||.++.+......... ..........+++.||.+.| ++.+||+|||+|+..... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC--cccc
Confidence 9965545444333322 33344556667777777754 346899999999876322 2233
Q ss_pred cccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc---------cCCcccc
Q 045271 185 NRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC---------EGNAQEL 254 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 254 (338)
....||+.|+|||++.... ++.++||||+||++|+|++|+.||......+............. .......
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 3468999999999988776 57899999999999999999999975432111111000000000 0000000
Q ss_pred cCcccccc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 255 MDPVLKES---FILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 255 ~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
........ ........+.+|+.+||+.||++|||+.|+++ +|++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 00000000 00011134678899999999999999999997 4554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=287.99 Aligned_cols=232 Identities=25% Similarity=0.346 Sum_probs=166.9
Q ss_pred CceecccCCeeEEEEEEcCC----cEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEe-CCEEEEEEecC
Q 045271 56 ENKLGEGGFGPVYKGVLNDD----KEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLE-GNELLLICEYM 126 (338)
Q Consensus 56 ~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~ 126 (338)
.++||+|+||+||+|.+..+ ..||||.++.... +.+.+|+++++.++||||+++++++.+ ++.+++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996442 2489999864322 346778889999999999999999875 56899999999
Q ss_pred CCCCHHHHHhccCccccc--cHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCC--ccc
Q 045271 127 PNKSLDFLLFDSTRSVQL--DWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSE--ANT 184 (338)
Q Consensus 127 ~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~--~~~ 184 (338)
++|+|.+++......... ......+++.||.+.| ++.+||+|||+++........ ...
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999999988765543322 3345566777777754 356999999999876432221 122
Q ss_pred cccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCcccccccc
Q 045271 185 NRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVLKESFI 264 (338)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (338)
....||..|+|||++.+..++.++|||||||++|||++|..||........ ....... +.... ... .
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i~~----g~~~~-~p~-----~- 258 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ----GRRLL-QPE-----Y- 258 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TCCCC-CCT-----T-
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc----CCCCC-Ccc-----c-
Confidence 235689999999999999999999999999999999998888764332211 1111100 00000 000 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCccc
Q 045271 265 LEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTIT 302 (338)
Q Consensus 265 ~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~~ 302 (338)
....+.+||.+||+.||++|||+.||++.|+.....
T Consensus 259 --~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 259 --CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112456788899999999999999999999887654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-39 Score=285.03 Aligned_cols=242 Identities=23% Similarity=0.278 Sum_probs=166.3
Q ss_pred cCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEec
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICEY 125 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 125 (338)
++|+++++||+|+||+||+|++.+++.||||++.... .+.+.+|+.+++.++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999996543 23466788899999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
+.++.+..+...... .......+..+++.+|.+.| ++.+||+|||.|....... .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 159 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTH 159 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--cccce
Confidence 977777766654432 33344555666777777644 4569999999998763221 22233
Q ss_pred cccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC---cccc------c-
Q 045271 187 VVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN---AQEL------M- 255 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~------~- 255 (338)
..|++.|+|||++.+. .++.++||||+||++|||++|+.||......+................ .... .
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 5789999999999865 578999999999999999999999975432111111000000000000 0000 0
Q ss_pred --CccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 256 --DPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 256 --~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
...............+.+|+.+||++||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000011234668899999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-39 Score=285.08 Aligned_cols=246 Identities=20% Similarity=0.292 Sum_probs=164.7
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cC-CcEEEEEEeccCC-----cccHHHHHHHHHhc---CCCceeeeeeEEEe----
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-ND-DKEIAVKRLSRSS-----GQGLQEFKNLIAKL---QHKNLVRLLGCCLE---- 115 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~-~~~vavK~~~~~~-----~~~~~~~~~~l~~l---~hpnIv~~~~~~~~---- 115 (338)
.++|+++++||+|+||+||+|++ .+ ++.||||++.... .....+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 4568999985322 23355666666554 89999999999863
Q ss_pred -CCEEEEEEecCCCCCHHHHHhccCccc--cccHHHHHHHHHHhhhcC------------------CCCeEEeeecccee
Q 045271 116 -GNELLLICEYMPNKSLDFLLFDSTRSV--QLDWNRRMCIINGIARDH------------------KMNPKISDFGMARV 174 (338)
Q Consensus 116 -~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~ 174 (338)
...++++||||.++.+........... ........+++.+|.++| .+.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 346899999998877765554433322 233445667777777654 35689999999876
Q ss_pred cCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHh-----hhccC
Q 045271 175 FGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWK-----LWCEG 249 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-----~~~~~ 249 (338)
.. ........+||+.|+|||++.+..|+.++||||+||++|||++|.+||......+....+..... .+...
T Consensus 166 ~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 42 22334457899999999999999999999999999999999999999975432221111110000 00000
Q ss_pred -C-cccccCccccc---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 250 -N-AQELMDPVLKE---SFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 250 -~-~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
. ........... .........+.+|+.+||++||++||||.|+++ +|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0 00000000000 000001124567888999999999999999986 4554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-38 Score=277.75 Aligned_cols=241 Identities=18% Similarity=0.146 Sum_probs=168.4
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHhcCCCce-eeeeeEEEeCCEEEEEEecCC
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRS-SGQGLQEFKNLIAKLQHKNL-VRLLGCCLEGNELLLICEYMP 127 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~ 127 (338)
++|++++.||+|+||.||+|.+ .+++.||||.+... ....+..|.++++.++|+|+ +.+.+++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 5799999999999999999995 45789999987643 34567788899999987764 55566667888999999999
Q ss_pred CCCHHHHHhccCc--cccccHHHHHHHHHHhhhcCC---------------------CCeEEeeeccceecCCCCCC---
Q 045271 128 NKSLDFLLFDSTR--SVQLDWNRRMCIINGIARDHK---------------------MNPKISDFGMARVFGGNQSE--- 181 (338)
Q Consensus 128 ~g~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~~~~---------------------~~vkL~Dfg~a~~~~~~~~~--- 181 (338)
++++...+..... ..........+++.+|.+.|+ ..+||+|||+|+.+......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence 5666555544332 333344555667777776443 34899999999987433221
Q ss_pred --ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccCccc
Q 045271 182 --ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMDPVL 259 (338)
Q Consensus 182 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
.......||+.|+|||++.+..++.++|||||||++|||++|..||..............................
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG-- 243 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT--
T ss_pred eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC--
Confidence 1223468999999999999999999999999999999999999999765443333222211111111111111110
Q ss_pred cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 260 KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 260 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
....+.+||..||+.||++||++.++.+.|+..+.
T Consensus 244 -------~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 244 -------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -------SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 01235678888999999999999999888876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-38 Score=284.66 Aligned_cols=240 Identities=15% Similarity=0.188 Sum_probs=169.8
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHhcC-CCceeeeeeEEEe--CCEEEEEEec
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSGQGLQEFKNLIAKLQ-HKNLVRLLGCCLE--GNELLLICEY 125 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~ 125 (338)
.++|+++++||+|+||+||+|+. .+++.||||+++....+.+.+|+.+|+.++ ||||++++++|.. ...+++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 35899999999999999999996 568889999998777777888999999985 9999999999985 3569999999
Q ss_pred CCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCCccccc
Q 045271 126 MPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSEANTNR 186 (338)
Q Consensus 126 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~~~~~~ 186 (338)
|.+++|..+.+ ............+++.||.++|+. .+||+|||+|...... .....
T Consensus 114 ~~~~~L~~~~~--~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~---~~~~~ 188 (328)
T d3bqca1 114 VNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNV 188 (328)
T ss_dssp CCSCBGGGTTT--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT---CCCCS
T ss_pred cCCCcHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC---Ccccc
Confidence 99999977643 233334455666788887775532 3899999999876432 22344
Q ss_pred cccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccc-hhh--------HHHhhhccCCc----c
Q 045271 187 VVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQS-LLT--------YTWKLWCEGNA----Q 252 (338)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~-~~~--------~~~~~~~~~~~----~ 252 (338)
.++|+.|+|||++.+. .++.++||||+||++|+|++|..||.......... ... ..+........ .
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 6799999999998876 48999999999999999999999987532211100 000 00000000000 0
Q ss_pred cc--------cCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 253 EL--------MDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 253 ~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. ................+.+||.+||++||++|||++|+|+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000000011111224678899999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=286.49 Aligned_cols=245 Identities=18% Similarity=0.184 Sum_probs=166.6
Q ss_pred CCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHhcCCCceeeeeeEEEeC------CEEEEEEe
Q 045271 52 NFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSGQGLQEFKNLIAKLQHKNLVRLLGCCLEG------NELLLICE 124 (338)
Q Consensus 52 ~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~l~~l~hpnIv~~~~~~~~~------~~~~lv~e 124 (338)
+|+.+++||+|+||+||+|++. +++.||||++..... ...+|+.+|+.++||||++++++|... .++|+|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 6899999999999999999964 588999999976543 345688899999999999999998642 35899999
Q ss_pred cCCCCCHHHHHhc---c-CccccccHHHHHHHHHHhhhcCCC-------------------CeEEeeeccceecCCCCCC
Q 045271 125 YMPNKSLDFLLFD---S-TRSVQLDWNRRMCIINGIARDHKM-------------------NPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 125 ~~~~g~L~~~l~~---~-~~~~~~~~~~~~~~~~~i~~~~~~-------------------~vkL~Dfg~a~~~~~~~~~ 181 (338)
||+++.+..+... . ............+++.||.++|+. .+||+|||++..+...
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--- 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--- 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT---
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC---
Confidence 9976654443321 1 122233445666788888886643 4899999999876432
Q ss_pred ccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhH--------HHhhhccC---
Q 045271 182 ANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTY--------TWKLWCEG--- 249 (338)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~--- 249 (338)
......+||..|+|||++.+. .|+.++||||+||++|||++|.+||......+....+.. .+......
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 223346899999999998865 689999999999999999999999975432221111100 00000000
Q ss_pred -CcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCc
Q 045271 250 -NAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATDT 300 (338)
Q Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~~ 300 (338)
.....................+.+|+.+||++||++||||.|+++ +|++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000000000000000111224677888999999999999999996 565543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=281.79 Aligned_cols=246 Identities=17% Similarity=0.214 Sum_probs=164.2
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHhcCCCceeeeeeEEEe--------
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSS-----GQGLQEFKNLIAKLQHKNLVRLLGCCLE-------- 115 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~l~~l~hpnIv~~~~~~~~-------- 115 (338)
.++|+++++||+|+||+||+|++ .+++.||||++.... .....+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999996 568899999985432 2346678899999999999999999864
Q ss_pred CCEEEEEEecCCCCCHHHHHhccCc-cccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecC
Q 045271 116 GNELLLICEYMPNKSLDFLLFDSTR-SVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFG 176 (338)
Q Consensus 116 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~ 176 (338)
.+.+|+|||||.++.+......... .......+..+++.+|.+.| ++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 3468999999977766555433222 22233455566777777755 3458999999998764
Q ss_pred CCCC--CccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC---
Q 045271 177 GNQS--EANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN--- 250 (338)
Q Consensus 177 ~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 250 (338)
.... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.......................
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 3222 1223345799999999999866 689999999999999999999999975332222111111110000000
Q ss_pred -----cccccCccccccccHHH-------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 045271 251 -----AQELMDPVLKESFILEE-------LLKRIHIGLLCVQEDPADRPTMSSVVFM 295 (338)
Q Consensus 251 -----~~~~~~~~~~~~~~~~~-------~~~~~~li~~cl~~dP~~Rps~~~vl~~ 295 (338)
................. ...+++||.+||++||++||||.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000001111111111 1245689999999999999999999963
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.1e-37 Score=271.18 Aligned_cols=242 Identities=15% Similarity=0.147 Sum_probs=175.3
Q ss_pred hcCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHhcCC-CceeeeeeEEEeCCEEEEEEecC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRS-SGQGLQEFKNLIAKLQH-KNLVRLLGCCLEGNELLLICEYM 126 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~ 126 (338)
.++|++++.||+|+||.||+|++. +++.||||++... ....+.+|.++++.+.| +||+.+++++..+...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 368999999999999999999954 5788999988543 34567788888988876 89999999999999999999999
Q ss_pred CCCCHHHHHhccCcccc--ccHHHHHHHHHHhhhcCC-----------------------CCeEEeeeccceecCCCCCC
Q 045271 127 PNKSLDFLLFDSTRSVQ--LDWNRRMCIINGIARDHK-----------------------MNPKISDFGMARVFGGNQSE 181 (338)
Q Consensus 127 ~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~~~~-----------------------~~vkL~Dfg~a~~~~~~~~~ 181 (338)
+++|.+++........ .......+++.+|.+.|+ +.+||+|||+|+.+......
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 7899888866543322 233455566677666443 34899999999876432211
Q ss_pred -----ccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 182 -----ANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 182 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
......+||+.|||||++.+..++.++|||||||++|||++|..||.........................++..
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTT
T ss_pred cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcC
Confidence 122346899999999999999999999999999999999999999975443332222111111101111111111
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVFMLATDTI 301 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~~L~~~~~ 301 (338)
. . ...+.+|+..||+.+|++||++..+.+.|++...
T Consensus 243 ~-----~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 243 G-----F----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp T-----S----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred C-----C----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1 0 1235567788999999999999999888877553
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=278.10 Aligned_cols=235 Identities=20% Similarity=0.206 Sum_probs=170.6
Q ss_pred hcCCCCCceecccCCeeEEEEEEc----CCcEEEEEEeccC-------CcccHHHHHHHHHhcCC-CceeeeeeEEEeCC
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVLN----DDKEIAVKRLSRS-------SGQGLQEFKNLIAKLQH-KNLVRLLGCCLEGN 117 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~-------~~~~~~~~~~~l~~l~h-pnIv~~~~~~~~~~ 117 (338)
.++|++++.||+|+||+||+|... +++.||||.+++. ..+.+.+|+.+++.++| |||+++++++.+.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999852 3678999998542 22456678889999977 89999999999999
Q ss_pred EEEEEEecCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 118 ELLLICEYMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 ~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
.+++||||+.+|+|..++...... .........+++.++.+.| ++.+||+|||+|+.+...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999999988765443 2333444556676666643 456999999999876432
Q ss_pred CCCccccccccCCccccccccccC--CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCCcccccC
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG--LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGNAQELMD 256 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (338)
. ........|++.|+|||.+.+. .++.++|||||||++|+|++|..||......+............... +.
T Consensus 183 ~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-----~~ 256 (322)
T d1vzoa_ 183 E-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-----YP 256 (322)
T ss_dssp G-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-----CC
T ss_pred c-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-----Cc
Confidence 2 2223446899999999999865 46789999999999999999999997654443333222222111110 00
Q ss_pred ccccccccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--Hhhc
Q 045271 257 PVLKESFILEELLKRIHIGLLCVQEDPADRP-----TMSSVVF--MLAT 298 (338)
Q Consensus 257 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~vl~--~L~~ 298 (338)
. .....+.+|+.+||++||++|| |++|+++ +++.
T Consensus 257 ~--------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 257 Q--------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred c--------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 0 1113456788899999999999 5889985 4543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=279.17 Aligned_cols=240 Identities=18% Similarity=0.222 Sum_probs=167.0
Q ss_pred HhcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 045271 49 ATRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN----- 117 (338)
Q Consensus 49 ~~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~----- 117 (338)
+.++|+++++||+|+||.||+|.. .+++.||||++..... +...+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 467999999999999999999995 4588899999975432 23567888999999999999999998654
Q ss_pred -EEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCC
Q 045271 118 -ELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGN 178 (338)
Q Consensus 118 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~ 178 (338)
.+|+||||| +++|..++...............+++.||.++| ++.+||+|||+|.....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 579999999 778888887666665666667777888888755 34689999999987632
Q ss_pred CCCccccccccCCccccccccccC-CCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH---------------
Q 045271 179 QSEANTNRVVGTYGYMAPEYALEG-LFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--------------- 242 (338)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--------------- 242 (338)
......||+.|+|||++.+. .++.++||||+||++|+|++|.+||...............
T Consensus 174 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp ----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred ----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 22346799999999999875 5789999999999999999999999754321111100000
Q ss_pred ----HhhhccCCcccccCccccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 045271 243 ----WKLWCEGNAQELMDPVLKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLATD 299 (338)
Q Consensus 243 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~~ 299 (338)
.................. .....+++|+.+||++||.+||||.|+|+ +|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILT-----NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCT-----TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhccCCcccccchHHhcc-----CCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000000000000 01124567889999999999999999997 46553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=281.61 Aligned_cols=248 Identities=20% Similarity=0.217 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc----ccHHHHHHHHHhcCCCceeeeeeEEEeCC-----EE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG----QGLQEFKNLIAKLQHKNLVRLLGCCLEGN-----EL 119 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~-----~~ 119 (338)
..+|+++++||+|+||+||+|.. .++..||||++..... +...+|+.+|+.++||||+++++++.... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999995 5788999999965433 24567888999999999999999997543 34
Q ss_pred EEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCC-
Q 045271 120 LLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQS- 180 (338)
Q Consensus 120 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~- 180 (338)
+++ +|+.+|+|.+++...............+++++|.+.|+ +.+||+|||+|........
T Consensus 87 ~l~-~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEE-EECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEE-EeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 555 55569999999987666655556677778888877553 4589999999987633221
Q ss_pred CccccccccCCcccccccccc-CCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhccCC--------c
Q 045271 181 EANTNRVVGTYGYMAPEYALE-GLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWCEGN--------A 251 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~ 251 (338)
.......+||+.|+|||++.. ..++.++||||+||++|+|++|..||....................... .
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 122344679999999999865 4688999999999999999999999975432111111100000000000 0
Q ss_pred cc-ccCccccccccHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhc
Q 045271 252 QE-LMDPVLKESFILE-----ELLKRIHIGLLCVQEDPADRPTMSSVVFM--LAT 298 (338)
Q Consensus 252 ~~-~~~~~~~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~vl~~--L~~ 298 (338)
.. ............. ....+++|+.+||+.||.+||||.|+|+. |+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00 0000000000000 01246789999999999999999999974 543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-37 Score=279.50 Aligned_cols=239 Identities=21% Similarity=0.180 Sum_probs=157.3
Q ss_pred cCCCCCceecccCCeeEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEe------CCE
Q 045271 51 RNFSNENKLGEGGFGPVYKGVLN-DDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLE------GNE 118 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~------~~~ 118 (338)
++|+++++||+|+||+||+|.+. ++..||||++..... ..+.+|+.+++.++||||++++++|.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999964 588999999975432 235678889999999999999999963 368
Q ss_pred EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
+|+|||||.++.+..+ .. ............+++.|+.++| ++.+|++|||+++....
T Consensus 97 ~~iv~Ey~~~~l~~~~-~~-~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~--- 171 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-QM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--- 171 (355)
T ss_dssp EEEEEECCSEEHHHHH-TS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eEEEEeccchHHHHhh-hc-CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc---
Confidence 9999999966555443 32 2333344555667777777755 34589999999886532
Q ss_pred CccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHH---------------hh
Q 045271 181 EANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTW---------------KL 245 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~---------------~~ 245 (338)
.......+||+.|+|||++.+..++.++||||+||++|+|++|+.||................ ..
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 223345689999999999999999999999999999999999999996443211111110000 00
Q ss_pred -------hccCCcccccCccccccc---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 246 -------WCEGNAQELMDPVLKESF---ILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 246 -------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.........+........ .......+.+|+.+||+.||++||||+|+|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000111111111111 1222335788999999999999999999995
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-37 Score=270.09 Aligned_cols=246 Identities=17% Similarity=0.199 Sum_probs=169.5
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeCCEEEEEEe
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEGNELLLICE 124 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 124 (338)
++|+++++||+|+||+||+|+. .+++.||||+++.... ..+.+|+.+++.++||||+++++++.+.+.+++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999995 4678899999864432 345678889999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCcc-ccccHHHHHHHHHHhhhcCC------------------CCeEEeeeccceecCCCCCCcccc
Q 045271 125 YMPNKSLDFLLFDSTRS-VQLDWNRRMCIINGIARDHK------------------MNPKISDFGMARVFGGNQSEANTN 185 (338)
Q Consensus 125 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~ 185 (338)
++.++++..++...... .........+++.+|.+.|. +.+||+|||.|........ ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cce
Confidence 99888888877655432 23334555667777777553 4589999999988643222 222
Q ss_pred ccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccc-cchhhHHHhhhccCCc---c--------
Q 045271 186 RVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQG-QSLLTYTWKLWCEGNA---Q-------- 252 (338)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~---~-------- 252 (338)
...++..|+|||++.+.. ++.++||||+||++|||++|..||........ ................ .
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 346788999999998765 68999999999999999999999753221111 1110000000000000 0
Q ss_pred cccCcc-ccccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 253 ELMDPV-LKESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 253 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
...... ............+.+|+.+||++||.+||||.|+|+ +|++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 000000 000000111224567888999999999999999986 4543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=276.24 Aligned_cols=244 Identities=19% Similarity=0.200 Sum_probs=165.9
Q ss_pred hcCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHhcCCCceeeeeeEEEeC-----CE
Q 045271 50 TRNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG-----QGLQEFKNLIAKLQHKNLVRLLGCCLEG-----NE 118 (338)
Q Consensus 50 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~l~~l~hpnIv~~~~~~~~~-----~~ 118 (338)
.++|+++++||+|+||+||+|+. .+++.||||++..... +...+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 5688999999975432 2356788899999999999999998643 23
Q ss_pred EEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcC------------------CCCeEEeeeccceecCCCCC
Q 045271 119 LLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDH------------------KMNPKISDFGMARVFGGNQS 180 (338)
Q Consensus 119 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~vkL~Dfg~a~~~~~~~~ 180 (338)
.+++|+|+.+|+|.+++...............+++.+|.++| ++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~---- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT----
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC----
Confidence 456667777999999997766555555666677888877755 3568999999997642
Q ss_pred CccccccccCCccccccccccCC-CCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHHHhhhc-----cC---Cc
Q 045271 181 EANTNRVVGTYGYMAPEYALEGL-FSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYTWKLWC-----EG---NA 251 (338)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----~~---~~ 251 (338)
.......|++.|+|||++.+.. ++.++||||+||++|+|++|.+||...........+........ .. ..
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 2233467899999999988764 68899999999999999999999975432221111110000000 00 00
Q ss_pred ccccCccccc-cccH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 045271 252 QELMDPVLKE-SFIL-----EELLKRIHIGLLCVQEDPADRPTMSSVVF--MLAT 298 (338)
Q Consensus 252 ~~~~~~~~~~-~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~~vl~--~L~~ 298 (338)
.......... .... .....+.+||.+||+.||.+||||.|+|+ +++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0000000000 0000 01124578899999999999999999997 5554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.4e-31 Score=239.15 Aligned_cols=242 Identities=17% Similarity=0.162 Sum_probs=155.2
Q ss_pred cCCCCCceecccCCeeEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHhcC-----------CCceeeeeeEEEe-
Q 045271 51 RNFSNENKLGEGGFGPVYKGVL-NDDKEIAVKRLSRSSG--QGLQEFKNLIAKLQ-----------HKNLVRLLGCCLE- 115 (338)
Q Consensus 51 ~~y~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~l~~l~-----------hpnIv~~~~~~~~- 115 (338)
++|+++++||+|+||+||+|+. .+++.||||++..... +...+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3699999999999999999995 5688999999975432 34456666666554 6889999998864
Q ss_pred -CCEEEEEEecCCCCCHHHH-HhccC-c--cccccHHHHHHHHHHhhhcCC-C------------------------CeE
Q 045271 116 -GNELLLICEYMPNKSLDFL-LFDST-R--SVQLDWNRRMCIINGIARDHK-M------------------------NPK 165 (338)
Q Consensus 116 -~~~~~lv~e~~~~g~L~~~-l~~~~-~--~~~~~~~~~~~~~~~i~~~~~-~------------------------~vk 165 (338)
....+++|+++..+..... ..... . ..........+++.++.+.|+ . .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 4567777777655443222 22111 1 112234455567777766543 1 279
Q ss_pred EeeeccceecCCCCCCccccccccCCccccccccccCCCCcccchHhHhHHHHHHHhCCCCCcccccccccchhhHH---
Q 045271 166 ISDFGMARVFGGNQSEANTNRVVGTYGYMAPEYALEGLFSVKSDVFSFGVLLLEIISGRKDTRFYLYEQGQSLLTYT--- 242 (338)
Q Consensus 166 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWSlGv~l~el~~g~~Pf~~~~~~~~~~~~~~~--- 242 (338)
++|||.+..... .....+||+.|+|||++.+..|+.++||||+||++++|++|..||...............
T Consensus 173 l~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 173 IADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp ECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred Eeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 999999986532 223467999999999999999999999999999999999999998753321111100000
Q ss_pred Hh------------------hhccCCcccccCccc----------cccccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 045271 243 WK------------------LWCEGNAQELMDPVL----------KESFILEELLKRIHIGLLCVQEDPADRPTMSSVVF 294 (338)
Q Consensus 243 ~~------------------~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~vl~ 294 (338)
.. .+........+.... ...........+.+|+.+||++||.+||||+|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000000000000000 00112334456788999999999999999999996
Q ss_pred --Hhh
Q 045271 295 --MLA 297 (338)
Q Consensus 295 --~L~ 297 (338)
+++
T Consensus 328 Hp~f~ 332 (362)
T d1q8ya_ 328 HPWLK 332 (362)
T ss_dssp CGGGT
T ss_pred CcccC
Confidence 455
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.45 E-value=2.2e-14 Score=117.21 Aligned_cols=142 Identities=16% Similarity=0.064 Sum_probs=91.2
Q ss_pred CCCCceecccCCeeEEEEEEcCCcEEEEEEeccCCc---------------------ccHHHHHHHHHhcCCCceeeeee
Q 045271 53 FSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSSG---------------------QGLQEFKNLIAKLQHKNLVRLLG 111 (338)
Q Consensus 53 y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~l~~l~hpnIv~~~~ 111 (338)
|.+.++||+|+||.||+|...+++.||||.++.... .....+...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998742110 01123455677889999998876
Q ss_pred EEEeCCEEEEEEecCCCCCHHHHHhccCccccccHHHHHHHHHHhhhcCC-----------------CCeEEeeecccee
Q 045271 112 CCLEGNELLLICEYMPNKSLDFLLFDSTRSVQLDWNRRMCIINGIARDHK-----------------MNPKISDFGMARV 174 (338)
Q Consensus 112 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-----------------~~vkL~Dfg~a~~ 174 (338)
+. . .+++|||+++..+..+. .........+++.++.+.|. .+++|+|||+|..
T Consensus 82 ~~--~--~~lvme~~~~~~~~~l~------~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~a~~ 151 (191)
T d1zara2 82 WE--G--NAVLMELIDAKELYRVR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVE 151 (191)
T ss_dssp EE--T--TEEEEECCCCEEGGGCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEE
T ss_pred ec--C--CEEEEEeeccccccchh------hHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCCccc
Confidence 53 2 37999999876654321 12223344556666665442 3489999999976
Q ss_pred cCCCCCCccccccccCCcccc------ccccccCCCCcccchHhHhH
Q 045271 175 FGGNQSEANTNRVVGTYGYMA------PEYALEGLFSVKSDVFSFGV 215 (338)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DiWSlGv 215 (338)
..... .. .|.. .+ +....|+.++|+||+.-
T Consensus 152 ~~~~~----~~------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 152 VGEEG----WR------EILERDVRNIIT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp TTSTT----HH------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHH
T ss_pred CCCCC----cH------HHHHHHHHHHHH-HHcCCCCCcccHHHHHH
Confidence 52111 10 1111 11 12456889999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=94.47 E-value=0.21 Score=40.11 Aligned_cols=90 Identities=10% Similarity=0.005 Sum_probs=63.7
Q ss_pred HHHHHhcCCCCCceecccCCeeEEEEEEcCCcEEEEEEeccCC---cccHHHHHHHHHhcC-CCceeeeeeEEEeCCEEE
Q 045271 45 LIHEATRNFSNENKLGEGGFGPVYKGVLNDDKEIAVKRLSRSS---GQGLQEFKNLIAKLQ-HKNLVRLLGCCLEGNELL 120 (338)
Q Consensus 45 ~~~~~~~~y~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~l~~l~-hpnIv~~~~~~~~~~~~~ 120 (338)
+.....+.|++.+..+-++.+.||+... +++.+++|...... ......|...++.+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4556667888777665566678998764 56677888875432 334667777776664 333567778888889999
Q ss_pred EEEecCCCCCHHHHH
Q 045271 121 LICEYMPNKSLDFLL 135 (338)
Q Consensus 121 lv~e~~~~g~L~~~l 135 (338)
+||+++++..+....
T Consensus 87 lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 87 LLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEECCSSEEHHHHT
T ss_pred EEEEecccccccccc
Confidence 999999888886654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.04 E-value=0.19 Score=40.09 Aligned_cols=75 Identities=16% Similarity=0.087 Sum_probs=54.9
Q ss_pred eecccC-CeeEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHhcCCC--ceeeeeeEEEeCCEEEEEEecCCCCCHH
Q 045271 58 KLGEGG-FGPVYKGVLNDDKEIAVKRLSRSSGQGLQEFKNLIAKLQHK--NLVRLLGCCLEGNELLLICEYMPNKSLD 132 (338)
Q Consensus 58 ~iG~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~~g~L~ 132 (338)
.+..|. .+.||+....++..+++|.........+..|...++.+... .+.+++.+..+++..++||+++++..+.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444554 36889998777778899987766666777888777766432 3566777777888899999999876653
|